Navigation auf zora.uzh.ch

Suche

ZORA (Zurich Open Repository and Archive)

View Scopus Subject Areas

Export as
Number of items at this level: 2608.

2025

Chmiel, Edward; Guckenberger, Matthias; Gillespie, Erin F; Siva, Shankar (2025). Sharper Focus, Greater Comfort? Lessons From the ROBOMET Trial. Journal of Clinical Oncology, 43(19):2142-2146.

Weiss, Fabian; Kolibius, Jonas; Freitag, Patrick C; Gantenbein, Felix; Kipar, Anja; Plückthun, Andreas (2025). Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21. Molecular therapy. Oncology, 33(2):200984.

Kapp, Jonas N; Verdurmen, Wouter P R; Schaefer, Jonas V; Kopra, Kari; Nagy-Davidescu, Gabriela; Richard, Elodie; Nokin, Marie-Julie; Ernst, Patrick; Tamaskovic, Rastislav; Schwill, Martin; Degen, Ralph; Scholl, Claudia; Santamaría, David; Plückthun, Andreas (2025). A nucleotide-independent, pan-RAS-targeted DARPin elicits anti-tumor activity in a multimodal manner. Molecular Oncology:Epub ahead of print.

Mayo, Charles S; Appelt, Ane L; Paradis, Kelly C; Dawson, Laura A; Andratschke, Nicolaus; Vasquez Osorio, Eliana M; Bentzen, Søren M; Yorke, Ellen D; Jackson, Andrew; Marks, Lawrence B; Yom, Sue S (2025). Joining Forces to Advance Reirradiation: Establishing the Reirradiation COllaborative Group (ReCOG). International Journal of Radiation Oncology, Biology, Physics, 122(2):234-240.

Guckenberger, Matthias; Opitz, Isabelle; Dellaporta, Tereza; Curioni-Fontecedro, Alessandra; Frauenfelder, Thomas; Ribi, Karin; Cerciello, Ferdinando; Sullivan, Ivana; Hendriks, Lizza; Dorta, Miriam; Callejo, Ana; Aerts, Joachim; Addeo, Alfredo; Dingemans, Anne-Marie C; Pasello, Giulia; Provencio, Mariano; de Marinis, Filippo; Mederos-Alfonso, Nuria; Roschitzki-Voser, Heidi; Ruepp, Barbara; Haberecker, Martina; Kammler, Roswitha; Dafni, Urania; Peters, Solange; Stahel, Rolf; ETOP 14-18 CHESS collaborators (2025). Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Lung Cancer, 204:108553.

Fleischmann, Maximilian; Kristen, Alexander; Winkelmann, Ria; Burck, Iris; Weigert, Andreas; Issing, Christian; Diefenhardt, Markus; Martin, Daniel; Brandts, Christian; Rödel, Franz; Balermpas, Panagiotis; von der Grün, Jens; Thönissen, Philipp; Rödel, Claus; Ghanaati, Shahram (2025). Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial. Oral Oncology, 164:107252.

Nägler, Franziska; Vorbach, Samuel; Mohamed, Ahmed Allam; Thaqi, Saranda; Adebahr, Sonja; Ehret, Felix; Kraft, Johannes; Fabian, Alexander; Weissmann, Thomas; Kaufmann, Justus; Drabke, Sophia; Looman, Esmée Lauren; Waltenberger, Maria; Kraus, Kim Melanie; Grohmann, Maximilian; Dehl, Kaja; Rogers, Susanne; Gawish, Ahmed; Becker, Jan-Niklas; Klement, Rainer J; Partl, Richard; Trommer, Maike; Grosu, Anca-Ligia; Rimner, Andreas; Gkika, Eleni; Riesterer, Oliver; Putz, Florian; Ganswindt, Ute; Moustakis, Christos; Nicolay, Nils H; et al (2025). Pulmonary Stereotactic Body Radiation Therapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma: A Multicenter Retrospective Study. International Journal of Radiation Oncology, Biology, Physics, 122(1):140-149.

Portik, Daniel; Lacombe, Denis; Faivre-Finn, Corinne; Achard, Vérane; Andratschke, Nicolaus; Correia, Dora; Spalek, Mateusz; Guckenberger, Matthias; Ost, Piet; Ehret, Felix (2025). The 2024 State of Science report from the European Organisation for Research and Treatment of Cancer's Radiation Oncology Scientific Council. European Journal of Cancer, 220:115334.

Alfaifi, Salem A; Louie, Alexander V; Siva, Shankar; Guckenberger, Matthias; Videtic, Gregory M M; Higgins, Kristin A; Alshafa, Faiz; AlGhamdi, Hamza; Gillespie, Erin F; Stephans, Kevin; Mula-Hussain, Layth; Harrow, Stephen; Palma, David A (2025). International Patterns of Practice for Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of practice for SABR for early-stage NSCLC. International Journal of Radiation Oncology, Biology, Physics:Epub ahead of print.

Xiong, Yuan; Knoedler, Samuel; Alfertshofer, Michael; Kim, Bong-Sung; Jiang, Dongsheng; Liu, Guohui; Rinkevich, Yuval; Mi, Bobin (2025). Mechanisms and therapeutic opportunities in metabolic aberrations of diabetic wounds: a narrative review. Cell Death and Disease, 16(1):341.

Surber, Jonathan; Semmler, Marie; Enderlin, Dominik; Affentranger, Andres; Scherer, Thomas; Sigg, Silvan; Kaufmann, Ernest; Gadient, Jana; Truscello, Luca; Scharl, Michael; Morsy, Yasser; Eberli, Daniel; Poyet, Cedric; Bieri, Uwe (2025). Microbiome landscapes of the bladder, intestine, and vagina in bladder cancer: a systematic review. Discover Oncology, 16(1):525.

Dee, Edward Christopher; Wu, James Fan; Feliciano, Erin Jay G; Ting, Frederic Ivan L; Willmann, Jonas; Ho, Frances Dominique V; Jain, Bhav; Jain, Urvish; Chen, Jenny; Moraes, Fabio Ynoe; Lee, Nancy Y; Iyengar, Puneeth; Nguyen, Paul L (2025). National Cancer System Characteristics and Global Pan-Cancer Outcomes. JAMA Oncology, 11(6):650-654.

Knoedler, Samuel; Matar, Dany Y; Schaschinger, Thomas; Boroumand, Sam; Tsolakidis, Savas; Könneker, Sören; Orgill, Dennis P; Panayi, Adriana C; Kim, Bong-Sung (2025). Single-Pedicled, Supercharged, or Bi-Pedicled? A Multi-Institutional Outcome Comparison of Pedicled TRAM Flap for Autologous Breast Reconstruction. Clinical Breast Cancer:Epub ahead of print.

Chiappetta, Marco; Lococo, Filippo; Sassorossi, Carolina; Moser, Bernhard; Van Schil, Paul; Podobed, Alexandr; Liberman, Moishe; Opitz, Isabelle; Zisis, Charalambros; Menghesha, Hruy; Furak, Jozsef; Mendogni, Paolo; Ruffini, Enrico; Guerrera, Francesco; Venuta, Federico; Voltolini, Luca; Londero, Francesco; Casiraghi, Monica; Bravio, Ivan; Voulaz, Emanuele; Barmin, Vitaly; Trancho, Florentino Hernan; Billè, Andrea; Cafarotti, Stefano; Campanella, Annalisa; Santoro, Gloria; Novoa, Nuria Maria; Margaritora, Stefano (2025). Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours. Lung Cancer, 203:108535.

Angori, Silvia; Lakshminarayanan, Harini; Banaei-Esfahani, Amir; Mühlbauer, Katharina; Bolck, Hella Anna; Kallioniemi, Olli; Pietiäinen, Vilja; Schraml, Peter; Moch, Holger (2025). Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma. International Journal of Cancer, 156(7):1457-1469.

Gallina, Filippo Tommaso; Marinelli, Daniele; Stiles, Brendon; Opitz, Isabelle; Spicer, Jonathan (2025). Establishing survival benchmarks in the era of peri-operative immunotherapy. Lung Cancer, 202:108491.

Knoedler, Samuel; Diatta, Fortunay; Klimitz, Felix J; Noel, Olivier; Kempa, Joanna; Obed, Doha; Song, Seung-Yong; Mayer, Horacio; Kim, Bong-Sung; Kauke-Navarro, Martin; Pomahac, Bohdan; Butler, Paris D (2025). Unveiling Inequities: Racial Disparities in Risk-Reducing Mastectomy for Breast Cancer Prevention. Clinical Breast Cancer, 25(3):e312-e320.

Jung, Wonyoung; Park, Sang Hyun; Park, Yong-Moon Mark; Song, Yun-Mi; Park, Jae Hyun; Yu, Jonghan; Cho, In Young; Kim, Bong Sung; Han, Kyungdo; Shin, Dong Wook (2025). Weight change and cardiovascular disease incidence in breast cancer survivors: a nationwide cohort study. Breast Cancer Research and Treatment, 210(3):583-593.

Volpe, Stefania; Vincini, Maria Giulia; Zaffaroni, Mattia; Gaeta, Aurora; Raimondi, Sara; Piperno, Gaia; Franzetti, Jessica; Colombo, Francesca; Camarda, Anna Maria; Mastroleo, Federico; Botta, Francesca; Spaggiari, Lorenzo; Gandini, Sara; Guckenberger, Matthias; Orecchia, Roberto; Casiraghi, Monica; Jereczek-Fossa, Barbara Alicja (2025). Harnessing Baseline Radiomic Features in Early-Stage NSCLC: What Role in Clinical Outcome Modeling for SBRT Candidates? Cancers, 17(5):908.

Montagna, Giacomo; Laws, Alison; Ferrucci, Massimo; Mrdutt, Mary M; Sun, Susie X; Bademler, Suleyman; Balbaloglu, Hakan; Balint-Lahat, Nora; Banys-Paluchowski, Maggie; Barrio, Andrea V; Benson, John; Bese, Nuran; Boughey, Judy C; Boyle, Marissa K; Diego, Emilia J; Eden, Claire; Eller, Ruth; Goldschmidt, Maite; Hlavin, Callie; Heidinger, Martin; Jelinska, Justyna; Karadeniz Cakmak, Güldeniz; Kesmodel, Susan B; King, Tari A; Kuerer, Henry M; Loesch, Julie; Milardi, Francesco; ICARO Study Group; et al; Vorburger, Denise (2025). Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. Journal of Clinical Oncology, 43(7):810-820.

Baumgartner, Valentin; Scherer, Thomas Paul; Mortezavi, Ashkan; Rupp, Niels; Moch, Holger; Wild, Peter; Dettwiler, Susanne; Wanner, Miriam; Enderlin, Dominik; Salemi, Souzan; Eberli, Daniel (2025). Upregulation of mitochondrial function is associated with advanced prostate cancer. Advances in cancer biology - metastasis, 13:100131.

Kretzschmar, Lena; Gabrys, Hubert; Joye, Anja; Kraft, Johannes; Guckenberger, Matthias; Andratschke, Nicolaus (2025). Postoperative stereotactic radiosurgery (SRS) vs hypofractionated stereotactic radiotherapy (SRT) for resected brain metastases - a single centre analysis. Clinical & Experimental Metastasis, 42(2):16.

Kraft, Agnieszka; Kirschner, Michaela B; Orlowski, Vanessa; Ronner, Manuel; Bodmer, Caroline; Boeva, Valentina; Opitz, Isabelle; Meerang, Mayura (2025). Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection. BMC Cancer, 25(1):212.

Duerinck, Johnny; Karschnia, Philipp; Broekman, Marike; Gempt, Jens; Petrescu, George E D; Jakola, Asgeir S; Grossman, Rachel; Goldbrunner, Roland; Jenkinson, Michael D; Widhalm, Georg; Neidert, Marian; Picart, Thiebaud; Quoilin, Caroline; Gorlia, Thierry; Le Rhun, Emilie; Minniti, Giuseppe; Preusser, Matthias; Weller, Michael (2025). Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group. European Journal of Cancer, 216:115198.

Ortí, Guillermo; Peczynski, Christophe; Boreland, William; O’Reilly, Maeve; von Bonin, Malte; Balduzzi, Adriana; Besley, Caroline; Kalwak, Krzysztof; Ryhänen, Samppa; Güngör, Tayfun; Wynn, Robert F; Bader, Peter; Mielke, Stephan; Blaise, Didier; Amrolia, Persis; Yakoub-Agha, Ibrahim; Calkoen, Friso; Schubert, Maria-Luisa; Potter, Victoria; Pichler, Herbert; Kröger, Nicolaus; Kwon, Mi; Sengeloev, Henrik; Torrent, Anna; Chalandon, Yves; van Gorkom, Gwendolyn; Koenecke, Christian; Graham, Charlotte; Schoemans, Helene; Moiseev, Ivan; et al (2025). Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study. Leukemia, 39(2):431-437.

Moustakis, Christos; Blanck, Oliver; Grohmann, Maximilian; Albers, Dirk; Bartels, Dennis; Bathen, Bastian; Borzì, Giuseppina Rita; Broggi, Sara; Bruschi, Andrea; Casale, Michelina; Delana, Anna; Doolan, Paul; Ebrahimi Tazehmahalleh, Fatemeh; Fabiani, Stefania; Falco, Maria Daniela; Fehr, Roman; Friedlein, Melissa; Gutser, Susanne; Hamada, Abdul Malek; Hancock, Timothy; Köhn, Janett; Kornhuber, Christine; Krieger, Thomas; Lambrecht, Ulrike; Lappi, Sara; Moretti, Eugenia; Mirus, Annalena; Muedder, Thomas; Plaude, Sandija; Polvika, Bernd; Wilke, Lotte; et al (2025). Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas With Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. International Journal of Radiation Oncology, Biology, Physics, 121(2):547-557.

Argyriadi, Eleni A; Steffen, Ingo G; Chen-Santel, Christiane; Lissat, Andrej; Attarbaschi, Andishe; Bourquin, Jean-Pierre; Henze, Guenter; von Stackelberg, Arend (2025). Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study. Leukemia, 39(2):337-345.

Weber, Mikiyo; Fuchs, Daniel; Pöschel, Amiskwia; Beebe, Erin; Garajova, Zuzana; Jarosch, Armin; Kunz, Laura; Wolski, Witold; Opitz, Lennart; Guscetti, Franco; Nolff, Mirja C; Markkanen, Enni (2025). Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes. Neoplasia, 60:101104.

Haberecker, Martina; Rüschoff, Jan H; Andriakopoulou, Charitini; Gray, Steven G; Nackaerts, Kristiaan; De Perrot, Marc; Brcic, Luka; Nadal, Ernest; Tsimpoukis, Sotirios; Ampollini, Luca; Aerts, Joachim G; Kirschner, Michaela B; Monkhorst, Kim; Weynand, Birgit; Bavaghar-Zaeimi, Fatemeh; Samarzija, Miroslav; Llatjos, Roger; Finn, Stephen P; Silini, Enrico; von der Thüsen, Jan; Vagenknecht, Patrick; Tsourti, Zoi; Kerr, Keith M; Kammler, Roswitha; Peters, Solange; Baas, Paul; Opitz, Isabelle; Stahel, Rolf A; Curioni-Fontecedro, Alessandra; ETOP Mesoscape Consortium; TransSCOT Consortium (2025). Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project. JCO precision oncology, 9:e2400675.

Weiss, Tobias; Lee, Sohyon; Snijder, Berend; Weller, Michael (2025). Next step towards functional precision medicine in neuro-oncology. Neuro-Oncology, 27(1):5-6.

Tabatabai, Ghazaleh; Platten, Michael; Preusser, Matthias; Weller, Michael; Wick, Wolfgang; van den Bent, Martin (2025). Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored? Neuro-Oncology, 27(1):302-305.

Graf, Markus; Ziegelmayer, Sebastian; Reischl, Stefan; Teumer, Yannick; Gassert, Florian T; Marka, Alexander W; Raffler, Philipp; Bachmann, Jeannine; Makowski, Marcus; Reim, Daniel; Lohöfer, Fabian; Burian, Egon; Braren, Rickmer (2025). CT-Derived Quantitative Image Features Predict Neoadjuvant Treatment Response in Adenocarcinoma of the Gastroesophageal Junction with High Accuracy. Cancers, 17(2):216.

Dietsche, Lisa; Stirm, Kristin; Lysenko, Veronika; Schneidawind, Corina; Tzankov, Alexandar; Müller, Anne; Theocharides, Alexandre P A (2025). Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes. Frontiers in Oncology, 14:1481713.

Wesle, Anton; Moraes Ribeiro, Emmanuelle; Schairer, Rebekka; Keppeler, Hildegard; Korkmaz, Fulya; Radszuweit, Pia; Bieber, Kristin; Lengerke, Claudia; Schneidawind, Dominik; Schneidawind, Corina (2025). CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity. Cytotherapy, 27(1):7-15.

Weller, Michael; Le Rhun, Emilie; Tsamtsouri, Lydia; Dummer, Reinhard; Guckenberger, Matthias; Ribi, Karin; di Giacomo, Anna Maria; Minuti, Gabriele; Collazo-Lorduy, Ana; Brandsma, Dieta; O'Brien, Mary; Ermis, Ekin; Fischer, Natalie; Ascierto, Paolo; Mandala, Mario; Minniti, Giuseppe; Iranzo, Patricia; Roschitzki-Voser, Heidi; Ruepp, Barbara; Grolimund, Eva; Dafni, Urania; Peters, Solange; Stahel, Rolf; ETOP 19-21 USZ-STRIKE collaborators (2025). Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study. Lung Cancer, 199:108069.

Wang, Baihui; Luo, Qiang; Medalia, Ohad (2025). Lamins and chromatin join forces. Advances in Biological Regulation, 95:101059.

Liner, Alessia G; van Gogh, Merel; Roblek, Marko; Heikenwalder, Matthias; Borsig, Lubor (2025). Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis. Neoplasia, 59:101089.

Trojani, Valeria; Grehn, Melanie; Botti, Andrea; Balgobind, Brian; Savini, Alessandro; Boda-Heggemann, Judit; Miszczyk, Marcin; Elicin, Olgun; Krug, David; Andratschke, Nicolaus; Schmidhalter, Daniel; van Elmpt, Wouter; Bogowicz, Marta; de Areba Iglesias, Javier; Dolla, Lukasz; Ehrbar, Stefanie; Fernandez-Velilla, Enric; Fleckenstein, Jens; Granero, Domingo; Henzen, Dominik; Hurkmans, Coen; Kluge, Anne; Knybel, Lukas; Loopeker, Sandy; Mirandola, Alfredo; Richetto, Veronica; Sicignano, Gianluisa; Vallet, Veronique; van Asselen, Bram; Worm, Esben; et al (2025). Refining Treatment Planning in STereotactic Arrhythmia Radioablation: Benchmark Results and Consensus Statement From the STOPSTORM.eu Consortium. International Journal of Radiation Oncology, Biology, Physics, 121(1):218-229.

Houda, Ilias; Bahce, Idris; Dickhoff, Chris; Kroese, Tiuri E; Kroeze, Stephanie G C; Mariolo, Alessio V; Tagliamento, Marco; Moliner, Laura; Brandão, Mariana; Pretzenbacher, Yassin; Edwards, John; Opitz, Isabelle; Brunelli, Alessandro; Guckenberger, Matthias; van Schil, Paul E; Popat, Sanjay; Blum, Torsten; Faivre-Finn, Corinne; de Ruysscher, Dirk; Remon, Jordi; Berghmans, Thierry; Dingemans, Anne-Marie C; Besse, Benjamin; Hendriks, Lizza E L (2025). An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer. Lung Cancer, 199:108061.

Gries, Alexandre; Santhana Kumar, Karthiga; Kuttler, Fabien; Özalp, Özgün; Akle, Veronica; Zhang, Hanqing; Grotzer, Michael A; Neuhauss, Stephan C F; Allalou, Amin; Baumgartner, Martin (2025). Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context. Neoplasia, 59:101078.

Armocida, Daniele; Bianconi, Andrea; Zancana, Giuseppa; Jiang, Tingting; Pesce, Alessandro; Tartara, Fulvio; Garbossa, Diego; Salvati, Maurizio; Santoro, Antonio; Serra, Carlo; Frati, Alessandro (2025). DTI fiber-tracking parameters adjacent to gliomas: the role of tract irregularity value in operative planning, resection, and outcome. Journal of Neuro-Oncology, 171(1):241-252.

Papagiannakis, Alkiviadis; Kwiatkowski, Maciej; Wyler, Stephen F; Mortezavi, Ashkan; Manka, Lukas; Wettstein, Marian S; Grobholz, Rainer; Hammerer-Lercher, Angelika; Eberli, Daniel; Prause, Lukas Werner (2025). Influence of Regular Statin Intake on Prostate-Specific Antigen Values, Prostate Cancer Incidence and Overall Survival in a Prospective Screening Trial (ERSPC Aarau). Cancer Medicine, 14(1):e70485.

Heitmann, Franziska; Christ, Sebastian; March, Christine; Pech, Maciej; Thormann, Maximilian; Damm, Robert (2025). Lesion Volume Divided by ADC Measures Is an Independent Prognostic Marker in Colorectal Liver Metastasis Treated by Y90-radioembolization. In Vivo, 39(1):292-301.

Schulze, Jan Ben; Dörner, Marc; Huber, Mona; Jordan, Katja-Daniela; von Känel, Roland; Euler, Sebastian (2025). Psychiatric Diagnoses and Their Treatment in Women With Breast Cancer: A Latent Class Analysis of 1062 Inpatients. Clinical Breast Cancer, 25(1):e22-e29.

Dimitriou, Florentia; Orloff, Marlana M; Koch Hein, Erica C; Cheng, Phil F; Hughes, Isaac F; Simeone, Ester; Montazeri, Kamaneh; Grover, Piyush; Mehmi, Inderjit; Gerard, Camille Lea; Gaudy-Marqueste, Caroline; Grob, Jean-Jacques; Michielin, Olivier; Hamid, Omid; Long, Georgina V; Sullivan, Ryan; Kapiteijn, Ellen; Johnson, Douglas B; Ascierto, Paolo A; Joshua, Anthony M; Carvajal, Richard D; Butler, Marcus O; Hassel, Jessica C; Dummer, Reinhard (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European Journal of Cancer, 214:115161.

2024

Rondeau, Justin D; Lipari, Sara; Mathieu, Barbara; Beckers, Claire; Van de Velde, Justine A; Mignion, Lionel; Da Silva Morais, Mauricio; Kreuzer, Marvin; Colauzzi, Ilaria; Capeloa, Tania; Pruschy, Martin; Gallez, Bernard; Sonveaux, Pierre (2024). Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption. Cell Death Discovery, 10(1):514.

von Stauffenberg, Franz; Poyet, Cédric; Beintner-Skawran, Stephan; Maurer, Alexander; Schmid, Florian A (2024). Current Clinical Applications of PSMA-PET for Prostate Cancer Diagnosis, Staging, and Treatment. Cancers, 16(24):4263.

Loos, Benjamin; Salas-Bastos, Adrian; Nordin, Anna; Debbache, Julien; Stierli, Salome; Cheng, Phil F; Rufli, Stefanie; Wyss, Conrad; Levesque, Mitchell P; Dummer, Reinhard; Wong, Wendy Wei-Lynn; Pascolo, Steve; Cantù, Claudio; Sommer, Lukas (2024). TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis. Cell Death and Disease, 15(12):925.

Bulatović, Milica; Hermann, Jan; Tinguely, Pascale; Paolucci, Iwan; Weber, Stefan (2024). Configuring thermal ablation volumes for treatment of distinct tumor shapes: a repeatability study using a robotic approach. Frontiers in Oncology, 14:1463686.

Münick, Philipp; Zielinski, Jasmin; Strubel, Alexander; Gutfreund, Niklas; Dreier, Birgit; Schaefer, Jonas V; Schäfer, Birgit; Gebel, Jakob; Osterburg, Christian; Chaikuad, Apirat; Knapp, Stefan; Plückthun, Andreas; Dötsch, Volker (2024). DARPins as a novel tool to detect and degrade p73. Cell Death and Disease, 15(12):909.

Vledder, Annegé; Paijens, Sterre T; Loiero, Dominik; Maagdenberg, Alexis; Duiker, Evelien W; Bart, Joost; Hendriks, Anne M; Jalving, Mathilde; Werner, Naomi; van Rooij, Nienke; Plat, Annechien; Wisman, G Bea A; Yigit, Refika; Roelofsen, Thijs; Kruse, Arnold J; de Lange, Nastascha M; Koelzer, Viktor H; de Bruyn, Marco; Nijman, Hans W (2024). B Cells Critical for Outcome in High Grade Serous Ovarian Carcinoma. International Journal of Cancer, 155(12):2265-2276.

Jolidon, Vladimir; Eicher, Manuela; Peytremann-Bridevaux, Isabelle; Aebi, Stefan; Anchisi, Sandro; Bettini, Adrienne; Chalandon, Yves; Dietrich, Pierre-Yves; Duchosal, Michel A; Dürr, Donat; Peters, Solange; von Moos, Roger; Wicki, Andreas; Arditi, Chantal (2024). Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study. Cancer, 130(24):4334-4346.

Knoedler, Samuel; Jiang, Jun; Moog, Philipp; Alfertshofer, Michael; Machens, Hans-Guenther; Kehrer, Andreas; Hundeshagen, Gabriel; Knoedler, Leonard; Könneker, Sören; Kim, Bong-Sung; Orgill, Dennis P; Panayi, Adriana C (2024). Preventive Paradox? Postoperative Outcomes After Risk-Reducing Mastectomy and Direct-to-Implant Breast Reconstruction. Clinical Breast Cancer, 24(8):746-754.

Katzendobler, Sophie; Niedermeyer, Sebastian; Blobner, Jens; Trumm, Christoph; Harter, Patrick N; von Baumgarten, Louisa; Stoecklein, Veit M; Tonn, Joerg-Christian; Weller, Michael; Thon, Niklas; Weller, Jonathan (2024). Determinants of long-term survival in patients with IDH-mutant gliomas. Journal of Neuro-Oncology, 170(3):655-664.

Balermpas, Panagiotis (2024). Do Not Deny a Curative Chance! International Journal of Radiation Oncology, Biology, Physics, 120(5):1207-1208.

Volta, Laura; Myburgh, Renier; Pellegrino, Christian; Koch, Christian; Maurer, Monique; Manfredi, Francesco; Hofstetter, Mara; Kaiser, Anne; Schneiter, Florin; Müller, Jan; Buehler, Marco M; De Luca, Roberto; Favalli, Nicholas; Magnani, Chiara F; Schroeder, Timm; Neri, Dario; Manz, Markus G (2024). Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells. Leukemia, 38(12):2598-2613.

Locher, Luca; Serra-Burriel, Miquel; Trapani, Dario; Nussli, Emanuel; Vokinger, Kerstin N (2024). Why effect sizes are systematically larger for progression-free survival than overall survival in cancer drug trials: Prognostic scores as a way forward. European Journal of Cancer, 213(115106):online.

Levy, Antonin; Berghmans, Thierry; Koller, Michael; Fournier, Beatrice; Mauer, Murielle; Andratschke, Nicolaus; Faivre-Finn, Corinne (2024). PRIMALung (EORTC-1901) : PRophylactic Cerebral Irradiation (PCI) or Active Brain MAgnetic Resonance Imaging (MRI) Surveillance in Small-Cell Lung Cancer (SCLC) Patients. Lung Cancer, 198:107993.

Knoedler, Samuel; Diatta, Fortunay; Kasparbauer, Felix; Knoedler, Leonard; Kim, Bong-Sung; Pomahac, Bohdan; Kauke-Navarro, Martin (2024). Perioperative safety of risk-reducing mastectomy. British Journal of Cancer, 131(11):1721-1723.

Bajrami Saipi, Mihada; Ruiba, Alessia; Schittenhelm, Marcus Matthias; Blumenstock, Gunnar; Győrffy, Balázs; Fazio, Serena; Hafner, Marlon; Ahrens, Anna-Lena; Aldinger, Lara; Aellig, Vanessa; Kavelaars, François G; Nombela-Arrieta, César; Fend, Falko; Valk, Peter J M; Christoph, Driessen; Kampa-Schittenhelm, Kerstin Maria (2024). High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML). Cell Death and Disease, 15(11):869.

Holzinger, Tim; Frei, Julia; Jarzebska, Natalia Teresa; Beer, Hans-Dietmar; Kündig, Thomas M; Pascolo, Steve; Läuchli, Severin; Mellett, Mark (2024). Differential functionality of fluoropyrimidine nucleosides for safe cancer therapy. Anti-Cancer Drugs, 35(10):912-921.

Woodford, Rachel; McKeown, Janet; Hoeijmakers, Lotte L; Mangana, Johanna; Dimitriou, Florentia; Allayous, Clara; Zaman, Farzana; Aya, Francisco; Marsiglio, John; Goodman, Rachel; Rayson, Victoria; Placzke, Joanna; Kessels, Jolien; Ramalyte, Egle; Haque, Waqas; Wilson, Isabella; Trojaniello, Claudia; Benannoune, Naima; Roberts-Thomson, Rachel; Robert, Caroline; Blank, Christian U; Dummer, Reinhard; Lebbe, Celeste; Haydon, Andrew; Arance, Ana; Hu-Lieskovan, Siwen; Johnson, Douglas B; Mcarthur, Grant A; Rutkowski, Piotr; Neyns, Bart; et al (2024). Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy. European Journal of Cancer, 212:115055.

Kuzmanov, Aleksandar; Salemi, Souzan; Eberli, Daniel; Kranzbühler, Benedikt (2024). Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin. Neoplasia, 57:101045.

Noseda, Roberta; Bedussi, Francesca; Giunchi, Valentina; Fusaroli, Michele; Raschi, Emanuel; Ceschi, Alessandro (2024). Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase. Journal for ImmunoTherapy of Cancer, 12(11):e009902.

Udovicich, Cristian; Lo, Simon S; Guckenberger, Matthias; Sahgal, Arjun (2024). Shifting the Landscape of Spine and Non-Spine Bone Metastases: A Review of Stereotactic Body Radiotherapy. Cancer Journal, 30(6):385-392.

von Buchwald, Christian; Jakobsen, Kathrine Kronberg; Carlander, Amanda-Louise Fenger; Tous, Sara; Grønhøj, Christian; Rasmussen, Jacob H; Brooks, Jill; Taberna, Miren; Mena, Marisa; Morey, Francisca; Bruni, Laia; Batis, Nikolaos; Brakenhoff, Ruud H; René Leemans, C; de Jong, Robert J Baatenburg; Klussmann, Jens Peter; Wuerdemann, Nora; Wagner, Steffen; Dalianis, Tina; Marklund, Linda; Mirghani, Haïtham; Schache, Andrew; James, Jaqueline A; Huang, Shao Hui; O’Sullivan, Brian; Nankivell, Paul; Broglie, Martina A; Hoffmann, Markus; Quabius, Elgar Susanne; Anderson, Lesley A; et al (2024). TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma. European Journal of Cancer, 211:114329.

Youssef, Khalil Kass; Narwade, Nitin; Arcas, Aida; Marquez-Galera, Angel; Jiménez-Castaño, Raúl; Lopez-Blau, Cristina; Fazilaty, Hassan; García-Gutierrez, David; Cano, Amparo; Galcerán, Joan; Moreno-Bueno, Gema; Lopez-Atalaya, Jose P; Nieto, M Angela (2024). Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nature Cancer, 5(11):1660-1680.

Ukegjini, Kristjan; Warschkow, René; Petrowsky, Henrik; Müller, Philip C; Oberholzer, José; Tarantino, Ignazio; Jonas, Jan Philipp; Schmied, Bruno M; Steffen, Thomas (2024). Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis. Cancers, 16(20):3531.

Calì, Bianca; Troiani, Martina; Bressan, Silvia; Attanasio, Giuseppe; Merler, Sara; Moscarda, Viola; Mosole, Simone; Ricci, Elena; Guo, Christina; Yuan, Wei; Gallagher, Lewis; Lundberg, Arian; Bernett, Ilona; Figueiredo, Ines; Arzola, Rydell Alvarez; Abreut, Ernesto Bermudez; D'Ambrosio, Mariantonietta; Bancaro, Nicolò; Brina, Daniela; Zumerle, Sara; Pasquini, Emiliano; Maddalena, Martino; Lai, Ping; Colucci, Manuel; Pernigoni, Nicolò; Rinaldi, Andrea; Minardi, Davide; Morlacco, Alessandro; Rüschoff, Jan Hendrik; Moch, Holger; et al (2024). Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer. Cancer Cell, 42(10):1676-1692.e11.

Suter, Flurina; Wanner, Miriam; Menges, Dominik; Wicki, Andreas; Korol, Dimitri; Rohrmann, Sabine (2024). Impact of the COVID-19 Pandemic and Lockdown on Cancer Diagnoses Using Swiss Cantonal Cancer Registry Data. Cancers, 16(19):3381.

Wilcox, Jessica A; Chukwueke, Ugonma N; Ahn, Myung-Ju; Aizer, Ayal A; Bale, Tejus A; Brandsma, Dieta; Brastianos, Priscilla K; Chang, Susan; Daras, Mariza; Forsyth, Peter; Garzia, Livia; Glantz, Michael; Oliva, Isabella C Glitza; Kumthekar, Priya; Le Rhun, Emilie; Nagpal, Seema; O’Brien, Barbara; Pentsova, Elena; Lee, Eudocia Quant; Remsik, Jan; Rudà, Roberta; Smalley, Inna; Taylor, Michael D; Weller, Michael; Wefel, Jeffrey; Yang, Jonathan T; Young, Robert J; Wen, Patrick Y; Boire, Adrienne A (2024). Leptomeningeal Metastases from Solid Tumors : A Society for Neuro-Oncology and American Society of Clinical Oncology Consensus Review on Clinical Management and Future Directions. Neuro-Oncology, 26(10):1781-1804.

Le Rhun, Emilie; Weller, Michael (2024). Tools and Toys beyond RANO 2.0 : Digital Flipbooks to Monitor Brain Tumor Growth Dynamics? Neuro-Oncology, 26(10):1837-1838.

Rowe, Steven P; Murtazaliev, Salikh; Oldan, Jorge D; Kaufmann, Basil; Khan, Amna; Allaf, Mohammad E; Singla, Nirmish; Pavlovich, Christian P; De Marzo, Angelo M; Baraban, Ezra; Gorin, Michael A; Solnes, Lilja B (2024). Imaging of Chromophobe Renal Cell Carcinoma with $^{99m}$Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification. Molecular Imaging and Biology, 26(5):768-773.

Peeters, Stephanie; Lau, Kelvin; Stefanidis, Konstantinos; Yasufuku, Kazuhiro; Ishiwata, Tsukasa; Rolfo, Christian; Schneiter, Didier; Hardavella, Georgia; Guckenberger, Matthias; Lauk, Olivia (2024). New diagnostic and nonsurgical local treatment modalities for early stage lung cancer. Lung Cancer, 196:107952.

Hegi, Monika E; Oppong, Felix B; Perry, James R; Wick, Wolfgang; Henriksson, Roger; Laperriere, Norman J; Gorlia, Thierry; Malmström, Annika; Weller, Michael (2024). No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients. Neuro-Oncology, 26(10):1867-1875.

Näther, Sophia; Elfgen, Constanze; Rodewald, Ann-Katrin; Fansa, Hisham; Frauchiger-Heuer, Heike; Varga, Zsuzsanna (2024). Retrospective analysis of core-needle and vacuum-assisted breast biopsies of B3 fibroepithelial lesions and correlation with results in subsequent surgical specimens. Journal of Cancer Research and Clinical Oncology, 150(9):436.

Janbain, Ali; Farolfi, Andrea; Guenegou-Arnoux, Armelle; Romengas, Louis; Scharl, Sophia; Fanti, Stefano; Serani, Francesca; Peeken, Jan C; Katsahian, Sandrine; Strouthos, Iosif; Ferentinos, Konstantinos; Koerber, Stefan A; Vogel, Marco E; Combs, Stephanie E; Vrachimis, Alexis; Morganti, Alessio Giuseppe; Spohn, Simon K B; Grosu, Anca-Ligia; Ceci, Francesco; Henkenberens, Christoph; Kroeze, Stephanie G C; Guckenberger, Matthias; Belka, Claus; Bartenstein, Peter; Hruby, George; Emmett, Louise; Omerieh, Ali Afshar; Schmidt-Hegemann, Nina-Sophie; Mose, Lucas; Aebersold, Daniel M; et al (2024). A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study. JMIR Cancer, 10:e60323.

von der Grün, Jens; Broglie, Martina; Guckenberger, Matthias; Balermpas, Panagiotis (2024). A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer. Cancer Immunology, Immunotherapy, 73(11):222.

Martini, Alberto; Wever, Lieke; Soeterik, Timo F W; Rakauskas, Arnas; Fankhauser, Christian Daniel; Grogg, Josias Bastian; Checcucci, Enrico; Amparore, Daniele; Haiquel, Luciano; Rodriguez-Sanchez, Lara; Ploussard, Guillaume; Qiang, Peng; Affentranger, Andres; Marquis, Alessandro; Marra, Giancarlo; Ettala, Otto; Zattoni, Fabio; Falagario, Ugo Giovanni; De Angelis, Mario; Kesch, Claudia; Apfelbeck, Maria; Al-Hammouri, Tarek; Kretschmer, Alexander; Kasivisvanathan, Veeru; Preisser, Felix; Lefebvre, Emilie; Olivier, Jonathan; Radtke, Jan Philipp; Carrieri, Giuseppe; Moro, Fabrizio Dal; et al (2024). An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy. Prostate Cancer and Prostatic Diseases, 27(3):520-524.

Le Rhun, Emilie; Weller, Michael; Anders, C; Larkin, J; Li, J; Moss, N S; Tawbi, H; Dummer, Reinhard (2024). “Symptomatic” melanoma brain metastases: A call for clear definitions and adoption of standardized tools. European Journal of Cancer, 208:114202.

Richter, Cornelia; Wildisen, Lea; Rohrmann, Sabine; Haile, Sarah R (2024). Better tools for better estimates: improving approaches to handling missing data in Swiss cancer registries. European Journal of Cancer Prevention, 33(5):400-406.

Afshan, Syeda; Kim, Yu Gang; Mattsson, Jesse; Åkerfelt, Malin; Härkönen, Pirkko; Baumgartner, Martin; Nees, Matthias (2024). Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models. Cancer Medicine, 13(18):e70240.

Dimitriou, Florentia; Cheng, Phil F; Saltari, Annalisa; Schaper-Gerhardt, Katrin; Staeger, Ramon; Haunerdinger, Veronika; Sella, Federica; Tastanova, Aizhan; Urban, Christian; Dettwiler, Susanne; Mihic-Probst, Daniela; Matter, Christian M; Michielin, Olivier; Gutzmer, Ralf; Long, Georgina V; Becher, Burkhard; Levesque, Mitchell P; Dummer, Reinhard (2024). A targetable type III immune response with increase of IL-17A expressing CD4$^{+}$ T cells is associated with immunotherapy-induced toxicity in melanoma. Nature Cancer, 5(9):1390-1408.

Prodi, Eleonora; Corbellari, Riccardo; Ghezzi, Lorenzo; Ciambellotti, Silvia; Catastini, Jacopo Elia; Rappuoli, Marco; Rotta, Giulia; Sakic, Irma; Weiss, Tobias; Weller, Michael; Pellegrino, Christian; Manz, Markus G; Neri, Dario; De Luca, Roberto (2024). Tripokin: A multi-specific immunocytokine for cancer immunotherapy. International Journal of Cancer, 156(1):216-228.

Haderlein, Marlen; von der Grün, Jens; Balermpas, Panagiotis; Rödel, Claus; Hautmann, Matthias G; Steger, Felix; Bohr, Christopher; Hehr, Thomas; Stromberger, Carmen; Budach, Volker; Schymalla, Markus; Engenhart-Cabillic, Rita; Kocik, Lukas; Geinitz, Hans; Nestle, Ursula; Klautke, Gunter; Scherl, Claudia; Gall, Christine; Frey, Benjamin; Schubert, Philipp; Semrau, Sabine; Ott, Oliver; Kesting, Marco; Iro, Heinrich; Mueller, Sarina K; Fietkau, Rainer (2024). De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial). Frontiers in Oncology, 14:1447123.

Di Nitto, Cesare; Ravazza, Domenico; Gilardoni, Ettore; Look, Thomas; Sun, Miaomiao; Prodi, Eleonora; Moisoiu, Vlad; Pellegrino, Christian; Manz, Markus G; Puca, Emanuele; Weller, Michael; Weiss, Tobias; Neri, Dario; De Luca, Roberto (2024). An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade. Journal for ImmunoTherapy of Cancer, 12(8):e008504.

de la Nava, Daniel; Ausejo-Mauleon, Iker; Laspidea, Virginia; Gonzalez-Huarriz, Marisol; Lacalle, Andrea; Casares, Noelia; Zalacain, Marta; Marrodan, Lucía; García-Moure, Marc; Ochoa, Maria C; Tallon-Cobos, Antonio Carlos; Hernandez-Osuna, Reyes; Marco-Sanz, Javier; Dhandapani, Laasya; Hervás-Corpión, Irati; Becher, Oren J; Nazarian, Javad; Mueller, Sabine; Phoenix, Timothy N; van der Lugt, Jasper; Hernaez, Mikel; Guruceaga, Elizabeth; Koschmann, Carl; Venneti, Sriram; Allen, Joshua E; Dun, Matthew D; Fueyo, Juan; Gomez-Manzano, Candelaria; Gallego Perez-Larraya, Jaime; Patiño-García, Ana; Labiano, Sara; Alonso, Marta M (2024). The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro-Oncology, 26(8):1509-1525.

Hayn, Dieter; Kreiner, Karl; Sandner, Emanuel; Baumgartner, Martin; Jammerbund, Bernhard; Falgenhauer, Markus; Düster, Vanessa; Devi-Marulkar, Priyanka; Schleiermacher, Gudrun; Ladenstein, Ruth; Schreier, Guenter (2024). Use Cases Requiring Privacy-Preserving Record Linkage in Paediatric Oncology. Cancers, 16(15):2696.

Rogge, Alizé A; Helmer, Stefanie M; Icke, Katja; Witt, Claudia M (2024). Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: 2‐year follow‐up of the multi‐center, cluster‐randomized KOKON‐KTO study. Cancer Medicine, 13(14):e70008.

Dietze, Anja; Neyer, Peter J; Speth, Marlene M; Metzler, Philipp; Elicin, Olgun; Balermpas, Panagiotis; Aebersold, Daniel M; Riesterer, Oliver; Stieb, Sonja (2024). Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol. BMC Cancer, 24(1):865.

Pellerino, Alessia; Verdijk, Robert M; Nichelli, Lucia; Andratschke, Nicolaus H; Idbaih, Ahmed; Goldbrunner, Roland (2024). Primary Meningeal Melanocytic Tumors of the Central Nervous System: A Review from the Ultra-Rare Brain Tumors Task Force of the European Network for Rare Cancers (EURACAN). Cancers, 16(14):2508.

Elsayed, Abdullah; Plüss, Louis; Nideroest, Larissa; Rotta, Giulia; Thoma, Marina; Zangger, Nathan; Peissert, Frederik; Pfister, Stefanie K; Pellegrino, Christian; Dakhel Plaza, Sheila; De Luca, Roberto; Manz, Markus G; Oxenius, Annette; Puca, Emanuele; Halin, Cornelia; Neri, Dario (2024). Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular Cancer Therapeutics, 23(7):1010-1020.

Burri, Elias; Mangana, Joanna; Cheng, Phil F; Schneider, Alia; Weber, Achim; Dummer, Reinhard; Ramelyte, Egle (2024). Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids. Journal for ImmunoTherapy of Cancer, 12(7):e008074.

Grever, Michael; Andritsos, Leslie; Anghelina, Mirela; Arons, Evgeny; Banerji, Versha; Barrientos, Jacqueline; Bhat, Seema A; Blachly, James; Broccoli, Alessandro; Call, Timothy; Dearden, Claire; Dietrich, Sascha; Else, Monica; Epperla, Narendranath; Fagarasanu, Andrei; Falini, Brunangelo; Forconi, Francesco; Gozzetti, Alessandro; Hampel, Paul; Hermel, David J; Iyengar, Sunil; Johnston, James B; Juliusson, Gunnar; Kreitman, Robert J; Lauria, Francesco; Lozanski, Gerard; Oakes, Christopher C; Parikh, Sameer A; Park, Jae; et al; Zenz, Thorsten (2024). Hairy cell leukemia variant and WHO classification correspondence Re: 5$^{th}$ edition WHO classification haematolymphoid tumors: lymphoid neoplasms. Leukemia, 38(7):1642-1644.

Armato, Samuel G; Katz, Sharyn I; Frauenfelder, Thomas; Jayasekera, Geeshath; Catino, Annamaria; Blyth, Kevin G; Theodoro, Taylla; Rousset, Pascal; Nackaerts, Kristiaan; Opitz, Isabelle (2024). Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 193:107832.

Freiberger, Sandra N; Ikenberg, Kristian; van Egmond, Demi; Claerhout, Sofie; van Wezel, Tom; Bempt, Isabelle Vanden; van Rossem, Jeroen N; Mueller, Simon A; Clement, Paul M; Poorten, Vincent Vander; Cohen, Danielle; Hauben, Esther; Rupp, Niels J (2024). Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathology, 132(7):435-446.

Kotrova, Michaela; Fronkova, Eva; Svaton, Michael; Drandi, Daniela; Schön, Felix; Hoogeveen, Patricia; Hancock, Jeremy; Skotnicova, Aneta; Schilhabel, Anke; Eckert, Cornelia; Clappier, Emmanuelle; Cazzaniga, Gianni; Schäfer, Beat W; van Dongen, Jacques J M; Ritgen, Matthias; Pott, Christiane; van der Velden, Vincent H J; Trka, Jan; Brüggemann, Monika (2024). The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category. Leukemia, 38(7):1617-1620.

Natallia, Lapava; Dama, Aida; Gorica, Era; Darya, Karaliova; Peña-Corona, Sheila I; Cortés, Hernán; Santini, Antonello; Büsselberg, Dietrich; Leyva-Gómez, Gerardo; Sharifi-Rad, Javad (2024). Genipin's potential as an anti-cancer agent: from phytochemical origins to clinical prospects. Medical Oncology, 41(8):186.

Domingo, Enric; Kelly, Caroline; Hay, Jennifer; Sansom, Owen; Maka, Noori; Oien, Karin; Iveson, Tim; Saunders, Mark; Kerr, Rachel; Tomlinson, Ian; Edwards, Joanne; Harkin, Andrea; Nowak, Marta; Koelzer, Viktor; Easton, Alistair; Boukovinas, Ioannis; Moustou, Eleni; Messaritakis, Ippokratis; Chondrozoumaki, Maria; Karagianni, Michaela; Pagès, Franck; Arnoux, Fanny; Lautard, Christelle; Lovera, Yoann; Boquet, Isabelle; Catteau, Aurélie; Galon, Jérôme; TransSCOT Consortium; Souglakos, Ioannis; Church, David N (2024). Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of Clinical Oncology, 42(18):2207-2218.

Schelling, Georg; Heesen, Philip; Tautermann, Boris; Wepf, Markus; Di Federico, Barbara; Frei, Annika; van Oudenaarde, Kim; Giovanoli, Pietro; Bode-Lesniewska, Beata; Studer, Gabriela; Fuchs, Bruno; On Behalf Of The Swiss Sarcoma Network (2024). Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare. Cancers, 16(12):2209.

Yates, Josephine; Schaufelberger, Helen; Steinacher, Roland; Schär, Primo; Truninger, Kaspar; Boeva, Valentina (2024). DNA-methylation variability in normal mucosa: a field cancerization marker in patients with adenomatous polyps. Journal of the National Cancer Institute, 116(6):974-982.

Nayak, Lakshmi; Bettegowda, Chetan; Scherer, Florian; Galldiks, Norbert; Ahluwalia, Manmeet; Baraniskin, Alexander; von Baumgarten, Louisa; Bromberg, Jacoline E C; Ferreri, Andrés J M; Grommes, Christian; Hoang-Xuan, Khê; Kühn, Julia; Rubenstein, James L; Rudà, Roberta; Weller, Michael; Chang, Susan M; van den Bent, Martin J; Wen, Patrick Y; Soffietti, Riccardo (2024). Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology, 26(6):993-1011.

Schadendorf, Dirk; Dummer, Reinhard; Flaherty, Keith T; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B; Garbe, Claus; Gogas, Helen J; Gutzmer, Ralf; Krajsová, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandalà, Mario; Yamazaki, Naoya; Queirolo, Paola; Guenzel, Carolin; Polli, Anna; Thakur, Mahgull; di Pietro, Alessandra; Ascierto, Paolo A (2024). COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma. European Journal of Cancer, 204:114073.

de Joode, Karlijn; Mora, Alfonso Rojas; van Schaik, Ron H N; Zippelius, Alfred; van der Veldt, Astrid; Gerard, Camille Léa; Läubli, Heinz; Michielin, Olivier; von Moos, Roger; Joerger, Markus; Levesque, Mitchell P; Aeppli, Stefanie; Mangana, Johanna; Mangas, Cristina; Trost, Nadine; Meyer, Stefan; Parvex, Sandra Leoni; Mathijssen, Ron; Metaxas, Yannis (2024). Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma. Journal of Immunotherapy, 47(5):190-194.

Grimm, Marc-Oliver; Schostak, Martin; Grün, Christine Barbara; Loidl, Wolfgang; Pichler, Martin; Zimmermann, Uwe; Schmitz-Dräger, Bernd; Steiner, Thomas; Roghmann, Florian; Niegisch, Günter; Bolenz, Christian; Schmitz, Marc; Baretton, Gustavo; Leucht, Katharina; Schumacher, Ulrike; Foller, Susan; Zengerling, Friedemann; Meran, Johannes; Lorch, Anja (2024). Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial. JAMA Oncology, 10(6):755-764.

Mikolajewicz, Nicholas; Yee, Patricia P; Bhanja, Debarati; Trifoi, Mara; Miller, Alexandra M; Metellus, Philippe; Bagley, Stephen J; Balaj, Leonora; de Macedo Filho, Leonardo J M; Zacharia, Brad E; Aregawi, Dawit; Glantz, Michael; Weller, Michael; Ahluwalia, Manmeet S; Kislinger, Thomas; Mansouri, Alireza (2024). Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application. Journal of Clinical Oncology, 42(16):1961-1974.

van der Velden, Vincent H J; Dombrink, Isabel; Alten, Julia; Cazzaniga, Giovanni; Clappier, Emmanuelle; Drandi, Daniela; Eckert, Cornelia; Fronkova, Eva; Hancock, Jeremy; Kotrova, Michaela; Kraemer, Rebekka; Montonen, Mirkka; Pfeifer, Heike; Pott, Christiane; Raff, Thorsten; Trautmann, Heiko; Cavé, Hélène; Schäfer, Beat W; van Dongen, Jacques J M; Trka, Jan; Brüggemann, Monika; EuroMRD Consortium (2024). Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines. Leukemia, 38(6):1315-1322.

Kroese, Tiuri E; Bronzwaer, Sebastiaan; van Rossum, Peter S N; Schoppman, Sebastian F; Deseyne, Pieter R A J; van Cutsem, Eric; Haustermans, Karin; Nafteux, Philippe; Thomas, Melissa; Obermannova, Radka; Mortensen, Hanna R; Nordsmark, Marianne; Pfeiffer, Per; Elme, Anneli; Adenis, Antoine; Piessen, Guillaume; Bruns, Christiane J; Lordick, Florian; Gockel, Ines; Moehler, Markus; Gani, Cihan; Liakakos, Theodore; Reynolds, John V; Morganti, Alessio G; Rosati, Riccardo; Castoro, Carlo; Cellini, Francesco; D'Ugo, Domenico; Roviello, Franco; Bencivenga, Maria; et al; Guckenberger, Matthias (2024). European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4). European Journal of Cancer, 204:114062.

Kirschenbaum, Daniel (2024). Investigating Immune Cells Across Time in Vivo. Nature Reviews Cancer, 24(6):359.

Hofer, Kevin D; Bühler, Marco M; Roncador, Marco; Rechsteiner, Markus; Maggio, Ewerton M; Tchinda, Joëlle; Schanz, Urs; Haralambieva, Eugenia; Widmer, Corinne C (2024). Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey. Leukemia & Lymphoma, 65(6):808-815.

Montagna, Giacomo; Mrdutt, Mary M; Sun, Susie X; Hlavin, Callie; Diego, Emilia J; Wong, Stephanie M; Barrio, Andrea V; van den Bruele, Astrid Botty; Cabioglu, Neslihan; Sevilimedu, Varadan; Rosenberger, Laura H; Hwang, E Shelley; Ingham, Abigail; Papassotiropoulos, Bärbel; Nguyen-Sträuli, Bich Doan; Kurzeder, Christian; Aybar, Danilo Díaz; Vorburger, Denise; Matlac, Dieter Michael; Ostapenko, Edvin; Riedel, Fabian; Fitzal, Florian; Meani, Francesco; Fick, Franziska; Sagasser, Jacqueline; Heil, Jörg; Karanlık, Hasan; Dedes, Konstantin J; Romics, Laszlo; Banys-Paluchowski, Maggie; et al (2024). Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncology, 10(6):793-798.

de Bloeme, Christiaan M; van Elst, Sabien; Galluzzi, Paolo; Jansen, Robin W; de Haan, Joeka; Göricke, Sophia; Moll, Annette C; Bot, Joseph C J; Munier, Francis L; Beck-Popovic, Maja; Puccinelli, Francesco; Aerts, Isabelle; Hadjistilianou, Theodora; Sirin, Selma; Koob, Mériam; Brisse, Hervé J; Cardoen, Liesbeth; Maeder, Philippe; de Jong, Marcus C; de Graaf, Pim (2024). MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma. Cancers, 16(10):1899.

Deng, Wei H; Zürcher, Simeon J; Schindera, Christina; Jung, Ruedi; Hebestreit, Helge; Bänteli, Iris; Bologna, Katja; von der Weid, Nicolas X; Kriemler, Susi; Rueegg, Corina S (2024). Effect of a 1-year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors-A randomized controlled trial (SURfit). Cancer, 130(10):1869-1883.

Hinzpeter, Ricarda; Mirshahvalad, Seyed Ali; Murad, Vanessa; Avery, Lisa; Kulanthaivelu, Roshini; Kohan, Andres; Ortega, Claudia; Elimova, Elena; Yeung, Jonathan; Hope, Andrew; Metser, Ur; Veit-Haibach, Patrick (2024). The [$^{18}$F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle Study. Cancers, 16(10):1873.

Egli, Lukas; Kaulfuss, Meike; Mietz, Juliane; Picozzi, Arianna; Verhoeyen, Els; Münz, Christian; Chijioke, Obinna (2024). CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison. Experimental Hematology & Oncology, 13(1):51.

Kähler, Katharina C; Gutzmer, Ralf; Angela, Yenny; Livingstone, Elisabeth; Lodde, Georg; Meiss, Frank; Rafei-Shamsabadi, David A; Weyer-Fahlbusch, Sera S; Nashan, Dorothée; Loquai, Carmen; Hassel, Jessica C; Sachse, Michael M M; Maul, Lara Valeska; Heinzerling, Lucie; Heppt, Markus V; Colapietro, Chiara; Rusch, Judith; Blome, Christine (2024). Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective. Journal of Cancer Research and Clinical Oncology, 150(5):252.

Kraehenbuehl, Lukas; Wolchok, Jedd D; Merghoub, Taha; Hirschhorn, Daniel (2024). Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effects. Cancer Cell, 42(5):738-741.

Albrecht, Lea Jessica; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B; Váraljai, Renáta; Lodde, Georg; Placke, Jan Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Roesch, Alexander; Schulz, Carsten; Berking, Carola; Pöttgen, Christoph; Menzies, Alexander M; Long, Georgina V; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa (2024). Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma. European Journal of Cancer, 202:113976.

Bührer, Emanuel; D'Haese, David; Daugaard, Gedske; de Wit, Ronald; Albany, Costantine; Tryakin, Alexey; Fizazi, Karim; Stahl, Olof; Gietema, Jourik A; De Giorgi, Ugo; Cafferty, Fay H; Hansen, Aaron R; Tandstad, Torgrim; Huddart, Robert A; Necchi, Andrea; Sweeney, Christopher J; Garcia-Del-Muro, Xavier; Heng, Daniel Y C; Lorch, Anja; Chovanec, Michal; Winquist, Eric; Grimison, Peter; Feldman, Darren R; Terbuch, Angelika; Hentrich, Marcus; Bokemeyer, Carsten; Negaard, Helene; Fankhauser, Christian; Shamash, Jonathan; Vaughn, David J; et al (2024). Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium. European Journal of Cancer, 202:114042.

Winkler, Julia K; Kommoss, Katharina S; Toberer, Ferdinand; Enk, Alexander; Maul, Lara Valeska; Navarini, Alexander A; Hudson, Jeremy; Salerni, Gabriel; Rosenberger, Albert; Haenssle, Holger A (2024). Performance of an automated total body mapping algorithm to detect melanocytic lesions of clinical relevance. European Journal of Cancer, 202:114026.

Chen, Liang; Li, Haotong; Liu, Xiaorui; Zhang, Ningning; Wang, Kui; Shi, Anteng; Gao, Hang; Akdis, Deniz; Saguner, Ardan M; Xu, Xinjie; Osto, Elena; van de Veen, Willem; Li, Guangyu; Bayés-Genís, Antoni; Duru, Firat; Song, Jiangping; Li, Xiangjie; Hu, Shengshou (2024). PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis. Signal Transduction and Targeted Therapy, 9(1):94.

Ganz, Patricia A; Bandos, Hanna; Španić, Tanja; Friedman, Sue; Müller, Volkmar; Kuemmel, Sherko; Delaloge, Suzette; Brain, Etienne; Toi, Masakazu; Yamauchi, Hideko; de Dueñas, Eduardo-M; Armstrong, Anne; Im, Seock-Ah; Song, Chuan-gui; Zheng, Hong; Sarosiek, Tomasz; Sharma, Priyanka; Geng, Cuizhi; Fu, Peifen; Rhiem, Kerstin; Frauchiger-Heuer, Heike; Wimberger, Pauline; t'Kint de Roodenbeke, Daphné; Liao, Ning; Goodwin, Annabel; Chakiba-Brugère, Camille; Friedlander, Michael; Lee, Keun Seok; Giacchetti, Sylvie; Takano, Toshimi; et al (2024). Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer. Journal of Clinical Oncology, 42(11):1288-1300.

Colucci, Manuel; Zumerle, Sara; Bressan, Silvia; Gianfanti, Federico; Troiani, Martina; Valdata, Aurora; D’Ambrosio, Mariantonietta; Pasquini, Emiliano; Varesi, Angelica; Cogo, Francesca; Mosole, Simone; Dongilli, Cristina; Desbats, Maria Andrea; Contu, Liliana; Revankdar, Ajinkya; Chen, Jingjing; Kalathur, Madhuri; Perciato, Maria Luna; Basilotta, Rossella; Endre, Laczko; Schauer, Stefan; Othman, Alaa; Guccini, Ilaria; Saponaro, Miriam; Maraccani, Luisa; Bancaro, Nicolò; Lai, Ping; Liu, Lei; Pernigoni, Nicolò; Mele, Federico; et al (2024). Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell, 42(4):646-661.e9.

Jiang, Xing; Pestoni, Giulia; Vinci, Linda; Suter, Flurina; Lorez, Matthias; Rohrmann, Sabine; Karavasiloglou, Nena (2024). Cancer cases attributable to modifiable lifestyle risk factors in Switzerland between 2015 and 2019. International Journal of Cancer, 154(7):1221-1234.

Mueller, Sabine; Kline, Cassie; Franson, Andrea; van der Lugt, Jasper; Prados, Michael; Waszak, Sebastian M; Plasschaert, Sabine L A; Molinaro, Annette M; Koschmann, Carl; Nazarian, Javad (2024). Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC. Neuro-Oncology, 26(2):S125-S135.

Roy, Debasish; Subramaniam, Bavani; Chong, Wai Chin; Bornhorst, Miriam; Packer, Roger J; Nazarian, Javad (2024). Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers. Cancers, 16(7):1361.

Wachtel, Marco; Surdez, Didier; Grunewald, Thomas G P; Schäfer, Beat W (2024). Functional Classification of Fusion Proteins in Sarcoma (2024/04/13). Cancers, 16(7):1355.

Mazzatenta, Diego; Rustici, Arianna; Serra, Carlo (2024). Editorial: Advances and controversies in skull base tumors: implication for diagnosis, treatment and management. Frontiers in Oncology, 14:1377868.

Riggenbach, Elena; Waser, Manuel; Mueller, Simon A; Aebersold, Daniel M; Giger, Roland; Elicin, Olgun (2024). Oncologic outcome with versus without target volume compartmentalization in postoperative radiotherapy for oral cavity squamous cell carcinoma. Frontiers in Oncology, 14:1362025.

Pöhlmann, Johannes; Weller, Michael; Marcellusi, Andrea; Grabe-Heyne, Kristin; Krott-Coi, Lucia; Rabar, Silvia; Pollock, Richard F (2024). High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma. Frontiers in Oncology, 14:1368606.

Janku, Filip; Choong, Grace M; Opyrchal, Mateusz; Dowlati, Afshin; Hierro, Cinta; Rodon, Jordi; Wicki, Andreas; Forster, Martin D; Blagden, Sarah P; Yin, Jun; Reid, Joel M; Muller, Helene; Cmiljanovic, Natasa; Cmiljanovic, Vladimir; Adjei, Alex A (2024). A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers, 16(6):1137.

Schadendorf, Dirk; Luke, Jason John; Ascierto, Paolo A; Long, Georgina V; Rutkowski, Piotr; Khattak, Adnan; Del Vecchio, Michele; de la Cruz-Merino, Luis; Mackiewicz, Jacek; Sileni, Vanna Chiarion; Kirkwood, John M; Robert, Caroline; Grob, Jean-Jacques; Dummer, Reinhard; Carlino, Matteo S; Zhao, Yujie; Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander; Scolyer, Richard A (2024). Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. Journal for ImmunoTherapy of Cancer, 12(3):e007501.

Thieme, Michael; Minadakis, Nikolaos; Himber, Christophe; Keller, Bettina; Xu, Wenbo; Rutowicz, Kinga; Matteoli, Calvin; Böhrer, Marcel; Rymen, Bart; Laudencia-Chingcuanco, Debbie; Vogel, John P; Sibout, Richard; Stritt, Christoph; Blevins, Todd; Roulin, Anne C (2024). Transposition of HOPPLA in siRNA-deficient plants suggests a limited effect of the environment on retrotransposon mobility in Brachypodium distachyon. PLoS Genetics, 20(3):e1011200.

Schumacher, Max; Beer, Sina; Moraes Ribeiro, Emmanuelle; Korkmaz, Fulya; Keppeler, Hildegard; Fitzel, Rahel; Erkner, Estelle; Radszuweit, Pia; Lengerke, Claudia; Schneidawind, Corina; Hoefert, Sebastian; Mauz, Paul Stefan; Schneidawind, Dominik (2024). Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype. Frontiers in Oncology, 14:1333640.

Stenz, Nadja A; Morand, Grégoire B; Schoch, Manuel; Werner, Jonas; Rajan, Gunesh P (2024). Use of Indocyanine Green Near-Infrared Imaging for Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Pilot Study. Molecular Imaging and Biology, 26(2):264-271.

Taylor, Amelia M; McKeown, Janet; Dimitriou, Florentia; Jacques, Sarah K; Zimmer, Lisa; Allayous, Clara; Yeoh, Hui-Ling; Haydon, Andrew; Ressler, Julia M; Galea, Claire; Woodford, Rachel; Kahler, Katharina; Hauschild, Axel; Festino, Lucia; Hoeller, Christoph; Schwarze, Julia K; Neyns, Bart; Wicky, Alexandre; Michielin, Olivier; Placzke, Joanna; Rutkowski, Piotr; Johnson, Douglas B; Lebbe, Celeste; Dummer, Reinhard; Ascierto, Paolo A; Lo, Serigne; Long, Georgina V; Carlino, Matteo S; Menzies, Alexander M (2024). Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy. European Journal of Cancer, 199:113561.

Steiner, Sabrina; Pliego-Mendieta, Alicia; Haberecker, Martina; Hussung, Saskia; Kollár, Anna; Fritsch, Ralph; Arnold, Fabian; Lenggenhager, Daniela; Planas-Paz, Lara; Pauli, Chantal (2024). Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilities. Cancer Letters, 584:216650.

de Souza, Natalie; Zhao, Shan; Bodenmiller, Bernd (2024). Multiplex protein imaging in tumour biology. Nature Reviews Cancer, 24(3):171-191.

Jacques, Sarah K; McKeown, Janet; Grover, Piyush; Johnson, Douglas B; Zaremba, Anne; Dimitriou, Florentia; Weiser, Roi; Farid, Mohamad; Namikawa, Kenjiro; Sullivan, Ryan J; Rutkowski, Piotr; Lebbe, Celeste; Hamid, Omid; Zager, Jonathan S; Michielin, Olivier; Neyns, Bart; Nakamura, Yasuhiro; Robert, Caroline; Mehnert, Janice; Ascierto, Paolo A; Bhave, Prachi; Park, Benjamin; Zimmer, Lisa; Mangana, Joanna; Mooradian, Megan; Placzke, Joanna; Allayous, Clare; Glitza Oliva, Isabella C; Mehmi, Inderjit; Depalo, Danielle; et al (2024). Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy. European Journal of Cancer, 199:113563.

de Boo, L W; Jóźwiak, K; Ter Hoeve, N D; van Diest, P J; Opdam, M; Wang, Y; Schmidt, M K; de Jong, V; Kleiterp, S; Cornelissen, S; Baars, D; Koornstra, R H T; Kerver, E D; van Dalen, T; Bins, A D; Beeker, A; van den Heiligenberg, S M; de Jong, P C; Bakker, S D; Rietbroek, R C; Konings, I R; Blankenburgh, R; Bijlsma, R M; Imholz, A L T; Stathonikos, N; Vreuls, W; Sanders, J; Rosenberg, E H; Koop, E A; Varga, Z; et al (2024). Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer. ESMO Open, 9(3):102923.

Ertl, Carolin; Ruf, Theresa; Mentzer, Dirk; Kong, Mingzi; Kramer, Rafaela; von Bergwelt-Baildon, Michael; Subklewe, Marion; Tomsitz, Dirk; Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen; Lebbe, Celeste; Long, Georgina V; McArthur, Grant; Neilan, Tomas G; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Zimmer, Lisa; Eigentler, Thomas; Grabbe, Stephan; Forschner, Andrea; Kähler, Katharina C; Milani, Valeria; Pföhler, Claudia; Hassel, Jessica; Gutzmer, Ralf; Loquai, Carmen; Routy, Bertrand; Furness, Andrew J S; et al (2024). The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects. European Journal of Cancer, 199:113505.

Hermanns, Thomas; Wettstein, Marian S; Kaufmann, Basil; Lautenbach, Noémie; Kaufmann, Ernest; Saba, Karim; Schmid, Florian A; Hötker, Andreas M; Müntener, Michael; Umbehr, Martin; Poyet, Cedric (2024). BioPrev-C - development and validation of a contemporary prostate cancer risk calculator. Frontiers in Oncology, 14:1343999.

Staeger, Ramon; Martínez-Gómez, Julia M; Turko, Patrick; Ramelyte, Egle; Kraehenbuehl, Lukas; Del Prete, Valerio; Hasan Ali, Omar; Levesque, Mitchell P; Dummer, Reinhard; Nägeli, Mirjam C; Mangana, Joanna (2024). Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland. Cancers, 16(5):854.

Bae, Sun Hyun; Chun, Seok-Joo; Chung, Joo-Hyun; Kim, Eunji; Kang, Jin-Kyu; Jang, Won Il; Moon, Ji Eun; Roquette, Isaure; Mirabel, Xavier; Kimura, Tomoki; Ueno, Masayuki; Su, Ting-Shi; Tree, Alison C; Guckenberger, Matthias; Lo, Simon S; Scorsetti, Marta; Slotman, Ben J; Kotecha, Rupesh; Sahgal, Arjun; Louie, Alexander V; Kim, Mi-Sook (2024). Stereotactic body radiotherapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines. International Journal of Radiation Oncology, Biology, Physics, 118(2):337-351.

Le Rhun, Emilie; Gorlia, Thierry; Felsberg, Jörg; Jongen, Joost; Maurage, Claude-Alain; Ducray, François; Gramatzki, Dorothee; Hau, Peter; Chinot, Olivier L; Preusser, Matthias; Cartalat, Stéphanie; Roth, Patrick; van den Bent, Martin; Furtner, Julia; Collienne, Maike; Reifenberger, Guido; Weller, Michael (2024). Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial. European Journal of Cancer, 198:113475.

Weber, Remi; Weller, Michael; Reifenberger, Guido; Vasella, Flavio (2024). Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells. Frontiers in Oncology, 14:1342114.

Moraes Ribeiro, Emmanuelle; Secker, Kathy-Ann; Nitulescu, Ana-Maria; Schairer, Rebekka; Keppeler, Hildegard; Wesle, Anton; Schmid, Hannes; Schmitt, Anita; Neuber, Brigitte; Chmiest, Daniela; Podavini, Silvia; Märklin, Melanie; Klimovich, Boris; Schmitt, Michael; Korkmaz, Fulya; Lengerke, Claudia; Schneidawind, Corina; Schneidawind, Dominik (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer, 12(1):e007829.

Kaur, Pushpinder; Ring, Alexander; Porras, Tania B; Zhou, Guang; Lu, Janice; Kang, Irene; Lang, Julie E (2024). Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes. Cancers, 16(3):516.

Heining, Franziska Maria; Bieri, Uwe; Niemann, Tilo; Maletzki, Philipp; Tschung, Christopher; Adank, Jean-Pascal; Rössler, Fabian; Nocito, Antonio; Hefermehl, Lukas John (2024). The Transabdominal Lumbar Approach (TALA) for Robotic Renal Surgery-A Retrospective Single-Center Comparative Study and Step-by-Step Description of a Novel Approach. Cancers, 16(2):446.

Erkner, Estelle; Hentrich, Thomas; Schairer, Rebekka; Fitzel, Rahel; Secker-Grob, Kathy-Ann; Jeong, Johan; Keppeler, Hildegard; Korkmaz, Fulya; Schulze-Hentrich, Julia M; Lengerke, Claudia; Schneidawind, Dominik; Schneidawind, Corina (2024). The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia. Oncogene, 43(4):281-293.

Mastall, Maximilian; Roth, Patrick; Bink, Andrea; Fischer Maranta, Angela; Läubli, Heinz; Hottinger, Andreas Felix; Hundsberger, Thomas; Migliorini, Denis; Ochsenbein, Adrian; Seystahl, Katharina; Imbach, Lukas; Hortobágyi, Tibor; Held, Leonhard; Weller, Michael; Wirsching, Hans-Georg (2024). A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC Cancer, 24(1):82.

Wagner, Nikolaus B; Lenders, Max M; Kühl, Kathrin; Reinhardt, Lydia; Fuchß, Milena; Ring, Natalie; Stäger, Ramon; Zellweger, Caroline; Ebel, Chiara; Kimeswenger, Susanne; Oellinger, Angela; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Klumpp, Bernhard; Hoetzenecker, Wolfram; Terheyden, Patrick; Mangana, Joanna; Loquai, Carmen; Cozzio, Antonio; Garbe, Claus; Meier, Friedegund; Eigentler, Thomas K; Flatz, Lukas (2024). Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy. European Journal of Cancer, 196:113425.

Huntjens, Daan W; Vanhommerig, Joost W; van de Veen, Willem; Crul, Mirjam (2024). Exclusion of Ranitidine From Premedication Regimens During Paclitaxel Treatment. JAMA Oncology, 10(1):131.

Mohan, Ajay-Mohan; Prasad, Sonal; Schmitz-Peiffer, Fabian; Lange, Catharina; Lukas, Mathias; Koziolek, Eva J; Albrecht, Jakob; Messroghli, Daniel; Stein, Ulrike; Ilmer, Matthias; Wang, Katharina; Schober, Laura; Reul, Astrid; Maurer, Julian; Friemel, Juliane; Weber, Achim; Zuellig, Richard A; Hantel, Constanze; Fritsch, Ralph; Reincke, Martin; Pacak, Karel; Grossman, Ashley B; Auernhammer, Christoph J; Beuschlein, Felix; Brenner, Winfried; Beindorff, Nicola; Nölting, Svenja (2024). Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model. Endocrine-Related Cancer, 31(1):15.

Hepner, Adriana; Versluis, Judith M; Wallace, Roslyn; Allayous, Clara; Brown, Lauren Julia; Trojaniello, Claudia; Gerard, Camille Lea; Jansen, Yanina JL; Bhave, Prachi; Neyns, Bart; Haydon, Andrew; Michielin, Olivier; Mangana, Joanna; Klein, Oliver; Shoushtari, Alexander N; Warner, Allison Betof; Ascierto, Paolo Antonio; McQuade, Jennifer Leigh; Carlino, Matteo S; Zimmer, Lisa; Lebbe, Celeste; Johnson, Douglas B; Sandhu, Shahneen; Atkinson, Victoria; Blank, Christian U; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M (2024). The features and management of acquired resistance to PD1-based therapy in metastatic melanoma. European Journal of Cancer, 196:113441.

Beckers, Claire; Pruschy, Martin; Vetrugno, Irene (2024). Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities. Seminars in Cancer Biology, 98:19-30.

Habringer, Stefan; Demel, Uta M; Fietz, Anne-Katrin; Lammer, Felicitas; Schroers, Roland; Hofer, Silvia; Bairey, Osnat; Braess, Jan; Meier-Stiegen, Anna Sofia; Stuhlmann, Reingard; Schmidt-Hieber, Martin; Hoffmann, Johannes; Zinngrebe, Bettina; Kaiser, Ulrich; Reimer, Peter; Möhle, Robert; Fix, Peter; Höffkes, Heinz-Gert; Langenkamp, Ulrich; Büschenfelde, Christian Meyer zum; Hopfer, Olaf; Stoltefuß, Andrea; La Rosée, Paul; Blasberg, Henning; Jordan, Karin; Kaun, Stephan; Meurer, Anna; Unteroberdörster, Meike; von Brünneck, Ann-Christin; Capper, David; et al (2024). A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma. European Journal of Cancer, 196:113436.

Janku, Filip; Kim, Tae Min; Iyer, Gopakumar; Spreafico, Anna; Elez, Elena; de Jonge, Maja; Yamamoto, Noboru; van der Wekken, Anthonie J; Ascierto, Paolo Antonio; Maur, Michela; Marmé, Frederik; Kiladjian, Jean-Jacques; Basu, Sumit; Baffert, Fabienne; Buigues, Amparo; Chen, Chi; Cooke, Vesselina; Giorgetti, Elisa; Kim, Jaeyeon; McCarthy, Fiona; Moschetta, Michele; Dummer, Reinhard (2024). First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations. European Journal of Cancer, 196:113458.

Gupta, Shibu; Guérin, Amandine; Herger, Aline; Hou, Xiaoyu; Schaufelberger, Myriam; Roulard, Romain; Diet, Anouck; Roffler, Stefan; Lefebvre, Valérie; Wicker, Thomas; Pelloux, Jérôme; Ringli, Christoph (2024). Growth-inhibiting effects of the unconventional plant APYRASE 7 of Arabidopsis thaliana influences the LRX/RALF/FER growth regulatory module. PLoS Genetics, 20(1):e1011087.

Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Arber, Caroline; Chalandon, Yves; Daskalakis, Michael; Diepold, Miriam; Diesch-Furlanetto, Tamara; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Heim, Dominik; Hitz, Felicitas; Holbro, Andreas; Masouridi-Levrat, Stavroula; Nair, Gayathri; Novak, Urban; Pabst, Thomas; Renner, Christoph; Stussi, Georg; Schneidawind, Dominik; Schanz, Urs; Wannesson, Luciano; Halter, Jörg P; Swiss Blood Stem Cell Transplantation Group (SBST) (2024). Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematological oncology, 42(1):e3241.

de Ramon Ortiz, Carmen; Wang, Sisi; Stathis, Anastasios; Bertoni, Francesco; Zenz, Thorsten; Novak, Urban; Simonetta, Federico (2024). How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? Hematological oncology, 42(1):e3237.

Guckenberger, Matthias; Andratschke, Nicolaus; Chung, Caroline; Fuller, Dave; Tanadini-Lang, Stephanie; Jaffray, David A (2024). The Future of MR-Guided Radiation Therapy. Seminars in Radiation Oncology, 34(1):135-144.

McDonald, Brigid A; Dal Bello, Riccardo; Fuller, Clifton D; Balermpas, Panagiotis (2024). The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance. Seminars in Radiation Oncology, 34(1):69-83.

Danielli, Sara G; Wurth, Jakob; Morice, Sarah; Kisele, Samanta; Surdez, Didier; Delattre, Olivier; Bode, Peter K; Wachtel, Marco; Schäfer, Beat W (2024). Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer (2024/03/13). Molecular Cancer Therapeutics, 23(6):864-876.

El Saadany, Tämer; Lorch, Anja; Milowsky, Matthew I; Vogl, Ursula Maria; Cathomas, Richard (2024). PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion. Frontiers in Oncology, 14:1427452.

2023

Janczak, Joanna; Ukegjini, Kristjan; Bischofberger, Stephan; Turina, Matthias; Müller, Philip C; Steffen, Thomas (2023). Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review. Cancers, 16(1):26.

Meissner, Ramona; Wixler, Viktor; Wulfert, Franziska Paulina; Jacob, Jasmin Carina; Hale, Benjamin G; Robeck, Thomas; Masemann, Dörthe; Boergeling, Yvonne; Ludwig, Stephan (2023). Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer. Molecular Therapy : Oncolytics, 31:100741.

Münz, Christian (2023). Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. Cancers, 15(24):5739.

Schmid, Peter; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Muñoz-Couselo, Eva; Lee, Keun Seok; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Mejia, Jaime A; Zhou, Xuan; Haiderali, Amin; Nguyen, Allison Martin; Cortes, Javier; Winer, Eric P (2023). Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study. European Journal of Cancer, 195:113393.

Abou Khouzam, Raefa; Janji, Bassam; Thiery, Jerome; Zaarour, Rania Faouzi; Chamseddine, Ali N; Mayr, Hemma; Savagner, Pierre; Kieda, Claudine; Gad, Sophie; Buart, Stéphanie; Lehn, Jean-Marie; Limani, Perparim; Chouaib, Salem (2023). Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy. Seminars in Cancer Biology, 97:104-123.

von der Grün, Jens; Ahmadsei, Maiwand; Breyer, Isabel; Britschgi, Christian; Eberli, Daniel; Hermanns, Thomas; Mangana, Joanna; Petrowsky, Henrik; Ramelyte, Egle; Roth, Patrick; Schär, Gabriel; Opitz, Isabelle; Weller, Michael; Wicki, Andreas; Witzel, Isabell; Balermpas, Panagiotis; Guckenberger, Matthias (2023). Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center. Neoplasia, 46:100946.

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix; Pacak, Karel; Skogseid, Britt; Crona, Joakim (2023). Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'. Endocrine-Related Cancer, 31(1):e230271.

Dirr, Valerian; Vetter, Diana; Sartoretti, Thomas; Schneider, Marcel André; Da Canal, Francesca; Gutschow, Christian A (2023). Quality of Life and Independent Factors Associated with Poor Digestive Function after Ivor Lewis Esophagectomy. Cancers, 15(23):5569.

Bachtiary, Barbara; Grawehr, Leonie; Grillo Ruggieri, Filippo; Held, Ulrike; Weber, Damien C (2023). Financial Toxicity in Swiss Cancer Patients Treated with Proton Therapy: An Observational Cross-Sectional Study on Self-Reported Outcome. Cancers, 15(23):5498.

Wen, Patrick Y; van den Bent, Martin; Youssef, Gilbert; Cloughesy, Timothy F; Ellingson, Benjamin M; Weller, Michael; Galanis, Evanthia; Barboriak, Daniel P; de Groot, John; Gilbert, Mark R; Huang, Raymond; Lassman, Andrew B; Mehta, Minesh; Molinaro, Annette M; Preusser, Matthias; Rahman, Rifaquat; Shankar, Lalitha K; Stupp, Roger; Villanueva-Meyer, Javier E; Wick, Wolfgang; Macdonald, David R; Reardon, David A; Vogelbaum, Michael A; Chang, Susan M (2023). RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Journal of Clinical Oncology, 41(33):5187-5199.

Ausejo-Mauleon, Iker; Labiano, Sara; de la Nava, Daniel; Laspidea, Virginia; Zalacain, Marta; Marrodán, Lucía; García-Moure, Marc; González-Huarriz, Marisol; Hervás-Corpión, Irati; Dhandapani, Laasya; Vicent, Silvestre; Collantes, Maria; Peñuelas, Iván; Becher, Oren J; Filbin, Mariella G; Jiang, Li; Labelle, Jenna; de Biagi-Junior, Carlos A O; Nazarian, Javad; Laternser, Sandra; Phoenix, Timothy N; van der Lugt, Jasper; Kranendonk, Mariette; Hoogendijk, Raoull; Mueller, Sabine; De Andrea, Carlos; Anderson, Ana C; Guruceaga, Elizabeth; Koschmann, Carl; Yadav, Viveka Nand; et al (2023). TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell, 41(11):1911-1926.e8.

Harnisch, Kim; Steiner, Sabrina; Pliego-Mendieta, Alicia; Chen, Yanjiang; Planas-Paz, Lara; Pauli, Chantal (2023). Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1). Human Cell, 37(1):356-363.

Raetz, Elizabeth A; Rebora, Paola; Conter, Valentino; Schrappe, Martin; Devidas, Meenakshi; Escherich, Gabriele; Imai, Chihaya; De Moerloose, Barbara; Schmiegelow, Kjeld; Burns, Melissa A; Elitzur, Sarah; Pieters, Rob; Attarbaschi, Andishe; Yeoh, Allen; Pui, Ching-Hon; Stary, Jan; Cario, Gunnar; Bodmer, Nicole; Moorman, Anthony V; Buldini, Barbara; Vora, Ajay; Valsecchi, Maria Grazia (2023). Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. Journal of Clinical Oncology, 41(32):5025-5034.

Pavic, Matea; Wolfer, Anita; Li, Qiyu; Gircys, Arunas; Juritz, Stephanie; Wicki, Andreas; Cerny, Thomas; Rohr, Ulrich-Peter (2023). Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective. Journal of Clinical Oncology, 41(32):4973-4975.

Voglis, Stefanos; Padevit, Luis; van Niftrik, Christiaan Hendrik Bas; Kälin, Vincens; Beyersdorf, Benjamin; Da Mutten, Raffaele; Stumpo, Vittorio; Bellomo, Jacopo; Sarnthein, Johannes; Staartjes, Victor Egon; Carretta, Alessandro; Krayenbühl, Niklaus; Regli, Luca; Serra, Carlo (2023). Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases. Journal of Neuro-Oncology, 165(2):271-278.

Hänsch, Lena; Peipp, Matthias; Mastall, Maximilian; Villars, Danielle; Myburgh, Renier; Silginer, Manuela; Weiss, Tobias; Gramatzki, Dorothee; Vasella, Flavio; Manz, Markus G; Weller, Michael; Roth, Patrick (2023). Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma. Neuro-Oncology, 25(11):2001-2014.

Roth, Patrick (2023). Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells? Neuro-Oncology, 25(11):2072-2073.

Mueller, Sabine; Kline, Cassie; Stoller, Schuyler; Lundy, Shannon; Christopher, Lauren; Reddy, Alyssa T; Banerjee, Anu; Cooney, Tabitha M; Raber, Shannon; Hoffman, Carly; Luks, Tracy; Wembacher-Schroeder, Eva; Lummel, Nina; Zhang, Yalan; Bonner, Erin R; Nazarian, Javad; Molinaro, Annette M; Prados, Michael; Villanueva-Meyer, Javier E; Gupta, Nalin (2023). PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. Neuro-Oncology, 25(11):2074-2086.

Westphalen, C B; Federer-Gsponer, J; Pauli, C; Karapetyan, A R; Chalabi, N; Durán-Pacheco, G; Beringer, A; Bochtler, T; Cook, N; Höglander, E; Jin, D X; Losa, F; Mileshkin, L; Moch, H; Ross, J S; Sokol, E S; Tothill, R W; Krämer, A (2023). Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. ESMO Open, 8(6):102035.

Fan, Xuehui; Yang, Guoqiang; Duru, Firat; Grilli, Maurizio; Akin, Ibrahim; Zhou, Xiaobo; Saguner, Ardan Muammer; Ei-Battrawy, Ibrahim (2023). Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology. Stem Cell Reviews and Reports, 19(8):2683-2708.

Naschberger, Elisabeth; Fuchs, Maximilian; Dickel, Nicholas; Kunz, Meik; Popp, Bernt; Anchang, Charles Gwellem; Demmler, Richard; Lyu, Yanmin; Uebe, Steffen; Ekici, Arif Bülent; Geppert, Carol Immanuel; Hartmann, Arndt; Flierl, Christian; Petter, Katja; Gass, Tobias; Völkl, Simon; Scharl, Michael; Ramming, Andreas; Günther, Claudia; Merkel, Susanne; Schellerer, Vera Simone; Stürzl, Michael (2023). Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome. Cancer Communications, 43(11):1280-1285.

Li, Minghao; Richter, Susan; Mohr, Hermine; Drukewitz, Stephan; Poser, Isabel; Stanke, Daniela; Calsina, Bruna; Martinez-Montes, Angel M; Quinkler, Marcus; Timmers, Henri J L M; Nölting, Svenja; Beuschlein, Felix; Remde, Hanna; Opocher, Giuseppe; Rapizzi, Elena; Pacak, Karel; Pamporaki, Christina; Robledo, Mercedes; Liu, Longfei; Jiang, Jingjing; Bornstein, Stefan R; Eisenhofer, Graeme; Fliedner, Stephanie M J; Bechmann, Nicole (2023). Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas. Endocrine-Related Cancer, 30(12):e230230.

Fischer, Alessa; Maccio, Umberto; Wang, Katharina; Friemel, Juliane; Broglie Daeppen, Martina A; Vetter, Diana; Lehmann, Kuno; Reul, Astrid; Robledo, Mercedes; Hantel, Constanze; Bechmann, Nicole; Pacak, Karel; Zitzmann, Kathrin; Auernhammer, Christoph J; Grossman, Ashley B; Beuschlein, Felix; Nölting, Svenja (2023). PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization. Cancers, 15(21):5199.

Spadarotto, Nadine; Sauck, Anja; Hainc, Nicolin; Keller, Isabelle; John, Hubert; Hohmann, Joachim (2023). Quantitative Evaluation of Apparent Diffusion Coefficient Values, ISUP Grades and Prostate-Specific Antigen Density Values of Potentially Malignant PI-RADS Lesions. Cancers, 15(21):5183.

Sarvan, Milos; Etienne, Harry; Bankel, Lorenz; Brown, Michelle L; Schneiter, Didier; Opitz, Isabelle (2023). Outcome Analysis of Treatment Modalities for Thoracic Sarcomas. Cancers, 15(21):5154.

Sajibu, Sija; Sonder, Emanuel; Tiwari, Amit; Orjuela, Stephany; Parker, Hannah R; Frans, Olivier The; Gubler, Christoph; Marra, Giancarlo; Robinson, Mark D (2023). Validation of hypermethylated DNA regions found in colorectal cancers as potential aging-independent biomarkers of precancerous colorectal lesions. BMC Cancer, 23(1):998.

Vrugt, Bart; Kirschner, Michaela B; Meerang, Mayura; Oehl, Kathrin; Wagner, Ulrich; Soltermann, Alex; Moch, Holger; Opitz, Isabelle; Wild, Peter J (2023). Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma. Cancers, 15(20):4978.

Strubel, Alexander; Münick, Philipp; Hartmann, Oliver; Chaikuad, Apirat; Dreier, Birgit; Schaefer, Jonas V; Gebel, Jakob; Osterburg, Christian; Tuppi, Marcel; Schäfer, Birgit; Buck, Viktoria; Rosenfeldt, Mathias; Knapp, Stefan; Plückthun, Andreas; Diefenbacher, Markus E; Dötsch, Volker (2023). DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma. Cell Death and Disease, 14(10):674.

Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Robert, Caroline; Flaherty, Keith T (2023). Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial. Journal of Clinical Oncology, 41(29):4621-4631.

Laetsch, Dominik R; Bisschop, Gertjan; Martin, Simon H; Aeschbacher, Simon; Setter, Derek; Lohse, Konrad (2023). Demographically explicit scans for barriers to gene flow using gIMble. PLoS Genetics, 19(10):e1010999.

Liebers, Nora; Bruch, Peter-Martin; Terzer, Tobias; Hernandez-Hernandez, Miguel; Paramasivam, Nagarajan; Fitzgerald, Donnacha; Altmann, Heidi; Roider, Tobias; Kolb, Carolin; Knoll, Mareike; Lenze, Angela; Platzbecker, Uwe; Röllig, Christoph; Baldus, Claudia; Serve, Hubert; Bornhäuser, Martin; Hübschmann, Daniel; Müller-Tidow, Carsten; Stölzel, Friedrich; Huber, Wolfgang; Benner, Axel; Zenz, Thorsten; Lu, Junyan; Dietrich, Sascha (2023). Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial. Nature Cancer, 4(12):1648-1659.

Le Rhun, Émilie; Weller, Michael; van den Bent, M; Brandsma, D; Furtner, J; Rudà, R; Schadendorf, D; Seoane, J; Tonn, J-C; Wesseling, P; Wick, W; Minniti, G; Peters, S; Curigliano, G; Preusser, M (2023). Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open, 8(5):101624.

Magnani, Chiara F; Myburgh, Renier; Brunn, Silvan; Chambovey, Morgane; Ponzo, Marianna; Volta, Laura; Manfredi, Francesco; Pellegrino, Christian; Pascolo, Steve; Miskey, Csaba; Ivics, Zoltán; Shizuru, Judith A; Neri, Dario; Manz, Markus G (2023). Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells. Molecular Therapy : Oncolytics, 30:56-71.

Champion, Ambroise; Zwhalen, Daniel Rudolf; Oehler, Christoph; Taussky, Daniel; Kroeze, Stephanie G C; Burger, Irene A; Benzaquen, David (2023). Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy? Frontiers in Oncology, 13:1268309.

De Saint-Hubert, Marijke; Boissonnat, Guillaume; Schneider, Uwe; Bäumer, Christian; Verbeek, Nico; Esser, Johannes; Wulff, Jörg; Stuckmann, Florian; Suesselbeck, Finja; Nabha, Racell; Dabin, Jérémie; Vasi, Fabiano; Radonic, Stephan; Rodriguez, Miguel; Simon, Anne Catherine; Journy, Neige; Timmermann, Beate; Thierry-Chef, Isabelle; Brualla, Lorenzo (2023). Complete patient exposure during paediatric brain cancer treatment for photon and proton therapy techniques including imaging procedures. Frontiers in Oncology, 13:1222800.

Luca, Edlira; Zitzmann, Kathrin; Bornstein, Stefan; Kugelmeier, Patrick; Beuschlein, Felix; Nölting, Svenja; Hantel, Constanze (2023). Three Dimensional Models of Endocrine Organs and Target Tissues Regulated by the Endocrine System. Cancers, 15(18):x-x.

Speicher, Philip; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Beyer, Jörg; Akhoundova, Dilara (2023). Excellent survival in relapsed stage I testicular cancer. BMC Cancer, 23(1):870.

Weiser, Annette; Sanchez Bergman, Astrid; Machaalani, Charbel; Bennett, Julie; Roth, Patrick; Reimann, Regina R; Nazarian, Javad; Guerreiro Stucklin, Ana S (2023). Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults. Frontiers in Oncology, 13:1254645.

Wagner, Sophia J; Reisenbüchler, Daniel; West, Nicholas P; Niehues, Jan Moritz; Zhu, Jiefu; Foersch, Sebastian; Veldhuizen, Gregory Patrick; Quirke, Philip; Grabsch, Heike I; van den Brandt, Piet A; Hutchins, Gordon G A; Richman, Susan D; Yuan, Tanwei; Langer, Rupert; Jenniskens, Josien C A; Offermans, Kelly; Mueller, Wolfram; Gray, Richard; Gruber, Stephen B; Greenson, Joel K; Rennert, Gad; Bonner, Joseph D; Schmolze, Daniel; Jonnagaddala, Jitendra; Hawkins, Nicholas J; Ward, Robyn L; Morton, Dion; Seymour, Matthew; Magill, Laura; Nowak, Marta; Koelzer, Viktor H; et al (2023). Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell, 41(9):1650-1661.e4.

Helmer, Stefanie M; Rogge, Alizé A; King, Ryan; Canella, Claudia; Pach, Daniel; Witt, Claudia M (2023). Effects of blended learning training for oncology physicians to advise their patients about complementary and integrative therapies: results from the multicenter cluster-randomized KOKON-KTO trial. BMC Cancer, 23(1):836.

Karschnia, Philipp; Dono, Antonio; Young, Jacob S; Juenger, Stephanie T; Teske, Nico; Häni, Levin; Sciortino, Tommaso; Mau, Christine Y; Bruno, Francesco; Nunez, Luis; Morshed, Ramin A; Haddad, Alexander F; Weller, Michael; van den Bent, Martin; Beck, Juergen; Hervey-Jumper, Shawn; Molinaro, Annette M; Tandon, Nitin; Rudà, Roberta; Vogelbaum, Michael A; Bello, Lorenzo; Schnell, Oliver; Grau, Stefan J; Chang, Susan M; Berger, Mitchel S; Esquenazi, Yoshua; Tonn, Joerg-Christian (2023). Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group. Neuro-Oncology, 25(9):1672-1685.

Trilla-Fuertes, Lucía; Gámez-Pozo, Angelo; Prado-Vázquez, Guillermo; López-Vacas, Rocío; Soriano, Virtudes; Garicano, Fernando; Lecumberri, M José; Rodríguez de la Borbolla, María; Majem, Margarita; Pérez-Ruiz, Elisabeth; González-Cao, María; Oramas, Juana; Magdaleno, Alejandra; Fra, Joaquín; Martín-Carnicero, Alfonso; Corral, Mónica; Puértolas, Teresa; Ramos-Ruiz, Ricardo; Dittmann, Antje; Nanni, Paolo; Fresno Vara, Juan Ángel; Espinosa, Enrique (2023). Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma. Cancers, 15(17):4407.

Cefalì, Marco; Scala, Isabel; Pavone, Giuliana; Helbling, Daniel; Hussung, Saskia; Fritsch, Ralph; Reiner, Cäcilia; Stocker, Soleen; Koeberle, Dieter; Kissling, Marc; Chianca, Vito; Del Grande, Filippo; De Dosso, Sara; Rizzo, Stefania (2023). Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients? Cancers, 15(17):4398.

Fuchs, Bruno; Schelling, Georg; Elyes, Maria; Studer, Gabriela; Bode-Lesniewska, Beata; Scaglioni, Mario F; Giovanoli, Pietro; Heesen, Philip; On Behalf Of The SwissSarcomaNetwork (2023). Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes. Cancers, 15(17):4395.

Syleouni, Maria-Eleni; Karavasiloglou, Nena; Manduchi, Laura; Wanner, Miriam; Korol, Dimitri; Ortelli, Laura; Bordoni, Andrea; Rohrmann, Sabine (2023). Predicting second breast cancer among women with primary breast cancer using machine learning algorithms, a population-based observational study. International Journal of Cancer, 153(5):932-941.

Pertz, Milena; Schlömer, Sabine; Seidel, Clemens; Hentschel, Bettina; Löffler, Markus; Schackert, Gabriele; Krex, Dietmar; Juratli, Tareq; Tonn, Joerg Christian; Schnell, Oliver; Vatter, Hartmut; Simon, Matthias; Westphal, Manfred; Martens, Tobias; Sabel, Michael; Bendszus, Martin; Dörner, Nils; Wick, Antje; Fliessbach, Klaus; Hoppe, Christian; Klingner, Marcel; Felsberg, Jörg; Reifenberger, Guido; Gramatzki, Dorothee; Weller, Michael; Schlegel, Uwe; German Glioma Network (2023). Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up. Journal of Neuro-Oncology, 164(2):353-366.

Schladerer, Sarah P; Otth, Maria; Scheinemann, Katrin (2023). Quality criteria for pediatric oncology centers: A systematic literature review. Cancer Medicine, 12(18):18999-19012.

Wanner, Miriam; Syleouni, Maria-Eleni; Karavasiloglou, Nena; Limam, Manuela; Bastiaannet, Esther; Korol, Dimitri; Rohrmann, Sabine (2023). Time-trends and age and stage differences in 5-year relative survival for common cancer types by sex in the canton of Zurich, Switzerland. Cancer Medicine, 12(17):18165-18175.

Rueegg, Corina S; Zürcher, Simeon J; Schindera, Christina; Jung, Ruedi; Deng, Wei H; Bänteli, Iris; Schaeff, Jonathan; Hebestreit, Helge; von der Weid, Nicolas X; Kriemler, Susi (2023). Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors-a randomised controlled trial (SURfit). British Journal of Cancer, 129(8):1284-1297.

Poel, Robert; Kamath, Amith J; Willmann, Jonas; Andratschke, Nicolaus; Ermiş, Ekin; Aebersold, Daniel M; Manser, Peter; Reyes, Mauricio (2023). Deep-Learning-Based Dose Predictor for Glioblastoma-Assessing the Sensitivity and Robustness for Dose Awareness in Contouring. Cancers, 15(17):4226.

Trilla‐Fuertes, Lucía; Gámez‐Pozo, Angelo; Nogué, Miguel; Busquier, Isabel; Arias, Fernando; López‐Campos, Fernando; Fernández‐Montes, Ana; Ruiz, Ana; Velázquez, Concepción; Martín‐Bravo, Celia; Pérez‐Ruiz, Elisabeth; Asensio, Elena; Hernández‐Yagüe, Xavier; Rodrigues, Aline; Ghanem, Ismael; López‐Vacas, Rocío; Hafez, Ahmed; Arias, Pedro; Dapía, Irene; Solís, Mario; Dittmann, Antje; Ramos, Ricardo; Llorens, Carlos; Maurel, Joan; Campos‐Barros, Ángel; Fresno Vara, Juan Ángel; Feliu, Jaime (2023). Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma. Cancer, 129(16):2581-2592.

Hoch, Dennis; Helnwein, Simon; Adrizzone, Davide; Lorch, Anja; Fankhauser, Christian; Hermanns, Thomas; Thalmann, George; Beyer, Jörg (2023). No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas. Oncology Research and Treatment, 46(10):433-437.

Freiberger, Sandra N; Holzmann, David; Morand, Grégoire B; Hüllner, Martin; Levesque, Mitchell Paul; Dummer, Reinhard; Koelzer, Viktor H; Rupp, Niels J (2023). Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients. Journal of Cancer Research and Clinical Oncology, 149(9):5645-5653.

Hertler, Caroline; Felsberg, Jörg; Gramatzki, Dorothee; Le Rhun, Emilie; Clarke, Jennifer; Soffietti, Riccardo; Wick, Wolfgang; Chinot, Olivier; Ducray, François; Roth, Patrick; McDonald, Kerrie; Hau, Peter; Hottinger, Andreas F; Reijneveld, Jaap; Schnell, Oliver; Marosi, Christine; Glantz, Michael; Darlix, Amélie; Lombardi, Giuseppe; Krex, Dietmar; Glas, Martin; Reardon, David A; van den Bent, Martin; Lefranc, Florence; Herrlinger, Ulrich; Razis, Evangelia; Carpentier, Antoine F; Phillips, Samuel; Rudà, Roberta; Wick, Antje; et al; Rushing, Elisabeth; Weller, Michael (2023). Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419). European Journal of Cancer, 189:112913.

Grockowiak, Elodie; Korn, Claudia; Rak, Justyna; Lysenko, Veronika; Hallou, Adrien; Panvini, Francesca M; Williams, Matthew; Fielding, Claire; Fang, Zijian; Khatib-Massalha, Eman; García-García, Andrés; Li, Juan; Khorshed, Reema A; González-Antón, Sara; Baxter, E Joanna; Kusumbe, Anjali; Wilkins, Bridget S; Green, Anna; Simons, Benjamin D; Harrison, Claire N; Green, Anthony R; Lo Celso, Cristina; Theocharides, Alexandre P A; Méndez-Ferrer, Simón (2023). Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms. Nature Cancer, 4(8):1193-1209.

Tonn, Svenja; Korshunov, Andrey; Obrecht, Denise; Sill, Martin; Spohn, Michael; von Hoff, Katja; Milde, Till; Pietsch, Torsten; Goschzik, Tobias; Bison, Brigitte; Juhnke, Björn-Ole; Struve, Nina; Sturm, Dominik; Sahm, Felix; Bockmayr, Michael; Friedrich, Carsten; von Bueren, André O; Gerber, Nicolas U; Benesch, Martin; Jones, David T W; Kool, Marcel; Wefers, Annika K; Schüller, Ulrich; Pfister, Stefan M; Rutkowski, Stefan; Mynarek, Martin (2023). Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups. Neuro-Oncology, 25(8):1518-1529.

Fan, Zheng; Ardicoglu, Raphaela; Batavia, Aashil A; Rust, Ruslan; von Ziegler, Lukas; Waag, Rebecca; Zhang, Jing; Desgeorges, Thibaut; Sturman, Oliver; Dang, Hairuo; Weber, Rebecca; Roszkowski, Martin; Moor, Andreas E; Schwab, Martin E; Germain, Pierre-Luc; Bohacek, Johannes; De Bock, Katrien (2023). The vascular gene Apold1 is dispensable for normal development but controls angiogenesis under pathological conditions. Angiogenesis, 26(3):385-407.

Brina, Daniela; Ponzoni, Adele; Troiani, Martina; Calì, Bianca; Pasquini, Emiliano; Attanasio, Giuseppe; Mosole, Simone; Mirenda, Michela; D'Ambrosio, Mariantonietta; Colucci, Manuel; Guccini, Ilaria; Revandkar, Ajinkya; Alajati, Abdullah; Tebaldi, Toma; Donzel, Deborah; Lauria, Fabio; Parhizgari, Nahjme; Valdata, Aurora; Maddalena, Martino; Calcinotto, Arianna; Bolis, Marco; Rinaldi, Andrea; Barry, Simon; Rüschoff, Jan Hendrik; Sabbadin, Marianna; Sumanasuriya, Semini; Crespo, Mateus; Sharp, Adam; Yuan, Wei; Grinu, Mathew; Moch, Holger; et al; Alimonti, Andrea (2023). The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nature Cancer, 4(8):1102-1121.

Jackson, Evangeline R; Duchatel, Ryan J; Staudt, Dilana E; Persson, Mika L; Mannan, Abdul; Yadavilli, Sridevi; Parackal, Sarah; Game, Shaye; Chong, Wai Chin; Jayasekara, W Samantha Nilanthi; Le Grand, Marion; Kearney, Padraic S; Douglas, Alicia M; Findlay, Izac J; Germon, Zacary P; McEwen, Holly P; Beitaki, Tyrone S; Patabendige, Adjanie; Skerrett-Byrne, David A; Nixon, Brett; Smith, Nathan D; Day, Bryan; Manoharan, Neevika; Nagabushan, Sumanth; Hansford, Jordan R; Govender, Dinisha; McCowage, Geoffrey B; Firestein, Ron; Howlett, Meegan; Nazarian, Javad; et al (2023). ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Cancer Research, 83(14):2421-2437.

Greenberg, Lauren; Ryom, Lene; Bakowska, Elzbieta; Wit, Ferdinand; Bucher, Heiner C; Braun, Dominique L; Phillips, Andrew; Sabin, Caroline; d'Arminio Monforte, Antonella; Zangerle, Robert; Smith, Colette; De Wit, Stéphane; Bonnet, Fabrice; Pradier, Christian; Mussini, Cristina; Muccini, Camilla; Vehreschild, Jörg J; Hoy, Jennifer; Svedhem, Veronica; Miró, Jose M; Wasmuth, Jan-Christian; Reiss, Peter; Llibre, Josep M; Chkhartishvili, Nikoloz; Stephan, Christoph; Hatleberg, Camilla I; Neesgaard, Bastian; Peters, Lars; Jaschinski, Nadine; Dedes, Nikos; et al (2023). Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV. Cancers, 15(14):3640.

Simnacher, Felice; Götz, Anna; Kling, Sabine; Schulze, Jan Ben; von Känel, R; Euler, Sebastian; Günther, Moritz P (2023). A short screening tool identifying systemic barriers to distress screening in cancer care. Cancer Medicine, 12(16):17313-17321.

Weller, Michael; Le Rhun, Émilie; Van den Bent, Martin; Chang, Susan M; Cloughesy, Timothy F; Goldbrunner, Roland; Hong, Yong-Kil; Jalali, Rakesh; Jenkinson, Michael D; Minniti, Giuseppe; Nagane, Motoo; Razis, Evangelia; Roth, Patrick; Rudà, Roberta; Tabatabai, Ghazaleh; Wen, Patrick Y; Short, Susan C; Preusser, Matthias (2023). Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro-Oncology, 25(7):1200-1224.

Kempska, Joanna; Oliveira-Ferrer, Leticia; Grottke, Astrid; Qi, Minyue; Alawi, Malik; Meyer, Felix; Borgmann, Kerstin; Hamester, Fabienne; Eylmann, Kathrin; Rossberg, Maila; Smit, Daniel J; Jücker, Manfred; Laakmann, Elena; Witzel, Isabell; Schmalfeldt, Barbara; Müller, Volkmar; Legler, Karen (2023). Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis. Frontiers in Oncology, 13:1129682.

Ettlin, Julia; Bauer, Alina; Opitz, Lennart; Malbon, Alexandra; Markkanen, Enni (2023). Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas. Journal of Mammary Gland Biology and Neoplasia, 28(1):14.

Ruggiero, Carmen; Tamburello, Mariangela; Rossini, Elisa; Zini, Silvia; Durand, Nelly; Cantini, Giulia; Cioppi, Francesca; Hantel, Constanze; Kiseljak-Vassiliades, Katja; Wierman, Margaret E; Landwehr, Laura-Sophie; Weigand, Isabel; Kurlbaum, Max; Zizioli, Daniela; Turtoi, Andrei; Yang, Shengyu; Berruti, Alfredo; Luconi, Michaela; Sigala, Sandra; Lalli, Enzo (2023). FSCN1 as a new druggable target in adrenocortical carcinoma. International Journal of Cancer, 153(1):210-223.

Sänger, Jonathan A; Graur, Alexander; Tahir, Ismail; Price, Melissa C; Keane, Florence K; Lanuti, Michael; Sharma, Amita; Fintelmann, Florian J (2023). Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study. Lung Cancer, 181:107231.

Rechsteiner, Anna; Dietrich, Daniel; Varga, Zsuzsanna (2023). Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: a retrospective analysis. Journal of Cancer Research and Clinical Oncology, 149(8):4967-4978.

Jung, Ruedi; Zürcher, Simeon J; Schindera, Christina; Braun, Julia; Deng, Wei Hai; von der Weid, Nicolas X; Rueegg, Corina S; Kriemler, Susi (2023). Adherence and contamination in a 1-year physical activity program in childhood cancer survivors: A report from the SURfit study. Cancer Medicine, 12(13):14731-14741.

Alafandi, A; van Garderen, K A; Klein, S; van der Voort, S R; Rizopoulos, D; Nabors, L; Stupp, R; Weller, Michael; Gorlia, T; Tonn, J-C; Smits, M (2023). Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status. European Journal of Cancer, 188:122-130.

Hench, Juergen; Mihic-Probst, Daniela; Agaimy, Abbas; Frank, Stephan; Meyer, Peter; Hultschig, Claus; Simi, Sara; Alos, Lucia; Balamurugan, Thiagarajah; Blokx, Willeke; Bosisio, Francesca; Cappellesso, Rocco; Griewank, Klaus; Hadaschik, Eva; van Kempen, Leon C; Kempf, Werner; Lentini, Maria; Mazzucchelli, Luca; Rinaldi, Gaetana; Rutkowski, Piotr; Schadendorf, Dirk; Schilling, Bastian; Szumera-Cieckiewicz, Anna; van den Oord, Joost; Mandalà, Mario; Massi, Daniela; EORTC Melanoma Group (2023). Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis. European Journal of Cancer, 187:7-14.

Fitzel, Rahel; Secker-Grob, Kathy-Ann; Keppeler, Hildegard; Korkmaz, Fulya; Schairer, Rebekka; Erkner, Estelle; Schneidawind, Dominik; Lengerke, Claudia; Hentrich, Thomas; Schulze-Hentrich, Julia M; Schneidawind, Corina (2023). Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity. Neoplasia, 41:100902.

Marion, William; Koppe, Tiago; Chen, Chun-Chin; Wang, Dahai; Frenis, Katie; Fierstein, Sara; Sensharma, Prerana; Aumais, Olivia; Peters, Michael; Ruiz-Torres, Sonya; Chihanga, Tafadzwa; Boettcher, Steffen; Shimamura, Akiko; Bauer, Daniel E; Schlaeger, Thorsten; Wells, Susanne I; Ebert, Benjamin L; Starczynowski, Daniel; da Rocha, Edroaldo Lummertz; Rowe, R Grant (2023). RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia. Leukemia, 37(8):1698-1708.

Tomsitz, Dirk; Ruf, Theresa; Heppt, Markus; Staeger, Ramon; Ramelyte, Egle; Dummer, Reinhard; Garzarolli, Marlene; Meier, Friedegund; Meier, Eileen; Richly, Heike; Gromke, Tanja; Siveke, Jens T; Franklin, Cindy; Klespe, Kai-Christian; Mauch, Cornelia; Kilian, Teresa; Seegräber, Marlene; Schilling, Bastian; French, Lars E; Berking, Carola; Heinzerling, Lucie (2023). Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. Cancers, 15(13):3430.

Schulze, Jan Ben; Euler, Sebastian; Coker, Penelope; von Känel, Roland; Günther, Moritz Philipp (2023). Early Impact of the COVID-19 Pandemic on Psycho-Oncological Support: A Latent Class Analysis. Oncology, 101(6):389-396.

Mayinger, Michael; Kotecha, Rupesh; Sahgal, Arjun; Kim, Mi-Sook; Lo, Simon S; Louie, Alexander V; Scorsetti, Marta; Slotman, Ben; Guckenberger, Matthias (2023). Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines. Lung Cancer, 182:107284.

Lourdes Frehner, Bianca; Christen, Matthias; Reichler, Iris M; Jagannathan, Vidhya; Novacco, Marilisa; Riond, Barbara; Peters, Laureen M; Sánchez-Andrade, José Suárez; Pieńkowska-Schelling, Aldona; Schelling, Claude; Kipar, Anja; Leeb, Tosso; Balogh, Orsolya (2023). Autosomal recessive hyposegmentation of granulocytes in Australian Shepherd Dogs indicates a role for LMBR1L in myeloid leukocytes. PLoS Genetics, 19(6):e1010805.

Yan, Michael; Louie, Alexander V; Kotecha, Rupesh; Ashfaq Ahmed, Md; Zhang, Zhenwei; Guckenberger, Matthias; Kim, Mi-Sook; Lo, Simon S; Scorsetti, Marta; Tree, Alison C; Sahgal, Arjun; Slotman, Ben J (2023). Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines. Lung Cancer, 182:107281.

Knowles, Truman; Huang, Tina; Qi, Jin; An, Shejuan; Burket, Noah; Cooper, Scott; Nazarian, Javad; Saratsis, Amanda M (2023). LIN28B and Let-7 in Diffuse Midline Glioma: A Review. Cancers, 15(12):3241.

Bodmer, Nicole; Hecker-Nolting, Stefanie; Friedel, Godehard; Blattmann, Claudia; Kager, Leo; Kessler, Torsten; Kevric, Matthias; Kühne, Thomas; Mettmann, Vanessa; Müller-Abt, Peter; Sorg, Benjamin; Theobald, Matthias; Bielack, Stefan S (2023). Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group. Cancer, 129(12):1895-1903.

Ellingson, Benjamin M; Wen, Patrick Y; Chang, Susan M; van den Bent, Martin; Vogelbaum, Michael A; Li, Gang; Li, Shanpeng; Kim, Jiyoon; Youssef, Gilbert; Wick, Wolfgang; Lassman, Andrew B; Gilbert, Mark R; de Groot, John F; Weller, Michael; Galanis, Evanthia; Cloughesy, Timothy F (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology, 25(6):1017-1028.

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix; Pacak, Karel; Skogseid, Britt; Crona, Joakim (2023). Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma. Endocrine-Related Cancer, 30(7):e220354.

Saesen, Robbe; Van Hemelrijck, Mieke; Bogaerts, Jan; Booth, Christopher M; Cornelissen, Jan J; Dekker, Andre; Eisenhauer, Elizabeth A; Freitas, André; Gronchi, Alessandro; Hernán, Miguel A; Hulstaert, Frank; Ost, Piet; Szturz, Petr; Verkooijen, Helena M; Weller, Michael; Wilson, Roger; Lacombe, Denis; van der Graaf, Winette T (2023). Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer. European Journal of Cancer, 186:52-61.

Deschamps, Frédéric; Tselikas, Lambros; Yevich, Steven; Bonnet, Baptiste; Roux, Charles; Kobe, Adrian; Besse, Benjamin; Berthelot, Kevin; Gaudin, Amelie; Mir, Lluis M; de Baère, Thierry (2023). Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patients. European Journal of Cancer, 186:62-68.

Looman, E L; Cheng, P F; Lai‐Kwon, J; Morgan, L; Wakkee, M; Dummer, R; Dimitriou, F (2023). Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors. Cancer Medicine, 12(11):12861-12873.

Lazaratos, Anna-Maria; Maritan, Sarah M; Quaiattini, Andrea; Darlix, Amélie; Ratosa, Ivica; Ferraro, Emanuela; Griguolo, Gaia; Guarneri, Valentina; Pellerino, Alessia; Hofer, Silvia; Jacot, William; Stemmler, Hans-Joachim; van den Broek, Marcel P H; Dobnikar, Nika; Panet, Francois; Lahijanian, Zubin; Morikawa, Aki; Seidman, Andrew D; Soffietti, Riccardo; Panasci, Lawrence; Petrecca, Kevin; Rose, April A N; Bouganim, Nathaniel; Dankner, Matthew (2023). Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases. Breast, 69:451-468.

Grossenbacher, Bettina; Lareida, Anna; Moors, Selina; Roth, Patrick; Kulcsár, Zsolt; Regli, Luca; Le Rhun, Emilie; Weller, Michael; Wolpert, Fabian (2023). Prognostic assessment in patients operated for brain metastasis from systemic tumors. Cancer Medicine, 12(11):12316-12324.

Tochtermann, Giulia; Nowack, Miriam; Hagen, Cristina; Rupp, Niels J; Ikenberg, Kristian; Broglie, Martina A; Saro, Francesca; Lenggenhager, Daniela; Bode, Peter K (2023). The Milan system for reporting salivary gland cytopathology—A single‐center study of 2156 cases. Cancer Medicine, 12(11):12198-12207.

Lysenko, Veronika; Schürch, Patrick M; Tuzlak, Selma; van Wijk, Nicole Wildner-Verhey; Kovtonyuk, Larisa V; Becher, Burkhard; Manz, Markus G; Kreutmair, Stefanie; Theocharides, Alexandre P A (2023). Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia, 37(6):1277-1286.

Mehra, Tarun; Dongre, Kanchan; Boesing, Maria; Frei, Patricia; Suenderhauf, Claudia; Zippelius, Alfred; Leuppi, Joerg D; Wicki, Andreas; Leuppi-Taegtmeyer, Anne B (2023). Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities. Cancer Medicine, 12(11):12253-12262.

Felley-Bosco, Emanuela (2023). Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy. Cancers, 15(11):2969.

Thonhauser, Rebecca; Poglitsch, Marcus; Jonas, Jan Philipp; Dong, Yawen; Tschögl, Madita; Gramberger, Mariel; Salem, Mohamed; Santol, Jonas; Brandl, Irmgard; Klimpfinger, Martin; Vierziger, Constantin; Gruenberger, Thomas (2023). The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer. Cancers, 15(11):2900.

Ascierto, Paolo Antonio; Lipson, Evan J; Dummer, Reinhard; Larkin, James; Long, Georgina V; Sanborn, Rachel E; Chiarion-Sileni, Vanna; Dréno, Brigitte; Dalle, Stéphane; Schadendorf, Dirk; Callahan, Margaret K; Nyakas, Marta; Atkinson, Victoria; Gomez-Roca, Carlos Alberto; Yamazaki, Naoya; Tawbi, Hussein A; Sarkis, Naomey; Warad, Deepti; Dolfi, Sonia; Mitra, Priyam; Suryawanshi, Satyendra; Grob, Jean-Jacques (2023). Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of Clinical Oncology, 41(15):2724-2735.

Pomella, Silvia; Danielli, Sara G; Alaggio, Rita; Breunis, Willemijn B; Hamed, Ebrahem; Selfe, Joanna; Wachtel, Marco; Walters, Zoe S; Schäfer, Beat W; Rota, Rossella; Shipley, Janet M; Hettmer, Simone (2023). Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. Cancers, 15(10):2823.

Laure, Alexander; Rigutto, Angelica; Kirschner, Michaela B; Opitz, Lennart; Grob, Linda; Opitz, Isabelle; Felley-Bosco, Emanuela; Hiltbrunner, Stefanie; Curioni-Fontecedro, Alessandra (2023). Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing. Cancers, 15(10):2813.

Sturtzel, C; Grissenberger, S; Bozatzi, P; Scheuringer, E; Wenninger-Weinzierl, A; Zajec, Z; Dernovšek, J; Pascoal, S; Gehl, V; Kutsch, A; Granig, A; Rifatbegovic, F; Carre, M; Lang, A; Valtingojer, I; Moll, J; Lötsch, D; Erhart, F; Widhalm, G; Surdez, D; Delattre, O; André, N; Stampfl, J; Tomašič, T; Taschner-Mandl, S; Distel, M (2023). Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts. NPJ precision oncology, 7(1):44.

Capper, David; Reifenberger, Guido; French, Pim J; Schweizer, Leonille; Weller, Michael; Touat, Mehdi; Niclou, Simone P; Euskirchen, Philipp; Haberler, Christine; Hegi, Monika E; Brandner, Sebastian; Le Rhun, Émilie; Rudà, Roberta; Sanson, Marc; Tabatabai, Ghazaleh; Sahm, Felix; Wen, Patrick Y; Wesseling, Pieter; Preusser, Matthias; van den Bent, Martin J (2023). EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro-Oncology, 25(5):813-826.

Bösch, Florian; Altendorf-Hofmann, Annelore; Koliogiannis, Vanessa; Ilhan, Harun; Jacob, Sven; Pretzsch, Elise; Nölting, Svenja; Werner, Jens; Klauschen, Frederick; Auernhammer, Christoph Josef; Angele, Martin K; Knösel, Thomas (2023). Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology, 149(5):1895-1903.

Kroese, Tiuri E; van Laarhoven, Hanneke W M; Schoppman, Sebastian F; Deseyne, Pieter R A J; van Cutsem, Eric; Haustermans, Karin; Nafteux, Philippe; Thomas, Melissa; Obermannova, Radka; Mortensen, Hanna R; Nordsmark, Marianne; Pfeiffer, Per; Elme, Anneli; Adenis, Antoine; Piessen, Guillaume; Bruns, Christiane J; Lordick, Florian; Gockel, Ines; Moehler, Markus; Gani, Cihan; Liakakos, Theodore; Reynolds, John; Morganti, Alessio G; Rosati, Riccardo; Castoro, Carlo; Cellini, Francesco; D'Ugo, Domenico; Roviello, Franco; Bencivenga, Maria; de Manzoni, Giovanni; et al; Guckenberger, Matthias; et al (2023). Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. European Journal of Cancer, 185:28-39.

Fernandez-Rodriguez, Laura; Cianciaruso, Chiara; Bill, Ruben; Trefny, Marcel P; Klar, Richard; Kirchhammer, Nicole; Buchi, Mélanie; Festag, Julia; Michel, Sven; Kohler, Rainer H; Jones, Elham; Maaske, Andre; vom Berg, Johannes; Kobold, Sebastian; Kashyap, Abhishek S; Jaschinski, Frank; Dixon, Karen O; Pittet, Mikael J; Zippelius, Alfred (2023). Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. Journal for ImmunoTherapy of Cancer, 11(5):e006714.

Kropivsek, Klara; Kachel, Paul; Goetze, Sandra; Wegmann, Rebekka; Festl, Yasmin; Severin, Yannik; Hale, Benjamin D; Mena, Julien; van Drogen, Audrey; Dietliker, Nadja; Tchinda, Joëlle; Wollscheid, Bernd; Manz, Markus G; Snijder, Berend (2023). Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nature Cancer, 4(5):734-753.

Meyer, C; Larghero, P; Almeida Lopes, B; Burmeister, T; Gröger, D; Sutton, R; Venn, N C; Cazzaniga, G; Corral Abascal, L; Tsaur, G; Fechina, L; Emerenciano, M; Pombo-de-Oliveira, M S; Lund-Aho, T; Lundán, T; Montonen, M; Juvonen, V; Zuna, J; Trka, J; Ballerini, P; Lapillonne, H; Van der Velden, V H J; Sonneveld, E; Delabesse, E; de Matos, R R C; Silva, M L M; Bomken, S; Katsibardi, K; Keernik, M; Schäfer, Beat W; et al (2023). The KMT2A recombinome of acute leukemias in 2023. Leukemia, 37(5):988-1005.

van Zogchel, Lieke M J; Lak, Nathalie S M; Gelineau, Nina U; Sergeeva, Irina; Stelloo, Ellen; Swennenhuis, Joost; Feitsma, Harma; van Min, Max; Splinter, Erik; Bleijs, Margit; Groot Koerkamp, Marian; Breunis, Willemijn; Meister, Michael Torsten; Kholossy, Waleed Hassan; Holstege, Frank C P; Molenaar, Jan J; de Leng, Wendy W J; Stutterheim, Janine; van der Schoot, C Ellen; Tytgat, Godelieve A M (2023). Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors. Frontiers in Oncology, 13:1124737.

Gallon, John; Rodriguez-Calero, Antonio; Benjak, Andrej; Akhoundova, Dilara; Maletti, Sina; Amstutz, Ursula; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; Bubendorf, Lukas; Moch, Holger; Thalmann, George; Feng, Felix Y; Gillessen, Silke; Ng, Charlotte K Y; Rubin, Mark A; Piscuoglio, Salvatore (2023). DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. Cancer Research, 83(8):1203-1213.

Eichhoff, Ossia M; Stoffel, Corinne I; Käsler, Jan; Briker, Luzia; Turko, Patrick; Karsai, Gergely; Zila, Nina; Paulitschke, Verena; Cheng, Phil F; Leitner, Alexander; Bileck, Andrea; Zamboni, Nicola; Irmisch, Anja; Balazs, Zsolt; Tastanova, Aizhan; Pascoal, Susana; Johansen, Pål; Wegmann, Rebekka; Mena, Julien; Othman, Alaa; Viswanathan, Vasanthi S; Wenzina, Judith; Aloia, Andrea; Saltari, Annalisa; Dzung, Andreas; Krauthammer, Michael; Schreiber, Stuart L; Hornemann, Thorsten; Distel, Martin; Snijder, Berend; Dummer, Reinhard; Levesque, Mitchell Paul (2023). ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer Research, 83(7):1128-1146.

Seliger, Corinna; Oppong, Felix Boakye; Lefranc, Florence; Chinot, Olivier; Stupp, Roger; Nabors, Burt; Gorlia, Thierry; Weller, Michael; EORTC Brain Tumor Group (2023). Association of antidepressant drug use with outcome of patients with glioblastoma. International Journal of Cancer, 152(7):1348-1359.

de With, M; Sadlon, A; Cecchin, E; Haufroid, V; Thomas, F; Joerger, M; van Schaik, R H N; Mathijssen, R H J; Largiadèr, C R (2023). Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe. ESMO Open, 8(2):101197.

Nieder, Carsten; Andratschke, Nicolaus H J; Grosu, Anca L (2023). Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy? Seminars in Radiation Oncology, 33(2):129-138.

Syed, Hasan R; Kilburn, Lindsay; Fonseca, Adriana; Nazarian, Javad; Oluigbo, Chima; Myseros, John S; Packer, Roger J; Keating, Robert F (2023). First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication. Journal of Neuro-Oncology, 162(2):449-451.

Larrue, Clement; Mouche, Sarah; Lin, Shan; Simonetta, Federico; Scheidegger, Nastassja K; Poulain, Laury; Birsen, Rudy; Sarry, Jean-Emmanuel; Stegmaier, Kimberly; Tamburini, Jerome (2023). Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia. Leukemia, 37(4):765-775.

Guckenberger, Matthias; Dahele, Max; Ong, Wee Loon; Sahgal, Arjun (2023). Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations. Seminars in Radiation Oncology, 33(2):159-171.

Morand, Grégoire B; Huellner, Martin W (2023). Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging. Translational Cancer Research, 12(3):676-679.

Pellerino, Alessia; Verdijk, Robert M; Nichelli, Lucia; Andratschke, Nicolaus H; Idbaih, Ahmed; Goldbrunner, Roland (2023). Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative. Cancers, 15(7):1930.

Amaro, Adriana; Reggiani, Francesco; Fenoglio, Daniela; Gangemi, Rosaria; Tosi, Anna; Parodi, Alessia; Banelli, Barbara; Rigo, Valentina; Mastracci, Luca; Grillo, Federica; Cereghetti, Alessandra; Tastanova, Aizhan; Ghosh, Adhideb; Sallustio, Fabio; Emionite, Laura; Daga, Antonio; Altosole, Tiziana; Filaci, Gilberto; Rosato, Antonio; Levesque, Mitchell; Maio, Michele; Pfeffer, Ulrich; Croce, Michela (2023). Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells. Journal of Experimental & Clinical Cancer Research, 42(1):67.

Reimer, Francesca; Bryan, Sarah; Legler, Karen; Karn, Thomas; Eppenberger-Castori, Serenella; Matschke, Jakob; Pereira-Veiga, Thais; Wikman, Harriet; Witzel, Isabell; Müller, Volkmar; Schmalfeldt, Barbara; Milde-Langosch, Karin; Schumacher, Udo; Stürken, Christine; Oliveira-Ferrer, Leticia (2023). The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients. Cancer Cell International, 23(1):47.

Rösler, Wiebke; Altenbuchinger, Michael; Baeßler, Bettina; Beissbarth, Tim; Beutel, Gernot; Bock, Robert; von Bubnoff, Nikolas; Eckardt, Jan-Niklas; Foersch, Sebastian; Loeffler, Chiara M L; Middeke, Jan Moritz; Mueller, Martha-Lena; Oellerich, Thomas; Risse, Benjamin; Scherag, André; Schliemann, Christoph; Scholz, Markus; Spang, Rainer; Thielscher, Christian; Tsoukakis, Ioannis; Kather, Jakob Nikolas (2023). An overview and a roadmap for artificial intelligence in hematology and oncology. Journal of Cancer Research and Clinical Oncology, 149(10):7997-8006.

Bornstein, Stefan; Shapiro, Igor; Mazumdar, Alekhya; Zitzmann, Kathrin; Nölting, Svenja; Luca, Edlira; Beuschlein, Felix; Sharma, Ashish; Hantel, Constanze (2023). The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions. Cancers, 15(6):1783.

Girardi, Fabio; Di Carlo, Veronica; Stiller, Charles; Gatta, Gemma; Woods, Ryan R; Visser, Otto; Lacour, Brigitte; Tucker, Thomas C; Coleman, Michel P; Allemani, Claudia (2023). Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Neuro-Oncology, 25(3):593-606.

Waller, Verena; Tschanz, Fabienne; Winkler, Rona; Pruschy, Martin (2023). The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration. Frontiers in Oncology, 13:1117326.

Coleman, Jonathan A; Yip, Wesley; Wong, Nathan C; Sjoberg, Daniel D; Bochner, Bernard H; Dalbagni, Guido; Donat, S Machele; Herr, Harry W; Cha, Eugene K; Donahue, Timothy F; Pietzak, Eugene J; Hakimi, A Ari; Kim, Kwanghee; Al-Ahmadie, Hikmat A; Vargas, H Alberto; Alvim, Ricardo G; Ghafoor, Soleen; Benfante, Nicole E; Meraney, Anoop M; Shichman, Steven J; Kamradt, Jeffrey M; Nair, Suresh G; Baccala, Angelo A; Palyca, Paul; Lash, Bradley W; Rizvi, Muhammad A; Swanson, Scott K; Muina, Antonio F; Apolo, Andrea B; Iyer, Gopa; et al (2023). Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of Clinical Oncology, 41(8):1618-1625.

Vu, Erwin; Steinmann, Nina; Schröder, Christina; Förster, Robert; Aebersold, Daniel M; Eychmüller, Steffen; Cihoric, Nikola; Hertler, Caroline; Windisch, Paul; Zwahlen, Daniel R (2023). Applications of Machine Learning in Palliative Care: A Systematic Review. Cancers, 15(5):1596.

Bhave, Prachi; Hong, Angela; Lo, Serigne N; Johnson, Rebecca; Mangana, Johanna; Johnson, Douglas B; Dulgar, Ozgecan; Eroglu, Zeynep; Yeoh, Hui-Ling; Haydon, Andrew; Lodde, Georg C; Livingstone, Elisabeth; Khattak, Adnan; Kähler, Katharina; Hausschild, Axel; McArthur, Grant A; Menzies, Alexander Maxwell; Long, Georgina; Wang, Wei; Carlino, Matteo S (2023). Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for ImmunoTherapy of Cancer, 11(3):e006629.

Speiser, Daniel E; Chijioke, Obinna; Schaeuble, Karin; Münz, Christian (2023). CD$4^{\text{+}}$ T cells in cancer. Nature Cancer, 4(3):317-329.

Parekh, Kavya; LeBlang, Suzanne; Nazarian, Javad; Mueller, Sabine; Zacharoulis, Stergios; Hynynen, Kullervo; Powlovich, Lauren (2023). Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting. Neoplasia, 37:100876.

Meier, Clemens-Magnus; Furtwängler, Rhoikos; Mergen, Marvin; Welter, Nils; Melchior, Patrick; Schenk, Jens-Peter; Vokuhl, Christian; Kager, Leo; Kroiss-Benninger, Sabine; Wagenpfeil, Stefan; Graf, Norbert (2023). Impact of Time to Surgery on Outcome in Wilms Tumor Treated with Preoperative Chemotherapy. Cancers, 15(5):1494.

Grossmann, Nico C; Soria, Francesco; Juvet, Tristan; Potretzke, Aaron M; Djaladat, Hooman; Ghoreifi, Alireza; Kikuchi, Eiji; Mari, Andrea; Khene, Zine-Eddine; Fujita, Kazutoshi; Raman, Jay D; Breda, Alberto; Fontana, Matteo; Sfakianos, John P; Pfail, John L; Laukhtina, Ekaterina; Rajwa, Pawel; Pallauf, Maximillian; Poyet, Cédric; Cacciamani, Giovanni E; van Doeveren, Thomas; Boormans, Joost L; Antonelli, Alessandro; Jamil, Marcus; Abdollah, Firas; Ploussard, Guillaume; Heidenreich, Axel; Storz, Enno; Daneshmand, Siamak; Boorjian, Stephen A; et al (2023). Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis. Cancers, 15(5):1409.

Vaupel, Peter; Piazena, Helmut; Notter, Markus; Thomsen, Andreas R; Grosu, Anca-Ligia; Scholkmann, Felix; Pockley, Alan Graham; Multhoff, Gabriele (2023). From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy. Cancers, 15(5):1394.

Hofer, Silvia; Hentschel, Leopold; Richter, Stephan; Blum, Veronika; Kramer, Michael; Kasper, Bernd; Riese, Christoph; Schuler, Markus K (2023). Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment. Cancers, 15(4):1233.

Nocito, Marta Claudia; Avena, Paola; Zavaglia, Lucia; De Luca, Arianna; Chimento, Adele; Hamad, Tarig; La Padula, Davide; Stancati, Davide; Hantel, Constanze; Sirianni, Rosa; Casaburi, Ivan; Pezzi, Vincenzo (2023). Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment. Cancers, 15(4):1050.

Schneider, Isabelle; Calcagni, Maurizio; Buschmann, Johanna (2023). Adipose-derived stem cells applied in skin diseases, wound healing and skin defects: a review. Cytotherapy, 25(2):105-119.

Ring, Alexander; Nguyen-Sträuli, Bich Doan; Wicki, Andreas; Aceto, Nicola (2023). Biology, vulnerabilities and clinical applications of circulating tumour cells. Nature Reviews Cancer, 23(2):95-111.

Rothermundt, Christian; Andreou, Dimosthenis; Blay, Jean-Yves; et al; Hofer, Silvia (2023). Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022. European Journal of Cancer, 180:158-179.

Abate, Andrea; Tamburello, Mariangela; Rossini, Elisa; Basnet, Ram Manohar; Ribaudo, Giovanni; Gianoncelli, Alessandra; Hantel, Constanze; Cosentini, Deborah; Laganà, Marta; Grisanti, Salvatore; Tiberio, Guido Alberto Massimo; Memo, Maurizio; Berruti, Alfredo; Sigala, Sandra (2023). Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models. Endocrine-Related Cancer, 30(2):e220273.

Mansouri, Larry; Thorvaldsdottir, Birna; Sutton, Lesley-Ann; Karakatsoulis, Georgios; Meggendorfer, Manja; Parker, Helen; Nadeu, Ferran; Brieghel, Christian; Laidou, Stamatia; Moia, Riccardo; Rossi, Davide; Catherwood, Mark; Kotaskova, Jana; Delgado, Julio; Rodríguez-Vicente, Ana E; Benito, Rocío; Rigolin, Gian Matteo; Bonfiglio, Silvia; Scarfo, Lydia; Mattsson, Mattias; Davis, Zadie; Gogia, Ajay; Rani, Lata; Baliakas, Panagiotis; Foroughi-Asl, Hassan; Jylhä, Cecilia; Skaftason, Aron; Rapado, Inmaculada; Miras, Fatima; Martinez-Lopez, Joaquín; Zenz, Thorsten; et al (2023). Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia, 37(2):339-347.

Blomberg, Evelina; Silginer, Manuela; Roth, Patrick; Weller, Michael (2023). Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models. Translational Oncology, 28:101607.

Stirm, Kristin; Leary, Peter; Wüst, Daria; Stark, Dominique; Joller, Nicole; Karakus, Ufuk; Boyman, Onur; Tzankov, Alexandar; Müller, Anne (2023). Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. Journal for ImmunoTherapy of Cancer, 11(2):e006263.

Banik, Ishani; Ghosh, Adhideb; Beebe, Erin; Burja, Blaž; Bertoncelj, Mojca Frank; Dooley, Christopher M; Markkanen, Enni; Dummer, Reinhard; Busch-Nentwich, Elisabeth M; Levesque, Mitchell P (2023). P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma. Cancers, 15(3):877.

Jung, Ruedi; Zürcher, Simeon J; Schindera, Christina; Eser, Prisca; Meier, Christian; Schai, Anna; Braun, Julia; Deng, Wei Hai; Hebestreit, Helge; Neuhaus, Cornelia; Schaeff, Jonathan; Rueegg, Corina S; von der Weid, Nicolas X; Kriemler, Susi (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit). International Journal of Cancer, 152(2):162-171.

Capogiri, Monica; De Micheli, Andrea J; Lassaletta, Alvaro; Muñoz, Denise P; Coppé, Jean-Philippe; Mueller, Sabine; Guerreiro Stucklin, Ana S (2023). Response and resistance to BRAF$^{V600E}$ inhibition in gliomas: Roadblocks ahead? Frontiers in Oncology, 12:1074726.

Miller, Julie J; Gonzalez Castro, L Nicolas; McBrayer, Samuel; Weller, Michael; Cloughesy, Timothy; Portnow, Jana; Andronesi, Ovidiu; Barnholtz-Sloan, Jill S; Baumert, Brigitta G; Berger, Mitchell S; Bi, Wenya Linda; Bindra, Ranjit; Cahill, Daniel P; Chang, Susan M; Costello, Joseph F; Horbinski, Craig; Huang, Raymond Y; Jenkins, Robert B; Ligon, Keith L; Mellinghoff, Ingo K; Nabors, L Burt; Platten, Michael; Reardon, David A; Shi, Diana D; Schiff, David; Wick, Wolfgang; Yan, Hai; von Deimling, Andreas; van den Bent, Martin; Kaelin, William G; et al (2023). Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology, 25(1):4-25.

Di Giacomo, Anna M; Mair, Maximilian J; Ceccarelli, Michele; Anichini, Andrea; Ibrahim, Ramy; Weller, Michael; Lahn, Michael; Eggermont, Alexander M M; Fox, Bernard; Maio, Michele (2023). Immunotherapy for brain metastases and primary brain tumors. European Journal of Cancer, 179:113-120.

Lehrnbecher, Thomas; Groll, Andreas H; Cesaro, Simone; Alten, Julia; Attarbaschi, Andishe; Barbaric, Draga; Bodmer, Nicole; Conter, Valentino; Izraeli, Shai; Mann, Georg; Möricke, Anja; Niggli, Felix; Schrappe, Martin; Stary, Jan; Zapotocka, Ester; Zimmermann, Martin; Elitzur, Sarah (2023). Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009. Leukemia, 37(1):72-78.

Pirson, Léopold; Lüer, Sonja C; Diezi, Manuel; Kroiss, Sabine; Brazzola, Pierluigi; Schilling, Freimut H; von der Weid, Nicolas; Scheinemann, Katrin; Greiner, Jeanette; Zuzak, Tycho Jan; von Bueren, André O (2023). Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study. Cancer Reports, 6(1):e1649.

Wang, Chunyang; Wojtynek, Matthias; Medalia, Ohad (2023). Structural investigation of eukaryotic cells: From the periphery to the interior by cryo-electron tomography. Advances in Biological Regulation, 87:100923.

Pfefferlé, Marc; Dubach, Irina L; Buzzi, Raphael M; Dürst, Elena; Schulthess-Lutz, Nadja; Baselgia, Livio; Hansen, Kerstin; Imhof, Larissa; Koernig, Sandra; Le Roy, Didier; Roger, Thierry; Humar, Rok; Schaer, Dominik J; Vallelian, Florence (2023). Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity. Journal for ImmunoTherapy of Cancer, 11(1):e005718.

Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2023). Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 42(2):168.

Bangerter, Jana Lucia; Harnisch, Kim Jannis; Chen, Yanjiang; Hagedorn, Catherine; Planas-Paz, Lara; Pauli, Chantal (2023). Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models. Human Cell, 36:446-455.

Kroese, Tiuri E; Takahashi, Yuko; Lordick, Florian; van Rossum, Peter S N; Ruurda, Jelle P; Lagarde, Sjoerd M; van Hillegersberg, Richard; Verhoeven, Rob H A; van Laarhoven, Hanneke W M (2023). Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study. European Journal of Cancer, 179:65-75.

Schmidt, Felix; Kohlbrenner, Dario; Malesevic, Stefan; Huang, Alice; Klein, Sabine D; Puhan, Milo A; Kohler, Malcolm (2023). Mapping the landscape of lung cancer breath analysis: A scoping review (ELCABA). Lung Cancer, 175:131-140.

Le Rhun, Emilie; Oppong, Felix Boakye; van den Bent, Martin; Wick, Wolfgang; Brandes, Alba A; Taphoorn, Martin Jb; Platten, Michael; Idbaih, Ahmed; Clement, Paul M; Preusser, Matthias; Golfinopoulos, Vassilis; Gorlia, Thierry; Weller, Michael (2023). Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101. European Journal of Cancer, 178:13-22.

Prunaretty, Jessica; Güngör, Gorkem; Gevaert, Thierry; Azria, David; Valdenaire, Simon; Balermpas, Panagiotis; Boldrini, Luca; Chuong, Michael David; De Ridder, Mark; Hardy, Leo; Kandiban, Sanmady; Maingon, Philippe; Mittauer, Kathryn Elizabeth; Ozyar, Enis; Roque, Thais; Colombo, Lorenzo; Paragios, Nikos; Pennell, Ryan; Placidi, Lorenzo; Shreshtha, Kumar; Speiser, M P; Tanadini-Lang, Stephanie; Valentini, Vincenzo; Fenoglietto, Pascal (2023). A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imaging. Frontiers in Oncology, 13:1245054.

Padevit, Luis; Vasella, Flavio; Friedman, Jason; Mutschler, Valentino; Jenkins, Freya; Held, Ulrike; Rushing, Elisabeth Jane; Wirsching, Hans-Georg; Weller, Michael; Regli, Luca; Neidert, Marian Christoph (2023). A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. Frontiers in Oncology, 13:1279933.

Beer, Patricia; Pauli, Chantal; Haberecker, Martina; Grest, Paula; Beebe, Erin; Fuchs, Daniel; Markkanen, Enni; Krudewig, Christiane; Nolff, Mirja Christine (2023). Cross-species evaluation of fibroblast activation protein alpha as potential imaging target for soft tissue sarcoma: a comparative immunohistochemical study in humans, dogs, and cats. Frontiers in Oncology, 13:1210004.

Rosa, Consuelo; Gasparini, Lucrezia; DI Guglielmo, Fiorella Cristina; Caravatta, Luciana; DI Tommaso, Monica; Delli Pizzi, Andrea; Martino, Gianluigi; Castaldi, Paola; Mazza, Rocco; Porreca, Annamaria; DI Nicola, Marta; Calcagni, Maria Lucia; Genovesi, Domenico (2023). DWI-MR and PET-CT Functional Imaging for Boost Tumor Volume Delineation in Neoadjuvant Rectal Cancer Treatment. In Vivo, 37(1):424-432.

Nieder, Carsten; Andratschke, Nicolaus H; Grosu, Anca L (2023). How we treat octogenarians with brain metastases. Frontiers in Oncology, 13:1213122.

Schön, Viola; Stocker, Daniel; Jüngst, Christoph; Dummer, Reinhard; Ramelyte, Egle (2023). Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report. Journal of Immunotherapy, 46(9):346-350.

Kasteler, Rahel; Fuchs, Philipp; Otth, Maria; Scheinemann, Katrin (2023). Interventions to improve neurocognitive late-effects in pediatric and adolescent CNS tumor patients and survivors - a systematic review. Frontiers in Oncology, 13:1150166.

Nieder, Carsten; Andratschke, Nicolaus H; Grosu, Anca L (2023). Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results? Frontiers in Oncology, 13:1156161.

Kaul, David; Berghoff, Anna S; Guckenberger, Matthias (2023). Precision medicine approaches in radiotherapy and systemic therapy of brain metastases. Frontiers in Oncology, 13:1190830.

2022

Ohm, Birte; Jungraithmayr, Wolfgang (2022). Balancing the Risk of Adverse Events against the Efficacy of Immunotherapy in Advanced Thymic Epithelial Tumors. Cancers, 15:289.

Hennig, Paulina; Di Filippo, Michela; Bilfeld, Gilles; Mellett, Mark; Beer, Hans-Dietmar (2022). High p62 expression suppresses the NLRP1 inflammasome and increases stress resistance in cutaneous SCC cells. Cell Death and Disease, 13(12):1077.

Peterziel, Heike; Jamaladdin, Nora; ElHarouni, Dina; Gerloff, Xenia F; Herter, Sonja; Fiesel, Petra; Berker, Yannick; Blattner-Johnson, Mirjam; Schramm, Kathrin; Jones, Barbara C; Reuss, David; Turunen, Laura; Friedenauer, Aileen; Holland-Letz, Tim; Sill, Martin; Weiser, Lena; Previti, Christopher; Balasubramanian, Gnanaprakash; Gerber, Nicolas U; Gojo, Johannes; Hutter, Caroline; Øra, Ingrid; Lohi, Olli; Kattamis, Antonis; de Wilde, Bram; Westermann, Frank; Tippelt, Stephan; Graf, Norbert; Nathrath, Michaela; Sparber-Sauer, Monika; et al (2022). Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. NPJ precision oncology, 6(1):94.

Akhoundova, Dilara; Hussung, Saskia; Sivakumar, Smruthy; Töpfer, Antonia; Rechsteiner, Markus; Kahraman, Abdullah; Arnold, Fabian; Angst, Florian; Britschgi, Christian; Zoche, Martin; Moch, Holger; Weber, Achim; Sokol, Ethan; Fritsch, Ralph M (2022). ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer. International Journal of Cancer, 151(12):2161-2171.

Blum, Veronika; Andrei, Vanghelita; Ameline, Baptiste; Hofer, Silvia; Fuchs, Bruno; Strobel, Klaus; Allemann, Anna; Bode, Beata; Baumhoer, Daniel (2022). Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report. Frontiers in Oncology, 12:1086677.

Grissenberger, Sarah; Sturtzel, Caterina; Wenninger-Weinzierl, Andrea; Radic-Sarikas, Branka; Scheuringer, Eva; Bierbaumer, Lisa; Etienne, Vesnie; Némati, Fariba; Pascoal, Susana; Tötzl, Marcus; Tomazou, Eleni M; Metzelder, Martin; Putz, Eva M; Decaudin, Didier; Delattre, Olivier; Surdez, Didier; Kovar, Heinrich; Halbritter, Florian; Distel, Martin (2022). High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma. Cancer Letters, 554:216028.

Rudolf Vegas, Alba; Podico, Giorgia; Canisso, Igor F; Bollwein, Heinrich; Fröhlich, Thomas; Bauersachs, Stefan; Almiñana, Carmen (2022). Dynamic regulation of the transcriptome and proteome of the equine embryo during maternal recognition of pregnancy. FASEB BioAdvances, 4(12):775-797.

Gabryś, H S; Basler, Lucas; Burgermeister, Simon; Hogan, Sabrina; Ahmadsei, Maiwand; Pavic, Matea; Bogowicz, Marta; Vuong, Diem; Tanadini-Lang, Stephanie; Förster, Robert; Kudura, Ken; Huellner, Martin; Dummer, Reinhard; Levesque, M P; Guckenberger, Matthias (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology, 12:977822.

Cantoni, Nathan; Sommavilla, Roberto; Seitz, Patrick; Kulenkampff, Elisabeth; Kahn, Stefan; Lambert, Jean-François; Schmidt, Adrian; Zenhaeusern, Reinhard; Balabanov, Stefan (2022). A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia. BMC Cancer, 22:1192.

Karavasiloglou, Nena; Pestoni, Giulia; Kühn, Tilman; Rohrmann, Sabine (2022). Adherence to cancer prevention recommendations and risk of breast cancer in situ in the United Kingdom Biobank. International Journal of Cancer, 151(10):1674-1683.

Müller, Sarah D; Both, Christian P; Sponholz, Christoph; Voelker, Maria Theresa; Christiansen, Holger; Niggli, Felix; Schmitz, Achim; Weiss, Markus; Thomas, Jörg; Stehr, Sebastian N; Piegeler, Tobias (2022). Association between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for Nephroblastoma. Cancers, 14(22):5585.

Bieri, Uwe; Kranzbühler, Benedikt; Seifert, Burkhardt; Helmchen, Birgit Maria; Gu, Alexander; Kaufmann, Basil; Lavrek, Dejan; Scherer, Thomas; Wettstein, Marian S; Poyet, Cédric; Hermanns, Thomas (2022). Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified? Cancers, 14(22):5586.

Guinot, A; Tabone-Eglinger, S; Isnardi, V; Bahri, H; Surdez, D; Delattre, O; Pierron, G; Villemeur, M; Lapouble, E; Brahmi, M; Bouhamama, A; Corradini, N; Marec-Bérard, Perrine (2022). Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. European Journal of Cancer, 179:56-64.

Lilly, Jena V; Rokita, Jo Lynne; Mason, Jennifer L; Stucklin, Ana Guerreiro; Gerber, Nicolas; Nazarian, Javad (2022). The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia, 35:100846.

Galldiks, Norbert; Langen, Karl-Josef; Albert, Nathalie L; Law, Ian; Kim, Michelle M; Villanueva-Meyer, Javier E; Soffietti, Riccardo; Wen, Patrick Y; Weller, Michael; Tonn, Joerg C (2022). Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group. Neuro-Oncology, 24(11):1815-1826.

Lim, Michael; Weller, Michael; Idbaih, Ahmed; Steinbach, Joachim; Finocchiaro, Gaetano; Raval, Raju R; Ansstas, George; Baehring, Joachim; Taylor, Jennie W; Honnorat, Jerome; Petrecca, Kevin; De Vos, Filip; Wick, Antje; Sumrall, Ashley; Sahebjam, Solmaz; Mellinghoff, Ingo K; Kinoshita, Masashi; Roberts, Mustimbo; Slepetis, Ruta; Warad, Deepti; Leung, David; Lee, Michelle; Reardon, David A; Omuro, Antonio (2022). Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neuro-Oncology, 24(11):1935-1949.

Quijano-Rubio, Clara; Silginer, Manuela; Weller, Michael (2022). CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models. Journal of Neuro-Oncology, 160(2):299-310.

Boesch, Maximilian; Baty, Florent; Kowatsch, Tobias; Wolf, Dominik; Früh, Martin; Brutsche, Martin Hugo (2022). Call for a holistic framework for cancer immunotherapy. Cancer, 128(21):3772-3774.

Nevens, Daan; Jongen, Aurélien; Kindts, Isabelle; Billiet, Charlotte; Deseyne, Pieter; Joye, Ines; Lievens, Yolande; Guckenberger, Matthias (2022). Completeness of Reporting Oligometastatic Disease Characteristics in Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature. International Journal of Radiation Oncology, Biology, Physics, 114(4):587-595.

de Rooij, Belle H; van den Hurk, Corina; Smaardijk, Veerle; Fernandez-Ortega, Paz; Navarro-Martin, Arturo; Barberio, Lidia; Guckenberger, Matthias; Schmid, Severin; Walraven, Iris; Vallow, Susan; Kotsi, Christina; Preusser, Matthias; Mosor, Erika; Klok, Jente M; Becker, Annemarie; Milani, Alessandra; Ninov, Lyudmil; van de Poll-Franse, Lonneke V (2022). Development of an updated, standardized, patient-centered outcome set for lung cancer. Lung Cancer, 173:5-13.

Fischer, Alessa; Bankel, Lorenz; Hiltbrunner, Stefanie; Rechsteiner, Markus; Rüschoff, Jan H; Rushing, Elisabeth Jane; Britschgi, Christian; Curioni-Fontecedro, Alessandra (2022). Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene. Targeted oncology, 17(6):683-694.

Madani, Indira; Sahgal, Arjun; Erler, Darby; Stish, Bradley J; Olivier, Kenneth R; Park, Sean S; Eppinga, W S C; Seravalli, Enrica; Redmond, Kristin J; Cao, Yilin; Siva, Shankar; Chang, David; Nguyen, Timothy K; O'Neil, Melissa; Guckenberger, Matthias (2022). Stereotactic Body Radiation Therapy for Metastases in Long Bones. International Journal of Radiation Oncology, Biology, Physics, 114(4):738-746.

Fiskus, Warren; Daver, Naval; Boettcher, Steffen; Mill, Christopher P; Sasaki, Koji; Birdwell, Christine E; Davis, John A; Das, Kaberi; Takahashi, Koichi; Kadia, Tapan M; DiNardo, Courtney D; Burrows, Francis; Loghavi, Sanam; Khoury, Joseph D; Ebert, Benjamin L; Bhalla, Kapil N (2022). Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia, 36(11):2729-2733.

Hiltbrunner, Stefanie; Fleischmann, Zoe; Sokol, Ethan S; Zoche, Martin; Felley-Bosco, Emanuela; Curioni-Fontecedro, Alessandra (2022). Genomic landscape of pleural and peritoneal mesothelioma tumours. British Journal of Cancer, 127(11):1997-2005.

Langenberg, Karin P S; Meister, Michael T; Bakhuizen, Jette J; et al; Breunis, Willemijn; Vormoor, H Josef (2022). Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'. European Journal of Cancer, 175:311-325.

Ceppi, Francesco; Gotti, Giacomo; Möricke, Anja; et al; Tchinda, Joelle (2022). Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies. European Journal of Cancer, 175:120-124.

Bührer, Elias D; Amrein, Michael A; Förster, Stefan; Isringhausen, Stephan; Schürch, Christian M; Bhate, Salil S; Brodie, Tess; Zindel, Joel; Stroka, Deborah; Sayed, Mohamad Al; Nombela-Arrieta, César; Radpour, Ramin; Riether, Carsten; Ochsenbein, Adrian F (2022). Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance. Leukemia, 36(11):2634-2646.

Mueller, Timothy; Laternser, Sandra; Guerreiro Stücklin, Ana S; Gerber, Nicolas U; Mourabit, Sulayman; Rizo, Marion; Rushing, Elisabeth J; Kottke, Raimund; Grotzer, Michael; Krayenbühl, Niklaus; Nazarian, Javad; Mueller, Sabine (2022). Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience. European Journal of Cancer, 178:171-179.

Ni, Ruiqing; Müller Herde, Adrienne; Haider, Ahmed; Keller, Claudia; Louloudis, Georgios; Vaas, Markus; Schibli, Roger; Ametamey, Simon M; Klohs, Jan; Mu, Linjing (2022). In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI. Molecular Imaging and Biology, 24(5):700-709.

Engelmann, Christine; Schuhmachers, Patrick; Zdimerova, Hana; Virdi, Sanamjeet; Hauri-Hohl, Mathias; Pachlopnik Schmid, Jana; Grundhoff, Adam; Marsh, Rebecca A; Wong, Wendy Wei-Lynn; Münz, Christian (2022). Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1. Cell Death and Disease, 13(10):892.

Immanuel, Tracey; Li, Jixia; Green, Taryn N; Bogdanova, Anna; Kalev-Zylinska, Maggie L (2022). Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential. Frontiers in Oncology, 12:1010506.

Bubendorf, Lukas; Zoche, Martin; Dafni, Urania; Rüschoff, Jan Hendrik; Prince, Spasenija Savic; Marti, Nesa; Stavrou, Androniki; Kammler, Roswitha; Finn, Stephen P; Moch, Holger; Peters, Solange; Stahel, Rolf A (2022). Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. Lung Cancer, 174:27-35.

Normanno, Nicola; Apostolidis, Kathi; Wolf, Audrey; Al Dieri, Raed; Deans, Zandra; Fairley, Jenni; Maas, Jörg; Martínez, Antonio; Moch, Holger; Nielsen, Søren; Pilz, Thomas; Rouleau, Etienne; Patton, Simon; Williams, Victoria (2022). Access and quality of biomarker testing for precision oncology in Europe. European Journal of Cancer, 176:70-77.

Moustakis, Christos; Eich, Hans Theodor; Blanck, Oliver; Chan, Mark K H; Boda-Heggemann, Judit; Andratschke, Nicolaus; Schmitt, Daniela (2022). In Reply to Oskan. International Journal of Radiation Oncology, Biology, Physics, 114(2):374-375.

Weller, Jonathan; Katzendobler, Sophie; Blobner, Jens; Thiele, Frederic; Becker, Hannes; Quach, Stefanie; Egensperger, Rupert; Niyazi, Maximilian; Suchorska, Bogdana; Thon, Niklas; Weller, Michael; Tonn, Joerg-Christian (2022). Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3. Journal of Neuro-Oncology, 160(1):149-158.

Kluge, Anne; Ehrbar, Stefanie; Grehn, Melanie; Fleckenstein, Jens; Baus, Wolfgang W; Siebert, Frank-Andre; Schweikard, Achim; Andratschke, Nicolaus; Mayinger, Michael C; Boda-Heggemann, Judit; Buergy, Daniel; Celik, Eren; Krug, David; Kovacs, Boldizsar; Saguner, Ardan M (2022). Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial. International Journal of Radiation Oncology, Biology, Physics, 114(2):360-372.

Mangana, Joanna; Zihler, Deborah; Bossart, Simon; Brönnimann, Daniel; Zachariah, Ralph; Gérard, Camille Léa (2022). Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice. Melanoma research, 32(5):366-372.

Felip, Enriqueta; Smit, Egbert F; Molina-Vila, Miguel A; Dafni, Urania; et al; Britschgi, Christian; Kammler, Roswitha; Ruepp, Barbara; Roschitzki-Voser, Heidi; Peters, Solange (2022). Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. Lung Cancer, 172:94-99.

Reibelt, Antonia; Mayinger, Michael; Borm, Kai J; Combs, Stephanie E; Duma, Marciana N (2022). Neuroanatomical changes seen in MRI in patients with cerebral metastasized breast cancer after radiotherapy. Tumori, 108(5):486-494.

Gerger, Armin; Eisterer, Wolfgang; Fuxius, Stefan; Bastian, Sara; et al; Sanoyan, Dilara Akhoundova; Fritsch, Ralph (2022). Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma – MORSECRC. Anticancer Research, 42(10):4773-4785.

Stamatis, Georgios; Leschber, Gunda; Schwarz, Birte; Brintrup, Diana Lütke; Flossdorf, Sarah; Passlick, Bernward; Hecker, Erich; Kugler, Christian; Eichhorn, Martin; Krbek, Thomas; Eggeling, Stephan; Hatz, Rudolf; Müller, Michael Rolf; Hillinger, Sven; Aigner, Clemens; Jöckel, Karl-Heinz (2022). Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm. Lung Cancer, 172:108-116.

Hermann, Nicola; Maul, Lara Valeska; Ameri, Milad; Traidl, Stephan; Ziadlou, Reihane; Papageorgiou, Karolina; Kolm, Isabel; Levesque, Mitchell; Maul, Julia-Tatjana; Brüggen, Marie-Charlotte (2022). Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study. Cancers, 14(19):4576.

Shulman, David S; Whittle, Sarah B; Surdez, Didier; Bailey, Kelly M; de Álava, Enrique; Yustein, Jason T; Shlien, Adam; Hayashi, Masanori; Bishop, Alexander J R; Crompton, Brian D; DuBois, Steven G; Shukla, Neerav; Leavey, Patrick J; Lessnick, Stephen L; Kovar, Heinrich; Delattre, Olivier; Grünewald, Thomas G P; Antonescu, Cristina R; Roberts, Ryan D; Toretsky, Jeffrey A; Tirode, Franck; Gorlick, Richard; Janeway, Katherine A; Reed, Damon; Lawlor, Elizabeth R; Grohar, Patrick J (2022). An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma. NPJ precision oncology, 6:65.

Voglis, Stefanos; Schaller, Valentina; Müller, Timothy; Gönel, Meltem; Winklhofer, Sebastian; Mangana, Joana; Dummer, Reinhard; Serra, Carlo; Weller, Michael; Regli, Luca; Le Rhun, Emilie; Neidert, Marian C (2022). Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival. European Journal of Cancer, 175:158-168.

Fisher, Natalie C; Byrne, Ryan M; Leslie, Holly; Wood, Colin; Legrini, Assya; Cameron, Andrew J; Ahmaderaghi, Baharak; Corry, Shania M; Malla, Sudhir B; Amirkhah, Raheleh; McCooey, Aoife J; Rogan, Emily; Redmond, Keara L; Sakhnevych, Svetlana; Domingo, Enric; Jackson, James; Loughrey, Maurice B; Leedham, Simon; Maughan, Tim; Lawler, Mark; Sansom, Owen J; Lamrock, Felicity; Koelzer, Viktor H; Jamieson, Nigel B; Dunne, Philip D (2022). Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data. Clinical Cancer Research, 28(18):4056-4069.

Tonnus, Wulf; Maremonti, Francesca; Belavgeni, Alexia; Latk, Markus; Kusunoki, Yoshihiro; Brucker, Anne; von Mässenhausen, Anne; Meyer, Claudia; Locke, Sophie; Gembardt, Florian; Beer, Kristina; Hoppenz, Paul; Becker, Jan U; Hugo, Christian; Anders, Hans-Joachim; Bornstein, Stefan R; Shao, Feng; Linkermann, Andreas (2022). Gasdermin D-deficient mice are hypersensitive to acute kidney injury. Cell Death and Disease, 13(9):792.

Kline, Cassie; Jain, Payal; Kilburn, Lindsay; Bonner, Erin R; Gupta, Nalin; Crawford, John R; Banerjee, Anu; Packer, Roger J; Villanueva-Meyer, Javier; Luks, Tracy; Zhang, Yalan; Kambhampati, Madhuri; Zhang, Jie; Yadavilli, Sridevi; Zhang, Bo; Gaonkar, Krutika S; Rokita, Jo Lynne; Kraya, Adam; Kuhn, John; Liang, Winnie; Byron, Sara; Berens, Michael; Molinaro, Annette; Prados, Michael; Resnick, Adam; Waszak, Sebastian M; Nazarian, Javad; Mueller, Sabine (2022). Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. Clinical Cancer Research, 28(18):3965-3978.

Ott, Pauline; Araúzo-Bravo, Marcos J; Hoffmann, Michèle J; Poyet, Cedric; Bendhack, Marcelo L; Santourlidis, Simeon; Erichsen, Lars (2022). Differential DNA Methylation of THOR and hTAPAS in the Regulation of hTERT and the Diagnosis of Cancer. Cancers, 14(18):4384.

Bonner, Erin R; Harrington, Robin; Eze, Augustine; Bornhorst, Miriam; Kline, Cassie N; Gordish-Dressman, Heather; Dawood, Adam; Das, Biswajit; Chen, Li; Pauly, Rini; Williams, P Mickey; Karlovich, Chris; Peach, Amanda; Howell, D'andra; Doroshow, James; Kilburn, Lindsay; Packer, Roger J; Mueller, Sabine; Nazarian, Javad (2022). Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. npj precision oncology, 6(1):63.

Krieg, Carsten; Weber, Lukas M; Fosso, Bruno; Marzano, Marinella; Hardiman, Gary; Olcina, Monica M; Domingo, Enric; El Aidy, Sahar; Mallah, Khalil; Robinson, Mark D; Guglietta, Silvia (2022). Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. Journal for ImmunoTherapy of Cancer, 10(9):e004717.

Adamina, Michel; Warlaumont, Maxime; Berger, Martin D; Däster, Silvio; Delaloye, Raphaël; Digklia, Antonia; Gloor, Beat; Fritsch, Ralph; Koeberle, Dieter; Koessler, Thibaud; Lehmann, Kuno; Müller, Phaedra; Peterli, Ralph; Ris, Frédéric; Steffen, Thomas; Weisshaupt, Christian Stefan; Hübner, Martin (2022). Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin. Cancers, 14(17):4275.

Rohrer Bley, Carla; Wolf, Friederike; Gonçalves Jorge, Patrik; Grilj, Veljko; Petridis, Ioannis; Petit, Benoit; Böhlen, Till T; Moeckli, Raphael; Limoli, Charles; Bourhis, Jean; Meier, Valeria; Vozenin, Marie-Catherine (2022). Dose- and Volume-Limiting Late Toxicity of FLASH Radiotherapy in Cats with Squamous Cell Carcinoma of the Nasal Planum and in Mini Pigs. Clinical Cancer Research, 28(17):3814-3823.

Przystal, Justyna M; Cianciolo Cosentino, Chiara; Yadavilli, Sridevi; Zhang, Jie; Laternser, Sandra; Bonner, Erin R; Prasad, Rachna; Dawood, Adam A; Lobeto, Nina; Chin Chong, Wai; Biery, Matt C; Myers, Carrie; Olson, James M; Panditharatna, Eshini; Kritzer, Bettina; Mourabit, Sulayman; Vitanza, Nicholas A; Filbin, Mariella G; de Iuliis, Geoffry N; Dun, Matthew D; Koschmann, Carl; Cain, Jason E; Grotzer, Michael A; Waszak, Sebastian M; Mueller, Sabine; Nazarian, Javad (2022). Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas. Neuro-Oncology, 24(9):1438-1451.

Le Rhun, Emilie; Oppong, Felix Boakye; Vanlancker, Maureen; Stupp, Roger; Nabors, Burt; Chinot, Olivier L; Wick, Wolfgang; Preusser, Matthias; Gorlia, Thierry; Weller, Michael (2022). Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma. Neuro-Oncology, 24(9):1533-1545.

Tselikas, Lambros; Dardenne, Antoine; de Baère, Thierry; Faron, Matthieu; Ammari, Samy; Farhane, Siham; Suzzoni, Steve; Danlos, François-Xavier; Raoult, Thibault; Susini, Sandrine; Al Shatti, Nael; Mouraud, Severine; Deschamps, Frédéric; Kobe, Adrian; Delpla, Alexandre; Roux, Charles; Baldini, Capucine; Soria, Jean-Charles; Barlesi, Fabrice; Massard, Christophe; Robert, Caroline; Champiat, Stéphane; Marabelle, Aurélien (2022). Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients. European Journal of Cancer, 172:1-12.

Nadal, Lisa; Peissert, Frederik; Elsayed, Abdullah; Weiss, Tobias; Look, Thomas; Weller, Michael; Piro, Geny; Carbone, Carmine; Tortora, Giampaolo; Matasci, Mattia; Favalli, Nicholas; Corbellari, Riccardo; Di Nitto, Cesare; Prodi, Eleonora; Libbra, Chiara; Galeazzi, Simone; Carotenuto, Claudiopietro; Halin, Cornelia; Puca, Emanuele; Neri, Dario; De Luca, Roberto (2022). Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody. Journal for ImmunoTherapy of Cancer, 10(9):e005282.

Hettmer, Simone; Linardic, Corinne M; Kelsey, Anna; Rudzinski, Erin R; Vokuhl, Christian; Selfe, Joanna; Ruhen, Olivia; Shern, Jack F; Khan, Javed; Kovach, Alexander R; Lupo, Philip J; Gatz, Susanne A; Schäfer, Beat W; Volchenboum, Samuel; Minard-Colin, Véronique; Koscielniak, Ewa; Hawkins, Douglas S; Bisogno, Gianni; Sparber-Sauer, Monika; Venkatramani, Rajkumar; Merks, Johannes H M; Shipley, Janet (2022). Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. European Journal of Cancer, 172:367-386.

Telarovic, Irma; Yong, Carmen S M; Guckenberger, Matthias; Unkelbach, Jan; Pruschy, Martin (2022). Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model. Neoplasia, 31:100812.

Grzmil, Michal; Boersema, Paul; Sharma, Ashish; Blanc, Alain; Imobersteg, Stefan; Pruschy, Martin; Picotti, Paola; Schibli, Roger; Behe, Martin (2022). Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT). Journal of Hematology & Oncology, 15:123.

Boerlin, Aurelio; Bellini, Elisa; Turko, Patrick; Cheng, Phil F; Levesque, Mitchell P; Dummer, Reinhard; Ramelyte, Egle (2022). The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. Cancers, 14(17):4158.

Lee, Seungjae; Chang, Ti-Cheng; Schreiner, Patrick; Fan, Yiping; Agarwal, Neeraj; Owens, Charles; Dummer, Reinhard; Kirkwood, John M; Barnhill, Raymond L; Theodorescu, Dan; Wu, Gang; Bahrami, Armita (2022). Targeted Long-Read Bisulfite Sequencing Identifies Differences in the TERT Promoter Methylation Profiles between TERT Wild-Type and TERT Mutant Cancer Cells. Cancers, 14(16):4018.

Aboouf, Mostafa A; Guscetti, Franco; von Büren, Nadine; Armbruster, Julia; Ademi, Hyrije; Ruetten, Maja; Melendez-Rodríguez, Florinda; Rülicke, Thomas; Seymer, Alexander; Jacobs, Robert A; Schneider Gasser, Edith M; Aragones, Julian; Neumann, Drorit; Gassmann, Max; Thiersch, Markus (2022). Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT. Frontiers in Oncology, 12:976961.

Penkert, Judith; Strüwe, Farina J; Dutzmann, Christina M; et al; Kroiss Benninger, Sabine (2022). Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry. Journal of Hematology & Oncology, 15(1):107.

Jahn, Anna Sophie; Navarini, Alexander Andreas; Cerminara, Sara Elisa; Kostner, Lisa; Huber, Stephanie Marie; Kunz, Michael; Maul, Julia-Tatjana; Dummer, Reinhard; Sommer, Seraina; Neuner, Anja Dominique; Levesque, Mitchell Paul; Cheng, Phil Fang; Maul, Lara Valeska (2022). Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients’ Perception. Cancers, 14(15):3829.

Zamboglou, Constantinos; Strouthos, Iosif; Sahlmann, Joerg; et al; Guckenberger, Matthias (2022). Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy. International Journal of Radiation Oncology, Biology, Physics, 113(5):1015-1024.

Schröder, Christina; Gramatzki, Dorothee; Vu, Erwin; Guckenberger, Matthias; Andratschke, Nicolaus; Weller, Michael; Hertler, Caroline (2022). Radiotherapy for glioblastoma patients with poor performance status. Journal of Cancer Research and Clinical Oncology, 148(8):2127-2136.

Buergy, Daniel; Würschmidt, Florian; Gkika, Eleni; et al; Balermpas, Panagiotis; Guckenberger, Matthias (2022). Stereotactic body radiotherapy of adrenal metastases-A dose-finding study. International Journal of Cancer, 151(3):412-421.

Kahraman, Abdullah; Arnold, Fabian M; Hanimann, Jacob; Nowak, Marta; Pauli, Chantal; Britschgi, Christian; Moch, Holger; Zoche, Martin (2022). MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards. JCO Clinical Cancer Informatics, 6:e2200032.

Schlömer, Sabine; Felsberg, Jörg; Pertz, Milena; et al; Weller, Michael (2022). Mid-term treatment-related cognitive sequelae in glioma patients. Journal of Neuro-Oncology, 159(1):65-79.

Kang, Therese Mj; Hardcastle, Nicholas; Singh, Anurag K; Slotman, Ben J; Videtic, Gregory M M; Stephans, Kevin L; Couñago, Felipe; Louie, Alexander V; Guckenberger, Matthias; Harden, Susan V; Plumridge, Nikki M; Siva, Shankar (2022). Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung. Lung Cancer, 170:185-193.

Costa, Ana; Thirant, Cécile; Kramdi, Amira; Pierre-Eugène, Cécile; Louis-Brennetot, Caroline; Blanchard, Orphée; Surdez, Didier; Gruel, Nadege; Lapouble, Eve; Pierron, Gaëlle; Sitbon, Deborah; Brisse, Hervé; Gauthier, Arnaud; Fréneaux, Paul; Bohec, Mylène; Raynal, Virginie; Baulande, Sylvain; Leclere, Renaud; Champenois, Gabriel; Nicolas, Andre; Meseure, Didier; Bellini, Angela; Marabelle, Aurelien; Geoerger, Birgit; Mechta-Grigoriou, Fatima; Schleiermacher, Gudrun; Menger, Laurie; Delattre, Olivier; Janoueix-Lerosey, Isabelle (2022). Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. Journal for ImmunoTherapy of Cancer, 10(8):e004807.

Quijano-Rubio, Clara; Silginer, Manuela; Weller, Michael (2022). CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner. Cell Death Discovery, 8:341.

Lombardi, Giuseppe; Poliani, Pietro Luigi; Manara, Renzo; Berhouma, Moncef; Minniti, Giuseppe; Tabouret, Emeline; Razis, Evangelia; Cerretti, Giulia; Zagonel, Vittorina; Weller, Michael; Idbaih, Ahmed (2022). Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview. Cancers, 14(15):3646.

Bornstein, Stefan; Shapiro, Igor; Malyukov, Maria; Züllig, Richard; Luca, Edlira; Gelfgat, Evgeny; Beuschlein, Felix; Nölting, Svenja; Berruti, Alfredo; Sigala, Sandra; Peitzsch, Mirko; Steenblock, Charlotte; Ludwig, Barbara; Kugelmeier, Patrick; Hantel, Constanze (2022). Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin. Cell Death and Disease, 13(7):648.

Haas, Rick; Stelmes, Jean-Jacques; Zaffaroni, Facundo; Sauvé, Nicolas; Clementel, Enrico; Bar-Deroma, Raquel; Le Péchoux, Cécile; Litière, Saskia; Marreaud, Sandrine; Alyamani, Najlaa; Andratschke, Nicolaus H J; Sangalli, Claudia; Chung, Peter W; Miah, Aisha; Hurkmans, Coen; Gronchi, Alessandro; Bovée, Judith V M G; Gelderblom, Hans; Kasper, Bernd; Weber, Damien Charles; Bonvalot, Sylvie (2022). Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trial. Cancer, 128(14):2796-2805.

Taromi, Sanaz; Firat, Elke; Simonis, Alexander; Braun, Lukas M; Apostolova, Petya; Elze, Mirjam; Passlick, Bernward; Schumacher, Alicia; Lagies, Simon; Frey, Anna; Schmitt-Graeff, Annette; Burger, Meike; Schmittlutz, Katrin; Follo, Marie; von Elverfeldt, Dominik; Zhu, Xuekai; Kammerer, Bernd; Diederichs, Sven; Duyster, Justus; Manz, Markus G; Niedermann, Gabriele; Zeiser, Robert (2022). Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer. Cancer Letters, 538:215697.

De Saint-Hubert, Marijke; Suesselbeck, Finja; Vasi, Fabiano; Stuckmann, Florian; Rodriguez, Miguel; Dabin, Jérémie; Timmermann, Beate; Thierry-Chef, Isabelle; Schneider, Uwe; Brualla, Lorenzo (2022). Experimental Validation of an Analytical Program and a Monte Carlo Simulation for the Computation of the Far Out-of-Field Dose in External Beam Photon Therapy Applied to Pediatric Patients. Frontiers in Oncology, 12:882506.

Allemann-Su, Yu-Yin; Vetter, Marcus; Koechlin, Helen; Paul, Steven M; Cooper, Bruce A; Oppegaard, Kate; Melisko, Michelle; Levine, Jon D; Conley, Yvette; Miaskowski, Christine; Katapodi, Maria C (2022). Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer. Cancers, 14(13):3281.

Dos Santos, Quenia; Wareham, Neval Ete; Mocroft, Amanda; Rasmussen, Allan; Gustafsson, Finn; Perch, Michael; Sørensen, Søren Schwartz; Manuel, Oriol; Müller, Nicolas J; Lundgren, Jens; Reekie, Joanne (2022). Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Cancers, 14(13):3279.

Vinante, Lorenzo; Caroli, Angela; Revelant, Alberto; Bertini, Federica; Giroldi, Anna; Marson, Marta; Franchin, Giovanni; Muraro, Elena; Brisotto, Giulia; Steffan, Agostino; Baboci, Lorena (2022). Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy. Breast, 65:49-54.

Kowalski, Benedikt; Valaperti, Alan; Bezel, Pascal; Steiner, Urs C; Scholtze, Dieter; Wieser, Stephan; Vonow-Eisenring, Maya; Widmer, Andrea; Kohler, Malcolm; Franzen, Daniel (2022). Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study. Journal of Cancer Research and Clinical Oncology, 148(7):1711-1720.

Pires da Silva, Ines; Zakria, Danny; Ahmed, Tasnia; Trojanello, Claudia; Dimitriou, Florentia; Allayous, Clara; Gerard, Camille; Zimmer, Lisa; Lo, Serigne; Michielin, Olivier; Lebbe, Celeste; Mangana, Johanna; Ascierto, Paolo Antonio; Johnson, Douglas B; Carlino, Matteo; Menzies, Alexander; Long, Georgina (2022). Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma. Journal for ImmunoTherapy of Cancer, 10(7):e004610.

Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N; Shoushtari, Alexander; Zaremba, Anne; Versluis, Judith M; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; Stansfeld, Anna; Allayous, Clara; Schwarze, Julia K; Mooradian, Meghan J; Klein, Oliver; Mehmi, Inderjit; Roberts-Thomson, Rachel; Maurichi, Andrea; Yeoh, Hui-Ling; Khattak, Adnan; Zimmer, Lisa; Blank, Christian U; Ramelyte, Egle; et al (2022). Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Journal for ImmunoTherapy of Cancer, 10(7):e004668.

Millward, Christopher P; Armstrong, Terri S; Barrington, Heather; et al; Weller, Michael (2022). Opportunities and Challenges for the development of 'Core Outcome Sets' in Neuro-Oncology. Neuro-Oncology, 24(7):1048-1055.

Taromi, Sanaz; Firat, Elke; Simonis, Alexander; et al; Manz, Markus G (2022). Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399]. Cancer Letters, 537:215680.

Holmberg, Carl-Jacob; Ny, Lars; Hieken, Tina J; Block, Matthew S; Carr, Michael J; Sondak, Vernon K; Örtenwall, Christoffer; Katseralias, Dimitrios; Dimitriou, Florentia; Menzies, Alexander M; Saw, Robyn P M; Rogiers, Aljosja; Straker, Richard J 3rd; Karakousis, Giorgos C; Applewaite, Rona; Pallan, Lalit; Han, Dale; Vetto, John T; Gyorki, David E; Nan Tie, Emilia; Vitale, Maria Grazia; Ascierto, Paolo A; Dummer, Reinhard; Cohen, Jade; Hui, Jane Yc; Schachter, Jacob; Asher, Nethanel; Helgadottir, Hildur; Chai, Harvey; Kroon, Hidde; et al (2022). The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study. European Journal of Cancer, 169:210-222.

Richter-Pechańska, Paulina; Kunz, Joachim B; Rausch, Tobias; Erarslan-Uysal, Büşra; Bornhauser, Beat; Frismantas, Viktoras; Assenov, Yassen; Zimmermann, Martin; Happich, Margit; von Knebel-Doeberitz, Caroline; von Neuhoff, Nils; Köhler, Rolf; Stanulla, Martin; Schrappe, Martin; Cario, Gunnar; Escherich, Gabriele; Kirschner-Schwabe, Renate; Eckert, Cornelia; Avigad, Smadar; Pfister, Stefan M; Muckenthaler, Martina U; Bourquin, Jean-Pierre; Korbel, Jan O; Kulozik, Andreas E (2022). Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution. Leukemia, 36(7):1759-1768.

White, Helen E; Salmon, Matthew; Albano, Francesco; et al; Balabanov, Stefan (2022). Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia, 36(7):1834-1842.

Buschmann, Johanna; Heuberger, Dorothea M; Kivrak Pfiffner, Fatma; Wolint, Petra; Jang, Jae-Hwi; Jungraithmayr, Wolfgang; Giovanoli, Pietro; Calcagni, Maurizio; Waschkies, Conny F (2022). Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI. Cancers, 14(13):3114.

Sobhani, Navid; Chahwan, Richard; Roudi, Raheleh; Morris, Rachel; Volinia, Stefano; Chai, Dafei; D'Angelo, Alberto; Generali, Daniele (2022). Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer. Cancers, 14(12):2952.

De Saint-Hubert, Marijke; Verbeek, Nico; Bäumer, Christian; Esser, Johannes; Wulff, Jörg; Nabha, Racell; Van Hoey, Olivier; Dabin, Jérémie; Stuckmann, Florian; Vasi, Fabiano; Radonic, Stephan; Boissonnat, Guillaume; Schneider, Uwe; Rodriguez, Miguel; Timmermann, Beate; Thierry-Chef, Isabelle; Brualla, Lorenzo (2022). Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy. Frontiers in Oncology, 12:882489.

Orjuela, Stephany; Parker, Hannah R; Sajibu, Sija; Cereatti, Fabrizio; Sauter, Matthias; Buffoli, Federico; Robinson, Mark D; Marra, Giancarlo (2022). Disentangling tumorigenesis-associated DNA methylation changes in colorectal tissues from those associated with ageing. Epigenetics, 17(6):677-694.

Sidorov, Semjon; Fux, Lara; Steiner, Katja; Bounlom, Samyo; Traxel, Sabrina; Azzi, Tarik; Berisha, Arbeneshe; Berger, Christoph; Bernasconi, Michele; Niggli, Felix K; Perner, Yvonne; Pather, Sugeshnee; Kempf, Werner; Nadal, David; Bürgler, Simone (2022). CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes. Cancer Immunology, Immunotherapy, 71(6):1371-1392.

He, Mi; Soni, Bhavesh; Schwalie, Petra C; Hüsser, Tamara; Waltzinger, Caroline; De Silva, Duvini; Prinz, Ylva; Krümpelmann, Laura; Calabro, Samuele; Matos, Ines; Trumpfheller, Christine; Bacac, Marina; Umaña, Pablo; Levesque, Mitchell P; Dummer, Reinhard; van den Broek, Maries; Gasser, Stephan (2022). Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. Journal for ImmunoTherapy of Cancer, 10(6):e004268.

Lassman, Andrew B; Sepúlveda-Sánchez, Juan Manuel; Cloughesy, Timothy F; Gil-Gil, Miguel J; Puduvalli, Vinay K; Raizer, Jeffrey J; De Vos, Filip Y F; Wen, Patrick Y; Butowski, Nicholas A; Clement, Paul M J; Groves, Morris D; Belda-Iniesta, Cristóbal; Giglio, Pierre; Soifer, Harris S; Rowsey, Steven; Xu, Cindy; Avogadri, Francesca; Wei, Ge; Moran, Susan; Roth, Patrick (2022). Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical Cancer Research, 28(11):2270-2277.

Soffietti, Riccardo; Bettegowda, Chetan; Mellinghoff, Ingo K; Warren, Katherine E; Ahluwalia, Manmeet S; De Groot, John F; Galanis, Evanthia; Gilbert, Mark R; Jaeckle, Kurt A; Le Rhun, Émilie; Rudà, Roberta; Seoane, Joan; Thon, Niklas; Umemura, Yoshie; Weller, Michael; van den Bent, Martin J; Vogelbaum, Michael A; Chang, Susan M; Wen, Patrick Y (2022). Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Neuro-Oncology, 24(6):855-871.

Lindegaard, Jacob Christian; Petric, Primoz; Schmid, Maximilian Paul; Nesvacil, Nicole; Haie-Meder, Christine; Fokdal, Lars Ulrik; Sturdza, Alina Emiliana; Hoskin, Peter; Mahantshetty, Umesh; Segedin, Barbara; Bruheim, Kjersti; Huang, Fleur; Rai, Bhavana; Cooper, Rachel; van der Steen-Banasik, Elzbieta; Van Limbergen, Erik; Pieters, Bradley Rumwell; Tan, Li-Tee; Nout, Remi A; De Leeuw, Astrid Agatha Catharina; Kirchheiner, Kathrin; Spampinato, Sofia; Jürgenliemk-Schulz, Ina; Tanderup, Kari; Kirisits, Christian; Pötter, Richard (2022). Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study. International Journal of Radiation Oncology, Biology, Physics, 113(2):379-389.

Draaisma, Kaspar; Tesileanu, C Mircea S; de Heer, Iris; Klein, Martin; Smits, Marion; Reijneveld, Jaap C; Clement, Paul M; de Vos, Filip Y F; Wick, Antje; Mulholland, Paul J; Taphoorn, Martin J B; Weller, Michael; Chinot, Olivier L; Kros, Johan M; Verschuere, Tina; Coens, Corneel; Golfinopoulos, Vassilis; Gorlia, Thierry; Idbaih, Ahmed; Robe, Pierre A; van den Bent, Martin J; French, Pim J (2022). Prognostic significance of DNA methylation profiles at MRI enhancing tumor recurrence: a report from the EORTC 26091 TAVAREC trial. Clinical Cancer Research, 28(11):2440-2448.

Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Ribas, Antoni; Sullivan, Ryan J; Panella, Timothy; McKean, Meredith; Santos, Edgardo S; Brill, Kimberli; Polli, Anna; Pietro, Alessandra di; Ascierto, Paolo A (2022). STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future Oncology (London, England), 18(17):2041-2051.

Günther, Moritz Philipp; Schulze, Jan Ben; Kirchebner, Johannes; Jordan, Katja-Daniela; von Känel, Roland; Euler, Sebastian (2022). Severe mental illness in cancer is associated with disparities in psycho-oncological support. Current Problems in Cancer, 46(3):100849.

Tawbi, Hussein A; Robert, Caroline; Brase, Jan C; Gusenleitner, Daniel; Gasal, Eduard; Garrett, James; Savchenko, Alexander; Görgün, Güllü; Flaherty, Keith T; Ribas, Antoni; Dummer, Reinhard; Schadendorf, Dirk; Long, Georgina V; Nathan, Paul D; Ascierto, Paolo A (2022). Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with $\textit{BRAF}$V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for ImmunoTherapy of Cancer, 10(6):e004226.

Jacoby, Elad; Ghorashian, Sara; Vormoor, Britta; De Moerloose, Barbara; Bodmer, Nicole; Molostova, Olga; Yanir, Asaf D; Buechner, Jochen; Elhasid, Ronit; Bielorai, Bella; Rogosic, Srdan; Dourthe, Marie-Emilie; Maschan, Michael; Rossig, Claudia; Toren, Amos; von Stackelberg, Arend; Locatelli, Franco; Bader, Peter; Zimmermann, Martin; Bourquin, Jean Pierre; Baruchel, Andre (2022). CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study. Leukemia, 36(6):1525-1532.

König, D; Schär, S; Vuong, Diem; Guckenberger, Matthias; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M (2022). Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO Open, 7(3):100494.

Boller, Danielle; Doepfner, Kathrin T; Laurentiis, Angela D E; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; Waterfield, Michael D; Arcaro, Alexandre (2022). Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours. Anticancer Research, 42(6):3217-3230.

Veillon, Rémi; Sakai, Hiroshi; Le, Xiuning; Felip, Enriqueta; et al; Britschgi, Christian (2022). Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management. Clinical Lung Cancer, 23(4):320-332.

Fergin, Aleksandra; Boesch, Gabriel; Greter, Nadja R; Berger, Simon; Hajnal, Alex (2022). Tissue-specific inhibition of protein sumoylation uncovers diverse SUMO functions during C. elegans vulval development. PLoS Genetics, 18(6):e1009978.

Trilla-Fuertes, Lucía; Gámez-Pozo, Angelo; Lumbreras-Herrera, María Isabel; López-Vacas, Rocío; Heredia-Soto, Victoria; Ghanem, Ismael; López-Camacho, Elena; Zapater-Moros, Andrea; Miguel, María; Peña-Burgos, Eva M; Palacios, Elena; De Uribe, Marta; Guerra, Laura; Dittmann, Antje; Mendiola, Marta; Fresno Vara, Juan Ángel; Feliu, Jaime (2022). Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics. Cancers, 14(10):2414.

Kostner, Lisa; Cerminara, Sara Elisa; Pamplona, Gustavo Santo Pedro; Maul, Julia-Tatjana; Dummer, Reinhard; Ramelyte, Egle; Mangana, Johanna; Wagner, Nikolaus Benjamin; Cozzio, Antonio; Kreiter, Saskia; Kogler, Angelika; Streit, Markus; Wysocki, Anja; Zippelius, Alfred; Läubli, Heinz; Navarini, Alexander Andreas; Maul, Lara Valeska (2022). Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers, 14(10):2360.

Buchou, Charlie; Laud-Duval, Karine; van der Ent, Wietske; Grossetête, Sandrine; Zaidi, Sakina; Gentric, Géraldine; Corbé, Maxime; Müller, Kévin; Del Nery, Elaine; Surdez, Didier; Delattre, Olivier (2022). Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins. Cancers, 14(9):2327.

Homicsko, Krisztian; Dummer, Reinhard; Hoeller, Christoph; Wolchok, Jedd D; Hodi, F Stephen; Larkin, James; Ascierto, Paolo A; Atkinson, Victoria; Robert, Caroline; Postow, Michael A; Re, Sandra; Paulucci, David; Dobler, Darin; Michielin, Olivier (2022). Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers, 14(9):2300.

Fischer, Galina Farina; Brügge, Detlef; Andratschke, Nicolaus; Baumert, Brigitta Gertrud; Bosetti, Davide Giovanni; Caparrotti, Francesca; Herrmann, Evelyn; Papachristofilou, Alexandros; Rogers, Susanne; Schwyzer, Lucia; Zwahlen, Daniel Rudolf; Hundsberger, Thomas; Putora, Paul Martin (2022). Postoperative radiotherapy for meningiomas - a decision-making analysis. BMC Cancer, 22:492.

Fankhauser, Christian D; Christiansen, Ailsa J; Rothermundt, Christian; Cathomas, Richard; Wettstein, Marian S; Grossmann, Nico C; Grogg, Josias B; Templeton, Arnoud J; Hirschi-Blickenstorfer, Anita; Lorch, Anja; Gillessen, Silke; Moch, Holger; Beyer, Joerg; Hermanns, Thomas (2022). Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. British Journal of Cancer, 126(8):1140-1144.

Beck, Marcus; Sassowsky, Manfred; Schär, Sämi; Mathier, Etienne; Halter, Matthias; Zwahlen, Daniel R; Hölscher, Tobias; Arnold, Winfried; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Putora, Paul M; Papachristofilou, Alexandros; Hayoz, Stefanie; Schär, Corinne; Li, Qiyu; Sumila, Marcin; Zaugg, Kathrin; Guckenberger, Matthias; Ost, Piet; Bosetti, Davide G; Reuter, Christiane; Gomez, Silvia; Khanfir, Kaouthar; Aebersold, Daniel M; Ghadjar, Pirus; Pra, Alan Dal (2022). Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial. International Journal of Radiation Oncology, Biology, Physics, 113(1):80-91.

Moustakis, Christos; Blanck, Oliver; Chan, Mark Ka Heng; Boda-Heggemann, Judit; et al; Andratschke, Nicolaus; Guckenberger, Matthias; Wilke, Lotte (2022). Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery. International Journal of Radiation Oncology, Biology, Physics, 113(1):214-227.

Wang, Dongdong; Huang, Jiansheng; Gui, Ting; Yang, Yaxin; Feng, Tingting; Tzvetkov, Nikolay T; Xu, Tao; Gai, Zhibo; Zhou, Ying; Zhang, Jingjie; Atanasov, Atanas G (2022). SR-BI as a target of natural products and its significance in cancer. Seminars in Cancer Biology, 80:18-38.

Kroese, Tiuri E; van Laarhoven, Hanneke W M; Nilsson, Magnus; Lordick, Florian; Guckenberger, Matthias; et al (2022). Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. European Journal of Cancer, 166:254-269.

Pedot, Gloria; Marques, Joana Graça; Ambühl, Philip P; Wachtel, Marco; Kasper, Stephanie; Ngo, Quy A; Niggli, Felix K; Schäfer, Beat W (2022). RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization. Neoplasia, 27:100784.

Mikhail Lette, Miriam N; Paez, Diana; Shulman, Lawrence N; Guckenberger, Matthias; Douillard, Jean-Yves; Oyen, Wim J G; Giammarile, Francesco; Rangarajan, Venkatesh; Ginsberg, Michelle; Pellet, Olivier; Liao, Zhongxing; Abdel Wahab, May (2022). Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine. JCO Global Oncology, 8:e2100100.

Pamporaki, Christina; Prodanov, Tamara; Meuter, Leah; Berends, Annika M A; Bechmann, Nicole; Constantinescu, Georgiana; Beuschlein, Felix; Remde, Hanna; Januszewicz, Andrzej; Kerstens, Michiel N; Timmers, Henri J L M; Taieb, David; Robledo, Mercedes; Lenders, Jacques W M; Pacak, Karel; Eisenhofer, Graeme (2022). Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. European Journal of Cancer, 169:32-41.

Cho, Choi-Fong; Farquhar, Charlotte E; Fadzen, Colin M; Scott, Benjamin; Zhuang, Pei; von Spreckelsen, Niklas; Loas, Andrei; Hartrampf, Nina; Pentelute, Bradley L; Lawler, Sean E (2022). A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma. Cancers, 14(9):2207.

Joerger, Markus; Metaxas, Yannis; Zaman, Khalil; Michielin, Olivier; Mach, Nicolas; Bettini, Adrienne; Schmitt, Andreas M; Cantoni, Nathan; Caspar, Clemens B; Stettler, Sonja; Malval, Roma; Pless, Miklos; Britschgi, Christian; Renner, Christoph; Koeberle, Dieter; Schulz, Jessica D; Kopp, Christoph; Hayoz, Stefanie; Stathis, Anastasios; von Moos, Roger; Swiss Group for Clinical Cancer Research (SAKK) (2022). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers, 14(9):2191.

Anagnostopoulos, Gerasimos; Motiño, Omar; Li, Sijing; Carbonnier, Vincent; Chen, Hui; Sica, Valentina; Durand, Sylvère; Bourgin, Mélanie; Aprahamian, Fanny; Nirmalathasan, Nitharsshini; Donne, Romain; Desdouets, Chantal; Sola, Marcelo Simon; Kotta, Konstantina; Montégut, Léa; Lambertucci, Flavia; Surdez, Didier; Sandrine, Grossetête; Delattre, Olivier; Maiuri, Maria Chiara; Bravo-San Pedro, José Manuel; Martins, Isabelle; Kroemer, Guido (2022). An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor. Cell Death and Disease, 13(4):356.

Mele, Valentina; Basso, Camilla; Governa, Valeria; Glaus Garzon, Jesus F; Muraro, Manuele G; Däster, Silvio; Nebiker, Christian A; Mechera, Robert; Bolli, Martin; Schmidt, Alexander; Geiger, Roger; Spagnoli, Giulio C; Christoforidis, Dimitri; Majno, Pietro E; Borsig, Lubor; Iezzi, Giandomenica (2022). Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells. Cancers, 14(8):2024.

Raschzok, Nathanael; Stintzing, Sebastian; Heinemann, Volker; Rauch, Geraldine; Ricke, Jens; Guckenberger, Matthias; et al (2022). FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer. BMC Cancer, 22:359.

Bauml, Joshua M; Li, Bob T; Velcheti, Vamsidhar; Govindan, Ramaswamy; Curioni-Fontecedro, Alessandra; Dooms, Christophe; Takahashi, Toshiaki; Duda, Andrew W; Odegaard, Justin I; Cruz-Guilloty, Fernando; Jin, Liming; Zhang, Ying; Anderson, Abraham; Skoulidis, Ferdinandos (2022). Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. Lung Cancer, 166:270-278.

Häfliger, Janine; Morsy, Yasser; Scharl, Michael; Wawrzyniak, Marcin (2022). From Patient Material to New Discoveries: a Methodological Review and Guide for Intestinal Stem Cell Researchers. Stem Cell Reviews and Reports, 18(4):1309-1321.

Bertram, Katrin; Leary, Peter John; Boudesco, Christophe; Fullin, Jonas; Stirm, Kristin; Dalal, Vineet; Zenz, Thorsten; Tzankov, Alexandar; Müller, Anne (2022). Inhibitors of Bcl-2 and Bruton's tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models. Leukemia, 36(4):1035-1047.

Říhová, Kamila; Dúcka, Monika; Zambo, Iva Staniczková; Vymětalová, Ladislava; Šrámek, Martin; Trčka, Filip; Verner, Jan; Drápela, Stanislav; Fedr, Radek; Suchánková, Tereza; Pavlatovská, Barbora; Ondroušková, Eva; Kubelková, Irena; Zapletalová, Danica; Tuček, Štěpán; Múdry, Peter; Krákorová, Dagmar Adámková; Knopfová, Lucia; Šmarda, Jan; Souček, Karel; Borsig, Lubor; Beneš, Petr (2022). Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clinical & Experimental Metastasis, 39(2):375-390.

Metzger, Sarah; Weiser, Annette; Gerber, Nicolas U; Otth, Maria; Scheinemann, Katrin; Krayenbühl, Niklaus; Grotzer, Michael A; Guerreiro Stucklin, Ana S (2022). Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. Journal of Neuro-Oncology, 157(2):307-317.

Metzger, Sarah; Weiser, Annette; Gerber, Nicolas U; Otth, Maria; Scheinemann, Katrin; Krayenbühl, Niklaus; Grotzer, Michael A; Guerreiro Stucklin, Ana S (2022). Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. Journal of Neuro-Oncology, 157(2):319.

König, D; Schär, S; Vuong, Diem; Guckenberger, Matthias; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; Pless, M; Früh, M (2022). Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials. ESMO Open, 7(2):100455.

Schoot, Reineke A; Otth, Maria A; Frederix, Gerardus W J; Leufkens, Hubert G M; Vassal, Gilles (2022). Market access to new anticancer medicines for children and adolescents with cancer in Europe. European Journal of Cancer, 165:146-153.

Orlova, Anna; Pavlova, Ksenia; Kurnikov, Aleksey; Maslennikova, Anna; Myagcheva, Marina; Zakharov, Evgeniy; Skamnitskiy, Dmitry; Perekatova, Valeria; Khilov, Alexander; Kovalchuk, Andrey; Moiseev, Alexander; Turchin, Ilya; Razansky, Daniel; Subochev, Pavel (2022). Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling. Neoplasia, 26:100778.

Erlmeier, Franziska; Sun, Na; Shen, Jian; Feuchtinger, Annette; Buck, Achim; Prade, Verena M; Kunzke, Thomas; Schraml, Peter; Moch, Holger; Autenrieth, Michael; Weichert, Wilko; Hartmann, Arndt; Walch, Axel (2022). MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas. Cancers, 14(7):14.

Richter, Susan; Qiu, Bei; Ghering, Mirthe; Kunath, Carola; Constantinescu, Georgiana; Luths, Charlotte; Pamporaki, Christina; Bechmann, Nicole; Meuter, Leah; Kwapiszewska, Aleksandra; Deutschbein, Timo; Nölting, Svenja; Peitzsch, Mirko; Robledo, Mercedes; Prejbisz, Aleksander; Pacak, Karel; Gudziol, Volker; Timmers, Henri J L M; Eisenhofer, Graeme (2022). Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Endocrine-Related Cancer, 29(4):213-224.

Frei, Annika; Scaglioni, Mario F; Giovanoli, Pietro; Breitenstein, Stefan; Heesen, Philip; Fuchs, Bruno; On Behalf Of The Swiss Sarcoma Network (2022). Definition of the Surgical Case Complexity in the Treatment of Soft Tissue Tumors of the Extremities and Trunk. Cancers, 14(6):1559.

Pinello, Katia; Baldassarre, Valeria; Steiger, Katja; Paciello, Orlando; Pires, Isabel; Laufer-Amorim, Renée; Oevermann, Anna; Niza-Ribeiro, João; Aresu, Luca; Rous, Brian; Znaor, Ariana; Cree, Ian A; Guscetti, Franco; Palmieri, Chiara; Dagli, Maria Lucia Zaidan (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers, 14(6):1529.

Daetwyler, Eveline; Bargetzi, Mario; Otth, Maria; Scheinemann, Katrin (2022). Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review. BMC Cancer, 22(1):267.

Tonnus, Wulf; Locke, Sophie; Meyer, Claudia; Maremonti, Francesca; Eggert, Lena; von Mässenhausen, Anne; Bornstein, Stefan R; Green, Douglas R; Linkermann, Andreas (2022). Rubicon-deficiency sensitizes mice to mixed lineage kinase domain-like (MLKL)-mediated kidney ischemia-reperfusion injury. Cell Death and Disease, 13:236.

Guida, Lelio; Stumpo, Vittorio; Bellomo, Jacopo; Bas van Niftrik, Christiaan Hendrik; Sebök, Martina; Berhouma, Moncef; Bink, Andrea; Weller, Michael; Kulcsar, Zsolt; Regli, Luca; Fierstra, Jorn (2022). Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading. Cancers, 14(6):1432.

Stumpo, Vittorio; Guida, Lelio; Bellomo, Jacopo; Van Niftrik, Christiaan Hendrik Bas; Sebök, Martina; Berhouma, Moncef; Bink, Andrea; Weller, Michael; Kulcsar, Zsolt; Regli, Luca; Fierstra, Jorn (2022). Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions. Cancers, 14(5):1342.

Steiner, Sabrina; Seleznik, Gitta M; Reding, Theresia; Stopic, Matea; Lenggenhager, Daniela; ten Buren, Emiel; Eshmuminov, Dilmurodjon; Endhardt, Katharina; Hagedorn, Catherine; Heidenblut, Anna M; Bratus-Neuenschwander, Anna; Grossmann, Jonas; Trachsel, Christian; Jabbar, Karolina S; Hahn, Stephan A; vom Berg, Johannes; Graf, Rolf; Gupta, Anurag (2022). De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. Oncogene, 41(10):1507-1517.

Montagna, Giacomo; Schaffar, Robin; Bordoni, Andrea; Spitale, Alessandra; Terribile, Daniela A; Rossi, Lorenzo; Bergeron, Yvan; van der Linden, Bernadette W A; Konzelmann, Isabelle; Rohrmann, Sabine; Staehelin, Katharina; Maspoli-Conconi, Manuela; Bulliard, Jean-Luc; Meani, Francesco; Pagani, Olivia; Rapiti, Elisabetta (2022). Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland. Cancers, 14(5):1328.

Alonso-Miguel, Daniel; Valdivia, Guillermo; Guerrera, Diego; Perez-Alenza, Maria Dolores; Pantelyushin, Stanislav; Alonso-Diez, Angela; Beiss, Veronique; Fiering, Steven; Steinmetz, Nicole F; Suarez-Redondo, Maria; vom Berg, Johannes; Peña, Laura; Arias-Pulido, Hugo (2022). Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer. Journal for ImmunoTherapy of Cancer, 10(3):e004044.

Swaminath, Anand; Ritter, Timothy; Louie, Alexander V; Palma, David A; Guckenberger, Matthias; Senan, Suresh; Bezjak, Andrea; Moghanaki, Drew (2022). Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? International Journal of Radiation Oncology, Biology, Physics, 112(3):586-589.

Fankhauser, Christian Daniel; Grogg, Josias Bastian; Rothermundt, Christian; Clarke, Noel William (2022). Treatment and follow-up of rare testis tumours. Journal of Cancer Research and Clinical Oncology, 148(3):667-671.

Obrecht, Denise; Mynarek, Martin; Hagel, Christian; Kwiecien, Robert; Spohn, Michael; Bockmayr, Michael; Bison, Brigitte; Pfister, Stefan M; Jones, David T W; Sturm, Dominik; von Deimling, Andreas; Sahm, Felix; von Hoff, Katja; Juhnke, B-Ole; Benesch, Martin; Gerber, Nicolas U; Friedrich, Carsten; von Bueren, André O; Kortmann, Rolf-Dieter; Schwarz, Rudolf; Pietsch, Torsten; Fleischhack, Gudrun; Schüller, Ulrich; Rutkowski, Stefan (2022). Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies. Journal of Neuro-Oncology, 157(1):37-48.

Kroese, Tiuri E; van Hillegersberg, Richard; Schoppmann, Sebastian; et al; Guckenberger, Matthias (2022). Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. European Journal of Cancer, 164:18-29.

Beckmann, Kerri; Crawley, Danielle; Nelson, William G; Platz, Elizabeth A; Selvin, Elizabeth; Van Hemelrijck, Mieke; Rohrmann, Sabine (2022). Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer. Cancer Causes & Control, 33(3):429-440.

Hagel, Christian; Sloman, Veronika; Mynarek, Martin; Petrasch, Katharina; Obrecht, Denise; Kühl, Joachim; Deinlein, Frank; Schmid, Renate; von Bueren, André O; Friedrich, Carsten; Juhnke, B-Ole; Gerber, Nicolas U; Kwiecien, Robert; Girschick, Hermann; Höller, Alexandra; Zapf, Antonia; von Hoff, Katja; Rutkowski, Stefan (2022). Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. European Journal of Cancer, 164:30-38.

Brivio, Erica; Baruchel, André; Beishuizen, Auke; Bourquin, Jean-Pierre; Brown, Patrick A; Cooper, Todd; Gore, Lia; Kolb, E Anders; Locatelli, Franco; Maude, Shannon L; Mussai, Francis J; Vormoor-Bürger, Britta; Vormoor, Josef; von Stackelberg, Arend; Zwaan, C Michel (2022). Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma. European Journal of Cancer, 164:1-17.

Sum, Eva; Rapp, Moritz; Dürr, Harald; Mazumdar, Alekhya; Romero, Pedro J; Trumpfheller, Christine; Umaña, Pablo (2022). The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. Journal for ImmunoTherapy of Cancer, 10(3):e003264.

Goodman, William; Bagnall, Anne-Marie; Ashley, Laura; Azizoddin, Desiree; Muehlensiepen, Felix; Blum, David; Bennett, Michael I; Allsop, Matthew (2022). The Extent of Engagement With Telehealth Approaches by Patients With Advanced Cancer: Systematic Review. JMIR Cancer, 8(1):e33355.

Boonen, Rick A C M; Wiegant, Wouter W; Celosse, Nandi; Vroling, Bas; Heijl, Stephan; Kote-Jarai, Zsofia; Mijuskovic, Martina; Cristea, Simona; Solleveld-Westerink, Nienke; van Wezel, Tom; Beerenwinkel, Niko; Eeles, Rosalind; Devilee, Peter; Vreeswijk, Maaike P G; Marra, Giancarlo; van Attikum, Haico (2022). Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk. Cancer Research, 82(4):615-631.

Wichmann, Jürgen; Rynn, Caroline; Friess, Thomas; Petrig-Schaffland, Jeannine; Kornacker, Martin; Handl, Cornelia; Emmenegger, Jasmin; Eckmann, Jan; Herting, Frank; Frances, Nicolas; Hunziker, Daniel; Krummenacher, Daniela; Rüttinger, Dominik; Ribeiro, Alison; Bacac, Marina; Brigo, Alessandro; Hewings, David S; Dummer, Reinhard; Levesque, Mitchell P; Schnetzler, Gabriel; Martoglio, Bruno; Bischoff, James R; Pettazzoni, Piergiorgio (2022). Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor. Clinical Cancer Research, 28(4):770-780.

Glatzer, Markus; Tanderup, Kari; Rovirosa, Angeles; Fokdal, Lars; Ordeanu, Claudia; Tagliaferri, Luca; Chargari, Cyrus; Strnad, Vratislav; Dimopoulos, Johannes Athanasios; Šegedin, Barbara; Cooper, Rachel; Nakken, Esten Søndrol; Petric, Primoz; van der Steen-Banasik, Elzbieta; Lössl, Kristina; Jürgenliemk-Schulz, Ina M; Niehoff, Peter; Hermansson, Ruth S; Nout, Remi A; Putora, Paul Martin; Plasswilm, Ludwig; Tselis, Nikolaos (2022). Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers, 14(4):906.

Roblek, Marko; Bicher, Julia; van Gogh, Merel; György, Attila; Seeböck, Rita; Szulc, Bozena; Damme, Markus; Olczak, Mariusz; Borsig, Lubor; Siekhaus, Daria E (2022). The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis. Frontiers in Oncology, 12:777634.

Fischer, Susanne; Kuebler, Ulrike; Abbruzzese, Elvira; Breymann, Christian; Mernone, Laura; Ehlert, Ulrike (2022). Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence. BMC Cancer, 22(1):145.

Tallón de Lara, Paulino; Castañón, Héctor; Sterpi, Michelle; van den Broek, Maries (2022). Antimetastatic defense by CD8+ T cells. Trends in cancer, 8(2):145-157.

Nguyen, Timothy K; Chin, Lee; Sahgal, Arjun; Dagan, Roi; Eppinga, Wietse; Guckenberger, Matthias; Kim, Jin Ho; Lo, Simon S; Redmond, Kristin J; Siva, Shankar; Stish, Bradley J; Chan, Rachel; Lawrence, Liam; Lau, Angus; Tseng, Chia-Lin (2022). International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases. International Journal of Radiation Oncology, Biology, Physics, 112(2):351-360.

Bakunina, Katerina; Putter, Hein; Versluis, Jurjen; Koster, Eva A S; van der Holt, Bronno; Manz, Markus G; Breems, Dimitri A; Gjertsen, Bjorn T; Cloos, Jacqueline; Valk, Peter J M; Passweg, Jakob; Pabst, Thomas; Ossenkoppele, Gert J; Löwenberg, Bob; Cornelissen, Jan J; de Wreede, Liesbeth C (2022). The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed. Cancer Medicine, 11(3):630-640.

Goldinger, Simone M; Buder-Bakhaya, Kristina; Lo, Serigne N; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; et al (2022). Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. European Journal of Cancer, 162:22-33.

Busenhart, Philipp; Montalban-Arques, Ana; Katkeviciute, Egle; Morsy, Yasser; Van Passen, Chiara; Hering, Larissa; Atrott, Kirstin; Lang, Silvia; Garzon, Jesus Francisco Glaus; Naschberger, Elisabeth; Hartmann, Arndt; Rogler, Gerhard; Stürzl, Michael; Spalinger, Marianne Rebecca; Scharl, Michael (2022). Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer. Journal for ImmunoTherapy of Cancer, 10(2):e003465.

Sessa, Cristiana; Cortes, Juan; Conte, P; Cardoso, F; Choueiri, T; Dummer, Reinhard; Lorusso, P; Ottmann, O; Ryll, B; Mok, T; Tempero, M; Comis, S; Oliva, C; Peters, S; Tabernero, J (2022). The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective. ESMO Open, 7(1):100339.

Erker, Craig; Lane, Adam; Chaney, Brooklyn; Leary, Sarah; Minturn, Jane E; Bartels, Ute; Packer, Roger J; Dorris, Kathleen; Gottardo, Nicholas G; Warren, Katherine E; Broniscer, Alberto; Kieran, Mark W; Zhu, Xiaoting; White, Peter; Dexheimer, Phillip J; Black, Katie; Asher, Anthony; DeWire, Mariko; Hansford, Jordan R; Gururangan, Sridharan; Nazarian, Javad; Ziegler, David S; Sandler, Eric; Bartlett, Allison; Goldman, Stewart; Shih, Chie-Schin; Hassall, Tim; Dholaria, Hetal; Bandopadhayay, Pratiti; Samson, Yvan; et al (2022). Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Neuro-Oncology, 24(1):141-152.

Juhnke, B-Ole; Gessi, Marco; Gerber, Nicolas U; Friedrich, Carsten; Mynarek, Martin; von Bueren, André O; Haberler, Christine; Schüller, Ulrich; Kortmann, Rolf-Dieter; Timmermann, Beate; Bison, Brigitte; Warmuth-Metz, Monika; Kwiecien, Robert; Pfister, Stefan M; Spix, Claudia; Pietsch, Torsten; Kool, Marcel; Rutkowski, Stefan; von Hoff, Katja (2022). Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro-Oncology, 24(1):127-137.

Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies. Edited by: Pasello, Giulia; Felley-Bosco, Emanuela; Remon, Jordi (2022). Lausanne: Frontiers Media SA.

Pánisová, Elena; Lünemann, Anna; Bürgler, Simone; Kotur, Monika; Lazarovici, Julien; Danu, Alina; Kaulfuss, Meike; Mietz, Juliane; Chijioke, Obinna; Münz, Christian; Busson, Pierre; Berger, Christoph; Ghez, David; Azzi, Tarik (2022). Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma. Cancer Immunology, Immunotherapy, 71(1):13-24.

Kuett, Laura; Catena, Raúl; Özcan, Alaz; Plüss, Alex; Schraml, Peter; Moch, Holger; de Souza, Natalie; Bodenmiller, Bernd; Cancer Grand Challenges IMAXT Consortium (2022). Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment. Nature Cancer, 3(1):122-133.

Otth, Maria; Scheinemann, Katrin (2022). Back to school - The teachers' worries and needs having a childhood cancer patient or survivor in their class. Frontiers in Oncology, 12:992584.

Otth, Maria; Denzler, Sibylle; Diesch-Furlanetto, Tamara; Scheinemann, Katrin (2022). Cancer knowledge and health-consciousness in childhood cancer survivors following transition into adult care-results from the ACCS project. Frontiers in Oncology, 12:946281.

Tettero, Jesse M; Al-Badri, Waleed K W; Ngai, Lok Lam; Bachas, Costa; Breems, Dimitri A; van Elssen, Catharina H M J; Fischer, Thomas; Gjertsen, Bjorn T; van Gorkom, Gwendolyn N Y; Gradowska, Patrycja; Greuter, Marjolein J E; Griskevicius, Laimonas; Juliusson, Gunnar; Maertens, Johan; Manz, Markus G; Pabst, Thomas; Passweg, Jakob; Porkka, Kimmo; Löwenberg, Bob; Ossenkoppele, Gert J; Janssen, Jeroen J W M; Cloos, Jacqueline (2022). Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis. Frontiers in Oncology, 12:999822.

Galactionova, Katya; Loibl, Sibylle; Salari, Paola; Marmé, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé R; Kim, Sung-Bae; Bear, Harry D; McCarthy, Nicole; Gelmon, Karen A; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Gnant, Michael; Makris, Andreas; Burchardi, Nicole; Schwenkglenks, Matthias (2022). Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial. Frontiers in Oncology, 12:886831.

Pasello, Giulia; Remon, Jordi; Felley-Bosco, Emanuela (2022). Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies. Frontiers in Oncology, 12:871544.

Bieri, Uwe; Enderlin, Dominik; Buser, Lorenz; Wettstein, Marian S; Eberli, Daniel; Moch, Holger; Hermanns, Thomas; Poyet, Cedric (2022). Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study. Frontiers in Oncology, 12:964672.

von der Grün, Jens; Winkelmann, Ria; Burck, Iris; et al; Balermpas, Panagiotis (2022). Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial. Frontiers in Oncology, 12:817692.

Nieder, Carsten; Andratschke, Nicolaus H; Grosu, Anca L (2022). Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review). Frontiers in Oncology, 12:1081558.

Keek, Simon A; Beuque, Manon; Primakov, Sergey; Woodruff, Henry C; Chatterjee, Avishek; van Timmeren, Janita E; Vallières, Martin; Hendriks, Lizza E L; Kraft, Johannes; Andratschke, Nicolaus; Braunstein, Steve E; Morin, Olivier; Lambin, Philippe (2022). Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics. Frontiers in Oncology, 12:920393.

Schmid, Severin; Becker, Heiko; Fritsch, Ralph; Bausch, Johannes; Hunter, Natalie; Jenkner, Carolin; Hassan, Mohamed; Passlick, Bernward (2022). Study Protocol for a Randomised Controlled Trial on Pulmonary Metastasectomy vs. Standard of Care in Colorectal Cancer Patients With ≥ 3 Lung Metastases (PUCC-Trial). Frontiers in Oncology, 12:913896.

Akhoundova, Dilara; Haberecker, Martina; Fritsch, Ralph; Höller, Sylvia; Kiessling, Michael K; Rechsteiner, Markus; Rüschoff, Jan H; Curioni-Fontecedro, Alessandra (2022). Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in Oncology, 12:911294.

Fremond, Sarah; Koelzer, Viktor Hendrik; Horeweg, Nanda; Bosse, Tjalling (2022). The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning. Frontiers in Oncology, 12:928977.

De Baere, Thierry; Tselikas, Lambros; Delpla, Alexandre; Roux, Charles; Varin, Eloi; Kobe, Adrian; Yevich, Steven; Deschamps, Frédéric (2022). Thermal ablation in the management of oligometastatic colorectal cancer. International Journal of Hyperthermia, 39(1):627-632.

2021

Hiltbrunner, Stefanie; Spohn, Meta-Lina; Wechsler, Ramona; Akhoundova, Dilara; Bankel, Lorenz; Kasser, Sabrina; Bihr, Svenja; Britschgi, Christian; Maathuis, Marloes H; Curioni-Fontecedro, Alessandra (2021). Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer. Cancers, 14:75.

Roth, Lilian; Russo, Linda; Ulugoel, Sima; dos Santos, Rafael Freire; Breuer, Eva; Gupta, Anurag; Lehmann, Kuno (2021). Peritoneal Metastasis: Current Status and Treatment Options. Cancers, 14:60.

Werner, Raphael S; Opitz, Isabelle (2021). Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer. Cancers, 13(24):6374.

Daskalakis, Michael; Feller, Anita; Noetzli, Jasmine; Bonadies, Nicolas; Arndt, Volker; Baerlocher, Gabriela Maria (2021). Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers, 13(24):6269.

Zhylka, Andrey; Sollmann, Nico; Kofler, Florian; Radwan, Ahmed; De Luca, Alberto; Gempt, Jens; Wiestler, Benedikt; Menze, Bjoern; Krieg, Sandro M; Zimmer, Claus; Kirschke, Jan S; Sunaert, Stefan; Leemans, Alexander; Pluim, Josien P W (2021). Tracking the Corticospinal Tract in Patients With High-Grade Glioma: Clinical Evaluation of Multi-Level Fiber Tracking and Comparison to Conventional Deterministic Approaches. Frontiers in Oncology, 11:761169.

Maurer-Granofszky, Margarita; Schumich, Angela; Buldini, Barbara; Gaipa, Giuseppe; Kappelmayer, Janos; Mejstrikova, Ester; Karawajew, Leonid; Rossi, Jorge; Suzan, Adın Çınar; Agriello, Evangelina; Anastasiou-Grenzelia, Theodora; Barcala, Virna; Barna, Gábor; Batinić, Drago; Bourquin, Jean-Pierre; Brüggemann, Monika; Bukowska-Strakova, Karolina; Burnusuzov, Hasan; Carelli, Daniela; Deniz, Günnur; Dubravčić, Klara; Feuerstein, Tamar; Gaillard, Marie Isabel; Galeano, Adriana; Giordano, Hugo; Gonzalez, Alejandro; Groeneveld-Krentz, Stefanie; Hevessy, Zsuzsanna; Hrusak, Ondrej; Iarossi, Maria Belen; et al (2021). An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report. Cancers, 13(23):6148.

Adam, Salomé; Rossi, Silvia Emma; Moatti, Nathalie; De Marco Zompit, Mara; Xue, Yibo; Ng, Timothy F; Álvarez-Quilón, Alejandro; Desjardins, Jessica; Bhaskaran, Vivek; Martino, Giovanni; Setiaputra, Dheva; Noordermeer, Sylvie M; Ohsumi, Toshiro K; Hustedt, Nicole; Szilard, Rachel K; Chaudhary, Natasha; Munro, Meagan; Veloso, Artur; Melo, Henrique; Yin, Shou Yun; Papp, Robert; Young, Jordan T F; Zinda, Michael; Stucki, Manuel; Durocher, Daniel (2021). The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer. Nature cancer, 2(12):1357-1371.

Gutzmer, Ralf; Robert, Caroline; Loquai, Carmen; Schadendorf, Dirk; Squittieri, Nicholas; Arntz, Ramon; Martelli, Serena; Dummer, Reinhard (2021). Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis. BMC Cancer, 21:1244.

Sobottka-Brillout, Bettina; Moch, Holger; Varga, Zsuzsanna (2021). Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of breast cancer. Breast Cancer Research, 23:4.

Kranzbühler, Benedikt; Sousa, Rosa; Prause, Lukas Werner; Burger, Irene A; Rupp, Niels J; Sulser, Tullio; Salemi, Souzan; Eberli, Daniel (2021). Impact of short-term Dutasteride treatment on prostate-specific membrane antigen expression in a mouse xenograft model. Cancer Reports, 4(6):e1418.

Telarovic, Irma; Wenger, Roland H; Pruschy, Martin (2021). Interfering with Tumor Hypoxia for Radiotherapy Optimization. Journal of Experimental & Clinical Cancer Research, 40:197.

Weber, Walter P; Matrai, Zoltan; Hayoz, Stefanie; Tausch, Christoph; Henke, Guido; Zwahlen, Daniel R; Gruber, Günther; Zimmermann, Frank; Seiler, Stefanie; Maddox, Charlotte; Ruhstaller, Thomas; Muenst, Simone; Ackerknecht, Markus; Kuemmel, Sherko; Bjelic-Radisic, Vesna; Kurzeder, Christian; Újhelyi, Mihály; Vrieling, Conny; Satler, Rok; Meyer, Inna; Becciolini, Charles; Bucher, Susanne; Simonson, Colin; Fehr, Peter M; Gabriel, Natalie; Maráz, Robert; Sarlos, Dimitri; Dedes, Konstantin J; Leo, Cornelia; Berclaz, Gilles; et al (2021). Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101). Breast, 60:98-110.

Hainc, Nicolin; Alsafwani, Noor; Gao, Andrew; O'Halloran, Philip J; Kongkham, Paul; Zadeh, Gelareh; Gutierrez, Enrique; Shultz, David; Krings, Timo; Alcaide-Leon, Paula (2021). The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery. Journal of Neuro-Oncology, 155(3):325-333.

van der Zwet, Jordy C G; Buijs-Gladdines, Jessica G C A M; Cordo', Valentina; Debets, Donna O; Smits, Willem K; Chen, Zhongli; Dylus, Jelle; Zaman, Guido J R; Altelaar, Maarten; Oshima, Koichi; Bornhauser, Beat; Bourquin, Jean-Pierre; Cools, Jan; Ferrando, Adolfo A; Vormoor, Josef; Pieters, Rob; Vormoor, Britta; Meijerink, Jules P P (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia, 35(12):3394-3405.

Bautista, Francisco; Paoletti, Xavier; Rubino, Jonathan; Brard, Caroline; Rezai, Keyvan; Nebchi, Souad; Andre, Nicolas; Aerts, Isabelle; De Carli, Emilie; van Eijkelenburg, Natasha; Thebaud, Estelle; Corradini, Nadege; Defachelles, Anne-Sophie; Ducassou, Stephane; Morscher, Raphael J; Vassal, Gilles; Geoerger, Birgit (2021). Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. Journal of Clinical Oncology, 39(32):3546-3560.

Spyroglou, Ariadni; Piaditis, George P; Kaltsas, Gregory; Alexandraki, Krystallenia I (2021). Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism. Cancers, 13(21):5582.

Porcheri, Cristina; Mitsiadis, Thimios A (2021). New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas. Cancers, 13(21):5515.

Frappaz, Didier; Barritault, Marc; Montané, Laure; Laigle-Donadey, Florence; Chinot, Olivier; Le Rhun, Emilie; Bonneville-Levard, Alice; Hottinger, Andreas F; Meyronnet, David; Bidaux, Anne-Sophie; Garin, Gwenaële; Pérol, David (2021). MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. Neuro-Oncology, 23(11):1949-1960.

Morscher, Raphael J; Brard, Caroline; Berlanga, Pablo; Marshall, Lynley V; André, Nicolas; Rubino, Jonathan; Aerts, Isabelle; De Carli, Emilie; Corradini, Nadège; Nebchi, Souad; Paoletti, Xavier; Mortimer, Peter; Lacroix, Ludovic; Pierron, Gaelle; Schleiermacher, Gudrun; Vassal, Gilles; Geoerger, Birgit (2021). First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial. European Journal of Cancer, 157:268-277.

Dimitriou, Florentia; Hogan, Sabrina; Menzies, Alexander M; Dummer, Reinhard; Long, Georgina V (2021). Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy. European Journal of Cancer, 157:214-224.

Tsao, Chih-Chieh; Baumann, Julia; Huang, Sheng-Fu; Kindler, Diana; Schroeter, Aileen; Kachappilly, Nicole; Gassmann, Max; Rudin, Markus; Ogunshola, Omolara O (2021). Pericyte hypoxia-inducible factor-1 (HIF-1) drives blood-brain barrier disruption and impacts acute ischemic stroke outcome. Angiogenesis, 24(4):823-842.

Taromi, Sanaz; Firat, Elke; Simonis, Alexander; et al; Manz, Markus G (2021). RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer. Cancer Letters, 520:385-399.

Süveg, Krisztian; Le Péchoux, Cécile; Faivre-Finn, Corinne; Putora, Paul M; De Ruysscher, Dirk; Widder, Joachim; Van Houtte, Paul; Troost, Esther G C; Slotman, Ben J; Ramella, Sara; Pöttgen, Christoph; Peeters, Stephanie T H; Nestle, Ursula; McDonald, Fiona; Dziadziuszko, Rafal; Belderbos, José; Ricardi, Umberto; Manapov, Farkhad; Lievens, Yolande; Geets, Xavier; Dieckmann, Karin; Guckenberger, Matthias; Andratschke, Nicolaus; Glatzer, Markus (2021). Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. Clinical Lung Cancer, 22(6):579-586.

Rogers, S; Stauffer, A; Lomax, N; Alonso, S; Eberle, B; Gomez Ordoñez, S; Lazeroms, T; Kessler, E; Brendel, M; Schwyzer, L; Riesterer, O (2021). Five fraction stereotactic radiotherapy after brain metastasectomy: a single-institution experience and literature review. Journal of Neuro-Oncology, 155(1):35-43.

van Timmeren, Janita E; Chamberlain, Madalyne; Bogowicz, Marta; Ehrbar, Stefanie; Dal Bello, Riccardo; Garcia Schüler, Helena; Krayenbuehl, Jérôme; Wilke, Lotte; Andratschke, Nicolaus; Guckenberger, Matthias; Tanadini-Lang, Stephanie; Balermpas, Panagiotis (2021). MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands. Cancers, 13(21):5404.

Forconi, Catherine S; Mulama, David H; Saikumar Lakshmi, Priya; Foley, Joslyn; Otieno, Juliana A; Kurtis, Jonathan D; Berg, Leslie J; Ong'echa, John M; Münz, Christian; Moormann, Ann M (2021). Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4+ and CD8+ T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma. Cancers, 13(21):5375.

Longo, João Paulo Figueiró; Muehlmann, Luis Alexandre; Calderón, Marcelo; Stockmann, Christian; Azevedo, Ricardo Bentes (2021). Editorial: Nanomedicine in Cancer Targeting and Therapy. Frontiers in Oncology, 11:788210.

Correia de Sousa, Marta; Calo, Nicolas; Sobolewski, Cyril; Gjorgjieva, Monika; Clément, Sophie; Maeder, Christine; Dolicka, Dobrochna; Fournier, Margot; Vinet, Laurent; Montet, Xavier; Dufour, Jean-François; Humar, Bostjan; Negro, Francesco; Sempoux, Christine; Foti, Michelangelo (2021). Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers, 13(19):4983.

Hettmer, Simone; Dachy, Guillaume; Seitz, Guido; Agaimy, Abbas; Duncan, Catriona; Jongmans, Marjolijn; Hirsch, Steffen; Kventsel, Iris; Kordes, Uwe; de Krijger, Ronald R; Metzler, Markus; Michaeli, Orli; Nemes, Karolina; Poluha, Anna; Ripperger, Tim; Russo, Alexandra; Smetsers, Stephanie; Sparber-Sauer, Monika; Stutz, Eveline; Bourdeaut, Franck; Kratz, Christian P; Demoulin, Jean-Baptiste (2021). Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group. Familial cancer, 20(4):327-336.

Halle, Briana Rose; Betof Warner, Allison; Zaman, Farzana Y; Haydon, Andrew; Bhave, Prachi; et al; Dimitriou, Florentia (2021). Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy. Journal for ImmunoTherapy of Cancer, 9(10):e003066.

Bennan, Amit Ben Antony; Unkelbach, Jan; Wahl, Niklas; Salome, Patrick; Bangert, Mark (2021). Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma. International Journal of Radiation Oncology, Biology, Physics, 111(2):559-572.

Hilbers, Marie-Luise; Dimitriou, Florentia; Lau, Peter; Bhave, Prachi; McArthur, Grant A; Zimmer, Lisa; Kudura, Ken; Gérard, Camille L; Levesque, Mitchell P; Michielin, Olivier; Dummer, Reinhard; Cheng, Phil F; Mangana, Joanna (2021). Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. European Journal of Cancer, 156:149-163.

Poortmans, Philip M; Struikmans, Henk; De Brouwer, Peter; Weltens, Caroline; Fortpied, Catherine; Kirkove, Carine; Budach, Volker; Peignaux-Casasnovas, Karine; van der Leij, Femke; Vonk, Ernest; Valli, Mariacarla; vanTienhoven, Geertjan; Weidner, Nicola; Noel, Georges; Guckenberger, Matthias; Koiter, Eveline; vanLimbergen, Erik; Engelen, Antoine; Fourquet, Alain; Bartelink, Harry (2021). Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925. Journal of the National Cancer Institute, 113(10):1360-1368.

Girardi, Fabio; Rous, Brian; Stiller, Charles A; Gatta, Gemma; Fersht, Naomi; Storm, Hans H; Rodrigues, Jessica R; Herrmann, Christian; Marcos-Gragera, Rafael; Peris-Bonet, Rafael; Valkov, Mikhail; Weir, Hannah K; Woods, Ryan R; You, Hui; Cueva, Patricia A; De, Prithwish; Di Carlo, Veronica; Johannesen, Tom Børge; Lima, Carlos A; Lynch, Charles F; Coleman, Michel P; Allemani, Claudia (2021). The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology, 23(10):1765-1776.

Lewis, Richard; Maurer, H Carlo; Singh, Nikita; et al; Zenz, Thorsten (2021). CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness. Leukemia, 35(10):2895-2905.

Herbst, Friederike; Lang, Tonio J L; Eckert, Elias S P; Wünsche, Peer; Wurm, Alexander A; Kindinger, Tim; Laaber, Karin; Hemmati, Shayda; Hotz-Wagenblatt, Agnes; Zavidij, Oksana; Paruzynski, Anna; Lu, Junyan; von Kalle, Christof; Zenz, Thorsten; Klein, Christoph; Schmidt, Manfred; Ball, Claudia R; Glimm, Hanno (2021). The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision. Leukemia, 35(10):2948-2963.

Kroeze, Stephanie G C; Mackeprang, Paul-Henry; De Angelis, Claudio; Pica, Alessia; Bachtiary, Barbara; Kliebsch, Ulrike L; Weber, Damien C (2021). A Prospective Study on Health-Related Quality of Life and Patient-Reported Outcomes in Adult Brain Tumor Patients Treated with Pencil Beam Scanning Proton Therapy. Cancers, 13(19):4892.

Werner, Raphael S; Kirschner, Michaela B; Opitz, Isabelle (2021). Primary Lung Cancer Organoids for Personalized Medicine-Are They Ready for Clinical Use? Cancers, 13(19):4832.

Ahmadov, Ulvi; Picard, Daniel; Bartl, Jasmin; Silginer, Manuela; et al; Roth, Patrick (2021). The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma. Cell Death and Disease, 12(10):885.

Kroeze, Stephanie G C; Fritz, Corinna; Schaule, Jana; Blanck, Oliver; Kahl, Klaus Henning; Kaul, David; Siva, Shankar; Gerum, Sabine; Claes, An; Sundahl, Nora; Adebahr, Sonja; Stera, Susanne; Schymalla, Markus M; Abbasi-Senger, Nasrin; Buergy, Daniel; Geier, Michael; Szuecs, Marcella; Lohaus, Fabian; Henke, Guido; Combs, Stephanie E; Guckenberger, Matthias (2021). Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis. Cancers, 13(19):4780.

Monteagudo, María; Martínez, Paula; Leandro-García, Luis J; et al; Beuschlein, Felix (2021). Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma. Cancers, 13(19):4758.

Euler, André; Laqua, Fabian Christopher; Cester, Davide; Lohaus, Niklas; Sartoretti, Thomas; Dos Santos, Daniel Pinto; Alkadhi, Hatem; Baessler, Bettina (2021). Virtual Monoenergetic Images of Dual-Energy CT-Impact on Repeatability, Reproducibility, and Classification in Radiomics. Cancers, 13(18):4710.

Vokinger, Kerstin N; Hwang, Thomas J; Daniore, Paola; Lee, ChangWon C; Tibau, Ariadna; Grischott, Thomas; Rosemann, Thomas J; Kesselheim, Aaron S (2021). Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe. JAMA Oncology, 7(9):e212026.

Grogg, Josias Bastian; Fronzaroli, Jordi Nicola; Oliveira, Pedro; Bode, Peter-Karl; Lorch, Anja; Issa, Allaudin; Beyer, Joerg; Eberli, Daniel; Sangar, Vijay; Hermanns, Thomas; Clarke, Noel William; Fankhauser, Christian Daniel (2021). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. Journal of Cancer Research and Clinical Oncology, 147(9):2671-2679.

Felley-Bosco, Emanuela (2021). Non-coding RNA regulatory networks in mesothelioma: a narrative review of their implication in innate immune signaling pathways. Precision Cancer Medicine, 4:23.

Loizeau, Nicolas; Fabiano, Silvia; Papp, Dávid; Stützer, Kristin; Jakobi, Annika; Bandurska-Luque, Anna; Troost, Esther G C; Richter, Christian; Unkelbach, Jan (2021). Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 111(1):196-207.

Tesileanu, C M S; van den Bent, M J; Sanson, M; Wick, W; Brandes, A A; Clement, P M; et al; Weller, Michael (2021). Prognostic significance of genome-wide DNA methylation profiles within the randomised, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology, 23(9):1547-1559.

Zaremba, Anne; Eggermont, Alexander M M; Robert, Caroline; Dummer, Reinhardt; Ugurel, Selma; Livingstone, Elisabeth; Ascierto, Paolo A; Long, Georgina V; Schadendorf, Dirk; Zimmer, Lisa (2021). The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients. European Journal of Cancer, 155:268-280.

von Hoff, Katja; Haberler, Christine; Schmitt-Hoffner, Felix; Schepke, Elizabeth; de Rojas, Teresa; Jacobs, Sandra; Zapotocky, Michal; Sumerauer, David; Perek-Polnik, Marta; Dufour, Christelle; van Vuurden, Dannis; Slavc, Irene; Gojo, Johannes; Pickles, Jessica C; Gerber, Nicolas U; Massimino, Maura; Gil-da-Costa, Maria Joao; Garami, Miklos; Kumirova, Ella; Sehested, Astrid; Scheie, David; Cruz, Ofelia; Moreno, Lucas; Cho, Jaeho; Zeller, Bernward; Bovenschen, Niels; Grotzer, Michael; Alderete, Daniel; Snuderl, Matija; Zheludkova, Olga; et al (2021). Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro-Oncology, 23(9):1597-1611.

Bauer, Sebastian; Demetri, George D; Halilovic, Ensar; Dummer, Reinhard; Meille, Christophe; Tan, Daniel S W; Guerreiro, Nelson; Jullion, Astrid; Ferretti, Stephane; Jeay, Sébastien; van Bree, Laurence; Hourcade-Potelleret, Florence; Wuerthner, Jens U; Fabre, Claire; Cassier, Philippe A (2021). Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies. British Journal of Cancer, 125(5):687-698.

Bothou, Christina; Sharma, Ashish; Oo, Adrian; Kim, Baek; Perge, Pal; Igaz, Peter; Ronchi, Cristina L; Shapiro, Igor; Hantel, Constanze (2021). Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment. Cancers, 13(16):4200.

Karschnia, Philipp; Le Rhun, Emilie; Vogelbaum, Michael A; van den Bent, Martin; Grau, Stefan J; Preusser, Matthias; Soffietti, Riccardo; von Baumgarten, Louisa; Westphal, Manfred; Weller, Michael; Tonn, Joerg-Christian (2021). The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. European Journal of Cancer, 156:93-108.

Ch'ng, Sydney; Uyulmaz, Semra; Carlino, Matteo S; Pennington, Thomas E; Shannon, Kerwin F; Rtshiladze, Michael; Stretch, Jonathan R; Nieweg, Omgo E; Varey, Alexander H R; Hsiao, Edward; Kapoor, Rony; Pires da Silva, Ines; Lo, Serigne N; Spillane, Andrew J; Scolyer, Richard A; Long, Georgina V; Hong, Angela M; Saw, Robyn P M; Thompson, John F; Menzies, Alexander M (2021). Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. European Journal of Cancer, 153:8-15.

Vaidya, Jayant S; Bulsara, Max; Baum, Michael; et al; Gruber, Günther; Dedes, Konstantin J (2021). New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. British Journal of Cancer, 125(3):380-389.

van den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; de Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; Krause, Scott; Ansell, Pete; Nuyens, Sarah; Spruyt, Maarten; Brilhante, Joana; Coens, Corneel; Gorlia, Thierry; Golfinopoulos, Vassilis (2021). Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Neuro-Oncology, 23(8):1415.

Breuer, Eva; Hebeisen, Monika; Schneider, Marcel André; Roth, Lilian; Pauli, Chantal; Frischer-Ordu, Katharina; Eden, Janina; Pache, Basile; Steffen, Thomas; Hübner, Martin; Villeneuve, Laurent; Kepenekian, Vahan; Passot, Guillaume; Gertsch, Philippe; Gupta, Anurag; Glehen, Olivier; Lehmann, Kuno (2021). Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis. Journal of the National Cancer Institute, 113(8):1027-1035.

Sole, Anna; Grossetête, Sandrine; Heintzé, Maxime; Babin, Loelia; Zaïdi, Sakina; Revy, Patrick; Renouf, Benjamin; De Cian, Anne; Giovannangeli, Carine; Pierre-Eugène, Cécile; Janoueix-Lerosey, Isabelle; Couronné, Lucile; Kaltenbach, Sophie; Tomishima, Mark; Jasin, Maria; Grünewald, Thomas G P; Delattre, Olivier; Surdez, Didier; Brunet, Erika (2021). Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. Cancer Research, 81(19):4994-5006.

Radonic, Stephan; Besserer, Jürgen; Meier, Valeria; Rohrer Bley, Carla; Schneider, Uwe (2021). A novel analytical population tumor control probability model includes cell density and volume variations: application to canine brain tumor. International Journal of Radiation Oncology, Biology, Physics, 110(5):1530-1537.

Rogge, Alizé A; Helmer, Stefanie M; King, Ryan; Canella, Claudia; Icke, Katja; Pach, Daniel; Witt, Claudia M (2021). Effects of training oncology physicians advising patients on complementary and integrative therapies on patient‐reported outcomes: A multicenter, cluster‐randomized trial. Cancer, 127(15):2683-2692.

Michalopoulou, Eleftheria; Matthes, Katarina Luise; Karavasiloglou, Nena; Wanner, Miriam; Limam, Manuela; Korol, Dimitri; Held, Leonhard; Rohrmann, Sabine (2021). Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study. Cancer Epidemiology, 73:101962.

Schadendorf, Dirk; Robert, Caroline; Dummer, Reinhard; Flaherty, Keith T; Tawbi, Hussein A; Menzies, Alexander M; Banerjee, Hiya; Lau, Mike; Long, Georgina V (2021). Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers. European Journal of Cancer, 153:234-241.

Traxel, Sabrina; Lehmann, Julia; Richard, Stefanie; Sidorov, Semjon; Niggli, Felix; Berger, Christoph; Nadal, David; Bürgler, Simone (2021). Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis. Cancer Immunology, Immunotherapy, 70(8):2275-2289.

Todisco, Gabriele; Creignou, Maria; Gallì, Anna; Guglielmelli, Paola; Rumi, Elisa; Roncador, Marco; et al (2021). Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms. Leukemia, 35(8):2371-2381.

Lu, Junyan; Cannizzaro, Ester; Meier-Abt, Fabienne; Scheinost, Sebastian; Bruch, Peter-Martin; Giles, Holly A R; Lütge, Almut; Hüllein, Jennifer; Wagner, Lena; Giacopelli, Brian; Nadeu, Ferran; Delgado, Julio; Campo, Elías; Mangolini, Maurizio; Ringshausen, Ingo; Böttcher, Martin; Mougiakakos, Dimitrios; Jacobs, Andrea; Bodenmiller, Bernd; Dietrich, Sascha; Oakes, Christopher C; Zenz, Thorsten; Huber, Wolfgang (2021). Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia. Nature cancer, 2(8):853-864.

Kudura, Ken; Dimitriou, Florentia; Basler, Lucas; Förster, Robert; Mihic-Probst, Daniela; Kutzker, Tim; Dummer, Reinhard; Mangana, Joanna; Burger, Irene A; Kreissl, Michael C (2021). Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers, 13(15):3830.

Manzella, Gabriele; Moonamale, Devmini C; Römmele, Michaela; Bode, Peter; Wachtel, Marco; Schäfer, Beat W (2021). A combinatorial drug screen in PDX-derived primary rhabdomyosarcoma cells identifies the NOXA - BCL-XL/MCL-1 balance as target for re-sensitization to first-line therapy in recurrent tumors. Neoplasia, 23(9):929-938.

Le Rhun, Emilie; Devos, Patrick; Weller, Johannes; Seystahl, Katharina; Mo, Francesca; Compter, Anette; Berghoff, Anna S; Jongen, Joost L M; Wolpert, Fabian; Rudà, Roberta; Brandsma, Dieta; van den Bent, Martin; Preusser, Matthias; Herrlinger, Ulrich; Weller, Michael (2021). Erratum to: Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology:2126.

Christ, Sebastian M; Siddig, Shaimaa; Elbashir, Fawzia; Abuelgasim, Mohamed; Alamin Azrag, Alsadeg Awad; Abdelrahman, Omama Mustafa; Gafer, Nahla; Thormann, Maximilian; Petric, Primoz; Willmann, Jonas (2021). Radiation Oncology in the Land of the Pyramids: How Sudan Continues to Push the Frontiers of Cancer Care in Eastern Africa. International Journal of Radiation Oncology, Biology, Physics, 110(4):931-939.

Buergy, Daniel; Würschmidt, Florian; Gkika, Eleni; Hörner-Rieber, Juliane; Knippen, Stefan; Gerum, Sabine; Balermpas, Panagiotis; Henkenberens, Christoph; Voglhuber, Theresa; Kornhuber, Christine; Barczyk, Steffen; Röper, Barbara; Rashid, Ali; Blanck, Oliver; Wittig, Andrea; Herold, Hans-Ulrich; Brunner, Thomas B; Klement, Rainer J; Kahl, Klaus Henning; Ciernik, Ilja F; Ottinger, Annette; Izaguirre, Victor; Putz, Florian; König, Laila; Hoffmann, Michael; Combs, Stephanie E; Guckenberger, Matthias; Boda-Heggemann, Judit (2021). Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis. International Journal of Cancer, 149(2):358-370.

Grgic, Ivo; Tschanz, Fabienne; Borgeaud, Nathalie; Gupta, Anurag; Clavien, Pierre-Alain; Guckenberger, Matthias; Graf, Rolf; Pruschy, Martin (2021). Tumor Oxygenation by Myo-Inositol Trispyrophosphate Enhances Radiation Response. International Journal of Radiation Oncology, Biology, Physics, 110(4):1222-1233.

Hau, Peter; Frappaz, Didier; Hovey, Elizabeth; McCabe, Martin G; et al; Hofer, Silvia; Weller, Michael (2021). Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23. Cancers, 13(14):3451.

Bezel, Pascal; Valaperti, Alan; Steiner, Urs; Scholtze, Dieter; Wieser, Stephan; Vonow-Eisenring, Maya; Widmer, Andrea; Kowalski, Benedikt; Kohler, Malcolm; Franzen, Daniel P (2021). Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis. Cancer Immunology, Immunotherapy, 70(7):1867-1876.

Boda-Heggemann, Judit; Blanck, Oliver; Mehrhof, Felix; Ernst, Floris; Buergy, Daniel; Fleckenstein, Jens; Tülümen, Erol; Krug, David; Siebert, Frank-Andre; Zaman, Adrian; Kluge, Anne K; Parwani, Abdul Shokor; Andratschke, Nicolaus; Mayinger, Michael C; Ehrbar, Stefanie; Saguner, Ardan M; Celik, Eren; Baus, Wolfgang W; Stauber, Annina; Vogel, Lena; Schweikard, Achim; Budach, Volker; Dunst, Jürgen; Boldt, Leif-Hendrik; Bonnemeier, Hendrik; Rudic, Boris (2021). Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial. International Journal of Radiation Oncology, Biology, Physics, 110(3):745-756.

Le Rhun, Emilie; Devos, Patrick; Weller, Johannes; Seystahl, Katharina; Mo, Francesca; Compter, Anette; Berghoff, Anna S; Jongen, Joost L M; Wolpert, Fabian; Rudà, Roberta; Brandsma, Dieta; van den Bent, Martin; Preusser, Matthias; Herrlinger, Ulrich; Weller, Michael (2021). Prognostic factors in leptomeningeal metastases. Neuro-Oncology, 23(7):1208-1209.

Le Rhun, Emilie; Devos, Patrick; Weller, Johannes; Seystahl, Katharina; Mo, Francesca; Compter, Annette; Berghoff, Anna S; Jongen, Joost L M; Wolpert, Fabian; Rudà, Roberta; Brandsma, Dieta; van den Bent, Martin; Preusser, Matthias; Herrlinger, Ulrich; Weller, Michael (2021). Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology, 23(7):1100-1112.

Versluis, Judith M; Hendriks, Anne M; Weppler, Alison M; Brown, Lauren J; et al; Mangana, Johanna (2021). The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis. European Journal of Cancer, 151:72-83.

Grever, Michael; Andritsos, Leslie; Banerji, Versha; et al; Zenz, Thorsten (2021). Hairy cell leukemia and COVID-19 adaptation of treatment guidelines. Leukemia, 35(7):1864-1872.

Leone, Valentina; Ali, Adnan; Weber, Achim; Tschaharganeh, Darjus Felix; Heikenwalder, Mathias (2021). Liver Inflammation and Hepatobiliary Cancers. Trends in cancer, 7(7):606-623.

Eckert, Cornelia; Parker, Catriona; Moorman, Anthony V; Irving, Julie Ae; Kirschner-Schwabe, Renate; Groeneveld-Krentz, Stefanie; Révész, Tamas; Hoogerbrugge, Peter; Hancock, Jeremy; Sutton, Rosemary; Henze, Guenter; Chen-Santel, Christiane; Attarbaschi, Andishe; Bourquin, Jean-Pierre; Sramkova, Lucie; Zimmermann, Martin; Krishnan, Shekhar; von Stackelberg, Arend; Saha, Vaskar (2021). Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. European Journal of Cancer, 151:175-189.

Goldbrunner, Roland; Stavrinou, Pantelis; Jenkinson, Michael D; Sahm, Felix; Mawrin, Christian; Weber, Damien C; Preusser, Matthias; Minniti, Giuseppe; Lund-Johansen, Morten; Lefranc, Florence; Houdart, Emanuel; Sallabanda, Kita; Le Rhun, Emilie; Nieuwenhuizen, David; Tabatabai, Ghazaleh; Soffietti, Riccardo; Weller, Michael (2021). EANO guideline on the diagnosis and management of meningiomas. Neuro-Oncology, 23(11):1821-1834.

Wirsching, Hans-Georg; Weller, Michael; Balabanov, Stefan; Roth, Patrick (2021). Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma. Cancers, 13(12):3073.

La Greca Saint-Esteven, Agustina; Vuong, Diem; Tschanz, Fabienne; van Timmeren, Janita E; Dal Bello, Riccardo; Waller, Verena; Pruschy, Martin; Guckenberger, Matthias; Tanadini-Lang, Stephanie (2021). Systematic Review on the Association of Radiomics with Tumor Biological Endpoints. Cancers, 13(12):3015.

Affo, Silvia; Nair, Ajay; Brundu, Francesco; Ravichandra, Aashreya; Bhattacharjee, Sonakshi; et al; Leblond, Anne-Laure; Weber, Achim; Riener, Marc-Oliver (2021). Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell, 39(6):866-882.e11.

Frese, Laura; Darwiche, Salim E; von Rechenberg, Brigitte; Hoerstrup, Simon P; Giovanoli, Pietro; Calcagni, Maurizio (2021). Thermal conditioning improves quality and speed of keratinocyte sheet production for burn wound treatment. Cytotherapy, 23(6):536-547.

Dimitriou, Florentia; Staeger, Ramon; Ak, Melike; Maissen, Matias; Kudura, Ken; Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil F; Dummer, Reinhard; Mangana, Joanna (2021). Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis. Cancers, 13(12):2931.

Seidel, Sabine; Margold, Michelle; Kowalski, Thomas; Baraniskin, Alexander; Schroers, Roland; Korfel, Agnieszka; Thiel, Eckhard; Weller, Michael; Martus, Peter; Schlegel, Uwe (2021). Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome. Cancers, 13(12):2934.

Navarro, Fernando; Dapper, Hendrik; Asadpour, Rebecca; Knebel, Carolin; Spraker, Matthew B; Schwarze, Vincent; Schaub, Stephanie K; Mayr, Nina A; Specht, Katja; Woodruff, Henry C; Lambin, Philippe; Gersing, Alexandra S; Nyflot, Matthew J; Menze, Bjoern H; Combs, Stephanie E; Peeken, Jan C (2021). Development and External Validation of Deep-Learning-Based Tumor Grading Models in Soft-Tissue Sarcoma Patients Using MR Imaging. Cancers, 13(12):2866.

Galldiks, Norbert; Niyazi, Maximilian; Grosu, Anca L; Kocher, Martin; Langen, Karl-Josef; Law, Ian; Minniti, Giuseppe; Kim, Michelle M; Tsien, Christina; Dhermain, Frederic; Soffietti, Riccardo; Mehta, Minesh P; Weller, Michael; Tonn, Jörg-Christian (2021). Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. Neuro-Oncology, 23(6):881-893.

Sun, Suna; Frontini, Francesca; Qi, Weihong; Hariharan, Ananya; Ronner, Manuel; Wipplinger, Martin; Blanquart, Christophe; Rehrauer, Hubert; Fonteneau, Jean-François; Felley-Bosco, Emanuela (2021). Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development. Cancer Letters, 507:26-38.

Guckenberger, Matthias; Mantel, Frederick; Sweeney, Reinhart A; Hawkins, Maria; Belderbos, José; Ahmed, Merina; Andratschke, Nicolaus; Madani, Indira; Flentje, Michael (2021). Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases. International Journal of Radiation Oncology, Biology, Physics, 110(2):348-357.

Weller, Jonathan; Katzendobler, Sophie; Karschnia, Philipp; Lietke, Stefanie; Egensperger, Rupert; Thon, Niklas; Weller, Michael; Suchorska, Bogdana; Tonn, Joerg-Christian (2021). PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression. Journal of Neuro-Oncology, 153(2):283-291.

Kazimova, Tamara; Tschanz, Fabienne; Sharma, Ashish; Telarovic, Irma; Wachtel, Marco; Pedot, Gloria; Schäfer, Beat; Pruschy, Martin (2021). Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance. Molecular Cancer Research, 19(6):1051-1062.

Steeb, Theresa; Wessely, Anja; Alter, Mareike; et al; Dummer, Reinhard (2021). Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG). Journal of Cancer Research and Clinical Oncology, 147(6):1763-1771.

Blum, D; Seiler, A; Schmidt, E; Pavic, M; Strasser, F (2021). Patterns of integrating palliative care into standard oncology in an early ESMO designated center: a 10-year experience. ESMO Open, 6(3):100147.

Freiberger, Sandra N; Turko, Patrick; Hüllner, Martin; Dummer, Reinhard; Morand, Grégoire B; Levesque, Mitchell P; Holzmann, David; Rupp, Niels J (2021). Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma. Cancers, 13(11):2725.

Schindera, Christina; Zürcher, Simeon Joel; Jung, Ruedi; Boehringer, Sarah; Balder, Jan Willem; Rueegg, Corina Silvia; Kriemler, Susi; von der Weid, Nicolas Xavier (2021). Physical fitness and modifiable cardiovascular disease risk factors in survivors of childhood cancer: A report from the SURfit study. Cancer, 127(10):1690-1698.

Rasche, Mareike; Zimmermann, Martin; Steidel, Emma; Alonzo, Todd; Aplenc, Richard; Bourquin, Jean-Pierre; Boztug, Heidrun; Cooper, Todd; Gamis, Alan S; Gerbing, Robert B; Janotova, Iveta; Klusmann, Jan-Henning; Lehrnbecher, Thomas; Mühlegger, Nora; von Neuhoff, Nils; Niktoreh, Naghmeh; Sramkova, Lucie; Stary, Jan; Waack, Katharina; Walter, Christiane; Creutzig, Ursula; Dworzak, Michael; Kaspers, Gertjan; Kolb, Edward Anders; Reinhardt, Dirk (2021). Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG. Cancers, 13(10):2336.

Gillessen, Silke; Sauvé, Nicolas; Collette, Laurence; Daugaard, Gedske; de Wit, Ronald; et al; Lorch, Anja; Fankhauser, Christian (2021). Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of Clinical Oncology, 39(14):1563-1574.

Deng, Yun; Münz, Christian (2021). Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus. Cancers, 13(9):2275.

Beyer, Jörg; Collette, Laurence; Sauvé, Nicolas; Daugaard, Gedske; Feldman, Darren R; et al; Lorch, Anja; Fankhauser, Christian; Stark, Daniel; Grimison, Peter; Necchi, Andrea; Cathomas, Richard; Gillessen, Silke (2021). Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of Clinical Oncology, 39(14):1553-1562.

Bühler, Marco M; Lu, Junyan; Scheinost, Sebastian; Nadeu, Ferran; Roos-Weil, Damien; Hensel, Manfred; Thavayogarajah, Tharshika; Moch, Holger; Manz, Markus G; Haralambieva, Eugenia; Marques Maggio, Ewerton; Beà, Sílvia; Giné, Eva; Campo, Elías; Bernard, Olivier A; Huber, Wolfgang; Zenz, Thorsten (2021). SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues. Leukemia Research, 107:106608.

Klement, Rainer J; Andratschke, Nicolaus; Guckenberger, Matthias (2021). Local Control Following Stereotactic Body: Radiation Therapy for Liver Tumors: In Regard to Ohri et al. International Journal of Radiation Oncology, Biology, Physics, 110(1):249-250.

Wagner, Nikolaus B; Lenders, Max M; Kühl, Kathrin; Reinhardt, Lydia; et al; Stäger, Ramon; Zellweger, Caroline; Mangana, Johanna (2021). Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. Journal for ImmunoTherapy of Cancer, 9(5):e002350.

Kim, Youn H; Prince, H Miles; Whittaker, Sean; Horwitz, Steven M; Duvic, Madeleine; et al; Dummer, Reinhard (2021). Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. European Journal of Cancer, 148:411-421.

Pauli, Chantal; Bochtler, Tilmann; Mileshkin, Linda; Baciarello, Giulia; Losa, Ferran; Ross, Jeffrey S; Pentheroudakis, George; Zarkavelis, George; Yalcin, Suayib; Özgüroğlu, Mustafa; Beringer, Andreas; Scarato, Jeremy; Mueller-Ohldach, Mathis; Thomas, Marlene; Moch, Holger; Krämer, Alwin (2021). A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience. The oncologist, 26(5):e769-e779.

Limam, Manuela; Matthes, Katarina Luise; Pestoni, Giulia; Michalopoulou, Eleftheria; Held, Leonhard; Dehler, Silvia; Korol, Dimitri; Rohrmann, Sabine (2021). Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study. Journal of Cancer Research and Clinical Oncology, 147(5):1407-1419.

Karschnia, Philipp; Vogelbaum, Michael A; van den Bent, Martin; Cahill, Daniel P; Bello, Lorenzo; Narita, Yoshitaka; Berger, Mitchel S; Weller, Michael; Tonn, Joerg-Christian (2021). Evidence-based recommendations on categories for extent of resection in diffuse glioma. European Journal of Cancer, 149:23-33.

Dimitriou, Florentia; Zaremba, Anne; Allayous, Clara; Kähler, Katharina C; Gerard, Camille L; Festino, Lucia; Schäfer, Sarah; Toussaint, Frédéric; Heinzerling, Lucie; Hassel, Jessica C; Ascierto, Paolo A; Michielin, Olivier; Hauschild, Axel; Lebbe, Céleste; Livingstone, Elisabeth; Ramelyte, Egle; Cheng, Phil F; Dummer, Reinhard; Mangana, Joanna (2021). Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response. European Journal of Cancer, 149:37-48.

Alexandraki, Krystallenia I; Spyroglou, Ariadni; Kykalos, Stylianos; Daskalakis, Kosmas; Kyriakopoulos, Georgios; Sotiropoulos, Georgios C; Kaltsas, Gregory A; Grossman, Ashley B (2021). Changing biological behaviour of NETs during the evolution of the disease: progress on progression. Endocrine-Related Cancer, 28(5):R121-R140.

Vaidya, Jayant S; Bulsara, Max; Baum, Michael; Tobias, Jeffrey S; Dedes, Konstantin J (2021). Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. British Journal of Cancer, 124(9):1469-1474.

Cuomo, Pierluigi; Scoccianti, Guido; Schiavo, Alberto; Tortolini, Valentina; Wigley, Catrin; Muratori, Francesco; Matera, Davide; Kukushkina, Mariia; Funovics, Philipp Theodor; Lingitz, Marie-Theres; Windhager, Reinhard; Dijkstra, Sander; Jasper, Jorrit; Müller, Daniel A; Kaiser, Dominik; Perlaky, Tamás; Leithner, Andreas; Smolle, Maria Anna; Campanacci, Domenico Andrea (2021). Extra-abdominal desmoid tumor fibromatosis: a multicenter EMSOS study. BMC Cancer, 21:437-443.

Muller, Christina K S; Spagnuolo, Julian; Audigé, Annette; Chancellor, Andrew; Russenberger, Doris; Scherrer, Alexandra U; Hoffmann, Matthias; Kouyos, Roger; Battegay, Manuel; De Libero, Gennaro; Speck, Roberto F; Swiss HIV Cohort Study (2021). Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma. Infectious Agents and Cancer, 16:24.

Freiberger, Sandra N; Brada, Muriel; Fritz, Christine; Höller, Sylvia; Vogetseder, Alexander; Horcic, Milo; Bihl, Michel; Michal, Michal; Lanzer, Martin; Wartenberg, Martin; Borner, Urs; Bode, Peter K; Broglie, Martina A; Rordorf, Tamara; Morand, Grégoire B; Rupp, Niels J (2021). SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia, 23(5):473-487.

Kuebler, Ulrike; Fischer, Susanne; Mernone, Laura; Breymann, Christian; Abbruzzese, Elvira; Ehlert, Ulrike (2021). Is stress related to the presence and persistence of oncogenic human papillomavirus infection in young women? BMC Cancer, 21(1):419.

Oehl, Kathrin; Vrugt, Bart; Wagner, Ulrich; Kirschner, Michaela B; Meerang, Mayura; Weder, Walter; Felley-Bosco, Emanuela; Wollscheid, Bernd; Bankov, Katrin; Demes, Melanie C; Opitz, Isabelle; Wild, Peter J (2021). Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma. Clinical Cancer Research, 27(8):2277-2291.

Daffrè, Elisa; Prieto, Mathilde; Martini, Katharina; Hoang-Thi, Trieu-Nghi; Halm, Nara; Dermine, Hervè; Bobbio, Antonio; Chassagnon, Guillaume; Revel, Marie Pierre; Alifano, Marco (2021). Total Psoas Area and Total Muscular Parietal Area Affect Long-Term Survival of Patients Undergoing Pneumonectomy for Non-Small Cell Lung Cancer. Cancers, 13(8):1888.

Muscas, Giovanni; van Niftrik, Christiaan Hendrik Bas; Sebök, Martina; Della Puppa, Alessandro; Seystahl, Katharina; Andratschke, Nicolaus; Brown, Michelle; Weller, Michael; Regli, Luca; Piccirelli, Marco; Fierstra, Jorn (2021). Distinct Cerebrovascular Reactivity Patterns for Brain Radiation Necrosis. Cancers, 13(8):1840.

Catalano, Antonella; Adlesic, Mojca; Kaltenbacher, Thorsten; Klar, Rhena F U; Albers, Joachim; Seidel, Philipp; Brandt, Laura P; Hejhal, Tomas; Busenhart, Philipp; Röhner, Niklas; Zodel, Kyra; Fritsch, Kornelia; Wild, Peter J; Duyster, Justus; Fritsch, Ralph; Brummer, Tilman; Frew, Ian J (2021). Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers, 13(8):1852.

Bosshart, Salome L; Morand, Grégoire B; Broglie, Martina A (2021). Frequency and Localization of Second Primary Tumors in Patients with Oropharyngeal Carcinoma—The Influence of the Human Papilloma Virus. Cancers, 13(8):1755.

Reyes, Ryan Michael; Deng, Yilun; Zhang, Deyi; Ji, Niannian; Mukherjee, Neelam; Wheeler, Karen; Gupta, Harshita B; Padron, Alvaro S; Kancharla, Aravind; Zhang, Chenghao; Garcia, Myrna; Kornepati, Anand V R; Boyman, Onur; Conejo-Garcia, Jose R; Svatek, Robert S; Curiel, Tyler J (2021). CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation. Journal for ImmunoTherapy of Cancer, 9(4):e002051.

Pöschel, Amiskwia; Beebe, Erin; Kunz, Laura; Amini, Parisa; Guscetti, Franco; Malbon, Alexandra; Markkanen, Enni (2021). Identification of disease-promoting stromal components by comparative proteomic and transcriptomic profiling of canine mammary tumors using laser-capture microdissected FFPE tissue. Neoplasia, 23(4):400-412.

Marcu, Ana; Bichmann, Leon; Kuchenbecker, Leon; Kowalewski, Daniel Johannes; Freudenmann, Lena Katharina; Backert, Linus; Mühlenbruch, Lena; Szolek, András; Lübke, Maren; Wagner, Philipp; Engler, Tobias; Matovina, Sabine; Wang, Jian; Hauri-Hohl, Mathias; Martin, Roland; Kapolou, Konstantina; Walz, Juliane Sarah; Velz, Julia; Moch, Holger; Regli, Luca; Silginer, Manuela; Weller, Michael; Löffler, Markus W; Erhard, Florian; Schlosser, Andreas; Kohlbacher, Oliver; Stevanović, Stefan; Rammensee, Hans-Georg; Neidert, Marian Christoph (2021). HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9(4):18.

Clement, Paul M J; Dirven, Linda; Eoli, Marica; Sepulveda-Sanchez, Juan M; Walenkamp, Annemiek M E; Frenel, Jean S; Franceschi, Enrico; Weller, Michael; et al (2021). Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma. European Journal of Cancer, 147:1-12.

Kraft, Johannes; Mayinger, Michael; Willmann, Jonas; Brown, Michelle; Tanadini-Lang, Stephanie; Wilke, Lotte; Guckenberger, Matthias; Andratschke, Nicolaus (2021). Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology. Journal of Neuro-Oncology, 152(2):395-404.

Gramatzki, Dorothee; Felsberg, Jörg; Hentschel, Bettina; Wolter, Marietta; Schackert, Gabriele; Westphal, Manfred; Regli, Luca; Thon, Niklas; Tatagiba, Marcos; Wick, Wolfgang; Schlegel, Uwe; Krex, Dietmar; Matschke, Jakob; Roth, Patrick; Suresh, Marian P; Kamp, Marcel A; Rushing, Elisabeth J; Pietsch, Torsten; von Deimling, Andreas; Sabel, Michael; Loeffler, Markus; Weller, Michael; Reifenberger, Guido (2021). Telomerase reverse transcriptase promoter mutation- and O 6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link? European Journal of Cancer, 147:84-94.

Wirsching, Hans-Georg; Silginer, Manuela; Ventura, Elisa; Macnair, Will; Burghardt, Isabel; Claassen, Manfred; Gatti, Silvia; Wichmann, Jürgen; Riemer, Claus; Schneider, Hannah; Weller, Michael (2021). Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma. Molecular Therapy : Oncolytics, 20:166-174.

Wen, Patrick Y; Weller, Michael; Chiocca, Ennio Antonio; Lim, Michael; Tonn, Joerg-Christian; Zadeh, Gelareh; Aldape, Kenneth; van den Bent, Martin (2021). Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez. Neuro-Oncology, 23(3):506-507.

Jin, Xi-Feng; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Auernhammer, Christoph Josef (2021). Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro. Cancers, 13(6):1485.

Hoefflin, Rouven; Lazarou, Adriana; Hess, Maria Elena; Reiser, Meike; Wehrle, Julius; Metzger, Patrick; Frey, Anna Verena; Becker, Heiko; et al; Fritsch, Ralph (2021). Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers, 13(5):?-?.

Pietge, Heike; Sánchez-Velázquez, Patricia; Akhoundova, Dilara; Siebenhüner, Alexander; Winder, Thomas; Bachmann, Helga; Nguyen-Kim, Thi Dan Linh; Breitenstein, Stefan; Knuth, Alexander; Petrowsky, Henrik; Pestalozzi, Bernhard; Clavien, Pierre-Alain; Samaras, Panagiotis (2021). Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study. Oncology, 99(5):300-309.

Kumar, Rahul; Smith, Kyle S; Deng, Maximilian; Terhune, Colt; Robinson, Giles W; Orr, Brent A; Liu, Anthony P Y; Lin, Tong; Billups, Catherine A; Chintagumpala, Murali; Bowers, Daniel C; Hassall, Timothy E; Hansford, Jordan R; Khuong-Quang, Dong Anh; Crawford, John R; Bendel, Anne E; Gururangan, Sridharan; Schroeder, Kristin; Bouffet, Eric; Bartels, Ute; Fisher, Michael J; Cohn, Richard; Partap, Sonia; Kellie, Stewart J; McCowage, Geoffrey; Paulino, Arnold C; Rutkowski, Stefan; Fleischhack, Gudrun; Dhall, Girish; Klesse, Laura J; et al; Nazarian, Javad (2021). Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. Journal of Clinical Oncology, 39(7):807-821.

Roeschert, Isabelle; Poon, Evon; Henssen, Anton G; Dorado Garcia, Heathcliff; Gatti, Marco; Giansanti, Celeste; Jamin, Yann; Ade, Carsten P; Gallant, Peter; Schülein-Völk, Christina; Beli, Petra; Richards, Mark; Rosenfeldt, Mathias; Altmeyer, Matthias; Anderson, John; Eggert, Angelika; Dobbelstein, Matthias; Bayliss, Richard; Chesler, Louis; Büchel, Gabriele; Eilers, Martin (2021). Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma. Nature Cancer, 2(3):312-326.

Ramelyte, Egle; Tastanova, Aizhan; Balázs, Zsolt; Ignatova, Desislava; Turko, Patrick; Menzel, Ulrike; Guenova, Emmanuella; Beisel, Christian; Krauthammer, Michael; Levesque, Mitchell Paul; Dummer, Reinhard (2021). Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective. Cancer Cell, 39(3):394-406.e4.

Irmisch, Anja; Bonilla, Ximena; Chevrier, Stéphane; Lehmann, Kjong-Van; Singer, Franziska; Toussaint, Nora C; Esposito, Cinzia; Mena, Julien; Milani, Emanuela S; Casanova, Ruben; Stekhoven, Daniel J; Wegmann, Rebekka; Jacob, Francis; Sobottka-Brillout, Bettina; Goetze, Sandra; Kuipers, Jack; Sarabia del Castillo, Jacobo; Prummer, Michael; Tuncel, Mustafa A; Menzel, Ulrike; Jacobs, Andrea; Engler, Stefanie; Sivapatham, Sujana; Frei, Anja L; Gut, Gabriele; Ficek, Joanna; Miglino, Nicola; Aebersold, Rudolf; Bacac, Marina; Beerenwinkel, Niko; Moch, Holger; Beisel, Christian; Bodenmiller, Bernd; Dummer, Reinhard; Heinzelmann-Schwarz, Viola; Koelzer, Viktor H; Manz, Markus G; Pelkmans, Lucas; Snijder, Berend; Theocharides, Alexandre P A; Tolnay, Markus; Wicki, Andreas; Wollscheid, Bernd; Rätsch, Gunnar; Levesque, Mitchell Paul (2021). The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support. Cancer Cell, 39(3):288-293.

Russkamp, Norman F; Myburgh, Renier; Kiefer, Jonathan D; Neri, Dario; Manz, Markus G (2021). Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells. Experimental Hematology, 95:31-45.

Waespe, Nicolas; Belle, Fabiën N; Redmond, Shelagh; Schindera, Christina; Spycher, Ben D; Rössler, Jochen; Ansari, Marc; Kuehni, Claudia E (2021). Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer - A national cohort study. European Journal of Cancer, 145:71-80.

Benzing, Valentin; Siegwart, Valerie; Spitzhüttl, Janine; Schmid, Jürg; Grotzer, Michael; Roebers, Claudia M; Steinlin, Maja; Leibundgut, Kurt; Everts, Regula; Schmidt, Mirko (2021). Motor ability, physical self-concept and health-related quality of life in pediatric cancer survivors. Cancer Medicine, 10(5):1860-1871.

Dúcka, Monika; Kučeríková, Martina; Trčka, Filip; Červinka, Jakub; Biglieri, Elisabetta; Šmarda, Jan; Borsig, Lubor; Beneš, Petr; Knopfová, Lucia (2021). c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells. Neoplasia, 23(3):326-336.

Wennmann, Markus; Hielscher, Thomas; Kintzelé, Laurent; Menze, Bjoern H; Langs, Georg; Merz, Maximilian; Sauer, Sandra; Kauczor, Hans-Ulrich; Schlemmer, Heinz-Peter; Delorme, Stefan; Goldschmidt, Hartmut; Weinhold, Niels; Hillengass, Jens; Weber, Marc-André (2021). Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns. Cancers, 13(5):961.

Sántha, Petra; Lenggenhager, Daniela; Finstadsveen, Anette; Dorg, Linda; Tøndel, Kristin; Amrutkar, Manoj; Gladhaug, Ivar P; Verbeke, Caroline (2021). Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence. Cancers, 13(4):895.

Rasche, Mareike; Steidel, Emma; Zimmermann, Martin; Bourquin, Jean-Pierre; Boztug, Heidrun; Janotova, Iveta; Kolb, E Anders; Lehrnbecher, Thomas; von Neuhoff, Nils; Niktoreh, Naghmeh; Mühlegger, Nora; Sramkova, Lucie; Stary, Jan; Walter, Christiane; Creutzig, Ursula; Dworzak, Michael; Reinhardt, Dirk (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers, 13(4):789.

Pantelyushin, Stanislav; Ranninger, Elisabeth; Guerrera, Diego; Hutter, Gregor; Maake, Caroline; Markkanen, Enni; Bettschart-Wolfensberger, Regula; Rohrer Bley, Carla; Läubli, Heinz; vom Berg, Johannes (2021). Cross-reactivity and functionality of approved human immune checkpoint blockers in dogs. Cancers, 13(4):785.

Robert, Caroline; Hwu, Wen-Jen; Hamid, Omid; Ribas, Antoni; Weber, Jeffrey S; Daud, Adil I; Hodi, F Stephen; Wolchok, Jedd D; Mitchell, Tara C; Hersey, Peter; Dronca, Roxana; Joseph, Richard W; Boutros, Celine; Min, Le; Long, Georgina V; Schachter, Jacob; Puzanov, Igor; Dummer, Reinhard; Lin, Jianxin; Ibrahim, Nageatte; Diede, Scott J; Carlino, Matteo S; Joshua, Anthony M (2021). Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma. European Journal of Cancer, 144:182-191.

Martin, Sebastian; Maus, Stephan; Stemler, Tobias; Rosar, Florian; Khreish, Fadi; Holland, Jason P; Ezziddin, Samer; Bartholomä, Mark D (2021). Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular Imaging and Biology, 23(1):95-108.

Ressler, Julia Maria; Karasek, Matthias; Koch, Lukas; Silmbrod, Rita; Mangana, Joanna; Latifyan, Sofiya; Aedo-Lopez, Veronica; Kehrer, Helmut; Weihsengruber, Felix; Koelblinger, Peter; Posch, Christian; Kofler, Julian; Michielin, Olivier; Richtig, Erika; Hafner, Christine; Hoeller, Christoph (2021). Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. Journal for ImmunoTherapy of Cancer, 9(2):e001701.

Dimitriou, Florentia; Urner-Bloch, Ursula; Eggenschwiler, Corinne; Mitsakakis, Nicholas; Mangana, Joanna; Dummer, Reinhard; Urner, Martin (2021). The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanoma. European Journal of Cancer, 144:215-223.

Peters, Christina; Dalle, Jean-Hugues; Locatelli, Franco; Poetschger, Ulrike; Sedlacek, Petr; Buechner, Jochen; et al; Güngör, Tayfun; von Stackelberg, Arend (2021). Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. Journal of Clinical Oncology, 39(4):295-307.

Hasan Ali, Omar; Berner, Fiamma; Ackermann, Christoph Jakob; Ring, Sandra Stephanie; Moulin, Alexandre; Müller, Joachim; Markert, Eva; Pop, Oltin Tiberiu; Müller, Stefanie; Diem, Stefan; Hundsberger, Thomas; Flatz, Lukas (2021). Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunology, Immunotherapy, 70(2):563-568.

Herth, Matthias M; Ametamey, Simon; Antuganov, Dmitrii; Bauman, Andreas; Berndt, Mathias; Brooks, Allen F; Bormans, Guy; Choe, Yearn Seong; Gillings, Nic; Häfeli, Urs O; James, Michelle L; Kopka, Klaus; Kramer, Vasko; Krasikova, Raisa; Madsen, Jacob; Mu, Linjing; Neumaier, Bernd; Piel, Markus; Rösch, Frank; Ross, Tobias; Schibli, Roger; Scott, Peter J H; Shalgunov, Vladimir; Vasdev, Neil; Wadsak, Wolfgang; Zeglis, Brian M (2021). On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion. Nuclear medicine and biology, 93:19-21.

van Ewijk, Roelof; Vaarwerk, Bas; Breunis, Willemijn B; Schoot, Reineke A; Ter Horst, Simone A J; van Rijn, Rick R; van der Lee, Johanna H; Merks, Johannes H M (2021). The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma. Cancers, 13(3):510.

Bauer, Christoph; Quante, Meret; Breunis, Willemijn B; Regina, Carla; Schneider, Michaela; Andrieux, Geoffroy; Gorka, Oliver; Groß, Olaf; Boerries, Melanie; Kammerer, Bernd; Hettmer, Simone (2021). Lack of Electron Acceptors Contributes to Redox Stress and Growth Arrest in Asparagine-Starved Sarcoma Cells. Cancers, 13(3):412.

Volk, Valery; Theobald, Sebastian J; Danisch, Simon; Khailaie, Sahamoddin; Kalbarczyk, Maja; Schneider, Andreas; Bialek-Waldmann, Julia; Krönke, Nicole; Deng, Yun; Eiz-Vesper, Britta; Dragon, Anna Christina; von Kaisenberg, Constantin; Lienenklaus, Stefan; Bleich, Andre; Keck, James; Meyer-Hermann, Michael; Klawonn, Frank; Hammerschmidt, Wolfgang; Delecluse, Henri-Jacques; Münz, Christian; Feuerhake, Friedrich; Stripecke, Renata (2021). PD-1 Blockade Aggravates Epstein–Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations. Frontiers in Oncology, 10:614876.

Hussung, Saskia; Akhoundova, Dilara; Hipp, Julian; Follo, Marie; Klar, Rhena F U; Philipp, Ulrike; Scherer, Florian; von Bubnoff, Nikolas; Duyster, Justus; Boerries, Melanie; Wittel, Uwe; Fritsch, Ralph M (2021). Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer. BMC Cancer, 21:49.

Guccini, Ilaria; Revandkar, Ajinkya; D'Ambrosio, Mariantonietta; Colucci, Manuel; Pasquini, Emiliano; Mosole, Simone; Troiani, Martina; Brina, Daniela; Sheibani-Tezerji, Raheleh; Elia, Angela Rita; Rinaldi, Andrea; Pernigoni, Nicolò; Rüschoff, Jan Hendrik; Dettwiler, Susanne; De Marzo, Angelo M; Antonarakis, Emmanuel S; Borrelli, Costanza; Moor, Andreas E; Garcia-Escudero, Ramon; Alajati, Abdullah; Attanasio, Giuseppe; Losa, Marco; Moch, Holger; Wild, Peter; Egger, Gerda; Alimonti, Andrea (2021). Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis. Cancer Cell, 39(1):68-82.e9.

Bierbaumer, Lisa; Katschnig, Anna M; Radic-Sarikas, Branka; Kauer, Maximilian O; Petro, Jeffrey A; Högler, Sandra; Gurnhofer, Elisabeth; Pedot, Gloria; Schäfer, Beat W; Schwentner, Raphaela; Mühlbacher, Karin; Kromp, Florian; Aryee, Dave N T; Kenner, Lukas; Uren, Aykut; Kovar, Heinrich (2021). YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells. Oncogenesis, 10:2.

Malla, Sudhir B; Fisher, David J; Domingo, Enric; Blake, Andrew; Hassanieh, Sylvana; et al; Koelzer, Viktor H (2021). In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer. Clinical Cancer Research, 27(1):288-300.

Meier, Daniela; Lodberg, Andreas; Gvozdenovic, Ana; Pellegrini, Giovanni; Neklyudova, Olga; Born, Walter; Fuchs, Bruno; Eijken, Marco; Botter, Sander M (2021). Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma. Cancer Medicine, 10(1):286-296.

Farrall, Alexandra L; Lienhard, Matthias; Grimm, Christina; Kuhl, Heiner; Sluka, Susanna H M; Caparros, Marta; Forejt, Jiri; Timmermann, Bernd; Herwig, Ralf; Herrmann, Bernhard G; Morkel, Markus (2021). PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress Apc Min-Triggered Intestinal Tumor Formation. Cancer Research, 81(1):38-49.

Leitzke, M; Schimpf, S; Altrock, M; Schönknecht, P; Bischoff, S; Schubert, H; Hoyer, D; Bauer, R; Olbrich, Sebastian (2021). Afferent vagal stimulation via gastric electrical stimulation alters sympathetic-vagal balance in domestic pigs - a pilot trial. Journal of Biological Regulators and Homeostatic Agents, 35(1):11-24.

Siebenhüner, Alexander R; De Dosso, Sara; Helbling, Daniel; Astaras, Christoforos; Szturz, Petr; Moosmann, Peter; Pederiva, Stefanie; Winder, Thomas; Von Burg, Philippe; Borner, Markus (2021). Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article. Oncology Research and Treatment, 44(9):485-494.

Waller, Verena; Pruschy, Martin (2021). Combined Radiochemotherapy: Metalloproteinases Revisited. Frontiers in Oncology, 11:676583.

Kirste, Simon; Kroeze, Stephanie G C; Henkenberens, Christoph; Schmidt-Hegemann, Nina-Sophie; Vogel, Marco M E; Becker, Jessica; Zamboglou, Constantinos; Burger, Irene; Derlin, Thorsten; Bartenstein, Peter; Ruf, Juri; la Fougère, Christian; Eiber, Matthias; Christiansen, Hans; Combs, Stephanie E; Müller, Arndt-Christian; Belka, Claus; Guckenberger, Matthias; Grosu, Anca-Ligia (2021). Combining 68 Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study. Frontiers in Oncology, 11:640467.

Trebeschi, Stefano; Bodalal, Zuhir; van Dijk, Nick; Boellaard, Thierry N; Apfaltrer, Paul; Tareco Bucho, Teresa M; Nguyen-Kim, Thi Dan Linh; van der Heijden, Michiel S; Aerts, Hugo J W L; Beets-Tan, Regina G H (2021). Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy. Frontiers in Oncology, 11:637804.

Bertok, Tomas; Bertokova, Aniko; Jane, Eduard; Hires, Michal; Aguedo, Juvissan; Potocarova, Maria; Lukac, Ludovit; Vikartovska, Alica; Kasak, Peter; Borsig, Lubor; Tkac, Jan (2021). Identification of Whole-Serum Glycobiomarkers for Colorectal Carcinoma Using Reverse-Phase Lectin Microarray. Frontiers in Oncology, 11:735338.

Boeke, Simon; Mönnich, David; van Timmeren, Janita E; Balermpas, Panagiotis (2021). MR-Guided Radiotherapy for Head and Neck Cancer: Current Developments, Perspectives, and Challenges. Frontiers in Oncology, 11:616156.

Münz, Christian (2021). Modification of EBV-Associated Pathologies and Immune Control by Coinfections. Frontiers in Oncology, 11:756480.

Trebeschi, Stefano; Bodalal, Zuhir; Boellaard, Thierry N; Tareco Bucho, Teresa M; Drago, Silvia G; Kurilova, Ieva; Calin-Vainak, Adriana M; Delli Pizzi, Andrea; Muller, Mirte; Hummelink, Karlijn; Hartemink, Koen J; Nguyen-Kim, Thi Dan Linh; Smit, Egbert F; Aerts, Hugo J W L; Beets-Tan, Regina G H (2021). Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy. Frontiers in Oncology, 11:609054.

Vils, Alex; Bogowicz, Marta; Tanadini-Lang, Stephanie; Vuong, Diem; Saltybaeva, Natalia; Kraft, Johannes; Wirsching, Hans-Georg; Gramatzki, Dorothee; Wick, Wolfgang; Rushing, Elisabeth; Reifenberger, Guido; Guckenberger, Matthias; Weller, Michael; Andratschke, Nicolaus (2021). Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial. Frontiers in Oncology, 11:636672.

Karavasiloglou, Nena; Matthes, Katarina L; Pestoni, Giulia; Limam, Manuela; Korol, Dimitri; Wanner, Miriam; Rohrmann, Sabine (2021). Risk for Invasive Cancers in Women With Breast Cancer In Situ: Results From a Population Not Covered by Organized Mammographic Screening. Frontiers in Oncology, 11:606747.

Stefanescu, Cristina; Van Gogh, Merel; Roblek, Marko; Heikenwalder, Mathias; Borsig, Lubor (2021). TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms. Frontiers in Oncology, 11:765151.

Koeberle, Dieter; Fritsch, Ralph (2021). Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities. Oncology Research and Treatment, 44(1-2):1-3.

Bogowicz, Marta; Pavic, Matea; Riesterer, Oliver; Finazzi, Tobias; Garcia Schüler, Helena; Holz-Sapra, Edna; Rudofsky, Leonie; Basler, Lucas; Spaniol, Manon; Ambrusch, Andreas; Hüllner, Martin; Guckenberger, Matthias; Tanadini-Lang, Stephanie (2021). Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes. Frontiers in Oncology, 11:664304.

Hiltbrunner, Stefanie; Mannarino, Laura; Kirschner, Michaela B; Opitz, Isabelle; Rigutto, Angelica; Laure, Alexander; Lia, Michela; Nozza, Paolo; Maconi, Antonio; Marchini, Sergio; D'Incalci, Maurizio; Curioni-Fontecedro, Alessandra; Grosso, Federica (2021). Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma. Frontiers in Oncology, 11:660039.

2020

Yim, Kevin Ho Wai; Al Hrout, Ala'a; Borgoni, Simone; Chahwan, Richard (2020). Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks. Cancers, 12(12):3696.

Vuong, Diem; Tanadini-Lang, Stephanie; Wu, Ze; Marks, Robert; Unkelbach, Jan; Hillinger, Sven; Eboulet, Eric Innocents; Thierstein, Sandra; Peters, Solange; Pless, Miklos; Guckenberger, Matthias; Bogowicz, Marta (2020). Radiomics Feature Activation Maps as a New Tool for Signature Interpretability. Frontiers in Oncology, 10:578895.

Cascione, Luciano; Aresu, Luca; Baudis, Michael; Bertoni, Francesco (2020). DNA Copy Number Changes in Diffuse Large B Cell Lymphomas. Frontiers in Oncology, 10:584095.

Weller, Michael; Tatsuoka, Kay; Reardon, David A (2020). Appropriate analysis of duration of response data in cancer trials-reply. JAMA Oncology, 6(12):1978.

Guscetti, Franco; Nassiri, Sina; Beebe, Erin; Rito Brandao, Inês; Graf, Ramona; Markkanen, Enni (2020). Molecular homology between canine spontaneous oral squamous cell carcinomas and human head-and-neck squamous cell carcinomas reveals disease drivers and therapeutic vulnerabilities. Neoplasia, 22(12):778-788.

Lafci, Berkan; Merčep, Elena; Herraiz, Joaquin L; Deán-Ben, Xosé Luís; Razansky, Daniel (2020). Noninvasive multiparametric characterization of mammary tumors with transmission-reflection optoacoustic ultrasound. Neoplasia, 22(12):770-777.

Kesar, Nikolina; Winkelmann, Ria; Oppermann, Julius; Ghanaati, Shahram; Martin, Daniel; Neumayer, Thomas; Balster, Sven; Rödel, Claus; Rödel, Franz; von der Grün, Jens; Balermpas, Panagiotis (2020). Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer. Oral Oncology, 111:104931.

Feller, Anita; Matthes, Katarina L; Bordoni, Andrea; Bouchardy, Christine; Bulliard, Jean-Luc; Herrmann, Christian; Konzelmann, Isabelle; Maspoli, Manuela; Mousavi, Mohsen; Rohrmann, Sabine; Staehelin, Katharina; Arndt, Volker (2020). The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer, 20:51.

Hecht, Markus; Hahn, Dennis; Wolber, Philipp; Hautmann, Matthias G; Reichert, Dietmar; Weniger, Steffi; Belka, Claus; Bergmann, Tobias; Göhler, Thomas; Welslau, Manfred; Große-Thie, Christina; Guntinas-Lichius, Orlando; von der Grün, Jens; Balermpas, Panagiotis; Orlowski, Katrin; Messinger, Diethelm; Stenzel, Karsten G; Fietkau, Rainer (2020). Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC Cancer, 20(933):1-11.

Glaus Garzon, Jesus F; Pastrello, Chiara; Jurisica, Igor; Hottiger, Michael O; Wenger, Roland H; Borsig, Lubor (2020). Tumor cell endogenous HIF-1α activity induces aberrant angiogenesis and interacts with TRAF6 pathway required for colorectal cancer development. Neoplasia, 22(12):745-758.

Rubio-San-Simón, Alba; André, Nicolas; Cefalo, Maria Giuseppina; Aerts, Isabelle; et al; Gerber, N U (2020). Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium. European Journal of Cancer, 141:82-91.

Horeweg, Nanda; de Bruyn, Marco; Nout, Remi A; Stelloo, Ellen; Kedziersza, Katarzyna; León-Castillo, Alicia; Plat, Annechien; Mertz, Kirsten D; Osse, Michelle; Jürgenliemk-Schulz, Ina M; Lutgens, Ludy C H W; Jobsen, Jan J; van der Steen-Banasik, Elzbieta M; Smit, Vincent T; Creutzberg, Carien L; Bosse, Tjalling; Nijman, Hans W; Koelzer, Viktor H; Church, David N (2020). Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer. Cancer Immunology Research, 8(12):1508-1519.

von Achenbach, Caroline; Le Rhun, Emilie; Sahm, Felix; Wang, Sophie S; Sievers, Philipp; Neidert, Marian C; Rushing, Elisabeth J; Lawhon, Tracy; Schneider, Hannah; von Deimling, Andreas; Weller, Michael (2020). Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02. Translational Oncology, 13(12):100852.

Le Rhun, Emilie; Weller, Michael; Le Deley, Marie Cecile (2020). The DEPOSEIN - how meaningful was the benefit from intrathecal chemotherapy? Neuro-Oncology, 22(11):1710-1711.

An, Shejuan; Camarillo, Jeannie M; Huang, Tina Yi-Ting; Li, Daphne; Morris, Juliette A; Zoltek, Madeline A; Qi, Jin; Behbahani, Mandana; Kambhampati, Madhuri; Kelleher, Neil L; Nazarian, Javad; Thomas, Paul M; Saratsis, Amanda M (2020). Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma. Journal of Experimental & Clinical Cancer Research, 39:261.

Mazumdar, Alekhya; Urdinez, Joaquin; Boro, Aleksandar; Arlt, Matthias J E; Egli, Fabian E; Niederöst, Barbara; Jaeger, Patrick K; Moschini, Greta; Muff, Roman; Fuchs, Bruno; Snedeker, Jess G; Gvozdenovic, Ana (2020). Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model. Cancers, 12(11):3457.

Meerang, Mayura; Kreienbühl, Jessica; Orlowski, Vanessa; Müller, Seraina L C; Kirschner, Michaela B; Opitz, Isabelle (2020). Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma. Cancers, 12(11):3460.

Alijaj, Nagjie; Moutel, Sandrine; Gouveia, Zelia L; Gray, Maxim; Roveri, Maurizio; Dzhumashev, Dzhangar; Weber, Florian; Meier, Gianmarco; Luciani, Paola; Rössler, Jochen K; Schäfer, Beat W; Perez, Franck; Bernasconi, Michele (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers, 12(11):3313.

Le Rhun, Emilie; Weller, Michael (2020). Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours. ESMO Open, 5(4):e001034.

Sokolowska, Milena (2020). Outsmarting SARS-CoV-2 by empowering a decoy ACE2. Signal Transduction and Targeted Therapy, 5(1):260.

Fabiano, Silvia; Bangert, Mark; Guckenberger, Matthias; Unkelbach, Jan (2020). Accounting for Range Uncertainties in the Optimization of Combined Proton-Photon Treatments Via Stochastic Optimization. International Journal of Radiation Oncology, Biology, Physics, 108(3):792-801.

Münz, Christian (2020). Autophagy proteins influence endocytosis for MHC restricted antigen presentation. Seminars in Cancer Biology, 66:110-115.

Melchior, Patrick; Dzierma, Yvonne; Rübe, Christian; Graf, Norbert; Kager, Leo; Dieckmann, Karin; Kroiss, Sabine; Hubertus, Jochen; Warmann, Steven; Schenk, Jens-Peter; Leuschner, Ivo; Nemes, Karolina; Meier, Clemens Magnus; Vokuhl, Christian; Frühwald, Michael; Furtwängler, Rhoikos (2020). Local Stage Dependent Necessity of Radiation Therapy in Rhabdoid Tumors of the Kidney (RTK). International Journal of Radiation Oncology, Biology, Physics, 108(3):667-675.

Matter, Alexandra Valeska; Micaletto, Sara; Urner‐Bloch, Ursula; Dummer, Reinhard; Goldinger, Simone M (2020). Long‐term response to intermittent binimetinib in patients with NRAS‐mutant melanoma. The oncologist, 25(11):e1593-e1597.

Lukas, Marina; Velten, Britta; Sellner, Leopold; Tomska, Katarzyna; Hüellein, Jennifer; Walther, Tatjana; Wagner, Lena; Muley, Carolin; Wu, Bian; Oleś, Małgorzata; Dietrich, Sascha; Jethwa, Alexander; Bohnenberger, Hanibal; Lu, Junyan; Huber, Wolfgang; Zenz, Thorsten (2020). Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies. Leukemia, 34(11):2934-2950.

Bechmann, Nicole; Moskopp, Mats Leif; Ullrich, Martin; Calsina, Bruna; Wallace, Pål William; Richter, Susan; Friedemann, Markus; Langton, Katharina; Fliedner, Stephanie M J; Timmers, Henri J L M; Nölting, Svenja; Beuschlein, Felix; Fassnacht, Martin; Prejbisz, Aleksander; Pacak, Karel; Ghayee, Hans K; Bornstein, Stefan R; Dieterich, Peter; Pietzsch, Jens; Wielockx, Ben; Robledo, Mercedes; Qin, Nan; Eisenhofer, Graeme (2020). HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. Endocrine-Related Cancer, 27(11):625-640.

Wyvekens, Nicolas; Valtcheva, Nadejda; Mischo, Axel; Helmchen, Birgit; Hermanns, Thomas; Choschzick, Matthias; Hötker, Andreas M; Rauch, Anita; Mühleisen, Beda; Akhoundova, Dilara; Weber, Achim; Moch, Holger; Rupp, Niels J (2020). Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Genes, Chromosomes and Cancer, 59(11):611-619.

Grogg, Josias Bastian; Schneider, Kym; Bode, Peter-Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Joerg; Lorch, Anja; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data. Journal of Cancer Research and Clinical Oncology, 146(11):2829-2841.

Martini, Katharina; Chassagnon, Guillaume; Fournel, Ludovic; Prieto, Mathilde; Hoang-Thi, Trieu-Nghi; Halm, Nara; Bobbio, Antonio; Revel, Marie-Pierre; Alifano, Marco (2020). Sarcopenia as independent risk factor of postpneumonectomy respiratory failure, ARDS and mortality. Lung Cancer, 149:130-136.

Hertler, Caroline; Seiler, Annina; Gramatzki, Dorothee; Schettle, Markus; Blum, David (2020). Sex-specific and gender-specific aspects in patient-reported outcomes. ESMO Open, 5(Suppl 4):e000837.

Porcheri, Cristina; Meisel, Christian T; Mitsiadis, Thimios A (2020). Molecular and Cellular Modelling of Salivary Gland Tumors Open New Landscapes in Diagnosis and Treatment. Cancers, 12(11):3107.

Leger, Stefan; Zwanenburg, Alex; Leger, Karoline; Lohaus, Fabian; Linge, Annett; Schreiber, Andreas; Kalinauskaite, Goda; Tinhofer, Inge; Guberina, Nika; Guberina, Maja; Balermpas, Panagiotis; von der Grün, Jens; Ganswindt, Ute; Belka, Claus; Peeken, Jan C; Combs, Stephanie E; Boeke, Simon; Zips, Daniel; Richter, Christian; Krause, Mechthild; Baumann, Michael; Troost, Esther G C; Löck, Steffen (2020). Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC. Cancers, 12:3047.

Fukuoka, Kohei; Mamatjan, Yasin; Tatevossian, Ruth; Zapotocky, Michal; Ryall, Scott; Stucklin, Ana Guerreiro; et al (2020). Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas. Neuro-Oncology, 22(10):1474-1483.

Guerreiro Stücklin, Ana S; Mueller, Sabine (2020). Opportunities for the treatment of NF1-associated low-grade gliomas: how to decide on the best treatment options for patients? Neuro-Oncology, 22(10):1415-1416.

Andratschke, Nicolaus; Belderbos, José; Mayinger, Michael; Schagen, Sanne B; De Ruysscher, Dirk (2020). Hippocampal Avoidance and Memantine for Whole-Brain Radiotherapy: Long-Term Follow-Up Warranted. Journal of Clinical Oncology, 38(29):3454-3455.

Myburgh, Renier; Kiefer, Jonathan D; Russkamp, Norman F; Magnani, Chiara F; Núñez, Nicolás Gonzalo; Simonis, Alexander; Pfister, Surema; Wilk, C Matthias; McHugh, Donal; Friemel, Juliane; Müller, Antonia M; Becher, Burkhard; Münz, Christian; van den Broek, Maries; Neri, Dario; Manz, Markus G (2020). Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells. Leukemia, 34(10):2688-2703.

Meattini, I; Andratschke, Nicolaus; Kirby, A M; Sviri, G; Offersen, B V; Poortmans, P; Kaidar Person, O (2020). Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm. Clinical & Translational Oncology, 22(10):1698-1709.

Hainc, Nicolin; Federau, Christian; Tyndall, Anthony; Mittermeier, Andreas; Bink, Andrea; Stippich, Christoph; Schubert, Tilman (2020). Evaluation of the clinical utility of maximum intensity projections of 3D contrast-enhanced, T1-weighted imaging for the detection of brain metastases. Cancer Reports, 3(5):e1277.

Michielin, Olivier; Atkins, Michael B; Koon, Henry B; Dummer, Reinhard; Ascierto, Paolo Antonio (2020). Evolving impact of long-term survival results on metastatic melanoma treatment. Journal for ImmunoTherapy of Cancer, 8(2):e000948.

Zürcher, Simeon J; Jung, Ruedi; Monnerat, Sophie; Schindera, Christina; Eser, Prisca; Meier, Christian; Rueegg, Corina S; von der Weid, Nicolas X; Kriemler, Susi (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit. International Journal of Cancer, 147(7):1845-1854.

Hecht, Markus; Gostian, Antoniu Oreste; Eckstein, Markus; Rutzner, Sandra; von der Grün, Jens; Illmer, Thomas; Hautmann, Matthias G; Klautke, Gunther; Laban, Simon; Brunner, Thomas; Hinke, Axel; Becker, Ina; Frey, Benjamin; Semrau, Sabine; Geppert, Carol I; Hartmann, Arndt; Balermpas, Panagiotis; Budach, Wilfried; Gaipl, Udo S; Iro, Heinrich; Fietkau, Rainer (2020). Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. Journal for ImmunoTherapy of Cancer, 8:e001378.

Kozyra, Emilia J; Pastor, Victor B; et al; Schmugge, Markus (2020). Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia, 34(10):2673-2687.

Ivankovic, Ivana; Déan-Ben, Xosé Luís; Haas, Helena; Kimm, Melanie A; Wildgruber, Moritz; Razansky, Daniel (2020). Volumetric Optoacoustic Tomography Differentiates Myocardial Remodelling. Molecular Imaging and Biology, 22(5):1235-1243.

Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; A von dem Borne, P; Chalandon, Y; Cloos, J; Deeren, D; Fehr, M; Gjertsen, B; Graux, C; Huls, G; Janssen, J J J W; Jaspers, A; Jongen-Lavrencic, M; de Jongh, E; Klein, S K; van der Klift, M; van Marwijk Kooy, M; Maertens, J; Michaux, L; van der Poel, M W M; van Rhenen, A; Tick, L; Valk, P; Vekemans, M C; van der Velden, W J F M; de Weerdt, O; et al (2020). Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, 34(10):2820.

Benz, Rudolf; Zimmermann, Kathrin; Rechsteiner, Markus; Balabanov, Stefan; Manz, Markus G; Widmer, Corinne C (2020). Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis. Leukemia & Lymphoma, 61(10):2533-2535.

Groen, Emma J; Hudecek, Jan; Mulder, Lennart; van Seijen, Maartje; Almekinders, Mathilde M; Alexov, Stoyan; Kovács, Anikó; Ryska, Ales; Varga, Zsuzsanna; et al (2020). Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Research and Treatment, 183(3):759-770.

Thomson, David J; Yom, Sue S; Saeed, Hina; El Naqa, Issam; Ballas, Leslie; Bentzen, Soren M; Chao, Samuel T; Choudhury, Ananya; Coles, Charlotte E; Dover, Laura; Guadagnolo, B Ashleigh; Guckenberger, Matthias; Hoskin, Peter; Jabbour, Salma K; Katz, Matthew S; Mukherjee, Somnath; Rembielak, Agata; Sebag-Montefiore, David; Sher, David J; Terezakis, Stephanie A; Thomas, Toms V; Vogel, Jennifer; Estes, Christopher (2020). Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development. International Journal of Radiation Oncology, Biology, Physics, 108(2):379-389.

Schönholzer, Marc Thomas; Migliavacca, Jessica; Alvarez, Elena; Santhana Kumar, Karthiga; Neve, Anuja; Gries, Alexandre; Ma, Min; Grotzer, Michael A; Baumgartner, Martin (2020). Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion. Neoplasia, 22(10):470-483.

Boxerman, Jerrold L; Quarles, Chad C; Hu, Leland S; Erickson, Bradley J; Gerstner, Elizabeth R; Smits, Marion; Kaufmann, Timothy J; Barboriak, Daniel P; Huang, Raymond H; Wick, Wolfgang; Weller, Michael; Galanis, Evanthia; Kalpathy-Cramer, Jayashree; Shankar, Lalitha; Jacobs, Paula; Chung, Caroline; van den Bent, Martin J; Chang, Susan; Al Yung, W K; Cloughesy, Timothy F; Wen, Patrick Y; Gilbert, Mark R; Rosen, Bruce R; Ellingson, Benjamin M; Schmainda, Kathleen M (2020). Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro-Oncology, 22(9):1262-1275.

Kessler, Tobias; Berberich, Anne; Sadik, Ahmed; Sahm, Felix; Gorlia, Thierry; Meisner, Christoph; Hoffmann, Dirk C; Wick, Antje; Kickingereder, Philipp; Rübmann, Petra; Bendszus, Martin; Opitz, Christiane; Weller, Michael; van den Bent, Martin; Stupp, Roger; Winkler, Frank; Brandes, Alba; von Deimling, Andreas; Platten, Michael; Wick, Wolfgang (2020). Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes. Cancer Medicine, 9(22):8373-8385.

Bailey, Cavan P; Figueroa, Mary; Gangadharan, Achintyan; Yang, Yanwen; Romero, Megan M; Kennis, Bridget A; Yadavilli, Sridevi; Henry, Verlene; Collier, Tiara; Monje, Michelle; Lee, Dean A; Wang, Linghua; Nazarian, Javad; Gopalakrishnan, Vidya; Zaky, Wafik; Becher, Oren J; Chandra, Joya (2020). Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Neuro-Oncology, 22(9):1302-1314.

Wennmann, Markus; Hielscher, Thomas; Kintzelé, Laurent; Menze, Bjoern H; Langs, Georg; Merz, Maximilian; Sauer, Sandra; Kauczor, Hans-Ulrich; Schlemmer, Heinz-Peter; Delorme, Stefan; Goldschmidt, Hartmut; Weinhold, Niels; Hillengass, Jens; Weber, Marc-André (2020). Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria. Cancers, 12(9):2537.

Deán-Ben, Xosé Luís; Weidenfeld, Ina; Degtyaruk, Oleksiy; Ntziachristos, Vasilis; Stiel, Andre C; Razansky, Daniel (2020). Deep tissue volumetric optoacoustic tracking of individual circulating tumor cells in an intracardially perfused mouse model. Neoplasia, 22(9):441-446.

Stocker, Albina; Trojan, Andreas; Elfgen, Constanze; Hilbers, Marie-Louis; Moskovszky, Linda; Varga, Zsuzsanna (2020). Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer. Breast Cancer Research and Treatment, 183(2):311-319.

Casanova, Ruben; Leblond, Anne-Laure; Wu, Chengguang; Haberecker, Martina; Burger, Irene A; Soltermann, Alex (2020). Enhanced prognostic stratification of neoadjuvant treated lung squamous cell carcinoma by computationally-guided tumor regression scoring. Lung Cancer, 147:49-55.

Wanner, Miriam; Rohrmann, Sabine; Korol, Dimitri; Shenglia, Nino; Gigineishvili, Teimuraz; Gigineishvili, David (2020). Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country. Journal of Neuro-Oncology, 149(2):273-282.

Gachechiladze, Mariam; Škarda, Josef; Skanderová, Daniela; Überall, Ivo; Kolek, Vítězslav; Smičkova, Petra; Vojta, Petr; Vbrková, Jana; Hajdúch, Marián; Shani, Ilay; Kolář, Zdeněk; Stahel, Rolf; Weder, Walter; Rulle, Undine; Soltermann, Alex; Joerger, Markus (2020). Prognostic value of tumor-infiltrating lymphocytes (TILs) and their association with PD-L1 expression and DNA repair protein RAD51 in patients with resected non-small cell lung carcinoma. Lung Cancer, 147:30-38.

Kaufmann, Timothy J; Smits, Marion; Boxerman, Jerrold; Huang, Raymond; Barboriak, Daniel P; Weller, Michael; Chung, Caroline; Tsien, Christina; Brown, Paul D; Shankar, Lalitha; Galanis, Evanthia; Gerstner, Elizabeth; van den Bent, Martin J; Burns, Terry C; Parney, Ian F; Dunn, Gavin; Brastianos, Priscilla K; Lin, Nancy U; Wen, Patrick Y; Ellingson, Benjamin M (2020). Response to Letter to Editor. Neuro-Oncology, 22(11):1706-1707.

Wen, Patrick Y; Weller, Michael; Lee, Eudocia Quant; Alexander, Brian M; Barnholtz-Sloan, Jill S; Barthel, Floris P; Batchelor, Tracy T; Bindra, Ranjit S; Chang, Susan M; Chiocca, E Antonio; Cloughesy, Timothy F; DeGroot, John F; Galanis, Evanthia; Gilbert, Mark R; Hegi, Monika E; Horbinski, Craig; Huang, Raymond Y; Lassman, Andrew B; Le Rhun, Emilie; Lim, Michael; Mehta, Minesh P; Mellinghoff, Ingo K; Minniti, Giuseppe; Nathanson, David; Platten, Michael; Preusser, Matthias; Roth, Patrick; Sanson, Marc; Schiff, David; Short, Susan C; et al (2020). Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology, 22(8):1073-1113.

McCuaig, Sarah; Barras, David; Mann, Elizabeth H; Friedrich, Matthias; Bullers, Samuel J; Janney, Alina; Garner, Lucy C; Domingo, Enric; Koelzer, Viktor Hendrik; Delorenzi, Mauro; Tejpar, Sabine; Maughan, Timothy S; West, Nathaniel R; Powrie, Fiona (2020). The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer. Clinical Cancer Research, 26(16):4313-4325.

Kamat, Pranitha; Frueh, Florian S; McLuckie, Michelle; Sanchez-Macedo, Nadia; Wolint, Petra; Lindenblatt, Nicole; Plock, Jan A; Calcagni, Maurizio; Buschmann, Johanna (2020). Adipose tissue and the vascularization of biomaterials: Stem cells, microvascular fragments and nanofat-a review. Cytotherapy, 22(8):400-411.

Lang, Claudia C V; Ramelyte, Egle; Dummer, Reinhard (2020). Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma. Frontiers in Oncology, 10:1-6.

Combes, Jean-Damien; Clifford, Gary M; Günthard, Huldrych F; Hauser, Christoph; Darling, Katharine E A; Valladares, Pablo; Battegay, Manuel; Waldeck, Frederike; Bernasconi, Enos; Bertisch, Barbara; Hirsch, Hans H; Brenner, Nicole; Waterboer, Tim; Scherrer, Alexandra U; Swiss HIV Cohort Study (2020). Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction. International Journal of Cancer, 147(3):757-765.

Adam, Salome; Martin‐Diener, Eva; Camey, Bertrand; Egger Hayoz, Céline; Konzelmann, Isabelle; Mohsen Mousavi, Seyed; Herrmann, Christian; Rohrmann, Sabine; Wanner, Miriam; Staehelin, Katharina; Strebel, Räto T; Randazzo, Marco; John, Hubert; Schmid, Hans‐Peter; Arndt, Volker (2020). Health‐related quality of life in long‐term prostate cancer survivors after nerve‐sparing and non‐nerve‐sparing radical prostatectomy—Results from the multiregional PROCAS study. Cancer Medicine, 9(15):5416-5424.

Le Rhun, Emilie; Wolpert, Fabian; Fialek, Maud; Devos, Patrick; Andratschke, Nicolaus; Reyns, Nicolas; Regli, Luca; Dummer, Reinhard; Mortier, Laurent; Weller, Michael (2020). Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma. ESMO Open, 5(4):e000763.

Stahel, Rolf A; Curioni-Fontecedro, A; Rohrmann, S; Dafni, U; Sandner, U; Opitz, I; Andratschke, N; Franzen, D; Dimopoulou, G; Matthes, K L; Kohler, Malcolm; Guckenberger, M; Weder, W (2020). Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug. Lung Cancer, 146:217-223.

Akeret, Kevin; Staartjes, Victor E; Vasella, Flavio; Serra, Carlo; Fierstra, Jorn; Neidert, Marian Christoph; Regli, Luca; Krayenbühl, Niklaus (2020). Distinct topographic-anatomical patterns in primary and secondary brain tumors and their therapeutic potential. Journal of Neuro-Oncology, 149(1):73-85.

Berghoff, Anna S; Wippel, Christoph; Starzer, Angelika M; Ballarini, Nicolas; Wolpert, Fabian; Bergen, Elisabeth; Wolf, Peter; Steindl, Ariane; Widhalm, Georg; Gatterbauer, Brigitte; Marosi, Christine; Dieckmann, Karin; Bartsch, Rupert; Scherer, Thomas; Koenig, Franz; Krebs, Michael; Weller, Michael; Preusser, Matthias (2020). Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer. European Journal of Cancer, 135:150-158.

Schmid, Sabine; Mauti, Laetitia A; Friedlaender, Alex; Blum, Veronika; Rothschild, Sacha I; Bouchaab, Hasna; Frösch, Patrizia; Britschgi, Christian; König, David; Wannesson, Luciano; Janthur, Wolf-Dieter; Schär, Sämi; Demmer, Izadora; Addeo, Alfredo; Jochum, Wolfram; Früh, Martin (2020). Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort. Cancer Immunology, Immunotherapy, 69(8):1605-1613.

Amoroso, Loredana; Castel, Victoria; Bisogno, Gianni; Casanova, Michela; Marquez-Vega, Catalina; Chisholm, Julia C; Doz, François; Moreno, Lucas; Ruggiero, Antonio; Gerber, Nicolas U; Fagioli, Franca; Hingorani, Pooja; Melcón, Soledad G; Slepetis, Ruta; Chen, Nianhang; le Bruchec, Yvan; Simcock, Mathew; Vassal, Gilles (2020). Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network. European Journal of Cancer, 135:89-97.

Basler, Lucas; Gabryś, Hubert S; Hogan, Sabrina A; Pavic, Matea; Bogowicz, Marta; Vuong, Diem; Tanadini-Lang, Stephanie; Förster, Robert; Kudura, Ken; Huellner, Martin W; Dummer, Reinhard; Guckenberger, Matthias; Levesque, Mitchell P (2020). Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition. Clinical Cancer Research, 26(16):4414-4425.

Fiore, Michele; Taralli, Silvia; Trecca, Pasquale; Scolozzi, Valentina; Marinelli, Luca; Triumbari, Elizabeth K A; Caputo, Damiano; Angeletti, Silvia; Ciccozzi, Massimo; Coppola, Alessandro; Greco, Carlo; Ippolito, Edy; Calcagni, Maria Lucia; Coppola, Roberto; Ramella, Sara (2020). A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer. Cancers, 12(8):E2016.

de Lima, Jefferson Muniz; Morand, Grégoire B; Macedo, Carolina Carneiro Soares; Diesel, Luciana; Hier, Michael P; Mlynarek, Alex; Kowalski, Luiz P; Maschietto, Mariana; Alaoui-Jamali, Moulay A; da Silva, Sabrina Daniela (2020). Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. Carcinogenesis, 41(6):769-777.

Vaidya, Jayant S; Bulsara, Max; Saunders, Christobel; et al; Gruber, Günther; Dedes, Konstantin J (2020). Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer. JAMA Oncology, 6(7):e200249.

Frühwald, Michael C; Hasselblatt, Martin; Nemes, Karolina; Bens, Susanne; Steinbügl, Mona; Johann, Pascal D; Kerl, Kornelius; Hauser, Peter; Quiroga, Eduardo; Solano-Paez, Palma; Biassoni, Veronica; Gil-da-Costa, Maria Joao; Perek-Polnik, Martha; van de Wetering, Marianne; Sumerauer, David; Pears, Jane; Stabell, Niklas; Holm, Stefan; Hengartner, Heinz; Gerber, Nicolas U; Grotzer, Michael; Boos, Joachim; Ebinger, Martin; Tippelt, Stefan; Paulus, Werner; Furtwängler, Rhoikos; Hernáiz-Driever, Pablo; Reinhard, Harald; Rutkowski, Stefan; Schlegel, Paul-Gerhardt; et al (2020). Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors. Neuro-Oncology, 22(7):1006-1017.

Laurent, Anouchka P; Siret, Aurélie; Ignacimouttou, Cathy; Panchal, Kunjal; Diop, M'Boyba; Jenni, Silvia; Tsai, Yi-Chien; Roos-Weil, Damien; Aid, Zakia; Prade, Nais; Lagarde, Stephanie; Plassard, Damien; Pierron, Gaelle; Daudigeos, Estelle; Lecluse, Yann; Droin, Nathalie; Bornhauser, Beat C; Cheung, Laurence C; Crispino, John D; Gaudry, Muriel; Bernard, Olivier A; Macintyre, Elizabeth; Barin Bonnigal, Carole; Kotecha, Rishi S; Geoerger, Birgit; Ballerini, Paola; Bourquin, Jean-Pierre; Delabesse, Eric; Mercher, Thomas; Malinge, Sebastien (2020). Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia. Clinical Cancer Research, 26(13):3307-3318.

Klement, Rainer J; Sonke, Jan-Jakob; Allgäuer, Michael; Andratschke, Nicolaus; Appold, Steffen; Belderbos, José; Belka, Claus; Blanck, Oliver; Dieckmann, Karin; Eich, Hans T; Mantel, Frederick; Eble, Michael; Hope, Andrew; Grosu, Anca L; Nevinny-Stickel, Meinhard; Semrau, Sabine; Sweeney, Reinhart A; Hörner-Rieber, Juliane; Werner-Wasik, Maria; Engenhart-Cabillic, Rita; Ye, Hong; Grills, Inga; Guckenberger, Matthias (2020). Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments. International Journal of Radiation Oncology, Biology, Physics, 107(3):579-586.

Reardon, David A; Brandes, Alba A; Omuro, Antonio; Mulholland, Paul; Lim, Michael; Wick, Antje; Baehring, Joachim; Ahluwalia, Manmeet S; Roth, Patrick; Bähr, Oliver; Phuphanich, Surasak; Sepulveda, Juan Manuel; De Souza, Paul; Sahebjam, Solmaz; Carleton, Michael; Tatsuoka, Kay; Taitt, Corina; Zwirtes, Ricardo; Sampson, John; Weller, Michael (2020). Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial. JAMA Oncology, 6(7):1003-1010.

Grégoire, Vincent; Guckenberger, Matthias; Haustermans, Karin; Lagendijk, Jan J W; Ménard, Cynthia; Pötter, Richard; Slotman, Ben J; Tanderup, Kari; Thorwarth, Daniela; van Herk, Marcel; Zips, Daniel (2020). Image guidance in radiation therapy for better cure of cancer. Molecular Oncology, 14(7):1470-1491.

Ossenkoppele, G J; Breems, D A; Stuessi, G; van Norden, Y; Bargetzi, M; Biemond, B J; et al; Chalandon, Y; Cloos, J; Deeren, D; Fehr, Mirjam; Pabst, Thomas; Manz, Markus G (2020). Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. Leukemia, 34(7):1751-1759.

Dummer, Reinhard; Prince, Henry M; Whittaker, Sean; Horwitz, Steven M; Kim, Youn H; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Eradat, Herbert; Pinter-Brown, Lauren; Sanches, Jose A; Ortiz-Romero, Pablo L; Akilov, Oleg E; Geskin, Larisa; Huen, Auris; Walewski, Jan; Wang, Yinghui; Lisano, Julie; Richhariya, Akshara; Feliciano, Joseph; Zhu, Yanyan; Bunn, Veronica; Little, Meredith; Zagadailov, Erin; Dalal, Mehul R; Duvic, Madeleine (2020). Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. European Journal of Cancer, 133:120-130.

Guckenberger, Matthias; Belka, Claus; Bezjak, Andrea; Bradley, Jeffrey; Daly, Megan E; et al (2020). Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement / International Journal of Radiation Oncology, Biology, Physics. International Journal of Radiation Oncology, Biology, Physics, 107(4):631-640.

Grogg, Josias; Schneider, Kym; Bode, Peter Karl; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Lorch, Anja; Beyer, Joerg; Hermanns, Thomas; Fankhauser, Christian Daniel (2020). Sertoli cell tumors of the testes: systematic literature review and meta-analysis of outcomes in 435 patients. The oncologist, 25(7):585-590.

Witt, Claudia M; Helmer, Stefanie M; Schofield, Penelope; Wastell, Marisa; Canella, Claudia; Thomae, Anita Verena; Rogge, Alizé A (2020). Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual‐guided consultation. Cancer, 126(13):3031-3041.

Thomson, David J; Palma, David; Guckenberger, Matthias; Balermpas, Panagiotis; et al (2020). Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. International Journal of Radiation Oncology, Biology, Physics, 107(4):618-627.

Wolpert, Fabian; Berghoff, Anna S; Grossenbacher, Bettina; Lareida, Anna; Löb, Raphael; Roth, Patrick; Neidert, Marian C; Andratschke, Nicolaus; Le Rhun, Emilie; Preusser, Matthias; Weller, Michael (2020). Venous thromboembolic events in patients with brain metastases: the PICOS score. European Journal of Cancer, 134:75-85.

Le Rhun, Emilie; Seoane, Joan; Salzet, Michel; Soffietti, Riccardo; Weller, Michael (2020). Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system. Cancer Letters, 480:24-28.

Ianevski, Aleksandr; Kulesskiy, Evgeny; Krpina, Klara; Lou, Guofeng; Aman, Yahyah; Bugai, Andrii; Aasumets, Koit; Akimov, Yevhen; Bulanova, Daria; Gildemann, Kiira; Arutyunyan, Albert F; Susova, Olga Yu; Zhuze, Alexei L; Ji, Ping; Wang, Wei; Holien, Toril; Bugge, Marit; Zusinaite, Eva; Oksenych, Valentyn; Lysvand, Hilde; Gerhold, Joachim M; Bjørås, Magnar; Johansen, Pål; Waage, Anders; Heckman, Caroline A; Fang, Evandro F; Kainov, Denis E (2020). Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis. Cancers, 12(6):1694.

Mynarek, Martin; von Hoff, Katja; Pietsch, Torsten; Ottensmeier, Holger; Warmuth-Metz, Monika; et al; Rushing, Elisabeth Jane; Grotzer, Michael; Gerber, Nicolas U (2020). Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. Journal of Clinical Oncology, 38(18):2028-2040.

Herger, Aline; Gupta, Shibu; Kadler, Gabor; Franck, Christina Maria; Boisson-Dernier, Aurélien; Ringli, Christoph (2020). Overlapping functions and protein-protein interactions of LRR-extensins in Arabidopsis. PLoS Genetics, 16(6):e1008847.

Kountouras, Jannis; Papaefthymiou, Apostolis; Polyzos, Stergios A; Zavos, Christos; Doulberis, Michael (2020). Response to letter to the editor of Carcinogenesis by Li et al., 2020. Carcinogenesis, 41(4):539-540.

Kaufmann, Timothy J; Smits, Marion; Boxerman, Jerrold; Huang, Raymond; Barboriak, Daniel P; Weller, Michael; Chung, Caroline; Tsien, Christina; Brown, Paul D; Shankar, Lalitha; Galanis, Evanthia; Gerstner, Elizabeth; van den Bent, Martin J; Burns, Terry C; Parney, Ian F; Dunn, Gavin; Brastianos, Priscilla K; Lin, Nancy U; Wen, Patrick Y; Ellingson, Benjamin M (2020). Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM). Neuro-Oncology, 22(6):757-772.

Moskovszky, Linda; Berger, Barbara; Fleischmann, Achim; Friedrich, Thomas; Helmchen, Birgit; Körner, Meike; Rau, Tilman T; Varga, Zsuzsanna (2020). Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists. Journal of Cancer Research and Clinical Oncology, 146(6):1473-1478.

Braun, Lukas M; Lagies, Simon; Klar, Rhena F U; Hussung, Saskia; Fritsch, Ralph M; Kammerer, Bernd; Wittel, Uwe A (2020). Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures. Cancers, 12(6):1440.

Attarbaschi, Andishe; Mann, Georg; Zimmermann, Martin; Bader, Peter; Barisone, Elena; Basso, Giuseppe; Biondi, Andrea; Cario, Gunnar; Cazzaniga, Gianni; Colombini, Antonella; Flotho, Christian; Kuhlen, Michaela; Lang, Peter; Lauten, Melchior; Linderkamp, Christin; Locatelli, Franco; Lo Nigro, Luca; Möricke, Anja; Niggli, Felix; Panzer-Grümayer, Renate; Parasole, Rosanna; Peters, Christina; Caterina Putti, Maria; Rizzari, Carmelo; Suttorp, Meinolf; Valsecchi, Maria Grazia; Conter, Valentino; Schrappe, Martin; on behalf of the AIEOP-BFM (Associazione Italiana di Ematologia (2020). Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial. Leukemia, 34(6):1694-1700.

von Achenbach, Caroline; Silginer, Manuela; Blot, Vincent; Weiss, William A; Weller, Michael (2020). Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR Y1068 Phosphorylation. Molecular Cancer Therapeutics, 19(6):1328-1339.

Rusthoven, Chad G; Yamamoto, Masaaki; Bernhardt, Denise; Smith, Derek E; Gao, Dexiang; et al; Guckenberger, Matthias; Andratschke, Nicolaus (2020). Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases. JAMA Oncology, 6(7):1028-1037.

Hrusak, Ondrej; Kalina, Tomas; Wolf, Joshua; Balduzzi, Adriana; Provenzi, Massimo; et al; Bourquin, Jean-Pierre (2020). Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. European Journal of Cancer, 132:11-16.

Seidel, Christoph; Daugaard, Gedske; Nestler, Tim; Tryakin, Alexey; Fedyanin, Mikhail; Fankhauser, Christian; Hermanns, Thomas; Aparicio, Jorge; Heinzelbecker, Julia; Paffenholz, Pia; Heidenreich, Axel; De Giorgi, Ugo; Cathomas, Richard; Lorch, Anja; Fingerhut, Anna; Gayer, Fabian; Bremmer, Felix; Giannatempo, Patrizia; Necchi, Andrea; Aurilio, Gaetano; Casadei, Chiara; Tran, Ben; Dieckmann, Klaus-Peter; Brito, Margarida; Ruf, Christian; Oing, Christoph; Bokemeyer, Carsten (2020). Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3). European Journal of Cancer, 132:127-135.

Warde, Kate M; Schoenmakers, Erik; Ribes Martinez, Eduardo; Lim, Yi Jan; Leonard, Maeve; Lawless, Sarah J; O'Shea, Paula; Chatterjee, Krishna V; Gurnell, Mark; Hantel, Constanze; Dennedy, Michael Conall (2020). Liver X receptor inhibition potentiates mitotane-induced adrenotoxicity in ACC. Endocrine-Related Cancer, 27(6):361-373.

Guarino, Maria; Kumar, Pavitra; Felser, Andrea; Terracciano, Luigi M; Guixé-Muntet, Sergi; Humar, Bostjan; Foti, Michelangelo; Nuoffer, Jean-Marc; St-Pierre, Marie V; Dufour, Jean-François (2020). Exercise attenuates the transition from fatty liver to steatohepatitis and reduces tumor formation in mice. Cancers, 12(6):1407.

Silva, Christiane F S; Motta, Juliana M; Teixeira, Felipe C O B; Gomes, Angélica M; Vilanova, Eduardo; Kozlowski, Eliene O; Borsig, Lubor; Pavão, Mauro S G (2020). Non-Anticoagulant Heparan Sulfate from the Ascidian Phallusia nigra Prevents Colon Carcinoma Metastasis in Mice by Disrupting Platelet-Tumor Cell Interaction. Cancers, 12(6):1353.

Canella, Claudia; Mikolasek, Michael; Rostock, Matthias; Guckenberger, Matthias; Jenewein, Josef; Linka, Esther; Six, Claudia; Stoll, Sarah; Stupp, Roger; Witt, Claudia M (2020). Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue. BMC Cancer, 20:458.

Bestard-Escalas, Joan; Maimó-Barceló, Albert; Lopez, Daniel H; Reigada, Rebeca; Guardiola-Serrano, Francisca; Ramos-Vivas, José; Hornemann, Thorsten; Okazaki, Toshiro; Barceló-Coblijn, Gwendolyn (2020). Common and Differential Traits of the Membrane Lipidome of Colon Cancer Cell Lines and their Secreted Vesicles: Impact on Studies Using Cell Lines. Cancers, 12(5):1293.

Van Den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; De Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; Krause, Scott; Ansell, Pete; Nuyens, Sarah; Spruyt, Maarten; Brilhante, Joana; Coens, Corneel; Gorlia, Thierry; Golfinopoulos, Vassilis (2020). INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Neuro-Oncology, 22(5):684-693.

Lee, Eudocia Q; Weller, Michael; Sul, Joohee; Bagley, Stephen J; Sahebjam, Solmaz; van den Bent, Martin; Ahluwalia, Manmeet; Campian, Jian L; Galanis, Evanthia; Gilbert, Mark R; Holdhoff, Matthias; Lesser, Glenn J; Lieberman, Frank S; Mehta, Minesh P; Penas-Prado, Marta; Schreck, Karisa C; Strowd, Roy E; Vogelbaum, Michael A; Walbert, Tobias; Chang, Susan M; Nabors, L Burt; Grossman, Stuart; Reardon, David A; Wen, Patrick Y (2020). Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro-Oncology, 22(5):601-612.

Hiltpold, Maya; Niu, Guanglin; Kadri, Naveen Kumar; Crysnanto, Danang; Fang, Zih-Hua; Spengeler, Mirjam; Schmitz-Hsu, Fritz; Fuerst, Christian; Schwarzenbacher, Hermann; Seefried, Franz R; Seehusen, Frauke; Witschi, Ulrich; Schnieke, Angelika; Fries, Ruedi; Bollwein, Heiner; Flisikowski, Krzysztof; Pausch, Hubert (2020). Activation of cryptic splicing in bovine WDR19 is associated with reduced semen quality and male fertility. PLoS Genetics, 16(5):e1008804.

Chen, Zhiyong; Berquez, Marine; Luciani, Alessandro (2020). Mitochondria, mitophagy, and metabolic disease: towards assembling the puzzle. Cell Stress, 4(6):147-150.

De Bruycker, A; Spiessens, A; Dirix, P; Koutsouvelis, N; Semac, I; Liefhooghe, N; Gomez-Iturriaga, A; Everaerts, W; Otte, F; Papachristofilou, A; Scorsetti, M; Shelan, M; Siva, S; Ameye, F; Guckenberger, Matthias; Heikkilä, R; Putora, P M; Zapatero, A; Conde-Moreno, A; Couñago, F; Vanhoutte, F; Goetghebeur, E; Reynders, D; Zilli, T; Ost, P (2020). PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC Cancer, 20:406.

Kiesel, Barbara; Thomé, Carina M; Weiss, Tobias; Jakola, Asgeir S; Darlix, Amélie; Pellerino, Alessia; Furtner, Julia; Kerschbaumer, Johannes; Freyschlag, Christian F; Wick, Wolfgang; Preusser, Matthias; Widhalm, Georg; Berghoff, Anna S (2020). Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee. BMC Cancer, 20:410.

Schell, Marianne; Pflüger, Irada; Brugnara, Gianluca; Isensee, Fabian; Neuberger, Ulf; Foltyn, Martha; Kessler, Tobias; Sahm, Felix; Wick, Antje; Nowosielski, Martha; Heiland, Sabine; Weller, Michael; Platten, Michael; Maier-Hein, Klaus H; von Deimling, Andreas; van den Bent, Martin J; Gorlia, Thierry; Wick, Wolfgang; Bendszus, Martin; Kickingereder, Philipp (2020). Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial. Neuro-Oncology, 22(11):1667-1676.

Koch, Eva L; Guillaume, Frédéric (2020). Additive and mostly adaptive plastic responses of gene expression to multiple stress in Tribolium castaneum. PLoS Genetics, 16(5):e1008768.

Windisch, Paul; Hertler, Caroline; Blum, David; Zwahlen, Daniel; Förster, Robert (2020). Leveraging advances in artificial intelligence to improve the quality and timing of palliative care. Cancers, 12(5):1149.

Liebers, Nora; Roider, Tobias; Bohn, Jan-Paul; Haberbosch, Isabella; Pircher, Andreas; Ferstl, Barbara; Ebnöther, Monika; Wendtner, Clemens-Martin; Dearden, Claire; Follows, George A; Ho, Anthony D; Müller-Tidow, Carsten; Dreger, Peter; Troussard, Xavier; Zenz, Thorsten; Dietrich, Sascha (2020). BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials. Leukemia, 34(5):1454-1457.

Cruzeiro, Gustavo Alencastro Veiga; Lira, Regia Caroline Peixoto; de Almeida Magalhães, Taciani; Scrideli, Carlos Alberto; Valera, Elvis Terci; Baumgartner, Martin; Tone, Luiz Gonzaga (2020). CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cancer Gene Therapy, 27(5):378-382.

Horisberger, Karoline; Portenkirchner, Carmen; Rickenbacher, Andreas; Biedermann, Luc; Gubler, Christoph; Turina, Matthias (2020). Complete recovery of immune checkpoint inhibitor-induced colitis by diverting loop ileostomy. Journal of Immunotherapy, 43(4):145-148.

Staeger, Ramon; Ramelyte, Egle; Dummer, Reinhard (2020). Recurrent squamous cell carcinoma of the perianal skin: a case report. ESMO Open, 5(3):e000786.

Uka, Rexhep; Britschgi, Christian; Krättli, Anja; Matter, Claudia; Mihic, Daniela; Okoniewski, Michal J; Gualandi, Marco; Stupp, Roger; Cinelli, Paolo; Dummer, Reinhard; Levesque, Mitchell P; Shakhova, Olga (2020). Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth. Oncogene, 39(20):4132-4154.

Puca, Emanuele; Probst, Philipp; Stringhini, Marco; Murer, Patrizia; Pellegrini, Giovanni; Cazzamalli, Samuele; Hutmacher, Cornelia; Gouyou, Baptiste; Wulhfard, Sarah; Matasci, Mattia; Villa, Alessandra; Neri, Dario (2020). The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8+T cell activity and synergizes with immune checkpoint inhibitors. International Journal of Cancer, 146(9):2518-2530.

Peris, Ketty; Fargnoli, Maria C; Garbe, Claus; Kaufmann, Roland; Bastholt, Lars; Seguin, Nicole B; Bataille, Veronique; Del Marmol, Veronique; Dummer, Reinhard; Harwood, Catherine A; Hauschild, Axel; Höller, Christoph; Haedersdal, Merete; Malvehy, Josep; Middleton, Mark R; Morton, Colin A; Nagore, Eduardo; Stratigos, Alexander J; Szeimies, Rolf-Markus; Tagliaferri, Luca; Trakatelli, Myrto; Zalaudek, Iris; Eggermont, Alexander; Grob, Jean J (2020). Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'. European Journal of Cancer, 131:100-103.

Hertler, Caroline; Eisele, Günter; Gramatzki, Dorothee; Seystahl, Katharina; Wolpert, Fabian; Roth, Patrick; Weller, Michael (2020). End-of-life care for glioma patients; the caregivers' perspective. Journal of Neuro-Oncology, 147(3):663-669.

Weller, Michael; Preusser, Matthias (2020). How we treat patients with brain tumour during the COVID-19 pandemic. ESMO Open, 4(Suppl 2):e000789.

Dirven, Linda; Luerding, Ralf; Beier, Dagmar; Bumes, Elisabeth; Reinert, Christiane; Seidel, Clemens; Bonsanto, Matteo Mario; Bremer, Michael; Rieken, Stefan; Combs, Stephanie E; Herrlinger, Ulrich; Seliger, Corinna; Kuntze, Holger; Mayer-Steinacker, Regine; Dieing, Annette; Bartels, Claudius; Schnell, Oliver; Weyerbrock, Astrid; Seidel, Sabine; Grauer, Oliver; Nadji-Ohl, Minou; Paulsen, Frank; Weller, Michael; Wick, Wolfgang; Hau, Peter (2020). Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. Journal of Neuro-Oncology, 148(1):117-130.

Wettstein, Marian S; Naimark, David; Hermanns, Thomas; Herrera-Caceres, Jaime O; Ahmad, Ardalan; Jewett, Michael A S; Kulkarni, Girish S (2020). Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes? Cancer Medicine, 9(10):3287-3296.

Thomas, Gillian; Eisenhauer, Elizabeth; Bristow, Robert G; Grau, Cai; Hurkmans, Coen; Ost, Piet; Guckenberger, Matthias; Deutsch, Eric; Lacombe, Denis; Weber, Damien C (2020). The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. European Journal of Cancer, 131:76-88.

Fischer, Stefanie; Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Thibault, Constance; Vincenzi, Bruno; Klingbiel, Dirk; Albany, Costantine; Necchi, Andrea; Terbuch, Angelika; Lorch, Anja; Aparicio, Jorge; Heidenreich, Axel; Hentrich, Marcus; Wheater, Matthew; Langberg, Carl W; Ståhl, Olof; Fankhauser, Christian Daniel; Hamid, Anis A; Koutsoukos, Konstantinos; Shamash, Jonathan; White, Jeff; Bokemeyer, Carsten; Beyer, Jörg; Gillessen, Silke (2020). Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma. Journal of Clinical Oncology, 38(12):1322-1331.

Boegeholz, J; Brueggen, C S; Pauli, C; Dimitriou, F; Haralambieva, E; Dummer, R; Manz, M G; Widmer, C C (2020). Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect. BMC Cancer, 20:300.

Ryall, Scott; Zapotocky, Michal; Fukuoka, Kohei; Nobre, Liana; Guerreiro Stucklin, Ana; Bennett, Julie; Siddaway, Robert; Li, Christopher; Pajovic, Sanja; Arnoldo, Anthony; Kowalski, Paul E; Johnson, Monique; Sheth, Javal; Lassaletta, Alvaro; Tatevossian, Ruth G; Orisme, Wilda; Qaddoumi, Ibrahim; Surrey, Lea F; Li, Marilyn M; Waanders, Angela J; Gilheeney, Stephen; Rosenblum, Marc; Bale, Tejus; Tsang, Derek S; Laperriere, Normand; Kulkarni, Abhaya; Ibrahim, George M; Drake, James; Dirks, Peter; Taylor, Michael D; et al (2020). Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. Cancer Cell, 37(4):569-583.e5.

Abate, Andrea; Rossini, Elisa; Bonini, Sara Anna; Fragni, Martina; Cosentini, Deborah; Tiberio, Guido Albero Massimo; Benetti, Diego; Hantel, Constanze; Laganà, Marta; Grisanti, Salvatore; Terzolo, Massimo; Memo, Maurizio; Berruti, Alfredo; Sigala, Sandra (2020). Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells. Cancers, 12(4):928.

Belavgeni, Alexia; Bornstein, Stefan R; Linkermann, Andreas (2020). Stress will kill you anyway! Cell Death and Disease, 11(4):218.

Orjuela, Stephany; Menigatti, Mirco; Schraml, Peter; Kambakamba, Patryk; Robinson, Mark D; Marra, Giancarlo (2020). The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers. BMC Cancer, 20:290.

Bozinov, Oliver; Yang, Yang; Oertel, Markus F; Neidert, Marian C; Nakaji, Peter (2020). Laser interstitial thermal therapy in gliomas. Cancer Letters, 474:151-157.

Arshad, Usman; Ploylearmsaeng, Su-arpa; Karlsson, Mats O; Doroshyenko, Oxana; Langer, Dorothee; Schömig, Edgar; Kunze, Sabine; Güner, Semih A; Skripnichenko, Roman; Ullah, Sami; Jaehde, Ulrich; Fuhr, Uwe; Jetter, Alexander; Taubert, Max (2020). Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients. Cancer Chemotherapy and Pharmacology, 85(4):711-722.

Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Tchinda, Joëlle; Legros, Myriam; Scarpelli, Ilaria; Hewer, Ekkehard; Novak, Urban; Schoumans, Jacqueline; Bacher, Ulrike; Pabst, Thomas (2020). Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia. Genes, Chromosomes and Cancer, 59(4):268-274.

Andres, Fabio; Schwill, Martin; Boersma, Ykelien L; Plückthun, Andreas (2020). High-Throughput Generation of Bispecific Binding Proteins by Sortase A-Mediated Coupling for Direct Functional Screening in Cell Culture. Molecular Cancer Therapeutics, 19(4):1080-1088.

Lohmann, Birthe; Le Rhun, Emilie; Silginer, Manuela; Epskamp, Mirka; Weller, Michael (2020). Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02. Oncology Letters, 19(4):2649-2656.

Deeren, Dries; Balabanov, Stefan; Nickel, Katharina; Giannopoulou, Christina; Gonzalez-McQuire, Sebastian; Kutikova, Lucie; Bouwmeester, Walter; Spyridonidis, Alexandros (2020). Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland. Leukemia Research, 91:106334.

Siebenhüner, Alexander R; Güller, Ulrich; Warschkow, Rene (2020). Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases. BMC Cancer, 20:246.

Regouc, Manuel; Belge, Gazanfer; Lorch, Anja; Dieckmann, Klaus-Peter; Pichler, Martin (2020). Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer. Cancers, 12(3):749.

Lindegaard, Jacob Christian; Petric, Primoz; Lindegaard, Anne Marie; Tanderup, Kari; Fokdal, Lars Ulrik (2020). Evaluation of a New Prognostic Tumor Score in Locally Advanced Cervical Cancer Integrating Clinical Examination and Magnetic Resonance Imaging. International Journal of Radiation Oncology, Biology, Physics, 106(4):754-763.

Calaminus, Gabriele; Schneider, Dominik T; von Schweinitz, Dietrich; Jürgens, Heribert; Infed, Nacera; Schönberger, Stefan; Olson, Thomas A; Albers, Peter; Vokuhl, Christian; Stein, Raimund; Looijenga, Leendert; Sehouli, Jalid; Metzelder, Martin; Claviez, Alexander; Dworzak, Michael; Eggert, Angelika; Fröhlich, Birgit; Gerber, Nicolas U; Kratz, Christian P; Faber, Jörg; Klingebiel, Thomas; Harms, Dieter; Göbel, Ulrich (2020). Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology. Cancers, 12(3):611.

Cam, Maren; Charan, Manish; Welker, Alessandra M; Dravid, Piyush; Studebaker, Adam W; Leonard, Jeffrey R; Pierson, Christopher R; Nakano, Ichiro; Beattie, Christine E; Hwang, Eugene I; Kambhampati, Madhuri; Nazarian, Javad; Finlay, Jonathan L; Cam, Hakan (2020). ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma. Neuro-Oncology, 22(3):345-356.

Seystahl, Katharina; Hentschel, Bettina; Loew, Sarah; Gramatzki, Dorothee; Felsberg, Jörg; Herrlinger, Ulrich; Westphal, Manfred; Schackert, Gabriele; Thon, Niklas; Tatagiba, Marcos; Pietsch, Torsten; Reifenberger, Guido; Löffler, Markus; Wick, Wolfgang; Weller, Michael (2020). Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma. Journal of Cancer Research and Clinical Oncology, 146(3):659-670.

Stahel, Rolf A; Lacombe, Denis; Cardoso, Fatima; Casali, Paolo G; Negrouk, Anastassia; Marais, Richard; Hiltbrunner, Anita; Vyas, Malvika (2020). Current models, challenges and best practices for work conducted between European academic cooperative groups and industry. ESMO Open, 5(2)::e000628.

Coleman, Christina; Stoller, Schuyler; Grotzer, Michael; Stucklin, Ana Guerreiro; Nazarian, Javad; Mueller, Sabine (2020). Pediatric hemispheric high-grade glioma: targeting the future. Cancer Metastasis Reviews, 39(1):245-260.

Deng, Ting; Stempor, Przemyslaw; Appert, Alex; Daube, Michael; Ahringer, Julie; Hajnal, Alex; Lattmann, Evelyn (2020). The Caenorhabditis elegans homolog of the Evi1 proto-oncogene, egl-43, coordinates G1 cell cycle arrest with pro-invasive gene expression during anchor cell invasion. PLoS Genetics, 16(3):e1008470.

Ohashi, Riuko; Angori, Silvia; Batavia, Aashil A; Rupp, Niels J; Ajioka, Yoichi; Schraml, Peter; Moch, Holger (2020). Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients. Cancers, 12(2):E465.

Wick, Antje; Kessler, Tobias; Platten, Michael; Meisner, Christoph; Bamberg, Michael; Herrlinger, Ulrich; Felsberg, Jörg; Weyerbrock, Astrid; Papsdorf, Kirsten; Steinbach, Joachim P; Sabel, Michael; Vesper, Jan; Debus, Jürgen; Meixensberger, Jürgen; Ketter, Ralf; Hertler, Caroline; Mayer-Steinacker, Regine; Weisang, Sarah; Bölting, Hanna; Reuss, David; Reifenberger, Guido; Sahm, Felix; von Deimling, Andreas; Weller, Michael; Wick, Wolfgang; NOA-08 Study Group of the Neurooncology Working Group (NOA) of t (2020). Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter-methylated malignant astrocytoma. Neuro-Oncology, 22(8):1162-1172.

Ommer, Johannes; Selfe, Joanna L; Wachtel, Marco; O'Brien, Eleanor M; Laubscher, Dominik; Roemmele, Michaela; Kasper, Stephanie; Delattre, Olivier; Surdez, Didier; Petts, Gemma; Kelsey, Anna; Shipley, Janet; Schäfer, Beat W (2020). Aurora A kinase inhibition destabilizes PAX3-FOXO1 and MYCN and synergizes with Navitoclax to induce Rhabdomyosarcoma cell death. Cancer Research, 80(4):832-842.

Jin, Xi-Feng; Spoettl, Gerald; Maurer, Julian; Nölting, Svenja; Auernhammer, Christoph Josef (2020). Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral Effects. Cancers, 12(2):345.

Hirsova, Petra; Bohm, Friederike; Dohnalkova, Ester; Nozickova, Barbora; Heikenwalder, Mathias; Gores, Gregory J; Weber, Achim (2020). Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis. Cell Death and Disease, 11(2):80.

Rohner, Eliane; Bütikofer, Lukas; Schmidlin, Kurt; Sengayi, Mazvita; Maskew, Mhairi; Giddy, Janet; Taghavi, Katayoun; Moore, Richard D; Goedert, James J; Gill, M John; Silverberg, Michael J; D'Souza, Gypsyamber; Patel, Pragna; Castilho, Jessica L; Ross, Jeremy; Sohn, Annette; Bani-Sadr, Firouze; Taylor, Ninon; Paparizos, Vassilios; Bonnet, Fabrice; Verbon, Annelies; Vehreschild, Jörg Janne; Post, Frank A; Sabin, Caroline; Mocroft, Amanda; Dronda, Fernando; Obel, Niels; Grabar, Sophie; Spagnuolo, Vincenzo; Quiros-Roldan, Eugenia; Hasse, Barbara; et al (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. International Journal of Cancer, 146(3):601-609.

Okonska, Agata; Bühler, Saskja; Rao, Vasundhara; Ronner, Manuel; Blijlevens, Maxime; van der Meulen-Muileman, Ida H; de Menezes, Renée X; Wipplinger, Martin; Oehl, Kathrin; Smit, Egbert F; Weder, Walter; Stahel, Rolf A; Penengo, Lorenza; van Beusechem, Victor W; Felley-Bosco, Emanuela (2020). Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated-protein-1 induces chemoresistance to ribonucleotide reductase inhibition. Molecular Cancer Therapeutics, 19(2):552-563.

Boström, Adrian E; Chatzittofis, Andreas; Ciuculete, Diana-Maria; Flanagan, John N; Krattinger, Regina; Bandstein, Marcus; Mwinyi, Jessica; Kullak-Ublick, Gerd A; Öberg, Katarina Görts; Arver, Stefan; Schiöth, Helgi B; Jokinen, Jussi (2020). Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes. Epigenetics, 15(1-2):145-160.

Seliger, Corinna; Genbrugge, Els; Gorlia, Thierry; Chinot, Olivier; Stupp, Roger; Nabors, Burt; Weller, Michael; Hau, Peter (2020). Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis. International Journal of Cancer, 146(3):803-809.

Oing, Christoph; Hentrich, Marcus; Lorch, Anja; Gläser, Dietrich; Rumpold, Holger; Ochsenreither, Sebastian; Richter, Stephan; Dieing, Annette; Zschäbitz, Stefanie; Pereira, Ronnie Rodrigues; Bokemeyer, Carsten; Seidel, Christoph (2020). Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series. Journal of Cancer Research and Clinical Oncology, 146(2):449-455.

Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen J; Flaherty, Keith T; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D; Robert, Caroline (2020). Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma. European Journal of Cancer, 126:33-44.

Richter, Günther H S; Hensel, Tim; Schmidt, Oxana; Saratov, Vadim; von Heyking, Kristina; Becker-Dettling, Fiona; Prexler, Carolin; Yen, Hsi-Yu; Steiger, Katja; Fulda, Simone; Dirksen, Uta; Weichert, Wilko; Wang, Shudong; Burdach, Stefan; Schäfer, Beat W (2020). Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma. Cancers, 12(2):304.

Terraneo, Nastassja; Jacob, Francis; Peitzsch, Claudia; Dubrovska, Anna; Krudewig, Christiane; Huang, Yen-Lin; Heinzelmann-Schwarz, Viola; Schibli, Roger; Béhé, Martin; Grünberg, Jürgen (2020). L1 Cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population. Cancers, 12(1):E217.

Goldbrunner, Roland; Weller, Michael; Regis, Jean; Lund-Johansen, Morten; Stavrinou, Pantelis; Reuss, David; Evans, D Gareth; Lefranc, Florence; Sallabanda, Kita; Falini, Andrea; Axon, Patrick; Sterkers, Olivier; Fariselli, Laura; Wick, Wolfgang; Tonn, Joerg-Christian (2020). EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma. Neuro-Oncology, 22(1):31-45.

Galldiks, Norbert; Kocher, Martin; Ceccon, Garry; Werner, Jan-Michael; Brunn, Anna; Deckert, Martina; Pope, Whitney B; Soffietti, Riccardo; Le Rhun, Emilie; Weller, Michael; Tonn, Jörg C; Fink, Gereon R; Langen, Karl-Josef (2020). Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression. Neuro-Oncology, 22(1):17-30.

Ijaz, Heba; Koptyra, Mateusz; Gaonkar, Krutika S; Rokita, Jo Lynne; Baubet, Valerie P; Children’s Brain Tumor Tissue Consortium; et al; Nazarian, Javad (2020). Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. Neuro-Oncology, 22(1):163-165.

Šošić, Lara; Selbo, Pål Kristian; Kotkowska, Zuzanna K; Kündig, Thomas M; Høgset, Anders; Johansen, Pål (2020). Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines. Cancers, 12(1):165.

Knop, Janin; Spilgies, Lisanne M; Rufli, Stefanie; Reinhart, Ramona; Vasilikos, Lazaros; Yabal, Monica; Owsley, Erika; Jost, Philipp J; Marsh, Rebecca A; Wajant, Harald; Robinson, Mark D; Kaufmann, Thomas; Wong, W Wei-Lynn (2020). Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death and Disease, 11(1):56.

Wirsching, Hans-Georg; Weller, Michael (2020). Does Neuronal Activity Promote Glioma Progression? Trends in Cancer, 6(1):1-3.

Pavic, Matea; Klaas, Vanessa; Theile, Gudrun; Kraft, Johannes; Tröster, Gerhard; Guckenberger, Matthias (2020). Feasibility and Usability Aspects of Continuous Remote Monitoring of Health Status in Palliative Cancer Patients Using Wearables. Oncology, 98(Suppl. 6):386-395.

Tran, Ben; Ruiz-Morales, Jose M; Gonzalez-Billalabeitia, Enrique; Patrikidou, Anna; Amir, Eitan; Seidel, Christoph; Bokemeyer, Carsten; Fankhauser, Christian; Hermanns, Thomas; Rumyantsev, Alexey; Tryakin, Alexey; Brito, Margarida; Fléchon, Aude; Kwan, Edmond Michael; Cheng, Tina; Castellano, Daniel; Garcia Del Muro, Xavier; Hamid, Anis A; Ottaviano, Margaret; Palmieri, Giovannella; Kitson, Robert; Reid, Alison; Heng, Daniel Y C; Bedard, Philippe L (2020). Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). Cancer Medicine, 9(1):116-124.

Carrio-Cordo, Paula; Baudis, Michael (2020). Mountains and Chasms: Surveying the Oncogenomic Publication Landscape. Oncology, 98(Suppl. 6):332-343.

Putora, Paul Martin; Baudis, Michael; Beadle, Beth M; El Naqa, Issam; Giordano, Frank A; Nicolay, Nils H (2020). Oncology Informatics: Status Quo and Outlook. Oncology, 98(Suppl. 6):329-331.

Razansky, Daniel; Ntziachristos, Vasilis (2020). Optical and Optoacoustic Imaging. In: Schober, Otmar; Kiessling, Fabian; Debus, Jürgen. Molecular Imaging in Oncology. Cham: Springer, 155-187.

Heinhuis, Kimberley M; Carlino, Matteo; Joerger, Markus; Di Nicola, Massimo; Meniawy, Tarek; Rottey, Sylvie; Moreno, Victor; Gazzah, Anas; Delord, Jean-Pierre; Paz-Ares, Luis; Britschgi, Christian; Schilder, Russell J; O'Byrne, Kenneth; Curigliano, Giuseppe; Romano, Emanuela; Patah, Poliana; Wang, Rui; Liu, Yali; Bajaj, Gaurav; Siu, Lillian L (2020). Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor-related protein agonist alone or in combination with nivolumab for patients with advanced solid tumors: a phase 1/2a dose-escalation and cohort-expansion clinical trial. JAMA Oncology, 6(1):100.

Borel, Nicole; Sauer-Durand, Anna Maria; Hartel, Mark; Kuratli, Jasmin; Vaupel, Peter; Scherr, Nicole; Pluschke, Gerd (2020). wIRA: hyperthermia as a treatment option for intracellular bacteria, with special focus on Chlamydiae and Mycobacteria. International Journal of Hyperthermia, 37(1):373-383.

Santoro, Raffaela; Zanotto, Marco; Simionato, Francesca; Zecchetto, Camilla; Merz, Valeria; Cavallini, Chiara; Piro, Geny; Sabbadini, Fabio; Boschi, Federico; Scarpa, Aldo; Melisi, Davide (2020). Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer. Molecular Cancer Therapeutics, 19(1):247-257.

Barone, D; Onetto, M; Conio, M; Paganuzzi, M; Saccomanno, S; Aste, H; Pugliese, V (2020). CA 19-9 assay in patients with extrahepatic cholestatic jaundice. The International Journal of Biological Markers, 3(2):95-100.

Müller, Martin; Güth, Uwe; Varga, Zsuzsanna; Reeve, Kelly; Bjelic-Radisic, Vesna; Fleisch, Markus; Tausch, Christoph J; Elfgen, Constanze (2020). Clinical Imaging of the Heterogeneous Group of Triple-negative Breast Cancer. Anticancer Research, 40(4):2125-2131.

Oehus, Ann-Kathrin; Kroeze, Stephanie G C; Schmidt-Hegemann, Nina-Sophie; Vogel, Marco M E; Kirste, Simon; Becker, Jessica; Burger, Irene A; Derlin, Thorsten; Bartenstein, Peter; Eiber, Matthias; Mix, Michael; la Fougère, Christian; Belka, Claus; Combs, Stephanie E; Grosu, Anca-Ligia; Müller, Arndt-Christian; Guckenberger, Matthias; Christiansen, Hans; Henkenberens, Christoph (2020). Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy. BMC Cancer, 20:362.

Morand, G B; Broglie, Martina A; Schumann, Paul; Hüllner, Martin W; Rupp, Niels J (2020). Histometabolic tumor imaging of hypoxia in oral cancer: clinicopathological correlation for prediction of an aggressive phenotype. Frontiers in Oncology:10:1670.

Lakshminarayanan, Harini; Rutishauser, Dorothea; Schraml, Peter; Moch, Holger; Bolck, Hella A (2020). Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease. Frontiers in Oncology, 10:582843.

Siebenhüner, Alexander; De Dosso, Sara; Meisel, Alexander; Wagner, Anna Dorothea; Borner, Markus (2020). Metastatic Colorectal Carcinoma after Second Progression and the Role of Trifluridine-Tipiracil (TAS-102) in Switzerland. Oncology Research and Treatment, 43(5):237-244.

Foschini, Maria P; Morandi, Luca; Sanchez, Alejandro M; Santoro, Angela; Mulè, Antonino; Zannoni, Gian Franco; Varga, Zsuzsanna; Moskovszky, Linda; Cucchi, Maria C; Moelans, Cathy B; Giove, Gianluca; van Diest, Paul J; Masetti, Riccardo (2020). Methylation Profile of X-Chromosome-Related Genes in Male Breast Cancer. Frontiers in Oncology, 10:784.

Britschgi, Christian; Addeo, Alfredo; Rechsteiner, Markus; Delaloye, Raphaël; Früh, Martin; Metro, Giulio; Banini, Marco; Gautschi, Oliver; Rothschild, Sacha I; Wild, Peter J; Banna, Giuseppe L; Curioni-Fontecedro, Alessandra (2020). Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients. Frontiers in Oncology, 10:1299.

Huang, Yun; Bourquin, Jean-Pierre (2020). Targeting the oncogenic activity of TCF3-HLF in leukemia. Molecular, 7(3):1709391.

Leeksma, Alexander C; Derks, Ingrid A M; Kasem, M Haidar; Kilic, Emine; de Klein, Annelies; Jager, Martine J; van de Loosdrecht, Arjan A; Jansen, Joop H; Navrkalova, Veronika; Faber, Laura M; Zaborsky, Nadja; Egle, Alexander; Zenz, Thorsten; Pospisilova, Sarka; Abdel-Wahab, Omar; Kater, Arnon P; Eldering, Eric (2020). The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer. Frontiers in Oncology, 10:609409.

Lauk, Olivia; Bruestle, Karina; Neuer, Thomas; Battilana, Bianca; Nguyen, Thi Dan Linh; Frauenfelder, Thomas; Stahel, Rolf; Weder, Walter; Curioni-Fontecedro, Alessandra; Opitz, Isabelle (2020). The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis. Frontiers in Oncology, 10:588563.

2019

Wirsching, Hans-Georg; Arora, Sonali; Zhang, Huajia; Szulzewsky, Frank; Cimino, Patrick J; Quéva, Christophe; Houghton, A McGarry; Glorioso, Joseph C; Weller, Michael; Holland, Eric C (2019). Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma dependends on MMP9. Neuro-Oncology, 21(12):1607-1609.

Furtner, Julia; Genbrugge, Els; Gorlia, Thierry; Bendszus, Martin; Nowosielski, Martha; Golfinopoulos, Vassilis; Weller, Michael; van den Bent, Martin J; Wick, Wolfgang; Preusser, Matthias (2019). Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial. Neuro-Oncology, 21(12):1587-1594.

Laban, Simon; Gangkofner, Dominik S; Holzinger, Dana; Schroeder, Lea; Eichmüller, Stefan B; Zörnig, Inka; Jäger, Dirk; Wichmann, Gunnar; Dietz, Andreas; Broglie, Martina A; Herold-Mende, Christel C; Dyckhoff, Gerhard; Boscolo-Rizzo, Paolo; Ezić, Jasmin; Marienfeld, Ralf; Möller, Peter; Kraus, Johann M; Völkel, Gunnar; Kestler, Hans A; Brunner, Cornelia; Schuler, Patrick J; Wigand, Marlene C; Theodoraki, Marie-Nicole; Doescher, Johannes; Hoffmann, Thomas K; Pawlita, Michael; Waterboer, Tim; Butt, Julia (2019). Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients. Clinical Cancer Research, 25(24):7405-7412.

Balakrishnan, Ashwini; Rajan, Anusha; Salter, Alexander I; Kosasih, Paula L; Wu, Qian; Voutsinas, Jenna; Jensen, Michael C; Plückthun, Andreas; Riddell, Stanley R (2019). Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors. Clinical Cancer Research, 25(24):7506-7516.

Gangkofner, Dominik S; Holzinger, Dana; Schroeder, Lea; Eichmüller, Stefan B; Zörnig, Inka; Jäger, Dirk; Wichmann, Gunnar; Dietz, Andreas; Broglie, Martina A; Herold‐Mende, Christel; Dyckhoff, Gerhard; Boscolo‐Rizzo, Paolo; Ezic, Jasmin; Marienfeld, Ralf B; Möller, Peter; Völkel, Gunnar; Kraus, Johann M; Kestler, Hans A; Brunner, Cornelia; Schuler, Patrick J; Wigand, Marlene; Theodoraki, Marie N; Doescher, Johannes; Hoffmann, Thomas K; Pawlita, Michael; Butt, Julia; Waterboer, Tim; Laban, Simon (2019). Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status. International Journal of Cancer, 145(12):3436-3444.

Neve, Anuja; Migliavacca, Jessica; Capdeville, Charles; Schönholzer, Marc Thomas; Gries, Alexandre; Ma, Min; Santhana Kumar, Karthiga; Grotzer, Michael; Baumgartner, Martin (2019). Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma. Cancers, 11:12.

Mayinger, Michael; Kraft, Johannes; Lohaus, Niklas; Weller, Michael; Schanne, Daniel; Heitmann, Jana; Willmann, Jonas; Wilke, Lotte; Krayenbuehl, Jérôme; Tanadini-Lang, Stephanie; Guckenberger, Matthias; Andratschke, Nicolaus (2019). Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. European Journal of Cancer, 124:194-203.

Wu, Chengguang; Mairinger, Fabian; Casanova, Ruben; Batavia, Aashil A; Leblond, Anne-Laure; Soltermann, Alex (2019). Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis. Cancers, 11(12):14.

Codilupi, Tamara; Taube, Doreen; Naegeli, Hanspeter (2019). CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling. BMC Cancer, 19(1):1042.

Le Rhun, Emilie; Devos, Patrick; Bourg, Véronique; Darlix, Amélie; Lorgis, Véronique; Ahle, Guido; Boone, Mathieu; Taillandier, Luc; Curtit, Elsa; Gras, Louis; Lebrun Frenay, Christine; Gramatzki, Dorothee; Ramirez, Carole; Simon, Nicolas; Weller, Michael (2019). Complementary and alternative medicine use in glioma patients in France. Journal of Neuro-Oncology, 145(3):487-499.

Schwotzer, Rahel; Manz, Markus Gabriel; Pederiva, Stefanie; Waibel, Christine; Caspar, Clemens; Lerch, Erika; Flammer, Andreas J; Brouwers, Sofie; Seeger, Harald; Heimgartner, Raphael; Fehr, Thomas; Rossi, Davide; Bianchi, Elena; Stussi, Georg; Ghilardi, Guido; Gerber, Bernhard (2019). Daratumumab for Relapsed or Refractory AL Amyloidosis with high Plasma Cell Burden. Hematological oncology, 37(5):595-600.

Kollár, Attila; Rothermundt, Christian; Klenke, Frank; Bode, Beata; Baumhoer, Daniel; Arndt, Volker; Feller, Anita (2019). Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiology, 63:101596.

Fischer, F; Helmer, S; Rogge, A; Arraras, J I; Buchholz, A; Hannawa, A; Horneber, M; Kiss, A; Rose, M; Söllner, W; Stein, B; Weis, J; Schofield, P; Witt, C M (2019). Outcomes and outcome measures used in evaluation of communication training in oncology – a systematic literature review, an expert workshop, and recommendations for future research. BMC Cancer, 19:808.

Brinkhaus, Benno; Kirschbaum, Barbara; Stöckigt, Barbara; Binting, Sylvia; Roll, Stephanie; Carstensen, Martin; Witt, Claudia M (2019). Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study. Breast Cancer Research and Treatment, 178(3):617-628.

Mangana, Joanna; Dimitriou, Florentia; Braun, Ralph; Ludwig, Sabine; Dummer, Reinhard; Barysch, Marjam J (2019). Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanoma. Melanoma research, 29(6):648-654.

Huang, Yun; Mouttet, Brice; Warnatz, Hans-Jörg; Risch, Thomas; Rietmann, Fabian; Frommelt, Fabian; Ngo, Quy A; Dobay, Maria Pamela; Marovca, Blerim; Jenni, Silvia; Tsai, Yi-Chien; Matzk, Sören; Amstislavskiy, Vyacheslav; Schrappe, Martin; Stanulla, Martin; Gstaiger, Matthias; Bornhauser, Beat; Yaspo, Marie-Laure; Bourquin, Jean-Pierre (2019). The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell, 36(6):630-644.e9.

Klement, Rainer J; Abbasi-Senger, N; Adebahr, S; Alheid, H; Allgaeuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Eble, M J; Ernst, I; Gerum, S; Habermehl, D; Hass, P; Henkenberens, C; Hildebrandt, G; Imhoff, D; Kahl, H; Klass, N D; Krempien, R; Lewitzki, V; Lohaus, F; Ostheimer, C; Papachristofilou, A; Petersen, C; Rieber, J; Schneider, T; Schrade, E; Semrau, R; Wachter, S; Wittig, A; Guckenberger, Matthias; Andratschke, N (2019). The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC Cancer, 19(1):173.

Stevanovic, Lidija; Choschzick, Matthias; Moskovszky, Linda; Varga, Zsuzsanna (2019). Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018. Journal of Cancer Research and Clinical Oncology, 145(12):2983-2994.

Merentitis, Danae; Nguyen, Bich Doan; Samartzis, Eleftherios Pierre; Noske, Aurelia; Brandt, Simone; Dedes, Konstantin J (2019). Loss of MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR Deficiency. Anticancer Research, 39(12):6547-6553.

Stamatis, Georgios; Leschber, Gunda; Schwarz, Birte; Brintrup, Diana Lütke; Ose, Claudia; Weinreich, Gerhard; Passlick, Bernward; Hecker, Erich; Kugler, Christian; Dienemann, Hendrik; Krbek, Thomas; Eggeling, Stephan; Hatz, Rudolf; Müller, Michael Rolf; Weder, Walter; Aigner, Clemens; Jöckel, Karl-Heinz (2019). Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system). Lung Cancer, 138:19-26.

Yiu, Stephanie Pei Tung; Hui, Kwai Fung; Münz, Christian; Lo, Kwok-Wai; Tsao, Sai Wah; Kao, Richard Yi Tsun; Yang, Dan; Chiang, Alan Kwok Shing (2019). Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma. Cancers, 11(12):E1871.

Borger, Pieter; Schneider, Marcel; Frick, Lukas; Langiewicz, Magda; Sorokin, Maksim; Buzdin, Anton; Kachaylo, Ekaterina; Graf, Rolf; Humar, Bostjan; Clavien, Pierre-Alain (2019). Exploration of the Transcriptional Landscape of ALPPS Reveals the Pathways of Accelerated Liver Regeneration. Frontiers in Oncology:9:1206.

Aloia, Andrea; Müllhaupt, Daniela; Chabbert, Christophe D; Eberhart, Tanja; Flückiger-Mangual, Stefanie; Vukolic, Ana; Eichhoff, Ossia; Irmisch, Anja; Alexander, Leila T; Scibona, Ernesto; Frederick, Dennie T; Miao, Benchun; Tian, Tian; Cheng, Chaoran; Kwong, Lawrence N; Wei, Zhi; Sullivan, Ryan J; Boland, Genevieve M; Herlyn, Meenhard; Flaherty, Keith T; Zamboni, Nicola; Dummer, Reinhard; Zhang, Gao; Levesque, Mitchell P; Krek, Wilhelm; Kovacs, Werner J (2019). A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors. Clinical Cancer Research, 25(22):6852-6867.

Dieterich, Lothar C; Kapaklikaya, Kübra; Cetintas, Timur; Proulx, Steven T; Commerford, Catharina D; Ikenberg, Kristian; Bachmann, Samia B; Scholl, Jeannette; Detmar, Michael (2019). Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability. International Journal of Cancer, 145(10):2804-2815.

Wujanto, Caryn; Vellayappan, Balamurugan; Siva, Shankar; Louie, Alexander V; Guckenberger, Matthias; Slotman, Ben J; Onishi, Hiroshi; Nagata, Yasushi; Liu, Mitchell; Lo, Simon S (2019). Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer. Frontiers in Oncology, 9:01219.

Martin, Daniel; Rödel, Franz; Balermpas, Panagiotis; Winkelmann, Ria; Fokas, Emmanouil; Rödel, Claus (2019). C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy. Frontiers in Oncology, 9:1200.

Bomze, David; Hasan Ali, Omar; Bate, Andrew; Flatz, Lukas (2019). Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden. JAMA Oncology, 5(11):1633.

Zhu, Yi; Weiss, Tobias; Zhang, Qiushi; Sun, Rui; et al; Gillet, Ludovic; Weller, Michael (2019). High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification. Molecular Oncology, 13(11):2305-2328.

Hörner-Rieber, Juliane; Bernhardt, Denise; Blanck, Oliver; Duma, Marciana; Eich, Hans Th; Gerum, Sabine; Gkika, Eleni; Hass, Peter; Henkenberens, Christoph; Herold, Hans-Ulrich; Hildebrandt, Guido; Imhoff, Detlef; Kahl, Henning; Janssen, Stefan; Jurianz, Katrin; Krempien, Robert; Lautenschläger, Stefan Friedrich; Lohaus, Fabian; Mueller, Arndt-Christian; Petersen, Cordula; Sackerer, Irina; Scafa, Davide; Schrade, Elsge; Uhlmann, Lorenz; Wittig, Andrea; Guckenberger, Matthias (2019). Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT. Clinical Lung Cancer, 20(6):e667-e677.

Lareida, Anna; Terziev, Robert; Grossenbacher, Bettina; Andratschke, Nicolaus; Roth, Patrick; Rohrmann, Sabine; Stahel, Rolf; Guckenberger, Matthias; Le Rhun, Emilie; Weller, Michael; Wolpert, Fabian (2019). Underweight and weight loss are predictors of poor outcome in patients with brain metastasis. Journal of Neuro-Oncology, 145(2):339-347.

Okonska, Agata; Felley-Bosco, Emanuela (2019). BAP1 missense mutations in cancer: friend or foe? Trends in Cancer, 5(11):659-662.

Testi, Anna Maria; Attarbaschi, Andishe; Valsecchi, Maria Grazia; Möricke, Anja; Cario, Gunnar; Niggli, Felix; Silvestri, Daniela; Bader, Peter; Kuhlen, Michaela; Parasole, Rosanna; Putti, Maria Caterina; Lang, Peter; Flotho, Christian; Mann, Georg; Rizzari, Carmelo; Barisone, Elena; Locatelli, Franco; Linderkamp, Christin; Lauten, Melchior; Suttorp, Meinolf; Zimmermann, Martin; Basso, Guiseppe; Biondi, Andrea; Conter, Valentino; Schrappe, Martin; AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pedia (2019). Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. European Journal of Cancer, 122:61-71.

Bernatz, Simon; Ilina, Elena I; Devraj, Kavi; Harter, Patrick N; Mueller, Klaus; Kleber, Sascha; Braun, Yannick; Penski, Cornelia; Renner, Christoph; Halder, Rashi; Jennewein, Lukas; Solbach, Christine; Thorsen, Frits; Pestalozzi, Bernhard C; Mischo, Axel; Mittelbronn, Michel (2019). Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases. Journal of Experimental & Clinical Cancer Research, 38(1):434.

Dulguerov, Pavel; Broglie, Martina A; Henke, Guido; Siano, Marco; Putora, Paul Martin; Simon, Christian; Zwahlen, Daniel; Huber, Gerhard F; Ballerini, Giorgio; Beffa, Lorenza; Giger, Roland; Rothschild, Sacha; Negri, Sandro V; Elicin, Olgun (2019). A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 1 (Head and Neck Surgery). Frontiers in Oncology, 9:1126.

Elicin, Olgun; Putora, Paul Martin; Siano, Marco; Broglie, Martina A; Simon, Christian; Zwahlen, Daniel; Huber, Gerhard F; Ballerini, Giorgio; Beffa, Lorenza; Giger, Roland; Rothschild, Sacha; Negri, Sandro V; Dulguerov, Pavel; Henke, Guido (2019). A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 2 (Radiation Oncology). Frontiers in Oncology, 9:1126.

Siano, Marco; Dulguerov, Pavel; Broglie, Martina A; Henke, Guido; Putora, Paul Martin; Simon, Christian; Zwahlen, Daniel; Huber, Gerhard F; Ballerini, Giorgio; Beffa, Lorenza; Giger, Roland; Rothschild, Sacha; Negri, Sandro V; Elicin, Olgun (2019). A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 3 (Medical Oncology). Frontiers in Oncology, 9:1127.

Broglie, Martina A; Dulguerov, Pavel; Henke, Guido; Siano, Marco; Putora, Paul Martin; Simon, Christian; Zwahlen, Daniel; Huber, Gerhard F; Ballerini, Giorgio; Beffa, Lorenza; Giger, Roland; Rothschild, Sacha; Negri, Sandro V; Elicin, Olgun (2019). A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 4 (Biomarkers). Frontiers in Oncology, 9:1128.

Grogg, Josias Bastian; Schneider, Kym; Bode, Peter-Karl; Wettstein, Marian Severin; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Joerg; Hermanns, Thomas; Fankhauser, Christian Daniel (2019). A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis. Journal of Cancer Research and Clinical Oncology, 145(12):3037-3045.

Eckert, Cornelia; Groeneveld-Krentz, Stefanie; Kirschner-Schwabe, Renate; Hagedorn, Nikola; Chen-Santel, Christiane; Bader, Peter; Borkhardt, Arndt; Cario, Gunnar; Escherich, Gabriele; Panzer-Grümayer, Renate; Astrahantseff, Kathy; Eggert, Angelika; Sramkova, Lucie; Attarbaschi, Andishe; Bourquin, Jean-Pierre; Peters, Christina; Henze, Günter; von Stackelberg, Arend (2019). Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics. Journal of Clinical Oncology, 37(36):3493.

Stelmes, Jean-Jacques; Gregoire, Vincent; Poorten, Vincent Vander; Golusiñski, Wojciech; Szewczyk, Mateusz; Jones, Terry; Ansarin, Mohssen; Broglie, Martina A; Giger, Roland; Klussmann, Jens Peter; Evans, Mererid; Bourhis, Jean; Leemans, C René; Spriano, Giuseppe; Dietz, Andreas; Hunter, Keith; Zimmermann, Frank; Tinhofer, Ingeborg; Patterson, Joanne M; Quaglini, Silvana; Govaerts, Anne-Sophie; Fortpied, Catherine; Simon, Christian (2019). Organ preservation and late functional outcome in oropharyngeal carcinoma: rationale of EORTC 1420, the “Best of” Trial. Frontiers in Oncology, 9:999.

Kron, Philipp; Linecker, Michael; Jones, Robert P; Toogood, Giles J; Clavien, Pierre-Alain; Lodge, J P A (2019). Ablation or resection for colorectal liver metastases? A systematic review of the literature. Frontiers in Oncology, 9:1052.

French, Pim J; Eoli, Marica; Sepulveda, Juan Manuel; de Heer, Iris; Kros, Johan M; Walenkamp, Annemiek; Frenel, Jean-Sebastien; Franceschi, Enrico; Clement, Paul M; Weller, Michael; Ansell, Peter; Looman, Jim; Bain, Earle; Morfouace, Marie; Gorlia, Thierry; van den Bent, Martin (2019). Defining EGFR amplification status for clinical trial inclusion. Neuro-Oncology, 21(10):1263-1272.

Nölting, Svenja; Ullrich, Martin; Pietzsch, Jens; Ziegler, Christian G; Eisenhofer, Graeme; Grossman, Ashley; Pacak, Karel (2019). Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine. Cancers, 11(10):1505.

Ohashi, Riuko; Schraml, Peter; Angori, Silvia; Batavia, Aashil A; Rupp, Niels J; Ohe, Chisato; Otsuki, Yoshiro; Kawasaki, Takashi; Kobayashi, Hiroshi; Kobayashi, Kazuhiro; Miyazaki, Tatsuhiko; Shibuya, Hiroyuki; Usuda, Hiroyuki; Umezu, Hajime; Fujishima, Fumiyoshi; Furusato, Bungo; Osakabe, Mitsumasa; Sugai, Tamotsu; Kuroda, Naoto; Tsuzuki, Toyonori; Nagashima, Yoji; Ajioka, Yoichi; Moch, Holger (2019). Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype. Cancers, 11(10):14.

Karches, Clara H; Benmebarek, Mohamed-Reda; Schmidbauer, Moritz L; Kurzay, Mathias; Klaus, Richard; Geiger, Martina; Rataj, Felicitas; Cadilha, Bruno L; Lesch, Stefanie; Heise, Constanze; Murr, Ramona; vom Berg, Johannes; Jastroch, Martin; Lamp, Daniel; Ding, Jian; Duewell, Peter; Niederfellner, Gerhard; Sustmann, Claudio; Endres, Stefan; Klein, Christian; Kobold, Sebastian (2019). Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy. Clinical Cancer Research, 25(19):5890-5900.

Milanese, Gianluca; Silva, Mario; Frauenfelder, Thomas; Eberhard, Matthias; Sabia, Federica; Martini, Chiara; Marchianò, Alfonso; Prokop, Mathias; Sverzellati, Nicola; Pastorino, Ugo (2019). Comparison of ultra-low dose chest CT scanning protocols for the detection of pulmonary nodules: a phantom study. Tumori, 105(5):394-403.

Assié, Guillaume; Jouinot, Anne; Fassnacht, Martin; et al; Beuschlein, Felix (2019). Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma. JAMA Oncology, 5(10):1440-1447.

Trilla-Fuertes, Lucía; Gámez-Pozo, Angelo; Díaz-Almirón, Mariana; Prado-Vázquez, Guillermo; Zapater-Moros, Andrea; López-Vacas, Rocío; Nanni, Paolo; Zamora, Pilar; Espinosa, Enrique; Fresno Vara, Juan Ángel (2019). Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients. Future Oncology (London, England), 15(30):3483-3490.

Stilgenbauer, Stephan; Aurran Schleinitz, Thérèse; Eichhorst, Barbara; Lang, Fabian; Offner, Fritz; Rossi, Jean-François; Schroyens, Wilfried; Van Den Neste, Eric; Ysebaert, Loïc; von Wangenheim, Ute; Ursula Kress, Uta; Blum, Petra; Zenz, Thorsten (2019). Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia. Leukemia, 33(10):2531-2535.

Schadendorf, Dirk; Ascierto, Paolo A; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C; Nathan, Paul (2019). Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172). European Journal of Cancer, 121:144-153.

Elicin, Olgun; Ermiş, Ekin; Oehler, Christoph; Aebersold, Daniel M; Caparrotti, Francesca; Zimmermann, Frank; Studer, Gabriela; Henke, Guido; Adam, Lukas; Anschuetz, Lukas; Ozsahin, Mahmut; Guckenberger, Matthias; Shelan, Mohamed; Kaydıhan, Nuri; Riesterer, Oliver; Prestwich, Robin J D; Spielmann, Thierry; Giger, Roland; Şen, Mehmet (2019). Influencing factors on radiotherapy outcome in stage I-II Glottic Larynx cancer: a multicenter study. Frontiers in Oncology, 9:932.

Knop, Janin; Spilgies, Lisanne M; Rufli, Stefanie; Reinhart, Ramona; Vasilikos, Lazaros; Yabal, Monica; Owsley, Erika; Jost, Philipp J; Marsh, Rebecca A; Wajant, Harald; Robinson, Mark D; Kaufmann, Thomas; Wong, W Wei-Lynn (2019). TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death and Disease, 10(10):700.

Papachristodoulou, Alexandros; Silginer, Manuela; Weller, Michael; Schneider, Hannah; Hasenbach, Kathy; Janicot, Michel; Roth, Patrick (2019). Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas. Clinical Cancer Research, 25(23):7189-7201.

Ron, Avihai; Deán-Ben, Xosé Luís; Gottschalk, Sven; Razansky, Daniel (2019). Volumetric Optoacoustic Imaging Unveils High-Resolution Patterns of Acute and Cyclic Hypoxia in a Murine Model of Breast Cancer. Cancer Research, 79(18):4767-4775.

Schmid, Sabine; Klingbiel, Dirk; Aebi, Stefan; Goldhirsch, Aron; Mamot, Christoph; Munzone, Elisabetta; Nolè, Franco; Oehlschlegel, Christian; Pagani, Olivia; Pestalozzi, Bernhard; Rochlitz, Christoph; Thürlimann, Beat; von Moos, Roger; Weder, Patrik; Zaman, Khalil; Ruhstaller, Thomas (2019). Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data. BMC Cancer, 19:902.

Freiberger, Sandra N; Morand, Grégoire B; Turko, Patrick; Wager, Ulrich; Dummer, Reinhard; Hüllner, Martin; Holzmann, David; Rupp, Niels J; Levesque, Mitchell P (2019). Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma. Cancers, 11(9):1329.

Lee, Eudocia Q; Chukwueke, Ugonma N; Hervey-Jumper, Shawn L; et al; Weller, Michael (2019). Barriers to Accrual and Enrollment in Brain Tumor Trials. Neuro-Oncology, 21(9):1100-1117.

Anderegg, Linda; Im Hof Gut, Michelle; Hetzel, Udo; Howerth, Elizabeth W; Leuthard, Fabienne; Kyöstilä, Kaisa; Lohi, Hannes; Pettitt, Louise; Mellersh, Cathryn; Minor, Katie M; Mickelson, James R; Batcher, Kevin; Bannasch, Danika; Jagannathan, Vidhya; Leeb, Tosso (2019). NME5 frameshift variant in Alaskan Malamutes with primary ciliary dyskinesia. PLoS Genetics, 15(9):e1008378.

Lacour, Max; Hiltbrunner, Stefanie; Lee, Seok-Yun; Soltermann, Alex; Rushing, Elisabeth Jane; Soldini, Davide; Weder, Walter; Curioni-Fontecedro, Alessandra (2019). Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence. Clinical Lung Cancer, 20(5):391-396.

O'Connor, Tracy; Zhou, Xiaolan; Kosla, Jan; et al; Seleznik, Gitta; Bremer, Juliane; Bleul, Sabine; Weber, Achim; Aguzzi, A (2019). Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention. Cancer Cell, 36(3):250-267.e9.

Okuchi, Sachi; Rojas‐Garcia, Antonio; Ulyte, Agne; Lopez, Ingeborg; Ušinskienė, Jurgita; Lewis, Martin; Hassanein, Sara M; Sanverdi, Eser; Golay, Xavier; Thust, Stefanie; Panovska‐Griffiths, Jasmina; Bisdas, Sotirios (2019). Diagnostic accuracy of dynamic contrast‐enhanced perfusion MRI in stratifying gliomas: A systematic review and meta‐analysis. Cancer Medicine, 8(12):5564-5573.

Weide, Benjamin; Eigentler, Thomas; Catania, Chiara; Ascierto, Paolo Antonio; Cascinu, Stefano; Becker, Jürgen C; Hauschild, Axel; Romanini, Antonella; Danielli, Riccardo; Dummer, Reinhard; Trefzer, Uwe; Elia, Giuliano; Neri, Dario; Garbe, Claus (2019). A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients. Cancer Immunology, Immunotherapy, 68(9):1547-1559.

Hutmacher, Cornelia; Volta, Laura; Rinaldi, Francesco; Murer, Patrizia; Myburgh, Renier; Manz, Markus G; Neri, Dario (2019). Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia. Leukemia Research, 84:106178.

Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Böttcher, Sebastian; Kneba, Michael; Jäger, Ulrich; Zenz, Thorsten; Wenger, Michael K; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Döhner, Hartmut; Stilgenbauer, Stephan (2019). Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia, 33(9):2183-2194.

Nathan, Paul; Ascierto, Paolo A; Haanen, John; Espinosa, Enrique; Demidov, Lev; Garbe, Claus; Guida, Michele; Lorigan, Paul; Chiarion-Sileni, Vanna; Gogas, Helen; Maio, Michele; Fierro, Maria Teresa; Hoeller, Christoph; Terheyden, Patrick; Gutzmer, Ralf; Guren, Tormod K; Bafaloukos, Dimitrios; Rutkowski, Piotr; Plummer, Ruth; Waterston, Ashita; Kaatz, Martin; Mandala, Mario; Marquez-Rodas, Ivan; Muñoz-Couselo, Eva; Dummer, Reinhard; Grigoryeva, Elena; Young, Tina C; Schadendorf, Dirk (2019). Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172). European Journal of Cancer, 119:168-178.

Gogas, Helen J; Flaherty, Keith T; Dummer, Reinhard; Ascierto, Paolo A; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Sileni, Vanna Chiarion; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D; Robert, Caroline (2019). Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management. European Journal of Cancer, 119:97-106.

Varga, Zsuzsanna; Sinn, Peter; Seidman, Andrew D (2019). Comparing the performance of gene expression assays in breast cancer. International Journal of Cancer, 145(4):1163-1164.

Varga, Zsuzsanna; Sinn, Peter; Seidman, Andrew D (2019). Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer. International Journal of Cancer, 145(4):882-893.

Fankhauser, Christian Daniel; Roth, Lisa; Grossmann, Nico Christian; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Moch, Holger; Bode, Peter-Karl; Beyer, Joerg; Hermanns, Thomas (2019). CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors. BMC Cancer, 19:802.

Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo Antonio; Richards, Jon M; Lebbe, Celeste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Hosein, Fareeda; de Pril, Veerle; Kicinski, Michal; Suciu, Stefan; Testori, Alessandro (2019). Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial. European Journal of Cancer, 119:1-10.

Arnaud-Coffin, Patrick; Maillet, Denis; Gan, Hui K; Stelmes, Jean-Jacques; You, Benoit; Dalle, Stephane; Péron, Julien (2019). A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. International Journal of Cancer, 145(3):639-648.

Hench, Ivana Bratic; Cathomas, Richard; Costa, Luigi; Fischer, Natalie; Gillessen, Silke; Hench, Jürgen; Hermanns, Thomas; Kremer, Eloïse; Mingrone, Walter; Mestre, Ricardo Pereira; Püschel, Heike; Rothermundt, Christian; Ruiz, Christian; Tolnay, Markus; Von Burg, Philippe; Bubendorf, Lukas; Vlajnic, Tatjana (2019). Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial). Cancers, 11(8):E1099.

Elfgen, C; Reeve, K; Moskovszky, L; Güth, U; Bjelic-Radisic, V; Fleisch, M; Tausch, C; Varga, Z (2019). Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes. Journal of Cancer Research and Clinical Oncology, 145(8):2051-2059.

Elfgen, C; Varga, Z; Reeve, K; Moskovszky, L; Bjelic-Radisic, V; Tausch, C; Güth, U (2019). The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay. Breast Cancer Research and Treatment, 177(1):67-75.

Bengs, Susan; Becker, Eugenia; Busenhart, Philipp; Spalinger, Marianne R; Raselli, Tina; Kasper, Stephanie; Lang, Silvia; Atrott, Kirstin; Mamie, Celine; Vavricka, Stephan R; et al; Hruz, Petr; Turina, Matthias; Rickenbacher, Andreas; Petrowsky, Henrik; Weber, Achim; Frei, Pascal; Halama, Marcel; Fried, Michael; Rogler, Gerhard; Scharl, Michael (2019). β6-integrin serves as a novel serum tumor marker for colorectal carcinoma. International Journal of Cancer, 145(3):678-685.

Ron, Avihai; Deán-Ben, Xosé Luís; Reber, Josephine; Ntziachristos, Vasilis; Razansky, Daniel (2019). Characterization of Brown Adipose Tissue in a Diabetic Mouse Model with Spiral Volumetric Optoacoustic Tomography. Molecular Imaging and Biology, 21(4):620-625.

Seyfried, Felix; Demir, Salih; Hörl, Rebecca Louise; Stirnweiß, Felix Uli; Ryan, Jeremy; Scheffold, Annika; Villalobos-Ortiz, Mariana; Boldrin, Elena; Zinngrebe, Julia; Enzenmüller, Stefanie; Jenni, Silvia; Tsai, Yi-Chien; Bornhauser, Beat; Fürstberger, Axel; Kraus, Johann Michael; Kestler, Hans Armin; Bourquin, Jean-Pierre; Stilgenbauer, Stephan; Letai, Anthony; Debatin, Klaus-Michael; Meyer, Lüder Hinrich (2019). Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling. Cell Death and Disease, 10(8):571.

Caccuri, Francesca; Sommariva, Michele; Marsico, Stefania; Giordano, Francesca; Zani, Alberto; Giacomini, Arianna; Fraefel, Cornel; Balsari, Andrea; Caruso, Arnaldo (2019). Inhibition of DNA repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 U94. Cancers, 11(7):E1006.

Nassiri, Farshad; Mamatjan, Yasin; Suppiah, Suganth; Weller, Michael; et al (2019). DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, 21(7):901-910.

Najafi, Arash; Fuchs, Bruno; Binkert, Christoph A (2019). Mid-term results of MR-guided high-intensity focused ultrasound treatment for relapsing superficial desmoids. International Journal of Hyperthermia, 36(1):538-542.

Lionarons, Daniël A; Hancock, David C; Rana, Sareena; East, Philip; Moore, Christopher; Murillo, Miguel M; Carvalho, Joana; Spencer-Dene, Bradley; Herbert, Eleanor; Stamp, Gordon; Damry, Djamil; Calado, Dinis P; Rosewell, Ian; Fritsch, Ralph; Neubig, Richard R; Molina-Arcas, Miriam; Downward, Julian (2019). RAC1$^{P29S}$ induces a mesenchymal phenotypic switch via serum response factor to promote melanoma development and therapy resistance. Cancer Cell, 36(1):68-83.e9.

Peris, Ketty; Fargnoli, Maria Concetta; Garbe, Claus; Kaufmann, Roland; Bastholt, Lars; Seguin, Nicole Basset; Bataille, Veronique; Marmol, Veronique Del; Dummer, Reinhard; Harwood, Catherine A; Hauschild, Axel; Höller, Christoph; Haedersdal, Merete; Malvehy, Josep; Middleton, Mark R; Morton, Colin A; Nagore, Eduardo; Stratigos, Alexander J; Szeimies, Rolf-Markus; Tagliaferri, Luca; Trakatelli, Myrto; Zalaudek, Iris; Eggermont, Alexander; Grob, Jean Jacques (2019). Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. European Journal of Cancer, 118:10-34.

Anzengruber, Florian; Ignatova, Desislava; Schlaepfer, Tanja; Chang, Yun-Tsan; French, Lars E; Pascolo, Steve; Contassot, Emmanuel; Bobrowicz, Malgorzata; Hoetzenecker, Wolfram; Guenova, Emmanuella (2019). Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome. Leukemia & Lymphoma, 60(8):1899-1907.

Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar Hasan; Fässler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann, Christoph J; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil; van de Veen, Willem; Akdis, Mübeccel; Nikolaev, Sergey; Läubli, Heinz; Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Hönger, Gideon; Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Früh, Martin; Neefjes, Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N; Jochum, Wolfram; Speiser, Daniel E; Flatz, Lukas; et al (2019). Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer. JAMA Oncology, 5(7):1043.

Elfgen, Constanze; Montagna, Giacomo; Schmid, Seraina Margaretha; Bierbauer, Walter; Güth, Uwe (2019). Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists? Breast Cancer Research and Treatment, 176(2):469-476.

Ebner, Julian Jakob; Mehra, Tarun; Gander, Thomas; Schumann, Paul; Essig, Harald; Zweifel, Daniel; Rücker, Martin; Slankamenac, Ksenjia; Lanzer, Martin (2019). Novel application of the Clavien-Dindo classification system and the comprehensive complications index® in microvascular free tissue transfer to the head and neck. Oral Oncology, 94:21-25.

Le Rhun, Emilie; von Achenbach, Caroline; Lohmann, Birthe; Silginer, Manuela; Schneider, Hannah; Meetze, Kristan; Szabo, Emese; Weller, Michael (2019). Profound, durable and MGMT‐independent sensitivity of glioblastoma cells to cyclin‐dependent kinase inhibition. International Journal of Cancer, 145(1):242-253.

Friemel, Juliane; Frick, Lukas; Unger, Kristian; Egger, Michele; Parrotta, Rossella; Böge, Yannick T; Adili, Arlind; Karin, Michael; Luedde, Tom; Heikenwalder, Mathias; Weber, Achim (2019). Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach. Molecular Cancer Research, 17(7):1493-1502.

Rageth, Christoph J; O'Flynn, Elizabeth A M; Pinker, Katja; Kubik-Huch, Rahel A; Mundinger, Alexander; Decker, Thomas; Tausch, Christoph; Dammann, Florian; Baltzer, Pascal A; Fallenberg, Eva Maria; Foschini, Maria P; Dellas, Sophie; Knauer, Michael; Malhaire, Caroline; Sonnenschein, Martin; Boos, Andreas; Morris, Elisabeth; Varga, Zsuzsanna (2019). Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Research and Treatment, 176(2):481-482.

Lopez-Millan, Belen; Sanchéz-Martínez, Diego; Roca-Ho, Heleia; Gutiérrez-Agüera, Francisco; Molina, Oscar; Diaz de la Guardia, Rafael; Torres-Ruiz, Raúl; Fuster, Jose Luís; Ballerini, Paola; Suessbier, Ute; Nombela-Arrieta, Cesar; Bueno, Clara; Menéndez, Pablo (2019). NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia. Leukemia, 33(7):1557-1569.

Peters, S; Felip, E; Dafni, U; Belka, C; Guckenberger, M; Irigoyen, A; Nadal, E; Becker, A; Vees, H; Pless, M; Martinez-Marti, A; Tufman, A; Lambrecht, M; Andratschke, N; Piguet, A C; Kassapian, M; Roschitzki-Voser, H; Rabaglio-Poretti, M; Stahel, R A; Vansteenkiste, J; De Ruysscher, D (2019). Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. Lung Cancer, 133:83-87.

Coomans, Marijke; Dirven, Linda; Aaronson, Neil K; Baumert, Brigitta G; van den Bent, Martin; Bottomley, Andrew; Brandes, Alba A; Chinot, Olivier; Coens, Corneel; Gorlia, Thierry; Herrlinger, Ulrich; Keime-Guibert, Florence; Malmström, Annika; Martinelli, Francesca; Stupp, Roger; Talacchi, Andrea; Weller, Michael; Wick, Wolfgang; Reijneveld, Jaap C; Taphoorn, Martin J B; EORTC Quality of Life Group and the EORTC Brain Tumor Group (2019). The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. European Journal of Cancer, 116:190-198.

Boos, Laura A; Schmitt, Anja; Moch, Holger; Komminoth, Paul; Simillion, Cedric; Marinoni, Ilaria; Nikiforov, Yuri E; Nikiforova, Marina N; Perren, Aurel; Dettmer, Matthias S (2019). MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid Carcinoma. Cancers, 11(6):E885.

Hüllein, Jennifer; Słabicki, Mikołaj; Rosolowski, Maciej; Jethwa, Alexander; Habringer, Stefan; Tomska, Katarzyna; Kurilov, Roma; Lu, Junyan; Scheinost, Sebastian; Wagener, Rabea; Huang, Zhiqin; Lukas, Marina; Yavorska, Olena; Helfrich, Hanne; Scholtysik, René; Bonneau, Kyle; Tedesco, Donato; Küppers, Ralf; Klapper, Wolfram; Pott, Christiane; Stilgenbauer, Stephan; Burkhardt, Birgit; Löffler, Markus; Trümper, Lorenz H; Hummel, Michael; Brors, Benedikt; Zapatka, Marc; Siebert, Reiner; Kreuz, Markus; Keller, Ulrich; et al (2019). MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. Cancer Research, 79(12):3125-3138.

Ohashi, Riuko; Schraml, Peter; Batavia, Aashil; Angori, Silvia; Simmler, Patrik; Rupp, Niels; Ajioka, Yoichi; Oliva, Esther; Moch, Holger (2019). Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma. Translational Oncology, 12(9):1131-1137.

Gieldon, Laura; William, Doreen; Hackmann, Karl; Jahn, Winnie; Jahn, Arne; Wagner, Johannes; Rump, Andreas; Bechmann, Nicole; Nölting, Svenja; Knösel, Thomas; Gudziol, Volker; Constantinescu, Georgiana; Masjkur, Jimmy; Beuschlein, Felix; Timmers, Henri J L M; Canu, Letizia; Pacak, Karel; Robledo, Mercedes; Aust, Daniela; Schröck, Evelin; Eisenhofer, Graeme; Richter, Susan; Klink, Barbara (2019). Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches. Cancers, 11(6):E809.

Gogola, Ewa; Duarte, Alexandra A; de Ruiter, Julian R; Wiegant, Wouter W; Schmid, Jonas A; de Bruijn, Roebi; James, Dominic I; Llobet, Sergi Guerrero; Vis, Daniel J; Annunziato, Stefano; van den Broek, Bram; Barazas, Marco; Kersbergen, Ariena; van de Ven, Marieke; Tarsounas, Madalena; Ogilvie, Donald J; van Vugt, Marcel; Wessels, Lodewyk F A; Bartkova, Jirina; Gromova, Irina; Andújar-Sánchez, Miguel; Bartek, Jiri; Lopes, Massimo; van Attikum, Haico; Borst, Piet; Jonkers, Jos; Rottenberg, Sven (2019). Correction: Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. Cancer Cell, 35(6):950-952.

Fendler, Wolfgang P; Calais, Jeremie; Eiber, Matthias; Flavell, Robert R; Mishoe, Ashley; Feng, Felix Y; Nguyen, Hao G; Reiter, Robert E; Rettig, Matthew B; Okamoto, Shozo; Emmett, Louise; Zacho, Helle D; Ilhan, Harun; Wetter, Axel; Rischpler, Christoph; Schoder, Heiko; Burger, Irene A; Gartmann, Jeannine; Smith, Raven; Small, Eric J; Slavik, Roger; Carroll, Peter R; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A (2019). Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncology, 5(6):856.

Dieckmann, Klaus-Peter; Radtke, Arlo; Geczi, Lajos; et al; Hermanns, Thomas; Fankhauser, Christian Daniel (2019). Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. Journal of Clinical Oncology, 37(16):1412-1423.

Lebbe, Celeste; Garbe, Claus; Stratigos, Alexander J; Harwood, Catherine; Peris, Ketty; Marmol, Veronique Del; Malvehy, Josep; Zalaudek, Iris; Hoeller, Christoph; Dummer, Reinhard; Forsea, Ana Maria; Kandolf-Sekulovic, Lidija; Olah, Judith; Arenberger, Petr; Bylaite-Bucinskiene, Matilda; Vieira, Ricardo; Middleton, Mark; Levy, Antonin; Eggermont, Alexander M; Battistella, Maxime; Spano, Jean Philippe; Grob, Jean Jacques; Pages, Cecile; European Dermatology Forum (EDF), the European Association of De (2019). Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). European Journal of Cancer, 114:117-127.

MacRae, Robert M; Ashton, Miranda; Lauk, Olivia; Wilson, Wesley; O'Rourke, Noelle; Simone, Charles B; Rimner, Andreas (2019). The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group. Lung Cancer, 132:24-27.

Long, Georgina V; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M; Hauschild, Axel (2019). Reply to E. Hindié and K.R. Hess. Journal of Clinical Oncology, 37(15):1356-1358.

Boire, Adrienne; Brandsma, Dieta; Brastianos, Priscilla K; Le Rhun, Emilie; Ahluwalia, Manmeet; Junck, Larry; Glantz, Michael; et al; Weller, Michael (2019). Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro-Oncology, 21(5):571-584.

Galldiks, Norbert; Langen, Karl-Josef; Albert, Nathalie L; Chamberlain, Marc; Soffietti, Riccardo; Kim, Michelle M; Law, Ian; Le Rhun, Emilie; Chang, Susan; Schwarting, Julian; Combs, Stephanie E; Preusser, Matthias; Forsyth, Peter; Pope, Whitney; Weller, Michael; Tonn, Jörg C (2019). PET imaging in patients with brain metastasis-report of the RANO/PET group. Neuro-Oncology, 21(5):585-595.

Le Rhun, Emilie; Devos, Patrick; Boulanger, Thomas; Smits, Marion; Brandsma, Dieta; Rudà, Roberta; Furtner, Julia; Hempel, Johann-Martin; Postma, Tjeerd J; Roth, Patrick; Snijders, Tom J; Winkler, Frank; Winklhofer, Sebastian; Castellano, Antonella; Hattingen, Elke; Capellades, Jaume; Gorlia, Thierry; Van den Bent, Martin; Wen, Patrick Y; Bendszus, Martin; Weller, Michael (2019). The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal. Neuro-Oncology, 21(5):648-658.

Zeijlemaker, Wendelien; Grob, Tim; Meijer, Rosa; Hanekamp, Diana; Kelder, Angèle; Carbaat-Ham, Jannemieke C; Oussoren-Brockhoff, Yvonne J M; Snel, Alexander N; Veldhuizen, Dennis; Scholten, Willemijn J; Maertens, Johan; Breems, Dimitri A; Pabst, Thomas; Manz, Markus G; van der Velden, Vincent H J; Slomp, Jennichjen; Preijers, Frank; Cloos, Jacqueline; van de Loosdrecht, Arjan A; Löwenberg, Bob; Valk, Peter J M; Jongen-Lavrencic, Mojca; Ossenkoppele, Gert J; Schuurhuis, Gerrit J (2019). $CD34^+CD38^-$ leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia, 33(5):1102-1112.

Wolters, Celina; Darwiche, Kaid; Franzen, Daniel; Hager, Thomas; Bode-Lesnievska, Beata; Kneuertz, Peter J; He, Kai; Koenig, Michael; Freitag, Lutz; Wei, Lai; Eisenmann, Stephan; Taube, Christian; Weinreich, Gerhard; Oezkan, Filiz (2019). A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content. Clinical Lung Cancer, 20(3):e265-e273.

Mangana, Joanna; Buset, Caroline S; Dummer, Reinhard (2019). Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab Therapy. JAMA Oncology, 5(5):730.

Kerr, Keith M; Thunnissen, Erik; Dafni, Urania; Finn, Stephen P; Bubendorf, Lukas; Soltermann, Alex; Verbeken, Eric; Biernat, Wojciech; Warth, Arne; Marchetti, Antonio; Speel, Ernst-Jan M; Pokharel, Sarawati; Quinn, Anne Marie; Monkhorst, Kim; Navarro, Atilio; Madsen, Line Bille; Radonic, Teodora; Wilson, Joan; De Luca, Graziano; Gray, Steven G; Cheney, Richard; Savic, Spasenija; Martorell, Miguel; Muley, Thomas; Baas, Paul; Meldgaard, Peter; Blackhall, Fiona; Dingemans, Anne-Marie; Dziadziuszko, Rafal; Vansteenkiste, Johan; Weder, Walter; Stahel, Rrolf; et al (2019). A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. Lung Cancer, 131:95-103.

Luijckx, Eefje; Lohse, Tina; Faeh, David; Rohrmann, Sabine (2019). Joints effects of BMI and smoking on mortality of all-causes, CVD, and cancer. Cancer Causes & Control, 30(5):549-557.

Sun, Michael Shoujie; Weber, Joe; Blattner, Ariane C; Chaurasia, Soumya; Lehner, Christian F (2019). MNM and SNM maintain but do not establish achiasmate homolog conjunction during Drosophila male meiosis. PLoS Genetics, 15(5):e1008162.

Curioni-Fontecedro, Alessandra; Perentes, Jean Yannis; Gelpke, Hans; Xyrafas, Alexandros; Bouchaab, Hasna; Mach, Nicolas; Matzinger, Oscar; Stojcheva, Nina; Frueh, Martin; Weder, Walter; Cathomas, Richard; Gargiulo, Piera; Bubendorf, Lukas; Pless, Miklos; Betticher, Daniel; Peters, Solange (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer, 120(10):968-974.

Korpershoek, Esther; Dieduksman, Daphne A E R; Grinwis, Guy C M; Day, Michael J; Reusch, Claudia E; Hilbe, Monika; Fracassi, Federico; Krol, Niels M G; Uitterlinden, André G; de Klein, Annelies; Eussen, Bert; Stoop, Hans; de Krijger, Ronald R; Galac, Sara; Dinjens, Winand N M (2019). Molecular alterations in dog pheochromocytomas and paragangliomas. Cancers, 11(5):E607.

Jang, Jae-Hwi; Janker, Florian; De Meester, Ingrid; Arni, Stephan; Borgeaud, Nathalie; Yamada, Yoshito; Gil Bazo, Ignacio; Weder, Walter; Jungraithmayr, Wolfgang (2019). The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. Carcinogenesis, 40(2):324-334.

Forget, Patrice; Aguirre, Jose A; Bencic, Ivanka; Borgeat, Alain; Cama, Allessandro; Condron, Claire; Eintrei, Christina; Eroles, Pilar; Gupta, Anil; Hales, Tim G; Ionescu, Daniela; Johnson, Mark; Kabata, Pawel; Kirac, Iva; Ma, Daqing; Mokini, Zhirajr; Guerrero Orriach, Jose Luis; Retsky, Michael; Sandrucci, Sergio; Siekmann, Wiebke; Štefančić, Ljilja; Votta-Vellis, Gina; Connolly, Cara; Buggy, Donal (2019). How Anesthetic, Analgesic and Other Non-Surgical Techniques During Cancer Surgery Might Affect Postoperative Oncologic Outcomes: A Summary of Current State of Evidence. Cancers, 11(5):592.

Mohsen, Mona O; Heath, Matthew D; Cabral-Miranda, Gustavo; Lipp, Cyrill; Zeltins, Andris; Sande, Marcos; Stein, Jens V; Riether, Carsten; Roesti, Elisa; Zha, Lisha; Engeroff, Paul; El-Turabi, Aadil; Kundig, Thomas M; Vogel, Monique; Skinner, Murray A; Speiser, Daniel E; Knuth, Alexander; Kramer, Matthias F; Bachmann, Martin F (2019). Vaccination with nanoparticles combined with micro-adjuvants protects against cancer. Journal for ImmunoTherapy of Cancer, 7(1):114.

Körber, Verena; Yang, Jing; Barah, Pankaj; Wu, Yonghe; Stichel, Damian; Gu, Zuguang; et al; Weller, Michael (2019). Evolutionary Trajectories of IDH Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis. Cancer Cell, 35(4):692-704.e12.

Luong-Gardiol, Noemie; Siddiqui, Imran; Pizzitola, Irene; Jeevan-Raj, Beena; Charmoy, Mélanie; Huang, Yun; Irmisch, Anja; Curtet, Sara; Angelov, Georgi S; Danilo, Maxime; Juilland, Mélanie; Bornhauser, Beat; Thome, Margot; Hantschel, Oliver; Chalandon, Yves; Cazzaniga, Gianni; Bourquin, Jean-Pierre; Huelsken, Joerg; Held, Werner (2019). γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia. Cancer Cell, 35(4):649-663.e10.

von der Grün, Jens; Rödel, Franz; Brandts, Christian; Fokas, Emmanouil; Guckenberger, Matthias; Rödel, Claus; Balermpas, Panagiotis (2019). Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? Cancers, 11:472.

Leão, Ricardo; Lee, Donghyun; Figueiredo, Arnaldo; Hermanns, Thomas; Wild, Peter; Komosa, Martin; Lau, Irene; Mistry, Mathew; Nunes, Nuno Miguel; Price, Aryeh J; Zhang, Cindy; Lipman, Tatiana; Poyet, Cédric; Valtcheva, Nadejda; Oehl, Kathrin; et al (2019). Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behaviour of bladder cancer. International Journal of Cancer, 144(7):1676-1684.

Nasri, Soroush; Humara, Bostjan; Anjomshoaa, Ahmad; Moradi, Nourodin; Gholipour, Naghmeh; Mashjoor, Sakineh; Zhang, Peng (2019). Early hereditary diffuse gastric cancer (eHDGC) is characterized by subtle genomic Instability and active DNA damage response. Pathology Oncology Research, 25(2):711-721.

Dorhoi, Anca; Glaría, Estibaliz; Garcia-Tellez, Thalia; Nieuwenhuizen, Natalie E; Zelinskyy, Gennadiy; Favier, Benoit; Singh, Anurag; Ehrchen, Jan; Gujer, Cornelia; Münz, Christian; Saraiva, Margarida; Sohrabi, Yahya; Sousa, Ana E; Delputte, Peter; Müller-Trutwin, Michaela; Valledor, Annabel F (2019). MDSCs in infectious diseases: regulation, roles, and readjustment. Cancer Immunology, Immunotherapy, 68(4):673-685.

Zimpfer, Annette; Schneider, Bjoern; Blanck, Oliver; Riedel, Katrin; Zhivov, Andrey; Jonigk, Danny; Erbersdobler, Andreas; Jünemann, Anselm; Andratschke, Nicolaus; Hildebrandt, Guido; Guthoff, Rudolf F; Kakkassery, Vinodh (2019). Pathologic features of tumor activity and stability in uveal melanoma specimens after fractionated CyberKnife radiosurgery. Pathology Oncology Research, 25(2):731-740.

Rageth, Christoph J; O’Flynn, Elizabeth A M; Pinker, Katja; Kubik-Huch, Rahel A; Mundinger, Alexander; Decker, Thomas; Tausch, Christoph; Dammann, Florian; Baltzer, Pascal A; Fallenberg, Eva Maria; Foschini, Maria P; Dellas, Sophie; Knauer, Michael; Malhaire, Caroline; Sonnenschein, Martin; Boos, Andreas; Morris, Elisabeth; Varga, Zsuzsanna (2019). Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Research and Treatment, 174(2):279-296.

Stera, Susanne; Balermpas, Panagiotis; Blanck, Oliver; Wolff, Robert; Wurster, Stefan; Baumann, Rene; Szücs, Marcella; Loutfi-Krauss, Britta; Wilhelm, Maria-Lisa; Seifert, Volker; Rades, Dirk; Rödel, Claus; Dunst, Jürgen; Hildebrandt, Guido; Arnold, Andreas; Meissner, Markus; Kähler, Katharina C (2019). Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma. Melanoma research, 29(2):187-195.

Benzarti, Sonia; Daskalakis, Michael; Feller, Anita; Bacher, Vera Ulrike; Schnegg-Kaufmann, Annatina; Rüfer, Axel; Holbro, Andreas; Schmidt, Adrian; Benz, Rudolf; Solenthaler, Max; Stussi, Georg; Arndt, Volker; Bonadies, Nicolas (2019). Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries. Cancer Epidemiology, 59:51-57.

Bhojwani, Deepa; Sposto, Richard; Shah, Nirali N; Rodriguez, Vilmarie; Yuan, Constance; Stetler-Stevenson, Maryalice; O'Brien, Maureen M; McNeer, Jennifer L; Quereshi, Amrana; Cabannes, Aurelie; Schlegel, Paul; Rossig, Claudia; Dalla-Pozza, Luciano; August, Keith; Alexander, Sarah; Bourquin, Jean-Pierre; Zwaan, Michel; Raetz, Elizabeth A; Loh, Mignon L; Rheingold, Susan R (2019). Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia, 33(4):1061-1062.

Fritsch, Kristin; Pigeot, Sébastien; Feng, Xiaomin; Bourgine, Paul E; Schroeder, Timm; Martin, Ivan; Manz, Markus G; Takizawa, Hitoshi (2019). Erratum to "Engineered humanized bone organs maintain human hematopoiesis in vivo": [Experimental Hematology 61 (2018) 45-51]. Experimental Hematology, 72:72.

Armato, Samuel G; Francis, Roslyn J; Katz, Sharyn I; Ak, Guntulu; Opitz, Isabelle; Gudmundsson, Eyjolfur; Blyth, Kevin G; Gupta, Ashish (2019). Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 130:108-114.

Diem, Stefan; Fässler, Mirjam; Bomze, David; Ali, Omar Hasan; Berner, Fiamma; Niederer, Rebekka; Hillmann, Dorothea; Mangana, Joanna; Levesque, Mitchell P; Dummer, Reinhard; Risch, Lorenz; Recher, Mike; Risch, Martin; Flatz, Lukas (2019). Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. Journal of Immunotherapy, 42(3):89-93.

Bhojwani, Deepa; Sposto, Richard; Shah, Nirali N; Rodriguez, Vilmarie; Yuan, Constance; Stetler-Stevenson, Maryalice; O'Brien, Maureen M; McNeer, Jennifer L; Quereshi, Amrana; Cabannes, Aurelie; Schlegel, Paul; Rossig, Claudia; Dalla-Pozza, Luciano; August, Keith; Alexander, Sarah; Bourquin, Jean-Pierre; Zwaan, Michel; Raetz, Elizabeth A; Loh, Mignon L; Rheingold, Susan R (2019). Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia, 33(4):884-892.

Schmid, S; Klingbiel, D; Aeppli, S; Britschgi, C; Gautschi, O; Pless, M; Rothschild, S; Wannesson, L; Janthur, W; Foerbs, D; Demmer, I; Jochum, W; Früh, M (2019). Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study. Lung Cancer, 130:149-155.

Hutmacher, Cornelia; Núñez, Nicolás Gonzalo; Liuzzi, Anna Rita; Becher, Burkhard; Neri, Dario (2019). Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8 T Cells. Cancer Immunology Research, 7(4):572-583.

Heinzerling, Lucie; Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen; Grob, Jean-Jacques; Lebbe, Celeste; Long, Georgina V; McArthur, Grant; Moslehi, Javid J; Neilan, Tomas G; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D; Hauschild, Axel (2019). Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. European Journal of Cancer, 112:29-31.

Dessinioti, Clio; Dimou, Niki; Geller, Alan C; Stergiopoulou, Aravella; Lo, Serigne; Keim, Ulrike; Gershenwald, Jeffrey E; Haydu, Lauren E; Ribero, Simone; Quaglino, Pietro; Puig, Susana; Malvehy, Josep; et al; Dummer, Reinhard; Mangana, Joanna; Hauschild, Axel; Egberts, Friederike; Peris, Ketty (2019). Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers. Journal of the National Cancer Institute:1-9.

Traxel, Sabrina; Schadt, Linda; Eyer, Tatjana; Mordasini, Vanessa; Gysin, Claudine; Munthe, Ludvig A; Niggli, Felix; Nadal, David; Bürgler, Simone (2019). Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients. Oncogene, 38(13):2420-2431.

Roblek, Marko; Protsyuk, Darya; Becker, Paul F; Stefanescu, Cristina; Gorzelanny, Christian; Glaus Garzon, Jesus F; Knopfova, Lucia; Heikenwalder, Mathias; Luckow, Bruno; Schneider, Stefan W; Borsig, Lubor (2019). CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis. Molecular Cancer Research, 17(3):783-793.

Karavasiloglou, Nena; Matthes, Katarina L; Berlin, Claudia; Limam, Manuela; Wanner, Miriam; Korol, Dimitri; Rohrmann, Sabine (2019). Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003-2014. Journal of Cancer Research and Clinical Oncology, 145(3):653-660.

Andratschke, Nicolaus; Kraft, Johannes; Nieder, Carsten; Tay, Rebecca; Califano, Raffaele; Soffietti, Riccardo; Guckenberger, Matthias (2019). Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC). Lung Cancer, 129:63-71.

Fankhauser, Christian Daniel; Gerke, Travis A; Roth, Lisa; Sander, Sophia; Grossmann, Nico Christian; Kranzbühler, Benedikt; Eberli, Daniel; Sulser, Tullio; Beyer, Joerg; Hermanns, Thomas (2019). Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment. Journal of Cancer Research and Clinical Oncology, 145(3):781-785.

Zattra, Costanza Maria; Zhang, David Y; Broggi, Morgan; Velz, Julia; Vasella, Flavio; Seggewiss, Dominik; Schiavolin, Silvia; Bozinov, Oliver; Krayenbühl, Niklaus; Sarnthein, Johannes; Ferroli, Paolo; Regli, Luca; Stienen, Martin N (2019). Repeated craniotomies for intracranial tumors: is the risk increased? Pooled analysis of two prospective, institutional registries of complications and outcomes. Journal of Neuro-Oncology, 142(1):49-57.

Pfeifer, H; Cazzaniga, G; van der Velden, V H J; Cayuela, J M; Schäfer, B; Spinelli, O; Akiki, S; Avigad, S; Bendit, I; Borg, K; Cavé, H; Elia, L; Reshmi, S C; Gerrard, G; Hayette, S; Hermanson, M; Juh, A; Jurcek, T; Chillón, M C; Homburg, C; Martinelli, G; Kairisto, V; Lange, T; Lion, T; Mueller, M C; Pane, F; Rai, L; Damm-Welk, C; Sacha, T; Schnittger, S; et al (2019). Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia, 33(8):1910-1922.

Mürner, Céline M; Stenner-Liewen, Frank; Seifert, Burkhardt; Mueller, Nicolas J; Schmidt, Adrian; Renner, Christoph; Schanz, Urs; Knuth, Alexander; Manz, Markus G; Scharl, Michael; Gerber, Bernhard; Samaras, Panagiotis (2019). Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation. Leukemia & Lymphoma, 60(3):685-695.

Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hopfinger, Georg (2019). New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leukemia & Lymphoma, 60(3):649-657.

Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; Del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Martin; Speiser, Daniel E; Ludewig, Burkhard; Levesque, Mitchell P; Dummer, Reinhard; Flatz, Lukas (2019). Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Journal for ImmunoTherapy of Cancer, 7:50.

Jaerapong, Nattharat; Jamil, Qurratul Ain; Riha, Juliane; Milovanovic, Daniela; Krupitza, Georg; Stieger, Bruno; Jarukomjorn, Kanokwan; Jäger, Walter (2019). Organic anion‑transporting polypeptides contribute to the uptake of curcumin and its main metabolites by human breast cancer cells: Impact on antitumor activity. Oncology Reports, 41(4):2558-2566.

Huang, Raymond Y; Unadkat, Prashin; Linda Bi, Wenya; George, Elizabeth; Preusser, Matthias; McCracken, Jay D; Keen, Joseph R; Read, William L; Olson, Jeffrey J; Seystahl, Katharina; Le Rhun, Emilie; Roelcke, Ulrich; Koeppen, Susanne; Furtner, Julia; Weller, Michael; Raizer, Jeffrey J; Schiff, David; Wen, Patrick Y (2019). Response Assessment of Meningioma: 1D, 2D and Volumetric Criteria for Treatment Response and Tumor Progression. Neuro-Oncology, 21(2):234-241.

Romer, C A E; Broglie Daeppen, Martina A; Mueller, M; Huber, G F; Guesewell, S; Stoeckli, Sandro J (2019). Long-term Speech and Swallowing Function after Primary Resection and Sentinel Node Biopsy for Early Oral Squamous Cell Carcinoma. Oral Oncology, 89:127-132.

Wolint, Petra; Bopp, Annina; Woloszyk, Anna; Tian, Yinghua; Evrova, Olivera; Hilbe, Monika; Giovanoli, Pietro; Calcagni, Maurizio; Hoerstrup, Simon P; Buschmann, Johanna; Emmert, Maximilian Y (2019). Cellular self-assembly into 3D microtissues enhances the angiogenic activity and functional neovascularization capacity of human cardiopoietic stem cells. Angiogenesis, 22(1):37-52.

Leeksma, Alexander C; Taylor, Justin; Wu, Bian; et al; Zenz, Thorsten (2019). Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia, 33(2):390-402.

Román, Marta; López, Inés; Guruceaga, Elizabeth; Baraibar, Iosune; et al; Jang, Jae Hwi; Weder, Walter (2019). Inhibitor of differentiation-1 (Id1) sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network. Cancer Research, 79(3):625-638.

Drago, Joshua Z; Lawrence, Donald; Livingstone, Elisabeth; Zimmer, Lisa; Chen, Tianqi; Giobbie-Hurder, Anita; Amann, Valerie C; Mangana, Joanna; Siano, Marco; Zippelius, Alfred; Dummer, Reinhard; Goldinger, Simone M; Sullivan, Ryan J (2019). Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study. Melanoma research, 29(1):65-69.

Dimitriou, Florentia; Mangana, Joanna; Micaletto, Sara; Braun, Ralph P; Dummer, Reinhard (2019). Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma. Melanoma research, 29(1):107-108.

Scheer, Monika; Vokuhl, Christian; Blank, Bernd; Hallmen, Erika; von Kalle, Thekla; Münter, Marc; Wessalowski, Rüdiger; Hartwig, Maite; Sparber-Sauer, Monika; Schlegel, Paul-Gerhardt; Kramm, Christof M; Kontny, Udo; Spriewald, Bernd; Kegel, Thomas; Bauer, Sebastian; Kazanowska, Bernarda; Niggli, Felix; Ladenstein, Ruth; Ljungman, Gustaf; Jahnukainen, Kirsi; Fuchs, Jörg; Bielack, Stefan S; Klingebiel, Thomas; Koscielniak, Ewa; Cooperative Weichteilsarkom Studiengruppe [CWS] (2019). Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. Cancer Medicine, 8(2):527-542.

Bihr, Svenja; Ohashi, Riuko; Moore, Ariane L; Rüschoff, Jan H; Beisel, Christian; Hermanns, Thomas; Mischo, Axel; Corrò, Claudia; Beyer, Jörg; Beerenwinkel, Niko; Moch, Holger; Schraml, Peter (2019). Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma. Neoplasia, 21(2):247-256.

van Gijn, Stephanie; Wierenga, Elles; van den Tempel, Nathalie; Kok, Yannick P; Heijink, Anne Margriet; Spierings, Diana C J; Foijer, Floris; van Vugt, Marcel A T M; Fehrmann, Rudolf S N (2019). TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells. Oncogene, 38(6):852-867.

Egli-Gany, Dianne; Spaar Zographos, Anne; Diebold, Joachim; Masserey Spicher, Virginie; Frey Tirri, Brigitte; Heusser, Rolf; Dillner, Joakim; Petignat, Patrick; Sahli, Roland; Low, Nicola (2019). Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study. BMC Cancer, 19:111.

Robert, Caroline; Flaherty, Keith; Nathan, Paul; Hersey, Peter; Garbe, Claus; Milhem, Mohammed; Demidov, Lev; Mohr, Peter; Hassel, Jessica C; Rutkowski, Piotr; Dummer, Reinhard; Utikal, Jochen; Kiecker, Felix; Larkin, James; D'Amelio, Anthony; Mookerjee, Bijoyesh; Schadendorf, Dirk (2019). Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma. European Journal of Cancer, 109:61-69.

von der Grün, Jens; Winkelmann, Ria; Meissner, Markus; Wieland, Ulrike; Silling, Steffi; Martin, Daniel; Fokas, Emmanouil; Rödel, Claus; Rödel, Franz; Balermpas, Panagiotis (2019). Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma. Frontiers in Oncology, 9:20.

Arlt, Matthias J; Kuzmanov, Aleksandar; Snedeker, Jess G; Fuchs, Bruno; Silvan, Unai; Sabile, Adam A (2019). Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome. BMC Cancer, 19(1):83.

Dimitriou, Florentia; Matter, Alexandra V; Mangana, Joanna; Urosevic-Maiwald, Mirjana; Micaletto, Sara; Braun, Ralph P; French, Lars E; Dummer, Reinhard (2019). Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma. Journal of Immunotherapy, 42(1):29-32.

Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Fässler, Mirjam; Diem, Stefan; Cozzio, Antonio; Jörger, Markus; Früh, Martin; Driessen, Christoph; Lenz, Tobias L; Flatz, Lukas (2019). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer, 107:8-14.

Rödel, Franz; Martin, Daniel; Balermpas, Panagiotis; Wieland, Ulrike; Winkelmann, Ria; Riekmann, Thorsten; Falk, Stephan; Rödel, Claus; Fokas, Emmanouil (2019). Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy. Elsevier Oceanography Series, 1871(1):126-137.

Xekouki, Paraskevi; Lodge, Emily Jane; Matschke, Jakob; Santambrogio, Alice; Apps, John R; Sharif, Ariane; Jacques, Thomas S; Aylwin, Simon; Prevot, Vincent; Li, Ran; Flitsch, Jörg; Bornstein, Stefan R; Theodoropoulou, Marily; Andoniadou, Cynthia L (2019). Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ. Endocrine-Related Cancer, 26(1):215-225.

Hogan, Sabrina A; Courtier, Anaïs; Cheng, Phil F; Jaberg-Bentele, Nicoletta F; Goldinger, Simone M; Manuel, Manuarii; Perez, Solène; Plantier, Nadia; Mouret, Jean-François; Nguyen-Kim, Thi Dan Linh; Raaijmakers, Marieke I G; Kvistborg, Pia; Pasqual, Nicolas; Haanen, John B A G; Dummer, Reinhard; Levesque, Mitchell P (2019). Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma. Cancer Immunology Research, 7(1):77-85.

Huang, Raymond Y; Bi, Wenya Linda; Weller, Michael; Kaley, Thomas; Blakeley, Jaishri; Dunn, Ian; Galanis, Evanthia; Preusser, Matthias; McDermott, Michael; Rogers, Leland; Raizer, Jeffrey; Schiff, David; Soffietti, Riccardo; Tonn, Jörg-Christian; Vogelbaum, Michael; Weber, Damien; Reardon, David A; Wen, Patrick Y (2019). Proposed Response Assessment and Endpoints for Meningioma Clinical Trials: Report from the Response Assessment in Neuro-Oncology (RANO) Working Group. Neuro-Oncology, 21(1):26-36.

Stam, Barbara; Kwint, Margriet; Guckenberger, Matthias; Mantel, Frederick; Hope, Andrew; Giuliani, Meredith; Werner-Wasik, Maria; Grills, Inga; Sonke, Jan-Jakob; Belderbos, José (2019). Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT. International Journal of Radiation Oncology, Biology, Physics, 103(1):132-141.

Piazena, Helmut; Müller, Werner; Pendl, Wolfgang; von Ah, Sereina; Cap, V H; Hug, Petra Julia; Sidler, Xaver; Pluschke, Gerd; Vaupel, Peter (2019). Thermal field formation during wIRA-hyperthermia: temperature measurements in skin and subcutis of piglets as a basis for thermotherapy of superficial tumors and local skin infections caused by thermosensitive microbial pathogens. International Journal of Hyperthermia, 36(1):938-952.

Peters, Solange; Stahel, Rolf; Bubendorf, Lukas; Bonomi, Philip; Villegas, Augusto; Kowalski, Dariusz M; Baik, Christina S; Isla, Dolores; De Castro Carpeno, Javier; Garrido, Pilar; Rittmeyer, Achim; Tiseo, Marcello; Meyenberg, Christoph; de Haas, Sanne; Lam, Lisa H; Lu, Michael W; Stinchcombe, Thomas E (2019). Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers. Clinical Cancer Research, 25(1):64-72.

Aronson, Daniel C; Weeda, Víola B; Maibach, Rudolf; Czauderna, Piotr; Dall'Igna, Patrizia; de Ville de Goyet, Jean; Branchereau, Sophie; Perilongo, Giorgio; Brock, Penelope; Zsiros, Joszef; Semeraro, Michaela; Chardot, Christophe; Wildhaber, Barbara; Morland, Bruce; Brugières, Laurence (2019). Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. European Journal of Cancer, 106:126-132.

Wu, Licun; Dell'Anno, Irene; Lapidot, Moshe; Sekido, Yoshitaka; Chan, Mei-Lin; Kohno, Mikihiro; Serre-Beinier, Veronique; Felley-Bosco, Emanuela; de Perrot, Marc (2019). Progress of malignant mesothelioma research in basic science: a review of the 14th international conference of the international mesothelioma interest group (iMig2018). Lung Cancer, 127:138-145.

Gatz, Susanne A; Aladowicz, Ewa; Casanova, Michela; Chisholm, Julia C; Kearns, Pamela R; Fulda, Simone; Geoerger, Birgit; Schäfer, Beat W; Shipley, Janet M (2019). A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas. Frontiers in Oncology, 9:1271.

Srinivasan, Vishnu; Nimptsch, Katharina; Rohrmann, Sabine (2019). Associations of Current, Childhood, and Adolescent Milk Intake with Serum Insulin-like Growth Factor (IGF)-1 and IGF Binding Protein 3 Concentrations in Adulthood. Nutrition and Cancer, 71(6):931-938.

Mock, Andreas; Heilig, Christoph E; Kreutzfeldt, Simon; Huebschmann, Daniel; Heining, Christoph; Schröck, Evelin; Brors, Benedikt; Stenzinger, Albrecht; Jäger, Dirk; Schlenk, Richard; Glimm, Hanno; Fröhling, Stefan; Horak, Peter (2019). Community-driven development of a modified progression-free survival ratio for precision oncology. ESMO Open, 4(6):e000583.

Goebell, Peter J; Hermann, Edwin; Kube, Ulrich; Doehn, Christian; Marschner, Norbert; Dietel, Anja; Blumenstengel, Katja; Grimm, Marc-Oliver; Scheffler, Michael; Rogler, Anja; Bergmann, Lothar (2019). Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study. Oncology Research and Treatment, 42(1-2):57-66.

Bühler, Silja; Ramharter, Michael (2019). Flucelvax Tetra: a surface antigen, inactivated, influenza vaccine prepared in cell cultures. ESMO Open, 4:e000481.

Weller, M; Watts, Colin; Reardon, David A; Mehta, Minesh P (2019). Glioblastoma. In: Tonn, J C; Reardon, David A; Rutka, J T; Westphal, M. Oncology of CNS Tumors (3. Auflage). Cham: Springer, 237-247.

Trenner, Anika; Sartori, Alessandro A (2019). Harnessing DNA Double-Strand Break Repair for Cancer Treatment. Frontiers in Oncology, 9:1388.

Weller, Michael; Le Rhun, Emilie; Preusser, Matthias; Tonn, Jörg-Christian; Roth, Patrick (2019). How we treat glioblastoma. ESMO Open, 4(Suppl 2):e000520.

Le Rhun, Emilie; Preusser, Matthias; van den Bent, Martin; Andratschke, Nicolaus; Weller, Michael (2019). How we treat patients with leptomeningeal metastases. ESMO Open, 4(Suppl 2):e000507.

Hegi, Monika E; Genbrugge, Els; Gorlia, Thierry; Stupp, Roger; Gilbert, Mark R; Chinot, Olivier Louis; Nabors, Louis Burt; Jones, Greg; van Criekinge, Wim; Straub, Josef; Weller, Michael (2019). MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials. Clinical Cancer Research, 25(6):1809-1816.

Felley-Bosco, Emanuela; Gray, Steven G (2019). Mesothelioma driver genes, ferroptosis, and therapy. Frontiers in Oncology, 9:1318.

Rüschoff, Jan H; Gradhand, Elise; Kahraman, Abdullah; Rees, Helen; Ferguson, Jane L; Curioni-Fontecedro, Alessandra; Zoche, Martin; Moch, Holger; Vrugt, Bart (2019). STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment. JCO precision oncology, 3:PO.19.00048.

Lee, Sulgi; Kambhampati, Madhuri; Almira-Suarez, M Isabel; Ho, Cheng-Ying; Panditharatna, Eshini; Berger, Seth I; Turner, Joyce; Van Mater, David; Kilburn, Lindsay; Packer, Roger J; Myseros, John S; Vilain, Eric; Nazarian, Javad; Bornhorst, Miriam (2019). Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings. Frontiers in Oncology, 9:1507.

Schröder, Christina; Opitz, Isabelle; Guckenberger, Matthias; Stahel, Rolf; Weder, Walter; Förster, Robert; Andratschke, Nicolaus; Lauk, Olivia (2019). Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy. Frontiers in Oncology, 9:961.

La Starza, Roberta; Cambò, Benedetta; Pierini, Antonio; Bornhauser, Beat; Montanaro, Anna; Bourquin, Jean-Pierre; Mecucci, Cristina; Roti, Giovanni (2019). Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia. JCO precision oncology, 3:PO.19.00172.

2018

Tallón de Lara, Paulino; Cecconi, Virginia; Hiltbrunner, Stefanie; Yagita, Hideo; Friess, Martina; Bode, Beata; Opitz, Isabelle; Vrugt, Bart; Weder, Walter; Stolzmann, Paul; Felley-Bosco, Emanuela; Stahel, Rolf A; Tischler, Verena; Britschgi, Christian; Soldini, Davide; van den Broek, Maries; Curioni Fontecedro, Alessandra (2018). Gemcitabine synergizes with immune checkpoint inhibitors and overcomes resistance in a preclinical model and mesothelioma patients. Clinical Cancer Research, 24(24):6345-6354.

Bassan, Renato; Bourquin, Jean-Pierre; DeAngelo, Daniel J; Chiaretti, Sabina (2018). New Approaches to the Management of Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 36(35):3504-3519.

Lindenblatt, Dennis; Terraneo, Nastassja; Pellegrini, Giovanni; Cohrs, Susan; Spycher, Philipp René; Vukovic, David; Béhé, Martin; Schibli, Roger; Grünberg, Jürgen (2018). Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma. BMC Cancer, 18(1):922.

You, Wenpeng; Rühli, Frank J; Henneberg, Renata J; Henneberg, Maciej (2018). Greater family size is associated with less cancer risk: an ecological analysis of 178 countries. BMC Cancer, 18:924.

Conconi, Annarita; Zucca, Emanuele; Margiotta-Casaluci, Gloria; Darling, Katharine; Hasse, Barbara; Battegay, Manuel; Staehelin, Cornelia; Novak, Urban; Schmid, Patrick; Scherrer, Alexandra; Dirnhofer, Stephan; Kwee, Ivo; Nassi, Luca; Cavalli, Franco; Gaidano, Gianluca; Bertoni, Francesco; Bernasconi, Enos; Swiss HIV Cohort Study (2018). Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology, 36(5):757-764.

Wirsching, Hans-Georg; Richter, Johannes Konstantin; Sahm, Felix; Morel, Corinne; Krayenbuehl, Niklaus; Rushing, Elisabeth Jane; von Deimling, Andreas; Valavanis, Antonios; Weller, Michael (2018). Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients. Journal of Neuro-Oncology, 140(3):659-667.

Cathomas, Richard; Klingbiel, Dirk; Bernard, Brandon; Lorch, Anja; Garcia Del Muro, Xavier; Morelli, Franco; De Giorgi, Ugo; Fedyanin, Mikhail; Oing, Christoph; Sagstuen Haugnes, Hege; Hentrich, Marcus; Fankhauser, Christian; Gillessen, Silke; Beyer, Jörg (2018). Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry. Journal of Clinical Oncology, 36(34):3381-3387.

Martínez-González, Nahara Anani; Neuner-Jehle, Stefan; Plate, Andreas; Rosemann, Thomas; Senn, Oliver (2018). The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis. BMC Cancer, 18:1015.

Schwyzer, Moritz; Ferraro, Daniela A; Muehlematter, Urs J; Curioni-Fontecedro, Alessandra; Huellner, Martin W; von Schulthess, Gustav K; Kaufmann, Philipp A; Burger, Irene A; Messerli, Michael (2018). Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results. Lung Cancer, 126:170-173.

Hirschmann, A; Lupatsch, J E; Schwenkglenks, M; Panje, C M; Matter-Walstra, K; Espeli, V; Dedes, K J; Siano, M (2018). Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral Oncology, 87:104-110.

Guckenberger, Matthias (2018). Radiotherapy dose escalation in locally advanced NSCLC - The limits of conventional radiochemotherapy. Lung Cancer, 126:208-209.

Moreira, Alvaro; Loquai, Carmen; Pföhler, Claudia; Kähler, Katharina C; Knauss, Samuel; Heppt, Markus V; Gutzmer, Ralf; Dimitriou, Florentia; Meier, Friedegund; Mitzel-Rink, Heidrun; Schuler, Gerold; Terheyden, Patrick; Thoms, Kai-Martin; Türk, Matthias; Dummer, Reinhard; Zimmer, Lisa; Schröder, Rolf; Heinzerling, Lucie (2018). Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European Journal of Cancer, 106:12-23.

Witt, Hendrik; Gramatzki, Dorothee; Hentschel, Bettina; et al; Weller, Michael; German Glioma Network (2018). DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro-Oncology, 20(12):1616-1624.

Parker, Hannah R; Orjuela, Stephany; Martinho Oliveira, Andreia; Cereatti, Fabrizio; Sauter, Matthias; Heinrich, Henriette; Tanzi, Giulia; Weber, Achim; Komminoth, Paul; Vavricka, Stephan; Albanese, Luca; Buffoli, Federico; Robinson, Mark D; Marra, Giancarlo (2018). The proto CpG island methylator phenotype of sessile serrated adenomas/polyps. Epigenetics, 13(10/11):1088-1105.

Morand, Grégoire B; Helmchen, Birgit M; Steinert, Hans C; Schmid, Christoph; Broglie, Martina A (2018). 18F-Choline-PET in parathyroid carcinoma. Oral Oncology, 86:314-315.

Kandolf Sekulovic, L; et al; Dummer, R (2018). Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. European Journal of Cancer, 104:201-209.

Schirmer, Uwe; Fiegl, Heidi; Pfeifer, Marco; Zeimet, Alain G; Müller-Holzner, Elisabeth; Bode, Peter K; Tischler, Verena; Altevogt, Peter (2018). Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens. BMC Cancer, 18(1):1047.

Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M; Long, Georgina V (2018). Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma. Journal of Clinical Oncology:JCO1801219.

Tio, Martin; Rai, Rajat; Ezeoke, Ogochukwu M; et al; Goldinger, Simone M (2018). Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European Journal of Cancer, 104:137-144.

Ullrich, Martin; Liers, Josephine; Peitzsch, Mirko; Feldmann, Anja; Bergmann, Ralf; Sommer, Ulrich; Richter, Susan; Bornstein, Stefan R; Bachmann, Michael; Eisenhofer, Graeme; Ziegler, Christian G; Pietzsch, Jens (2018). Strain-specific metastatic phenotypes in pheochromocytoma allograft mice. Endocrine-Related Cancer, 25(12):993-1004.

Sánchez-Velázquez, P; Pera, M; Jiménez-Toscano, M; Mayol, X; Rogés, X; Lorente, L; Iglesias, M; Gallén, M (2018). Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer. Clinical & Translational Oncology, 20(10):1321-1328.

Häfliger, Esther M; Ramelyte, Egle; Mangana, Joanna; Kunz, Michael; Kazakov, Dmitry V; Dummer, Reinhard; Cheng, Phil F (2018). Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis. Melanoma research, 28(5):442-450.

Rasche, Mareike; Zimmermann, Martin; Borschel, Lisa; Bourquin, Jean-Pierre; Dworzak, Michael; Klingebiel, Thomas; Lehrnbecher, Thomas; Creutzig, Ursula; Klusmann, Jan-Henning; Reinhardt, Dirk (2018). Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia, 32(10):2167-2177.

Jin, Qi; Martinez, Carlos A; Arcipowski, Kelly M; et al; Bourquin, Jean-Pierre; Bornhauser, Beat (2018). USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. Clinical Cancer Research, 25(1):222-239.

Pich, Christine; Meylan, Patrick; Mastelic-Gavillet, Beatris; Nguyen, Thanh Nhan; Loyon, Romain; Trang, Bao Khanh; Moser, Hélène; Moret, Catherine; Goepfert, Christine; Hafner, Jürg; Levesque, Mitchell P; Romero, Pedro; Jandus, Camilla; Michalik, Liliane (2018). Induction of paracrine signaling in metastatic melanoma cells by PPARγ agonist rosiglitazone activates stromal cells and enhances tumor growth. Cancer Research, 78(22):6447-6461.

Faletti, Laura; Peintner, Lukas; Neumann, Simon; Sandler, Sandra; Grabinger, Thomas; Mac Nelly, Sabine; Merfort, Irmgard; Huang, Chun-Hao; Tschaharganeh, Darjus; Kang, Tae-Won; Heinzmann, Florian; D'Artista, Luana; Maurer, Ulrich; Brunner, Thomas; Lowe, Scott; Zender, Lars; Borner, Christoph (2018). TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation. Cell Death and Disease, 9(9):909.

Cimino, Patrick J; McFerrin, Lisa; Wirsching, Hans-Georg; Arora, Sonali; Bolouri, Hamid; Rabadan, Raul; Weller, Michael; Holland, Eric C (2018). Copy number profiling across glioblastoma populations has implications for clinical trial design. Neuro-Oncology, 20(10):1368-1373.

Binder, Carmen; Matthes, Katarina Luise; Korol, Dimitri; Rohrmann, Sabine; Moch, Holger (2018). Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling. Cancer Medicine, 7(9):4814-4824.

Place, Andrew E; Goldsmith, Kelly; Bourquin, Jean-Pierre; Loh, Mignon L; Gore, Lia; Morgenstern, Daniel A; Sanzgiri, Yeshwant; Hoffman, David; Zhou, Ying; Ross, Jeremy A; Prine, Betty; Shebley, Mohamad; McNamee, Megan; Farazi, Thalia; Kim, Su Young; Verdugo, Maria; Lash-Fleming, Leanne; Zwaan, C Michel; Vormoor, Josef (2018). Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future Oncology (London, England), 14(21):2115-2129.

Le Rhun, Emilie; Genbrugge, Els; Stupp, Roger; Chinot, Olivier L; Nabors, L Burt; Cloughesy, Timothy; Reardon, David A; Wick, Wolfgang; Gorlia, Thierry; Weller, Michael (2018). Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. European Journal of Cancer, 101:95-104.

Moreno, Lucas; Casanova, Michela; Chisholm, Julia C; Berlanga, Pablo; Chastagner, Pascal B; Baruchel, Sylvain; Amoroso, Loredana; Gallego Melcón, Soledad; Gerber, Nicolas U; Bisogno, Gianni; Fagioli, Franca; Geoerger, Birgit; Glade Bender, Julia L; Aerts, Isabelle; Bergeron, Christophe; Hingorani, Pooja; Elias, Ileana; Simcock, Mathew; Ferrara, Stefano; Le Bruchec, Yvan; Slepetis, Ruta; Chen, Nianhang; Vassal, Gilles (2018). Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. European Journal of Cancer, 100:27-34.

Sprave, Tanja; Verma, Vivek; Förster, Robert; Schlampp, Ingmar; Hees, Katharina; Bruckner, Thomas; Bostel, Tilman; El Shafie, Rami Ateyah; Welzel, Thomas; Nicolay, Nils Henrik; Debus, Jürgen; Rief, Harald (2018). Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial. BMC Cancer, 18(1):859.

Boda-Heggemann, Judit; Gkika, Eleni; Andratschke, Nicolaus; Blanck, Oliver; Guckenberger, Matthias; Lohr, Frank; Brunner, Thomas B (2018). Correspondence on Rajyaguru et al. Journal of Clinical Oncology, 36(24):2561-2562.

Gulati, Pratiksha; Rühl, Julia; Kannan, Abhilash; Pircher, Magdalena; Schuberth, Petra; Nytko, Katarzyna J; Pruschy, Martin; Sulser, Simon; Haefner, Mark; Jensen, Shawn; Soltermann, Alex; Jungraithmayr, Wolfgang; Eisenring, Maya; Winder, Thomas; Samaras, Panagiotis; Tabor, Annett; Stenger, Rene; Stupp, Roger; Weder, Walter; Renner, Christoph; Münz, Christian; Petrausch, Ulf (2018). Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice. Clinical Cancer Research, 24(16):3981-3993.

Vanden Bempt, Marlies; Demeyer, Sofie; Broux, Michaël; De Bie, Jolien; Bornschein, Simon; Mentens, Nicole; Vandepoel, Roel; Geerdens, Ellen; Radaelli, Enrico; Bornhauser, Beat C; Kulozik, Andreas E; Meijerink, Jules P; Bourquin, Jean-Pierre; de Bock, Charles E; Cools, Jan (2018). Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia. Cancer Cell, 34(2):271-285.e7.

Laufer, Ilya; Lo, Simon S; Chang, Eric L; Sheehan, Jason; Guckenberger, Matthias; Sohn, Moon-Jun; Ryu, Samuel; Foote, Matthew; Muacevic, Alexander; Soltys, Scott G; Chao, Samuel; Myrehaug, Sten; Gerszten, Peter C; Lis, Eric; Maralani, Pejman; Bilsky, Mark; Fisher, Charles; Rhines, Laurence; Verlaan, Jorrit-Jan; Schiff, David; Fehlings, Michael G; Ma, Lijun; Chang, Susan; Parulekar, Wendy R; Vogelbaum, Michael A; Sahgal, Arjun (2018). Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report. Neuro-Oncology, 20(9):1215-1224.

Cazzamalli, Samuele; Ziffels, Barbara; Widmayer, Fontaine; Murer, Patrizia; Pellegrini, Giovanni; Pretto, Francesca; Wulhfard, Sarah; Neri, Dario (2018). Enhanced therapeutic activity of non-internalizing small-molecule-drug conjugates targeting carbonic anhydrase IX in combination with targeted interleukin-2. Clinical Cancer Research, 24(15):3656-3667.

Busenhart, Dan Mike; Erb, Juliane; Rigakos, Georgios; Eliades, Theodore; Papageorgiou, Spyridon N (2018). Adverse effects of chemotherapy on the teeth and surrounding tissues of children with cancer: A systematic review with meta-analysis. Oral Oncology, 83:64-72.

Sprave, Tanja; Verma, Vivek; Förster, Robert; Schlampp, Ingmar; Bruckner, Thomas; Bostel, Tilman; El Shafie, Rami Ateayh; Nicolay, Nils Henrik; Debus, Jürgen; Rief, Harald (2018). Quality of Life Following Stereotactic Body Radiotherapy Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial. Anticancer Research, 38(8):4961-4968.

Sprave, Tanja; Verma, Vivek; Förster, Robert; Schlampp, Ingmar; Hees, Katharina; Bruckner, Thomas; Bostel, Tilman; El Shafie, Rami; Nicolay, Nils Henrik; Debus, Jürgen; Rief, Harald (2018). Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial. Anticancer Research, 38(8):4953-4960.

Weber, Kari A; Heaphy, Christopher M; Joshu, Corinne E; Lu, Jiayun; Rohrmann, Sabine; Bienstock, Jessica L; Agurs-Collins, Tanya; Meeker, Alan K; Platz, Elizabeth A (2018). Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations. Cancer Causes & Control, 29(8):759-767.

Binder, Zev A; Thorne, Amy Haseley; Bakas, Spyridon; et al; Weller, Michael (2018). Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development. Cancer Cell, 34(1):163-177.e7.

Hirsch, Daniela; Wangsa, Darawalee; Zhu, Yuelin J; Hu, Yue; Edelman, Daniel C; Meltzer, Paul S; Heselmeyer-Haddad, Kerstin; Ott, Claudia; Kienle, Peter; Galata, Christian; Horisberger, Karoline; Ried, Thomas; Gaiser, Timo (2018). Dynamics of Genome Alterations in Crohn's Disease–Associated Colorectal Carcinogenesis. Clinical Cancer Research, 24(20):4997-5011.

Hoffman, Lindsey M; Veldhuijzen van Zanten, Sophie E M; Colditz, Niclas; Baugh, Joshua; Chaney, Brooklyn; Hoffmann, Marion; Lane, Adam; Fuller, Christine; Miles, Lili; Hawkins, Cynthia; Bartels, Ute; Bouffet, Eric; Goldman, Stewart; Leary, Sarah; Foreman, Nicholas K; Packer, Roger; Warren, Katherine E; Broniscer, Alberto; Kieran, Mark W; Minturn, Jane; Comito, Melanie; Broxson, Emmett; Shih, Chie-Schin; Khatua, Soumen; Chintagumpala, Murali; Carret, Anne Sophie; Escorza, Nancy Yanez; Hassall, Timothy; Ziegler, David S; Gottardo, Nicholas; et al; Grotzer, M A; Gerber, N U (2018). Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of Clinical Oncology, 36(19):1963-1972.

Iyer, Gopa; Balar, Arjun V; Milowsky, Matthew I; et al (2018). Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. Journal of Clinical Oncology, 36(19):1949-1956.

Crona, J; Beuschlein, F; Pacak, K; Skogseid, B (2018). Advances in adrenal tumors 2018. Endocrine-Related Cancer, 25(7):R405-R420.

Tomonaga, Yuki; Ten Haaf, Kevin; Frauenfelder, Thomas; Kohler, Malcolm; Kouyos, Roger D; Shilaih, Mohaned; Lorez, Matthias; de Koning, Harry J; Schwenkglenks, Matthias; Puhan, Milo A (2018). Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study. Lung Cancer, 121:61-69.

Zingg, Daniel; Debbache, Julien; Peña-Hernández, Rodrigo; Antunes, Ana T; Schaefer, Simon M; Cheng, Phil F; Zimmerli, Dario; Haeusel, Jessica; Calçada, Raquel R; Tuncer, Eylul; Zhang, Yudong; Bossart, Raphaël; Wong, Kwok-Kin; Basler, Konrad; Dummer, Reinhard; Santoro, Raffaella; Levesque, Mitchell P; Sommer, Lukas (2018). EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation. Cancer Cell, 34(1):69-84.

Arvold, Nils D; Armstrong, Terri S; Warren, Katherine E; et al; Weller, Michael (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology, 20(7):897-906.

Aristizabal Prada, Elke Tatjana; Spoettl, Gerald; Maurer, Julian; Lauseker, Michael; Koziolek, Eva Jolante; Schrader, Jörg; Grossman, Ashley; Pacak, Karel; Beuschlein, Felix; Auernhammer, Christoph J; Nölting, Svenja (2018). The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance. Endocrine-Related Cancer, 25(10):893-908.

Gillison, Maura L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Li, Li; Ferris, Robert L (2018). CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. The Oncologist, 23(9):1079-1082.

Notter, Tina; Meyer, Urs (2018). Letter to the Editor re: Increased expression of Translocator Protein (TSPO) marks pro-inflammatory microglia but does not predict neurodegeneration. Molecular Imaging and Biology, 20(3):352-353.

Ros, Oriol; Barrecheguren, Pablo José; Cotrufo, Tiziana; Schaettin, Martina; Roselló-Busquets, Cristina; Vílchez-Acosta, Alba; Hernaiz-Llorens, Marc; Martínez-Marmol, Ramón; Ulloa, Fausto; Stoeckli, Esther T; Araújo, Sofia J; Soriano, Eduardo (2018). A conserved role for Syntaxin-1 in pre- and post-commissural midline axonal guidance in fly, chick, and mouse. PLoS Genetics, 14(6):e1007432.

Giebel, Sebastian; Labopin, Myriam; Potter, Michael; Poiré, Xavier; Sengeloev, Henrik; Socié, Gerard; Huynh, Anne; Afanasyev, Boris V; Schanz, Urs; Ringden, Olle; Kalhs, Peter; Beelen, Dietrich W; Campos, Antonio M; Masszi, Tamás; Canaani, Jonathan; Mohty, Mohamad; Nagler, Arnon (2018). Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. European Journal of Cancer, 96:73-81.

Weller, Michael (2018). Next generation neuro-oncology. European Journal of Cancer, 96:1-5.

Ferris, Robert L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L (2018). Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncology, 81:45-51.

Dimitriou, Florentia; Frauchiger, Anna L; Urosevic-Maiwald, Mirjana; Naegeli, Mirjam C; Goldinger, Simone M; Barysch, Marjam; Franzen, Daniel; Kamarachev, Jivko; Braun, Ralph; Dummer, Reinhard; Mangana, Joanna (2018). Sarcoid-like reactions in patients receiving modern melanoma treatment. Melanoma research, 28(3):230-236.

Rohrmann, Sabine; Shvetsov, Yurii B; Morimoto, Yukiko; Wilkens, Lynne R; Monroe, Kristine R; Le Marchand, Loïc; Franke, Adrian A; Kolonel, Laurence N; Maskarinec, Gertraud (2018). Self-reported dietary flavonoid intake and serum markers of inflammation: the multiethnic cohort. Cancer Causes & Control, 29(6):601-607.

von Mässenhausen, Anne; Tonnus, Wulf; Himmerkus, Nina; Parmentier, Simon; Saleh, Danish; Rodriguez, Diego; Ousingsawat, Jiraporn; Ang, Rosalind L; Weinberg, Joel M; Sanz, Ana B; Ortiz, Alberto; Zierleyn, Adrian; Becker, Jan Ulrich; Baratte, Blandine; Desban, Nathalie; Bach, Stéphane; Schiessl, Ina Maria; Nogusa, Shoko; Balachandran, Siddharth; Anders, Hans Joachim; Ting, Adrian T; Bleich, Markus; Degterev, Alexei; Kunzelmann, Karl; Bornstein, Stefan R; Green, Douglas R; Hugo, Christian; Linkermann, Andreas (2018). Correction to: Phenytoin inhibits necroptosis. Cell Death and Disease, 9(6):622.

Bruni, Antonio; Pepper, Andrew R; Pawlick, Rena L; Gala-Lopez, Boris; Gamble, Anissa F; Kin, Tatsuya; Seeberger, Karen; Korbutt, Gregory S; Bornstein, Stefan R; Linkermann, Andreas; Shapiro, A M James (2018). Ferroptosis-inducing agents compromise in vitro human islet viability and function. Cell Death and Disease, 9(6):595.

Cánovas, Begoña; Igea, Ana; Sartori, Alessandro A; Gomis, Roger R; Paull, Tanya T; Isoda, Michitaka; Pérez-Montoyo, Héctor; Serra, Violeta; González-Suárez, Eva; Stracker, Travis H; Nebreda, Angel R (2018). Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells. Cancer Cell, 33(6):1094-1110.e8.

Schneider, Paul M; Eshmuminov, Dilmurodjon; Rordorf, Tamara; Vetter, Diana; Veit-Haibach, Patrick; Weber, Achim; Bauerfeind, Peter; Samaras, Panagiotis; Lehmann, Kuno (2018). 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study. BMC Cancer, 18:548.

Guckenberger, Matthias; Sweeney, Reinhart A; Hawkins, Maria; Belderbos, Jose; Andratschke, Nicolaus; Ahmed, Merina; Madani, Indira; Mantel, Frederick; Steigerwald, Sabrina; Flentje, Michael (2018). Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study. Cancer, 124(9):2001-2009.

Läppchen, Tilman; Kiefer, Yvonne; Holland, Jason P; Bartholomä, Mark D (2018). In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector. Nuclear medicine and biology, 60:45-54.

Gradzka, Sylwia; Thomas, Oliver S; Kretz, Oliver; Haimovici, Aladin; Vasilikos, Lazaros; Wong, Wendy Wei-Lynn; Häcker, Georg; Gentle, Ian E (2018). Inhibitor of apoptosis proteins are required for effective fusion of autophagosomes with lysosomes. Cell Death and Disease, 9(5):529.

Hanemaaijer, Saskia H; van Gijn, Stephanie; Oosting, Sjoukje F; Plaat, Boudewijn E C; Moek, Kirsten L; Schuuring, Ed M; van der Laan, Bernard F A M; Roodenburg, Jan L N; van Vugt, Marcel A T M; van der Vegt, Bert; Fehrmann, Rudolf S N (2018). Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma. Oral Oncology, 80:33-39.

Happold, Caroline; Gorlia, Thierry; Nabors, L Burt; Erridge, Sara C; Reardon, David A; Hicking, Christine; Picard, Martin; Stupp, Roger; Weller, Michael (2018). Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma? Journal of Neuro-Oncology, 138(1):163-171.

Chaurasia, Soumya; Lehner, Christian F (2018). Dynamics and control of sister kinetochore behavior during the meiotic divisions in Drosophila spermatocytes. PLoS Genetics, 14(5):e1007372.

Fritsch, Kristin; Pigeot, Sébastien; Feng, Xiaomin; Bourgine, Paul E; Schroeder, Timm; Martin, Ivan; Manz, Markus G; Takizawa, Hitoshi (2018). Engineered humanized bone organs maintain human hematopoiesis in vivo. Experimental Hematology, 61:45-51.e5.

Rehrauer, Hubert; Wu, Licun; Blum, Walter; Pecze, Lazslo; Henzi, Thomas; Serre-Beinier, Véronique; Aquino, Catherine; Vrugt, Bart; de Perrot, Marc; Schwaller, Beat; Felley-Bosco, Emanuela (2018). How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations. Oncogene, 37(20):2645-2659.

Aristizabal Prada, Elke Tatjana; Heinzle, Vera; Knösel, Thomas; Nölting, Svenja; Spöttl, Gerald; Maurer, Julian; Spitzweg, Christine; Angele, Martin; Schmidt, Nina; Beuschlein, Felix; Stalla, Günter K; Blaser, Rainer; Kuhn, Klaus A; Auernhammer, Christoph J (2018). Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. Endocrine-Related Cancer, 25(5):547-560.

Sprouffske, Kathleen; Aguilar-Rodríguez, José; Sniegowski, Paul; Wagner, Andreas (2018). High mutation rates limit evolutionary adaptation in Escherichia coli. PLoS Genetics, 14(4):e1007324.

Wu, Licun; Blum, Walter; Zhu, Chang-Qi; Yun, Zhihong; Pecze, Laszlo; Kohno, Mikihiro; Chan, Mei-Lin; Zhao, Yidan; Felley-Bosco, Emanuela; Schwaller, Beat; de Perrot, Marc (2018). Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma. BMC Cancer, 18(1):471.

Stanulla, Martin; Dagdan, Elif; Zaliova, Marketa; et al; Bourquin, Jean-Pierre; Bornhauser, Beat (2018). IKZF1 Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 36(12):1240-1249.

Zimmerli, Dario; Cecconi, Virginia; Valenta, Tomas; Hausmann, George; Cantù, Claudio; Restivo, Gaetana; Hafner, Jürg; Basler, Konrad; van den Broek, Maries (2018). WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma. Oncogene, 37(27):3753-3762.

Trenner, Anika; Godau, Julia; Sartori, Alessandro A (2018). A short BRCA2-derived cell-penetrating peptide targets RAD51 function and confers hypersensitivity towards PARP inhibition. Molecular Cancer Therapeutics, 17(7):1392-1404.

McClain, Kenneth L; Picarsic, Jennifer; Chakraborty, Rikhia; et al; Manz, M G (2018). CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer, 124(12):2607-2620.

Finazzi, T; Rordorf, T; Ikenberg, K; Huber, G F; Guckenberger, M; Garcia Schueler, H I (2018). Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy. BMC Cancer, 18(1):395.

Basler, Lucas; Kowalczyk, Aleksandra; Heidenreich, Regina; Fotin-Mleczek, Mariola; Tsitsekidis, Savas; Zips, Daniel; Eckert, Franziska; Huber, Stephan M (2018). Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model. Cancer Immunology, Immunotherapy, 67(4):653-662.

Taphoorn, Martin J B; Dirven, Linda; Kanner, Andrew A; Lavy-Shahaf, Gitit; Weinberg, Uri; Taillibert, Sophie; Toms, Steven A; Honnorat, Jerome; Chen, Thomas C; Sroubek, Jan; David, Carlos; Idbaih, Ahmed; Easaw, Jacob C; Kim, Chae-Yong; Bruna, Jordi; Hottinger, Andreas F; Kew, Yvonne; Roth, Patrick; et al (2018). Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncology, 4(4):495-504.

Alongi, Filippo; Mazzola, Rosario; Figlia, Vanessa; Guckenberger, Matthias (2018). Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria. Tumori, 104(3):148-156.

Weller, Michael (2018). Where does O -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma? Cancer, 124(7):1316-1318.

Tétu, Pauline; Mangana, Joanna; Dummer, Reinhard; Dutriaux, Caroline; Beneton, Nathalie; Dalle, Stéphane; Meyer, Nicolas; Oriano, Bastien; Michielin, Olivier; Lebbe, Céleste (2018). Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma. European Journal of Cancer, 93:147-149.

Tirado-Gonzalez, I; Czlonka, E; Nevmerzhitskaya, A; Soetopo, D; Bergonzani, E; Mahmoud, A; Contreras, A; Jeremias, I; Platzbecker, U; Bourquin, J P; Kloz, U; Van der Hoeven, F; Medyouf, H (2018). CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. Leukemia, 32(4):1049-1052.

Rothenbühler, Christoph; Held, Ulrike; Manz, Markus G; Schanz, Urs; Gerber, Bernhard (2018). Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia. Hematological oncology, 36(2):471-480.

Valpione, Sara; Carlino, Matteo S; Mangana, Johanna; et al (2018). Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]. European Journal of Cancer, 93:158.

Matthes, Katarina Luise; Limam, Manuela; Pestoni, Giulia; Held, Leonhard; Korol, Dimitri; Rohrmann, Sabine (2018). Impact of comorbidities at diagnosis on prostate cancer treatment and survival. Journal of Cancer Research and Clinical Oncology, 144(4):707-715.

Unkelbach, Jan; Paganetti, Harald (2018). Robust Proton Treatment Planning: Physical and Biological Optimization. Seminars in Radiation Oncology, 28(2):88-96.

Feller, Anita; Schmidlin, Kurt; Bordoni, Andrea; Bouchardy, Christine; Bulliard, Jean-Luc; Camey, Bertrand; Konzelmann, Isabelle; Maspoli, Manuela; Wanner, Miriam; Zwahlen, Marcel; Clough-Gorr, Kerri M (2018). Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study. Cancer Medicine, 7(4):1498-1510.

Andres, Martin; Feller, Anita; Arndt, Volker (2018). Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer Epidemiology, 53:105-110.

Rudà, Roberta; Reifenberger, Guido; Frappaz, Didier; Pfister, Stefan M; Laprie, Anne; Santarius, Thomas; Roth, Patrick; Tonn, Joerg Christian; Soffietti, Riccardo; Weller, Michael (2018). EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro-Oncology, 20(4):445-456.

Andratschke, N; Alheid, H; Allgäuer, M; Becker, G; Blanck, O; Boda-Heggemann, J; Brunner, T; Duma, M; Gerum, S; Guckenberger, M; Hildebrandt, G; Klement, R J; Lewitzki, V; Ostheimer, C; Papachristofilou, A; Petersen, C; Schneider, T; Semrau, R; Wachter, S; Habermehl, D (2018). The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer, 18(1):283.

Alharbi, Abdullah A; Alshehri, Fahad M; Albatly, Abdulrahman A; Sah, Bert-Ram; Schmid, Christoph; Huber, Gerhard F; Huellner, Martin W (2018). [F]Fluorocholine uptake of parathyroid adenoma is correlated with parathyroid hormone level. Molecular Imaging and Biology, 20(5):857-867.

von Mässenhausen, Anne; Tonnus, Wulf; Himmerkus, Nina; Parmentier, Simon; Saleh, Danish; Rodriguez, Diego; Ousingsawat, Jiraporn; Ang, Rosalind L; Weinberg, Joel M; Sanz, Ana B; Ortiz, Alberto; Zierleyn, Adrian; Becker, Jan Ulrich; Baratte, Blandine; Desban, Nathalie; Bach, Stéphane; Schiessl, Ina Maria; Nogusa, Shoko; Balachandran, Siddharth; Anders, Hans Joachim; Ting, Adrian T; Bleich, Markus; Degterev, Alexei; Kunzelmann, Karl; Bornstein, Stefan R; Green, Douglas R; Hugo, Christian; Linkermann, Andreas (2018). Phenytoin inhibits necroptosis. Cell Death and Disease, 9(3):359.

Koelblinger, Peter; Thuerigen, Olaf; Dummer, Reinhard (2018). Development of encorafenib for BRAF-mutated advanced melanoma. Current Opinion in Oncology, 30(2):125-133.

Andersson, E I; Pützer, S; et al; Mustjoki, S (2018). Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. Leukemia, 32(3):774-787.

Konstantinoudis, Garyfallos; Kreis, Christian; Ammann, Roland A; Niggli, Felix; Kuehni, Claudia E; Spycher, Ben D; Swiss Paediatric Oncology Group; Swiss National Cohort Study Group (2018). Spatial clustering of childhood cancers in Switzerland: a nationwide study. Cancer Causes & Control, 29(3):353-362.

Dummer, Reinhard (2018). The dynamics of medical care in skin cancers. Current Opinion in Oncology, 30(2):105-106.

Fankhauser, Christian Daniel; Sander, Sophia Isabella; Roth, Lisa; Gross, Oliver; Eberli, Daniel; Sulser, Tullio; Seifert, Burkhardt; Beyer, Jörg; Hermanns, Thomas (2018). Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. British Journal of Cancer, 118(6):825-830.

Sinnberg, Tobias; Levesque, Mitchell P; Krochmann, Jelena; Cheng, Phil F; Ikenberg, Kristian; Meraz-Torres, Francisco; Niessner, Heike; Garbe, Claus; Busch, Christian (2018). Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype. Molecular Cancer, 17(1):59.

Lötzerich, Mark; Roulin, Pascal S; Boucke, Karin; Witte, Robert; Georgiev, Oleg; Greber, Urs F (2018). Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. Cell Death and Disease, 9(3):272.

Hasanovic, Anida; Ruggiero, Carmen; Jung, Sara; Rapa, Ida; Signetti, Laurie; Ben Hadj, Monia; Terzolo, Massimo; Beuschlein, Felix; Volante, Marco; Hantel, Constanze; Lalli, Enzo; Mus-Veteau, Isabelle (2018). Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo. International Journal of Cancer, 143(1):199-211.

Malcikova, J; Tausch, E; Rossi, D; Sutton, L A; Soussi, T; Zenz, T; Kater, A P; Niemann, C U; Gonzalez, D; Davi, F; Gonzalez Diaz, M; Moreno, C; Gaidano, G; Stamatopoulos, K; Rosenquist, R; Stilgenbauer, S; Ghia, P; Pospisilova, S (2018). ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation. Leukemia, 32(5):1070-1080.

Krähenbühl, Lukas; Goldinger, Simone M; Mangana, Joanna; Kerl, Katrin; Chevolet, Ines; Brochez, Liève; Horak, Christine; Levesque, Mitch; Dummer, Reinhard; Cheng, Phil F (2018). A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma. Neoplasia, 20(2):218-225.

Tanadini-Lang, Stephanie; Bogowicz, Marta; Veit-Haibach, Patrick; Huellner, Martin; Pauli, Chantal; Shukla, Vyoma; Guckenberger, Matthias; Riesterer, Oliver (2018). Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer. Anticancer Research, 38(2):685-690.

Fischer, Angela; Bastian, Sara; Cogliatti, Sergio; Mey, Ulrich; Saub, Jenny; Schanz, Urs; Padberg, Barbara; Hohloch, Karin (2018). Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome. Hematological oncology, 36(1):370-371.

Schnegg-Kaufmann, A; Feller, A; Baldomero, H; Rovo, A; Manz, M G; Gregor, M; Efthymiou, A; Bargetzi, M; Hess, U; Spertini, O; Chalandon, Y; Passweg, J R; Stussi, G; Arndt, V; Bonadies, N; NICER Working Group; Rohrmann, Sabine (2018). Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Cancer Epidemiology, 52:55-62.

Meyer, C; Burmeister, T; Gröger, D; Tsaur, G; Fechina, L; Renneville, A; Sutton, R; Venn, N C; Emerenciano, M; Pombo-de-Oliveira, M S; Barbieri Blunck, C; Almeida Lopes, B; Zuna, J; Trka, J; Ballerini, P; Lapillonne, H; De Braekeleer, M; Cazzaniga, G; Corral Abascal, L; van der Velden, V H J; Delabesse, E; Park, T S; Oh, S H; Silva, M L M; Lund-Aho, T; Juvonen, V; Moore, A S; Heidenreich, O; Vormoor, J; Zerkalenkova, E; et al; Schafer, B W; Kubetzko, S; et al (2018). The MLL recombinome of acute leukemias in 2017. Leukemia, 32(2):273-284.

Lang, B M; Peveling-Oberhag, A; Faidt, D; Hötker, A M; Weyer-Elberich, V; Grabbe, S; Loquai, C (2018). Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting. Medical Oncology, 35(3):24.

Schrappe, Martin; Bleckmann, Kirsten; Zimmermann, Martin; Biondi, Andrea; Möricke, Anja; Locatelli, Franco; Cario, Gunnar; Rizzari, Carmelo; Attarbaschi, Andishe; Valsecchi, Maria Grazia; Bartram, Claus R; Barisone, Elena; Niggli, Felix; Niemeyer, Charlotte; Testi, Anna Maria; Mann, Georg; Ziino, Ottavio; Schäfer, Beat; Panzer-Grümayer, Renate; Beier, Rita; Parasole, Rosanna; Göhring, Gudrun; Ludwig, Wolf-Dieter; Casale, Fiorina; Schlegel, Paul-Gerhardt; Basso, Giuseppe; Conter, Valentino (2018). Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). Journal of Clinical Oncology, 36(3):244-253.

Sand, Jennifer; Haertel, Eric; Biedermann, Thomas; Contassot, Emmanuel; Reichmann, Ernst; French, Lars E; Werner, Sabine; Beer, Hans-Dietmar (2018). Expression of inflammasome proteins and inflammasome activation occurs in human, but not in murine keratinocytes. Cell Death and Disease, 9(2):24.

Siebenhüner, Alexander R; Seifert, Heike; Bachmann, Helga; Seifert, Burkhardt; Winder, Thomas; Feilchenfeldt, Jonas; Breitenstein, Stefan; Clavien, Pierre-Alain; Stupp, Roger; Knuth, Alexander; Pestalozzi, Bernhard; Samaras, Panagiotis (2018). Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study. BMC Cancer, 18(1):72.

Benzing, Valentin; Eggenberger, Noëmi; Spitzhüttl, Janine; Siegwart, Valerie; Pastore-Wapp, Manuela; Kiefer, Claus; Slavova, Nedelina; Grotzer, Michael; Heinks, Theda; Schmidt, Mirko; Conzelmann, Achim; Steinlin, Maja; Everts, Regula; Leibundgut, Kurt (2018). The Brainfit study: efficacy of cognitive training and exergaming in pediatric cancer survivors - a randomized controlled trial. BMC Cancer, 18(1):18.

Schelch, Karin; Kirschner, Michaela B; Williams, Marissa; Cheng, Yuen Y; van Zandwijk, Nico; Grusch, Michael; Reid, Glen (2018). A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma. Molecular Oncology, 12(1):58-73.

Frey, Tanja; Platz, Elizabeth A; Kanarek, Norma; Bradwin, Gary; Dobs, Adrian S; Rohrmann, Sabine (2018). Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men. Cancer Causes & Control, 29(1):157-166.

Jyotsana, N; Sharma, A; Chaturvedi, A; Scherr, M; Kuchenbauer, F; Sajti, L; Barchanski, A; Lindner, R; Noyan, F; Sühs, K-W; Grote-Koska, D; Brand, K; Vornlocher, H-P; Stanulla, M; Bornhauser, B; Bourquin, J-P; Eder, M; Thol, F; Ganser, A; Humphries, R K; Ramsay, E; Cullis, P; Heuser, M (2018). RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo. Leukemia, 32(1):224-226.

Kim, Tae-Han; Suh, Yun-Suhk; Huh, Yeon-Ju; Son, Young-Gil; Park, Ji-Ho; Yang, Jun-Young; Kong, Seong-Ho; Ahn, Hye Seong; Lee, Hyuk-Joon; Slankamenac, Ksenija; Clavien, Pierre Alain; Yang, Han-Kwang (2018). The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien-Dindo classification in radical gastric cancer surgery. Gastric Cancer, 21(1):171-181.

Strickler, Nicole; Balabanov, Stefan; Casauro, Katharina; Schanz, Urs; Manz, Markus G; Gerber, Bernhard (2018). Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase. Leukemia & Lymphoma, 59(4):855-862.

Juskevicius, Darius; Müller, Anne; Hashwah, Hind; Lundberg, Pontus; Tzankov, Alexandar; Menter, Thomas (2018). Characterization of the mutational profile of 11 diffuse large B-cell lymphoma cell lines. Leukemia & Lymphoma, 59(7):1710-1716.

Wolpert, Fabian; Weller, Michael; Berghoff, Anna Sophie; Rushing, Elisabeth; Füreder, Lisa Michaela; Petyt, Gregory; Leske, Henning; Andratschke, Nicolaus; Regli, Luca; Neidert, Marian Christoph; Stupp, Roger; Stahel, Rolf; Dummer, Reinhard; Frauenfelder, Thomas; Roth, Patrick; Reyns, Nicolas; Kaufmann, Philipp A; Preusser, Matthias; Le Rhun, Emilie (2018). Diagnostic value of 18 F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. European Journal of Cancer, 96:64-72.

Liu, He; He, Zhaoyue; Bode, Peter; Moch, Holger; Simon, Hans-Uwe (2018). Downregulation of Autophagy-Related Proteins 1, 5, and 16 in Testicular Germ Cell Tumors Parallels Lowered LC3B and Elevated p62 Levels, Suggesting Reduced Basal Autophagy. Frontiers in Oncology, 8:366.

Grob, Jean Jacques; Schadendorf, Dirk; Lorigan, Paul; Ascierto, Paolo; Larkin, James; Nathan, Paul; Robert, Caroline; Hauschild, Axel; Weber, Jeffrey; Daud, Adil; Hamid, Omid; Dummer, Reinhard; Hansson, Johan; Hoeller, Christoph; Schachter, Jacob; Van Akkooi, Alexander C J; Garbe, Claus (2018). Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III. European Journal of Cancer, 91:168-170.

Rida, Padmashree; Ogden, Angela; Ellis, Ian O; Varga, Zsuzsanna; Wolff, Antonio C; Traina, Tiffany A; Hatzis, Christos; Palmer, Julie R; Ambrosone, Christine B; Lehmann, Brian D; Nanda, Rita; Montgomery Rice, Valerie; Brawley, Otis W; Torres, Mylin A; Rakha, Emad; Aneja, Ritu (2018). First international TNBC conference meeting report. Breast Cancer Research and Treatment, 169(3):407-412.

Koch, C; Ramsauer, A S; Drögemüller, M; Ackermann, M; Gerber, V; Tobler, K (2018). Genomic comparison of bovine papillomavirus 1 isolates from bovine, equine and asinine lesional tissue samples. Virus Research, 244:6-12.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

Suchorska, Bogdana; Giese, Armin; Biczok, Annamaria; Unterrainer, Marcus; Weller, Michael; Drexler, Mark; Bartenstein, Peter; Schüller, Ulrich; Tonn, Jörg-Christian; Albert, Nathalie L (2018). Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-Oncology, 20(2):279-288.

Ferguson, Scott K; Harral, Julie W; Pak, David I; Redinius, Katherine M; Stenmark, Kurt R; Schaer, Dominik J; Buehler, Paul W; Irwin, David C (2018). Impact of cell-free hemoglobin on contracting skeletal muscle microvascular oxygen pressure dynamics. Nitric Oxide, 76:29-36.

Franzen, Daniel; Schad, Karin; Kowalski, Benedikt; Clarenbach, Christian F; Stupp, Roger; Dummer, Reinhard; Kohler, Malcolm (2018). Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study. Cancer Immunology, Immunotherapy, 67(1):127-134.

Oehl, Kathrin; Kresoja-Rakic, Jelena; Opitz, Isabelle; Vrugt, Bart; Weder, Walter; Stahel, Rolf; Wild, Peter; Felley-Bosco, Emanuela (2018). Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression. Frontiers in Oncology, 8:40.

Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie (2018). MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients. European Journal of Cancer, 98:10-16.

Hogan, Sabrina A; Levesque, Mitchell P; Cheng, Phil F (2018). Melanoma Immunotherapy: Next-Generation Biomarkers. Frontiers in Oncology:8:178.

Kessler, Tobias; Sahm, Felix; Sadik, Ahmed; Stichel, Damian; Hertenstein, Anne; Reifenberger, Guido; Zacher, Angela; Sabel, Michael; Tabatabai, Ghazaleh; Steinbach, Joachim; Sure, Ulrich; Krex, Dietmar; Grosu, Anca-L; Bewerunge-Hudler, Melanie; Jones, David; Pfister, Stefan M; Weller, Michael; Opitz, Christiane; Bendszus, Martin; von Deimling, Andreas; Platten, Michael; Wick, Wolfgang (2018). Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-Oncology, 20(3):367-379.

Beier, Dagmar; Proescholdt, Martin; Reinert, Christiane; Pietsch, Torsten; Jones, David T W; Pfister, Stefan M; Hattingen, Elke; Seidel, Clemens; Dirven, Linda; Luerding, Ralf; Reijneveld, Jaap; Warmuth-Metz, Monika; Bonsanto, Matteo; Bremer, Michael; Combs, Stephanie E; Rieken, Stefan; Herrlinger, Ulrich; Kuntze, Holger; Mayer-Steinacker, Regine; Moskopp, Dag; Schneider, Thomas; Beringer, Andreas; Schlegel, Uwe; Stummer, Walter; Welker, Helmut; Weyerbrock, Astrid; Paulsen, Frank; Rutkowski, Stefan; Weller, Michael; Wick, Wolfgang; et al (2018). Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro-Oncology, 20(3):400-410.

Weiss, Tobias; Weller, Michael; Guckenberger, Matthias; Sentman, Charles L; Roth, Patrick (2018). NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma. Cancer Research, 78(4):1031-1043.

Weiss, Tobias; Schneider, Hannah; Silginer, Manuela; Steinle, Alexander; Pruschy, Martin; Polic, Bojan; Weller, Michael; Roth, Patrick (2018). NKG2D-dependent anti-tumor effects of chemotherapy and radiotherapy against glioblastoma. Clinical Cancer Research, 24(4):882-895.

Wachtel, Marco; Schäfer, Beat W (2018). PAX3-FOXO1: Zooming in on an "undruggable" target. Seminars in Cancer Biology, 50:115-123.

Spalinger, Marianne R; Scharl, Michael (2018). PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation. Molecular, 5(4):e1465013.

Dummer, Reinhard; Michielin, Olivier; Nägeli, Mirjam Chantal; Goldinger, Simone M; Campigotto, Federico; Kriemler-Krahn, Ulrike; Schmid, Herbert; Pedroncelli, Alberto; Micaletto, Sara; Schadendorf, Dirk (2018). Phase I, open-label study of pasireotide in patients with wild type and -wild type, unresectable and/or metastatic melanoma. ESMO Open, 3:e000388.

Biserni, Giovanni Battista; Di Oto, Enrico; Moskovszky, Linda Eszter; Foschini, Maria Pia; Varga, Zsuzsanna (2018). Preferential expression of NY-BR-1 and GATA-3 in male breast cancer. Journal of Cancer Research and Clinical Oncology, 144(2):199-204.

Fritz, Corinna; Borsky, Kim; Stark, Luisa S; Tanadini-Lang, S; Kroeze, Stephanie G C; Krayenbühl, Jérôme; Guckenberger, Matthias; Andratschke, Nicolaus (2018). Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity. Frontiers in Oncology, 8:551.

Haslett, Kate; De Ruysscher, Dirk; Dziadziuszko, Rafal; Guckenberger, Matthias; Pechoux, Cecile Le; Nestle, Ursula; Slotman, Ben; Faivre-Finn, Corinne (2018). Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice. Cancer Treatment and Research Communications, 17:18-22.

Rechsteiner, Markus; Dedes, Konstantin; Fink, Daniel; Pestalozzi, Bernhard; Sobottka-Brillout, Bettina; Moch, Holger; Wild, Peter; Varga, Zsuzsanna (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology, 144(5):865-874.

Stienen, Martin N; Zhang, David Y; Broggi, Morgan; Seggewiss, Dominik; Villa, Stefano; Schiavolin, Silvia; Bozinov, Oliver; Krayenbühl, Niklaus; Sarnthein, Johannes; Ferroli, Paolo; Regli, Luca (2018). The influence of preoperative dependency on mortality, functional recovery and complications after microsurgical resection of intracranial tumors. Journal of Neuro-Oncology, 139(2):441-448.

Knopfová, L; Biglieri, E; Volodko, N; Masařík, M; Hermanová, M; Glaus Garzón, J F; Dúcka, M; Kučírková, T; Souček, K; Šmarda, J; Beneš, P; Borsig, L (2018). Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. Oncogene, 37(8):1020-1030.

Wanner, Miriam; Richard, Aline; Matthes, Katarina; Ortelli, Laura; Lorez, Matthias; Korol, Dimitri; Bordoni, Andrea; Rohrmann, Sabine (2018). Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage. Cancer Causes & Control, 29(2):269-277.

Diem, Stefan; Hasan Ali, Omar; Ackermann, Christoph J; Bomze, David; Koelzer, Viktor H; Jochum, Wolfram; Speiser, Daniel E; Mertz, Kirsten D; Flatz, Lukas (2018). Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease. Cancer Immunology, Immunotherapy, 67(1):39-45.

Dimitriou, Florentia; Braun, Ralph Peter; Mangana, Joanna (2018). Update on adjuvant melanoma therapy. Current Opinion in Oncology, 30(2):118-124.

Küsters-Vandevelde, Heidi V N; Germans, Menno R; Rabbie, Roy; Rashid, Mamunur; Ten Broek, Roel; Blokx, Willeke A M; Prinsen, Clemens F M; Adams, David J; Ter Laan, Mark (2018). Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma. Brain Tumor Pathology, 35(2):127-130.

2017

Ojeda Naharros, Irene; Gesemann, Matthias; Mateos, José María; Barmettler, Gery; Forbes, Austin; Ziegler, Urs; Neuhauss, Stephan C F; Bachmann-Gagescu, Ruxandra (2017). Loss-of-function of the ciliopathy protein Cc2d2a disorganizes the vesicle fusion machinery at the periciliary membrane and indirectly affects Rab8-trafficking in zebrafish photoreceptors. PLoS Genetics, 13(12):e1007150.

Ohs, Isabel; Ducimetière, Laura; Marinho, Joana; Kulig, Paulina; Becher, Burkhard; Tugues, Sonia (2017). Restoration of natural killer cell antimetastatic activity by IL12 and checkpoint blockade. Cancer Research, 77(24):7059-7071.

Papa, Eleanna; Weller, Michael; Weiss, Tobias; Ventura, Elisa; Burghardt, Isabel; Szabó, Emese (2017). Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Cell Death and Disease, 8(12):3210.

Van Hemelrijck, Mieke; Karagiannis, Sophia N; Rohrmann, Sabine (2017). Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans? Cancer Immunology, Immunotherapy, 66(12):1557-1562.

Colombo, Daniele F; Burger, Lukas; Baubec, Tuncay; Schübeler, Dirk (2017). Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content. PLoS Genetics, 13(12):e1007102.

Rasche, M; von Neuhoff, C; Dworzak, M; Bourquin, J-P; Bradtke, J; Göhring, G; Escherich, G; Fleischhack, G; Graf, N; Gruhn, B; Haas, O A; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Stackelberg, A; Tchinda, J; Zemanova, Z; Thiede, C; von Neuhoff, N; Zimmermann, M; Creutzig, U; Reinhardt, D (2017). Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004. Leukemia, 31(12):2807-2814.

Le Rhun, Emilie; Bertrand, Nicolas; Dumont, Aurélie; Tresch, Emmanuelle; Le Deley, Marie-Cécile; Mailliez, Audrey; Preusser, Matthias; Weller, Michael; Revillion, Françoise; Bonneterre, Jacques (2017). Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer. European Journal of Cancer, 87:189-198.

Morand, Grégoire B; Anderegg, Nanina; Vital, Domenic; Ikenberg, Kristian; Huber, Gerhard F; Soyka, Michael B; Egger, Matthias; Holzmann, David (2017). Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis. Oral Oncology, 75:28-34.

Witt, Claudia M; Balneaves, Lynda G; Cardoso, Maria J; Cohen, Lorenzo; Greenlee, Heather; Johnstone, Peter; Kücük, Ömer; Mailman, Josh; Mao, Jun J (2017). A comprehensive definition for integrative oncology. Journal of the National Cancer Institute. Monographs, 2017(52):3-8.

Witt, Claudia M; Herman, Patricia M; Tunis, Sean (2017). Comparative effectiveness research in integrative oncology. Journal of the National Cancer Institute. Monographs, 2017(52):43-45.

Datta, Niloy R; Stutz, Emanuel; Rogers, Susanne; Bodis, Stephan (2017). Conventional Versus Hypofractionated Radiation Therapy for Localized or Locally Advanced Prostate Cancer: A Systematic Review and Meta-analysis along with Therapeutic Implications. International Journal of Radiation Oncology, Biology, Physics, 99(3):573-589.

Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D; Robert, Caroline; Pavlick, Anna C; Gonzalez, Rene; Hodi, F Stephen; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Gangadhar, Tara C; Wei, Ziwen; Ebbinghaus, Scot; Ibrahim, Nageatte; Ribas, Antoni (2017). Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. European Journal of Cancer, 86:37-45.

De Luca, Roberto; Soltermann, Alex; Pretto, Francesca; Pemberton-Ross, Catherine; Pellegrini, Giovanni; Wulhfard, Sarah; Neri, Dario (2017). Potency-matched dual cytokine-antibody fusion proteins for cancer therapy. Molecular Cancer Therapeutics, 16(11):2442-2451.

Anugraham, Merrina; Jacob, Francis; Everest-Dass, Arun V; Schoetzau, Andreas; Nixdorf, Sheri; Hacker, Neville F; Fink, Daniel; Heinzelmann-Schwarz, Viola; Packer, Nicolle H (2017). Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. Molecular Oncology, 11(11):1595-1615.

Basset-Séguin, N; Hauschild, A; Kunstfeld, R; Grob, J; Dréno, B; Mortier, L; Ascierto, P A; Licitra, L; Dutriaux, C; Thomas, L; Meyer, N; Guillot, B; Dummer, R; Arenberger, P; Fife, K; Raimundo, A; Dika, E; Dimier, N; Fittipaldo, A; Xynos, I; Hansson, J (2017). Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial. European Journal of Cancer, 86:334-348.

Renfrow, Jaclyn J; Weller, Michael; Strowd, Roy E (2017). Meeting Update-World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017. Neuro-Oncology, 19(11):1457-1459.

Feller, Anita; Schmidlin, Kurt; Bordoni, Andrea; Bouchardy, Christine; Bulliard, Jean-Luc; Camey, Bertrand; Konzelmann, Isabelle; Maspoli, Manuela; Wanner, Miriam; Clough-Gorr, Kerri M (2017). Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study. International Journal of Cancer, 141(8):1529-1539.

Peverelli, E; Catalano, R; Giardino, E; Treppiedi, D; Morelli, V; Ronchi, C L; Vaczlavik, A; Fusco, N; Ferrero, S; Bertherat, J; Beuschlein, F; Chiodini, I; Arosio, M; Spada, A; Mantovani, G (2017). Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells. Cancer Letters, 406:54-63.

Mackay, Alan; Burford, Anna; Carvalho, Diana; Izquierdo, Elisa; Fazal-Salom, Janat; Taylor, Kathryn R; Bjerke, Lynn; Clarke, Matthew; Vinci, Mara; Nandhabalan, Meera; Temelso, Sara; Popov, Sergey; Molinari, Valeria; Raman, Pichai; Waanders, Angela J; Han, Harry J; Gupta, Saumya; Marshall, Lynley; Zacharoulis, Stergios; Vaidya, Sucheta; Mandeville, Henry C; Bridges, Leslie R; Martin, Andrew J; Al-Sarraj, Safa; Chandler, Christopher; Ng, Ho-Keung; Li, Xingang; Mu, Kun; Trabelsi, Saoussen; Brahim, Dorra H'mida-Ben; Baudis, Michael; Jones, Chris; et al (2017). Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell, 32(4):520-537.e5.

Samaras, Panagiotis; Tusup, Marina; Nguyen-Kim, Thi Dan Linh; Seifert, Burkhardt; Bachmann, Helga; von Moos, Roger; Knuth, Alexander; Pascolo, Steve (2017). Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer. Cancer Chemotherapy and Pharmacology, 80(5):1005-1012.

Silginer, Manuela; Nagy, Sara; Happold, Caroline; Schneider, Hannah; Weller, Michael; Roth, Patrick (2017). Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma. Neuro-Oncology, 19(10):1338-1349.

Kilday, John-Paul; Caldarelli, Massimo; Massimi, Luca; Chen, Robert Hsin-Hung; Lee, Yi Yen; Liang, Muh-Lii; Parkes, Jeanette; Naiker, Thuran; van Veelen, Marie-Lise; Michiels, Erna; Mallucci, Conor; Pettorini, Benedetta; Meijer, Lisethe; Dorfer, Christian; Czech, Thomas; Diezi, Manuel; Schouten-van Meeteren, Antoinette Y N; Holm, Stefan; Gustavsson, Bengt; Benesch, Martin; Müller, Hermann L; Hoffmann, Anika; Rutkowski, Stefan; Flitsch, Joerg; Escherich, Gabriele; Grotzer, Michael; Spoudeas, Helen A; Azquikina, Kristian; Capra, Michael; Jiménez-Guerra, Rolando; MacDonald, Patrick; Johnston, Donna L; Dvir, Rina; Constantini, Shlomi; Kuo, Meng-Fai; Yang, Shih-Hung; Bartels, Ute (2017). Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-Oncology, 19(10):1398-1407.

Konstantinoudis, Garyfallos; Kreis, Christian; Ammann, Roland A; Niggli, Felix; Kuehni, Claudia E; Spycher, Ben D; Swiss Paediatric Oncology Group; Swiss National Cohort Study Group (2017). Spatial clustering of childhood leukaemia in Switzerland: A nationwide study. International Journal of Cancer, 141(7):1324-1332.

Stainier, Didier Y R; Raz, Erez; Lawson, Nathan D; Ekker, Stephen C; Burdine, Rebecca D; Eisen, Judith S; Ingham, Philip W; Schulte-Merker, Stefan; Yelon, Deborah; Weinstein, Brant M; Mullins, Mary C; Wilson, Stephen W; Ramakrishnan, Lalita; Amacher, Sharon L; Neuhauss, Stephan C F; Meng, Anming; Mochizuki, Naoki; Panula, Pertti; Moens, Cecilia B (2017). Guidelines for morpholino use in zebrafish. PLoS Genetics, 13(10):e1007000.

de Groot, Claire; Floriou-Servou, Amalia; Tsai, Yuan-Chen; Früh, Simon; Kohler, Manuela; Parkin, Georgia; Schwerdel, Cornelia; Bosshard, Giovanna; Kaila, Kai; Fritschy, Jean-Marc; Tyagarajan, Shiva K (2017). RhoGEF9 splice isoforms influence neuronal maturation and synapse formation downstream of α2 GABAA receptors. PLoS Genetics, 13(10):e1007073.

Eggermont, Alexander M M; Dummer, Reinhard (2017). The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients. European Journal of Cancer, 86:101-105.

Malchers, Florian; Ercanoglu, Meryem; Schütte, Daniel; Castiglione, Roberta; Tischler, Verena; Michels, Sebastian; Dahmen, Ilona; Brägelmann, Johannes; Menon, Roopika; Heuckmann, Johannes M; George, Julie; Ansén, Sascha; Sos, Martin L; Soltermann, Alex; Peifer, Martin; Wolf, Jürgen; Büttner, Reinhard; Thomas, Roman K (2017). Mechanisms of primary drug resistance in FGFR1-amplified lung cancer. Clinical Cancer Research, 23(18):5527-5536.

Boege, Yannick; Malehmir, Mohsen; Healy, Marc E; Wolf, Monika Julia; Böhm, Friederike; Frick, Lukas; Maire, Renaud; Moch, Holger; Heikenwalder, Mathias; Weber, Achim; Lopes, Massimo; et al (2017). A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development. Cancer Cell, 32(3):342-359.e10.

Panje, Cédric; Riesterer, Oliver; Glanzmann, Christoph; Studer, Gabriela (2017). Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer. BMC Cancer, 17(1):643.

Berghoff, Anna S; Wolpert, Fabian; Holland-Letz, Tim; Koller, Romina; Widhalm, Georg; Gatterbauer, Brigitte; Dieckmann, Karin; Birner, Peter; Bartsch, Rupert; Zielinski, Christoph C; Weller, Michael; Preusser, Matthias (2017). Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score. Neuro-Oncology, 19(9):1255-1262.

Lorez, Matthias; Bordoni, Andrea; Bouchardy, Christine; Bulliard, Jean-Luc; Camey, Bertrand; Dehler, Silvia; Frick, Harald; Konzelmann, Isabelle; Maspoli, Manuela; Mousavi, Seyed M; Rohrmann, Sabine; Arndt, Volker (2017). Evaluation of completeness of case ascertainment in Swiss cancer registration. European Journal of Cancer Prevention, 26:S139-S146.

Perez-Rivas, Luis G; Oßwald, Andrea; Knösel, Thomas; Lucia, Kristin; Schaaf, Christian; Hristov, Michael; Fazel, Julia; Kirchner, Thomas; Beuschlein, Felix; Reincke, Martin; Theodoropoulou, Marily (2017). Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome. Endocrine-Related Cancer, 24(9):L73-L77.

Felsberg, Joerg; Hentschel, Bettina; Kaulich, Kerstin; Gramatzki, Dorothee; Zacher, Angela; Malzkorn, Bastian; Kamp, Marcel; Sabel, Michael; Simon, Matthias; Westphal, Manfred; Schackert, Gabriele; Tonn, Jörg-Christian; Pietsch, Torsten; von Deimling, Andreas; Loeffler, Markus; Reifenberger, Guido; Weller, Michael (2017). Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas. Clinical Cancer Research, 23(22):6846-6855.

Jaaks, Patricia; Bernasconi, Michele (2017). The proprotein convertase furin in tumour progression. International Journal of Cancer, 141(4):654-663.

Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.

Izar, Benjamin; Sharfman, William; Hodi, F Stephen; Lawrence, Donald; Flaherty, Keith T; Amaravadi, Ravi; Kim, Kevin B; Puzanov, Igor; Sosman, Jeffrey; Dummer, Reinhard; Goldinger, Simone M; Lam, Lyhping; Kakar, Shefali; Tang, Zhongwen; Krieter, Oliver; McDermott, David F; Atkins, Michael B (2017). A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. Cancer Medicine, 6(8):1904-1914.

Koelblinger, Peter; Dornbierer, Joelle; Dummer, Reinhard (2017). A review of binimetinib for the treatment of mutant cutaneous melanoma. Future Oncology (London, England), 13(20):1755-1766.

Frauchiger, Anna L; Brüggen, Marie-Charlotte; Goldinger, Simone M; Dummer, Reinhard (2017). Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. Melanoma research, 27(4):400-401.

Mangana, Joanna; Cheng, Phil F; Kaufmann, Corina; Amann, Valerie C; Frauchiger, Anna L; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P; Levesque, Mitchell P; Goldinger, Simone M; Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma research, 27(4):358-368.

Murer, Carla; Kränzlin-Stieger, Pascale; French, Lars E; Dummer, Reinhard; Goldinger, Simone M (2017). Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report. Melanoma research, 27(4):396-398.

Kulkarni, Girish S; Hermanns, Thomas; Wei, Yanliang; Bhindi, Bimal; Satkunasivam, Raj; Athanasopoulos, Paul; Bostrom, Peter J; Kuk, Cynthia; Li, Kathy; Templeton, Arnoud J; Sridhar, Srikala S; van der Kwast, Theodorus H; Chung, Peter; Bristow, Robert G; Milosevic, Michael; Warde, Padraig; Fleshner, Neil E; Jewett, Michael A S; Bashir, Shaheena; Zlotta, Alexandre R (2017). Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. Journal of Clinical Oncology, 35(20):2299-2305.

Herdman, Chelsea; Mars, Jean-Clement; Stefanovsky, Victor Y; Tremblay, Michel G; Sabourin-Felix, Marianne; Lindsay, Helen; Robinson, Mark D; Moss, Tom (2017). A unique enhancer boundary complex on the mouse ribosomal RNA genes persists after loss of Rrn3 or UBF and the inactivation of RNA polymerase I transcription. PLoS Genetics, 13(7):e1006899.

Schadendorf, Dirk; et al; Dummer, Reinhard (2017). Health-related quality of life results from the phase III CheckMate 067 study. European Journal of Cancer, 82:80-91.

Bogowicz, Marta; Riesterer, Oliver; Ikenberg, Kristian; Stieb, Sonja; Moch, Holger; Studer, Gabriela; Guckenberger, Matthias; Tanadini-Lang, Stephanie (2017). Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 99(4):921-928.

Lorch, Anja; Beyer, Jörg (2017). How we treat germ cell cancers. Cancer, 123(12):2190-2192.

Brüggemann, C; Kirchberger, M C; Goldinger, S M; Weide, B; Konrad, A; Erdmann, M; Schadendorf, D; Croner, R S; Krähenbühl, L; Kähler, K C; Hafner, C; Leisgang, W; Kiesewetter, F; Dummer, R; Schuler, G; Stürzl, M; Heinzerling, L (2017). Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab. Journal of Cancer Research and Clinical Oncology, 143(10):1977-1984.

Delord, Jean-Pierre; Robert, Caroline; Nyakas, Marta; McArthur, Grant A; Kudchakar, Ragini; Mahipal, Amit; Yamada, Yasuhide; Sullivan, Ryan; Arance, Ana; Kefford, Richard F; Carlino, Matteo S; Hidalgo, Manuel; Gomez-Roca, Carlos; Michel, Daniela; Seroutou, Abdelkader; Aslanis, Vassilios; Caponigro, Giordano; Stuart, Darrin D; Moutouh-de Parseval, Laure; Demuth, Tim; Dummer, Reinhard (2017). Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma. Clinical Cancer Research:1-38.

Yuan, Detian; Huang, Shan; Berger, Emanuel; et al; Weber, Achim (2017). Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. Cancer Cell, 31(6):771-789.e6.

Galldiks, Norbert; Albert, Nathalie L; Sommerauer, Michael; Grosu, Anca L; Ganswindt, Ute; Law, Ian; Preusser, Matthias; Le Rhun, Emilie; Vogelbaum, Michael A; Zadeh, Gelareh; Dhermain, Frédéric; Weller, Michael; Langen, Karl-Josef; Tonn, Jörg C (2017). PET Imaging in Patients with Meningioma - Report of the RANO/PET Group. Neuro-Oncology, 19(12):1576-1587.

Van der Does, Dieuwertje; Boutrot, Freddy; Engelsdorf, Timo; Rhodes, Jack; McKenna, Joseph F; Vernhettes, Samantha; Koevoets, Iko; Tintor, Nico; Veerabagu, Manikandan; Miedes, Eva; Segonzac, Cécile; Roux, Milena; Breda, Alice S; Hardtke, Christian S; Molina, Antonio; Rep, Martijn; Testerink, Christa; Mouille, Grégory; Höfte, Herman; Hamann, Thorsten; Zipfel, Cyril (2017). The Arabidopsis leucine-rich repeat receptor kinase MIK2/LRR-KISS connects cell wall integrity sensing, root growth and response to abiotic and bioticstresses. PLoS Genetics, 13(6):e1006832.

Seystahl, Katharina; Papachristodoulou, Alexandros; Burghardt, Isabel; Schneider, Hannah; Hasenbach, Kathy; Janicot, Michel; Roth, Patrick; Weller, Michael (2017). Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma. Molecular Cancer Therapeutics, 16(6):1177-1186.

Matter-Walstra, K; Schwenkglenks, Matthias; Dedes, K J (2017). Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting. Breast Cancer Research and Treatment, 163(3):635.

Robl, Bernhard; Botter, Sander Martijn; Boro, Aleksandar; Meier, Daniela; Neri, Dario; Fuchs, Bruno (2017). Evaluation of F8-TNF-α in Models of Early and Progressive Metastatic Osteosarcoma. Translational Oncology, 10(3):419-430.

Angelousi, Anna; Dimitriadis, Georgios K; Zografos, Georgios; Nölting, Svenja; Kaltsas, Gregory; Grossman, Ashley (2017). Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocrine-Related Cancer, 24(6):R239-R259.

Stämpfli, Simon F; Akhmedov, Alexander; Hausladen, Silke; Varga, Zsuzsanna; Dedes, Konstantin J; Hellermann, Jens; Lüscher, Thomas F; Kristiansen, Glen; Tanner, Felix C; Breitenstein, Alexander (2017). Tissue Factor Expression Does Not Predict Mortality in Breast Cancer Patients. Anticancer Research, 37(6):3259-3264.

Castañón, Eduardo; Soltermann, Alex; López, Inés; Román, Marta; Ecay, Margarita; Collantes, María; Redrado, Miriam; Baraibar, Iosune; López-Picazo, José María; Rolfo, Christian; Vidal-Vanaclocha, Fernando; Raez, Luis; Weder, Walter; Calvo, Alfonso; Gil-Bazo, Ignacio (2017). The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer Letters, 402:43-51.

Gvozdenovic, Ana; Boro, Aleksandar; Born, Walter; Muff, Roman; Fuchs, Bruno (2017). A bispecific antibody targeting IGF-IR and EGFR has tumor and metastasis suppressive activity in an orthotopic xenograft osteosarcoma mouse model. American Journal of Cancer Research, 7(7):1435-1449.

Gachechiladze, Mariam; Škarda, Josef; Soltermann, Alex; Joerger, Markus (2017). RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies. International Journal of Cancer, 141(7):1286-1294.

van den Bent, Martin J; Weller, Michael; Wen, Patrick Y; Kros, Johan M; Aldape, Ken; Chang, Susan (2017). A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics. Neuro-Oncology, 19(5):614-624.

Tumeh, Paul C; Hellmann, Matthew D; Dummer, Reinhard; et al (2017). Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC. Cancer Immunology Research, 5(5):417-424.

Le Rhun, Emilie; Rudà, Roberta; Devos, Patrick; Hoang-Xuan, Khê; Brandsma, Dieta; Pérez Segura, Pedro; Soffietti, Riccardo; Weller, Michael (2017). Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. Journal of Neuro-Oncology, 133(2):419-427.

Herrlinger, Ulrich; Schäfer, Niklas; Fimmers, Rolf; Griesinger, Frank; Rauch, Michael; Kirchen, Heinz; Roth, Patrick; Glas, Martin; Bamberg, Michael; Martus, Peter; Thiel, Eckhard; Korfel, Agnieszka; Weller, Michael (2017). Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. Journal of Cancer Research and Clinical Oncology, 143(9):1815-1821.

Silginer, Manuela; Weller, Michael; Stupp, Roger; Roth, Patrick (2017). Biological activity of tumor-treating fields in preclinical glioma models. Cell Death and Disease, 8(4):e2753.

Byrne, Karl Smith; Agudo, Antonio; Ardanaz, Eva; Boeing, Heiner; Kaaks, Rudolf; Khaw, Kay-Tee; Larrañaga, Nerea; Navarro, Carmen; Olsen, Anja; Overvad, Kim; Rohrmann, Sabine; Tjønneland, Anne; Tsilidis, Konstantinos K; Johansson, Mattias; Riboli, Elio; Key, Timothy J; Travis, Ruth C; et al (2017). Vasectomy and prostate cancer risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Journal of Clinical Oncology, 35(12):1297-1303.

Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan; Swiss Group for Clinical Cancer Research (SAKK) (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC Cancer, 17(1):265.

Schaefer, S M; Segalada, C; Cheng, P F; Bonalli, M; Parfejevs, V; Levesque, M P; Dummer, R; Nicolis, S K; Sommer, L (2017). Sox2 is dispensable for primary melanoma and metastasis formation. Oncogene, 36(31):4516-4524.

Tost, Jorg; Gay, Steffen; Firestein, Gary (2017). Epigenetics of the immune system and alterations in inflammation and autoimmunity. Epigenomics, 9(4):371-373.

Olkhov-Mitsel, Ekaterina; Savio, Andrea J; Kron, Ken J; Pethe, Vaijayanti V; Hermanns, Thomas; Fleshner, Neil E; van Rhijn, Bas W; van der Kwast, Theodorus H; Zlotta, Alexandre R; Bapat, Bharati (2017). Epigenome-wide DNA methylation profiling identifies differential methylation biomarkers in high-grade bladder cancer. Translational Oncology, 10(2):168-177.

Ravindran, Ethiraj; Hu, Hao; Yuzwa, Scott A; Hernandez-Miranda, Luis R; Kraemer, Nadine; Ninnemann, Olaf; Musante, Luciana; Boltshauser, Eugen; Schindler, Detlev; Hübner, Angela; Reinecker, Hans-Christian; Ropers, Hans-Hilger; Birchmeier, Carmen; Miller, Freda D; Wienker, Thomas F; Hübner, Christoph; Kaindl, Angela M (2017). Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. PLoS Genetics, 13(4):e1006746.

Sailer, Verena; Pauli, Chantal; Merzier, Elyze C; Mosquera, Juan Miguel; Beltran, Himisha; Rubin, Mark A; Rao, Rema A (2017). On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study. Anticancer Research, 37(4):1569-1573.

Franz, Alexandra; Shlyueva, Daria; Brunner, Erich; Stark, Alexander; Basler, Konrad (2017). Probing the canonicity of the Wnt/Wingless signaling pathway. PLoS Genetics, 13(4):e1006700.

Wehrli, M; Oppliger Leibundgut, E; Gattiker, H H; Manz, Markus G; Müller, Antonia M S; Goede, J S (2017). Response to tyrosine kinase hnhibitors in myeloproliferative neoplasia with 8p11 translocation and CEP110-FGFR1 rearrangement. The Oncologist, 22(4):480-483.

Basler, L; Kroeze, S G C; Guckenberger, M (2017). SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer, 106:50-57.

Casanova, Ruben; Xia, Daniel; Rulle, Undīne; Nanni, Paolo; Grossmann, Jonas; Vrugt, Bart; Wettstein, Reto; Ballester, Rafael; Astolfo, Alberto; Weder, Walter; Moch, Holger; Stampanoni, Marco; Beck, Andrew H; Soltermann, Alex (2017). Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness. Cancer Research, 77(10):2585-2593.

Nosrati, Adi; Tsai, Katy K; Goldinger, Simone M; Tumeh, Paul; Grimes, Barbara; Loo, Kimberly; Algazi, Alain P; Nguyen-Kim, Thi Dan Linh; Levesque, Mitchell; Dummer, Reinhard; Hamid, Omid; Daud, Adil (2017). Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy. British Journal of Cancer, 116(9):1141-1147.

Frank-Bertoncelj, Mojca; Klein, Kerstin; Gay, Steffen (2017). Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis. Epigenomics, 9(4):493-504.

Landfried, Britta; Samardzija, Marijana; Barben, Maya; Schori, Christian; Klee, Katrin; Storti, Federica; Grimm, Christian (2017). Digoxin-induced retinal degeneration depends on rhodopsin. Cell Death and Disease, 8(3):e2670.

Guckenberger, Matthias (2017). SBRT in eight fractions. International Journal of Radiation Oncology, Biology, Physics, 97(4):653.

Weller, Michael; Roth, Patrick; Sahm, Felix; Burghardt, Isabel; Schuknecht, Bernhard; Rushing, Elisabeth J; Regli, Luca; Lindemann, Justin P; von Deimling, Andreas (2017). Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363. Journal of the National Cancer Institute, 109(3):1-4.

Dummer, Reinhard; Ramelyte, Egle; Levesque, Mitch; Goldinger, Simone M; Braun, Ralph P (2017). Critical aspects to achieve a high-quality melanoma clinic. Current Opinion in Oncology, 29(2):145-150.

Acuna-Hidalgo, Rocio; Deriziotis, Pelagia; Steehouwer, Marloes; Gilissen, Christian; Graham, Sarah A; van Dam, Sipko; Hoover-Fong, Julie; Telegrafi, Aida B; Destree, Anne; Smigiel, Robert; Lambie, Lindsday A; Kayserili, Hülya; Altunoglu, Umut; Lapi, Elisabetta; Uzielli, Maria Luisa; Aracena, Mariana; Nur, Banu G; Mihci, Ercan; Moreira, Lilia M A; Borges Ferreira, Viviane; Horovitz, Dafne D G; da Rocha, Katia M; Jezela-Stanek, Aleksandra; Brooks, Alice S; Reutter, Heiko; Cohen, Julie S; Fatemi, Ali; Smitka, Martin; Grebe, Theresa A; Di Donato, Nataliya; et al (2017). Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies. PLoS Genetics, 13(3):e1006683.

Gachechiladze, Mariam; Škarda, Josef; Kolek, Vítězslav; Grygárková, Ivona; Langová, Kateřina; Bouchal, Jan; Kolář, Zdeněk; Baty, Florent; Stahel, Rolf; Weder, Walter; Soltermann, Alex; Joerger, Markus (2017). Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer, 105:31-38.

Wagner, Franca; Hakami, Yahya Ali; Warnock, Geoffrey; Fischer, Gabriel; Huellner, Martin W; Veit-Haibach, Patrick (2017). Comparison of contrast-enhanced CT and [(18)F]FDG PET/CT analysis using kurtosis and skewness in patients with primary colorectal cancer. Molecular Imaging and Biology, 19(5):795-803.

Wang, Hui; Schaefer, Thorsten; Konantz, Martina; Braun, Martin; Varga, Zsuzsanna; Paczulla, Anna M; Reich, Selina; Jacob, Francis; Perner, Sven; Moch, Holger; Fehm, Tanja N; Kanz, Lothar; Schulze-Osthoff, Klaus; Lengerke, Claudia (2017). Prominent oncogenic roles of EVI1 in breast carcinoma. Cancer Research, 77(8):2148-2160.

Soffietti, Riccardo; Abacioglu, Ufuk; Baumert, Brigitta; Combs, Stephanie E; Kinhult, Sara; Kros, Johan M; Marosi, Christine; Metellus, Philippe; Radbruch, Alexander; Villa Freixa, Salvador S; Brada, Michael; Carapella, Carmine M; Preusser, Matthias; Le Rhun, Emilie; Rudà, Roberta; Tonn, Joerg C; Weber, Damien C; Weller, Michael (2017). Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro-Oncology, 19(2):162-174.

Bonadies, Nicolas; Feller, Anita; Rovo, Alicia; Ruefer, Axel; Blum, Sabine; Gerber, Bernhard; Stuessi, Georg; Benz, Rudolf; Cantoni, Nathan; Holbro, Andreas; Schmidt, Adrian; Lehmann, Thomas; Wilk, C Matthias; Arndt, Volker; NICER Working Group (2017). Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Cancer Epidemiology, 46:85-92.

Walser, Michael; Umbricht, Christoph Alois; Fröhli, Erika; Nanni, Paolo; Hajnal, Alex (2017). β-Integrin de-phosphorylation by the Density-Enhanced Phosphatase DEP-1 attenuates EGFR signaling in C. elegans. PLoS Genetics, 13(1):e1006592.

Cloughesy, Timothy; Finocchiaro, Gaetano; Belda-Iniesta, Cristóbal; Recht, Lawrence; Brandes, Alba A; Pineda, Estela; Mikkelsen, Tom; Chinot, Olivier L; Balana, Carmen; Macdonald, David R; Westphal, Manfred; Hopkins, Kirsten; Weller, Michael; Bais, Carlos; Sandmann, Thomas; Bruey, Jean-Marie; Koeppen, Hartmut; Liu, Bo; Verret, Wendy; Phan, See-Chun; Shames, David S (2017). Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O(6)-Methylguanine-DNA Methyltransferase Biomarker Analyses. Journal of Clinical Oncology, 35(3):343-351.

Valtcheva, Nadejda; Lang, Franziska M; Noske, Aurelia; Samartzis, Eleftherios Pierre; Schmidt, Anna-Maria; Bellini, Elisa; Fink, Daniel; Moch, Holger; Rechsteiner, Markus; Dedes, Konstantin J; Wild, Peter J (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer, 17(1):66.

Peirs, S; Frismantas, V; Matthijssens, F; Van Loocke, W; Pieters, T; Vandamme, N; Lintermans, B; Dobay, M P; Berx, G; Poppe, B; Goossens, S; Bornhauser, B C; Bourquin, J-P; Van Vlierberghe, P (2017). Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Leukemia, 31(10):2037-2047.

Fischer, Stefanie; Tandstad, Torgrim; Wheater, Matthew; Porfiri, Emilio; Fléchon, Aude; Aparicio, Jorge; Klingbiel, Dirk; Skrbinc, Breda; Basso, Umberto; Shamash, Jonathan; Lorch, Anja; Dieckmann, Klaus-Peter; Cohn-Cedermark, Gabriella; Ståhl, Olof; Chau, Caroline; Arriola, Edurne; Marti, Kalena; Hutton, Paul; Laguerre, Brigitte; Maroto, Pablo; Beyer, Jörg; Gillessen, Silke (2017). Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. Journal of Clinical Oncology, 35(2):194-200.

Giuliani, Meredith; Hope, Andrew; Guckenberger, Matthias; Mantel, Frederick; Peulen, Heike; Sonke, Jan-Jakob; Belderbos, José; Werner-Wasik, Maria; Ye, Hong; Grills, Inga S (2017). Stereotactic body radiation therapy in octo- and nonagenarians for the treatment of early-stage lung cancer. International Journal of Radiation Oncology, Biology, Physics, 98(4):893-899.

Dafflon, C; Craig, V J; Méreau, H; Gräsel, J; Schacher Engstler, B; Hoffman, G; Nigsch, F; Gaulis, S; Barys, L; Ito, M; Aguadé-Gorgorió, J; Bornhauser, B; Bourquin, J-P; Proske, A; Stork-Fux, C; Murakami, M; Sellers, W R; Hofmann, F; Schwaller, J; Tiedt, R (2017). Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia. Leukemia, 31(6):1269-1277.

Schindler, Matthias; Belle, Fabiën N; Grotzer, Michael A; von der Weid, Nicolas X; Kuehni, Claudia E; Swiss Paediatric Oncology Group (2017). Childhood cancer survival in Switzerland (1976-2013): Time-trends and predictors. International Journal of Cancer, 140(1):62-74.

von Moos, Roger; Costa, Luis; Ripamonti, Carla Ida; Niepel, Daniela; Santini, Daniele (2017). Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. European Journal of Cancer, 71:80-94.

Brandt, Simone; Samartzis, Eleftherios Pierre; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Hahn, M; Bürckert, J-P; Luttenberger, C A; Klebow, S; Hess, M; Al-Maarri, M; Vogt, M; Reißig, S; Hallek, M; Wienecke-Baldacchino, A; Buch, T; Muller, C P; Pallasch, C P; Wunderlich, F T; Waisman, A; Hövelmeyer, N (2017). Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. Leukemia, 32(1):72-82.

Varga, Zsuzsanna; Lebeau, Annette; Bu, Hong; Hartmann, Arndt; Penault-Llorca, Frederique; Guerini-Rocco, Elena; Schraml, Peter; Symmans, Fraser; Stoehr, Robert; Teng, Xiaodong; Turzynski, Andreas; von Wasielewski, Reinhard; Gürtler, Claudia; Laible, Mark; Schlombs, Kornelia; Joensuu, Heikki; Keller, Thomas; Sinn, Peter; Sahin, Ugur; Bartlett, John; Viale, Giuseppe (2017). An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®. Breast Cancer Research, 19:55.

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (SAKK) (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Meletta, Romana; Steier, Larissa; Borel, Nicole; Mu, Linjing; Keller, Claudia; Chiotellis, Aristeidis; Russo, Erica; Halin, Cornelia; Ametamey, Simon M; Schibli, Roger; Krämer, Stefanie D; Müller Herde, Adrienne (2017). CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers. Molecular Imaging and Biology, 19(1):90-99.

Meletta, Romana; Slavik, Roger; Mu, Linjing; Rancic, Zoran; Borel, Nicole; Schibli, Roger; Ametamey, Simon M; Krämer, Stefanie D; Müller Herde, Adrienne (2017). Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: evaluation of the novel radiotracer [ 11 c]rs-016 targeting CB2 in atherosclerosis. Nuclear medicine and biology, 47:31-43.

Bossart, Simon; Thurneysen, Selina; Rushing, Elisabeth; Frontzek, Karl; Leske, Henning; Mihic‐Probst, Daniela; Nagel, Hannes W; Mangana, Johanna; Goldinger, Simone M; Dummer, Reinhard (2017). Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma. The Oncologist, 22(6):749-753.

Scherz, Nathalie; Bachmann-Mettler, Irène; Chmiel, Corinne; Senn, Oliver; Boss, Nathalie; Bardheci, Katarina; Rosemann, Thomas (2017). Case management to increase quality of life after cancer treatment: a randomized controlled trial. BMC Cancer, 17(1):223.

Fridle, Chantal; Medinger, Michael; Wilk, Matthias C; Seipel, Katja; Passweg, Jakob; Manz, Markus G; Pabst, Thomas (2017). Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leukemia & Lymphoma, 58(5):1068-1075.

Dummer, Reinhard; Hoeller, Christoph; Gruter, Isabella Pezzani; Michielin, Olivier (2017). Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors. Cancer Immunology, Immunotherapy, 66(6):683-695.

Velizheva, Nadezda P; Rechsteiner, Markus P; Wong, Christine E; Zhong, Qing; Rössle, Matthias; Bode, Beata; Moch, Holger; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2017). Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathology, 125(1):30-40.

Haueis, Silvia A; Kränzlin, Pascale; Mangana, Joanna; Cheng, Phil F; Urosevic-Maiwald, Mirjana; Braun, Ralph P; Levesque, Mitchell P; Dummer, Reinhard; Goldinger, Simone M (2017). Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching? Melanoma research, 27(3):231-237.

Trautinger, Franz; Eder, Johanna; Assaf, Chalid; Bagot, Martine; Cozzio, Antonio; Dummer, Reinhard; Gniadecki, Robert; Klemke, Claus-Detlev; Ortiz-Romero, Pablo L; Papadavid, Evangelia; Pimpinelli, Nicola; Quaglino, Pietro; Ranki, Annamari; Scarisbrick, Julia; Stadler, Rudolf; Väkevä, Liisa; Vermeer, Maarten H; Whittaker, Sean; Willemze, Rein; Knobler, Robert (2017). European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. European Journal of Cancer, 77:57-74.

Meier, Daniela; Botter, Sander M; Campanile, Carmen; Robl, Bernhard; Gräfe, Susanna; Pellegrini, Giovanni; Born, Walter; Fuchs, Bruno (2017). Foscan and Foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models. International Journal of Cancer, 140(7):1680-1692.

Minini, Remo; Rohrmann, Sabine; Braun, Ralph; Korol, Dimitri; Dehler, Silvia (2017). Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the canton of Zurich, Switzerland. Melanoma research, 27(2):145-151.

Rieber, Juliane; Abbassi-Senger, Nasrin; Adebahr, Sonja; Andratschke, Nicolaus; Blanck, Oliver; Duma, Marciana; Eble, Michael J; Ernst, Iris; Flentje, Michael; Gerum, Sabine; Hass, Peter; Henkenberens, Christoph; Hildebrandt, Guido; Imhoff, Detlef; Kahl, Henning; Klass, Nathalie Desirée; Krempien, Robert; Lohaus, Fabian; Lohr, Frank; Petersen, Cordula; Schrade, Elsge; Streblow, Jan; Uhlmann, Lorenz; Wittig, Andrea; Sterzing, Florian; Guckenberger, Matthias (2017). Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. International Journal of Radiation Oncology, Biology, Physics, 98(3):511-520.

Behera, Reeti; Kaur, Amanpreet; Webster, Marie R; Kim, Suyeon; Ndoye, Abibatou; Kugel, Curtis H; Alicea, Gretchen M; Wang, Joshua; Ghosh, Kanad; Cheng, Phil; Lisanti, Sofia; Marchbank, Katie; Dang, Vanessa; Levesque, Mitchell; Dummer, Reinhard; Xu, Xiaowei; Herlyn, Meenhard; Aplin, Andrew E; Roesch, Alexander; Caino, Cecilia; Altieri, Dario C; Weeraratna, Ashani T (2017). Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho. Clinical Cancer Research, 23(12):3181-3190.

Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M; Loquai, Carmen; Markovic, Svetomir N; Joseph, Richard W; Markey, Kelly; Utikal, Jochen S; Weishaupt, Carsten; Goldinger, Simone M; Sondak, Vernon K; Zager, Jonathan S; Schadendorf, Dirk; Khushalani, Nikhil I (2017). Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. European Journal of Cancer, 75:47-55.

Roth, Patrick; Valavanis, Antonios; Weller, Michael (2017). Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab. Neuro-Oncology, 19(3):454-456.

Levesque, Mitchell P; Cheng, Phil F; Raaijmakers, Marieke I G; Saltari, Annalisa; Dummer, Reinhard (2017). Metastatic melanoma moves on: translational science in the era of personalized medicine. Cancer Metastasis Reviews, 36(1):7-21.

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, J-J; Nathan, P; Dummer, R; Forsea, A-M; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; et al (2017). More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. European Journal of Cancer, 75:313-322.

Long, Georgina V; Weber, Jeffrey S; Larkin, James; Atkinson, Victoria; Grob, Jean-Jacques; Schadendorf, Dirk; Dummer, Reinhard; Robert, Caroline; Márquez-Rodas, Ivan; McNeil, Catriona; Schmidt, Henrik; Briscoe, Karen; Baurain, Jean-François; Hodi, F Stephen; Wolchok, Jedd D (2017). Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials. JAMA Oncology, 3(11):1511.

Gébleux, Rémy; Stringhini, Marco; Casanova, Ruben; Soltermann, Alex; Neri, Dario (2017). Non-internalizing antibody-drug conjugates display potent anti-cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix. International Journal of Cancer, 140(7):1670-1679.

Wu, Licun; Allo, Ghassan; John, Thomas; Li, Ming; Tagawa, Tetsuzo; Opitz, Isabelle; Anraku, Masaki; Yun, Zhihong; Pintilie, Melania; Pitcher, Bethany; Liu, Geoffrey; Feld, Ron; Johnston, Michael R; de Perrot, Marc; Tsao, Ming-Sound (2017). Patient-derived xenograft establishment from human malignant pleural mesothelioma. Clinical Cancer Research, 23(4):1060-1067.

Giuliani, Meredith E; Hope, Andrew; Mangona, Victor; Guckenberger, Matthias; Mantel, Frederick; Peulen, Heike; Sonke, Jan-Jakob; Belderbos, José; Werner-Wasik, Maria; Ye, Hong; Grills, Inga S (2017). Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group. Clinical Lung Cancer, 18(2):162-168.

Bubendorf, Lukas; Dafni, Urania; Schöbel, Martin; Finn, Stephen P; Tischler, Verena; Sejda, Aleksandra; Marchetti, Antonio; Thunnissen, Erik; Verbeken, Eric K; Warth, Arne; Sansano, Irene; Cheney, Richard; Speel, Ernst Jan M; Nonaka, Daisuke; Monkhorst, Kim; Hager, Henrik; Martorell, Miguel; Savic, Spasenija; Kerr, Keith M; Tan, Qiang; Tsourti, Zoi; Geiger, Thomas R; Kammler, Roswitha; Schulze, Katja; Das-Gupta, Ashis; Shames, David; Peters, Solange; Stahel, Rolf A (2017). Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Lung Cancer, 111:143-149.

Matthes, Katarina L; Limam, Manuela; Dehler, Silvia; Korol, Dimitri; Rohrmann, Sabine (2017). Primary treatment choice over time and relative survival of prostate cancer patients: influence of age, grade, and stage. Oncology Research and Treatment, 40(9):484-489.

Hänggi, Kay; Vasilikos, Lazaros; Valls, Aida Freire; Yerbes, Rosario; Knop, Janin; Spilgies, Lisanne M; Rieck, Kristy; Misra, Tvisha; Bertin, John; Gough, Peter J; Schmidt, Thomas; de Almodòvar, Carmen Ruiz; Wong, W Wei-Lynn (2017). RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function. Cell Death and Disease, 8(2):e2588.

Negrouk, Anastassia; Lacombe, Denis; Cardoso, Fatima; Morin, Franck; Carrasco, Eva; Maurel, Joan; Maibach, Rudolf; Aranda, Enrique; Marais, Richard; Stahel, Rolf A (2017). Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open, 2(3):e000187.

Avila, E K; Chamberlain, M; Schiff, D; Reijneveld, J C; Armstrong, T S; Ruda, R; Wen, P Y; Weller, M; Koekkoek, J A F; Mittal, S; Arakawa, Y; Choucair, A; Gonzalez-Martinez, J; MacDonald, D R; Nishikawa, R; Shah, A; Vecht, C J; Warren, P; van den Bent, M J; DeAngelis, L M (2017). Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-Oncology, 19(1):12-21.

Paasinen-Sohns, Aino; Koelzer, Viktor H; Frank, Angela; Schafroth, Julian; Gisler, Aline; Sachs, Melanie; Graber, Anne; Rothschild, Sacha I; Wicki, Andreas; Cathomas, Gieri; Mertz, Kirsten D (2017). Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors. Neoplasia, 19(3):196-206.

Zia, Farah Z; Olaku, Oluwadamilola; Bao, Ting; Berger, Ann; Deng, Gary; Yin Fan, Arthur; Garcia, Mary K; Herman, Patricia M; Kaptchuk, Ted J; Ladas, Elena J; Langevin, Helene M; Lao, Lixing; Lu, Weidong; Napadow, Vitaly; Niemtzow, Richard C; Vickers, Andrew J; Shelley Wang, Xin; Witt, Claudia M; Mao, Jun J (2017). The National Cancer Institute’s conference on acupuncture for symptom management in oncology: state of the science, evidence, and research gaps. Journal of the National Cancer Institute. Monographs, 2017(52):68-73.

Ter Voert, Edwin E G W; Delso, Gaspar; de Galiza Barbosa, Felipe; Huellner, Martin; Veit-Haibach, Patrick (2017). The effect of defective PET detectors in clinical simultaneous [(18)F]FDG time-of-flight PET/MR imaging. Molecular Imaging and Biology, 19(4):626-635.

Vom Berg, Johannes; Kobold, Sebastian (2017). The need for speed: how PD1-blockade only works if T cells are properly activated. Translational Cancer Research, 6(S6):S1018-S1021.

Gadeyne, S; Menvielle, G; Kulhanova, I; Bopp, Matthias; Deboosere, P; Eikemo, T A; Hoffmann, R; Kovács, K; Leinsalu, M; Martikainen, P; Regidor, E; Rychtarikova, J; Spadea, T; Strand, B H; Trewin, C; Wojtyniak, B; Mackenbach, J P (2017). The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s. International Journal of Cancer, 141(1):33-44.

2016

Dyshlovoy, S A; Menchinskaya, E S; Venz, S; Rast, S; et al (2016). The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. International Journal of Cancer, 138(10):2450-2465.

Boro, Aleksandar; Bauer, David; Born, Walter; Fuchs, Bruno (2016). Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma. American Journal of Cancer Research, 6(2):544-552.

Creutzig, Ursula; Zimmermann, Martin; Reinhardt, Dirk; Rasche, Mareike; von Neuhoff, Christine; Alpermann, Tamara; Dworzak, Michael; Perglerová, Karolína; Zemanova, Zuzana; Tchinda, Joelle; Bradtke, Jutta; Thiede, Christian; Haferlach, Claudia (2016). Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups. Cancer, 122(24):3821-3830.

Ardissone, Silvia; Redder, Peter; Russo, Giancarlo; Frandi, Antonio; Fumeaux, Coralie; Patrignani, Andrea; Schlapbach, Ralph; Falquet, Laurent; Viollier, Patrick H (2016). Cell cycle constraints and environmental control of local DNA hypomethylation in α-proteobacteria. PLoS Genetics, 12(12):e1006499.

Meller, Sebastian; Van Ellen, Anne; Gevensleben, Heidrun; Bicker, Anne; Hankeln, Thomas; Gorr, Thomas A; Sailer, Verena; Dröge, Freya; Schröck, Friederike; Bootz, Friedrich; Schröck, Andreas; Perner, Sven; Dietrich, Dimo; Kristiansen, Glen (2016). Ectopic myoglobin expression is associated with a favourable outcome in head and neck squamous cell carcinoma patients. Anticancer Research, 36(12):6235-6241.

Blödt, Susanne; Mittring, Nadine; Schützler, Lena; Fischer, Felix; Holmberg, Christine; Horneber, Markus; Stapf, Adele; Witt, Claudia M (2016). A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study. BMC Cancer, 16:843.

Datta, Niloy R; Rogers, Susanne; Klingbiel, Dirk; Gomez, Silvia; Puric, Emsad; Bodis, Stephan (2016). Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses. International Journal of Hyperthermia, 32(7):809-821.

Armato, Samuel G; Blyth, Kevin G; Keating, Jane J; Katz, Sharyn; Tsim, Selina; Coolen, Johan; Gudmundsson, Eyjolfur; Opitz, Isabelle; Nowak, Anna K (2016). Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 101:48-58.

Eggermont, A M M; Suciu, S; Rutkowski, Piotr; Kruit, Willem H; Punt, Cornelis J; Dummer, Reinhard; Salès, Francois; Keilholz, Ulrich; De Schaetzen, Gaetan; Testori, Alessandro (2016). Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIBeIII cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity. European Journal of Cancer, 55:111-121.

Wick, W; Roth, P; Hartmann, C; Hau, P; Nakamura, M; Stockhammer, F; Sabel, M C; Wick, A; Koeppen, S; Ketter, R; Vajkoczy, P; Eyupoglu, I; Kalff, R; Pietsch, T; Happold, C; Galldiks, N; Schmidt-Graf, F; Bamberg, M; Reifenberger, G; Platten, M; von Deimling, A; Meisner, C; Wiestler, B; Weller, M (2016). Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology, 18(11):1529-1537.

Limani, Perparim; Linecker, Michael; Kron, Philipp; Samaras, Panagiotis; Pestalozzi, Bernhard; Stupp, Roger; Jetter, Alexander; Dutkowski, Philipp; Müllhaupt, Beat; Schlegel, Andrea; Nicolau, Claude; Lehn, Jean-Marie; Petrowsky, Henrik; Humar, Bostjan; Graf, Rolf; Clavien, Pierre-Alain (2016). Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial. BMC Cancer, 16(1):812.

Rochlitz, Christoph; Bigler, Martin; von Moos, Roger; Bernhard, Jürg; Matter-Walstra, Klazien; Wicki, Andreas; Zaman, Khalil; Anchisi, Sandro; Küng, Marc; Na, Kyung-Jae; Bärtschi, Daniela; Borner, Markus; Rordorf, Tamara; Rauch, Daniel; Müller, Andreas; Ruhstaller, Thomas; Vetter, Marcus; Trojan, Andreas; Hasler-Strub, Ursula; Cathomas, Richard; Winterhalder, Ralph (2016). SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial. BMC Cancer, 16:780.

Ajdacic-Gross, Vladeta; Rodgers, Stephanie; Aleksandrowicz, Aleksandra; Mutsch, Margot; Steinemann, Nina; von Wyl, Viktor; von Känel, Roland; Bopp, Matthias (2016). Cancer co-occurrence patterns in Parkinson's disease and multiple sclerosis-Do they mirror immune system imbalances? Cancer Epidemiology, 44:167-173.

Luis, T C; Tremblay, C S; Manz, M G; North, T E; King, K Y; Challen, G A (2016). Inflammatory signals in HSPC development and homeostasis: Too much of a good thing? Experimental Hematology, 44(10):908-912.

Jung, Sara; Nagy, Zoltan; Fassnacht, Martin; Zambetti, Gerard; Weiss, Max; Reincke, Martin; Igaz, Peter; Beuschlein, Felix; Hantel, Constanze (2016). Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. Endocrine-Related Cancer, 23(10):825-837.

Nieder, Carsten; Andratschke, Nicolaus H; Grosu, Anca L (2016). Re-irradiation for Recurrent Primary Brain Tumors. Anticancer Research, 36(10):4985-4995.

Hottinger, Andreas F; Pacheco, Patricia; Stupp, Roger (2016). Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro-Oncology, 18(10):1338-1349.

Häuselmann, Irina; Roblek, M; Protsyuk, D; Huck, V; Knopfova, L; Grässle, S; Bauer, A T; Schneider, S W; Borsig, L (2016). Monocyte induction of e-selectin-mediated endothelial activation releases VE-Cadherin junctions to promote tumor cell extravasation in the metastasis cascade. Cancer Research, 76(18):5302-5312.

Gramatzki, D; Weller, M (2016). Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer, 122(23):3740-3741.

Schadendorf, Dirk; Dummer, Reinhard; Hauschild, Axel; Robert, Caroline; Hamid, Omid; Daud, Adil; van den Eertwegh, Alfons; Cranmer, Lee; O'Day, Steven; Puzanov, Igor; Schachter, Jacob; Blank, Christian; Salama, April; Loquai, Carmen; Mehnert, Janice M; Hille, Darcy; Ebbinghaus, Scot; Kang, S Peter; Zhou, Wei; Ribas, Antoni (2016). Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma. European Journal of Cancer, 67:46-54.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Reply to F. Felix et al and M.F. Fay et al. Journal of Clinical Oncology, 34(25):3107-3108.

Sharma, Ashish; Bender, Sabine; Zimmermann, Martina; Riesterer, Oliver; Broggini-Tenzer, Angela; Pruschy, Martin N (2016). Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer. Clinical Cancer Research, 22(17):4428-4439.

Peulen, Heike; Mantel, Frederick; Guckenberger, Matthias; Belderbos, José; Werner-Wasik, Maria; Hope, Andrew; Giuliani, Meredith; Grills, Inga; Sonke, Jan-Jakob (2016). Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, 96(1):134-141.

Lehmann, Steffi; Perera, Ramanil; Grimm, Hans-Peter; Sam, Johannes; Colombetti, Sara; Fauti, Tanja; Fahrni, Linda; Schaller, Teilo; Freimoser-Grundschober, Anne; Zielonka, Jörg; Stoma, Szymon; Rudin, Markus; Klein, Christian; Umana, Pablo; Gerdes, Christian; Bacac, Marina (2016). in vivo fluorescence imaging of the activity of CEA TCB, a novel t-cell bispecific antibody, reveals highly specific tumor targeting and fast induction of t-cell-mediated tumor killing. Clinical Cancer Research, 22(17):4417-4427.

Phillips, Robert S; Bhuller, Kaljit; Sung, Lillian; Ammann, Roland A; Tissing, Wim J E; Lehrnbecher, Thomas; Stewart, Lesley A; PICNICC Collaboration (2016). Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer. European Journal of Cancer, 64:101-106.

Neklyudova, Olga; Arlt, Matthias J E; Brennecke, Patrick; Thelen, Marcus; Gvozdenovic, Ana; Kuzmanov, Aleksandar; Robl, Bernhard; Botter, Sander M; Born, Walter; Fuchs, Bruno (2016). Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis. Journal of Cancer Research and Clinical Oncology, 142(8):1739-50.

Bailey, D L; Pichler, B J; et al; Veit-Haibach, P (2016). Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany. Molecular Imaging and Biology, 18(5):637-650.

Lacouture, Mario E; Dréno, Brigitte; Ascierto, Paolo Antonio; Dummer, Reinhard; Basset-Seguin, Nicole; Fife, Kate; Ernst, Scott; Licitra, Lisa; Neves, Rogerio I; Peris, Ketty; Puig, Susana; Sokolof, Jonas; Sekulic, Aleksandar; Hauschild, Axel; Kunstfeld, Rainer (2016). Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma. The Oncologist, 21(10):1218-1229.

Zheng, Siyuan; Cherniack, Andrew D; Dewal, Ninad; Moffitt, Richard A; Danilova, Ludmila; et al; Beuschlein, Felix (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 30(2):363.

Endig, Jessica; Buitrago-Molina, Laura Elisa; Marhenke, Silke; Reisinger, Florian; Saborowski, Anna; Schütt, Jutta; Limbourg, Florian; Könecke, Christian; Schreder, Alina; Michael, Alina; Misslitz, Ana Clara; Healy, Marc Eammonn; Geffers, Robert; Clavel, Thomas; Haller, Dirk; Unger, Kristian; Finegold, Milton; Weber, Achim; Manns, Michael P; Longerich, Thomas; Heikenwälder, Mathias; Vogel, Arndt (2016). Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development. Cancer Cell, 30(2):308-323.

Datta, Niloy R; Heuser, Michael; Bodis, Stephan (2016). A roadmap and cost implications of establishing comprehensive cancer care using a teleradiotherapy network in a group of sub-saharan african countries with no access to radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 95(5):1334-1343.

Piegeler, Tobias; Winder, Thomas; Kern, Sabine; Pestalozzi, Bernhard; Schneider, Paul Magnus; Beck-Schimmer, Beatrice (2016). Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch(®) system: An observational feasibility study. Oncology Letters, 12(2):1513-1518.

Strehlow, F; Bauer, S; Martus, P; Weller, M; Roth, P; Schlegel, U; Seidel, S; Scheibenbogen, C; Korfel, A; Kreher, S (2016). Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma. Journal of Neuro-Oncology, 129(1):165-171.

Ramaswamy, Vijay; Hielscher, Thomas; Mack, Stephen C; Lassaletta, Alvaro; Lin, Tong; Pajtler, Kristian W; Jones, David T W; Luu, Betty; Cavalli, Florence M G; Aldape, Kenneth; Remke, Marc; Mynarek, Martin; Rutkowski, Stefan; Gururangan, Sridharan; McLendon, Roger E; Lipp, Eric S; Dunham, Christopher; Hukin, Juliette; Eisenstat, David D; Fulton, Dorcas; van Landeghem, Frank K H; Santi, Mariarita; van Veelen, Marie-Lise C; Van Meir, Erwin G; Osuka, Satoru; Fan, Xing; Muraszko, Karin M; Tirapelli, Daniela P C; Oba-Shinjo, Sueli M; Marie, Suely K N; et al (2016). Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. Journal of Clinical Oncology, 34(21):2468-2477.

Robl, Bernhard; Botter, Sander Martijn; Pellegrini, Giovanni; Neklyudova, Olga; Fuchs, Bruno (2016). Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model. Journal of Experimental & Clinical Cancer Research, 35(1):online.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2016). PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. International Journal of Cancer, 139(2):396-403.

Lehman, Norman L; Hattab, Eyas M; Mobley, Bret C; Usubalieva, Aisulu; Schniederjan, Matthew J; McLendon, Roger E; Paulus, Werner; Rushing, Elisabeth J; Georgescu, Maria-Magdalena; Couce, Marta; Dulai, Mohanpal S; Cohen, Mark L; Pierson, Christopher R; Raisanen, Jack M; Martin, Sarah E; Lehman, Trang D; Lipp, Eric S; Bonnin, Jose M; Al-Abbadi, Mousa A; Kenworthy, Kara; Zhao, Kevin; Mohamed, Nehad; Zhang, Guojuan; Zhao, Weiqiang (2016). Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. Neuro-Oncology, 19(1):31-42.

Weber, Achim; Heikenwalder, Mathias (2016). P(URI)fying Novel Drivers of NASH and HCC: A Feedforward Loop of IL17A via White Adipose Tissue. Cancer Cell, 30(1):15-17.

Gramatzki, Dorothee; Frei, Karl; Cathomas, Gieri; Moch, Holger; Weller, Michael; Mertz, Kirsten Diana (2016). Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology Letters, 12(1):445-452.

Matter-Walstra, Klazien; Ruhstaller, T; Klingbiel, D; Schwenkglenks, Matthias; Dedes, K J (2016). Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer Research and Treatment, 158(1):51-57.

Rieber, Juliane; Streblow, Jan; Uhlmann, Lorenz; Flentje, Michael; Duma, Marciana; Ernst, Iris; Blanck, Oliver; Wittig, Andrea; Boda-Heggemann, Judit; Krempien, Robert; Lohaus, Fabian; Klass, Nathalie Desirée; Eble, Michael J; Imhoff, Detlef; Kahl, Henning; Petersen, Cordula; Gerum, Sabine; Henkenberens, Christoph; Adebahr, Sonja; Hass, Peter; Schrade, Elsge; Wendt, Thomas G; Hildebrandt, Guido; Andratschke, Nicolaus; Sterzing, Florian; Guckenberger, Matthias (2016). Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Lung Cancer, 97:51-58.

Meerang, Mayura; Bérard, Karima; Friess, Martina; Bitanihirwe, Byron K Y; Soltermann, Alex; Vrugt, Bart; Felley-Bosco, Emanuela; Bueno, Raphael; Richards, William G; Seifert, Burkhardt; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2016). Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma. Molecular Oncology, 10(8):1255-1265.

Adam, Martin; Rueegg, Corina S; Schmidlin, Kurt; Spoerri, Adrian; Niggli, Felix; Grotzer, Michael; von der Weid, Nicolas X; Egger, Matthias; Probst-Hensch, Nicole; Zwahlen, Marcel; Kuehni, Claudia E; Swiss Paediatric Oncology Group; Swiss National Cohort Study Group (2016). Socioeconomic disparities in childhood cancer survival in Switzerland. International Journal of Cancer, 138(12):2856-2866.

Groner, Anna C; Cato, Laura; de Tribolet-Hardy, Jonas; Bernasocchi, Tiziano; Janouskova, Hana; Melchers, Diana; Houtman, René; Cato, Andrew C B; Tschopp, Patrick; Gu, Lei; Corsinotti, Andrea; Zhong, Qing; Fankhauser, Christian; Fritz, Christine; Poyet, Cédric; Wagner, Ulrich; Guo, Tiannan; Aebersold, Ruedi; Garraway, Levi A; Wild, Peter J; Theurillat, Jean-Philippe; Brown, Myles (2016). TRIM24 is an oncogenic transcriptional activator in prostate cancer. Cancer Cell, 29(6):846-858.

Mangani, D; Weller, M; Seyed Sadr, E; Willscher, E; Seystahl, K; Reifenberger, G; Tabatabai, G; Binder, H; Schneider, H (2016). Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models. Neuro-Oncology, 18(12):1610-1621.

Stracquadanio, Giovanni; Vrugt, Bart; Flury, Renata; Schraml, Peter; Würl, Peter; Müller, Thomas H; Knippschild, Uwe; Henne-Bruns, Doris; Breitenstein, Stefan; Clavien, Pierre-Alain; Graf, Rolf; Bond, Gareth L; Grochola, Lukasz F (2016). CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma. Clinical Cancer Research:31.

Hoda, Mir Alireza; Dong, Yawen; Rozsas, Anita; Klikovits, Thomas; Laszlo, Viktoria; Ghanim, Bahil; Stockhammer, Paul; Ozsvar, Judit; Jakopovic, Marko; Samarzija, Miroslav; Brcic, Luka; Bendek, Matyas; Szirtes, Ildiko; Reid, Glen; Kirschner, Michaela B; Kao, Steven C; Opitz, Isabelle; Weder, Walter; Frauenfelder, Thomas; Nguyen-Kim, Thi Dan Linh; Aigner, Clemens; Klepetko, Walter; van Zandwijk, Nico; Berger, Walter; Dome, Balazs; Grusch, Michael; Hegedus, Balazs (2016). Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. European Journal of Cancer, 63:64-73.

Cheng, Yuen Yee; Wright, Casey M; Kirschner, Michaela B; Williams, Marissa; Sarun, Kadir H; Sytnyk, Vladimir; Leshchynska, Iryna; Edelman, J James; Vallely, Michael P; McCaughan, Brian C; Klebe, Sonja; van Zandwijk, Nico; Lin, Ruby C Y; Reid, Glen (2016). KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer, 15:44.

Schneider, H; Weller, M (2016). Boswellic acid activity against glioblastoma stem-like cells. Oncology Letters, 11(6):4187-4192.

Datta, Niloy R; Eberle, Brigitte; Puric, Emsad; Meister, Andreas; Marder, Dietmar; Tim, Olaf; Klimov, Anton; Bodis, Stephan (2016). Is hyperthermia combined with radiotherapy adequate in elderly patients with muscle-invasive bladder cancers? Thermo-radiobiological implications from an audit of initial results. International Journal of Hyperthermia, 32(4):390-397.

Haldrup, Christa; Lynnerup, Anne-Sofie; Storebjerg, Tine Maj; Vang, Søren; Wild, Peter; Visakorpi, Tapio; Arsov, Christian; Schulz, Wolfgang A; Lindberg, Johan; Grönberg, Henrik; Egevad, Lars; Borre, Michael; Ørntoft, Torben Falck; Høyer, Søren; Sørensen, Karina Dalsgaard (2016). Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels. Molecular Oncology, 10(6):825-837.

Zimmer, Lisa; Goldinger, Simone M; Hofmann, Lars; Loquai, Carmen; Ugurel, Selma; Thomas, Ioannis; Schmidgen, Maria I; Gutzmer, Ralf; Utikal, Jochen S; Göppner, Daniela; Hassel, Jessica C; Meier, Friedegund; Tietze, Julia K; Forschner, Andrea; Weishaupt, Carsten; Leverkus, Martin; Wahl, Renate; Dietrich, Ursula; Garbe, Claus; Kirchberger, Michael C; Eigentler, Thomas; Berking, Carola; Gesierich, Anja; Krackhardt, Angela M; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie M (2016). Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. European Journal of Cancer, 60:210-225.

Niessner, H; Schmitz, J; Tabatabai, G; et al; Dummer, Reinhard (2016). PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo. Clinical Cancer Research, 22(23):5818-5828.

Henning, Benjamin; Stieger, Pascale; Kamarachev, Jivko; Dummer, Reinhard; Goldinger, Simone M (2016). Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation. Melanoma research, 26(3):304-7.

De Lella Ezcurra, Ana Laura; Bertolin, Agustina Paola; Kim, Kevin; Katz, Maximiliano Javier; Gándara, Lautaro; Misra, Tvisha; Luschnig, Stefan; Perrimon, Norbert; Melani, Mariana; Wappner, Pablo (2016). miR-190 Enhances HIF-Dependent Responses to Hypoxia in Drosophila by Inhibiting the Prolyl-4-hydroxylase Fatiga. PLoS Genetics, 12(5):e1006073.

Korfel, Agnieszka; Chamberlain, Marc; Neuwelt, Ed; Thiel, Eckhard; Doolittle, Nancy; Schlegel, Uwe; Dreyling, Martin; Rubenstein, James; Fischer, Lars; Björkholm, Magnus; Martus, Peter; Weller, Michael; Glantz, Michael (2016). Therapy for secondary CNS involvement in malignant lymphomas: No standard yet! Journal of Clinical Oncology, 34(15):1829-1830.

Laubli, H; Varki, A; Borsig, L (2016). Antimetastatic properties of low molecular weight heparin. Journal of Clinical Oncology, 34(21):2560-2561.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Kreis, Christian; Grotzer, Michael; Hengartner, Heinz; Spycher, Ben Daniel; Swiss Paediatric Oncology Group; Swiss National Cohort Study Group (2016). Space-time clustering of childhood cancers in Switzerland: A nationwide study. International Journal of Cancer, 138(9):2127-2135.

Janssen, Stefan; Glanzmann, Christoph; Lang, Stephanie; Verlaan, Sarah; Streller, Tino; Linsenmeier, Claudia; Rades, Dirk; Studer, Gabriela (2016). Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A Regime. Anticancer Research, 36(5):2513-2522.

Ares, Carmen; Albertini, Francesca; Frei-Welte, Martina; Bolsi, Alessandra; Grotzer, Michael A; Goitein, Gudrun; Weber, Damien C (2016). Pencil beam scanning proton therapy for pediatric intracranial ependymoma. Journal of Neuro-Oncology, 128(1):137-145.

Blattner, Ariane C; Chaurasia, Soumya; McKee, Bruce D; Lehner, Christian F (2016). Separase is required for homolog and sister disjunction during drosophila melanogaster male meiosis, but not for biorientation of sister centromeres. PLoS Genetics, 12(4):e1005996.

Albert, Nathalie L; Weller, Michael; Suchorska, Bogdana; Galldiks, Norbert; Soffietti, Riccardo; Kim, Michelle M; la Fougère, Christian; Pope, Whitney; Law, Ian; Arbizu, Javier; Chamberlain, Marc C; Vogelbaum, Michael A; Ellingson, Ben M; Tonn, Joerg C (2016). Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology, 18(9):1199-1208.

Seystahl, Katharina; Stoecklein, Veit; Schüller, Ulrich; Rushing, Elisabeth; Nicolas, Guillaume; Schäfer, Niklaus; Ilhan, Harun; Pangalu, Athina; Weller, Michael; Tonn, Jörg-Christian; Sommerauer, Michael; Albert, Nathalie L (2016). Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. Neuro-Oncology, 18(11):1538-1547.

Gramatzki, Dorothee; Dehler, Silvia; Rushing, Elisabeth Jane; Zaugg, Kathrin; Hofer, Silvia; Yonekawa, Yasuhiro; Bertalanffy, Helmut; Valavanis, Anton; Korol, Dimitri; Rohrmann, Sabine; Pless, Miklos; Oberle, Joachim; Roth, Patrick; Ohgaki, Hiroko; Weller, Michael (2016). Glioblastoma in the canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer, 122(14):2206-2215.

Datta, Niloy R; Puric, Emsad; Klingbiel, Dirk; Gomez, Silvia; Bodis, Stephan (2016). Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. International Journal of Radiation Oncology, Biology, Physics, 94(5):1073-1087.

Suchorska, B; Weller, M; Tabatabai, G; Senft, C; Hau, P; Sabel, M C; Herrlinger, U; Ketter, R; Schlegel, U; Marosi, C; Reifenberger, G; Wick, W; Tonn, J C; Wirsching, H G (2016). Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro-Oncology, 18(4):549-556.

Martini, Katharina; Meier, Andreas; Opitz, Isabelle; Weder, Walter; Veit-Haibach, Patrick; Stahel, Rolf A; Frauenfelder, Thomas (2016). Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma. Lung Cancer, 94:40-45.

Seifert, Heike; Fisher, Rosalie; Martin-Liberal, Juan; Edmonds, Kim; Hughes, Peta; Khabra, Komel; Gore, Martin; Larkin, James (2016). Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib. Melanoma research, 26(2):138-144.

Wang, C; Qu, C; Alippe, Y; Bonar, S L; Civitelli, R; Abu-Amer, Y; Hottiger, M O; Mbalaviele, G (2016). Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation. Cell Death and Disease, 7(3):e2153.

Szabo, E; Schneider, H; Seystahl, K; Rushing, E J; Herting, F; Weidner, K M; Weller, M (2016). Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo. Neuro-Oncology, 18(9):1242-1252.

Karlo, Christoph A; Kou, Lei; Di Paolo, Pier Luigi; Kattan, Michael W; Motzer, Robert J; Russo, Paul; Tickoo, Satish K; Akin, Oguz; Hricak, Hedvig (2016). Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. European Journal of Cancer, 59:57-64.

Klement, Rainer J; Allgäuer, Michael; Andratschke, Nicolaus; Blanck, Oliver; Boda-Heggemann, Judit; Dieckmann, Karin; Duma, Marciana; Ernst, Iris; Flentje, Michael; Ganswindt, Ute; Hass, Peter; Henkenberens, Christoph; Imhoff, Detlef; Kahl, Henning K; Krempien, Robert; Lohaus, Fabian; Nestle, Ursula; Nevinny-Stickel, Meinhard; Petersen, Cordula; Schmitt, Vanessa; Semrau, Sabine; Sterzing, Florian; Streblow, Jan; Wendt, Thomas G; Wittig, Andrea; Guckenberger, Matthias (2016). Bayesian cure rate modeling of local tumor control: evaluation in stereotactic body radiation therapy for pulmonary metastases. International Journal of Radiation Oncology, Biology, Physics, 94(4):841-849.

Phillips, Robert S; Sung, Lillian; Amman, Roland A; Riley, Richard D; Castagnola, Elio; Haeusler, Gabrielle M; Klaassen, Robert; Tissing, Wim J E; Lehrnbecher, Thomas; Chisholm, Julia; Hakim, Hana; Ranasinghe, Neil; Paesmans, Marianne; Hann, Ian M; Stewart, Lesley A; PICNICC Collaboration (2016). Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. British Journal of Cancer, 114(6):623-630.

Johann, Pascal D; Erkek, Serap; Zapatka, Marc; et al (2016). Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell, 29(3):379-393.

Smith, Michael P; Brunton, Holly; Rowling, Emily J; Ferguson, Jennifer; Arozarena, Imanol; Miskolczi, Zsofia; Lee, Jessica L; Girotti, Maria R; Marais, Richard; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Dennie T; Flaherty, Keith T; Cooper, Zachary A; Wargo, Jennifer A; Wellbrock, Claudia (2016). Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy. Cancer Cell, 29(3):270-84.

Goldinger, Simone M; Stieger, Pascale; Meier, Barbara; Micaletto, Sara; Contassot, Emmanuel; French, Lars E; Dummer, Reinhard (2016). Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy. Clinical Cancer Research, 22(16):4023-4029.

Kao, Steven C; Kirschner, Michaela B; Cooper, Wendy A; Tran, Thang; Burgers, Sjaak; Wright, Casey; Korse, Tiny; van den Broek, Daan; Edelman, James; Vallely, Michael; McCaughan, Brian; Pavlakis, Nick; Clarke, Stephen; Molloy, Mark P; van Zandwijk, Nico; Reid, Glen (2016). A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma. British Journal of Cancer, 114(5):524-531.

Happold, C; Gorlia, T; Chinot, O; Gilbert, M R; Nabors, L B; Wick, W; Pugh, S L; Hegi, M; Cloughesy, T; Roth, P; Reardon, D A; Perry, J R; Mehta, M P; Stupp, R; Weller, M (2016). Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. Journal of Clinical Oncology, 34(7):731-739.

Sommerauer, M; Burkhardt, J K; Frontzek, K; Rushing, E; Buck, A; Krayenbuehl, N; Weller, M; Schaefer, N; Kuhn, F P (2016). 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? Neuro-Oncology, 18(7):1021-1027.

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Feldman, Darren R; Lorch, Anja; Kramar, Andrew; Albany, Costantine; Einhorn, Lawrence H; Giannatempo, Patrizia; Necchi, Andrea; Flechon, Aude; Boyle, Helen; Chung, Peter; Huddart, Robert A; Bokemeyer, Carsten; Tryakin, Alexey; Sava, Teodoro; Winquist, Eric William; De Giorgi, Ugo; Aparicio, Jorge; Sweeney, Christopher J; Cohn Cedermark, Gabriella; Beyer, Jörg; Powles, Thomas (2016). Brain metastases in patients with germ cell tumors: prognostic factors and treatment options: an analysis from the global germ cell cancer group. Journal of Clinical Oncology, 34(4):345-351.

Bhindi, Bimal; Hermanns, Thomas; Wei, Yanliang; Yu, Julie; Richard, Patrick O; Wettstein, Marian S; Templeton, Arnoud; Li, Kathy; Sridhar, Srikala S; Jewett, Michael A S; Fleshner, Neil E; Zlotta, Alexandre R; Kulkarni, Girish S (2016). Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy. British Journal of Cancer, 114(2):207-212.

Roblek, Marko; Strutzmann, Elisabeth; Zankl, Christina; Adage, Tiziana; Heikenwalder, Mathias; Atlic, Aid; Weis, Roland; Kungl, Andreas; Borsig, Lubor (2016). Targeting of CCL2-CCR2-glycosaminoglycan axis using a CCL2 decoy protein attenuates metastasis through inhibition of tumor cell seeding. Neoplasia, 18(1):49-59.

Schönenberger, Désirée; Harlander, Sabine; Rajski, Michal; Jacobs, Robert A; Lundby, Anne-Kristine; Adlesic, Mojca; Hejhal, Tomas; Wild, Peter J; Lundby, Carsten; Frew, Ian J (2016). Formation of renal cysts and tumors in Vhl/Trp53-deficient mice requires HIF-1α and HIF-2α. Cancer Research, 76(7):2025-2036.

Bezel, Pascal; Tischler, Verena; Robinson, Cecile; Baumueller, Stephan; Bode-Lesniewska, Beata; Kohler, Malcolm; Freitag, Lutz; Franzen, Daniel (2016). Diagnostic Value of Bronchoalveolar Lavage for Diagnosis of Suspected Peripheral Lung Cancer. Clinical Lung Cancer, 17(5):e151-e156.

Näf, Ernst; Laubscher, Dominik; Hopfer, Helmut; Streit, Markus; Matyas, Gabor (2016). Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas. Familial cancer, 15(1):127-32.

Moch, H; Bonsib, S M; Delahunt, B; Eble, J N; Egevad, L; Grignon, D J; Linehan, W M; Reuter, V E; Srigley, J R; Sulser, T; Tan, P H (2016). Clear cell renal cell carcinoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 18-21.

Versluis, J; In't Hout, F E; Devillier, R; van Putten, W L; Manz, Markus G; Vekemans, M C; Legdeur, M C; Passweg, J R; Maertens, J; Kuball, J; Biemond, B J; Valk, P J; van der Reijden, B A; Meloni, G; Schouten, Harry C; Vellenga, Edo; Pabst, Thomas; Willemze, R; Löwenberg, B; Ossenkoppele, G; Baron, F; Huls, G; Cornelissen, J J (2016). Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio. Leukemia, 31(1):26-33.

König, Matthias A; Canepa, Daisy D; Cadosch, Dieter; Casanova, Elisa; Heinzelmann, Michael; Rittirsch, Daniel; Plecko, Michael; Hemmi, Sonja; Simmen, Hans-Peter; Cinelli, Paolo; Wanner, Guido A (2016). Direct transplantation of native pericytes from adipose tissue: A new perspective to stimulate healing in critical size bone defects. Cytotherapy, 18(1):41-52.

Kulig, Paulina; Burkhard, Sara; Mikita-Geoffroy, Joanna; Croxford, Andrew L; Hövelmeyer, Nadine; Gyülveszi, Gabor; Gorzelanny, Christian; Waisman, Ari; Borsig, Lubor; Becher, Burkhard (2016). IL-17A mediated endothelial breach promotes metastasis formation. Cancer immunology research, 4(1):26-32.

Fuchs, Hans; Hölscher, Arnulf H; Leers, Jessica; Bludau, Marc; Brinkmann, Sebastian; Schröder, Wolfgang; Alakus, Hakan; Mönig, Stefan; Gutschow, Christian A (2016). Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? Gastric Cancer, 19(1):312-317.

Wulaningsih, Wahyu; Holmberg, Lars; Ng, Tony; Rohrmann, Sabine; Van Hemelrijck, Mieke (2016). Serum leptin, C-reactive protein, and cancer mortality in the NHANES III. Cancer Medicine, 5(1):120-128.

Stalder, Hanspeter; Hug, Corinne; Zanoni, Reto; Vogt, Hans-Rudolf; Peterhans, Ernst; Schweizer, Matthias; Bachofen, Claudia (2016). A nationwide database linking information on the hosts with sequence data of their virus strains: A useful tool for the eradication of bovine viral diarrhea (BVD) in Switzerland. Virus Research, 218:49-56.

Nowicka, A M; Häuselmann, I; Borsig, L; Bolduan, S; Schindler, M; Schraml, P; Heikenwalder, M; Moch, H (2016). A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization. Oncogene, 35(24):3125-3138.

Jenni, D; Karpova, M B; Mühleisen, B; Mangana, J; Dreier, J; Hafner, J; Dummer, R (2016). A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis. ESMO Open, 1:e000003.

Catrysse, L; Farhang Ghahremani, M; Vereecke, L; Youssef, S A; Mc Guire, C; Sze, M; Weber, A; Heikenwalder, M; de Bruin, A; Beyaert, R; van Loo, G (2016). A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death. Cell Death and Disease, 7(6):e2250.

Auvinen, Anssi; Moss, Sue M; Tammela, Teuvo L J; Taari, Kimmo; Roobol, Monique J; Schröder, Fritz H; Bangma, Chris H; Carlsson, Sigrid; Aus, Gunnar; Zappa, Marco; Puliti, Donella; Denis, Louis J; Nelen, Vera; Kwiatkowski, Maciej; Randazzo, Marco; Paez, Alvaro; Lujan, Marcos; Hugosson, Jonas (2016). Absolute effect of prostate cancer screening: balance of benefits and harms by center within the European randomized study of prostate cancer screening. Clinical Cancer Research, 22(1):243-249.

Roelcke, U; Wyss, M T; Nowosielski, M; Rudà, R; Roth, P; Hofer, S; Galldiks, N; Crippa, F; Weller, M; Soffietti, R (2016). Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-Oncology, 18(5):744-751.

Limani, P; Linecker, M; Kachaylo, E; Tschuor, C; Kron, P; Schlegel, A; Ungethuem, U; Jang, J H; Georgiopoulou, S; Claude Nicolau, C; Lehn, J-M; Graf, R; Humar, B; Clavien, P-A (2016). Antihypoxic potentiation of standard therapy for experimental colorectal liver metastasis through myo-inositol trispyrophosphate. Clinical Cancer Research, 22(23):5887-5897.

Richter, Andre; Jenewein, J; Krayenbühl, N; Woernle, C; Bellut, D (2016). Are preoperative sex-related differences of affective symptoms in primary brain tumor patients associated with postoperative histopathological grading? Journal of Neuro-Oncology, 126(1):151-156.

Scherr, Anna-Lena; Gdynia, Georg; Salou, Mariam; Radhakrishnan, Praveen; Duglova, Katarina; Heller, Anette; Keim, Sophia; Kautz, Nicole; Jassowicz, Adam; Elssner, Christin; He, You-Wen; Jaeger, Dirk; Heikenwalder, Mathias; Schneider, Martin; Weber, Achim; Roth, Wilfried; Schulze-Bergkamen, Henning; Koehler, Bruno Christian (2016). Bcl-xL is an oncogenic driver in colorectal cancer. Cell Death and Disease, 7(8):e2342.

Tabernero, Josep; Vyas, Malvika; Giuliani, Rosa; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo G; Cervantes, Andres; Eggermont, Alexander Mm; Eniu, Alexandru; Jassem, Jacek; Pentheroudakis, George; Peters, Solange; Rauh, Stefan; Zielinski, Christoph C; Stahel, Rolf A; Voest, Emile; Douillard, Jean-Yves; McGregor, Keith; Ciardiello, Fortunato (2016). Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open, 1(6):e000142.

Morgan, Gilberto; Lambertini, Matteo; Kourie, Hampig Raphael; Amaral, Teresa; Argiles, Guillem; Banerjee, Susana; Cardone, Claudia; Corral, Jesus; De Mattos-Arruda, Letticia; Öztürk, Akif; Petrova, Mila; Poulsen, Laurids; Strijbos, Michiel; Tyulyandina, Alexandra; Vidra, Radu; Califano, Raffaele; de Azambuja, Evandro; Garrido Lopez, Pilar; Guarneri, Valentina; Reck, Martin; Moiseyenko, Vladimir; Martinelli, Erika; Douillard, Jean-Yves; Stahel, Rolf; Voest, Emile; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo; Cervantes, Andrés; Eggermont, Alexander M M; et al (2016). Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO). ESMO Open, 1:e000107.

Witt, Claudia M (2016). Challenging results make us think. Oncology Research and Treatment, 39(5):258-259.

Razafinjatovo, Caroline; Bihr, Svenja; Mischo, Axel; Vogl, Ursula; Schmidinger, Manuela; Moch, Holger; Schraml, Peter (2016). Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer, 16:638.

Gramatzki, Dorothee; Roth, P; Felsberg, J; Hofer, S; Rushing, E J; Hentschel, B; Westphal, M; Krex, D; Simon, M; Schnell, O; Wick, W; Reifenberger, G; Weller, M (2016). Chemotherapy for intracranial ependymoma in adults. BMC Cancer, 16(1):287.

Koelzer, Viktor H; Steuer, Karl; Gross, Ulrike Camenisch; Zimmermann, Dieter; Paasinen-Sohns, Aino; Mertz, Kirsten D; Cathomas, Gieri (2016). Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome. Frontiers in Oncology, 6:252.

Ren, Wuwei; Elmer, Andreas; Buehlmann, David; Augath, Mark-Aurel; Vats, Divya; Ripoll, Jorge; Rudin, Markus (2016). Dynamic measurement of tumor vascular permeability and perfusion using a hybrid system for simultaneous magnetic resonance and fluorescence imaging. Molecular Imaging and Biology, 18(2):191-200.

Dittrich, Christian; Kosty, Michael; Jezdic, Svetlana; Pyle, Doug; Berardi, Rossana; Bergh, Jonas; El-Saghir, Nagi; Lotz, Jean-Pierre; Österlund, Pia; Pavlidis, Nicholas; Purkalne, Gunta; Awada, Ahmad; Banerjee, Susana; Bhatia, Smita; Bogaerts, Jan; Buckner, Jan; Cardoso, Fatima; Casali, Paolo; Chu, Edward; Close, Julia Lee; Coiffier, Bertrand; Connolly, Roisin; Coupland, Sarah; De Petris, Luigi; De Santis, Maria; de Vries, Elisabeth G E; Dizon, Don S; Duff, Jennifer; Duska, Linda R; Eniu, Alexandru; et al (2016). ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016. ESMO Open, 1(5):e000097.

Hanauer, Jan Rh; Gottschlich, Lisa; Riehl, Dennis; Rusch, Tillmann; Koch, Vivian; Friedrich, Katrin; Hutzler, Stefan; Prüfer, Steffen; Friedel, Thorsten; Hanschmann, Kay-Martin; Münch, Robert C; Jost, Christian; Plückthun, Andreas; Cichutek, Klaus; Buchholz, Christian J; Mühlebach, Michael D (2016). Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors. Molecular Therapy : Oncolytics, 3:16003.

Rageth, Christoph J; O'Flynn, Elizabeth A M; Comstock, Christopher; Kurtz, Claudia; Kubik, Rahel; Madjar, Helmut; Lepori, Domenico; Kampmann, Gert; Mundinger, Alexander; Baege, Astrid; Decker, Thomas; Hosch, Stefanie; Tausch, Christoph; Delaloye, Jean-François; Morris, Elisabeth; Varga, Zsuzsanna (2016). First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Research and Treatment:11.

Rothermundt, Christian; Seddon, Beatrice M; Dileo, Palma; Strauss, Sandra J; Coleman, Joanne; Briggs, Timothy W; Haile, Sarah R; Whelan, Jeremy S (2016). Follow-up practices for high-grade extremity Osteosarcoma. BMC Cancer, 16:301.

Koelzer, Viktor H; Buser, Tobias; Willi, Niels; Rothschild, Sacha I; Wicki, Andreas; Schiller, Peter; Cathomas, Gieri; Zippelius, Alfred; Mertz, Kirsten D (2016). Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. Journal for ImmunoTherapy of Cancer, 4:47.

Magnus, C; Reh, L; Trkola, Alexandra (2016). HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution. Virus Research, 218:57-70.

Deuel, J W; Schaer, C A; Boretti, F S; Opitz, L; Garcia-Rubio, I; Baek, J H; Spahn, D R; Buehler, P W; Schaer, D J (2016). Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response. Cell Death and Disease, 7:e2064.

Datta, Niloy R; Rogers, Susanne; Gomez Ordoñez, Silvia; Puric, Emsad; Bodis, Stephan (2016). Hyperthermia and radiotherapy in the management of head and neck cancers: a systematic review and meta-analysis. International Journal of Hyperthermia, 32(1):31-40.

Brooks, Danielle L Peacock; Schwab, Luciana P; Krutilina, Raisa; Parke, Deanna N; Sethuraman, Aarti; Hoogewijs, David; Schörg, Alexandra; Gotwald, Lauren; Fan, Meiyun; Wenger, Roland H; Seagroves, Tiffany N (2016). ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Molecular Cancer, 15:26.

Clifford, Gary M; Franceschi, Silvia; Keiser, Olivia; Schöni-Affolter, Franziska; Lise, Mauro; Dehler, Silvia; Levi, Fabio; Mousavi, Mohsen; Bouchardy, Christine; Wolfensberger, Aline; Darling, Katharine E; Staehelin, Cornelia; Bertisch, Barbara; Kuenzli, Esther; Bernasconi, Enos; Pawlita, Michael; Egger, Matthias (2016). Immunodeficiency and the risk of cervical intra-epithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV Cohort Study. International Journal of Cancer, 138(7):1732-1740.

Roth, P; Preusser, M; Weller, M (2016). Immunotherapy of Brain Cancer. Oncology Research and Treatment, 39(6):326-334.

Becirovic, Elvir; Böhm, Sybille; Nguyen, Ong Nam Phuong; Riedmayr, Lisa Maria; Koch, Mirja Annika; Schulze, Elisabeth; Kohl, Susanne; Borsch, Oliver; Santos-Ferreira, Tiago; Ader, Marius; Michalakis, Stylianos; Biel, Martin (2016). In Vivo Analysis of Disease-Associated Point Mutations Unveils Profound Differences in mRNA Splicing of Peripherin-2 in Rod and Cone Photoreceptors. PLoS Genetics, 12(1):e1005811.

Prater, Julia; Valeri, Fabio; Korol, Dimitri; Rohrmann, Sabine; Dehler, Silvia (2016). Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry. Journal of Cancer Research and Clinical Oncology, 142(2):365-371.

Weber, Kari A; Heaphy, Christopher M; Rohrmann, Sabine; Gonzalez, Beverly; Bienstock, Jessica L; Agurs-Collins, Tanya; Platz, Elizabeth A; Meeker, Alan K (2016). Influence of In utero maternal and neonate factors on cord blood leukocyte telomere length: clues to the racial disparity in prostate cancer? Prostate Cancer, 2016:3691650.

Furtner, J; Schöpf, V; Seystahl, K; Le Rhun, E; Rudà, R; Roelcke, U; Koeppen, S; Berghoff, A S; Marosi, C; Clement, P; Faedi, M; Watts, C; Wick, W; Soffietti, R; Weller, M; Preusser, M (2016). Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology, 18(3):401-407.

Wicki, S; Gurzeler, U; Wong, W Wei-Lynn; Jost, P J; Bachmann, D; Kaufmann, T (2016). Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils. Cell Death and Disease, 7(10):e2422.

Urner-Bloch, U; Urner, M; Jaberg-Bentele, N; Frauchiger, A L; Dummer, R; Goldinger, S M (2016). MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects. European Journal of Cancer, 65:130-138.

Eichholzer, Monika; Richard, Aline; Rohrmann, Sabine; Schmid, Seraina; Güth, Uwe (2016). Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. European Journal of Cancer Prevention, 25(2):130-136.

Hundsberger, T; Hottinger, A F; Roelcke, U; Roth, P; Migliorini, D; Dietrich, P Y; Conen, K; Pesce, G; Hermann, E; Pica, A; Gross, M W; Brügge, D; Plasswilm, L; Weller, M; Putora, P M (2016). Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. Journal of Neuro-Oncology, 126(1):175-183.

Diem, Stefan; Keller, Fabienne; Rüesch, Reinhard; Maillard, Samia A; Speiser, Daniel E; Dummer, Reinhard; Siano, Marco; Urner-Bloch, Ursula; Goldinger, Simone M; Flatz, Lukas (2016). Pembrolizumab-triggered uveitis: an additional surrogate marker for responders in melanoma immunotherapy? Journal of Immunotherapy, 39(9):379-382.

Wirsching, Hans-Georg; Morel, Corinne; Gmür, Corinne; Neidert, Marian Christoph; Baumann, Christian Richard; Valavanis, Antonios; Rushing, Elisabeth Jane; Krayenbühl, Niklaus; Weller, Michael (2016). Predicting outcome of epilepsy after meningioma resection. Neuro-Oncology, 18(7):1002-1010.

Pires, Nuno D; Bemer, Marian; Müller, Lena M; Baroux, Célia; Spillane, Charles; Grossniklaus, Ueli (2016). Quantitative genetics identifies cryptic genetic variation involved in the paternal regulation of seed development. PLoS Genetics, 12(1):e1005806.

Rozati, Sima; Cheng, Phil F; Widmer, Daniel S; Fujii, Kazuyasu; Levesque, Mitchell Paul; Dummer, Reinhard (2016). Romidepsin and azacitidine synergize in their epigenetic modulatory effects to induce apoptosis in CTCL. Clinical Cancer Research, 22(8):2020-2031.

Koelzer, Viktor H; Rothschild, Sacha I; Zihler, Deborah; Wicki, Andreas; Willi, Berenika; Willi, Niels; Voegeli, Michèle; Cathomas, Gieri; Zippelius, Alfred; Mertz, Kirsten D (2016). Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study. Journal for ImmunoTherapy of Cancer, 4:13.

Satheesha, S; Manzella, G; Bovay, A; Casanova, E A; Bode, P K; Belle, R; Feuchtgruber, S; Jaaks, P; Dogan, N; Koscielniak, E; Schäfer, B W (2016). Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma. Oncogene, 35(16):2020-2030.

Lalaoui, N; Hänggi, K; Brumatti, G; Chau, D; Nguyen, N Y N; Vasilikos, L; Spilgies, L M; Heckmann, D A; Ma, C; Ghisi, M; Salmon, J M; Matthews, G M; de Valle, E; Moujalled, D M; Menon, M B; Spall, S K; Glaser, S P; Richmond, J; Lock, R B; Condon, S M; Gugasyan, R; Gaestel, M; Guthridge, M; Johnstone, R W; Munoz, L; Wei, A; Ekert, P G; Vaux, D L; Wong, W Wei-Lynn; Silke, J (2016). Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics. Cancer Cell, 29(2):145-158.

Silginer, M; Burghardt, I; Gramatzki, D; Bunse, L; Leske, H; Rushing, E J; Hao, N; Platten, M; Weller, M; Roth, P (2016). The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Oncogene, 35(25):3260-3271.

Toll-Riera, Macarena; San Millan, Alvaro; Wagner, Andreas; MacLean, R Craig (2016). The genomic basis of evolutionary innovation in pseudomonas aeruginosa. PLoS Genetics, 12(5):e1006005.

Lafranchi, Lorenzo; Sartori, Alessandro A (2016). The ubiquitin ligase APC/C(Cdh1) puts the brakes on DNA-end resection. Molecular & Cellular Oncology, 2(4):e1000696.

2015

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Corrigendum: Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(12):1747.

Roth, P; Keller, A; Hoheisel, J D; Codo, P; Bauer, A S; Backes, C; Leidinger, P; Meese, E; Thiel, E; Korfel, A; Weller, M (2015). Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients. European Journal of Cancer, 51(3):382-390.

Ghadjar, P; Hayoz, S; Bernhard, J; Zwahlen, D R; Holscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Müller, A-C; Plasswilm, L; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbuhler, H; Najafi, Y; Ost, P; Azinwi, N C; Reuter, C; Bodis, S; Kaouthar, K; Wust, P; Thalmann, G N; Aebersold, D M (2015). Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. Journal of Clinical Oncology, 33(35):4158-4166.

Yang, Yi; Gorzelanny, Christian; Bauer, A T; Halter, Natalia; Komljenovic, D; Bäuerle, T; Borsig, Lubor; Roblek, Marko; Schneider, Stefan W (2015). Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity. Oncogene, 34:5832-5842.

Guckenberger, Matthias (2015). Dose and fractionation in stereotactic body radiation therapy for stage i non-small cell lung cancer: lessons learned and where do we go next? International Journal of Radiation Oncology, Biology, Physics, 93(4):765-768.

Agelopoulos, Konstantin; Richter, Günther H S; Schmidt, Eva; Dirksen, Uta; von Heyking, Kristina; Moser, Benjamin; Klein, Hans-Ulrich; Kontny, Udo; Dugas, Martin; Poos, Kathrin; Korsching, Eberhard; Buch, Thorsten; Weckesser, Matthias; Schulze, Isabell; Besoke, Regina; Witten, Anika; Stoll, Monika; Köhler, Gabriele; Hartmann, Wolfgang; Wardelmann, Eva; Rossig, Claudia; Baumhoer, Daniel; Jürgens, Heribert; Burdach, Stefan; Berdel, Wolfgang E; Müller-Tidow, Carsten (2015). Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in ewing sarcoma. Clinical Cancer Research, 21(21):4935-4946.

Creutzig, U; Dworzak, M N; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Stackelberg, A V; Starý, J; Reinhardt, D (2015). Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival. Leukemia, 29(11):2260-2263.

Reardon, D A; Weller, M (2015). Dedication: Andrew T. Parsa. Neuro-Oncology, 17 Suppl:vii2.

Nduom, E K; Weller, M; Heimberger, A B (2015). Immunosuppressive mechanisms in glioblastoma. Neuro-Oncology, 17 Suppl:vii9-vii14.

Wirsching, H G; Happold, C; Roth, P; Weller, M (2015). Management of diffusely infiltrating glioma in the elderly. Current Opinion in Oncology, 27(6):502-509.

Bransi, Ali; Salgado, Oscar Camilo; Beffinger, Michal; Milo, Karim; Silina, Karina; Yagita, Hideo; Becher, Burkhard; Knuth, Alexander; van den Broek, Maries (2015). Rational combination of immunotherapies with clinical efficacy in mice with advanced cancer. Cancer immunology research, 3(11):1279-1288.

Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.

Pfister, Sophia X; Markkanen, Enni; Jiang, Yanyan; Sarkar, Sovan; Woodcock, Mick; Orlando, Giulia; Mavrommati, Ioanna; Pai, Chen-Chun; Zalmas, Lykourgos-Panagiotis; Drobnitzky, Neele; Dianov, Grigory L; Verrill, Clare; Macaulay, Valentine M; Ying, Songmin; La Thangue, Nicholas B; D'Angiolella, Vincenzo; Ryan, Anderson J; Humphrey, Timothy C (2015). Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation. Cancer Cell, 28(5):557-568.

Dona, Margo; Bachmann-Gagescu, Ruxandra; Texier, Yves; Toedt, Grischa; Hetterschijt, Lisette; Tonnaer, Edith L; Peters, Theo A; van Beersum, Sylvia E C; Bergboer, Judith G M; Horn, Nicola; de Vrieze, Erik; Slijkerman, Ralph W N; van Reeuwijk, Jeroen; Flik, Gert; Keunen, Jan E; Ueffing, Marius; Gibson, Toby J; Roepman, Ronald; Boldt, Karsten; Kremer, Hannie; van Wijk, Erwin (2015). NINL and DZANK1 co-function in vesicle transport and are essential for photoreceptor development in Zebrafish. PLoS Genetics, 11(10):e1005574.

Wein, Axel; Emmert, Martin; Merkel, Susanne; Harich, Hanns-Detlev; Siebler, Juergen; Thiemann, Roland; Lamberti, Christof; Göttler, Bernhard; Fries, Stefan; Kiani, Alexander; Schlag, Rudolf; Grüner, Marcus; Steinbild, Simone; Eberl, Sonja; Pohl-Dernick, Katharina; Dörje, Frank; Horbach, Thomas; Schöffski, Oliver; Neurath, Markus F; Hohenberger, Werner (2015). Palliative treatment of colorectal cancer with secondary metastasis resection in Germany - impact of the multidisciplinary treatment approach on prognosis and cost: The Northern Bavaria IVOPAK I project. Oncology, 88(2):103-121.

Pomp, Victoria; Leo, Cornelia; Mauracher, Andrea; Korol, Dimitri; Guo, Wenjun; Varga, Zsuzsanna (2015). Differential expression of epithelial-mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer. Breast Cancer Research and Treatment, 154(1):45-55.

Datta, Niloy R; Samiei, Massoud; Bodis, Stephan (2015). Are state-sponsored new radiation therapy facilities economically viable in low- and middle-income countries? International Journal of Radiation Oncology, Biology, Physics, 93(2):229-240.

Jang, Jae-Hwi; Baerts, Lesley; Waumans, Yannick; De Meester, Ingrid; Yamada, Yoshito; Limani, Perparim; Gil-Bazo, Ignacio; Weder, Walter; Jungraithmayr, Wolfgang (2015). Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. Clinical & Experimental Metastasis, 32(7):677-687.

Bachmann-Gagescu, Ruxandra; Dona, Margo; Hetterschijt, Lisette; Tonnaer, Edith; Peters, Theo; de Vrieze, Erik; Mans, Dorus A; van Beersum, Sylvia E C; Phelps, Ian G; Arts, Heleen H; Keunen, Jan E; Ueffing, Marius; Roepman, Ronald; Boldt, Karsten; Doherty, Dan; Moens, Cecilia B; Neuhauss, Stephan C F; Kremer, Hannie; van Wijk, Erwin (2015). The ciliopathy protein CC2D2A Associates with NINL and functions in RAB8-MICAL3-regulated vesicle trafficking. PLoS Genetics, 11(10):e1005575.

Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Larkin, James; Lebbé, Celeste; Hauschild, Axel (2015). Integrating first-line treatment options into clinical practice: what's new in advanced melanoma? Melanoma research, 25(6):461-469.

Hermann, Silke; Friedrich, Susanne; Haug, Ulrike; Rohrmann, Sabine; Becker, Nikolaus; Kaaks, Rudolf (2015). Association between socioeconomic and demographic characteristics and utilization of colonoscopy in the EPIC-Heidelberg cohort. European Journal of Cancer Prevention, 24(2):81-88.

Shalaby, Tarek; Grotzer, Michael A (2015). MCY as Therapeutic Target for Embryonal Tumors: Potential and Challenges. Current Cancer Drug Targets, 16(1):2-21.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Ellingson, B M; Bendszus, M; Boxerman, J; Barboriak, D; Erickson, B J; Smits, M; Nelson, S J; Gerstner, E; Alexander, B; Goldmacher, G; Wick, W; Vogelbaum, M; Weller, M; Galanis, E; Kalpathy-Cramer, J; Shankar, L; Jacobs, P; Pope, W B; Yang, D; Chung, C; Knopp, M V; Cha, S; van den Bent, M J; Chang, S; Al Yung, W K; Cloughesy, T F; Wen, P Y; Gilbert, M R (2015). Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro-Oncology, 17(9):1188-1198.

Cihoric, Nikola; Tsikkinis, Alexandros; van Rhoon, Gerard; Crezee, Hans; Aebersold, Daniel M; Bodis, Stephan; Beck, Marcus; Nadobny, Jacek; Budach, Volker; Wust, Peter; Ghadjar, Pirus (2015). Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. International Journal of Hyperthermia, 31(6):609-614.

Freiberger, Sandra N; Cheng, Phil F; Iotzova-Weiss, Guergana; Neu, Johannes; Liu, Qinxiu; Dziunycz, Piotr; Zibert, John R; Dummer, Reinhard; Skak, Kresten; Levesque, Mitchell P; Hofbauer, Günther F L (2015). Ingenol mebutate signals via PKC/MEK/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Molecular Cancer Therapeutics, 14(9):2132-2142.

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(5):716-721.

Filatenkov, A; Baker, J; Mueller, A M S; Kenkel, J; Ahn, G-O; Dutt, S; Zhang, N; Kohrt, H; Jensen, K; Dejbakhsh-Jones, S; Shizuru, J A; Negrin, R N; Engleman, E G; Strober, S (2015). Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions. Clinical Cancer Research, 21(16):3727-3739.

Adel Fahmideh, Maral; Lavebratt, Catharina; Schüz, Joachim; Röösli, Martin; Tynes, Tore; Grotzer, Michael A; Johansen, Christoffer; Kuehni, Claudia E; Lannering, Birgitta; Prochazka, Michaela; Schmidt, Lisbeth S; Feychting, Maria (2015). CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility. Carcinogenesis, 36(8):876-882.

Eckert, C; Hagedorn, N; Sramkova, L; Mann, G; Panzer-Grümayer, R; Peters, C; Bourquin, J-P; Klingebiel, T; Borkhardt, A; Cario, G; Alten, J; Escherich, G; Astrahantseff, K; Seeger, K; Henze, G; von Stackelberg, A (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8):1648-1655.

Aigner, Elmar; Stadlmayr, Andreas; Huber-Schönauer, Ursula; Zwerina, Jochen; Husar-Memmer, Emma; Niederseer, David; Eder, Sebastian K; Stickel, Felix; Pirich, Christian; Schett, Georg; Patsch, Wolfgang; Datz, Christian (2015). Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women but not men. Hormones and Cancer, 6(4):153-160.

Berghoff, A S; Kiesel, B; Widhalm, G; Rajky, O; Ricken, G; Wöhrer, A; Dieckmann, K; Filipits, M; Brandstetter, A; Weller, M; Kurscheid, S; Hegi, M E; Zielinski, C C; Marosi, C; Hainfellner, J A; Preusser, M; Wick, W (2015). Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro-Oncology, 17(8):1064-1075.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Levy, Antonin; Guckenberger, Matthias; Hurkmans, Coen; Nestle, Ursula; Belderbos, José; De Ruysscher, Dirk; Faivre-Finn, Corinne; Le Péchoux, Cécile (2015). SBRT dose and survival in non-small cell lung cancer: in regard to koshy et al. International Journal of Radiation Oncology, Biology, Physics, 92(4):945-946.

Weber, Achim; O'Connor, Tracy; Heikenwalder, Mathias (2015). Next Generation of Preclinical Liver Cancer Models. Clinical Cancer Research, 21(19):4254-4256.

Gemble, Simon; Ahuja, Akshay; Buhagiar-Labarchède, Géraldine; Onclercq-Delic, Rosine; Dairou, Julien; Biard, Denis S F; Lambert, Sarah; Lopes, Massimo; Amor-Guéret, Mounira (2015). Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA. PLoS Genetics, 11(7):e1005384.

Diel, Ingo J; Body, Jean-Jacques; Stopeck, Alison T; Vadhan-Raj, Saroj; Spencer, Andrew; Steger, Günther; von Moos, Roger; Goldwasser, François; Feng, Amy; Braun, Ada (2015). The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European Journal of Cancer, 51(11):1467-1475.

Haller, Stephanie; Reber, Josefine; Brandt, Simone; Bernhardt, Peter; Groehn, Viola; Schibli, Roger; Müller, Cristina (2015). Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy. Nuclear medicine and biology, 42(10):770-779.

Gámez-Pozo, Angelo; Berges-Soria, Julia; Arevalillo, Jorge M; Nanni, Paolo; López-Vacas, Rocío; Navarro, Hilario; Grossmann, Jonas; Castaneda, Carlos A; Main, Paloma; Díaz-Almirón, Mariana; Espinosa, Enrique; Ciruelos, Eva; Fresno Vara, Juan Ángel (2015). Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications. Cancer Research, 75(11):2243-2253.

Wagner, N B; Weide, B; Reith, M; Tarnanidis, K; Kehrel, C; Lichtenberger, R; Pflugfelder, A; Herpel, E; Eubel, J; Ikenberg, K; Busch, C; Holland-Letz, T; Naeher, H; Garbe, C; Umansky, V; Enk, A; Utikal, J; Gebhardt, C (2015). Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma. International Journal of Cancer, 137(11):2607-2617.

Azzouzi, Imane; Moest, Hansjoerg; Wollscheid, Bernd; Schmugge, Markus; Eekels, Julia J M; Speer, Oliver (2015). Deep sequencing and proteomic analysis of the microRNA-induced silencing complex in human red blood cells. Experimental Hematology, 43(5):382-392.

Schmid, Tobias; Snoek, L Basten; Fröhli, Erika; van der Bent, M Leontien; Kammenga, Jan; Hajnal, Alex (2015). Systemic regulation of RAS/MAPK signaling by the serotonin metabolite 5-HIAA. PLoS Genetics, 11(5):e1005236.

Datta, Niloy Ranjan; Grobholz, Rainer; Puric, Emsad; Bode-Lesniewska, Beata; Lomax, Nicoletta; Khan, Shaka; Gaipl, Udo S; Fuchs, Bruno; Bodis, Stephan (2015). Enhanced tumour regression in a patient of liposarcoma treated with radiotherapy and hyperthermia: Hint for dynamic immunomodulation by hyperthermia. International Journal of Hyperthermia, 31(5):574-577.

Dettmer, Matthias S; Schmitt, Anja; Steinert, Hans; Capper, David; Moch, Holger; Komminoth, Paul; Perren, Aurel (2015). Tall cell Papillary Thyroid Carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocrine-Related Cancer, 22(3):419-429.

Peters, Christina; Schrappe, Martin; von Stackelberg, Arend; Schrauder, André; Bader, Peter; Ebell, Wolfram; Lang, Peter; Sykora, Karl-Walter; Schrum, Johanna; Kremens, Bernhard; Ehlert, Karoline; Albert, Michael H; Meisel, Roland; Matthes-Martin, Susanne; Güngör, Tayfun; Holter, Wolfgang; Strahm, Brigitte; Gruhn, Bernd; Schulz, Ansgar; Woessmann, Wilhelm; Poetschger, Ulrike; Zimmermann, Martin; Klingebiel, Thomas (2015). Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. Journal of Clinical Oncology, 33(11):1265-1274.

Zhao, Rongbao; Visentin, Michele; Goldman, I David (2015). Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis. Cancer Chemotherapy and Pharmacology, 75(6):1163-1173.

Zeimpekis, Konstantinos G; Barbosa, Felipe; Hüllner, Martin; Ter Voert, Edwin; Davison, Helen; Veit-Haibach, Patrick; Delso, Gaspar (2015). Clinical evaluation of PET image quality as a function of acquisition time in a new TOF-PET/MRI compared to TOF-PET/CT-initial results. Molecular Imaging and Biology, 17(5):735-744.

Weber, Damien C; Wang, Yucai; Miller, Robert; Villà, Salvador; Zaucha, Renata; Pica, Alessia; Poortmans, Philip; Anacak, Yavuz; Ozygit, Gokhan; Baumert, Birgitta; Haller, Guy; Preusser, Matthias; Li, Jing (2015). Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro-Oncology, 17(4):588-595.

Kreher, S; Jöhrens, K; Strehlow, F; Martus, P; Borowiec, K; Radke, J; Heppner, F; Roth, P; Thiel, E; Pietsch, T; Weller, M; Korfel, A (2015). Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma. Neuro-Oncology, 17(7):1016-1021.

Lau, E; Sedy, J; Sander, C; Shaw, M A; Feng, Y; Scortegagna, M; Claps, G; Robinson, S; Cheng, P; Srivas, R; Soonthornvacharin, S; Ideker, T; Bosenberg, M; Gonzalez, R; Robinson, W; Chanda, S K; Ware, C; Dummer, R; Hoon, D; Kirkwood, J M; Ronai, Z A (2015). Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy. Oncogene, 34(46):5739-5748.

Rohrmann, Sabine; et al (2015). Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. International Journal of Cancer, 136(5):E423-31.

Dummer, Reinhard; Goldinger, Simone M; Paulitschke, Verena; Levesque, Mitchell P (2015). Curing advanced melanoma by 2025. Current Opinion in Oncology, 27(2):125-127.

DeSimone, Jennifer A; Sodha, Pooja; Ignatova, Desislava; Dummer, Reinhard; Cozzio, Antonio; Guenova, Emmanuella (2015). Recent advances in primary cutaneous T-cell lymphoma. Current Opinion in Oncology, 27(2):128-133.

Ruf, Melanie; Mittmann, Christiane; Nowicka, Anna M; Hartmann, Arndt; Hermanns, Thomas; Poyet, Cédric; van den Broek, Maries; Sulser, Tullio; Moch, Holger; Schraml, Peter (2015). pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clinical Cancer Research, 21(4):889-98.

Wegert, Jenny; Ishaque, Naveed; Vardapour, Romina; Geörg, Christina; Gu, Zuguang; Bieg, Matthias; Ziegler, Barbara; Bausenwein, Sabrina; Nourkami, Nasenien; Ludwig, Nicole; Keller, Andreas; Grimm, Clemens; Kneitz, Susanne; Williams, Richard D; Chagtai, Tas; Pritchard-Jones, Kathy; van Sluis, Peter; Volckmann, Richard; Koster, Jan; Versteeg, Rogier; Acha, Tomas; O'Sullivan, Maureen J; Bode, Peter K; Niggli, Felix; Tytgat, Godelieve A; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M; Meese, Eckart; Vokuhl, Christian; Leuschner, Ivo; Graf, Norbert; Eils, Roland; Pfister, Stefan M; Kool, Marcel; Gessler, Manfred (2015). Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell, 27(2):298-311.

Lassen, U; Chinot, O L; McBain, C; Mau-Sørensen, M; Larsen, V A; Barrie, M; Roth, P; Krieter, O; Wang, K; Habben, K; Tessier, J; Lahr, A; Weller, M (2015). Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. Neuro-Oncology, 17(7):1007-1015.

Weller, Michael; Tabatabai, G; Kästner, B; Felsberg, J; Steinbach, J P; Wick, A; Schnell, O; Hau, P; Herrlinger, U; Sabel, M C; Wirsching, H G; Ketter, R; Bähr, O; Platten, M; Tonn, J C; Schlegel, U; Marosi, C; Goldbrunner, R; Stupp, R; Homicsko, K; Pichler, J; Nikkhah, G; Meixensberger, J; Vajkoczy, P; Kollias, S; Hüsing, J; Reifenberger, G; Wick, W (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research, 21(9):2057-2064.

Broggini-Tenzer, Angela; Sharma, Ashish; Nytko, Katarzyna J; Bender, Sabine; Vuong, Van; Orlowski, Katrin; Hug, Daniel; O'Reilly, Terence; Pruschy, Martin (2015). Combined treatment strategies for microtubule stabilizing agent-resistant tumors. Journal of the National Cancer Institute, 107(4):dju504.

Shakhova, Olga; Cheng, Phil; Mishra, Pravin J; Zingg, Daniel; Schaefer, Simon M; Debbache, Julien; Häusel, Jessica; Matter, Claudia; Guo, Theresa; Davis, Sean; Meltzer, Paul; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Merlino, Glenn; Levesque, Mitchell P; Dummer, Reinhard; Santoro, Raffaella; Cinelli, Paolo; Sommer, Lukas (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genetics, 11(1):e1004877.

Hofer, Silvia; Mengele, Karin; Schmitt, Manfred; Pestalozzi, Bernhard; Aebi, Stefan (2015). Complement activation and rituximab distribution in CNS NHL: letter. Clinical Cancer Research, 21(2):490.

Tsilidis, Konstantinos K; Allen, Naomi E; Appleby, Paul N; Rohrmann, Sabine; Nöthlings, Ute; Arriola, Larraitz; Gunter, Marc J; Chajes, Veronique; Rinaldi, Sabina; Romieu, Isabelle; Murphy, Neil; Riboli, Elio; Tzoulaki, Ioanna; Kaaks, Rudolf; Lukanova, Annekatrin; Boeing, Heiner; Pischon, Tobias; Dahm, Christina C; Overvad, Kim; Quirós, J Ramón; Fonseca-Nunes, Ana; Molina-Montes, Esther; Gavrila Chervase, Diana; Ardanaz, Eva; Khaw, Kay T; Wareham, Nick J; Roswall, Nina; Tjønneland, Anne; Lagiou, Pagona; Trichopoulos, Dimitrios; Trichopoulou, Antonia; Palli, Domenico; Pala, Valeria; Tumino, Rosario; Vineis, Paolo; Bueno-de-Mesquita, H Bas; Malm, Johan; Orho-Melander, Marju; Johansson, Mattias; Stattin, Pär; Travis, Ruth C; Key, Timothy J (2015). Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 136(2):372-381.

Otsuka, Atsushi; Dreier, Jil; Cheng, Phil F; Nägeli, Mirjam; Lehmann, Holger; Felderer, Lea; Frew, Ian J; Matsushita, Shigeto; Levesque, Mitchell P; Dummer, Reinhard (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research:1289-1297.

Randazzo, Marco; Beatrice, Josef; Huber, Andreas; Grobholz, Rainer; Manka, Lukas; Chun, Felix K; Kluth, Luis A; Wyler, Stephen F; Recker, Franz; Kwiatkowski, Maciej (2015). Is further screening of men with baseline psa < 1ng/ml worthwhile? the discussion continues - results of the Swiss ERSPC (Aarau). International Journal of Cancer, 137(3):553-559.

Jenkinson, Michael D; Weber, Damien C; Haylock, Brian J; Mallucci, Conor L; Zakaria, Rasheed; Javadpour, Mohsen (2015). Atypical meningoma: current management dilemmas and prospective clinical trials. Journal of Neuro-Oncology, 121(1):1-7.

Theocharides, A P; Dobson, S M; Laurenti, E; Notta, F; Voisin, V; Cheng, P Y; Yuan, J S; Guidos, C J; Minden, M D; Mullighan, C G; Torlakovic, E; Dick, J E (2015). Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia, 29(1):177-187.

Church, David N; Stelloo, Ellen; Nout, Remi A; Valtcheva, Nadejda; Depreeuw, Jeroen; Ter Haar, Natalja; Noske, Aurelia; Amant, Frederic; Tomlinson, Ian P M; Wild, Peter J; Lambrechts, Diether; Jürgenliemk-Schulz, Ina M; Jobsen, Jan J; Smit, Vincent T H B M; Creutzberg, Carien L; Bosse, Tjalling (2015). Prognostic significance of POLE proofreading mutations in endometrial cancer. Journal of the National Cancer Institute, 107(1):1-8.

Brenner, Stefan; Riha, Juliane; Giessrigl, Benedikt; Thalhammer, Theresia; Grusch, Michael; Krupitza, Georg; Stieger, Bruno; Jäger, Walter (2015). The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells. International Journal of Oncology, 46(1):324-332.

Gürsel, Demirkan B; Banu, Matei A; Berry, Nicholas; Marongiu, Roberta; Burkhardt, Jan-Karl; Kobylarz, Keith; Kaplitt, Michael G; Rafii, Shahin; Boockvar, John A (2015). Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. Journal of Neuro-Oncology, 121(1):19-29.

Weber, Damien C; Ares, Carmen; Malyapa, Robert; Albertini, Francesca; Calaminus, Gabriele; Kliebsch, Ulrike; Mikroutsikos, Lorentzos; Morach, Petra; Bolsi, Alessandra; Lomax, Tony; Schneider, Ralf (2015). Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy. Journal of Neuro-Oncology, 121(2):389-397.

Johnson, Douglas B; et al; Goldinger, Simone M (2015). Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms. European Journal of Cancer, 51(18):2792-2799.

Hempen, Aline; Samartzis, Eleftherios Pierre; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15:507.

Wanner, Miriam; Richard, Aline; Martin, Brian; Linseisen, Jakob; Rohrmann, Sabine (2015). Associations between objective and self-reported physical activity and vitamin D serum levels in the US population. Cancer Causes & Control, 26(6):881-891.

Geiger, P; Barben, M; Grimm, C; Samardzija, M (2015). Blue light-induced retinal lesions, intraretinal vascular leakage and edema formation in the all-cone mouse retina. Cell Death and Disease, 6:e1985.

Birnbaum, J H; Bali, J; Rajendran, L; Nitsch, R M; Tackenberg, C (2015). Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss. Cell Death and Disease, 6:e1791.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1):67-76.

Cornelissen, J J; Versluis, J; Passweg, J R; van Putten, W L; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J; van Marwijk, Kooy M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M C; Breems, D A; Verdonck, L F; Fey, M F; Jongen-Lavrencic, M; Janssen, J J; Huls, G; Kuball, J; Pabst, T; Graux, C; Schouten, H C; Gratwohl, A; Vellenga, E; Ossenkoppele, G; Löwenberg, B (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5):1041-1050.

Huber, F; Montani, M; Sulser, T; Jaggi, R; Wild, P; Moch, H; Gevensleben, H; Schmid, M; Wyder, S; Kristiansen, G (2015). Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies. British Journal of Cancer, 112:140-148.

Herrmann, Ken; Queiroz, Marcelo; Huellner, Martin W; de Galiza Barbosa, Felipe; Buck, Andreas; Schaefer, Niklaus; Stolzman, Paul; Veit-Haibach, Patrick (2015). Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT. BMC Cancer, 15(1002):online.

Seystahl, K; Tritschler, I; Szabo, E; Tabatabai, G; Weller, M (2015). Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro-Oncology, 17(2):254-265.

Thon, N; Kunz, M; Lemke, L; Jansen, N L; Eigenbrod, S; Kreth, S; Lutz, J; Egensperger, R; Giese, A; Herms, J; Weller, M; Kretzschmar, H; Tonn, J C; laFougère, C; Kreth, F W (2015). Dynamic (18) F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. International Journal of Cancer, 136(9):2132-2145.

Witt, Claudia M; Außerer, Oskar; Baier, Susanne; Heidegger, Herbert; Icke, Katja; Mayr, Oswald; Mitterer, Manfred; Roll, Stephanie; Spizzo, Gilbert; Scherer, Arthur; Thuile, Christian; Wieser, Anton; Schützler, Lena (2015). Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial. Breast Cancer Research and Treatment, 149(2):449-460.

Gemuenden, Cornelia; Benz, Rudolf; Senn, Oliver; Goede, Jeroen S; Manz, Markus G; Gerber, Bernhard (2015). Efficacy of Azacitidine in de Novo and relapsed acute Myeloid Leukemia: A retrospective comparative study. Clinical Lymphoma, Myeloma & Leukemia, 15(12):811-815.

McKinney, Nicole; Yuan, Liangping; Zhang, Hongying; Liu, Jingbo; Cho, Yoon-Jae; Rushing, Elisabeth; Schniederjan, Matthew; MacDonald, Tobey J (2015). EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. Journal of Neuro-Oncology, 121(1):109-118.

Kros, J M; Huizer, K; Hernandez-Lain, A; Marucci, G; Michotte, A; Pollo, B; Rushing, E J; Ribalta, T; French, P; Jamine, D; Bekka, N; Lacombe, D; van den Bent, M J; Gorlia, T (2015). Evidence-based diagnostic algorithm for glioma: analysis of the results of pathology panel review and molecular parameters of EORTC 26951 and 26882 trials. Journal of Clinical Oncology, 33(17):1943-1950.

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

Parviainen, S; Ahonen, M; Diaconu, I; Kipar, A; Siurala, M; Vähä-Koskela, M; Kanerva, A; Cerullo, V; Hemminki, A (2015). GMCSF-armed vaccinia virus induces an antitumor immune response. International Journal of Cancer, 136(5):1065-1072.

Kumar, Ram Mohan Ram; Fuchs, Bruno (2015). Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma. Cancers, 7(2):784-794.

Koelzer, Viktor H; Herrmann, Pia; Zlobec, Inti; Karamitopoulou, Eva; Lugli, Alessandro; Stein, Ulrike (2015). Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study. BMC Cancer, 15:160.

Lissat, Andrej; Joerschke, Mandy; Shinde, Dheeraj A; Braunschweig, Till; Meier, Angelina; Makowska, Anna; Bortnick, Rachel; Henneke, Philipp; Herget, Georg; Gorr, Thomas A; Kontny, Udo (2015). IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells. BMC Cancer, 15(552):online.

Echeverry, N; Ziltener, G; Barbone, D; Weder, W; Stahel, R A; Broaddus, V C; Felley-Bosco, E (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease, 6:e1757.

Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, L A; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M (2015). Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: Final analysis of a randomized phase III dermatologic cooperative oncology group trial. Journal of Clinical Oncology, 33(34):4077-4084.

Friemel, Juliane; Rechsteiner, Markus Peter; Frick, Lukas; Boehm, Friederike; Struckmann, Kirsten; Sigg, Michele; Moch, Holger; Heikenwaelder, Mathias; Weber, Achim (2015). Intratumor heterogeneity in hepatocellular carcinoma. Clinical Cancer Research, 21(8):1951-1961.

Richard, Aline; Rohrmann, Sabine; Schmid, Seraina M; Tirri, Brigitte Frey; Huang, Dorothy J; Güth, Uwe; Eichholzer, Monika (2015). Lifestyle and health-related predictors of cervical cancer screening attendance in a Swiss population-based study. Cancer Epidemiology, 39(6):870-876.

Helfer-Hungerbuehler, A Katrin; Widmer, Stefan; Kessler, Yvonne; Riond, Barbara; Boretti, Felicitas S; Grest, Paula; Lutz, Hans; Hofmann-Lehmann, Regina (2015). Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes. Virus Research, 197:137-150.

Schönknecht, Christine; Hadjamu, Miriam; Oechsner, Markus; Andratschke, Nicolaus; Duma, Marciana-Nona (2015). Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature. Tumori, 101(5):e141-e144.

Collaud, Stéphane; Tischler, Verena; Atanassoff, Andrej; Wiedl, Thomas; Komminoth, Paul; Oehlschlegel, Christian; Weder, Walter; Soltermann, Alex (2015). Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN. BMC Cancer, 15(74):online.

Gross, C; et al; Steingotter, A (2015). Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical Cancer Research, 21(19):4440-4450.

Janssen, Stefan; Holz‑Sapra, Edna; Rades, Dirk; Moser, Alexander; Studer, Gabriela (2015). Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review). Oncology Letters, 9(6):2435-2441.

Reinau, Daphne; Surber, Christian; Jick, Susan S; Meier, Christoph R (2015). Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer. International Journal of Cancer, 137(1):144-153.

Siurala, M; Bramante, S; Vassilev, L; Hirvinen, M; Parviainen, S; Tähtinen, S; Guse, K; Cerullo, V; Kanerva, A; Kipar, A; Vähä-Koskela, M; Hemminki, A (2015). Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. International Journal of Cancer, 136(4):945-954.

Thalhammer, Verena; Lopez-Garcia, Laura A; Herrero Martín, David; Hecker, Regina; Laubscher, Dominik; Gierisch, Maria E; Wachtel, Marco; Bode, Peter; Nanni, Paolo; Blank, Bernd; Koscielniak, Ewa; Schäfer, Beat W (2015). PLK1 phosphorylates PAX3-FOXO1 the inhibition of which triggers regression of alveolar rhabdomyosarcoma. Cancer Research, 75(1):98-110.

Poyet, Cédric; Hermanns, Thomas; Zhong, Qing; Drescher, Eva; Eberli, Daniel; Burger, Maximilian; Hofstaedter, Ferdinand; Hartmann, Arndt; Stöhr, Robert; Zwarthoff, Ellen; Sulser, Tullio; Wild, Peter (2015). Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer. Oncology Letters, 10(5):2753-2760.

Valko, P O; Siddique, A; Linsenmeier, C; Zaugg, K; Held, U; Hofer, S (2015). Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro-Oncology, 17(2):274-281.

Rusch, Andreas; Ziltener, Gabriela; Nackaerts, Kristiaan; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2015). Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer, 87(1):77-79.

Rakha, E A; Tan, P H; Varga, Z; Tse, G M; Shaaban, A M; Climent, F; van Deurzen, C H M; Purnell, D; Dodwell, D; Chan, T; Ellis, I O (2015). Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. British Journal of Cancer, 112(2):283-289.

Boro, Aleksandar; Arlt, Matthias Je; Lengnick, Harald; Robl, Bernhard; Husmann, Maren; Bertz, Josefine; Born, Walter; Fuchs, Bruno (2015). Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma. American Journal of Translational Research, 7(3):640-653.

Robl, Bernhard; Pauli, Chantal; Botter, Sander Martijn; Bode-Lesniewska, Beata; Fuchs, Bruno (2015). Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer, 15:379.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Cathomas, Richard; Rothermundt, Christian; Bode, Beata; Fuchs, Bruno; von Moos, Roger; Schwitter, Michael (2015). RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward? Oncology, 88(4):257-260.

Steliarova-Foucher, Eva; Stiller, Charles; Colombet, Murielle; Kaatsch, Peter; Zanetti, Roberto; Peris-Bonet, Rafael (2015). Registration of childhood cancer: Moving towards pan-European coverage? European Journal of Cancer, 51(9):1064-1079.

Niegisch, G; Retz, M; Thalgott, M; Balabanov, S; Honecker, F; Ohlmann, C H; Stöckle, M; Bögemann, M; Vom Dorp, F; Gschwend, J; Hartmann, A; Ohmann, C; Albers, P (2015). Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09). Oncology, 89(2):70-78.

Schilling, Clare; Stoeckli, Sandro J; Haerle, Stephan K; et al; Huber, G F (2015). Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. European Journal of Cancer, 51(18):2777-2784.

Peters, Christina; Schrappe, Martin; von Stackelberg, Arend; Schrauder, André; Bader, Peter; Ebell, Wolfram; Lang, Peter; Sykora, Karl-Walter; Schrum, Johanna; Kremens, Bernhard; Ehlert, Karoline; Albert, Michael H; Meisel, Roland; Matthes-Martin, Susanne; Güngör, Tayfun; Holter, Wolfgang; Strahm, Brigitte; Gruhn, Bernd; Schulz, Ansgar; Woessmann, Wilhelm; Poetschger, Ulrike; Zimmermann, Martin; Klingebiel, Thomas (2015). Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors—The ALL-SCT-BFM-2003 Trial. Journal of Clinical Oncology, 33(11):1265-1274.

Kumar, Ram Mohan Ram; Arlt, Matthias Je; Kuzmanov, Aleksandar; Born, Walter; Fuchs, Bruno (2015). Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model. American Journal of Cancer Research, 5(7):2156-2168.

Anz, David; Rapp, Moritz; Eiber, Stephan; Koelzer, Viktor H; et al (2015). Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression. Cancer Research, 75(21):4483-4493.

Pircher, Magdalena; Schirrmann, Thomas; Petrausch, Ulf (2015). T Cell Engineering. In: Michielin, O; Coukos, G. Immuno-Oncology. Basel: Karger, 110-135.

Fujii, K; Karpova, M B; Asagoe, K; Georgiev, O; Dummer, R; Urosevic-Maiwald, M (2015). Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy. Leukemia, 29(10):2024-2032.

Oishi, Naoki; Duscha, Stefan; Boukari, Heithem; Meyer, Martin; Xie, Jing; Wei, Gao; Schrepfer, Thomas; Roschitzki, Bernd; Böttger, Erik C; Schacht, Jochen (2015). XBP1 mitigates aminoglycoside-induced endoplasmic reticulum stress and neuronal cell death. Cell Death and Disease, 6(e1763):online.

Hühn, D; Kousholt, A N; Sørensen, C S; Sartori, Alessandro A (2015). miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP. Oncogene, 34(30):3977-3984.

2014

Krug, Sebastian; Kühnemuth, Benjamin; Griesmann, Heidi; Neesse, Albrecht; Mühlberg, Leonie; Boch, Michael; Kortenhaus, Juliane; Fendrich, Volker; Wiese, Dominik; Sipos, Bence; Friemel, Juliane; Gress, Thomas M; Michl, Patrick (2014). CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms. Endocrine-Related Cancer, 21(6):879-890.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma / Erratum. International Journal of Oncology, 45(6):2605.

Jentzsch, Thorsten; Robl, Bernhard; Husmann, Maren; Bode-Lesniewska, Beata; Fuchs, Bruno (2014). Expression of MSH2 and MSH6 on a Tissue Microarray in Patients with Osteosarcoma. Anticancer Research, 34(12):6961-6972.

Balmativola, D; Marchiò, C; Maule, M; Chiusa, L; Annaratone, L; Maletta, F; Montemurro, F; Kulka, J; Figueiredo, P; Varga, Z; Liepniece-Karele, I; Cserni, G; Arkoumani, E; Amendoeira, I; Callagy, G; Reiner-Concin, A; Cordoba, A; Bianchi, S; Decker, T; Gläser, D; Focke, C; van Diest, P; Grabau, D; Lips, E; Wesseling, J; Arisio, R; Medico, E; Wells, C; Sapino, A (2014). Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast Cancer Research and Treatment, 148(3):511-523.

Batchelor, T T; Reardon, D A; de Groot, J F; Wick, W; Weller, M (2014). Antiangiogenic therapy for glioblastoma: current status and future prospects. Clinical Cancer Research, 20(22):5612-5619.

Datta, N R; Puric, E; Schneider, R; Weber, D C; Rogers, S; Bodis, S (2014). Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale. International Journal of Hyperthermia, 30(7):524-530.

Ning, Yan; Gerger, Armin; Zhang, Wu; Hanna, Diana L; Yang, Dongyun; Winder, Thomas; Wakatsuki, Takeru; Labonte, Melissa J; Stintzing, Sebastian; Volz, Nico; Sunakawa, Yu; Stremitzer, Stefan; El-Khoueiry, Rita; Lenz, Heinz-Josef (2014). Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Molecular Cancer Therapeutics, 13(2):528-539.

Martin, Ernst; Werner, Beat; Bauer, Ronald; van Leyen, Karin; Coluccia, Daniel; Fandino, Javier (2014). Clinical neurological HIFU applications: The Zurich experience. Translational Cancer Research, 3(5):449-458.

Wachtel, Marco; Rakic, Jelena; Okoniewski, Michal; Bode, Peter; Niggli, Felix; Schäfer, Beat W (2014). FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells. International Journal of Cancer, 135(7):1543-1552.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Skorobogata, Olga; Escobar-Restrepo, Juan M; Rocheleau, Christian E (2014). An AGEF-1/Arf GTPase/AP-1 ensemble antagonizes LET-23 EGFR basolateral localization and signaling during C. elegans vulva induction. PLoS Genetics, 10(10):e1004728.

Roth, P; Weller, M (2014). Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies. Neuro-Oncology, 16(suppl 8):viii14-viii19.

Vulsteke, Christof; Pfeil, Alena M; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Peeters, Marc; van Dam, Peter; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3):557-70.

Datta, Niloy Ranjan; Samiei, M; Bodis, S (2014). Radiotherapy infrastructure and human resources in Europe - Present status and its implications for 2020. European Journal of Cancer, 50(15):2735-2743.

Möhler, H; Pfirrmann, R W; Frei, K (2014). Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review). International Journal of Oncology, 45(4):1329-1336.

Rozati, Sima; Kempf, Werner; Ostheeren-Michaelis, Sonja; Bode-Lesniewska, Beata; Zimmermann, Dieter R; Dummer, Reinhard; Cozzio, Antonio (2014). Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS. Journal of Clinical Oncology:1-4.

Warth, A; Cortis, J; Soltermann, A; Meister, M; Budczies, J; Stenzinger, A; Goeppert, B; Thomas, M; Herth, F J F; Schirmacher, P; Schnabel, P A; Hoffmann, H; Dienemann, H; Muley, T; Weichert, W (2014). Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. British Journal of Cancer, 111(6):1222-1229.

Suryani, Santi; Carol, Hernan; Chonghaile, Triona Ni; Frismantas, Viktoras; Sarmah, Chintanu; High, Laura; Bornhauser, Beat; Cowley, Mark J; Szymanska, Barbara; Evans, Kathryn; Boehm, Ingrid; Tonna, Elise; Jones, Luke; Manesh, Donya Moradi; Kurmasheva, Raushan T; Billups, Catherine; Kaplan, Warren; Letai, Anthony; Bourquin, Jean-Pierre; Houghton, Peter J; Smith, Malcolm A; Lock, Richard B (2014). Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts. Clinical Cancer Research, 20(17):4520-4531.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Xie, Shule; Bredell, Marius; Yang, Hongyu; Shen, Shiyue; Yang, Huijun (2014). Basaloid squamous cell carcinoma of the maxillary gingiva: A case report and review of the literature. Oncology Letters, 8(3):1287-1290.

Nieder, C; Andratschke, N H; Grosu, A L (2014). Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns. Oncology Letters, 8(3):972-976.

Poetsch, Anna R; Lipka, Daniel B; Witte, Tania; Claus, Rainer; Nöllke, Peter; Zucknick, Manuela; Olk-Batz, Christiane; Fluhr, Silvia; Dworzak, Michael; De Moerloose, Barbara; Starý, Jan; Zecca, Marco; Hasle, Henrik; Schmugge, Markus; van den Heuvel-Eibrink, Marry M; Locatelli, Franco; Niemeyer, Charlotte M; Flotho, Christian; Plass, Christoph (2014). RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics, 9(9):1252-1260.

Soldini, Davide; Georgis, Antoin; Montagna, Chiara; Schüffler, Peter Johannes; Martin, Vittoria; Curioni-Fontecedro, Alessandra; Martinez, Antonio; Tinguely, Marianne (2014). The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. Hematological oncology, 32(3):120-125.

Langen, K J; Tonn, J C; Weller, M; Galldiks, N (2014). Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]. Journal of Neuro-Oncology, 120(3):665-666.

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Pfirrmann, M; Saussele, S; Hochhaus, A; Reiter, A; Berger, U; Hossfeld, D K; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Hellmann, A; Lechner, K; Falge, C; Sayer, H G; Bunjes, D; Ganser, A; Beelen, D W; Baldomero, H; Schanz, U; Heimpel, H; Kolb, H J; Hasford, J; Gratwohl, A; Hehlmann, R (2014). Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology, 140(8):1367-1381.

Müller, Adrienne; Krämer, Stefanie D; Meletta, Romana; Beck, Katharina; Selivanova, Svetlana V; Rancic, Zoran; Kaufmann, Philipp A; Vos, Bernhard; Meding, Jörg; Stellfeld, Timo; Heinrich, Tobias K; Bauser, Marcus; Hütter, Joachim; Dinkelborg, Ludger M; Schibli, Roger; Ametamey, Simon M (2014). Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Nuclear medicine and biology, 41(7):562-569.

Weller, M (2014). The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma. Neuro-Oncology, 16(8):1035-1036.

Jentzsch, Thorsten; Robl, Bernhard; Husmann, Maren; Bode-Lesniewska, Beata; Fuchs, Bruno (2014). Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray. Anticancer Research, 34(8):3881-3889.

Hermanns, T; Bhindi, B; Wei, Y; Yu, J; Noon, A P; Richard, P O; Bhatt, J R; Almatar, A; Jewett, M A S; Fleshner, N E; Zlotta, A R; Templeton, A J; Kulkarni, G S (2014). Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. British Journal of Cancer, 111(3):444-451.

van Oers, J M M; Edwards, Y; Chahwan, R; Zhang, W; Smith, C; Pechuan, X; Schaetzlein, S; Jin, B; Wang, Y; Bergman, A; Scharff, M D; Edelmann, W (2014). The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair. Oncogene, 33(30):3939-3946.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas D; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Dirven, Linda; Taphoorn, Martin J B; Reijneveld, Jaap C; Blazeby, Jane; Jacobs, Marc; Pusic, Andrea; La Sala, Edoardo; Stupp, Roger; Fayers, Peter; Efficace, Fabio (2014). The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review. European Journal of Cancer, 50(14):2432-2448.

Wiestler, B; Capper, D; Hovestadt, V; Sill, M; Jones, D T W; Hartmann, C; Felsberg, J; Platten, M; Feiden, W; Keyvani, K; Pfister, S M; Wiestler, O D; Meyermann, R; Reifenberger, G; Pietsch, T; von Deimling, A; Weller, M; Wick, W (2014). Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology, 16(12):1630-1638.

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.

Datta, N R; Samiei, M; Bodis, S (2014). Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. International Journal of Radiation Oncology, Biology, Physics, 89(3):448-457.

Schweizer, Riccardo; Kamat, Pranitha; Schweizer, Dennis; Dennler, Cyrill; Zhang, Shengye; Schnider, Jonas T; Salemi, Souzan; Giovanoli, Pietro; Eberli, Daniel; Enzmann, Volker; Erni, Dominique; Plock, Jan A (2014). Bone marrow-derived mesenchymal stromal cells improve vascular regeneration and reduce leukocyte-endothelium activation in critical ischemic murine skin in a dose-dependent manner. Cytotherapy, 16(10):1465-1469.

Lacombea, Denis; Burocka, Susen; Bogaertsa, Jan; Schoeffskib, Patrick; Golfinopoulosa, Vassilis; Stupp, Roger (2014). The dream and reality of histology agnostic cancer clinical trials. Molecular Oncology, 8(6):1057-1063.

Muendlein, Axel; Hubalek, Michael; et al (2014). Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. European Journal of Cancer, 50(12):2134-2141.

Müller, Adrienne; Chiotellis, Aristeidis; Keller, Claudia; Ametamey, Simon M; Schibli, Roger; Mu, Linjing; Krämer, Stefanie D (2014). Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine. Molecular Imaging and Biology, 16(3):412-420.

Mwinyi, Jessica; Vokinger, Kerstin Noëlle; Jetter, Alexander; Breitenstein, Urs; Hiller, Christian; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy. Cancer Chemotherapy and Pharmacology, 73(6):1181-1188.

Stupp, R; Weller, M (2014). Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Neuro-Oncology, 16(6):765-767.

Moradigaravand, Danesh; Kouyos, Roger; Hinkley, Trevor; Haddad, Mojgan; Petropoulos, Christos J; Engelstädter, Jan; Bonhoeffer, Sebastian (2014). Recombination accelerates adaptation on a large-scale empirical fitness landscape in HIV-1. PLoS Genetics, 10(6):e1004439.

Valletta, Daniela; Czech, Barbara; Spruss, Thilo; Ikenberg, Kristian; Wild, Peter; Hartmann, Arndt; Weiss, Thomas S; Oefner, Peter J; Müller, Martina; Bosserhoff, Anja-Katrin; Hellerbrand, Claus (2014). Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis, 35(6):1407-1415.

Schmidt, Anja; Schmid, Marc W; Klostermeier, Ulrich C; Qi, Weihong; Guthörl, Daniela; Sailer, Christian; Waller, Manuel; Rosenstiel, Philip; Grossniklaus, Ueli (2014). Apomictic and sexual germline development differ with respect to cell cycle, transcriptional, hormonal and epigenetic regulation. PLoS Genetics, 10(7):e1004476.

Weller, M; Kaulich, K; Hentschel, B; Felsberg, J; Gramatzki, D; Pietsch, T; Simon, M; Westphal, M; Schackert, G; Tonn, J C; von Deimling, A; Davis, T; Weiss, W A; Loeffler, M; Reifenberger, G (2014). Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. International Journal of Cancer, 134(10):2437-2447.

Haag, Andrea; Gutierrez, Peter; Bühler, Alessandra; Walser, Michael; Yang, Qiutan; Langouët, Maeva; Kradolfer, David; Fröhli, Erika; Herrmann, Christina J; Hajnal, Alex; Escobar-Restrepo, Juan M (2014). An in vivo EGF receptor localization screen in C. elegans Identifies the Ezrin homolog ERM-1 as a temporal regulator of signaling. PLoS Genetics, 10(5):e1004341.

Delbue, Serena; Ferrante, Pasquale; Provenzano, Maurizio (2014). Polyomavirus BK and prostate cancer: an unworthy scientific effort? Oncoscience, 1(4):296-303.

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh P (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Berger, M D; Meisel, A; Andres, M; Schanz, U; Schwarz, U; Stussi, G (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 32(9):e33-e34.

Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A (2014). A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical Cancer Research, 20(6):1687-1697.

Klement, R J; Allgaeuer, M; Appold, S; Dieckmann, K; Ernst, I; Ganswindt, U; Holy, R; Nestle, U; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Andratschke, N; Guckenberger, M (2014). Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics, 88(3):732-738.

Papatheodorou, Stefania I; Rohrmann, Sabine; Lopez, David S; Bradwin, Gary; Joshu, Corinne E; Kanarek, Norma; Nelson, William G; Rifai, Nader; Platz, Elizabeth A; Tsilidis, Konstantinos K (2014). Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men. Cancer Causes & Control, 25(3):353-363.

Brennecke, Patrick; Arlt, Matthias J E; Campanile, Carmen; Husmann, Knut; Gvozdenovic, Ana; Apuzzo, Tiziana; Thelen, Marcus; Born, Walter; Fuchs, Bruno (2014). CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clinical & Experimental Metastasis, 31(3):339-349.

Shakhova, Olga (2014). Neural crest stem cells in melanoma development. Current Opinion in Oncology, 26(2):215-221.

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Fiaschetti, G; Abela, L; Nonoguchi, N; Dubuc, A M; Remke, M; Boro, A; Grunder, E; Siler, U; Ohgaki, H; Taylor, M D; Baumgartner, M; Shalaby, T; Grotzer, M A (2014). Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. British Journal of Cancer, 110(3):636-647.

Hauselmann, Irina; Borsig, Lubor (2014). Altered tumor cell glycosylation promotes metastasis. Frontiers in Oncology:4:28.

Hoos, Alexandra; Protsyuk, Darya; Borsig, Lubor (2014). Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites. Cancer Research, 74(3):695-704.

Aalbers, A M; van der Velden, V H J; Yoshimi, A; Fischer, A; Noellke, P; Zwaan, C M; Baumann, I; Beverloo, H B; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Göhring, G; Schmugge, M; Stary, J; Zecca, M; Langerak, A W; van Dongen, J J M; Pieters, R; Niemeyer, C M; van den Heuvel-Eibrink, M M (2014). The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. Leukemia, 28(1):189-92.

Kishore, Shivendra; Piscuoglio, Salvatore; Kovac, Michal B; Gylling, Annette; Wenzel, Friedel; Trapani, Francesca; Altermatt, Hans Joerg; Mele, Valentina; Marra, Giancarlo; Peltomäki, Päivi; Terracciano, Luigi; Zavolan, Mihaela; Heinimann, Karl (2014). 3'-UTR Poly(T/U) tract deletions and altered expression of EWSR1 are a hallmark of mismatch repair-deficient cancers. Cancer Research, 74(1):224-234.

Müller, Antonia M; Florek, Mareike (2014). 5-Azacytidine/5-Azacitidine. Recent Results in Cancer Research, 201:299-324.

Rodon, Jordi; Tawbi, Hussein A; Thomas, Anne L; Stoller, Ronald; Turtschi, Christian P; Baselga, Jose; Sarantopoulos, John; Mahalingam, Devalingam; Shou, Yaping; Moles, Melissa A; Yang, Lin; Granvil, Camille; Hurh, Eunju; Rose, Kristine L; Amakye, Dereck D; Dummer, Reinhard; Mita, Alain C (2014). A Phase 1, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Hedgehog Inhibitor Sonidegib (LDE225) in Patients With Advanced Solid Tumors. Clinical Cancer Research, 20(7):1900-1909.

Vonlanthen, Janine; Okoniewski, Michal J; Menigatti, Mirco; Cattaneo, Elisa; Pellegrini-Ochsner, Daniela; Haider, Ritva; Jiricny, Josef; Staiano, Teresa; Buffoli, Federico; Marra, Giancarlo (2014). A comprehensive look at transcription factor gene expression changes in colorectal adenomas. BMC Cancer, 14:46.

Wolpert, F; Tritschler, I; Steinle, A; Weller, M; Eisele, G (2014). A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Neuro-Oncology, 16(3):382-391.

Kyriakou, Adamos; Neufeld, Esra; Werner, Beat; Paulides, Margarethus Marius; Szekely, Gabor; Kuster, Niels (2014). A review of numerical and experimental compensation techniques for skull-induced phase aberrations in transcranial focused ultrasound. International Journal of Hyperthermia, 30(1):36-46.

Stromberger, Carmen; Jann, David; Becker, Eva-Tessina; Raguse, Jan-Dirk; Tinhofer, Ingeborg; Marnitz, Simone; Budach, Volker (2014). Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure. Oral Oncology, 50(11):1114-1121.

Friedrich, Carsten; Müller, Klaus; von Hoff, Katja; Kwiecien, Robert; Pietsch, Torsten; Warmuth-Metz, Monika; Gerber, Nicolas U; Hau, Peter; Kuehl, Joachim; Kortmann, Rolf D; von Bueren, André O; Rutkowski, Stefan (2014). Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol. Journal of Neuro-Oncology, 116(3):567-575.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Harrison, C J; Bourquin, Jean-Pierre; et al (2014). An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia, 28(5):1015-1021.

Wyler, L; Napoli, C U; Ingold, B; Sulser, T; Heikenwälder, M; Schraml, P; Moch, H (2014). Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. British Journal of Cancer, 110(3):686-694.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Rogler, Gerhard (2014). Chronic ulcerative colitis and colorectal cancer. Cancer Letters, 345(2):235-241.

Eisele, G; Wick, A; Eisele, A C; Clément, P M; Tonn, J; Tabatabai, G; Ochsenbein, A; Schlegel, U; Neyns, B; Krex, D; Simon, M; Nikkhah, G; Picard, M; Stupp, R; Wick, W; Weller, M (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of Neuro-Oncology, 117(1):141-145.

Hundsberger, T; Tonder, M; Hottinger, A; Brügge, D; Roelcke, U; Putora, P M; Stupp, R; Weller, M (2014). Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of Neuro-Oncology, 118(2):321-328.

Jakovljevic, Mihajlo; Gutzwiller, Florian; Schwenkglenks, Matthias; Milovanovic, Olivera; Rancic, Nemanja; Varjacic, Mirjana; Stojadinovic, Dobrivoje; Dagovic, Aleksandar; Matter-Walstra, Klazien (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19(4):1111-1120.

Grosse, Nicole; van Loon, Barbara; Rohrer Bley, Carla (2014). DNA damage response and DNA repair - dog as a model? BMC Cancer, 14:203.

Bachmann, Samia B; Frommel, Sandra C; Camicia, Rosalba; Winkler, Hans C; Santoro, Raffaella; Hassa, Paul O (2014). DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. Molecular Cancer, 13:125.

Grosse, Nicole; Fontana, Andrea O; Hug, Eugen B; Lomax, Antony; Coray, Adolf; Augsburger, Marc; Paganetti, Harald; Sartori, Alessandro A; Pruschy, Martin (2014). Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation. International Journal of Radiation Oncology, Biology, Physics, 88(1):175-181.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. International Journal of Oncology, 44(6):1843-1852.

Comazzi, St; Guscetti, Franco; Marconato, L (2014). First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, 22 June 2013. Hematological oncology, 32(2):68-71.

Renganathan, Arun; Kresoja-Rakic, Jelena; Echeverry, Nohemy; Ziltener, Gabriela; Vrugt, Bart; Opitz, Isabelle; Stahel, Rolf A; Felley-Bosco, Emanuela (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Molecular Cancer, 13:119.

Bleich, Stefan; Semmler, Alexander; Frieling, Helge; Thumfart, L; Muschler, Marc; Hillemacher, Thomas; Kornhuber, Johannes; Kallweit, Ulf; Simon, Matthias; Linnebank, Michael (2014). Genetic variants of methionine metabolism and DNA methylation. Epigenomics, 6(6):585-591.

Gilardi, Federica; Migliavacca, Eugenia; Naldi, Aurélien; Baruchet, Michaël; Canella, Donatella; Le Martelot, Gwendal; Guex, Nicolas; Desvergne, Béatrice (2014). Genome-Wide Analysis of SREBP1 Activity around the Clock Reveals Its Combined Dependency on Nutrient and Circadian Signals. PLoS Genetics, 10(3):e1004155.

Riehmer, V; Gietzelt, J; Beyer, U; Hentschel, B; Westphal, M; Schackert, G; Sabel, M C; Radlwimmer, B; Pietsch, T; Reifenberger, G; Weller, M; Weber, R G; Loeffler, M (2014). Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. Genes, Chromosomes and Cancer, 53(7):589-605.

Stankov, M V; Bourquin, J P; et al (2014). Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia, 28(3):577-588.

Kristensen, Helle; Haldrup, Christa; Strand, Siri; Mundbjerg, Kamilla; Mortensen, Martin M; Thorsen, Kasper; Ostenfeld, Marie Stampe; Wild, Peter J; Arsov, Christian; Goering, Wolfgang; Visakorpi, Tapio; Egevad, Lars; Lindberg, Johan; Grönberg, Henrik; Høyer, Søren; Borre, Michael; Orntoft, Torben F; Sørensen, Karina D (2014). Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 20(8):2169-2181.

Helbig, L; Koi, L; Brüchner, K; Gurtner, K; Hess-Stumpp, H; Unterschemmann, K; Pruschy, M; Baumann, M; Yaromina, A; Zips, D (2014). Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. International Journal of Radiation Oncology, Biology, Physics, 88(1):159-166.

Tinguely, Marianne; Thies, Svenja; Frigerio, Simona; Reineke, Tanja; Korol, Dimitri; Zimmermann, Dieter R (2014). IRF8 is associated with a GCB-type of DLBCL and exceptionally involved in a translocation t(14;16) (q32.33;q24.1). Leukemia & Lymphoma, 55(1):136-142.

Hemminki, O; Immonen, R; et al (2014). In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders. International Journal of Cancer, 134(12):2878-2890.

Simon, Manuel; Stefan, Nikolas; Borsig, Lubor; Plückthun, Andreas; Zangemeister-Wittke, Uwe (2014). Increasing the antitumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation. Molecular Cancer Therapeutics, 13(2):375-385.

Borsig, Lubor; Wolf, Monika Julia; Roblek, Marko; Lorentzen, A; Heikenwalder, Mathias (2014). Inflammatory chemokines and metastasis – tracing the accessory. Oncogene, 33(25):3217-3224.

Silginer, M; Weller, M; Ziegler, U; Roth, P (2014). Integrin inhibition promotes atypical anoikis in glioma cells. Cell Death and Disease, 5:e1012.

Happold, C; Roth, P; Silginer, M; Florea, A M; Lamszus, K; Frei, K; Deenen, R; Reifenberger, G; Weller, M (2014). Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Molecular Cancer Therapeutics, 13(4):948-961.

Zlobec, I; Hädrich, M; Dawson, H; Koelzer, Viktor H; Borner, M; Mallaev, M; Schnüriger, B; Inderbitzin, D; Lugli, A (2014). Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. British Journal of Cancer, 110(4):1008-1013.

Grossen, Christine; Keller, Lukas F; Biebach, Iris; The International Goat Genome Consortium; Croll, Daniel (2014). Introgression from Domestic Goat Generated Variation at the Major Histocompatibility Complex of Alpine Ibex. PLoS Genetics, 10(6):e1004438.

Shen, C J; Sharma, A; Vuonag, D-V; Erler, J T; Pruschy, M (2014). Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer, 14:532.

Richard, Aline; Faeh, David; Rohrmann, Sabine; Braun, Julia; Tarnutzer, Silvan; Bopp, Matthias (2014). Italianity is associated with lower risk of prostate cancer mortality in Switzerland. Cancer Causes & Control, 25(11):1523-1529.

Rossetti, A O; Jeckelmann, S; Novy, J; Roth, P; Weller, M; Stupp, R (2014). Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology, 16(4):584-588.

Mamlouk, Soulafa; Kalucka, Joanna; Singh, Rashim Pal; Franke, Kristin; Muschter, Antje; Langer, Anika; Jakob, Christiane; Gassmann, Max; Baretton, Gustavo B; Wielockx, Ben (2014). Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. International Journal of Cancer, 134(4):849-858.

Palladini, G; Milani, P; Foli, A; Vidus Rosin, M; Basset, M; Lavatelli, F; Nuvolone, M; Obici, L; Perlini, S; Merlini, G (2014). Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: A matched case–control study on 174 patients. Leukemia, 28(12):2311-2316.

Wolf, Monika Julia; Adili, Arlind; Piotrowitz, Kira; et al; Boege, Yannick; Egger, Michèle; Moch, Holger; Kopf, Manfred; Weber, Achim; Heikenwalder, Mathias (2014). Metabolic activation of intrahepatic CD8(+) T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell, 26(4):549-564.

McCusker, Margaret; Basset-Seguin, Nicole; Dummer, Reinhard; Lewis, Karl; Schadendorf, Dirk; Sekulic, Aleksandar; Hou, Jeannie; Wang, Lisa; Yue, Huibin; Hauschild, Axel (2014). Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. European Journal of Cancer, 50(4):774-783.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Reifenberger, G; Weber, R G; Riehmer, V; Kaulich, K; Willscher, E; Wirth, H; Gietzelt, J; Hentschel, B; Westphal, M; Simon, M; Schackert, G; Schramm, J; Matschke, J; Sabel, M C; Gramatzki, D; Felsberg, J; Hartmann, C; Steinbach, J P; Schlegel, U; Wick, W; Radlwimmer, B; Pietsch, T; Tonn, J C; von Deimling, A; Binder, H; Weller, M; Loeffler, M (2014). Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International Journal of Cancer, 135(8):1822-1831.

Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14:201.

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W (2014). NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology, 117(1):25-32.

Seystahl, K; Weller, M; Bozinov, O; Reimann, R; Rushing, E (2014). Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncology Research and Treatment, 37(4):209-212.

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

Shanmugalingam, Thurkaa; Crawley, Danielle; Bosco, Cecilia; Melvin, Jennifer; Rohrmann, Sabine; Chowdhury, Simon; Holmberg, Lars; Van Hemelrijck, Mieke (2014). Obesity and cancer: the role of vitamin D. BMC Cancer, 14:712.

Hitz, Felicitas; Diem, Stefan; Haile, Sarah R; Ess, Silvia; Cerny, Thomas; Mey, Ulrich (2014). Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematological oncology, 32(4):192-196.

Dummer, Reinhard (2014). Precision medicine and skin cancer therapy: dealing with a moving target. Current Opinion in Oncology, 26(2):182-183.

Weller, Michael (2014). Primary central nervous system lymphoma in the elderly. Oncology Research and Treatment, 37(7-8):376-377.

Donati, Olivio F; Afaq, Asim; Mazaheri, Yousef; Vargas, Hebert Alberto; Junting, Zheng; Moskowitz, Chaya S; Hricak, Hedvig; Akin, Oguz (2014). Prostate MRI: Evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clinical Cancer Research, 20(14):3705-3711.

Dehler, Silvia; Tonev, Simeon; Korol, Dimitri; Rohrmann, Sabine; Dimitrova, Nadya (2014). Recent trends in cancer incidence: impact of risk factors, diagnostic activities and data quality of registration. Tumori, 100(4):399-405.

Blattner, Mirjam; Lee, Daniel J; O'Reilly, Catherine; Park, Kyung; MacDonald, Theresa Y; Khani, Francesca; Turner, Kevin R; Chiu, Ya-Lin; Wild, Peter J; Dolgalev, Igor; Heguy, Adriana; Sboner, Andrea; Ramazangolu, Sinan; Hieronymus, Haley; Sawyers, Charles; Tewari, Ashutosh K; Moch, Holger; Yoon, Ghil Suk; Known, Yong Chul; Andrén, Ove; Fall, Katja; Demichelis, Francecsa; Mosquera, Juan Miguel; Robinson, Brian D; Barbieri, Christopher E; Rubin, Mark A (2014). SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia, 16(1):14-20.

Bramante, S; Koski, A; Kipar, A; Diaconu, I; Liikanen, I; Hemminki, O; Vassilev, L; Parviainen, S; Cerullo, V; Pesonen, S K; Oksanen, M; Heiskanen, R; Rouvinen-Lagerström, N; Merisalo-Soikkeli, M; Hakonen, T; Joensuu, T; Kanerva, A; Pesonen, S; Hemminki, A (2014). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer, 135(3):720-730.

Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.

Kasenda, Benjamin; Bass, Annatina; Koeberle, Dieter; Pestalozzi, Bernhard; Borner, Markus; Herrmann, Richard; Jost, Lorenz; Lohri, Andreas; Hess, Viviane (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14:728.

Koelzer, Viktor H; Lugli, Alessandro (2014). The Tumor Border Configuration of Colorectal Cancer as a Histomorphological Prognostic Indicator. Frontiers in Oncology, 4:29.

Urban, Evelin; Nagarkar-Jaiswal, Sonal; Lehner, Christian F; Heidmann, Stefan K (2014). The cohesin subunit Rad21 is required for synaptonemal complex maintenance, but not sister chromatid cohesion, during Drosophila female meiosis. PLoS Genetics, 10(8):e1004540.

Georgis, Antoin. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. 2014, University of Zurich, Faculty of Medicine.

Weller, M; Soffietti, R; Brada, M (2014). The legend of cytomegalovirus and glioblastoma lives on. Neuro-Oncology, 16(1):166.

Miao, L; Fraefel, C; Sia, K C; Newman, J P; Mohamed-Bashir, S A; Ng, W H; Lam, P Y P (2014). The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy. British Journal of Cancer, 110(1):94-106.

Gerber, Nicolas U; von Hoff, Katja; Resch, Anika; Ottensmeier, Holger; Kwiecien, Robert; Faldum, Andreas; Matuschek, Christiane; Hornung, Dagmar; Bremer, Michael; Benesch, Martin; Pietsch, Torsten; Warmuth-Metz, Monika; Kuehl, Joachim; Rutkowski, Stefan; Kortmann, Rolf D (2014). Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 89(4):863-871.

Koelzer, Viktor H; Langer, Rupert; Zlobec, Inti; Lugli, Alessandro (2014). Tumor Budding in Upper Gastrointestinal Carcinomas. Frontiers in Oncology, 4:216.

Ghanjati, Foued; Beermann, Agnes; Hermanns, Thomas; Poyet, Cedric; Araúzo-Bravo, Marcos J; Seifert, Hans-Helge; Schmidtpeter, Martin; Goering, Wolfgang; Sorg, Rüdiger; Wernet, Peter; Santourlidis, Simeon (2014). Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNA. Cancer Biomarkers: Section A of Disease Markers, 14(5):295-302.

Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard (2014). Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. European Journal of Cancer, 50(2):406-410.

Eichholzer, Monika; Richard, Aline; Nicastro, Holly L; Platz, Elizabeth A; Linseisen, Jakob; Rohrmann, Sabine (2014). Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999–2004 and 2005–2008. Cancer Causes & Control, 25(3):395-403.

Zimmermann, Anne-Katrin; Camenisch, Ulrike; Rechsteiner, Markus P; Bode-Lesniewska, Beata; Rössle, Matthias (2014). Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Cancer Cytopathology, 122(1):48-58.

Dummer, Reinhard; Goldinger, Simone M; Turtschi, Christian P; Eggmann, Nina B; Michielin, Olivier; Mitchell, Lada; Veronese, Luisa; Hilfiker, Paul René; Felderer, Lea; Rinderknecht, Jeannine D (2014). Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study. European Journal of Cancer, 50(3):611-621.

Rothermundt, C; Whelan, J S; Dileo, P; Strauss, S J; Coleman, J; Briggs, T W; Haile, Sarah R; Seddon, B M (2014). What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. British Journal of Cancer, 110(10):2420-2426.

Kotov, Ilya N; Siebring-van Olst, Ellen; Knobel, Philip A; van der Meulen-Muileman, Ida H; Felley-Bosco, Emanuela; van Beusechem, Victor W; Smit, Egbert F; Stahel, Rolf A; Marti, Thomas M (2014). Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress. Molecular Oncology, 8(8):1747-1759.

Ram Kumar, Ram Mohan; Betz, Michael M; Robl, Bernhard; Born, Walter; Fuchs, Bruno (2014). ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2. BMC Cancer, 14:559.

Berghoff, A S; Kovanda, A K; Melchardt, T; Bartsch, R; Hainfellner, J A; Sipos, B; Schittenhelm, J; Zielinski, C C; Widhalm, G; Dieckmann, K; Weller, M; Goodman, S L; Birner, P; Preusser, M (2014). αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clinical & Experimental Metastasis, 31(7):841-851.

2013

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Terwijn, Monique; van Putten, Wim L J; Kelder, Angèle; van der Velden, Vincent H J; Brooimans, Rik A; Pabst, Thomas; Maertens, Johan; Boeckx, Nancy; de Greef, Georgine E; Valk, Peter J M; Preijers, Frank W M B; Huijgens, Peter C; Dräger, Angelika M; Schanz, Urs; Jongen-Lavrecic, Mojca; Biemond, Bart J; Passweg, Jakob R; van Gelder, Michel; Wijermans, Pierre; Graux, Carlos; Bargetzi, Mario; Legdeur, Marie-Cecile; Kuball, Jurgen; de Weerdt, Okke; Chalandon, Yves; Hess, Urs; Verdonck, Leo F; Gratama, Jan W; Oussoren, Yvonne J M; Scholten, Willemijn J; Slomp, Jennita; Snel, Alexander N; Vekemans, Marie-Christiane; Löwenberg, Bob; Ossenkoppele, Gert J; Schuurhuis, Gerrit J (2013). High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: Data from the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31):3889-3897.

Eberhard, Ralf; Stergiou, Lilli; Hofmann, E Randal; Hofmann, Jen; Haenni, Simon; Teo, Youjin; Furger, André; Hengartner, Michael O (2013). Ribosome synthesis and MAPK activity modulate ionizing radiation-induced germ cell apoptosis in Caenorhabditis elegans. PLoS Genetics, 9(11):e1003943.

Buschmann, Johanna; Gao, Shuping; Härter, Luc; Hemmi, Sonja; Welti, Manfred; Werner, Clement M L; Calcagni, Maurizio; Cinelli, Paolo; Wanner, Guido A (2013). Yield and proliferation rate of adipose-derived stromal cells as a function of age, body mass index and harvest site-increasing the yield by use of adherent and supernatant fractions? Cytotherapy, 15(9):1098-1105.

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Pernet, V; Joly, S; Jordi, N; Dalkara, D; Guzik-Kornacka, A; Flannery, J G; Schwab, M E (2013). Misguidance and modulation of axonal regeneration by Stat3 and Rho/ROCK signaling in the transparent optic nerve. Cell Death and Disease, 4:e734.

Eckert, Cornelia; Henze, Günter; Seeger, Karlheinz; Hagedorn, Nikola; Mann, Georg; Panzer-Grümayer, Renate; Peters, Christina; Klingebiel, Thomas; Borkhardt, Arndt; Schrappe, Martin; Schrauder, André; Escherich, Gabriele; Sramkova, Lucie; Niggli, Felix; Hitzler, Johann; von Stackelberg, Arend (2013). Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. Journal of Clinical Oncology, 31(21):2736-2742.

Dörffel, Wolfgang; Niggli, Felix; et al (2013). Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. Journal of Clinical Oncology, 31(12):1562-1568.

Zinn, Pascal O; Colen, Rivka R; Kasper, Ekkehard M; Burkhardt, Jan-Karl (2013). Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. International Journal of Oncology, 42(3):929-934.

Neidert, M C; Schoor, O; Trautwein, C; Trautwein, N; Christ, L; Melms, A; Honegger, J; Rammensee, H G; Herold-Mende, C; Dietrich, P Y; Stevanovic, S (2013). Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. Journal of Neuro-Oncology, 111(3):285-294.

Heikenwalder, Mathias; Borsig, Lubor (2013). Pathways of metastasizing intestinal cancer cells revealed: How will fighting metastases at the site of cancer cell arrest affect drug development? Future Oncology (London, England), 9(1):4pp.

Demierre, Nadine; Zoete, Vincent; Michielin, Olivier; Stauffer, Edouard; Zimmermann, Dieter R; Betticher, Daniel C; Peters, Solange (2013). A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable? Lung Cancer, 80(1):81-84.

Harris, Melissa L; Buac, Kristina; Shakhova, Olga; Hakami, Ramin M; Wegner, Michael; Sommer, Lukas; Pavan, William J (2013). A dual role for Sox10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genetics, 9(7):e1003644.

Gupta, Anurag; Nuber, Natko; Esslinger, Christoph; Wittenbrink, Mareike; Treder, Martin; Landshammer, Alexandro; Noguchi, Takuro; Kelly, Marcus; Gnjatic, Sacha; Ritter, Erika; von Boehmer, Lotta; Nishikawa, Hiroyoshi; Shiku, Hiroshi; Old, Lloyd; Ritter, Gerd; Knuth, Alexander; van den Broek, Maries (2013). A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. Cancer Immunity, 13:3.

Connor, Joseph P; Cristea, Mihaela C; Lewis, Nancy L; Lewis, Lionel D; Komarnitsky, Philip B; Mattiacci, Maria R; Felder, Mildred; Stewart, Sarah; Harter, Josephine; Henslee-Downey, Jean; Kramer, Daniel; Neugebauer, Roland; Stupp, Roger (2013). A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors. BMC Cancer, 13:20.

Eisele, G; Wolpert, F; Decrey, G; Weller, M (2013). APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. Anticancer Research, 33(9):3563-3571.

Hütt-Cabezas, Marianne; Karajannis, Matthias A; Zagzag, David; Shah, Smit; Horkayne-Szakaly, Iren; Rushing, Elisabeth J; Cameron, J Douglas; Jain, Deepali; Eberhart, Charles G; Raabe, Eric H; Rodriguez, Fausto J (2013). Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro-Oncology, 15(12):1604-1614.

Weller, M; Yung, W K A (2013). Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825. Neuro-Oncology, 15(8):971.

Jakka, Gopinadh; Schuberth, Petra C; Thiel, Markus; Held, Gerhard; Stenner, Frank; van den Broek, Maries; Renner, Christoph; Mischo, Axel; Petrausch, Ulf (2013). Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system. Anticancer Research, 33(10):4189-4201.

Aalbers, A M; van den Heuvel-Eibrink, M M; de Haas, V; Te Marvelde, J G; de Jong, A X; van der Burg, M; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Schmugge, M; Stary, J; Zecca, M; Zwaan, C M; van de Loosdrecht, A A; van Dongen, J J M; Niemeyer, C M; van der Velden, V H J (2013). Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia, 27(9):1923-1925.

Weller, M (2013). Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma? Neuro-Oncology, 15(7):809-810.

Weller, M (2013). Assessing the MGMT status in glioblastoma: one step forward, two steps back? Neuro-Oncology, 15(3):253-254.

Varga, Zsuzsanna; Noske, Aurelia; Ramach, Constanze; Padberg, Barbara; Moch, Holger (2013). Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study. BMC Cancer, 13:615.

Walser-Domjan, Esther; Richard, Aline; Eichholzer, Monika; Platz, Elizabeth A; Linseisen, Jakob; Rohrmann, Sabine (2013). Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey. Nutrition and Cancer, 65(6):813-819.

Nicastro, Holly L; Mondul, Alison M; Rohrmann, Sabine; Platz, Elizabeth A (2013). Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008. Cancer Causes & Control, 24(6):1185-1196.

Münz, Christian (2013). Autophagy in cellular transformation, survival and communication with the tumor microenvironment. Seminars in Cancer Biology, 23(5):299-300.

Anderson, T M R; Peacock, D L; Daniel, A R; Hubbard, G K; Lofgren, K A; Girard, B J; Schörg, Alexandra; Hoogewijs, D; Wenger, Roland H; Seagroves, T N; Lange, C A (2013). Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia- associated breast cancer progression. Cancer Research, 73(18):5810-5826.

Trojan, Andreas; Vergopoulos, Athanasios; Breitenstein, Urs; Tausch, Christoph; Seifert, Burkhardt; Joechle, Wolfgang (2013). CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients. Cancer Chemotherapy and Pharmacology, 71(2):301-306.

Lacher, Markus D; Provenzano, Maurizio (2013). Cancer T cell immunotherapy with bispecific antibodies and chimeric antigen receptors. Recent Patents on Anti-Cancer Drug Discovery, 8(3):239-254.

Doroshow, James H; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth (2013). Cancer clinical trials - do we need a new algorithm in the age of stratified medicine? The Oncologist, 18(6):651-652.

Dummer, R; Mangana, J (2013). Carboplatin, paclitaxel and sorafenib in advanced melanoma – what have we learned? Translational Cancer Research, 2:46-47.

Romao, Susana; Gannage, Monique; Münz, Christian (2013). Checking the garbage bin for problems in the house, or how autophagy assists in antigen presentation to the immune system. Seminars in Cancer Biology, 23(5):391-396.

Imesch, Patrick; Scheiner, David; Szabo, Emese; Fink, Daniel; Fedier, André (2013). Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Experimental and Therapeutic Medicine, 6(3):786-790.

Haldrup, Christa; Mundbjerg, Kamilla; Vestergaard, Else Marie; Lamy, Philippe; Wild, Peter; Schulz, Wolfgang A; Arsov, Christian; Visakorpi, Tapio; Borre, Michael; Høyer, Søren; Orntoft, Torben F; Sørensen, Karina D (2013). DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. Journal of Clinical Oncology, 31(26):3250-3258.

Abbas, Sascha; Linseisen, Jakob; Rohrmann, Sabine; Chang-Claude, Jenny; Peeters, Petra H; Engel, Pierre; Brustad, Magritt; Lund, Eiliv; Skeie, Guri; Olsen, Anja; Tjønneland, Anne; Overvad, Kim; Boutron-Ruault, Marie-Christine; Clavel-Chapelon, Francoise; Fagherazzi, Guy; Kaaks, Rudolf; Boeing, Heiner; Buijsse, Brian; Adarakis, George; Ouranos, Vassilis; Trichopoulou, Antonia; Masala, Giovanna; Krogh, Vittorio; Mattiello, Amalia; Tumino, Rosario; Sacerdote, Carlotta; Buckland, Genevieve; Suárez, Marcial Vicente Argüelles; Sánchez, Maria-José; Chirlaque, Maria-Dolores; Barricarte, Aurelio; Amiano, Pilar; Manjer, Jonas; Wirfält, Elisabet; Lenner, Per; Sund, Malin; Bueno-de-Mesquita, H B; van Duijnhoven, Fränzel J B; Khaw, Kay-Tee; Wareham, Nick; Key, Timothy J; Fedirko, Veronika; Romieu, Isabelle; Gallo, Valentina; Norat, Teresa; Wark, Petra A; Riboli, Elio (2013). Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Nutrition and Cancer, 65(2):178-187.

Pacheco-Villalobos, David; Sankar, Martial; Ljung, Karin; Hardtke, Christian S (2013). Disturbed Local Auxin Homeostasis Enhances Cellular Anisotropy and Reveals Alternative Wiring of Auxin-ethylene Crosstalk in Brachypodium distachyon Seminal Roots. PLoS Genetics, 9(6):e1003564.

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Rolfs, Frank; Huber, Marcel; Gruber, Florian; Böhm, Friederike; Pfister, Herbert J; Bochkov, Valery N; Tschachler, Erwin; Dummer, Reinhard; Hohl, Daniel; Schäfer, Matthias; Werner, Sabine (2013). Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Research, 73(11):3460-3469.

Fan, Q W; Cheng, C K; Gustafson, W C; Charron, E; Zipper, P; Wong, R A; Chen, J; Lau, J; Knobbe-Thomsen, C; Weller, M; Jura, N; Reifenberger, G; Shokat, K M; Weiss, W A (2013). EGFR Phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell, 24(4):438-449.

Schäfer, Beat W; Koscielniak, Ewa; Kovar, Heinrich; Fulda, Simone (2013). ESF-EMBO Symposium "Molecular biology and innovative therapies in sarcomas of childhood and adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland. Frontiers in Oncology:3:142.

Bernasconi, Michele; Ueda, Seigo; Krukowski, Patricia; Bornhauser, Beat C; Ladell, Kristin; Dorner, Marcus; Sigrist, Juerg A; Campidelli, Cristina; Aslandogmus, Roberta; Alessi, Davide; Berger, Christoph; Pileri, Stefano A; Speck, Roberto F; Nadal, David (2013). Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. International Journal of Cancer, 133(10):2341-2350.

König, Simone; Regen, Tommy; Dittmann, Kai; Engelke, Michael; Wienands, Jürgen; Schwendener, Reto; Hanisch, Uwe-Karsten; Pukrop, Tobias; Hahn, Heidi (2013). Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK 4 (BLP). Cancer Immunology, Immunotherapy, 62(10):1587-1597.

Heese, O; Vogeler, E; Martens, T; Schnell, O; Tonn, J C; Simon, M; Schramm, J; Krex, D; Schackert, G; Reithmeier, T; Nikkhah, G; Sabel, M; Steiger, H J; Schlegel, U; Löffler, M; Weller, M; Westphal, M (2013). End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey. Neuro-Oncology, 15(9):1251-1256.

Roudnicky, Filip; Poyet, Cedric; Wild, Peter; Krampitz, Sarah; Negrini, Fabrizia; Huggenberger, Reto; Rogler, Anja; Stöhr, Robert; Hartmann, Arndt; Provenzano, Maurizio; Otto, Vivianne I; Detmar, Michael (2013). Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Research, 73(3):1097-1106.

Schirmer, Uwe; Fiegl, Heidi; Pfeifer, Marco; Zeimet, Alain G; Müller-Holzner, Elisabeth; Bode, Peter K; Tischler, Verena; Altevogt, Peter (2013). Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens. BMC Cancer, 13:156.

Menigatti, M; Staiano, T; Manser, C N; Bauerfeind, P; Komljenovic, A; Robinson, Mark D; Jiricny, J; Buffoli, F; Marra, Giancarlo (2013). Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions. Oncogenesis, 2:e56.

Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.

Berndt, Kersten; Campanile, Carmen; Muff, Roman; Strehler, Emanuel; Born, Walter; Fuchs, Bruno (2013). Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Research, 33(4):1297-1306.

Samartzis, Nicolas. Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. 2013, University of Zurich, Faculty of Medicine.

Schwenkglenks, Matthias; Bendall, Kate Louise; Pfeil, Alena M; Szabo, Zsolt; Pettengell, Ruth (2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma, 54(11):2426-2432.

Frew, Ian J; Smole, Zlatko; Thoma, Claudio R; Krek, Wilhelm (2013). Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics. European Journal of Cancer, 49(10):2433-2440.

Raissig, Michael T; Bemer, Marian; Baroux, Célia; Grossniklaus, Ueli (2013). Genomic imprinting in the Arabidopsis embryo is partly regulated by PRC2. PLoS Genetics, 9(12):e1003862.

Koelzer, Viktor H; Karamitopoulou, E; Dawson, H; Kondi-Pafiti, A; Zlobec, I; Lugli, A (2013). Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer. British Journal of Cancer, 108(10):2088-2096.

Fenner, Lukas; Egger, Matthias; Bodmer, Thomas; Furrer, Hansjakob; Ballif, Marie; Battegay, Manuel; Helbling, Peter; Fehr, Jan; Gsponer, Thomas; Rieder, Hans L; Zwahlen, Marcel; Hoffmann, Matthias; Bernasconi, Enos; Cavassini, Matthias; Calmy, Alexandra; Dolina, Marisa; Frei, Reno; Janssens, Jean-Paul; Borrell, Sonia; Stucki, David; Schrenzel, Jacques; Böttger, Erik C; Gagneux, Sebastien (2013). HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genetics, 9(3):e1003318.

Wulfänger, Jens; Biehl, Katharina; Tetzner, Anja; Wild, Peter; Ikenberg, Kristian; Meyer, Stefanie; Seliger, Barbara (2013). Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma. International Journal of Cancer, 133(11):2522-2532.

Salaverria, Itziar; Martin-Guerrero, Idoia; Burkhardt, Birgit; Kreuz, Markus; Zenz, Thorsten; Oschlies, Ilske; Arnold, Norbert; Baudis, Michael; Bens, Susanne; García-Orad, Africa; Lisfeld, Jasmin; Schwaenen, Carsten; Szczepanowski, Monika; Wessendorf, Swen; Pfreundschuh, Michael; Trümper, Lorenz; Klapper, Wolfram; Siebert, Reiner (2013). High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas. Genes, Chromosomes and Cancer, 52(2):150-155.

Züllig, L; Roessle, M; Weber, C; Graf, N; Haerle, S K; Jochum, W; Stoeckli, S J; Moch, H; Huber, G F (2013). High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. European Journal of Cancer, 49(8):1915-1922.

Cachafeiro, M; Bemelmans, A P; Samardzija, M; Afanasieva, T; Pournaras, J A; Grimm, C; Kostic, C; Philippe, S; Wenzel, A; Arsenijevic, Y (2013). Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability. Cell Death and Disease, 4:e781.

Pflueger, Dorothee; Sboner, Andrea; Storz, Martina; Roth, Jasmine; Compérat, Eva; Bruder, Elisabeth; Rubin, Mark A; Schraml, Peter; Moch, Holger (2013). Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia, 15(11):1231-1240.

Kähkönen, Esa; Jambor, Ivan; Kemppainen, Jukka; Lehtiö, Kaisa; Grönroos, Tove J; Kuisma, Anna; Luoto, Pauliina; Sipilä, Henri J; Tolvanen, Tuula; Alanen, Kalle; Silén, Jonna; Kallajoki, Markku; Roivainen, Anne; Schäfer, Niklaus; Schibli, Roger; Dragic, Martina; Johayem, Anass; Valencia, Ray; Borkowski, Sandra; Minn, Heikki (2013). In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548. Clinical Cancer Research, 19(19):5434-5443.

Berghoff, A S; Rajky, O; Winkler, F; Bartsch, R; Furtner, J; Hainfellner, J A; Goodman, S L; Weller, M; Schittenhelm, J; Preusser, M (2013). Invasion patterns in brain metastases of solid cancers. Neuro-Oncology, 15(12):1664-1672.

Hell, Michael P; Duda, Maria; Weber, Thomas C; Moch, Holger; Krek, Wilhelm (2013). Ischemic renal injury reveals in vivo functions for the von Hippel-Lindau tumor suppressor in mitotic fidelity control. Cancer Research:1-32.

Wottawa, M; Leisering, P; von Ahlen, Melanie; Schnelle, M; Vogel, S; Malz, C; Bordoli, R M; Camenisch, G; Hesse, A; Napp, J; Alves Cardoso, F; Kristiansen, G; Farhat, K; Katschinski, D M (2013). Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-b1 processing. International Journal of Cancer, 132(12):2787-2798.

Dummer, Reinhard; Rozati, Sima; Guenova, Emmanuella; Cozzio, Antonio (2013). Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. Future Oncology (London, England), 9(8):1061-1064.

Hartmann, C; Hentschel, B; Simon, M; Westphal, M; Schackert, G; Tonn, J C; Loeffler, M; Reifenberger, G; Pietsch, T; von Deimling, A; Weller, M (2013). Longterm survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical Cancer Research, 19(18):5146-5157.

Dawson, Heather; Koelzer, Viktor H; Lukesch, Anne C; Mallaev, Makhmudbek; Inderbitzin, Daniel; Lugli, Alessandro; Zlobec, Inti (2013). Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer. Frontiers in Oncology:3:265.

Pawłowski, Rafal; Mühl, Sarah M; Sulser, Tullio; Krek, Wilhelm; Moch, Holger; Schraml, Peter (2013). Loss of PBRM1 expression is associated with renal cell carcinoma progression. International Journal of Cancer, 132(2):E11-7.

Perner, Sven; Rupp, Niels J; Braun, Martin; Rubin, Mark A; Moch, Holger; Dietel, Manfred; Wernert, Nicolas; Jung, Klaus; Stephan, Carsten; Kristiansen, Glen (2013). Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. International Journal of Cancer, 132(4):807-812.

Zimmermann, S; Curioni-Fontecedro, Alessandra; Stahel, R; Peters, S (2013). Lung Cancer. In: Dicato, M A. Side Effects of Medical Cancer Therapy. - Prevention and Treatment. London: Springer-Verlag, 119-138.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Wiestler, B; Claus, R; Hartlieb, S A; Schliesser, M G; Weiss, E K; Hielscher, T; Platten, M; Dittmann, L M; Meisner, C; Felsberg, J; Happold, C; Simon, M; Nikkhah, G; Papsdorf, K; Steinbach, J P; Sabel, M; Grimm, C; Weichenhan, D; Tews, B; Reifenberger, G; Capper, D; Müller, W; Plass, C; Weller, M; Wick, W (2013). Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology, 15(8):1017-1026.

Rohrmann, Sabine; Linseisen, Jakob; Nöthlings, Ute; Overvad, Kim; Egeberg, Rikke; Tjønneland, Anne; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Françoise; Cottet, Vanessa; Pala, Valeria; Tumino, Rosario; Palli, Domenico; Panico, Salvatore; Vineis, Paolo; Boeing, Heiner; Pischon, Tobias; Grote, Verena; Teucher, Birigit; Khaw, Kay-Tee; Wareham, Nicholas J; Crowe, Francesca L; Goufa, Ioulia; Orfanos, Philippos; Trichopoulou, Antonia; Jeurnink, Suzanne M; Siersema, Peter D; Peeters, Petra H M; Brustad, Magritt; Engeset, Dagrun; Skeie, Guri; Duell, Eric J; Amiano, Pilar; Barricarte, Aurelio; Molina-Montes, Esther; Rodríguez, Laudina; Tormo, María-José; Sund, Malin; Ye, Weimin; Lindkvist, Björn; Johansen, Dorthe; Ferrari, Pietro; Jenab, Mazda; Slimani, Nadia; Ward, Heather; Riboli, Elio; Norat, Teresa; Bueno-de-Mesquita, H Bas (2013). Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 132(3):617-624.

Rohrer Bley, Carla; Furmanova, Polina; Orlowski, Katrin; Grosse, Nicole; Broggini-Tenzer, Angela; McSheehy, Paul M J; Pruschy, Martin (2013). Microtubule stabilising agents and ionising radiation: Multiple exploitable mechanisms for combined treatment. European Journal of Cancer, 49(1):245-253.

Tackenberg, C; Grinschgl, S; Trutzel, A; Santuccione, A C; Frey, M C; Konietzko, U; Grimm, J; Brandt, R; Nitsch, R M (2013). NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death and Disease, 4:e608.

von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity, 13:12.

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Fischer, Roland; Collet, Tinh-Hai; Zeller, Andreas; Zimmerli, Lukas; Gaspoz, Jean-Michel; Giraudon, Karine; Rodondi, Nicolas; Cornuz, Jacques (2013). Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland. European Journal of Cancer Prevention, 22(5):425-430.

Bluwstein, A; Kumar, N; Léger, K; Traenkle, J; van Oostrum, J; Rehrauer, H; Baudis, Michael; Hottiger, M O (2013). PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts. Cell Death and Disease, 4:e498.

Duvic, Madeleine; Dummer, Reinhard; Becker, Jürgen C; Poulalhon, Nicolas; Ortiz Romero, Pablo; Grazia Bernengo, Maria; Lebbé, Celeste; Assaf, Chalid; Squier, Margaret; Williams, Denise; Marshood, Miriam; Tai, Feng; Prince, H Miles (2013). Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial. European Journal of Cancer, 49(2):386-394.

Davis, Lea K; Yu, Dongmei; Keenan, Clare L; Gamazon, Eric R; Konkashbaev, Anuar I; Derks, Eske M; Neale, Benjamin M; Yang, Jian; Lee, S Hong; Evans, Patrick; et al; Walitza, Susanne (2013). Partitioning the heritability of tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genetics, 9(10):e1003864.

Weber, Jeffrey S; Dummer, Reinhard; de Pril, Veerle; Lebbé, Celeste; Hodi, F Stephen (2013). Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer, 119(9):1675-1682.

Buchinger, Katharina; Stahel, Rolf; Niggemeier, Verena; Gubler, Christoph; Franzen, Daniel (2013). Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma. Lung Cancer, 80(3):347-349.

Steindorf, Karen; Ritte, Rebecca; Eomois, Piia-Piret; Lukanova, Annekatrin; Tjonneland, Anne; Johnsen, Nina Føns; Overvad, Kim; Ostergaard, Jane Nautrup; Clavel-Chapelon, Françoise; Fournier, Agnès; Dossus, Laure; Teucher, Birgit; Rohrmann, Sabine; Boeing, Heiner; Wientzek, Angelika; Trichopoulou, Antonia; Karapetyan, Tina; Trichopoulos, Dimitrios; Masala, Giovanna; Berrino, Franco; Mattiello, Amalia; Tumino, Rosario; Ricceri, Fulvio; Quirós, J Ramón; Travier, Noémie; Sánchez, María-José; Navarro, Carmen; Ardanaz, Eva; Amiano, Pilar; Bueno-de-Mesquita, H B As; van Duijnhoven, Franzel; Monninkhof, Evelyn; May, Anne M; Khaw, Kay-Tee; Wareham, Nick; Key, Tim J; Travis, Ruth C; Borch, Kristin Benjaminsen; Sund, Malin; Andersson, Anne; Fedirko, Veronika; Rinaldi, Sabina; Romieu, Isabelle; Wahrendorf, Jürgen; Riboli, Elio; Kaaks, Rudolf (2013). Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition. International Journal of Cancer, 132(7):1667-1678.

Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.

Dawson, Heather; Galván, José A; Helbling, Melina; Muller, Dominique-Elisabeth; Karamitopoulou, Eva; Koelzer, Viktor H; Economou, Mary; Hammer, Caroline; Lugli, Alessandro; Zlobec, Inti (2013). Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. International Journal of Cancer, 134(10):2342-2351.

Gigineishvili, David; Shengelia, Nino; Shalashvili, Giorgi; Rohrmann, Sabine; Tsiskaridze, Alexander; Shakarishvili, Roman (2013). Primary brain tumour epidemiology in Georgia: first-year results of a population-based study. Journal of Neuro-Oncology, 112(2):241-246.

Curioni-Fontecedro, A; Husmann, L; Soldini, D; Stahel, R A (2013). Primary non-small cell lung cancer response upon treatment with denosumab. Lung Cancer, 82(3):506-508.

Eichholzer, Monika; Platz, Elizabeth A; Bienstock, Jessica L; Monsegue, Deborah; Akereyeni, Folasade; Hollis, Bruce W; Horst, Ronald; Rifai, Nader; Pollak, Michael N; Barbir, Aline; Agurs-Collins, Tanya; Rohrmann, Sabine (2013). Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes & Control, 24(1):91-98.

Lopez, David S; Peskoe, Sarah B; Joshu, Corinne E; Dobs, Adrian; Feinleib, Manning; Kanarek, Norma; Nelson, William G; Selvin, Elizabeth; Rohrmann, Sabine; Platz, Elizabeth A (2013). Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males. Cancer Causes & Control, 24(4):817-826.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Zahnleiter, Diana; Uebe, Steffen; Ekici, Arif B; Hoyer, Juliane; Wiesener, Antje; Wieczorek, Dagmar; Kunstmann, Erdmute; Reis, André; Doerr, Helmuth-Guenther; Rauch, Anita; Thiel, Christian T (2013). Rare copy number variants are a common cause of short stature. PLoS Genetics, 9(3):e1003365.

Rozati, Sima; Naef, Lukas; Levesque, Mitchell P; French, Lars E; Dummer, Reinhard (2013). Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy. Journal of Immunotherapy, 36(1):52-56.

Bert, Saul A; Robinson, Mark D; Strbenac, Dario; Statham, Aaron L; Song, Jenny Z; Hulf, Toby; Sutherland, Robert L; Coolen, Marcel W; Stirzaker, Clare; Clark, Susan J (2013). Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell, 23(1):9-22.

Bischoff-Ferrari, Heike (2013). Relevance of vitamin d in bone and muscle health of cancer patients. Anti-Cancer Agents in Medicinal Chemistry, 13(1):58-64.

Cronin, Julia C; Watkins-Chow, Dawn E; Incao, Art; Hasskamp, Joanne H; Schönewolf, Nicola; Aoude, Lauren G; Hayward, Nicholas K; Bastian, Boris C; Dummer, Reinhard; Loftus, Stacie K; Pavan, William J (2013). SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Research, 73(18):5709-5718.

Rohrmann, S; Linseisen, J; Allen, N; Bueno-de-Mesquita, H B; Johnsen, N F; Tjønneland, A; Overvad, K; Kaaks, R; Teucher, B; Boeing, H; Pischon, T; Lagiou, P; Trichopoulou, A; Trichopoulos, D; Palli, D; Krogh, V; Tumino, R; Ricceri, F; Argüelles Suárez, M V; Agudo, A; Sánchez, M J; Chirlaque, M D; Barricarte, A; Larrañaga, N; Boshuizen, H; van Kranen, H J; Stattin, P; Johansson, M; Bjartell, A; Ulmert, D; Khaw, K T; Wareham, N J; Ferrari, P; Romieux, I; Gunter, M J R; Riboli, E; Key, T J (2013). Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. British Journal of Cancer, 108(3):708-714.

Tiwari, Neha; Tiwari, Vijay; Waldmeier, Lorenz; Balwierz, Piotr J; Arnold, Phil; Pachkov, Mikhail; Meyer-Schaller, Nathalie; Schübeler, Dirk; van Nimwegen, Erik; Christofori, Gerhard (2013). Sox4 is a master regulator of epithelial-mesenchymal transition by controlling ezh2 expression and epigenetic reprogramming. Cancer Cell, 23(6):768-83.

Dannenmann, Stefanie R; Hermanns, Thomas; Bransi, Ali; Matter, Claudia; von Boehmer, Lotta; Stevanovic, Stefan; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma. Cancer Immunology Research, 1(5):288-295.

Peier, Martin; Walpen, Thomas; Christofori, Gerhard; Battegay, Edouard; Humar, Rok (2013). Sprouty2 expression controls endothelial monolayer integrity and quiescence. Angiogenesis, 16(2):455-468.

Weller, M; Cloughesy, T; Perry, J R; Wick, W (2013). Standards of care for treatment of recurrent glioblastoma - are we there yet? Neuro-Oncology, 15(1):4-27.

Weiler, M; Pfenning, P N; Thiepold, A L; Blaes, J; Jestaedt, L; Gronych, J; Dittmann, L M; Berger, B; Jugold, M; Kosch, M; Combs, S E; von Deimling, A; Weller, M; Bendszus, M; Platten, M; Wick, W (2013). Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene, 32(9):1099-1109.

Cippà, Pietro E; Kamarashev, Jivko; Chen, Jin; Kraus, Anna K; Segerer, Stephan; Feldmeyer, Laurence; Fehr, Thomas (2013). Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A. Apoptosis, 18(3):315-323.

Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E; Desimone, Jennifer A; Jiang, Ying; Dowlatshahi, Mitra; Schlapbach, Christoph; Schaekel, Knut; Rook, Alain H; Tawa, Marianne; Fisher, David C; Kupper, Thomas S; Clark, Rachael A (2013). TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clinical Cancer Research, 19(14):3755-3763.

Eisele, G; Weller, M (2013). Targeting apoptosis pathways in glioblastoma. Cancer Letters, 332(2):335-345.

Wojtalla, Anna; Fischer, Barbara; Kotelevets, Nataliya; Mauri, Francesco A; Sobek, Jens; Rehrauer, Hubert; Wotzkow, Carlos; Tschan, Mario P; Seckl, Michael J; Zangemeister-Wittke, Uwe; Arcaro, Alexandre (2013). Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer. Clinical Cancer Research, 19(1):96-105.

Shakhova, Olga; Sommer, Lukas (2013). Testing the cancer stem cell hypothesis in melanoma: The clinics will tell. Cancer Letters, 338(1):74-81.

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

Mertens, Joachim C; Fingas, Christian D; Christensen, John D; Smoot, Rory L; Bronk, Steven F; Werneburg, Nathan W; Gustafson, Michael P; Dietz, Allan B; Roberts, Lewis R; Sirica, Alphonse E; Gores, Gregory J (2013). Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Research, 73(2):897-907.

Sabatino, G; Rigante, L; Minella, D; Novelli, G; Della Pepa, G M; Esposito, G; Albanese, A; Maira, G; Marchese, E (2013). Transcriptional profile characterization for the identification of peripheral blood biomarkers in patients with cerebral aneurysms. Journal of Biological Regulators and Homeostatic Agents, 27(3):729-38.

Friedrich, Carsten; von Bueren, André O; von Hoff, Katja; Gerber, Nicolas U; Ottensmeier, Holger; Deinlein, Frank; Benesch, Martin; Kwiecien, Robert; Pietsch, Torsten; Warmuth-Metz, Monika; Faldum, Andreas; Kuehl, Joachim; Kortmann, Rolf D; Rutkowski, Stefan (2013). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-Oncology, 15(2):224-234.

Lyons, A J; Crichton, S; Pezier, T (2013). Trismus following radiotherapy to the head and neck is likely to have distinct genotype dependent cause. Oral Oncology, 49(9):932-6.

Sassowsky, M; Gut, P; Hölscher, T; Hildebrandt, G; Müller, A C; Najafi, Y; Kohler, G; Kranzbühler, H; Guckenberger, M; Zwahlen, D R; Azinwi, N C; Plasswilm, L; Takacs, I; Reuter, C; Sumila, M; Manser, P; Ost, P; Böhmer, D; Pilop, C; Aebersold, D M; Ghadjar, P (2013). Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. International Journal of Radiation Oncology, Biology, Physics, 87(3):534-541.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Studer, Gabriela; Glanzmann, Christoph (2013). Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT. Oral Oncology, 49(3):269-276.

Agca, Cavit; Gubler, Andrea; Traber, Ghislaine; Beck, Christel; Imsand, Cornelia; Ail, Divya; Caprara, Christian; Grimm, Christian (2013). p38 MAPK signaling acts upstream of LIF-dependent neuroprotection during photoreceptor degeneration. Cell Death and Disease, 4:e785.

Vogetseder, A; Thies, S; Ingold, B; Roth, P; Weller, M; Schraml, P; Goodman, S L; Moch, H (2013). αv-Integrin isoform expression in primary human tumors and brain metastases. International Journal of Cancer, 133(10):2362-2371.

2012

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

Petrausch, U; Schuberth, P C; Hagedorn, C; Soltermann, A; Tomaszek, S; Stahel, R; Weder, W; Renner, C (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer, 12:615.

Collaud, Stéphane; Stahel, Rolf; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Kestenholz, Peter; Weder, Walter (2012). Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer, 78(3):234-238.

Fischer, Eliane; Chaitanya, Krishna; Wüest, Thomas; Wadle, Andreas; Scott, Andrew M; van den Broek, Maries; Schibli, Roger; Bauer, Stefan; Renner, Christoph (2012). Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clinical Cancer Research, 18(22):6208-6218.

Oberholzer, P A; Kee, D; Dziunycz, P; Sucker, A; Kamsukom, N; Jones, R; Roden, C; Chalk, C J; Ardlie, K; Palescandolo, E; Piris, A; Macconaill, L E; Robert, C; Hofbauer, G F L; McArthur, G A; Schadendorf, D; Garraway, L A (2012). RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors. Journal of Clinical Oncology, 30(3):316-321.

Schott, Sarah; Niessner, Heike; Sinnberg, Tobias; Venturelli, Sascha; Berger, Alexander; Ikenberg, Kristian; Villanueva, Jessie; Meier, Friedegund; Garbe, Claus; Busch, Christian (2012). Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells. International Journal of Cancer, 131(9):2165-2174.

von Bueren, A O; Bacolod, M D; Hagel, C; Heinimann, K; Fedier, A; Kordes, U; Pietsch, T; Koster, J; Grotzer, M A; Friedman, H S; Marra, Giancarlo; Kool, M; Rutkowski, S (2012). Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. British Journal of Cancer, 107(8):1399-1408.

Fischer, B; Frei, C; Moura, U; Stahel, R; Felley-Bosco, E (2012). Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer, 78(1):23-29.

Kuehni, Claudia E; Strippoli, Marie-Pierre F; Rueegg, Corina S; Rebholz, Cornelia E; Bergstraesser, Eva; Grotzer, Michael; von der Weid, Nicolas X; Michel, Gisela (2012). Educational achievement in Swiss childhood cancer survivors compared with the general population. Cancer:1439-1449.

Boller, Danielle; Doepfner, Kathrin T; De Laurentiis, Angela; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; Waterfield, Michael D; Arcaro, Alexandre (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Research, 32(8):3015-3027.

von Bueren, André O; Gerss, Joachim; Hagel, Christian; Cai, Haoyang; Remke, Marc; Hasselblatt, Martin; Feuerstein, Burt G; Pernet, Sarah; Delattre, Olivier; Korshunov, Andrey; Rutkowski, Stefan; Pfister, Stefan M; Baudis, Michael (2012). DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. Journal of Neuro-Oncology, 109(2):415-423.

Widenmeyer, M; Griesemann, H; Stevanović, S; Feyerabend, S; Klein, R; Attig, S; Hennenlotter, J; Wernet, D; Kuprash, D V; Sazykin, A Y; Pascolo, S; Stenzl, A; Gouttefangeas, C; Rammensee, H G (2012). Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. International Journal of Cancer, 131(1):140-149.

Shi, Yandong; Moura, Ubiratan; Opitz, Isabelle; Soltermann, Alex; Rehrauer, Hubert; Thies, Svenja; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2012). Role of hedgehog signaling in malignant pleural mesothelioma. Clinical Cancer Research, 18(17):4646-4656.

Boysen, Gunther; Bausch-Fluck, Damaris; Thoma, Claudio R; Nowicka, Anna M; Stiehl, Daniel P; Cima, Igor; Luu, Van-Duc; von Teichman, Adriana; Hermanns, Thomas; Sulser, Tullio; Ingold-Heppner, Barbara; Fankhauser, Niklaus; Wenger, Roland H; Krek, Wilhelm; Schraml, Peter; Wollscheid, Bernd; Moch, Holger (2012). Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia, 14(6):535-546.

Kovar, Heinrich; et al; Schäfer, Beat W; Ventura, Selena (2012). The first European interdisciplinary ewing sarcoma research summit. Frontiers in Oncology:2:54.

Künkele, Annette; De Preter, Katleen; Heukamp, Lukas; Thor, Theresa; Pajtler, Kristian W; Hartmann, Wolfgang; Mittelbronn, Michel; Grotzer, Michael A; Deubzer, Hedwig E; Speleman, Frank; Schramm, Alexander; Eggert, Angelika; Schulte, Johannes H (2012). Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro-oncology, 14(7):859-869.

Wernstedt, Annekatrin; Valtorta, Emanuele; Armelao, Franco; Togni, Roberto; Girlando, Salvatore; Baudis, Michael; Heinimann, Karl; Messiaen, Ludwine; Staehli, Noemie; Zschocke, Johannes; Marra, Giancarlo; Wimmer, Katharina (2012). Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL. Genes, Chromosomes & Cancer, 51(9):819-831.

Turato, Cristian; Buendia, Marie Annick; Fabre, Monique; Redon, Marie Josè; Branchereau, Sophie; Quarta, Santina; Ruvoletto, Mariagrazia; Perilongo, Giorgio; Grotzer, Michael Andreas; Gatta, Angelo; Pontisso, Patrizia (2012). Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? European Journal of Cancer, 48(8):1219-1226.

Jäger, E; Knuth, A (2012). The discovery of cancer/testis antigens by autologous typing with T cell clones and the evolution of cancer vaccines. Cancer Immunity, 12:6-9.

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Noguchi, T; Kato, T; Wang, L; Maeda, Y; Ikeda, H; Sato, E; Knuth, A; Gnjatic, S; Ritter, G; Sakaguchi, S; Old, L J; Shiku, H; Nishikawa, H (2012). Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. Cancer Research, 72(7):1672-1682.

Steinmann, Patrick; Walters, Denise K; Arlt, Matthias J E; Banke, Ingo J; Ziegler, Urs; Langsam, Bettina; Arbiser, Jack; Muff, Roman; Born, Walter; Fuchs, Bruno (2012). Antimetastatic activity of honokiol in osteosarcoma. Cancer, 118(8):2117-2127.

Boro, Aleksandar; Prêtre, Kathya; Rechfeld, Florian; Thalhammer, Verena; Oesch, Susanne; Wachtel, Marco; Schäfer, Beat W; Niggli, Felix K (2012). Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma. International Journal of Cancer, 131(9):2153-2164.

Sudha, T; Phillips, Patricia; Kanaan, C; Linhardt, R J; Borsig, L; Mousa, S A (2012). Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model. Clinical & Experimental Metastasis, 29(5):431-439.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Dummer, R; Beyer, M; Hymes, K; Epping, M T; Bernards, R; Steinhoff, M; Sterry, W; Kerl, H; Heath, K; Ahern, J D; Hardwick, J S; Garcia-Vargas, J; Baumann, K; Rizvi, S; Frankel, S R; Whittaker, S J; Assaf, C (2012). Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leukemia and Lymphoma, 53(8):1501-1508.

Eggermont, A M M; Suciu, S; Testori, A; Kruit, W H; Marsden, J; Punt, C J; Santinami, M; Salès, François; Schadendorf, D; Patel, P; Dummer, Reinhard; Robert, C; Keilholz, U; Yver, A; Spatz, A (2012). Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. European Journal of Cancer, 48(2):218-225.

Capper, D; Simon, M; Langhans, C D; Okun, J G; Tonn, J C; Weller, M; von Deimling, A; Hartmann, C (2012). 2-hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size. International Journal of Cancer, 131(3):766-768.

Stenner, Frank; Chastonay, Rahel; Liewen, Heike; Haile, Sarah R; Cathomas, Richard; Rothermundt, Christian; Siciliano, Raffaele D; Stoll, Susanna; Knuth, Alexander; Buchler, Tomas; Porta, Camillo; Renner, Christoph; Samaras, Panagiotis (2012). A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma. Oncology, 82(6):333-340.

Joerger, Markus; Thürlimann, Beat; Savidan, Anita; Frick, Harald; Bouchardy, Christine; Konzelmann, Isabelle; Probst-Hensch, Nicole; Ess, Silvia (2012). A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer. Clinical Breast Cancer, 12(2):102-109.

Scagliotti, Giorgio; Stahel, Rolf A; Rosell, Rafael; Thatcher, Nick; Soria, Jean-Charles (2012). ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. European Journal of Cancer, 48(7):961-973.

Ritte, Rebecca; Lukanova, Annekatrin; Berrino, Franco; Dossus, Laure; Tjønneland, Anne; Olsen, Anja; Overvad, Thure Filskov; Overvad, Kim; Clavel-Chapelon, Françoise; Fournier, Agnès; Fagherazzi, Guy; Rohrmann, Sabine; Teucher, Birgit; Boeing, Heiner; Aleksandrova, Krasimira; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Palli, Domenico; Sieri, Sabina; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Quirós, José Ramón; Buckland, Genevieve; Sánchez, Maria-José; Amiano, Pilar; Chirlaque, María-Dolores; Ardanaz, Eva; Sund, Malin; Lenner, Per; Bueno-de-Mesquita, Bas; van Gils, Carla H; Peeters, Petra Hm; Krum-Hansen, Sanda; Gram, Inger Torhild; Lund, Eiliv; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E; Key, Timothy J; Romieu, Isabelle; Rinaldi, Sabina; Siddiq, Afshan; Cox, David; Riboli, Elio; Kaaks, Rudolf (2012). Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Research, 14(3):R76.

Moch, Holger (2012). An overview of renal cell cancer: Pathology and genetics. Seminars in Cancer Biology, 23(1):3-9.

Weller, Michael (2012). Angiogenesis inhibition: quo vadis? Neuro-Oncology, 14(11):1315.

Nitzsche, B; Gloesenkamp, C; Schrader, M; Hoffmann, B; Zengerling, F; Balabanov, S; Honecker, F; Höpfner, M (2012). Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. British Journal of Cancer, 107(11):1853-1863.

Riklin, C; Seystahl, K; Hofer, S; Happold, C; Winterhalder, R; Weller, M (2012). Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie, 35(7-8):443-445.

Brandes, A A; Franceschi, E; Gorlia, T; Wick, W; Jacobs, A H; Baumert, B G; van den Bent, M; Weller, M; Stupp, R (2012). Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma. European Journal of Cancer, 48(6):896-903.

Poyet, C; Hof, D; Sulser, T; Müntener, M (2012). Artificial prostate-specific antigen persistence after radical prostatectomy. Journal of Clinical Oncology, 30(5):e62-3.

Linnebank, M; Moskau, S; Kowoll, A; Semmler, A; Bangard, C; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Schmidt-Wolf, I G H; Pels, H; Schlegel, U (2012). Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer:1-4.

Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E; Busam, Klaus; Carvajal, Richard D; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M; Dummer, Reinhard; Long, Georgina V; McArthur, Grant; Scherag, André; Sucker, Antje; Schadendorf, Dirk (2012). Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition. Journal of Clinical Oncology, 30(19):2375-2383.

Stahel, Rolf (2012). Biomarker testing in non-small cell lung cancer: to move forward with quality. Clinical and Translational Oncology, 14(5):321-322.

Aflaki, E; Doddapattar, P; Radović, B; Povoden, S; Kolb, D; Vujić, N; Wegscheider, M; Koefeler, H; Hornemann, T; Graier, W F; Malli, R; Madeo, F; Kratky, D (2012). C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages. Cell Death and Disease, 3:e280.

Bretz, N; Noske, A; Keller, S; Erbe-Hofmann, N; Schlange, T; Salnikov, A V; Moldenhauer, G; Kristiansen, G; Altevogt, P (2012). CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clinical and Experimental Metastasis, 29(1):27-38.

Morra, L; Rechsteiner, M; Casagrande, S; von Teichman, A; Schraml, P; Moch, H; Soltermann, A (2012). Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer, 76(2):183-190.

Varga, Z; Tubbs, R R; Wang, Z; Sun, Y; Noske, A; Kradolfer, D; Bosshard, G; Jochum, W; Moch, H; Öhlschlegel, C (2012). Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer. Breast Cancer Research and Treatment, 132(3):925-935.

Rohrmann, S; Grote, V A; Becker, S; Rinaldi, S; Tjønneland, A; Roswall, N; Grønbæk, H; Overvad, K; Boutron-Ruault, M C; Clavel-Chapelon, F; Racine, A; Teucher, B; Boeing, H; Drogan, D; Dilis, V; Lagiou, P; Trichopoulou, A; Palli, D; Tagliabue, G; Tumino, R; Vineis, P; Mattiello, A; Rodríguez, L; Duell, E J; Molina-Montes, E; Dorronsoro, M; Huerta, J M; Ardanaz, E; Jeurnink, S; Peeters, P H M; Lindkvist, B; Johansen, D; Sund, M; Ye, W; Khaw, K T; Wareham, N J; Allen, N E; Crowe, F L; Fedirko, V; Jenab, M; Michaud, D S; Norat, T; Riboli, E; Bueno-de-Mesquita, H B; Kaaks, R (2012). Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. British Journal of Cancer, 106(5):1004-1010.

Ghadjar, P; Simcock, M; Studer, G; Allal, A; Ozsahin, M; Bernier, J; Töpfer, M; Zimmermann, F; Betz, M; Glanzmann, C; Aebersold, D (2012). Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). International Journal of Radiation Oncology, Biology and Physics, 82(2):524-531.

Lemke, D; Pfenning, P N; Sahm, F; Klein, A C; Kempf, T; Warnken, U; Schnölzer, M; Tudoran, R; Weller, M; Platten, M; Wick, W (2012). Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Clinical Cancer Research, 18(1):105-117.

Tanos, Tamara; Rojo, Lucia Jimenez; Echeverria, Pablo; Brisken, Cathrin (2012). ER and PR signaling nodes during mammary gland development. Breast Cancer Research, 14(4):210.

Barbir, Aline; Linseisen, Jakob; Hermann, Silke; Kaaks, Rudolf; Teucher, Birgit; Eichholzer, Monika; Rohrmann, Sabine (2012). Effects of phenotypes in heterocyclic aromatic amine (HCA) metabolism-related genes on the association of HCA intake with the risk of colorectal adenomas. Cancer Causes & Control, 23(9):1429-1442.

Wolf, Monika Julia; Hoos, Alexandra; Bauer, Judith; Boettcher, Steffen; Knust, Markus; Weber, Achim; Simonavicius, Nicole; Schneider, Christoph; Lang, Matthias; Stürzl, Michael; Croner, Roland S; Konrad, Andreas; Manz, Markus G; Moch, Holger; Aguzzi, Adriano; van Loo, Geert; Pasparakis, Manolis; Prinz, Marco; Borsig, Lubor; Heikenwalder, Mathias (2012). Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell, 22(1):91-105.

Minner, S; Rump, D; Tennstedt, P; Simon, R; Burandt, E; Terracciano, L; Moch, H; Wilczak, W; Bokemeyer, C; Fisch, M; Sauter, G; Eichelberg, C (2012). Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer, 118(5):1268-1275.

Buerki, Nicole; Gautier, Lucienne; Kovac, Michal; Marra, Giancarlo; Buser, Mauro; Mueller, Hansjakob; Heinimann, Karl (2012). Evidence for breast cancer as an integral part of Lynch syndrome. Genes, Chromosomes & Cancer, 51(1):83-91.

Soll, Christopher; Riener, Marc-Oliver; Oberkofler, Christian Eugen; Hellerbrand, Claus; Wild, Peter J; DeOliveira, Michelle L; Clavien, Pierre-Alain (2012). Expression of serotonin receptors in human hepatocellular cancer. Clinical Cancer Research, 18(21):5902-5910.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Sander, A; von Stackelberg, A; Schmid, I; Starý, J; Steinbach, D; Vormoor, J; Reinhardt, D (2012). Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia, 26(4):654-661.

Guetg, Claudio; Santoro, Raffaella (2012). Formation of nuclear heterochromatin: the nucleolar point of view. Epigenetics, 7(8):811-814.

Grimminger, Peter P; Maus, Martin K H; Schneider, Paul M; Metzger, Ralf; Hölscher, Arnulf H; Sugita, Hirofumi; Danenberg, Peter V; Alakus, Hakan; Brabender, Jan (2012). Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Lung Cancer, 78(1):87-91.

Van Hemelrijck, Mieke; Rohrmann, Sabine; Steinbrecher, Astrid; Kaaks, Rudolf; Teucher, Birgit; Linseisen, Jakob (2012). Heterocyclic aromatic amine [HCA] intake and prostate cancer risk: effect modification by genetic variants. Nutrition and Cancer, 64(5):704-713.

Fankhauser, Niklaus; Cima, Igor; Wild, Peter; Krek, Wilhelm (2012). Identification of a gene expression signature common to distinct cancer pathways. Cancer Informatics, 11:139-146.

von Boehmer, Lotta; Draenert, Alice; Jungraithmayr, Wolfgang; Inci, Ilhan; Niklaus, Schäfer; Boehler, Annette; Hofer, Markus; Stahel, Rolf; Soltermann, Alex; van den Broek, Maries; Weder, Walter; Knuth, Alexander (2012). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer, 76(1):118-122.

Weller, M; Stupp, R; Hegi, M; Wick, W (2012). Individualized targeted therapy for glioblastoma: fact or fiction? Cancer Journal, 18(1):40-44.

Grote, V A; Kaaks, R; Nieters, A; Tjønneland, A; Halkjær, J; Overvad, K; Skjelbo Nielsen, M R; Boutron-Ruault, M C; Clavel-Chapelon, F; Racine, A; Teucher, B; Becker, S; Pischon, T; Boeing, H; Trichopoulou, A; Cassapa, C; Stratigakou, V; Palli, D; Krogh, V; Tumino, R; Vineis, P; Panico, S; Rodríguez, L; Duell, E J; Sánchez, M J; Dorronsoro, M; Navarro, C; Gurrea, A B; Siersema, P D; Peeters, P H M; Ye, W; Sund, M; Lindkvist, B; Johansen, D; Khaw, K T; Wareham, N; Allen, N E; Travis, R C; Fedirko, V; Jenab, M; Michaud, D S; Chuang, S C; Romaguera, D; Bueno-de-Mesquita, H B; Rohrmann, S (2012). Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. British Journal of Cancer, 106(11):1866-1874.

Kuonen, François; Laurent, Julien; Secondini, Chiara; Lorusso, Girieca; Stehle, Jean-Christophe; Rausch, Thierry; Faes-Van't Hull, Eveline; Bieler, Grégory; Alghisi, Gian-Carlo; Schwendener, Reto; Andrejevic-Blant, Snezana; Mirimanoff, René-Olivier; Rüegg, Curzio (2012). Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy. Clinical Cancer Research, 18(16):4365-4374.

Horneber, M; Mehnert, A; Roser, T; Rostock, M (2012). Integrative Aspekte der Thoraxonkologie. Onkologie, 35(Suppl 3):2-5.

Beleut, Manfred; Zimmermann, Philip; Baudis, Michael; Bruni, Nicole; Bühlmann, Peter; Laule, Oliver; Luu, Van-Duc; Gruissem, Wilhelm; Schraml, Peter; Moch, Holger (2012). Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. BMC Cancer, 12:310.

Bonde, Anne-Katrine; Tischler, Verena; Kumar, Sushil; Soltermann, Alex; Schwendener, Reto A (2012). Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer, 12:35.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Eggermont, Alexander M M; Suciu, Stefan; Testori, Alessandro; Santinami, Mario; Kruit, Wim H J; Marsden, Jeremy; Punt, Cornelis J A; Salès, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam M; de Schaetzen, Gaetan; Spatz, Alan; Keilholz, Ulrich (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of Clinical Oncology, 30(31):3810-3818.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Belani, Chandra P; Cappuzzo, Federico; Ciardiello, Fortunato; Fidias, Panagiotis; Paz-Ares, Luis; Perrone, Francesco; Pirker, Robert; De Petris, Luigi; Stahel, Rolf (2012). Maintenance treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer, 76(3):269-279.

Kwanhian, Wiyada; Lenze, Dido; Alles, Julia; Motsch, Natalie; Barth, Stephanie; Döll, Celina; Imig, Jochen; Hummel, Michael; Tinguely, Marianne; Trivedi, Pankaj; Lulitanond, Viraphong; Meister, Gunter; Renner, Christoph; Grässer, Friedrich A (2012). MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine, 1(2):141-155.

Weller, M (2012). Microglia: a novel treatment target in gliomas. Neuro-Oncology, 14(8):957.

Wojakowski, W; Landmesser, U; Bachowski, R; Jadczyk, T; Tendera, M (2012). Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia, 26(1):23-33.

Maglietta, Rosalia; Liuzzi, Vania Cosma; Cattaneo, Elisa; Laczko, Endre; Piepoli, Ada; Panza, Anna; Carella, Massimo; Palumbo, Orazio; Staiano, Teresa; Buffoli, Federico; Andriulli, Angelo; Marra, Giancarlo; Ancona, Nicola (2012). Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer, 12:608.

Hasenbach, K; Wiehr, S; Herrmann, C; Mannheim, J; Cay, F; von Kürthy, G; Bolmont, T; Grathwohl, S A; Weller, M; Lengerke, C; Pichler, B J; Tabatabai, G (2012). Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography. Neuro-oncology, 14(4):471-481.

Weller, M (2012). More on the immune privilege of glioblastoma. Neuro-Oncology, 14(5):527-528.

Stiehl, D P; Bordoli, M R; Abreu-Rodríguez, I; Wollenick, K; Schraml, P; Gradin, K; Poellinger, L; Kristiansen, G; Wenger, R H (2012). Non-canonical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene, 31(18):2283-2297.

Burger, M C; Brucker, D P; Baumgarten, P; Ronellenfitsch, M W; Wanka, C; Hasselblatt, M; Eccles, M R; Klingebiel, T; Weller, M; Rieger, J; Mittelbronn, M; Steinbach, J P (2012). PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma. International Journal of Oncology, 41(1):235-241.

Nakdimon, Itay; Walser, Michael; Fröhli, Erika; Hajnal, Alex (2012). PTEN negatively regulates MAPK signaling during Caenorhabditis elegans vulval development. PLoS Genetics, 8(8):e1002881.

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Weller, M; Stupp, R; Hegi, M E; van den Bent, M; Tonn, J C; Sanson, M; Wick, W; Reifenberger, G (2012). Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro-Oncology, 14(Suppl. 4):iv100-iv108.

Kirkwood, J M; Bastholt, L; Robert, C; Sosman, J; Larkin, J; Hersey, P; Middleton, M; Cantarini, M; Zazulina, V; Kemsley, K; Dummer, R (2012). Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. Clinical Cancer Research, 18(2):555-567.

Reifenberger, G; Hentschel, B; Felsberg, J; Schackert, G; Simon, M; Schnell, O; Westphal, M; Wick, W; Pietsch, T; Loeffler, M; Weller, M (2012). Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. International Journal of Cancer, 131(6):1342-1350.

Schraml, P; von Teichman, A; Mihic-Probst, D; Simcock, M; Ochsenbein, A; Dummer, R; Michieilin, O; Seifert, B; Schläppi, M; Moch, H; von Moos, R (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology Reports, 28(2):654-658.

Wulfänger, Jens; Schneider, Heike; Wild, Peter; Ikenberg, Kristian; Rodolfo, Monica; Rivoltini, Licia; Meyer, Stefanie; Riemann, Dagmar; Seliger, Barbara (2012). Promoter methylation of aminopeptidase N/CD13 in malignant melanoma. Carcinogenesis, 33(4):781-790.

Dummer, Reinhard; Quaglino, Pietro; Becker, Jürgen C; Hasan, Baktiar; Karrasch, Matthias; Whittaker, Sean; Morris, Stephen; Weichenthal, Michael; Stadler, Rudolf; Bagot, Martine; Cozzio, Antonio; Bernengo, Maria G; Knobler, Robert (2012). Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. Journal of Clinical Oncology, 30(33):4091-4097.

Ziegler, A; Cerciello, F; Bigosch, C; Bausch-Fluck, D; Felley-Bosco, E; Ossola, R; Soltermann, A; Stahel, R A; Wollscheid, B (2012). Proteomic surfaceome analysis of mesothelioma. Lung Cancer, 75(2):189-196.

Agurs-Collins, Tanya; Rohrmann, Sabine; Sutcliffe, Catherine; Bienstock, Jessica L; Monsegue, Deborah; Akereyeni, Folasade; Bradwin, Gary; Rifai, Nader; Pollak, Michael N; Platz, Elizabeth A (2012). Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates. Cancer Causes & Control, 23(3):445-454.

Lemm, Doreen; de Oliveira, Francine Hehn; Bernays, René-Ludwig; Kockro, Ralf Alfons; Kollias, Spyros; Fischer, Ingeborg; Rushing, Elisabeth J (2012). Rare suprasellar glioblastoma: report of two cases and review of the literature. Brain Tumor Pathology, 29(4):216-20.

Tsuchimatsu, Takashi; Kaiser, Pascal; Yew, Chow-Lih; Bachelier, Julien B; Shimizu, Kentaro K (2012). Recent loss of self-incompatibility by degradation of the male component in allotetraploid Arabidopsis kamchatica. PLoS Genetics, 8(7):e1002838.

Kueng, Stephanie; Tsai-Pflugfelder, Monika; Oppikofer, Mariano; Ferreira, Helder C; Roberts, Emma; Tsai, Chinyen; Roloff, Tim-Christoph; Sack, Ragna; Gasser, Susan M (2012). Regulating repression: roles for the sir4 N-terminus in linker DNA protection and stabilization of epigenetic states. PLoS Genetics, 8(5):e1002727.

Burger, Irene A; Huser, Dominic M; Burger, Cyrill; von Schulthess, Gustav K; Buck, Alfred (2012). Repeatability of FDG quantification in tumor imaging: averaged SUVs are superior to SUVmax. Nuclear medicine and biology, 39(5):666-670.

Dummer, Reinhard; Flaherty, Keith T (2012). Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights. Current Opinion in Oncology, 24(2):150-154.

Nasser, M W; Qamri, Z; Deol, Y S; Ravi, J; Powell, C A; Trikha, P; Schwendener, R A; Bai, X F; Shilo, K; Zou, X; Leone, G; Wolf, R; Yuspa, S H; Ganju, R K (2012). S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways. Cancer Research, 72(3):604-615.

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Schoenewolf, N L; Bull, C; Belloni, B; Holzmann, D; Tonolla, S; Lang, R; Mihic-Probst, D; Andres, C; Dummer, R (2012). Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. European Journal of Cancer, 48(12):1842-1852.

Shi, Yandong; Felley-Bosco, Emanuela; Marti, Thomas M; Orlowski, Katrin; Pruschy, Martin; Stahel, Rolf A (2012). Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC Cancer, 12:571.

Weller, M; Martus, P; Roth, P; Thiel, E; Korfel, A (2012). Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro-Oncology, 14(12):1481-1484.

Wanka, C; Brucker, D P; Bähr, O; Ronellenfitsch, M; Weller, M; Steinbach, J P; Rieger, J (2012). Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death. Oncogene, 31(33):3764-3776.

Craig, V J; Tzankov, A; Flori, M; Schmid, C A; Bader, A G; Müller, Anne (2012). Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia, 26(11):2421-2424.

Noack, J; Jordi, M; Zauner, L; Alessi, D; Burch, A; Tinguely, M; Hersberger, M; Bernasconi, M; Nadal, D (2012). TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism. Cell Death & Disease, 3:e323.

Arlt, Matthias J E; Born, Walter; Fuchs, Bruno (2012). Taurolidine: Mode of administration in mouse tumor models. International Journal of Cancer, 131(6):E1053-E1054.

Zwahlen, Daniel R; Lang, Stephanie; Hrbacek, Jan; Glanzmann, Christoph; Kloeck, Stephan; Najafi, Yousef; Streller, Tino; Studer, Gabriela; Zaugg, Kathrin; Luetolf, Urs M (2012). The Use of Photon Beams of a Flattening Filter-free Linear Accelerator for Hypofractionated Volumetric Modulated Arc Therapy in Localized Prostate Cancer. International Journal of Radiation Oncology, Biology and Physics, 83(5):1655-1660.

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Arlt, M J E; Walters, D K; Banke, I J; Steinmann, P; Puskas, G J; Bertz, J; Rentsch, K M; Ehrensperger, F; Born, W; Fuchs, B (2012). The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity. International Journal of Cancer, 131(5):E804-12.

Grote, V A; Rohrmann, S; Nieters, A; Dossus, L; Halkjær, J; Tjønneland, A; Overvad, K; Stegger, J; Chabbert-Buffet, N; Boutron-Ruault, M C; Clavel-Chapelon, F; Teucher, B; Becker, S; Montonen, J; Boeing, H; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Palli, D; Sieri, S; Tumino, R; Vineis, P; Mattiello, A; Argüelles, M; Duell, E J; Molina-Montes, E; Larrañaga, N; Chirlaque, M D; Gurrea, A B; Jeurnink, S M; Peeters, P H M; Ye, W; Sund, M; Lindkvist, B; Johansen, D; Khaw, K T; Wareham, N; Crowe, F L; Romieu, I; Rinaldi, S; Jenab, M; Romaguera, D; Michaud, D S; Riboli, E; Bas Bueno-de-Mesquita, H; Kaaks, R (2012). The association of circulating adiponectin levels with pancreatic cancer risk; a study within the prospective EPIC cohort. International Journal of Cancer, 130(10):2428-2437.

Xu, Shuqing; Schlüter, Philipp M; Grossniklaus, Ueli; Schiestl, Florian P (2012). The genetic basis of pollinator adaptation in a sexually deceptive orchid. PLoS Genetics, 8(8):e1002889.

Abrey, L E (2012). The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors. Journal of Neuro-Oncology, 108(2):285-290.

Johnsen, H E; Haioun, C; Lugtenburg, P J; Salar, A; Jaeger, U; Pettengell, R; Rossi, Fg; Verhoef, G; Schwenkglenks, M; Bendall, K; Duehrsen, U (2012). The importance of G-CSF prophylaxis in R-CHOP-14 therapy for diffuse large B-cell lymphoma in routine clinical practice. Leukemia and Lymphoma, 53(5):982-984.

Salar, Antonio; Haioun, Corinne; Rossi, Francesca G; Duehrsen, Ulrich; Pettengell, Ruth; Johnsen, Hans E; Jaeger, Ulrich; Verhoef, Gregor; Schwenkglenks, Matthias; Bacon, Pamela; Bendall, Kate; Lugtenburg, Pieternella J (2012). The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice. Leukemia Research, 36(5):548-553.

Kwiatkowska, Aneta; Didier, Sebastien; Fortin, Shannon; Chuang, Yayu; White, Timothy; Berens, Michael E; Rushing, Elisabeth; Eschbacher, Jennifer; Tran, Nhan L; Chan, Amanda; Symons, Marc (2012). The small GTPase RhoG mediates glioblastoma cell invasion. Molecular Cancer, 11:65.

Chew, Valerie; Tow, Charlene; Huang, Caleb; Bard-Chapeau, Emilie; Copeland, Neal G; Jenkins, Nancy A; Weber, Achim; Lim, Kiat Hon; Toh, Han Chong; Heikenwalder, Mathias; Ng, Irene Oi-Lin; Nardin, Alessandra; Abastado, Jean-Pierre (2012). Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients. Journal of the National Cancer Institute, 104(23):1796-1807.

Varga, Z; Moelans, C B; Zuerrer-Hardi, U; Ramach, C; Behnke, S; Kristiansen, G; Moch, H (2012). Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. Breast Cancer Research and Treatment, 133(3):929-935.

Horneber, M; Overkamp, F; Rostock, M (2012). Umsetzung integrativer Konzepte - eine Bestandsaufnahme. Onkologie, 35(Suppl 5):3-11.

Leske, Henning; Haase, Rudolf; Restle, Florian; Schichor, Christian; Albrecht, Valerie; Vizoso Pinto, Maria G; Tonn, Joerg C; Baiker, Armin; Thon, Niklas (2012). Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy? Anticancer Research, 32(4):1137-1144.

2011

Gerber, Nicolas U; von Hoff, Katja; von Bueren, André O; Treulieb, Wiebke; Deinlein, Frank; Benesch, Martin; Zwiener, Isabella; Soerensen, Niels; Warmuth-Metz, Monika; Pietsch, Torsten; Mittler, Uwe; Kuehl, Joachim; Kortmann, Rolf-Dieter; Grotzer, Michael A; Rutkowski, Stefan (2011). A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. European Journal of Cancer, 48(13):2028-2036.

Luethy, A; Stenner, F; Lohri, C; Muller, C; Samaras, P; Steiner, R; van den Broek, Maries; Mischo, A; Renner, C; Knuth, A; Ruegg, C; Wenger, R H; Zweifel, M (2011). Autologous Stem Cell Transplantation: Leukapheresis Product has Anti-angiogenic Effects In Vivo Correlating with Neutrophil-derived VEGFR1. Anticancer Research, 31(10):3115-3124.

Coulon, Aurélie; Flahaut, Marjorie; Mühlethaler-Mottet, Annick; Meier, Roland; Liberman, Julie; Balmas-Bourloud, Katia; Nardou, Katya; Yan, Pu; Tercier, Stephane; Joseph, Jean-Marc; Sommer, Lukas; Gross, Nicole (2011). Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Neoplasia, 13(10):991-1004.

Perez, Daniel; Hauswirth, Fabian; Jäger, Dirk; Metzger, Urs; Samartzis, Eleftherios Pierre; Went, Philip; Jungbluth, Achim (2011). Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors. International Journal of Cancer, 128(12):2947-2952.

Hegi, M E; Diserens, A C; Bady, P; Kamoshima, Y; Kouwenhoven, M C M; Delorenzi, M; Lambiv, W L; Hamou, M F; Matter, M S; Koch, A; Heppner, F L; Yonekawa, Y; Merlo, A; Frei, K; Mariani, L; Hofer, S (2011). Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase II trial. Molecular Cancer Therapeutics, 10(6):1102-1112.

Schwessinger, Benjamin; Roux, Milena; Kadota, Yasuhiro; Ntoukakis, Vardis; Sklenar, Jan; Jones, Alexandra; Zipfel, Cyril (2011). Phosphorylation-Dependent Differential Regulation of Plant Growth, Cell Death, and Innate Immunity by the Regulatory Receptor-Like Kinase BAK1. PLoS Genetics, 7(4):e1002046.

Rohrmann, S; Linseisen, J; Jakobsen, M U; Overvad, K; Raaschou-Nielsen, O; Tjonneland, A; Boutron-Ruault, M C; Kaaks, R; Becker, N; Bergmann, M; Boeing, H; Khaw, K T; Wareham, N J; Key, T J; Travis, R; Benetou, V; Naska, A; Trichopoulou, A; Pala, V; Tumino, R; Masala, G; Mattiello, A; Brustad, M; Lund, E; Skeie, G; Bueno-de-Mesquita, H B; Peeters, P H M; Vermeulen, R C H; Jakszyn, P; Dorronsoro, M; Barricarte, A; Tormo, M J; Molina, E; Argüelles, M; Melin, B; Ericson, U; Manjer, J; Rinaldi, S; Slimani, N; Boffetta, P; Vergnaud, A C; Khan, A; Norat, T; Vineis, P (2011). Consumption of meat and dairy and lymphoma risk in the european prospective investigation into cancer and nutrition. International Journal of Cancer, 128(3):623-634.

Barbus, Sebastian; Tews, Björn; Karra, Daniela; Hahn, Meinhard; Radlwimmer, Bernhard; Delhomme, Nicolas; Hartmann, Christian; Felsberg, Jörg; Krex, Dietmar; Schackert, Gabriele; Martinez, Ramon; Reifenberger, Guido; Lichter, Peter (2011). Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. Journal of the National Cancer Institute, 103(7):598-601.

Eisele, G; Roth, P; Hasenbach, K; Aulwurm, S; Wolpert, F; Tabatabai, G; Wick, W; Weller, M (2011). APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo. Neuro-Oncology, 13(2):155-164.

Noske, A; Loibl, S; Darb-Esfahani, S; Roller, M; Kronenwett, R; Müller, B M; Steffen, J; von Toerne, C; Wirtz, R; Baumann, I; Hoffmann, G; Heinrich, G; Grasshoff, S T; Ulmer, H U; Denkert, C; von Minckwitz, G (2011). Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Research and Treatment, 126(1):109-117.

Weller, M; Wick, W (2011). "Nanomania" ante portas of neurooncology? Journal of Neuro-Oncology, 104(2):613-614.

Haerle, S K; Fischer, D R; Schmid, D T; Ahmad, N; Huber, G F; Buck, A (2011). (18)F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with (18)F-FDG PET/CT. Molecular Imaging and Biology, 13(5):1036-1042.

Engels, K; Giannattasio, M; Muzi-Falconi, M; Lopes, Massimo; Ferrari, S (2011). 14-3-3 proteins regulate exonuclease 1-dependent processing of stalled replication forks. PLoS Genetics, 7(4):e1001367.

Palumbo, A; Hauler, F; Dziunycz, P; Schwager, K; Soltermann, A; Pretto, F; Alonso, C; Hofbauer, G F; Boyle, R W; Neri, D (2011). A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels. British Journal of Cancer, 104(7):1106-1115.

Martin-Killias, P; Stefan, N; Rothschild, S; Plückthun, A; Zangemeister-Wittke, U (2011). A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity. Clinical Cancer Research, 17(1):100-110.

Guerreiro, A S; Fattet, S; Kulesza, D W; Atamer, A; Elsing, A N; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular Cancer Research, 9(7):925-935.

Lissina, Elena; Young, Brian; Urbanus, Malene L; Guan, Xue Li; Lowenson, Jonathan; Hoon, Shawn; Baryshnikova, Anastasia; Riezman, Isabelle; Michaut, Magali; Riezman, Howard; Cowen, Leah E; Wenk, Markus R; Clarke, Steven G; Giaever, Guri; Nislow, Corey (2011). A systems biology approach reveals the role of a novel methyltransferase in response to chemical stress and lipid homeostasis. PLoS Genetics, 7(10):e1002332.

Heinrich, S; Pestalozzi, B; Lesurtel, M; Berrevoet, F; Laurent, S; Delpero, J R; Raoul, J L; Bachellier, P; Dufour, P; Moehler, M; Weber, A; Lang, H; Rogiers, X; Clavien, P A (2011). Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC Cancer, 11:346.

Schmitz, M; Bourquin, J P; Bornhauser, B C (2011). Alternative technique for intrafemoral injection and bone marrow sampling in mouse transplant models. Leukemia and Lymphoma, 52(9):1806-1808.

Widenmeyer, M; Shebzukhov, Y; Haen, S P; Schmidt, D; Clasen, S; Boss, A; Kuprash, D V; Nedospasov, S A; Stenzl, A; Aebert, H; Wernet, D; Stevanovic, S; Pereira, P L; Rammensee, H G; Gouttefangeas, C (2011). Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation. International Journal of Cancer, 128(11):2653-2662.

Haioun, C; Salar, A; Pettengell, R; Johnsen, H Erik; Duehrsen, U; Rossi, F Gaia; Verhoef, G; Schwenkglenks, M; Jaeger, U; Hamilton, L; Pujol, B; Lugtenburg, P J (2011). Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study. Leukemia and Lymphoma, 52(5):796-803.

Weller, M; Wick, W (2011). Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma? Neuro-Oncology, 13(4):365-366.

Mondul, A M; Rohrmann, S; Menke, A; Feinleib, M; Nelson, W G; Platz, E A; Albanes, D (2011). Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes & Control, 22(6):827-836.

Shi, Y; Hollenstein, A; Felley-Bosco, E; Fraefel, C; Ackermann, M; Soltermann, A; Weder, W; Stahel, R A; Pruschy, M; Opitz, I (2011). Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer, 71(3):370-371.

Rohrmann, S; Shiels, M S; Lopez, D S; Rifai, N; Nelson, W G; Kanarek, N; Guallar, E; Menke, A; Joshu, C E; Feinleib, M; Sutcliffe, S; Platz, E A (2011). Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes & Control, 22(8):1141-1151.

Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 30(25):2823-2835.

Anz, David; Mueller, Wolfgang; Golic, Michaela; Kunz, Wolfgang G; Rapp, Moritz; Koelzer, Viktor H; Ellermeier, Jonathan; Ellwart, Joachim W; Schnurr, Max; Bourquin, Carole; Endres, Stefan (2011). CD103 is a hallmark of tumor-infiltrating regulatory T cells. International Journal of Cancer, 129(10):2417-2426.

Smith, C; Santi, M; Rushing, E J; Cornelison, R; MacDonald, T J; Vukmanovic, S (2011). Characterization of signaling function and expression of HLA class I molecules in medulloblastoma. Journal of Neuro-Oncology, 103(2):197-206.

Reardon, D A; Neyns, B; Weller, M; Tonn, J C; Nabors, L B; Stupp, R (2011). Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies. Future Oncology, 7(3):339-354.

Rostock, M; Naumann, J; Guethlin, C; Guenther, L; Bartsch, H H; Walach, H (2011). Classical homeopathy in the treatment of cancer patients - a prospective observational study of two independent cohorts. BMC Cancer, 11:19.

Olsen, E A; Whittaker, S J; Kim, Y H; Duvic, M; Prince, H M; Lessin, S R; Wood, G S; Willemze, R; Demierre, M F; Pimpinelli, N; Bernengo, M G; Ortiz-Romero, P L; Bagot, M; Estrach, T; Guitart, J; Knobler, R; Sanches, J A; Iwatsuki, K; Sugaya, M; Dummer, R; Pittelkow, M; Hoppe, R; Parker, S; Geskin, L; Pinter-Brown, L; Girardi, M; Burg, G; Ranki, A; Vermeer, M H; Horwitz, S; Heald, P; Rosen, S; Cerroni, L; Dreno, B; Vonderheid, E C (2011). Clinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer. Journal of Clinical Oncology, 29(18):2598-2607.

Riesterer, O; Yang, Q; Raju, U; Torres, M; Molkentine, D; Patel, N; Valdecanas, D; Milas, L; Ang, K K (2011). Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers. International Journal of Radiation Oncology, Biology and Physics, 79(4):1179-1187.

Hrbacek, J; Lang, S; Klöck, S (2011). Commissioning of photon beams of a flattening filter-free linear accelerator and the accuracy of beam modeling using an anisotropic analytical algorithm. International Journal of Radiation Oncology, Biology, Physics, 80(4):1228-1237.

Linseisen, J; Rohrmann, S; Bueno-de-Mesquita, B; Büchner, F L; Boshuizen, H C; Agudo, A; Gram, I T; Dahm, C C; Overvad, K; Egeberg, R; Tjønneland, A; Boeing, H; Steffen, A; Kaaks, R; Lukanova, A; Berrino, F; Palli, D; Panico, S; Tumino, R; Ardanaz, E; Dorronsoro, M; Huerta, J M; Rodríguez, L; Sánchez, M J; Rasmuson, T; Hallmans, G; Manjer, J; Wirfält, E; Engeset, D; Skeie, G; Katsoulis, M; Oikonomou, E; Trichopoulou, A; Peeters, P H M; Khaw, K T; Wareham, N; Allen, N; Key, T; Brennan, P; Romieu, I; Slimani, N; Vergnaud, A C; Xun, W W; Vineis, P; Riboli, E (2011). Consumption of meat and fish and risk of lung cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Causes & Control, 22(6):909-918.

Teuffel, O; Kuster, S P; Hunger, S P; Conter, V; Hitzler, J; Ethier, M C; Shah, P S; Beyene, J; Sung, L (2011). Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia, 25(8):1232-1238.

Li, K; Kaaks, R; Linseisen, J; Rohrmann, S (2011). Dietary calcium and magnesium intake in relation to cancer incidence and mortality in a German prospective cohort (EPIC-Heidelberg). Cancer Causes & Control, 22(10):1375-1382.

Cserni, G; Amendoeira, I; Bianchi, S; Chmielik, E; Degaetano, J; Faverly, D; Figueiredo, P; Foschini, M P; Grabau, D; Jacquemier, J; Kaya, H; Kulka, J; Lacerda, M; Liepniece-Karele, I; Penuela, J M; Quinn, C; Regitnig, P; Reiner-Concin, A; Sapino, A; van Diest, P J; Varga, Z; Vezzosi, V; Wesseling, J; Zolota, V; Zozaya, E; Wells, C A (2011). Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. European Journal of Cancer, 47(6):887-894.

Müller, J M V; Feige, K; Wunderlin, P; Hödl, A; Meli, M L; Seltenhammer, M; Grest, P; Nicolson, L; Schelling, C; Heinzerling, L M (2011). Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses. Journal of Immunotherapy, 34(1):58-64.

Huber, G F; Zullig, L; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Studer, G; Jochum, W; Moch, H; Stoeckli, S J (2011). Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer, 11:217.

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Abildgaard, M O; Borre, M; Mortensen, M M; Ulhøi, B P; Tørring, N; Wild, Peter; Kristensen, H; Mansilla, F; Ottosen, P D; Dyrskjøt, L; Ørntoft, T F; Sørensen, K D (2011). Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis. International Journal of Cancer:1-11.

Karbach, J; Neumann, A; Atmaca, A; Wahle, C; Brand, K; von Boehmer, L; Knuth, A; Bender, A; Ritter, G; Old, L J; Jäger, E (2011). Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients. Clinical Cancer Research, 17(4):861-870.

Craig, V J; Cogliatti, S B; Rehrauer, H; Wündisch, T; Müller, Anne (2011). Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Research, 71(10):3616-3624.

Grauer, O; Pascher, C; Hartmann, C; Zeman, F; Weller, M; Proescholdt, M; Brawanski, A; Pietsch, T; Wick, W; Bogdahn, U; Hau, P (2011). Erratum to: Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). Journal of Neuro-Oncology, 105(3):671.

Loibl, S; Skacel, T; Nekljudova, V; Lück, H J; Schwenkglenks, M; Brodowicz, T; Zielinski, C; von Minckwitz, G (2011). Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis. BMC Cancer, 11:131.

Karpova, M B; Fujii, K; Jenni, D; Dummer, R; Urosevic-Maiwald, M (2011). Evaluation of lymphangiogenic markers in Sézary syndrome. Leukemia and Lymphoma, 52(3):491-501.

Faoro, D; von Bueren, A O; Shalaby, T; Sciuscio, D; Hürlimann, M L; Arnold, L; Gerber, N U; Haybaeck, J; Mittelbronn, M; Rutkowski, S; Hegi, M; Grotzer, M A (2011). Expression of O(6)-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology, 103(1):59-69.

Samartzis, Nicolas; Imesch, Patrick; Dedes, K J; Samartzis, Eleftherios Pierre; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Huber, G F; Albinger-Hegyi, A; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Holzmann, D; Moch, H; Hegyi, I (2011). Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer, 117(20):4659-4670.

Patel, P M; Suciu, S; Mortier, L; Kruit, W H; Robert, C; Schadendorf, D; Trefzer, U; Punt, C J A; Dummer, R; Davidson, N; Becker, Juergen; Conry, R; Thompson, J A; Hwu, W J; Engelen, K; Agarwala, S S; Keilholz, U; Eggermont, A M M; Spatz, A (2011). Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032). European Journal of Cancer, 47(10):1476-1483.

Kovac, M; Laczko, E; Haider, R; Jiricny, J; Mueller, H; Heinimann, K; Marra, Giancarlo (2011). Familial colorectal cancer: eleven years of data from a registry program in Switzerland. Familial Cancer, 10(3):605-616.

Salazar, F; Molina, M A; Sanchez-Ronco, M; Moran, T; Ramirez, J L; Sanchez, J M; Stahel, R; Garrido, P; Cobo, M; Isla, D; Bertran-Alamillo, J; Massuti, B; Cardenal, F; Manegold, C; Lianes, P; Trigo, J M; Sanchez, J J; Taron, M; Rosell, R (2011). First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients. Lung Cancer, 72(1):84-91.

Rebholz, C E; von der Weid, N X; Michel, G; Niggli, F K; Kuehni, C E (2011). Follow-up care amongst long-term childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor Study. European Journal of Cancer, 47(2):229-221.

Wagner, P L; Stiedl, A C; Wilbertz, T; Petersen, K; Scheble, V; Menon, R; Reischl, M; Mikut, R; Rubin, M A; Fend, F; Moch, H; Soltermann, A; Weder, W; Altorki, N K; Perner, S (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer, 74(1):118-123.

Rettig, L; Seidenberg, S; Parvanova, I; Samaras, P; Knuth, A; Pascolo, S (2011). Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. International Journal of Cancer, 129(4):832-.838.

Hemmi, S; Vidovszky, M Z; Ruminska, J; Ramelli, S; Decurtins, W; Greber, U F; Harrach, B (2011). Genomic and phylogenetic analyses of murine adenovirus 2. Virus Research, 160(1-2):128-135.

Studer, G; Brown, M; Salgueiro, E B; Schmückle, H; Romancuk, N; Winkler, G; Lee, S J; Sträuli, A; Kissling, B; Dummer, R; Glanzmann, C (2011). Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent Cetuximab and IMRT. International Journal of Radiation Oncology, Biology and Physics, 81(1):110-117.

Strahm, B; Nöllke, P; Zecca, M; Korthof, E T; Bierings, M; Furlan, I; Sedlacek, P; Chybicka, A; Schmugge, M; Bordon, V; Peters, C; O'Marcaigh, A; de Heredia, C D; Bergstraesser, E; Moerloose, B D; van den Heuvel-Eibrink, M M; Starý, J; Trebo, M; Wojcik, D; Niemeyer, C M; Locatelli, F (2011). Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia, 25(3):455-462.

Civenni, Gianluca; Walter, Anne; Kobert, Nikita; Mihic-Probst, Daniela; Zipser, Marie; Belloni, Benedetta; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; van den Broek, Maries; Sommer, Lukas (2011). Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Research, 71(8):3098-3109.

Koto, M; Choi, H; Riesterer, O; Giri, U; Story, M D; Ha, C S; Raju, U (2011). Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro. Anticancer Research, 31(1):33-38.

Arozarena, I; Bischof, H; Gilby, D; Belloni, B; Dummer, R; Wellbrock, C (2011). In melanoma, beta-catenin is a suppressor of invasion. Oncogene, 30(45):4531-4543.

Pettengell, R; Schwenkglenks, M (2011). Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups. Leukemia and Lymphoma, 52(6):1133-1136.

Nordentoft, I; Dyrskjøt, L; Bødker, J S; Wild, P J; Hartmann, A; Bertz, S; Lehmann, J; Orntoft, T F; Birkenkamp-Demtroder, K (2011). Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. BMC Cancer, 11:135.

Studer, G; Glanzmann, C (2011). Increased recurrences using IMRT in the postoperative setting? American Journal of Clinical Oncology, 34(4):442.

Sidi, R; Pasello, G; Opitz, I; Soltermann, A; Tutic, M; Rehrauer, H; Weder, W; Stahel, R A; Felley-Bosco, E (2011). Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. European Journal of Cancer, 47(2):326-332.

Knobel, Philip A; Kotov, Ilya N; Felley-Bosco, Emanuela; Stahel, Rolf A; Marti, Thomas M (2011). Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells. Neoplasia, 13(10):961-970.

Hu, J; Stiehl, D P; Setzer, C; Wichmann, D; Shinde, D A; Rehrauer, H; Hradecky, P; Gassmann, M; Gorr, T A (2011). Interaction of HIF and USF signaling pathways at human genes flanked by hypoxia-response elements and E-box palindromes. Molecular Cancer Research, 9(11):1520-1536.

Regan, M M; Price, K N; Giobbie-Hurder, A; Thürlimann, B; Gelber, R D (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Research, 13(3):209.

Butsch, R; Waelti, S L; Schaerer, S; Braun, Julia; Korol, D; Probst-Hensch, N; Moch, H; Kurrer, M (2011). Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leukemia and Lymphoma, 52(7):1230-1238.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Blank, P R; Moch, H; Szucs, T D; Schwenkglenks, M (2011). KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective. Clinical Cancer Research, 17(19):6338-6346.

Doberstein, K; Schramme, A; Lee, S B; Blaheta, R A; Wedel, S; Moch, H; Schraml, P; Pfeilschifter, J; Kristiansen, G; Gutwein, P (2011). L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis, 32(3):262-270.

Tischler, V; Pfeifer, M; Hausladen, S; Schirmer, U; Bonde, A K; Kristiansen, G; Sos, M L; Weder, W; Moch, H; Altevogt, P; Soltermann, A (2011). L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Molecular Cancer, 10:127.

Seppälä, E H; Jokinen, T S; Fukata, M; et al; Steffen, F (2011). LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genetics, 7(7):e1002194.

Moffat, Rebecca Elizabeth; Eichholzer, Monika; Myrick, Mary Elizabeth; Schmid, Seraina Margaretha; Raggi, Anna; de Geyter, Christian; Schötzau, Andreas; Güth, Uwe (2011). Menopausal state in breast cancer: How reliable is the data? Clinical Breast Cancer, 11(6):390-394.

Grunder, E; D'Ambrosio, R; Fiaschetti, G; Abela, L; Arcaro, A; Zuzak, T; Ohgaki, H; Lv, S Q; Shalaby, T; Grotzer, M (2011). MicroRNA-21 suppression impedes medulloblastoma cell migration. European Journal of Cancer, 47(16):2479-2490.

Aydin, D; Feychting, M; Schüz, J; Tynes, T; Andersen, T V; Schmidt, L S; Poulsen, A H; Johansen, C; Prochazka, M; Lannering, B; Klæboe, L; Eggen, T; Jenni, D; Grotzer, M; Von der Weid, N; Kuehni, C E; Röösli, M (2011). Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study. Journal of the National Cancer Institute, 103(16):1264-1276.

Hartmann, C; Hentschel, B; Tatagiba, M; Schramm, J; Schnell, O; Seidel, C; Stein, R; Reifenberger, G; Pietsch, T; von Deimling, A; Loeffler, M; Weller, M (2011). Molecular markers in low-grade gliomas: predictive or prognostic? Clinical Cancer Research, 17(13):4588-4599.

Rössle, M; Hirschmann, A; Diebold, J (2011). Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based study. European Journal of Cancer, 47(9):1305-1311.

Weller, M (2011). Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trials. Neuro-Oncology, 13(6):565.

Egilmez, N K; Harden, J L; Virtuoso, L P; Schwendener, R A; Kilinc, M O (2011). Nitric oxide short-circuits interleukin-12-mediated tumor regression. Cancer Immunology, Immunotherapy, 60(6):839-845.

Burkhardt, B; Oschlies, I; Klapper, W; Zimmermann, M; Woessmann, W; Meinhardt, A; Landmann, E; Attarbaschi, A; Niggli, F; Schrappe, M; Reiter, A (2011). Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia, 25(1):153-160.

Gerber, N U; von Hoff, K; von Bueren, A O; Treulieb, W; Warmuth-Metz, M; Pietsch, T; Soerensen, N; Faldum, A; Emser, A; Schlegel, P G; Deinlein, F; Kortmann, R D; Rutkowski, S (2011). Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. Journal of Neuro-Oncology, 102(3):459-469.

Engel, Philipp; Salzburger, Walter; Liesch, Marius; Chang, Chao-Chin; Maruyama, Soichi; Lanz, Christa; Calteau, Alexandra; Lajus, Aurélie; Médigue, Claudine; Schuster, Stephan C; Dehio, Christoph (2011). Parallel Evolution of a Type IV Secretion System in Radiating Lineages of the Host-Restricted Bacterial Pathogen Bartonella. PLoS Genetics, 7(2):e1001296.

Wick, W; Weller, M; Weiler, M; Batchelor, T; Yung, A W; Platten, M (2011). Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro-Oncology, 13(6):566-579.

Pettengell, R; Schwenkglenks, M; Bacon, P; Lawrinson, S; Duehrsen, U (2011). Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis. Hematological Oncology, 29(4):177-184.

Frei, C; Opitz, I; Soltermann, A; Fischer, B; Moura, U; Rehrauer, H; Weder, W; Stahel, R; Felley-Bosco, E (2011). Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis, 32(9):1324-1332.

Huber, G F; Fritzsche, F R; et al (2011). Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. International Journal of Cancer, 129(6):1404-1409.

Szucs, T D; Blank, P R; Schwenkglenks, M; Aapro, M (2011). Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81(1):45-49.

Krumbach, R; Schüler, J; Hofmann, M; Giesemann, T; Fiebig, H H; Beckers, T (2011). Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance. European Journal of Cancer, 47(8):1231-1243.

Bordoli, M R; Stiehl, D P; Borsig, L; Kristiansen, G; Hausladen, S; Schraml, P; Wenger, R H; Camenisch, G (2011). Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene, 30(5):548-560.

Felsberg, J; Thon, N; Eigenbrod, S; Hentschel, B; Sabel, M C; Westphal, M; Schackert, G; Kreth, F W; Pietsch, T; Löffler, M; Weller, M; Reifenberger, G; Tonn, J C (2011). Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. International Journal of Cancer, 129(3):659-670.

Mischo, A; Bubel, N; Cebon, J S; Samaras, P; Petrausch, U; Stenner-Liewen, F; Schaefer, N G; Kubuschok, B; Renner, C; Wadle, A (2011). Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis. International Journal of Oncology, 39(1):287-294.

Rohrer Bley, Carla; Orlowski, K; Furmanova, P; McSheehy, P M; Pruschy, Martin (2011). Regulation of VEGF-expression by patupilone and ionizing radiation in lung adenocarcinoma cells. Lung Cancer, 73(3):294-301.

Papadatos-Pastos, D; Dedes, K J; de Bono, J S; Kaye, S B (2011). Revisiting the role of antiandrogen strategies in ovarian cancer. The Oncologist, 16(10):1413-1421.

Thorwarth, D; Henke, G; Müller, A C; Reimold, M; Beyer, T; Boss, A; Kolb, A; Pichler, B; Pfannenberg, C (2011). Simultaneous (68)Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. International Journal of Radiation Oncology, Biology and Physics, 81(1):277-283.

Davies, D M; de Vries, P J; Johnson, S R; McCartney, D L; Cox, J A; Serra, A L; Watson, P C; Howe, C J; Doyle, T; Pointon, K; Cross, J J; Tattersfield, A E; Kingswood, J C; Sampson, J R (2011). Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clinical Cancer Research, 17(12):4071-4081.

Yang, H; Kim, C; Kim, M J; Schwendener, R A; Alitalo, K; Heston, W; Kim, I; Kim, W J; Koh, G Y (2011). Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Molecular Cancer, 10:36.

Borsig, Lubor; Vlodavsky, Israel; Ishai-Michaeli, Rivka; Torri, Giangiacomo; Vismara, Elena (2011). Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase. Neoplasia, 13(5):445-452.

Weide, B; Eigentler, T K; Pflugfelder, A; Leiter, U; Meier, F; Bauer, J; Schmidt, D; Radny, P; Pföhler, C; Garbe, C (2011). Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up. Cancer Immunology, Immunotherapy, 60(4):487-493.

Grauer, O; Pascher, C; Hartmann, C; Zeman, F; Weller, M; Proescholdt, M; Brawanski, A; Pietsch, T; Wick, W; Bogdahn, U; Hau, P (2011). Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). Journal of Neuro-Oncology, 104(3):801-809.

Imhof, L; Goldinger, S M; Baumann, K; Schad, K; French, L E; Röthlisberger, P; Dummer, R (2011). The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study. Melanoma Research, 21(1):80-83.

Oehler, C; von Bueren, A O; Furmanova, P; Broggini-Tenzer, A; Orlowski, K; Rutkowski, S; Frei, K; Grotzer, M A; Pruschy, M (2011). The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells. Neuro-Oncology, 13(9):1000-1010.

Haerle, S K; Schmid, D T; Ahmad, N; Hany, T F; Stoeckli, S J (2011). The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncology, 47(7):653-9.

Wick, W; Weller, M (2011). Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142). Neuro-Oncology, 13(5):559-560; author reply 561.

Knobel, P A; Marti, T M (2011). Translesion DNA synthesis in the context of cancer research. Cancer Cell International, 11:39.

Gridelli, C; Stahel, R; Besse, B; Ciardiello, F; Felip, E; Gasparini, S; Graziano, P; Rossi, A; de Marinis, F (2011). Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting. Lung Cancer, 74(3):544-548.

von Bueren, A O; von Hoff, K; Pietsch, T; Gerber, N U; Warmuth-Metz, M; Deinlein, F; Zwiener, I; Faldum, A; Fleischhack, G; Benesch, M; Krauss, J; Kuehl, J; Kortmann, R D; Rutkowski, S (2011). Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-Oncology, 13(6):669-679.

Gluz, O; Wild, P; Liedtke, C; Kates, R; Mendrik, H; Ehm, E; Artinger, V; Diallo-Danebrock, R; Ting, E; Mohrmann, S; Poremba, C; Harbeck, N; Nitz, U; Hartmann, A; Gaumann, A (2011). Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. Breast Cancer Research and Treatment, 126(3):643-651.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Rechsteiner, M P; von Teichman, A; Nowicka, A; Sulser, T; Schraml, P; Moch, H (2011). VHL gene mutations and their effects on hypoxia inducible factor HIF{alpha}: Identification of potential driver and passenger mutations. Cancer Research, 71(16):5500-5511.

Rueger, M A; Ameli, M; Li, H; Winkeler, A; Rueckriem, B; Vollmar, S; Galldiks, N; Hesselmann, V; Fraefel, C; Wienhard, K; Heiss, W D; Jacobs, A H (2011). [18F]FLT PET for Non-Invasive Monitoring of Early Response to Gene Therapy in Experimental Gliomas. Molecular Imaging and Biology, 13(3):547-557.

von Bueren, A O; Oehler, C; Shalaby, T; von Hoff, K; Pruschy, M; Seifert, Burkhardt; Gerber, N U; Warmuth-Metz, M; Stearns, D; Eberhart, C G; Kortmann, R D; Rutkowski, S; Grotzer, M A (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11:74.

Kasajima, A (2011). mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. Endocrine-Related Cancer, 18(1):181-92.

2010

Hemminki, O; Bauerschmitz, G; Hemmi, S; Lavilla-Alonso, S; Diaconu, I; Guse, K; Koski, A; Desmond, R A; Lappalainen, M; Kanerva, A; Cerullo, V; Pesonen, S; Hemminki, A (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy, 18:288-296.

Läubli, H; Borsig, L (2010). Selectins as mediators of lung metastasis. Cancer Microenviron, 3(1):97-105.

Burckhart, T; Thiel, Markus; Nishikawa, H; Wüest, T; Müller, D; Zippelius, A; Ritter, G; Old, L; Shiku, H; Renner, C (2010). Tumor-specific crosslinking of GITR as costimulation for immunotherapy. Journal of Immunotherapy, 33(9):925-934.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Pe'choux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 13(10):C23-C45.

Castelletti, D; Fiaschetti, G; Di Dato, V; Ziegler, U; Kumps, C; De Preter, K; Zollo, M; Speleman, F; Shalaby, T; De Martino, D; Berg, T; Eggert, A; Arcaro, A; Grotzer, M A (2010). The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors. Molecular Cancer Therapeutics, 9(12):3145-3157.

Speiser, D E; Schwarz, K; Baumgaertner, P; Conzett, K B; Manolova, V; Devevre, E; Sterry, W; Walden, P; Zippelius, A; Senti, G; Voelter, V; Cerottini, J P; Guggisberg, D; Willers, J; Geldhof, C; Romero, P; Kündig, T; Knuth, A; Dummer, R; Trefzer, U; Bachmann, M F (2010). Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. Journal of Immunotherapy, 33(8):848-858.

Hofer, Silvia; Lassman, Andrew B (2010). Molecular markers in gliomas: impact for the clinician. Targeted oncology, 5(3):201-210.

Läubli, H; Borsig, L (2010). Selectins promote tumor metastasis. Seminars in Cancer Biology, 20(3):169-177.

Studer, G; Peponi, E; Kloeck, S; Dossenbach, T; Huber, G; Glanzmann, C (2010). Surviving hypopharynx-larynx carcinoma in the era of IMRT. International Journal of Radiation Oncology, Biology and Physics, 77(5):1391-1396.

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Weiler, M; Hartmann, C; Wiewrodt, D; Herrlinger, U; Gorlia, T; Bähr, O; Meyermann, R; Bamberg, M; Tatagiba, M; von Deimling, A; Weller, M; Wick, W (2010). Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. International Journal of Radiation Oncology, Biology and Physics, 77(3):670-676.

Roth, P; Junker, M; Tritschler, I; Mittelbronn, M; Dombrowski, Y; Breit, S N; Tabatabai, G; Wick, W; Weller, M; Wischhusen, J (2010). GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clinical Cancer Research, 16(5):3851-3859.

Toller, I M; Altmeyer, M; Kohler, E; Hottiger, M O; Müller, Anne (2010). Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia. Cancer Research, 70(14):5912-5922.

Fritz, R D; Varga, Z; Radziwill, G (2010). CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis. Oncogene, 29(24):3575-3582.

Kristiansen, G; Rose, M; Geisler, C; Fritzsche, F R; Gerhardt, J; Lüke, C; Ladhoff, A-M; Knüchel, R; Dietel, M; Moch, H; Varga, Z; Theurillat, J-P; Gorr, T A; Dahl, E (2010). Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British Journal of Cancer, 102(12):1736-1745.

Albinger-Hegyi, A; Stoeckli, S J; Schmid, S; Storz, M; Iotzova, G; Probst-Hensch, N M; Rehrauer, H; Tinguely, M; Moch, H; Hegyi, I (2010). Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). International Journal of Cancer, 126(11):2653 -2662.

Ackermann, R; Semmler, A; Maurer, G D; Hattingen, E; Fornoff, F; Steinbach, J P; Linnebank, M (2010). Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites. Journal of Neuro-Oncology, 97(3):425-427.

Kurzwelly, D; Glas, M; Roth, P; Weimann, E; Lohner, H; Waha, A; Schabet, M; Reifenberger, G; Weller, M; Herrlinger, U (2010). Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status. Journal of Neuro-Oncology, 97(3):389-392.

Ess, S; Savidan, A; Frick, H; Rageth, C H; Vlastos, G; Lütolf, U; Thürlimann, B (2010). Geographic variation in breast cancer care in Switzerland. Cancer Epidemiology, 34(2):116-121.

Weller, M (2010). Immunotherapy for glioblastoma: a long and winding road. Neuro-Oncology, 12(4):319.

Hofstetter, B; Niemierko, A; Forrer, C; Benhattar, J; Albertini, V; Pruschy, M; Bosman, F T; Catapano, C V; Ciernik, I F (2010). Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. International Journal of Radiation Oncology, Biology and Physics, 76(5):1512-1519.

Stahel, R; Baas, P; Faivre-Finn, C; Dooms, C; Passlick, B; Mazières, J; Cappuzzo, F; Früh, M; Sorensen, J B; Blackhall, F; Taron, M; Gridelli, C; O'Byrne, K; Rosell, R (2010). Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP). Lung Cancer, 68(1):121-124.

Ammann, R A; Bodmer, N; Hirt, A; Niggli, F K; Nadal, D; Simon, A; Ozsahin, H; Kontny, U; Kühne, T; Beck Popovic, M; Ridolfi Lüthy, A; Aebi, C (2010). Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. Journal of Clinical Oncology, 28(12):2008-2014.

Zieker, D; Königsrainer, I; Tritschler, I; Löffler, M; Beckert, S; Traub, F; Nieselt, K; Bühler, S; Weller, M; Gaedcke, J; Taichman, R S; Northoff, H; Brücher, B L D M; Königsrainer, A (2010). Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. International Journal of Cancer, 126(6):1513-1520.

Shalaby, T; Hiyama, E; Grotzer, M A (2010). Telomere maintenance as therapeutic target in embryonal tumours. Anti-Cancer Agents in Medicinal Chemistry, 10(3):196-212.

Veit-Haibach, P; Schaefer, N G; Steinert, H C; Soyka, J D; Seifert, B; Stahel, R A (2010). Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer, 67(3):311-317.

Weller, M (2010). Temozolomide and MGMT forever? Neuro-Oncology, 12(3):219-220.

Jung, V; Fischer, E; Imig, J; Kleber, S; Nuber, N; Reinshagen, F; Kamradt, J; Grobholz, R; Knuth, A; Renner, C; Wadle, A (2010). Yeast-based identification of prostate tumor antigens provides an effective vaccine platform. Anticancer Research, 30(3):895-902.

Wick, W; Weller, M; van den Bent, M; Stupp, R (2010). Bevacizumab and recurrent malignant gliomas: a European perspective. Journal of Clinical Oncology, 28(12):e188-e189; author reply e190.

Dresemann, G; Weller, M; Rosenthal, M A; Wedding, U; Wagner, W; Engel, E; Heinrich, B; Mayer-Steinacker, R; Karup-Hansen, A; Fluge, O; Nowak, A; Mehdorn, M; Schleyer, E; Krex, D; Olver, I N; Steinbach, J P; Hosius, C; Sieder, C; Sorenson, G; Parker, R; Nikolova, Z (2010). Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. Journal of Neuro-Oncology, 96(3):393-402.

Shalaby, T; et al; Nagasawa, K; Jelesarov, I (2010). Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD. Molecular Cancer Therapeutics, 9(1):167-169.

Craig, V J; Cogliatti, S B; Arnold, I; Gerke, C; Balandat, J-E; Wündisch, T; Müller, Anne (2010). B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia, (24):1186-1196.

Deka, J; Wiedemann, N; Anderle, P; Murphy-Seiler, F; Bultinck, J; Eyckerman, S; Stehle, J C; André, S; Vilain, N; Zilian, O; Robine, S; Delorenzi, M; Basler, K; Aguet, M (2010). Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. Cancer Research, 70(16):6619-6628.

Sutter, R; Shakhova, O; Bhagat, H; Behesti, H; Sutter, C; Penkar, S; Santuccione, A; Bernays, R L; Heppner, F L; Schüller, U; Grotzer, M; Moch, H; Schrami, P; Marino, S (2010). Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene, 29(12):1845-1856.

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Wong, W W; Boutros, P C; Wasylishen, A R; Guckert, K D; O'Brien, E M; Griffiths, R; Martirosyan, A R; Bros, C; Jurisica, I; Langler, R F; Penn, L Z (2010). Characterization of the apoptotic response of human leukemia cells to organosulfur compounds. BMC Cancer, 10:351.

Weller, M (2010). Chemotherapy for low-grade gliomas: when? how? how long? Neuro-Oncology, 12(10):1013.

Lugthart, S; Gröschel, S; Beverloo, H B; et al (2010). Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. Journal of Clinical Oncology, 28(24):3890-3899.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Berger, B; Capper, D; Lemke, D; Pfenning, P N; Platten, M; Weller, M; von Deimling, A; Wick, W; Weiler, M (2010). Defective p53 antiangiogenic signaling in glioblastoma. Neuro-Oncology, 12(9):894-907.

Johnston, A J; Kirioukhova, O; Barrell, P J; Rutten, T; Moore, J M; Baskar, R; Grossniklaus, U; Gruissem, W (2010). Dosage-sensitive function of retinoblastoma related and convergent epigenetic control are required during the Arabidopsis life cycle. PLoS Genetics, 6(6):e1000988.

Zahnd, C; Kawe, M; Stumpp, M T; de Pasquale, C; Tamaskovic, R; Nagy-Davidescu, G; Dreier, B; Schibli, R; Binz, H K; Waibel, R; Plückthun, A (2010). Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. Cancer Research, 70(4):1595-1605.

Samaras, P; Buset, E M; Siciliano, R D; Haile, S R; Petrausch, U; Mischo, A; Honegger, H; Pestalozzi, B C; Schanz, U; Stüssi, G; Stahel, R A; Knuth, A; Renner, C; Stenner-Liewen, F (2010). Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation. Oncology, 79(1-2):93-97.

Burger, C; Deschwanden, A; Ametamey, S; Johayem, A; Mancosu, B; Wyss, M; Hasler, G; Buck, A (2010). Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5. Nuclear Medicine and Biology, 37(7):845-851.

Xu, L; Hausmann, M; Dietmaier, W; Kellermeier, S; Pesch, T; Stieber-Gunckel, M; Lippert, E; Klebl, F; Rogler, G (2010). Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. BMC Cancer, 10:302.

Alexaki, V I; Javelaud, D; Van Kempen, L C L; Mohammad, K S; Dennler, S; Luciani, F; Hoek, K S; Juàrez, P; Goydos, J S; Fournier, P J; Sibon, C; Bertolotto, C; Verrecchia, F; Saule, S; Delmas, V; Ballotti, R; Larue, L; Saiag, P; Guise, T A; Mauviel, A (2010). GLI2-mediated melanoma invasion and metastasis. Journal of the National Cancer Institute, 102(15):1148-1159.

Kurzwelly, D; Knop, S; Guenther, M; Loeffler, J; Korfel, A; Thiel, E; Hebart, H; Simon, M; Weller, M; Linnebank, M; Herrlinger, U (2010). Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. Journal of Neuro-Oncology, 100(2):187-192.

Tabatabai, G; Hasenbach, K; Herrmann, C; Maurer, G; Möhle, R; Marini, P; Grez, M; Wick, W; Weller, M (2010). Glioma tropism of lentivirally transduced hematopoietic progenitor cells. International Journal of Oncology, 36(6):1409-1417.

Schwenkglenks, M; Pettengell, R; Szucs, T D; Culakova, E; Lyman, G H (2010). Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. Journal of Hematology and Oncology, 3:27.

Blank, P R; Schwenkglenks, M; Moch, H; Szucs, T D (2010). Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast Cancer Research and Treatment, 124(2):497-507.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Kosmidis, M; Dziunycz, P; Suárez-Fariñas, M; Mühleisen, B; Schärer, L; Läuchli, S; Hafner, J; French, L E; Schmidt-Weber, C; Carucci, J A; Hofbauer, G F L (2010). Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. Journal of Immunotherapy, 33(5):538-546.

Peralta, R; Baudis, Michael; Vazquez, G; Juárez, S; Ortiz, R; Decanini, H; Hernandez, D; Gallegos, F; Valdivia, A; Piña, P; Salcedo, M (2010). Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology, 136(6):931-938.

Ikenberg, K; Fritzsche, F R; Zuerrer-Haerdi, U; Hofmann, I; Hermanns, T; Seifert, H; Müntener, M; Provenzano, M; Sulser, T; Behnke, S; Gerhardt, J; Mortezavi, A; Wild, P; Hofstädter, F; Burger, M; Moch, H; Kristiansen, G (2010). Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer, 10:341.

Sander, A; Linseisen, J; Rohrmann, S (2010). Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort. Cancer Causes & Control, 22(1):109-114.

Martinelli, G; Schmitz, S F H; Utiger, U; Cerny, T; Hess, U; Bassi, S; Okkinga, E; Stupp, R; Stahel, R; Heizmann, M; Vorobiof, D; Lohri, A; Dietrich, P Y; Zucca, E; Ghielmini, M (2010). Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. Journal of Clinical Oncology, 28(29):4480-4484.

Tallen, G; Ratei, R; Mann, G; Kaspers, G; Niggli, F; Karachunsky, A; Ebell, W; Escherich, G; Schrappe, M; Klingebiel, T; Fengler, R; Henze, G; von Stackelberg, A (2010). Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. Journal of Clinical Oncology, 28(14):2339-2347.

Möricke, A; Zimmermann, M; Reiter, A; Henze, G; Schrauder, A; Gadner, H; Ludwig, W D; Ritter, J; Harbott, J; Mann, G; Klingebiel, T; Zintl, F; Niemeyer, C; Kremens, B; Niggli, F; Niethammer, D; Welte, K; Stanulla, M; Odenwald, E; Riehm, H; Schrappe, M (2010). Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24(2):265-284.

Hoffmann, Andreas-Claudius; Wild, Peter J; Leicht, Christina; Bertz, Simone; Danenberg, Kathleen D; Danenberg, Peter V; Stöhr, Robert; Stöckle, Michael; Lehmann, Jan; Schuler, Martin; Hartmann, Arndt (2010). MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia, 12(8):628-636.

Hassel, J C; Sucker, A; Edler, L; Kurzen, H; Moll, I; Stresemann, C; Spieth, K; Mauch, C; Rass, K; Dummer, R; Schadendorf, D (2010). MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. British Journal of Cancer, 103(6):820-826.

Lacunza, E; Baudis, Michael; Colussi, A G; Segal-Eiras, A; Croce, M V; Abba, M C (2010). MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells. Cancer Genetics and Cytogenetics, 201(2):102-110.

Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clinical Cancer Research, 16(1):88-98.

Schad, K; Baumann Conzett, K; Zipser, M C; Enderlin, V; Kamarashev, J; French, L E; Dummer, R (2010). Mitogen-activated protein/extracellular signal-regulated kinase kinase inhibition results in biphasic alteration of epidermal homeostasis with keratinocytic apoptosis and pigmentation disorders. Clinical Cancer Research, 16(3):1058-1064.

Kager, L; Zoubek, A; Dominkus, M; Lang, S; Bodmer, N; Jundt, G; Klingebiel, T; Jürgens, H; Gadner, H; Bielack, S (2010). Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group. Cancer, 116(22):5316-5324.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology, 28(16):2712-2718.

Wick, W; Puduvalli, V K; Chamberlain, M C; van den Bent, M J; Carpentier, A F; Cher, L M; Mason, W; Weller, M; Hong, S; Musib, L; Liepa, A M; Thornton, D E; Fine, H A (2010). Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. Journal of Clinical Oncology, 28(7):1168-1174.

Knols, R H; de Bruin, E D; Shirato, K; Uebelhart, D; Aaronson, N K (2010). Physical activity interventions to improve daily walking activity in cancer survivors. BMC Cancer, 10:406.

Rajandram, R K; Jenewein, J; McGrath, Co P J; Zwahlen, R A (2010). Posttraumatic growth: a novel concept in oral cavity cancer care? Oral Oncology, 46(11):791-794.

N'Dongo, H W P; Raposinho, P D; Fernandes, C; Santos, I; Can, D; Schmutz, P; Spingler, B; Alberto, R (2010). Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting. Nuclear Medicine and Biology, 37(3):255-264.

Mauz-Körholz, C; Hasenclever, D; Dörffel, W; Ruschke, K; Pelz, T; Voigt, A; Stiefel, M; Winkler, M; Vilser, C; Dieckmann, K; Karlén, J; Bergsträsser, E; Fosså, A; Mann, G; Hummel, M; Klapper, W; Stein, H; Vordermark, D; Kluge, R; Körholz, D (2010). Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. Journal of Clinical Oncology, 28(23):3680-3686.

Zlobec, I; Molinari, F; Kovac, M; Bihl, M P; Altermatt, H J; Diebold, J; Frick, H; Germer, M; Horcic, M; Montani, M; Singer, G; Yurtsever, H; Zettl, A; Terracciano, L; Mazzucchelli, L; Saletti, P; Frattini, M; Heinimann, K; Lugli, A (2010). Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. British Journal of Cancer, 102(1):151-161.

von Neuhoff, C; Reinhardt, D; Sander, A; Zimmermann, M; Bradtke, J; Betts, D R; Zemanova, Z; Stary, J; Bourquin, J P; Haas, O A; Dworzak, M N; Creutzig, U (2010). Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. Journal of Clinical Oncology, 28(16):2682-2689.

Krayenbuehl, J; Hartmann, M; Lomax, A J; Kloeck, S; Hug, E B; Ciernik, I F (2010). Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. International Journal of Radiation Oncology, Biology and Physics, 78(2):628-634.

Michel, G; Rebholz, C E; von der Weid, N X; Bergsträsser, E; Kuehni, C E (2010). Psychological distress in adult survivors of childhood cancer: the Swiss Childhood Cancer Survivor study. Journal of Clinical Oncology, 28(10):1740-1748.

Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M J; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 28(33):e696-e697.

Gillessen, S; Templeton, A; Marra, Giancarlo; Kuo, Y F; Valtorta, E; Shahinian, V B (2010). Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. Journal of the National Cancer Institute, 102(23):1760-1770.

Weller, M; Wick, W; Hegi, M E; Stupp, R; Tabatabai, G (2010). Should biomarkers be used to design personalized medicine for the treatment of glioblastoma? Future Oncology, 6(9):1407-1414.

Richter-Ehrenstein, C; Arndt, J; Buckendahl, A C; Eucker, J; Weichert, W; Kasajima, A; Schneider, A; Noske, A (2010). Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Research and Treatment, 124(2):413-417.

Schiesser, M; Schneider, P M (2010). Surgical strategies for adenocarcinoma of the esophagogastric junction. Recent Results in Cancer Research, 182:93-106.

Erlic, Z; Ploeckinger, U; Cascon, A; Hoffmann, M M; von Duecker, L; Winter, A; Kammel, G; Bacher, J; Sullivan, M; Isermann, B; Fischer, L; Raffel, A; Knoefel, W T; Schott, M; Baumann, T; Schaefer, O; Keck, T; Baum, R P; Milos, I; Muresan, M; Peczkowska, M; Januszewicz, A; Cupisti, K; Tönjes, A; Fasshauer, M; Langrehr, J; von Wussow, P; Agaimy, A; Schlimok, G; Lamberts, R; Wiech, T; Schmid, K W; Weber, A; Nunez, M; Robledo, M; Eng, C; Neumann, H P H (2010). Systematic comparison of sporadic and syndromic pancreatic islet cell tumors. Endocrine-Related Cancer, 17(4):875-883.

Bettermann, K; Vucur, M; Haybaeck, J; Koppe, C; Janssen, J; Heymann, F; Weber, A; Weiskirchen, R; Liedtke, C; Gassler, N; Müller, M; de Vos, R; Wolf, M J; Boege, Y; Seleznik, G M; Zeller, N; Erny, D; Fuchs, T; Zoller, S; Cairo, S; Buendia, M A; Prinz, M; Akira, S; Tacke, F; Heikenwalder, M; Trautwein, C; Luedde, T (2010). TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell, 17(5):481-496.

Zauner, L; Melroe, G T; Sigrist, J A; Rechsteiner, M P; Dorner, M; Arnold, M; Berger, C; Bernasconi, M; Schaefer, B W; Speck, R F; Nadal, D (2010). TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. Oncogene, 29(32):4588-98.

Tabatabai, G; Weller, M; Nabors, B; Picard, M; Reardon, D; Mikkelsen, T; Ruegg, C; Stupp, R (2010). Targeting integrins in malignant glioma. Targeted Oncology, 5(3):175-181.

Weber, Achim; Chung, Hye-Jung; Springer, Erik; Heitzmann, Dirk; Warth, Richard (2010). The TFIIH subunit p89 (XPB) localizes to the centrosome during mitosis. Cellular Oncology, 32(1-2):121-130.

Eichhoff, O M; Zipser, M C; Xu, M; Weeraratna, A T; Mihic, D; Dummer, R; Hoek, K S (2010). The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report. Melanoma Research, 20(4):349-355.

Pavlidis, N; Gatzemeier, W; Popescu, R; Stahel, R; Pinedo, H; Cavalli, F; Costa, A (2010). The masterclass of the european school of oncology: the 'key educational event' of the school. European Journal of Cancer, 46(12):2159-2165.

Wolf, M J; Seleznik, G M; Zeller, N; Heikenwalder, M (2010). The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene, 29(36):5006-1508.

Worthington, J; Bertani, M; Chan, H L; Gerrits, B; Timms, J F (2010). Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation. BMC Cancer, 10:490.

Hecker, R M; Amstutz, R A; Wachtel, M; Walter, D; Niggli, F K; Schäfer, B W (2010). p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment. Oncogene, 29(27):3942-3952.

2009

Cai, Xiaoxiao; Lin, Yunfeng; Friedrich, Claudia C; Neville, Craig; Pomerantseva, Irina; Sundback, Cathryn A; Sharma, Parul; Zhang, Zhiyuan; Vacanti, Joseph P; Hauschka, Peter V; Grottkau, Brian E (2009). Bone marrow Derived Pluripotent Cells are Pericytes which Contribute to Vascularization. Stem Cell Reviews, 5(4):437-445.

Weller, M; Felsberg, J; Hartmann, C; Berger, H; Steinbach, J P; Schramm, J; Westphal, M; Schackert, G; Simon, M; Tonn, J C; Heese, O; Krex, D; Nikkhah, G; Pietsch, T; Wiestler, O; Reifenberger, G; von Deimling, A; Loeffler, M (2009). Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of Clinical Oncology, 27(34):5743-5750.

Wick, W; Hartmann, C; Engel, C; Stoffels, M; Felsberg, J; Stockhammer, F; Sabel, M C; Koeppen, S; Ketter, R; Meyermann, R; Rapp, M; Meisner, C; Kortmann, R D; Pietsch, T; Wiestler, O D; Ernemann, U; Bamberg, M; Reifenberger, G; von Deimling, A; Weller, M (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology, 27(32):5874-5880.

Halder, C; Ossendorf, C; Maran, A; Yaszemski, M; Bolander, M E; Fuchs, B; Sarkar, G (2009). Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma. Anticancer Research, 29(11):4317-4322.

Szucs, Thomas D; Dedes, Konstantin J (2009). Is cancer prevention ever going to be profitable? In: Senn, H J; Kapp, U; Ott, F. Cancer Prevention II. Berlin: Springer, 41-47.

Avneon, M; Lifshitz, L; Katz, O; Prutchi-Sagiv, S; Gassmann, M; Mittelman, M; Neumann, D (2009). Non-erythroid effects of erythropoietin: Are neutrophils a target? Leukemia Research, 33(10):1430-1432.

Lappe-Siefke, C; Loebrich, S; Hevers, W; Waidmann, O B; Schweizer, M; Fehr, S; Fritschy, J M; Dikic, I; Eilers, J; Wilson, S M; Kneussel, M (2009). The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice. PLoS Genetics, 5(9):e1000631.

Boneberg, E M; Legler, D F; Hoefer, M M; Ohlschlegel, C; Steininger, H; Füzesi, L; Beer, G M; Dupont-Lampert, V; Otto, F; Senn, H J; Fürstenberger, G (2009). Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. British Journal of Cancer, 101(4):605-614.

Pagani, O; Gelber, S; Simoncini, E; Castiglione-Gertsch, M; Price, K N; Gelber, R D; Holmberg, S B; Crivellari, D; Collins, J; Lindtner, J; Thürlimann, B; Fey, M F; Murray, E; Forbes, J F; Coates, A S; Goldhirsch, A (2009). Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast Cancer Research and Treatment, 116(3):491-500.

Kelly, B J; Fraefel, C; Cunningham, A L; Diefenbach, R J (2009). Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Research, 145(2):173-186.

Bauer, S; Oosterwijk-Wakka, J C; Adrian, N; Oosterwijk, E; Fischer, E; Wüest, T; Stenner, F; Perani, A; Cohen, Leonard; Knuth, A; Divgi, C; Jäger, D; Scott, A M; Ritter, G; Old, L J; Renner, C (2009). Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. International Journal of Cancer, 125(1):115-123.

Torroella-Kouri, M; Silvera, R; Rodriguez, D; Caso, R; Shatry, A; Opiela, S; Ilkovitch, D; Schwendener, Reto A; Iragavarapu-Charyulu, V; Cardentey, Y; Strbo, N; Lopez, D M (2009). Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Research, 69(11):4800-4809.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Läubli, H; Borsig, L (2009). Heparins attenuate cancer metastasis: are selectins the link? Cancer Investigation, 27(5):474-481.

Jenal, Mathias; Trinh, Emmanuelle; Britschgi, Christian; Britschgi, Adrian; Roh, Vincent; Vorburger, Stephan A; Tobler, Andreas; Leprince, Dominique; Fey, Martin F; Helin, Kristian; Tschan, Mario P (2009). The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Molecular Cancer Research, 7(6):916-922.

Balamurugan, K; Luu, V D; Kaufmann, M R; Hofmann, V S; Boysen, G; Barth, S; Bordoli, M R; Stiehl, D P; Moch, H; Schraml, P; Wenger, R H; Camenisch, G (2009). Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene:1-12.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Thurneysen, C; Opitz, I; Kurtz, S; Weder, W; Stahel, R A; Felley-Bosco, E (2009). Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer, 64(2):140-147.

Carteni, G; Manegold, C; Martin Garcia, G; Siena, S; Zielinski, C C; Amadori, D; Liu, Y; Blatter, J; Visseren-Grul, C; Stahel, R (2009). Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer, 64(2):211-218.

Yuan, J; Ossendorf, C; Szatkowski, J P; Bronk, J T; Maran, A; Yaszemski, M; Bolander, M E; Sarkar, G; Fuchs, B (2009). Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer investigation, 27(4):435-42.

Zellweger, T; Günther, S; Zlobec, I; Savic, S; Sauter, G; Moch, H; Mattarelli, G; Eichenberger, T; Curschellas, E; Rüfenacht, H; Bachmann, A; Gasser, T C; Mihatsch, M J; Bubendorf, L (2009). Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. International Journal of Cancer, 124(9):2116-2123.

Dellas, A; Jundt, G; Sartorius, G; Schneider, M; Moch, H (2009). Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas. Clinical Cancer Research, 15(7):2456-2462.

Civenni, G; Sommer, L (2009). Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis. Seminars in Cancer Biology, 19(2):68-75.

Pedretti, M; Soltermann, A; Arni, S; Weder, W; Neri, D; Hillinger, S (2009). Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 64(1):28-33.

Navarini-Meury, A A; Conrad, C (2009). Melanoma and innate immunity - active inflammation or just erroneous attraction? melanoma as the source of leukocyte-attracting chemokines. Seminars in Cancer Biology, 16(2):84-91.

Seifert, H; Mohr, B; Thiede, C; Oelschlägel, U; Schäkel, U; Illmer, T; Soucek, S; Ehninger, G; Schaich, M; Study Alliance Leukemia (SAL) (2009). The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia, 23(4):656-663.

Glas, M; Happold, C; Rieger, J; Wiewrodt, D; Bähr, O; Steinbach, J P; Wick, W; Kortmann, R; Reifenberger, G; Weller, M; Herrlinger, U (2009). Long-term survival of glioblastoma patients treated with radiotherapy and lomustine plus temozolomide. Journal of Clinical Oncology, 27(8):1257-1261.

Bauer, S; Adrian, N; Siebenborn, U; Fadle, N; Plesko, M; Fischer, E; Wüest, T; Stenner, F; Mertens, J C; Knuth, A; Ritter, G; Old, L J; Renner, C (2009). Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. Cancer Immunity, 9(2):1-10.

Happold, C (2009). ACNU-based chemotherapy for recurrent glioma in the temozolomide era. Journal of Neuro-Oncology, 92(1):45-48.

von Minckwitz, G; Schwenkglenks, M; Skacel, T; Lyman, G H; Lopez Pousa, A; Bacon, P; Easton, V; Aapro, M S (2009). Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis. European Journal of Cancer, 45(4):608-617.

Knights, A J; Nuber, N; Thomson, C W; de la Rosa, O; Jäger, E; Tiercy, J M; van den Broek, Maries; Pascolo, S; Knuth, A; Zippelius, A (2009). Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients. Cancer Immunology, Immunotherapy, 58(3):325-338.

Boerma, E G; Siebert, R; Kluin, P M; Baudis, Michael (2009). Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia, 23(2):225-234.

Marinov, M; Ziogas, A; Pardo, O E; Tan, L T; Dhillon, T; Mauri, F A; Lane, H A; Lemoine, N R; Zangemeister-Wittke, U; Seckl, M J; Arcaro, A (2009). AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clinical Cancer Research, 15(4):1277-1287.

Rohrer Bley, Carla; Jochum, W; Orlowski, K; Furmanova, P; Vuong, V; McSheehy, P M; Pruschy, Martin (2009). Role of the microenvironment for radiosensitization by patupilone. Clinical Cancer Research, 15(4):1335-1342.

Menigatti, M; Truninger, K; Gebbers, J O; Marbet, U; Marra, Giancarlo; Schär, P (2009). Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene, 28(6):899-909.

Linnebank, M; Moskau, S; Jurgens, A; Simon, M; Semmler, A; Orlopp, K; Glasmacher, A; Bargart, C; Vogt-Schaden, M; Urbach, H; Schmidt-Wolf, I G; Pels, H; Schlegel, U (2009). Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro-Oncology, 11(1):2-8.

Gutwein, P; Schramme, A; Sinke, N; Abdel-Bakky, M S; Voss, B; Obermüller, N; Doberstein, K; Koziolek, M; Fritzsche, F; Johannsen, M; Jung, K; Schaider, H; Altevogt, P; Ludwig, A; Pfeilschifter, J; Kristiansen, G (2009). Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. European Journal of Cancer, 45(3):478-489.

Bazhin, A V; Dalke, C; Willner, N; Abschütz, O; Wildberger, H G H; Philippov, P P; Dummer, R; Graw, J; Hrabé de Angelis, M; Schadendorf, D; Umansky, V; Eichmüller, S B (2009). Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy. International Journal of Cancer, 124(1):140-149.

Haybaeck, J; Zeller, N; Wolf, M J; Weber, A; Wagner, U; Kurrer, M O; Bremer, J; Iezzi, G; Graf, R; Clavien, P A; Thimme, R; Blum, H; Nedospasov, S A; Zatloukal, K; Ramzan, M; Ciesek, S; Pietschmann, T; Marche, P N; Karin, M; Kopf, M; Browning, J L; Aguzzi, A; Heikenwalder, M (2009). A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell, 16(4):295-308.

Drögemüller, Cord; Becker, Doreen; Brunner, Adrian; Haase, Bianca; Kircher, Patrick R; Seeliger, Frank; Fehr, Michael; Baumann, Ulrich; Lindblad-Toh, Kerstin; Leeb, Tosso (2009). A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genetics, 5(7):e1000579.

Hitz, F; Martinelli, G; Zucca, E; von Moos, R; Mingrone, W; Simcock, M; Peterson, J; Cogliatti, S B; Bertoni, F; Zimmermann, D R; Ghielmini, M (2009). A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. Hematological Oncology, 27(3):154-159.

Zhang, H; Gao, S; De Geyter, C (2009). A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok. International Journal of Oncology, 34(4):1135-1138.

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Wick, W; Weller, M (2009). Adjuvant therapy. In: Von Deimling, A. Gliomas. Berlin Heidelberg: Springer, 141-153.

Bottomley, A; Coens, C; Suciu, S; Santinami, M; Kruit, W; Testori, A; Marsden, J; Punt, C; Salès, F; Gore, M; Mackie, R; Kusic, Z; Dummer, R; Patel, P; Schadendorf, D; Spatz, A; Keilholz, U; Eggermont, A (2009). Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of Clinical Oncology, 27(18):2916-2923.

Vasei, M; Modjtahedi, H; Ale-Booyeh, O; Mosallaei, A; Kajbafzadeh, A M; Shahriari, M; Ghaderi, A A; Soleymanpour, H; Kosari, F; Moch, H; Sauter, G (2009). Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer Genetics and Cytogenetics, 194(2):88-95.

Gramatzki, D; Pantazis, G; Schittenhelm, J; Tabatabai, G; Köhle, C; Wick, W; Schwarz, M; Weller, M; Tritschler, I (2009). Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene, 28(28):2593-2605.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Ruhstaller, T; von Moos, R; Rufibach, K; Ribi, K; Glaus, A; Spaeti, B; Koeberle, D; Mueller, U; Hoefliger, M; Hess, D; Boehme, C; Thuerlimann, B (2009). Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology, 76(2):142-148.

Oesch, S; Walter, D; Wachtel, M; Prêtre, Kathya; Salazar, M; Guzmán, M; Velasco, G; Schäfer, B W (2009). Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Molecular Cancer Therapeutics, 8(7):1838-1845.

Moormann, A M; Heller, K N; Chelimo, K; Embury, P; Ploutz-Snyder, R; Otieno, J A; Oduor, M; Münz, C; Rochford, R (2009). Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses. International Journal of Cancer, 124(7):1721-1726.

Maurer, G D; Tritschler, I; Adams, B; Tabatabai, G; Wick, W; Stupp, R; Weller, M (2009). Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro. Neuro-Oncology, 11(6):747-756.

Dedes, K J; Fink, D (2009). Clinical Presentation and Surgical Management of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30:31-37.

Fellay, J; Ge, D; Shianna, K V; Colombo, S; Ledergerber, B; Cirulli, E T; Urban, T J; Zhang, K; Gumbs, C E; Smith, J P; Castagna, A; Cozzi-Lepri, A; De Luca, A; Easterbrook, P; Günthard, H F; Mallal, S; Mussini, C; Dalmau, J; Martinez-Picado, J; Miro, J M; Obel, N; Wolinsky, S M; Martinson, J J; Detels, R; Margolick, J B; Jacobson, L P; Descombes, P; Antonarakis, S E; Beckmann, J S; O'Brien, S J; Letvin, N L; McMichael, A J; Haynes, B F; Carrington, M; Feng, S; Telenti, A; Goldstein, D B (2009). Common genetic variation and the control of HIV-1 in humans. PLoS Genetics, 5(12):e1000791.

Templeton, A; Marra, Giancarlo; Valtorta, E; Heinimann, K; Müller, H; Köberle, D; Gillessen, S (2009). Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial Cancer, 8(2):167-171.

Seçkin, D; Hofbauer, G F L (2009). Cutaneous lymphomas. In: The SCOPE. Skin Cancer after Organ Transplantation. United States: Springer, 343-351.

Sconocchia, Giuseppe; Spagnoli, Giulio C; Del Principe, Domenico; Ferrone, Soldano; Anselmi, Maurizio; Wongsena, Wachanan; Cervelli, Valerio; Schultz-Thater, Elke; Wyler, Stephen; Carafa, Vincenza; Moch, Holger; Terracciano, Luigi; Tornillo, Luigi (2009). Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia, 11(7):662-671.

Kempkensteffen, C; Fritzsche, F R; Johannsen, M; Weikert, S; Hinz, S; Dietel, M; Riener, M O; Moch, H; Jung, K; Krause, H; Miller, K; Kristiansen, G (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9:276.

Gallant, P (2009). Drosophila Myc. Advances in Cancer Research, 103(1):111-144.

Wyss, M; Hofer, S; Bruehlmeier, M; Hefti, M; Uhlmann, C; Bärtschi, E; Buettner, U W; Roelcke, U (2009). Early metabolic responses in temozolomide treated low-grade glioma patients. Journal of Neuro-Oncology, 95(1):87-93.

Pels, H; Juergens, A; Glasmacher, A; Schulz, H; Engert, A; Linnebank, M; Schackert, G; Reichmann, H; Kroschinsky, F; Vogt-Schaden, M; Egerer, G; Bode, U; Schaller, C; Lamprecht, M; Hau, P; Deckert, M; Fimmers, R; Bangard, C; Schmidt-Wolf, Ingo G H; Schlegel, U (2009). Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. Journal of Neuro-Oncology, 91(3):299-305.

Zwahlen, D R; Ruben, J D; Jones, P; Gagliardi, F; Millar, J L; Schneider, U (2009). Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology, Biology and Physics, 74(2):539-545.

Winkler, J; Martin-Killias, P; Plückthun, A; Zangemeister-Wittke, U (2009). EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins. Molecular Cancer Therapeutics, 8(9):2674-2683.

Riener, M O; Wild, P J; Soll, C; Knuth, A; Jin, B; Jungbluth, A; Hellerbrand, C; Clavien, P A; Moch, H; Jochum, W (2009). Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. International Journal of Cancer, 124(2):352-357.

Sørensen, K D; Wild, P J; Mortezavi, A; Adolf, K; Tørring, N; Heebøll, S; Ulhøi, B P; Ottosen, P; Sulser, T; Hermanns, T; Moch, H; Borre, M; Ørntoft, T F; Dyrskjøt, L (2009). Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 15(4):1400-1410.

Theissen, J; Boensch, M; Spitz, R; Betts, D; Stegmaier, S; Christiansen, H; Niggli, F; Schilling, F; Schwab, M; Simon, T; Westermann, F; Berthold, F; Hero, B (2009). Heterogeneity of the MYCN oncogene in neuroblastoma. Clinical Cancer Research, 15(6):2085-2090.

Lehmann, A; Denkert, C; Budczies, J; Buckendahl, A C; Darb-Esfahani, S; Noske, A; Müller, B M; Bahra, M; Neuhaus, P; Dietel, M; Kristiansen, G; Weichert, W (2009). High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo. BMC Cancer, 9:395.

Varga, Z; Mallon, E (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Breast Disease, 30:15-19.

Witt, H; Hajdin, K; Iljin, K; Greiner, O; Niggli, F K; Schäfer, B W; Bernasconi, M (2009). Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1. International Journal of Cancer, 124(9):2026-2032.

Cho, H; Koto, M; Riesterer, O; Molkentine, D P; Giri, U; Milas, L; Story, M D; Ha, C S; Raju, U (2009). Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study. Anticancer Research, 29(11):4409-4415.

Stahel, R A; Weder, W (2009). Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach? Current Opinion in Oncology, 21(2):124-130.

Metzger, R; Vallböhmer, D; Müller-Tidow, C; Higashi, H; Bollschweiler, E; Warnecke-Eberz, U; Brabender, J; Baldus, S E; Xi, H; Berdel, W E; Serve, H; Hoelscher, A H; Schneider, P M (2009). Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Anticancer Research, 29(4):1157-1162.

Varga, Z; Mallon, E (2009). Infiltrating Lobular Carcinoma: Four Case Illustrations. Breast Disease, 30:57-61.

Dubois, L; Magagnin, M G; Cleven, A H G; Weppler, S A; Grenacher, B; Landuyt, W; Lieuwes, N; Lambin, P; Gorr, T A; Koritzinsky, M; Wouters, B G (2009). Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance. International Journal of Radiation Oncology, Biology and Physics, 73(4):1219-1227.

von Hoff, K; Hinkes, B; Gerber, N U; Deinlein, F; Mittler, U; Urban, C; Benesch, M; Warmuth-Metz, M; Soerensen, N; Zwiener, I; Goette, H; Schlegel, P G; Pietsch, T; Kortmann, R D; Kuehl, J; Rutkowski, S (2009). Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. European Journal of Cancer, 45(7):1209-1217.

Luu, V D; Boysen, G; Struckmann, K; Casagrande, S; von Teichman, A; Wild, P J; Sulser, T; Schraml, P; Moch, H (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clinical Cancer Research, 15(10):3297-3304.

Winklmeier, A; Poser, I; Hoek, K S; Bosserhoff, A K (2009). Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer, 9:52.

Orgaz, J L; Ladhani, O; Hoek, K S; Fernández-Barral, A; Mihic, D; Aguilera, O; Seftor, E A; Bernad, A; Rodríguez-Peralto, J L; Hendrix, M J C; Volpert, O V; Jiménez, B (2009). Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene, 28(47):4147-4161.

Zenhäusern, R; Von Rohr, A; Rufibach, K; Solenthaler, Max; Meyer-Monard, S; Gratwohl, A; Hess, U; Bargetzi, M J; Kovacsovic, T; Leoncini, L; Tobler, A (2009). Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia - a multicentre trial SAKK 32/95. Leukemia and Lymphoma, 50(1):133-136.

Smith, K A; Meisenburg, B L; Tam, V L; Pagarigan, R R; Wong, R; Joea, D K; Lantzy, L; Carrillo, M A; Gross, T M; Malyankar, U M; Chiang, C S; Da Silva, D M; Kündig, T M; Kast, W M; Qiu, Z; Bot, A (2009). Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clinical Cancer Research, 15(19):6167-6176.

Ghadjar, P; Blank-Liss, W; Simcock, M; Hegyi, I; Beer, K T; Moch, H; Aebersold, D M; Zimmer, Y (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical and Experimental Metastasis, 26(7):809-815.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Zwahlen, D; Jezioranski, J; Chan, P; Haider, M A; Cho, Y B; Yeung, I; Levin, W; Manchul, L; Fyles, A; Milosevic, M (2009). Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. International Journal of Radiation Oncology, Biology and Physics, 74(4):1157-1164.

Stahel, R A; Felley-Bosco, E; Opitz, I; Weder, W (2009). Malignant pleural mesothelioma. Future Oncology, 5(3):391-402.

Michael, M; Garzoli, E; Reiner, C S (2009). Mammography, Sonography and MRI for Detection and Characterization of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30 / 200:21-30.

Hoffmann, A C; Vallböhmer, D; Prenzel, K; Metzger, R; Heitmann, M; Neiss, S; Ling, F; Hölscher, A H; Schneider, P M; Brabender, J (2009). Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. Journal of Cancer Research and Clinical Oncology, 135(9):1231-1237.

Tritschler, I; Gramatzki, D; Capper, D; Mittelbronn, M; Meyermann, R; Saharinen, J; Wick, W; Keski-Oja, J; Weller, M (2009). Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells. International Journal of Cancer, 125(3):530-540.

Wick, W; Platten, M; Weller, M (2009). New (alternative) temozolomide regimens for the treatment of glioma. Neuro-Oncology, 11(1):69-79.

Meyer, C; Kowarz, E; Hofmann, J; Renneville, A; Zuna, J; Trka, J; Ben Abdelali, R; Macintyre, E; De Braekeleer, E; De Braekeleer, M; Delabesse, E; de Oliveira, M P; Cavé, H; Clappier, E; van Dongen, J J M; Balgobind, B V; van den Heuvel-Eibrink, M M; Beverloo, H B; Panzer-Grümayer, R; Teigler-Schlegel, A; Harbott, J; Kjeldsen, E; Schnittger, S; Koehl, U; Gruhn, B; Heidenreich, O; Chan, L C; Yip, S F; Krzywinski, M; Eckert, C; Möricke, A; Schrappe, M; Alonso, C N; Schäfer, B W; Krauter, J; Lee, D A; Zur Stadt, U; Te Kronnie, G; Sutton, R; Izraeli, S; Trakhtenbrot, L; Lo Nigro, L; Tsaur, G; Fechina, L; Szczepanski, T; Strehl, S; Ilencikova, D; Molkentin, M; Burmeister, T; Dingermann, T; Klingebiel, T; Marschalek, R (2009). New insights to the MLL recombinome of acute leukemias. Leukemia, 23(8):1490-1499.

Otto, W; Denzinger, S; Bertz, S; Gaumann, A; Wild, P J; Hartmann, A; Stoehr, R (2009). No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer. International Journal of Cancer, 125(9):2205-2208.

Wehrli, L A; Braun, Julia; Buetti, L N; Hagleitner, N; Hengartner, H; Kühne, T; Lüer, S; Ozsahin, H; Beck Popovic, M; Niggli, F K; Betts, D R; Bourquin, J P (2009). Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 189(1):29-36.

Dahl, E; En-Nia, A; Wiesmann, F; Krings, R; Djudjaj, S; Breuer, E; Fuchs, T; Wild, P J; Hartmann, A; Dunn, S E; Mertens, P R (2009). Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer, 9:410.

Menke, M N; Feke, G T; McMeel, J W; Treon, S P (2009). Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia. Clinical Lymphoma and Myeloma, 9(1):100-103.

Pfister, S; Remke, M; Benner, A; Mendrzyk, F; Toedt, G; Felsberg, J; Wittmann, A; Devens, F; Gerber, N U; Joos, S; Kulozik, A; Reifenberger, G; Rutkowski, S; Wiestler, O D; Radlwimmer, B; Scheurlen, W; Lichter, P; Korshunov, A (2009). Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. Journal of Clinical Oncology, 27(10):1627-1636.

Beroukhim, R; Brunet, J P; Di Napoli, A; Mertz, K D; Seeley, A; Pires, M M; Linhart, D; Worrell, R A; Moch, H; Rubin, M A; Sellers, W R; Meyerson, M; Linehan, W M; Kaelin, W G; Signoretti, S (2009). Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Research, 69(11):4674-4681.

Schneider, D; Monoranu, C M; Huang, B; Rutkowski, S; Gerber, N U; Krauss, J; Puppe, B; Roggendorf, W (2009). Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis. Cancer Genetics and Cytogenetics, 191(2):90-96.

Veeck, J; Wild, P J; Fuchs, T; Schüffler, P J; Hartmann, A; Knüchel, R; Dahl, E (2009). Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer, 9:217.

von Bueren, A O; Shalaby, T; Oehler-Jänne, C; Arnold, L; Stearns, D; Eberhart, C G; Arcaro, A; Pruschy, M; Grotzer, M A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer, 9:10.

Suehiro, M; Burgman, P; Carlin, S; Burke, S; Yang, G; Ouerfelli, O; Oehler-Janne, C; O'Donoghue, J; Ling, C; Humm, J (2009). Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker? Nuclear Medicine and Biology, 36(5):477-487.

Bug, S; Dürig, J; Oyen, F; Klein-Hitpass, L; Martin-Subero, J I; Harder, L; Baudis, Michael; Arnold, N; Kordes, U; Dührsen, U; Schneppenheim, R; Siebert, R (2009). Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. Cancer Genetics and Cytogenetics, 192(1):44-47.

Mallon, E; Varga, Z (2009). Relapse of Invasive Lobular Carcinoma. Breast Disease, 30:53-56.

Roth, P; Kissel, M; Herrmann, C; Eisele, G; Leban, J; Weller, M; Schmidt, F (2009). SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo. Clinical Cancer Research, 15(21):6609-6618.

Wurzenberger, Cornelia; Koelzer, Viktor H; Schreiber, Susanne; Anz, David; Vollmar, Angelika M; Schnurr, Max; Endres, Stefan; Bourquin, Carole (2009). Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Cancer Immunology, Immunotherapy, 58(6):901-913.

Almanzar, G; Olkhanud, P B; Bodogai, M; Dell'agnola, C; Baatar, D; Hewitt, S M; Ghimenton, C; Tummala, M K; Weeraratna, A T; Hoek, K S; Kouprina, N; Larionov, V; Biragyn, A (2009). Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clinical Cancer Research, 15(6):1954-1963.

Winkfield, K M; Linsenmeier, C; Yock, T I; Grant, P E; Yeap, B Y; Butler, W E; Tarbell, N J (2009). Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. International Journal of Radiation Oncology, Biology and Physics, 73(3):716-721.

Grotzer, M A; Castelletti, D; Fiaschetti, G; Shalaby, T; Arcaro, A (2009). Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Current Cancer Drug Targets, 9(2):176-188.

Flahaut, M; Meier, R; Coulon, A; Nardou, K A; Niggli, F K; Martinet, D; Beckmann, J S; Joseph, J-M; Mühlethaler-Mottet, A; Gross, N (2009). The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene, 28(23):2245-2256.

Savic, S; Zlobec, I; Thalmann, G N; Engeler, D; Schmauss, M; Lehmann, K; Mattarelli, G; Eichenberger, T; Dalquen, P; Spieler, P; Schoenegg, R; Gasser, T C; Sulser, T; Forster, T; Zellweger, T; Casella, R; Bubendorf, L (2009). The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. International Journal of Cancer, 124(12):2899-2904.

Menigatti, M; Cattaneo, E; Sabates-Bellver, J; Ilinsky, V V; Went, P; Buffoli, F; Marquez, V E; Jiricny, J; Marra, Giancarlo (2009). The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Molecular Cancer Therapeutics, 8:124.

Grimminger, P; Ling, F C; Neiss, S; Vallböhmer, D; Lurje, G; Schneider, P M; Hölscher, A H; Metzger, R; Brabender, J (2009). The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer. Anticancer Research, 29(4):1281-1286.

Westwood, J A; Haynes, N M; Sharkey, J; McLaughlin, N; Pegram, H J; Schwendener, R A; Smyth, M J; Darcy, P K; Kershaw, M H (2009). Toll-like receptor triggering and T-cell costimulation induce potent antitumor immunity in mice. Clinical Cancer Research, 15(24):7624-7633.

Rutkowski, S; Gerber, N U; von Hoff, K; Gnekow, A; Bode, U; Graf, N; et al (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology, 11(2):201-210.

Schmitt, A M; Schmid, S; Rudolph, T; Anlauf, M; Prinz, C; Klöppel, G; Moch, H; Heitz, P U; Komminoth, P; Perren, A (2009). VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocrine-Related Cancer, 16(4):1219-1227.

2008

Dissanayake, S K; Olkhanud, P B; O'Connell, M P; Carter, A; French, A D; Camilli, T C; Emeche, C D; Hewitt, K J; Rosenthal, D T; Leotlela, P D; Wade, M S; Yang, S W; Brant, L; Nickoloff, B J; Messina, J L; Biragyn, A; Hoek, K S; Taub, D D; Longo, D L; Sondak, V K; Hewitt, S M; Weeraratna, A T (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Research, 68(24):10205-10214.

Soltermann, A; Tischler, V; Arbogast, S; Braun, Julia; Probst-Hensch, Nicole; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Strelau, J; Schmeer, C; Peterziel, H; Sackmann, T; Herold-Mende, C; Steiner, Hans; Weller, M; Unsicker, K (2008). Expression and putative functions of GDF-15, a member of the TGF-β superfamily, in human glioma and glioblastoma cell lines. Cancer Letters, 270(1):30-39.

Held, G; Neumann, F; Sturm, C; Kaestner, L; Dauth, N; de Bruijn, D R; Renner, C; Lipp, P; Pfreundschuh, M (2008). Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells. International Journal of Cancer, 123(8):1841-1847.

Wirthner, R; Wrann, S; Balamurugan, K; Wenger, R H; Stiehl, D P (2008). Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1-alpha-deficient mouse embryonic fibroblasts. Carcinogenesis, 29(12):2306-2316.

Schuler, P; Contassot, E; Irla, M; Hugues, S; Preynat-Seauve, O; Beermann, F; Donda, A; French, L E; Huard, B (2008). Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells. Cancer Research, 68(20):8410-8418.

Feder-Mengus, C; Wyler, S; Hudolin, T; Ruszat, R; Bubendorf, L; Chiarugi, A; Pittelli, M; Weber, Walter P; Bachmann, A; Gasser, T C; Sulser, T; Heberer, M; Spagnoli, G C; Provenzano, M (2008). High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. European Journal of Cancer, 44(15):2266-2275.

Kurzwelly, D; Müller, C A; Korfel, A; Thiel, E; Linnebank, M; Weller, M; Herrlinger, U (2008). Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients. Journal of Neuro-Oncology, 90(1):53-55.

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Hauschild, A; Dummer, R; Ugurel, S; Kaehler, K C; Egberts, F; Fink, W; Both-Skalsky, J; Laetsch, B; Schadendorf, D (2008). Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study. Cancer, 113(6):1404-1411.

Stenner, F; Liewen, H; Zweifel, M; Weber, A; Tchinda, J; Bode, B; Samaras, P; Bauer, S; Knuth, A; Renner, C (2008). Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo. Cancer Science, 99(9):1847-1852.

Dooley, Kimberly A; Fraenkel, Paula G; Langer, Nathaniel B; Schmid, Bettina; Davidson, Alan J; Weber, Gerhard; Chiang, Ken; Foott, Helen; Dwyer, Caitlin; Wingert, Rebecca A; Zhou, Yi; Paw, Barry H; Zon, Leonard I (2008). montalcino, A zebrafish model for variegate porphyria. Experimental Hematology, 36(9):1132-1142.

Bernhard, J; Dietrich, D; Scheithauer, W; Gerber, D; Bodoky, G; Ruhstaller, T; Glimelius, B; Bajetta, E; Schüller, J; Saletti, P; Bauer, J; Figer, A; Pestalozzi, B C; Köhne, C H; Mingrone, W; Stemmer, S M; Tàmas, K; Kornek, G V; Koeberle, D; Herrmann, R (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001. Journal of Clinical Oncology, 26(22):3695-3701.

Perez, D; Herrmann, T; Jungbluth, A A; Samartzis, P; Spagnoli, G; Demartines, N; Clavien, P A; Marino, S; Seifert, B; Jaeger, D (2008). Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence. International Journal of Cancer, 123(7):1551-1555.

Benz, R; Goede, J S; Parlier, V; Mühlematter, D; Jotterand, M; Fehr, J (2008). G-CSF-induced remission in two cases of acute myeloid leukemia. Leukemia Research, 32(7):1148-1152.

Shebzukhov, Y V; Lavrik, I N; Karbach, J; Khlgatian, S V; Koroleva, B P; Belousov, P V; Kashkin, K N; Knuth, A; Jager, E; Chi, N W; Kuprash, D V; Nedospasov, S A (2008). Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients. Cancer Immunology, Immunotherapy, 57(6):871-881.

Golling, P; Cozzio, A; Dummer, R; French, L; Kempf, W (2008). Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leukemia and Lymphoma, 49(6):1094-1103.

Rosell, R; Manegold, C; Moran, T; Garrido, P; Blanco, R; Lianes, P; Stahel, R; Trigo, J M; Wei, J; Taron, M (2008). Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer, 9(Supplement):S76-S82.

Sarkaria, J N; Kitange, G J; James, C D; Plummer, R; Calvert, H; Weller, M; Wick, W (2008). Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clinical Cancer Research, 14(10):2900-2908.

Amstutz, R; Wachtel, M; Troxler, H; Kleinert, P; Ebauer, M; Haneke, T; Oehler-Jänne, C; Fabbro, D; Niggli, F K; Schäfer, B W (2008). Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities. Cancer Research, 68(10):3767-3776.

Schwab, M; Zanger, U M; Marx, C; Schaeffeler, E; Klein, K; Dippon, J; Kerb, R; Blievernicht, J; Fischer, J; Hofmann, U; Bokemeyer, C; Eichelbaum, M (2008). Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group. Journal of Clinical Oncology, 26(13):2131-2138.

Maga, G; Hübscher, U (2008). Repair and Translesion DNA Polymerases as Anticancer Drug Targets. Anti-Cancer Agents in Medicinal Chemistry, 8(4):431-447.

Waibel, R; Treichler, H; Schaefer, N G; van Staveren, D R; Mundwiler, S; Kunze, S; Küenzi, M; Alberto, R; Nüesch, J; Knuth, A; Moch, H; Schibli, R; Schubiger, P A (2008). New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Research, 68(8):2904-2911.

Fujimoto, Ryo; Kinoshita, Yuki; Kawabe, Akira; Kinoshita, Tetsu; Takashima, Kazuya; Nordborg, Magnus; Nasrallah, Mikhail E; Shimizu, Kentaro K; Kudoh, Hiroshi; Kakutani, Tetsuji (2008). Evolution and control of imprinted FWA genes in the genus Arabidopsis. PLoS Genetics, 4(4)::e1000048..

Hofbauer, G F L; Baur, T; Bonnet, M C; Tartour, E; Burg, G; Berinstein, N L; Dummer, R (2008). Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Research, 18(2):104-111.

Garbe, C; Hauschild, A; Volkenandt, M; Schadendorf, D; Stolz, W; Reinhold, U; Kortmann, R D; Kettelhack, C; Frerich, B; Keilholz, U; Dummer, R; Sebastian, G; Tilgen, W; Schuler, G; Mackensen, A; Kaufmann, R (2008). Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Research, 18(2):152-160.

Dantonello, T M; Int-Veen, C; Winkler, P; Leuschner, I; Schuck, A; Schmidt, B F; Lochbuehler, H; Kirsch, S; Hallmen, E; Veit-Friedrich, I; Bielack, S S; Niggli, F; Kazanowska, B; Ladenstein, R; Wiebe, T; Klingebiel, T; Treuner, J; Koscielniak, E (2008). Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. Journal of Clinical Oncology, 26(3):406-413.

Tinguely, M; Jenni, B; Knights, A; Lopes, B; Korol, D; Rousson, V; Curioni Fontecedro, A; Cogliatti, S B; Bittermann, A G; Schmid, U; Dommann-Scherrer, C; Maurer, R; Renner, C; Probst-Hensch, N M; Moch, H; Knuth, A; Zippelius, A (2008). MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Science, 99(4):720-725.

von Moos, R; Thuerlimann, B J K; Aapro, M; Rayson, D; Harrold, K; Sehouli, J; Scotte, F; Lorusso, D; Dummer, R; Lacouture, M E; Lademann, J; Hauschild, A (2008). Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts. European Journal of Cancer, 44(6):781-790.

Viale, G; Regan, M M; Maiorano, E; Stahel, R A (2008). Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Journal of Clinical Oncology, 26(9):1404-1410.

Al-Batran, S E; Hartmann, J T; Probst, S; Schmalenberg, H; Hollerbach, S; Hofheinz, R; Rethwisch, V; Seipelt, G; Homann, N; Wilhelm, G; Schuch, G; Stoehlmacher, J; Derigs, H G; Hegewisch-Becker, S; Grossmann, J; Pauligk, C; Atmaca, A; Bokemeyer, C; Knuth, A; Jäger, E (2008). Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology, 26(9):1435-1442.

Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, Lisa; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008). MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, 22(8):1646-1648.

Menvielle, G; Kunst, A E; Stirbu, I; Strand, B H; Borrell, C; Regidor, E; Leclerc, A; Esnaola, S; Bopp, M; Lundberg, O; Artnik, B; Costa, G; Deboosere, P; Martikainen, P; Mackenbach, J P (2008). Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. British Journal of Cancer, 98(5):1012-1019.

Szucs, T D (2008). Can we afford the war on cancer? Onkologie, 31(3):81.

Walters, D K; Steinmann, P; Langsam, B; Schmutz, S; Born, W; Fuchs, B (2008). Identification of potential chemoresistance genes in osteosarcoma. Anticancer Research, 28(2A):673-679.

Dummer, R; Hauschild, A; Becker, J C; Grob, J J; Schadendorf, D; Tebbs, V; Skalsky, J; Kaehler, K C; Moosbauer, S; Clark, R; Meng, T C; Urosevic, M (2008). An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma. Clinical Cancer Research, 14(3):856-864.

Garbe, C; Hauschild, A; Volkenandt, M; Schadendorf, D; Stolz, W; Reinhold, U; Kortmann, R D; Kettelhack, C; Frerich, B; Keilholz, U; Dummer, R; Sebastian, G; Tilgen, W; Schuler, G; Mackensen, A; Kaufmann, R (2008). Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Research, 18(1):61-67.

Urosevic, M; Dummer, R (2008). Human leukocyte antigen-G and cancer immunoediting. Cancer Research, 68(3):627-630.

Hoek, K S; Eichhoff, O M; Schlegel, N C; Döbbeling, U; Kobert, N; Schaerer, L; Hemmi, S; Dummer, R (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Research, 68(3):650-656.

Lin, W M; Baker, A C; Beroukhim, R; Winckler, W; Feng, W; Marmion, J M; Laine, E; Greulich, H; Tseng, H; Gates, C; Hodi, F S; Dranoff, G; Sellers, W R; Thomas, R K; Meyerson, M; Golub, T R; Dummer, R; Herlyn, M; Getz, G; Garraway, L A (2008). Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Research, 68(3):664-673.

Elser, M; Borsig, L; Hassa, P O; Erener, S; Messner, S; Valovka, T; Keller, S; Gassmann, M; Hottiger, M O (2008). Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. Molecular Cancer Research, 6(2):282-290.

Weide, B; Carralot, J P; Reese, A; Scheel, B; Eigentler, T K; Hoerr, I; Rammensee, H G; Garbe, C; Pascolo, S (2008). Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. Journal of Immunotherapy, 31(2):180-188.

Husmann, K; Muff, R; Bolander, M E; Sarkar, G; Born, W; Fuchs, B (2008). Cathepsins and osteosarcoma: Expression analysis identifies Cathepsin K as an indicator of metastasis. Molecular Carcinogenesis, 47(1):66-73.

Betts, D R; Stanchescu, R; Niggli, F K; Cohen, N; Rechavi, G; Amariglio, N; Trakhtenbrot, L (2008). SKY reveals a high frequency of unbalanced translocations involving chromosome 6 in t(12;21)-positive acute lymphoblastic leukemia. Leukemia Research, 32(1):39-43.

Wick, W; Stupp, P; Beule, A C; Bromberg, J; Wick, A; Ernemann, U; Platten, M; Marosi, C; Mason, W P; van den Bent, M; Weller, M; Rorden, C; Karnath, H O (2008). A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro-Oncology, 10(6):1019-1024.

Fritzsche, F R; Wassermann, K; Jung, M; Tölle, A; Kristiansen, I; Lein, M; Johannsen, M; Dietel, M; Jung, K; Kristiansen, G (2008). ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer, 8:179.

Riener, M O; Bawohl, M; Clavien, P A; Jochum, W (2008). Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver. British Journal of Cancer, 99(5):836.

Happold, C; Ernemann, U; Roth, P; Wick, W; Weller, M; Schmidt, F (2008). Anticoagulation for radiation-induced neurotoxicity revisited. Journal of Neuro-Oncology, 90(3):357-362.

Tandon, R; Cattori, V; Pepin, A C; Riond, Barbara; Meli, Marina L; McDonald, M; Doherr, M G; Lutz, H; Hofmann-Lehmann, Regina (2008). Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats. Virus Research, 135(1):136-143.

Mertz, K D; Demichelis, F; Sboner, A; Hirsch, M S; Cin, P D; Struckmann, K; Storz, M; Scherrer, S; Schmid, D M; Strebel, R T; Probst-Hensch, N M; Gerstein, M; Moch, H; Rubin, M A (2008). Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International Journal of Cancer, 123(3):569-576.

Weller, M; Yung, W K A (2008). Bevacizumab--news from the fast lane? Neuro-Oncology, 10(5):647.

Fritzsche, F R; Oelrich, B; Johannsen, M; Kristiansen, I; Moch, H; Jung, K; Kristiansen, G (2008). Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clinical Cancer Research, 14(21):7035-7042.

Oehler-Jänne, C; Taverna, C; Stanek, N; Negretti, L; Lütolf, U M; Ciernik, I F (2008). Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study. Hematological Oncology, 26(2):82-90.

Hegi, M E; Liu, L; Herman, J G; Stupp, R; Wick, W; Weller, M; Mehta, M P; Gilbert, M R (2008). Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. Journal of Clinical Oncology, 26(25):4189-4199.

Sassen, Andrea; Rochon, Justine; Wild, Peter; Hartmann, Arndt; Hofstaedter, Ferdinand; Schwarz, Stephan; Brockhoff, Gero (2008). Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Research, 10:R2.

Sedic, M; Poznic, M; Gehrig, P; Scott, M; Schlapbach, R; Hranjec, M; Karminski-Zamola, G; Pavelic, K; Kraljevic Pavelic, S (2008). Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-alpha]quinoline in colon cancer cells depending on their p53 status. Molecular Cancer Therapeutics, 7(7):2121-2132.

Zhao, J; Leonard, C; Gemsenjäger, E; Heitz, P U; Moch, H; Odermatt, B (2008). Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Oncology Reports, 19(2):329-337.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Perner, Sven; Wagner, Patrick L; Demichelis, Francesca; Mehra, Rohit; LaFargue, Christopher J; Moss, Benjamin J; Arbogast, Stefanie; Soltermann, Alex; Weder, Walter; Giordano, Thomas J; Beer, David G; Rickman, David S; Chinnaiyan, Arul M; Moch, Holger; Rubin, Mark A (2008). EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia, 10(3):298-302.

Zwahlen, D R; Martin, J M; Millar, J L; Schneider, U (2008). Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. International Journal of Radiation Oncology, Biology and Physics, 70(3):853-858.

Bracci, L; Schumacher, R; Provenzano, M; Adamina, M; Rosenthal, R; Groeper, C; Zajac, P; Iezzi, G; Proietti, E; Belardelli, F; Spagnoli, G C (2008). Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering. Journal of Immunotherapy, 31(5):466-474.

Templin, C; Kotlarz, D; Rathinam, C; Rudolph, C; Schätzlein, S; Ramireddy, K; Rudolph, K L; Schlegelberger, B; Klein, C; Drexler, H (2008). Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Experimental Hematology, 36(2):204-215.

Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25.

Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.

Haugen, A C; Goel, A; Yamada, K; Marra, Giancarlo; Nguyen, T P; Nagasaka, T; Kanazawa, S; Koike, J; Kikuchi, Y; Zhong, X; Arita, M; Shibuya, K; Oshimura, M; Hemmi, H; Boland, C R; Koi, M (2008). Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer. Cancer Research, 68(20):8465-8472.

Dip, R; Lenz, S; Antignac, J P; Le Bizec, B; Gmuender, H; Naegeli, H (2008). Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocrine-Related Cancer, 15(1):161-173.

Reschke, M; Mihic-Probst, D; van der Horst, E H; Knyazev, P; Wild, P J; Hutterer, M; Meyer, S; Dummer, R; Moch, H; Ullrich, A (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16):5188-5197.

Oehler-Jänne, C; Huguet, F; Provencher, S; Seifert, Burkhardt; Negretti, L; Riener, M O; Bonet, M; Allal, A S; Ciernik, I F (2008). HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. Journal of Clinical Oncology, 26(15):2550-2557.

Pestalozzi, B C; Gruttadauria, S; Clavien, P A (2008). Hepatic arterial infusion: the beginning of the combination era. Journal of Clinical Oncology, 26(13):2231-2232.

Cairo, S; Armengol, C; De Reyniès, A; Wei, Y; Thomas, E; Renard, C-A; Goga, A; Balakrishnan, A; Semeraro, M; Gresh, L; Pontoglio, M; Strick-Marchand, H; Levillayer, F; Nouet, Y; Rickman, D; Gauthier, F; Branchereau, S; Brugières, L; Laithier, V; Bouvier, R; Boman, F; Basso, G; Michiels, J-F; Hofman, P; Arbez-Gindre, F; Jouan, H; Rousselet-Chapeau, M-C; Berrebi, D; Marcellin, L; Plenat, F; Zachar, D; Joubert, M; Selves, J; Pasquier, D; Bioulac-Sage, P; Grotzer, M; Childs, M; Fabre, M; Buendia, M-A (2008). Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell, 14(6):471-484.

Weichert, W; Röske, A; Gekeler, V; Beckers, T; Stephan, C; Jung, K; Fritzsche, F R; Niesporek, S; Denkert, C; Dietel, M; Kristiansen, G (2008). Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. British Journal of Cancer, 98(3):604-610.

Münz, C; Moormann, A (2008). Immune escape by Epstein-Barr virus associated malignancies. Seminars in Cancer Biology, 18(6):381-387.

Brunhuber, T; Haybaeck, J; Schäfer, G; Mikuz, G; Langhoff, E; Saeland, S; Lebecque, S; Romani, N; Obrist, P (2008). Immunohistochemical tracking of an immune response in mammary Paget's disease. Cancer Letters, 272(2):206-220.

Samaras, P; Dold, S; Braun, Julia; Kestenholz, P; Breitenstein, S; Imhof, A; Renner, C; Stenner-Liewen, F; Pestalozzi, B C (2008). Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology, 74(3-4):237-244.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Muntean, A; Bergsträsser, E; Diepold, M; Niggli, F K; Betts, D R (2008). Karyotypic characterization of infant embryonal rhabdomyosarcoma. Cancer Genetics and Cytogenetics, 180(2):145-148.

Flohr, T; Schrauder, A; Cazzaniga, G; Panzer-Grümayer, R; van der Velden, V; Fischer, S; Stanulla, M; Basso, G; Niggli, F K; Schäfer, B W; Sutton, R; Koehler, R; Zimmermann, M; Valsecchi, M G; Gadner, H; Masera, G; Schrappe, M; van Dongen, J J M; Biondi, A; Bartram, C R (2008). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22(4):771-782.

Dahm, F; Bielawska, A; Nocito, A; Georgiev, P; Szulc, Z M; Bielawski, J; Jochum, W; Dindo, D; Hannun, Y A; Clavien, P A (2008). Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice. British Journal of Cancer, 98(1):98-105.

Harbeck, N; Nimmrich, I; Hartmann, A; Ross, J S; Cufer, T; Grützmann, R; Kristiansen, G; Paradiso, A; Hartmann, O; Margossian, A; Martens, J; Schwope, I; Lukas, A; Müller, V; Milde-Langosch, K; Nährig, J; Foekens, J; Maier, S; Schmitt, M; Lesche, R (2008). Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. Journal of Clinical Oncology, 26(31):5036-5042.

Huang, J; Grotzer, M A; Watanabe, T; Hewer, E; Pietsch, T; Rutkowski, S; Ohgaki, H (2008). Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clinical Cancer Research, 14(13):4053-4058.

Soltermann, A; Ossola, R; Kilgus-Hawelski, S; von Eckardstein, A; Suter, T; Aebersold, R; Moch, H (2008). N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer, 114(2):124-133.

Kohler, Georg; Heinle, A (2008). Nation. In: Gosepath, S; Hinsch, W; Rössler, B. Handbuch der Politischen Philosophie und Sozialphilosophie. Berlin, 875-880.

Gluz, O; Wild, P; Meiler, R; Diallo-Danebrock, R; Ting, E; Mohrmann, S; Schuett, G; Dahl, E; Fuchs, T; Herr, A; Gaumann, A; Frick, M; Poremba, C; Nitz, U A; Hartmann, A (2008). Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. International Journal of Cancer, 123(6):1433-1438.

Reinhard, H; Schmidt, A; Furtwängler, R; Leuschner, I; Rübe, C; Von Schweinitz, D; Zoubek, A; Niggli, F; Graf, N (2008). Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies. Oncology Reports, 20(2):463-467.

Heller, K N; Arrey, F; Steinherz, P; Portlock, C; Chadburn, A; Kelly, K; Münz, C (2008). Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. International Journal of Cancer, 123(12):2824-2831.

Studer, G M; Glanzmann, C (2008). Patterns of Failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385). International Journal of Radiation Oncology, Biology and Physics, 72(4):1271-1272.

Toubaji, A; Achtar, M; Provenzano, M; Herrin, V E; Behrens, R; Hamilton, M; Bernstein, S; Venzon, D; Gause, B; Marincola, F; Khleif, S N (2008). Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers. Cancer Immunology, Immunotherapy, 57(9):1413-1420.

Arcaro, K F; Anderton, D L (2008). Potential of using breast milk as a tool to study breast cancer and breast cancer risk. Future Oncology, 4(5):595-597.

Glas, M; Rasch, K; Wiewrodt, D; Weller, M; Herrlinger, U (2008). Procarbazine and CCNU as initial treatment in gliomatosis cerebri. Oncology, 75(3-4):182-185.

Jeon, B H; Jang, C; Han, J; Kataru, R P; Piao, L; Jung, K; Hye, Ji Cha; Schwendener, Reto A; Kyu, Yun Jang; Kim, K S; Alitalo, K; Koh, G Y (2008). Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Research, 68(4):1100-9.

Viale, G; Giobbie-Hurder, A; Regan, M M; Stahel, R A (2008). Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of Clinical Oncology, 26(34):5569-5575.

Heinrich, S; Pestalozzi, B C; Schäfer, M; Weber, A; Bauerfeind, P; Knuth, A; Clavien, P A (2008). Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology, 26(15):2526-2531.

Riener, M O; Bawohl, M; Clavien, P A; Jochum, W (2008). Rare PIK3CA hotspot mutations in carcinomas of the biliary tract. Genes, Chromosomes & Cancer, 47(5):363-367.

Riesterer, O; Gmür, J; Lütolf, U (2008). Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis. Onkologie, 31(6):325-327.

Strasser, F; Lutz, Thomas A; Maeder, M T; Thuerlimann, B; Bueche, D; Tschöp, M; Kaufmann, K; Holst, B; Brändle, M; von Moos, R; Demmer, R; Cerny, T (2008). Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. British Journal of Cancer, 98:300-308.

Nocito, A; Dahm, F; Jochum, W; Jang, J H; Georgiev, P; Bader, M; Graf, R; Clavien, P A (2008). Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Research, 68(13):5152-5158.

von Garnier, C; Kochuparackal, S; Miedinger, D; Leuppi, J D; Tamm, M; Battegay, E; Zeller, A (2008). Smoking cessation advice: Swiss physicians lack training. Cancer Detection and Prevention, 32(3):209-214.

Garbrecht, N; Anlauf, M; Schmitt, A; Henopp, T; Sipos, B; Raffel, A; Eisenberger, C F; Knoefel, W T; Pavel, M; Fottner, C; Musholt, T J; Rinke, A; Arnold, R; Berndt, U; Plöckinger, U; Wiedenmann, B; Moch, H; Heitz, P U; Komminoth, P; Perren, A; Klöppel, G (2008). Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocrine-Related Cancer, 15(1):229-241.

Hafner, J; Hess Schmid, M; Läuchli, S; Schärer, L; Burg, G (2008). Squamous Cell Carcinoma. In: Rusciani, L; Robins, P. Textbook of Dermatologic Surgery. Padova Italia: Piccin Nouva Libraria S.p.A., 347-375.

Belyanskaya, L L; Ziogas, A; Hopkins-Donaldson, S; Kurtz, S; Simon, H U; Stahel, R; Zangemeister-Wittke, U (2008). TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Lung Cancer, 60(3):355-365.

Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.

Boller, D; Schramme, A; Doepfner, K T; Shalaby, T; von Bueren, A O; Eggert, A; Grotzer, M A; Arcaro, A (2008). Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Clinical Cancer Research, 14(4):1172-1181.

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Weber, Achim; Kristiansen, Ilka; Johannsen, Manfred; Oelrich, Beibei; Scholmann, Katharina; Gunia, Sven; May, Matthias; Meyer, Hellmuth-Alexander; Behnke, Silvia; Moch, Holger; Kristiansen, Glen (2008). The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer, 8:369.

Veeck, J; Chorovicer, M; Naami, A; Breuer, E; Zafrakas, M; Bektas, N; Dürst, M; Kristiansen, G; Wild, P J; Hartmann, A; Knuechel, R; Dahl, E (2008). The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene, 27(6):865-876.

Guggenheim, M; Dummer, R; Jung, F J; Mihic-Probst, D; Steinert, H; Rousson, V; French, L E; Giovanoli, P (2008). The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases. British Journal of Cancer, 98(12):1922-1928.

Linnebank, M; Semmler, A; Moskau, S; Smulders, Y; Blom, H; Simon, M (2008). The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro-Oncology, 10(4):548-552.

Gaumann, A; Strubel, G; Bode-Lesniewska, B; Schmidtmann, I; Kriegsmann, J; Kirkpatrick, C J (2008). The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery. Oncology Reports, 20(2):309-318.

Bektas, N; Noetzel, E; Veeck, J; Press, M F; Kristiansen, G; Naami, A; Hartmann, A; Dimmler, A; Beckmann, M W; Knüchel, R; Fasching, P A; Dahl, E (2008). The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Research, 10(R58):4.

Bektas, N; Haaf, A; Veeck, J; Wild, P J; Lüscher-Firzlaff, J; Hartmann, A; Knüchel, R; Dahl, E (2008). Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer, 8:42.

Veeck, Jürgen; Bektas, Nuran; Hartmann, Arndt; Kristiansen, Glen; Heindrichs, Uwe; Knüchel, Ruth; Dahl, Edgar (2008). Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Breast Cancer Research, 10:R82.

2007

Krayenbuhel, J; Oertel, S; Davis, J B; Ciernik, I F (2007). Combined photon and electron three-dimensional conformal versus Intensity-Modulated Radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy. International Journal of Radiation Oncology, Biology and Physics, 69(5):1593-1599.

Baudis, Michael (2007). Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer, 7:226.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Storz, M; Probst-Hensch, N M; Seifert, Burkhardt; Fehr, M K; Fink, D; Ferrone, S; Pestalozzi, B; Jungbluth, A A; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology, Immunotherapy, 56(11):1723-1731.

Bode-Lesniewska, B; Frigerio, S; Exner, U; Abdou, M T; Moch, H; Zimmermann, D R (2007). Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Genes, Chromosomes and Cancer, 46(11):961-971.

Belyanskaya, Larisa L; Marti, Thomas M; Hopkins-Donaldson, Sally; Kurtz, Stefanie; Felley-Bosco, Emanuela; Stahel, Rolf A (2007). Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin. Molecular Cancer, 6:66.

Dürig, J; Bug, S; Klein-Hitpass, L; Boes, T; Jöns, T; Martin-Subero, J I; Harder, L; Baudis, Michael; Dührsen, U; Siebert, R (2007). Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia, 21(10):2153-2163.

Maurer, Jochen; Fuchs, Sebastian; Jäger, Richard; Kurz, Bodo; Sommer, Lukas; Schorle, Hubert (2007). Establishment and controlled differentiation of neural crest stem cell lines using conditional transgenesis. Differentiation; Research in Biological Diversity, 75(7):580-591.

Oehler-Jänne, Christoph; Jochum, Wolfram; Riesterer, Oliver; Broggini-Tenzer, Angela; Caravatti, Giorgio; Vuong, Van; Pruschy, Martin (2007). Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models. Molecular Cancer Therapeutics, 6(9):2496-2504.

Ziegler, Annemarie; Seemayer, Christian A; Hinterberger, Marc; Vogt, Peter; Bigosch, Colette; Gautschi, Oliver; Tornillo, Luigi; Betticher, Daniel C; Moch, Holger; Stahel, Rolf A (2007). Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer, 57(3):282-291.

El-Bassiouni, M; Ciernik, I F; Davis, J B; El-Attar, I; Reiner, B; Burger, C; Goerres, G W; Studer, G M (2007). [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer. International Journal of Radiation Oncology, Biology and Physics, 69(1):286-293.

Frigerio, Simona; Padberg, Barbara C; Strebel, Räto T; Lenggenhager, Daniela; Messthaler, Angelika; Abdou, Marie-Therese; Moch, Holger; Zimmermann, Dieter R (2007). Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. International Journal of Cancer, 121(2):329-338.

Ghosh, Arko; Keng, Peter C; Knauf, Philip A (2007). Hypertonicity induced apoptosis in HL-60 cells in the presence of intracellular potassium. Apoptosis, 12(7):1281-1288.

Zhao, J; Yart, A; Frigerio, S; Perren, A; Schraml, P; Weisstanner, C; Stallmach, T; Krek, W; Moch, H (2007). Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene, 26(23):3440-3449.

Zehnder-Fjällman, A H M; Marty, C; Halin, C; Hohn, A; Schibli, R; Ballmer-Hofer, K; Schwendener, R (2007). Evaluation of anti-VEGFR-3 specific scFv antibodies as potential therapeutic and diagnostic tools for tumor lymph-angiogenesis. Oncology Reports, 18(4):933-941.

Hofer, Silvia; Frei, Karl (2007). Gefitinib concentrations in human glioblastoma tissue. Journal of Neuro-Oncology, 82(2):175-176.

Rohrer Bley, Carla; Wergin, Melanie; Roos, Malgorzata; Grenacher, Beat; Kaser-Hotz, Barbara (2007). Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours. European Journal of Cancer, 43(5):963-967.

Zippelius, Alfred; Gati, Asma; Bartnick, Tammo; Walton, Senta; Odermatt, Bernhard; Jaeger, Elke; Dummer, Reinhold; Urosevic, Mirjana; Filonenko, Valeriy; Osanai, Kazuhiro; Moch, Holger; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jaeger, Dirk (2007). Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer Immunology, Immunotherapy, 56(2):249-258.

Huber, L C; Jüngel, A; Distler, J H W; Moritz, F; Gay, R E; Michel, B A; Pisetsky, D S; Gay, S; Distler, O (2007). The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis, 12(2):363-374.

Sammalkorpi, H; Alhopuro, P; Lehtonen, R; Tuimala, J; Mecklin, J-P; Järvinen, H J; Jiricny, J; Karhu, A; Aaltonen, L A (2007). Background mutation frequency in microsatellite-unstable colorectal cancer. Cancer Research, 67(12):5691-5698.

Pepin, A C; Tandon, R; Cattori, V; Niederer, E; Riond, Barbara; Willi, Barbara; Lutz, H; Hofmann-Lehmann, Regina (2007). Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Virus Research, 127(1):9-16.

Mihic-Probst, D; Kuster, A; Kilgus, S; Bode-Lesniewska, B; Ingold-Heppner, B; Leung, C; Storz, M; Seifert, Burkhardt; Marino, S; Schraml, P; Dummer, R; Moch, H (2007). Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. International Journal of Cancer, 121(8):1764-1770.

Wong, W Wei-Lynn; Clendening, J W; Martirosyan, A; Boutros, P C; Bros, C; Khosravi, F; Jurisica, I; Stewart, A K; Bergsagel, P L; Penn, L Z (2007). Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Molecular Cancer Therapeutics, 6(6):1886-1897.

Jacobs, A H; Rueger, M A; Winkeler, A; Li, H; Vollmar, S; Waerzeggers, Y; Rueckriem, B; Kummer, C; Dittmar, C; Klein, M; Heneka, M T; Herrlinger, U; Fraefel, C; Graf, R; Wienhard, K; Heiss, W-D (2007). Imaging-guided gene therapy of experimental gliomas. Cancer Research, 67(4):1706-1715.

Ameri, K; Hammond, E M; Culmsee, C; Raida, M; Katschinski, D M; Wenger, R H; Wagner, E; Davis, R J; Hai, T; Denko, N; Harris, A L (2007). Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene, 26(2):284-289.

Theurillat, J P; Ingold, F; Freitag, C; Zippelius, A; Varga, Z; Seifert, Burkhardt; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-ESO-1 protein expression in primary breast carcinoma and metastases - correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. International Journal of Cancer, 120(11):2411-2417.

Wu, F; Grossenbacher, D; Gehring, H (2007). New transition state-based inhibitor for human ornithine decarboxylase inhibits growth of tumor cells. Molecular Cancer Therapeutics, 6(6):1831-1839.

Menigatti, M; Pedroni, M; Verrone, A M; Borghi, F; Scarselli, A; Benatti, P; Losi, L; Di Gregorio, C; Schär, P; Marra, Giancarlo; Ponz de Leon, M; Roncucci, L (2007). O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis. Oncology Reports, 17(6):1421-1427.

Weiss, M B; Vitolo, M I; Baerenfaller, K; Marra, Giancarlo; Park, B H; Bachman, K E (2007). Persistent mismatch repair deficiency following targeted correction of hMLH1. Cancer Gene Therapy, 14(1):98-104.

Mnich, C D; Hoek, K S; Oberholzer, P A; Seifert, Burkhardt; Hafner, J; Dummer, R; Mihic, D (2007). Reduced pSmad2 immunodetection correlates with increased primary melanoma thickness. Melanoma Research, 17(2):131-136.

Menvielle, G; Kunst, A E; Stirbu, I; Borrell, C; Bopp, M; Regidor, E; Heine Strand, B; Deboosere, P; Lundberg, O; Leclerc, A; Costa, G; Chastang, J F; Esnaola, S; Martikainen, P; Mackenbach, J P (2007). Socioeconomic inequalities in alcohol related cancer mortality among men: to what extent do they differ between Western European populations? International Journal of Cancer, 121(3):649-655.

Jiao, R; Harrigan, J A; Shevelev, I; Dietschy, T; Selak, N; Indig, F E; Piotrowski, J; Janscak, Pavel; Bohr, V A; Stagljar, I (2007). The Werner syndrome protein is required for recruitment of chromatin assembly factor 1 following DNA damage. Oncogene, 26(26):3811-3822.

Betts, G; Twohig, J; van den Broek, Maries; Sierro, Sophie; Godkin, A; Gallimore, Awen (2007). The impact of regulatory T cells on carcinogen-induced sarcogenesis. British Journal of Cancer, 96:1849-1854.

Strand, B H; Kunst, A; Huisman, M; Menvielle, G; Glickman, M; Bopp, M; Borell, C; Borgan, J K; Costa, G; Deboosere, P; Regidor, E; Valkonen, T; Mackenbach, J P (2007). The reversed social gradient: higher breast cancer mortality in the higher educated compared to lower educated. A comparison of 11 European populations during the 1990s. European Journal of Cancer, 43(7):1200-1207.

Sabates-Bellver, J; Van der Flier, L G; de Palo, M; Cattaneo, E; Maake, C; Rehrauer, H; Laczko, E; Kurowski, M A; Bujnicki, J M; Menigatti, M; Luz, J; Ranalli, T V; Gomes, V; Pastorelli, A; Faggiani, R; Anti, M; Jiricny, J; Clevers, H; Marra, Giancarlo (2007). Transcriptome profile of human colorectal adenomas. Molecular Cancer Research, 5(12):1263-1275.

2006

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Buterin, T; Koch, C; Naegeli, Hanspeter (2006). Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis, 27(8):1567-1578.

Riesterer, Oliver; Honer, Michael; Jochum, Wolfram; Oehler, Christoph; Ametamey, Simon; Pruschy, Martin (2006). Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment. Clinical Cancer Research, 12(11):3518-3524.

Varga, Zsuzsanna; Theurillat, Jean-Philippe; Filonenko, Valeriy; Sasse, Bernd; Odermatt, Bernhard; Jungbluth, Achim A; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jäger, Dirk; Moch, Holger (2006). Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clinical Cancer Research, 12(9):2745-2751.

Staerkle, Ralph F; Lenzlinger, Philipp M; Suter, Stephan L; Varga, Zsuzsanna; Melcher, Gian A; Melcher, A (2006). Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Research and Treatment, 97(2):173-176.

Jermann, Monika; Stahel, Rolf A; Salzberg, Marc; Cerny, Thomas; Joerger, Markus; Gillessen, Silke; Morant, Rudolf; Egli, Fritz; Rhyner, Kaspar; Bauer, Jean A; Pless, Miklos (2006). A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer Chemotherapy and Pharmacology, 57(4):533-539.

Plasilova, M; Zhang, J; Okhowat, R; Marra, Giancarlo; Mettler, M; Mueller, H; Heinimann, K (2006). A de novo MLH1 germ line mutation in a 31-year-old colorectal cancer patient. Genes, Chromosomes & Cancer, 45(12):1106-1110.

Alvino, E; Castiglia, D; Caporali, S; Pepponi, R; Caporaso, P; Lacal, P M; Marra, Giancarlo; Fischer, F; Zambruno, G; Bonmassar, E; Jiricny, J; D'Atri, S (2006). A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system. International Journal of Oncology, 29(4):785-797.

von Goessel, Heiko; Hossle, Johann Peter; Seger, Reinhard; Güngör, Tayfun (2006). Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Experimental Hematology, 34(4):528-535.

Zeisberger, S M; Odermatt, B; Marty, C; Zehnder-Fjällman, A H M; Ballmer-Hofer, K; Schwendener, R (2006). Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. British Journal of Cancer, 95(3):272-281.

Zhang, J; Lindroos, A; Ollila, S; Russell, A; Marra, Giancarlo; Mueller, H; Peltomaki, P; Plasilova, M; Heinimann, K (2006). Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Research, 66(2):659-664.

Krystyniak, A; Garcia-Echeverria, C; Prigent, C; Ferrari, S (2006). Inhibition of Aurora A in response to DNA damage. Oncogene, 25(3):338-348.

Marty, C; Langer-Machova, Z; Sigrist, S; Schott, H; Schwendener, R; Ballmer-Hofer, K (2006). Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer Letters, 235(2):298-308.

Zavodna, K; Bujalkova, M; Krivulcik, T; Alemayehu, A; Skorvaga, M; Marra, Giancarlo; Fridrichova, I; Jiricny, J; Bartosova, Z (2006). Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia. Neoplasma, 53(4):269-276.

Dewey, Ricardo A; Díez, Inés Avedillo; Ballmaier, Matthias; Filipovich, Alexandra; Greil, Johann; Güngör, Tayfun; Happel, Christoph; Maschan, Alexey; Noyan, Fatih; Pannicke, Ulrich; Schwarz, Klaus; Snapper, Scott; Welte, Karl; Klein, Christoph (2006). Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. Experimental Hematology, 34(9):1161-1169.

Probst-Hensch, N M; Sun, C L; Van Den Berg, D; Ceschi, M; Koh, W P; Yu, M C (2006). The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis, 27(12):2475-2482.

Gerondakis, S; Grumont, R; Gugasyan, R; Wong, W W L; Isomura, I; Ho, W; Banerjee, A (2006). Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene, 25(51):6781-6799.

Jovanovic, M; Hengartner, M O (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25(46):6176-6187.

Mihic-Probst, D; Mnich, C D; Oberholzer, P A; Seifert, Burkhardt; Sasse, B; Moch, H; Dummer, R (2006). p16 expression in primary malignant melanoma is associated with prognosis and lymph node status. International Journal of Cancer, 118(9):2262-2268.

2005

Lardinois, Didier; Weder, Walter; Roudas, Marina; von Schulthess, Gustav K; Tutic, Michaela; Moch, Holger; Stahel, Rolf A; Steinert, Hans C (2005). Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. Journal of Clinical Oncology, 23(28):6846-6853.

Urosevic, Mirjana; Dummer, Reinhard; Conrad, Curdin; Beyeler, Mirjam; Laine, Elisabeth; Burg, Günter; Gilliet, Michel (2005). Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment. Journal of the National Cancer Institute, 97(15):1143-1153.

Cerciello, Ferdinando; Hofstetter, Barbara; Fatah, Sherweif Abdel; Zaghloul, Mohamed; Odermatt, Bernhard; Bodis, Stephan; Varga, Zsuzsanna; Pruschy, Martin; Ciernik, Ilja F (2005). G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 62(5):1390-1398.

Gallant, P (2005). Myc, cell competition, and compensatory proliferation. Cancer Research, 65(15):6485-6487.

Mundwiler, S; Waibel, R; Spingler, B; Kunze, S; Alberto, R (2005). Picolylamine-methylphosphonic acid esters as tridentate ligands for the labeling of alcohols with the fac-[M(CO)3]+ core (M = 99mTc, Re): synthesis and biodistribution of model compounds and of a 99mTc-labeled cobinamide. Nuclear Medicine and Biology, 32(5):473-484.

Hofer, Silvia; Seeger, Harald; Rordorf, Tamara; Knuth, Alexander; Janzer, Robert (2005). Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma. Journal of Neuro-Oncology, 72(3):239.

Clifford, G M; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6):425-432.

Simões-Wüst, Ana Paula; Sigrist, B; Belyanskaya, L; Hopkins Donaldson, S; Stahel, R A; Zangemeister-Wittke, U (2005). ΔNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells. Journal of Neuro-Oncology, 72(1):29-34.

Verma, D K; Nair, P N R; Luder, H U (2005). Quantitative histological features and ultrastructure of opercula of human teeth showing normal and delayed eruption. Journal of Oral Pathology & Medicine, 34(2):109-115.

Althaus, F R (2005). Poly(ADP-ribose): a co-regulator of DNA methylation? Oncogene, 24(1):11-12.

Szadkowski, M; Iaccarino, I; Heinimann, K; Marra, Giancarlo; Jiricny, J (2005). Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells. Cancer Research, 65(11):4525-4529.

El-Shemerly, M; Janscak, Pavel; Hess, D; Jiricny, J; Ferrari, S (2005). Degradation of human exonuclease 1b upon DNA synthesis inhibition. Cancer Research, 65(9):3604-3609.

Cannavo, E; Marra, Giancarlo; Sabates-Bellver, J; Menigatti, M; Lipkin, S M; Fischer, F; Cejka, P; Jiricny, Josef (2005). Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Research, 65(23):10759-10766.

Gressmann, H; Linz, B; Ghai, R; Pleissner, K P; Schlapbach, R; Yamaoka, Y; Kraft, C; Suerbaum, S; Meyer, T F; Achtman, M (2005). Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genetics, 1(4):e43.

Mao, X; Hamoudi, R A; Zhao, P; Baudis, Michael (2005). Genetic losses in breast cancer: toward an integrated molecular cytogenetic map. Cancer Genetics and Cytogenetics, 160(2):141-151.

Szucs, T D (2005). Health economics in the genomic age. Recent Results in Cancer Research, 166:299-313.

Carbone, D P; Ciernik, I F; Kelley, M J; Smith, M C; Nadaf, S; Kavanaugh, D; Maher, V E; Stipanov, M; Contois, D; Johnson, B E; Pendleton, C D; Seifert, Burkhardt; Carter, C; Read, E J; Greenblatt, J; Top, L E; Kelsey, M I; Minna, J D; Berzofsky, J A (2005). Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. Journal of Clinical Oncology, 23(22):5099-5107.

Ibrahim, N O; Hahn, T; Franke, C; Stiehl, D P; Wirthner, R; Wenger, R H; Katschinski, D M (2005). Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. Cancer Research, 65(23):11094-11100.

Gunter, M J; Probst-Hensch, N M; Cortessis, V K; Kulldorff, M; Haile, R W; Sinha, R (2005). Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis, 26(3):637-642.

Hidalgo, A; Baudis, Michael; Petersen, I; Arreola, H; Piña, P; Vázquez-Ortiz, G; Hernandez, D; Gonzáles, J; Lazos, M; Lopez, R; Perez, C; Garcia, J; Vazquez, K; Alatorre, B; Salcedo, M (2005). Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer, 5:77.

Buchholz, Julia; Kaser-Hotz, Barbara; Khan, Tania; Rohrer Bley, Carla; Melzer, Katj; Schwendener, Reto A; Roos, Malgorzata; Walt, Heinrich (2005). Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Clinical Cancer Research, 11(20):7538-7544.

von Minckwitz, G; Harder, S; Hövelmann, S; Jäger, E; Al-Batran, S E; Loibl, S G; Atmaca, A; Cimpoiasu, C; Neumann, A M; Abera, A; Knuth, A L; Kaufmann, M; Jäger, D; Maurer, A B; Wels, W S (2005). Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research, 7(5):R617.

Rubio Demirovic, A; Marty, C; Console, S; Zeisberger, S M; Ruch, C; Jaussi, R; Schwendener, R; Ballmer-Hofer, K (2005). Targeting human cancer cells with VEGF receptor-2-directed liposomes. Oncology Reports, 13(2):319-324.

Ceschi, M; Sun, C L; Van Den Berg, D; Koh, W P; Yu, M C; Probst-Hensch, N (2005). The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis, 26(8):1457-1464.

Vandesompele, J; Baudis, Michael; De Preter, K; Van Roy, N; Ambros, P; Bown, N; Brinkschmidt, C; Christiansen, H; Combaret, V; Lastowska, M; Nicholson, J; O'Meara, A; Plantaz, D; Stallings, R; Brichard, B; Van den Broecke, C; De Bie, S; De Paepe, A; Laureys, G; Speleman, F (2005). Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. Journal of Clinical Oncology, 23(10):2280-2299.

2004

Huarte, Eduardo; Karbach, Julia; Gnjatic, Sacha; Bender, Armin; Jäger, Dirk; Arand, Michael; Atanackovic, Djordje; Skipper, Jonathan; Ritter, Gerd; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jäger, Elke (2004). HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones. Cancer Immunity, 4:15.

Mihic-Probst, Daniela; Perren, Aurel; Schmid, Sonja; Saremaslani, Parvin; Komminoth, Paul; Heitz, Philipp U (2004). Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma. Anticancer Research, 24(4):2415-2418.

Baumann Kubetzko, F B (2004). The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis, 25(10):1839-1846.

Weissenberger, J; Loeffler, S; Kappeler, A; Kopf, M; Lukes, A; Afanasieva, T A; Aguzzi, A; Weis, J (2004). IL-6 is required for glioma development in a mouse model. Oncogene, 23(19):3308-3316.

Jäger, Dirk; Taverna, Christian; Zippelius, Alfred; Knuth, Alexander (2004). Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunology, Immunotherapy, 53(3):144-147.

Mihic-Probst, Daniela; Zhao, Jianming; Saremaslani, Parvin; Baer, Angela; Oehlschlegel, Christian; Paredes, Bruno; Komminoth, Paul; Heitz, Philipp U (2004). CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Research, 24(1):19-26.

Wu, J; Wong, W Wei-Lynn; Khosravi, F; Minden, M; Penn, L Z (2004). Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Research, 64:6461-6468.

Baumann, F; Bjeljac, M; Kollias, S S; Baumert, B G; Brandner, S; Rousson, V; Yonekawa, Y; Bernays, R L (2004). Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme. Journal of Neuro-Oncology, 67(1-2):191-200.

Papouli, E; Cejka, P; Jiricny, J (2004). Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Research, 64(10):3391-3394.

Eliaz, R E; Nir, S; Marty, C; Szoka, F C (2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Research, 64(2):711-718.

Ohgaki, H; Dessen, P; Jourde, B; Horstmann, S; Nishikawa, T; Di Patre, P L; Burkhard, C; Schüler, D; Probst-Hensch, N M; Maiorka, P C; Baeza, N; Pisani, P; Yonekawa, Y; Yasargil, M G; Lütolf, U M; Kleihues, P (2004). Genetic pathways to glioblastoma: a population-based study. Cancer Research, 64(19):6892-6899.

Mackenbach, J P; Huisman, M; Andersen, O; Bopp, M; Borgan, J K; Borrell, C; Costa, G; Deboosere, P; Donkin, A; Gadeyne, S; Minder, C; Regidor, E; Spadea, T; Valkonen, T; Kunst, A E (2004). Inequalities in lung cancer mortality by the educational level in 10 European populations. European Journal of Cancer, 40(1):126-135.

Plaschke, J; Krüger, S; Jeske, B; Theissig, F; Kreuz, F R; Pistorius, S; Saeger, H D; Iaccarino, I; Marra, Giancarlo; Schackert, H K (2004). Loss of MSH3 protein expression is frequent in MLH1-deficient colorectal cancer and is associated with disease progression. Cancer Research, 64(3):864-870.

Meier, S; Baumert, B G; Maier, T; Wellis, G; Burg, G; Seifert, Burkhardt; Dummer, R (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2):145-149.

2003

Goerres, G W; Schmid, D T; Grätz, K W; von Schulthess, G K; Eyrich, G K (2003). Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncology, 39(6):547-551.

Henneke, G; Koundrioukoff, S; Hübscher, U (2003). Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation. Oncogene, 22(28):4301-4313.

Penengo, Lorenza; Rubin, Chanan; Yarden, Yosef; Gaudino, Giovanni (2003). c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene, 22(24):3669-3679.

Kempf, W (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis, 24(2):301-306.

Castiglia, D; Pagani, E; Alvino, E; Vernole, P; Marra, Giancarlo; Cannavò, E; Jiricny, J; Zambruno, G; D'Atri, S (2003). Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma. Genes, Chromosomes & Cancer, 37(2):165-175.

Cejka, P; Marra, Giancarlo; Hemmerle, C; Cannavó, E; Storchova, Z; Jiricny, J (2003). Differential killing of mismatch repair-deficient and -proficient cells: towards the therapy of tumors with microsatellite instability. Cancer Research, 63(23):8113-8117.

Wintterle, S; Schreiner, B; Mitsdoerffer, M; Schneider, D; Chen, L; Meyermann, R; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Research, 63(21):7462-7467.

DeLellis, K; Ingles, S; Kolonel, L; McKean-Cowdin, R; Henderson, B; Stanczyk, F; Probst-Hensch, N M (2003). IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. British Journal of Cancer, 88(2):277-282.

Linden, T; Wenger, R H (2003). Iron chelation, angiogenesis and tumor therapy. International Journal of Cancer, 106(3):458-459.

Rohrer, S; Bischoff, M; Rossi, J; Berger-Bächi, B (2003). Mechanisms of methicillin resistance. In: Fluit, A; Schmitz, F. MRSA: Current perspectives. Trowbridge, UK: Cromwell Press Ltd., 31-53.

di Pietro, M; Marra, Giancarlo; Cejka, P; Stojic, L; Menigatti, M; Cattaruzza, M S; Jiricny, J (2003). Mismatch repair-dependent transcriptome changes in human cells treated with the methylating agent N-methyl-n'-nitro-N-nitrosoguanidine. Cancer Research, 63(23):8158-8166.

Taussky, D; Schneider, U; Rousson, V; Pescia, R (2003). Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate. American Journal of Clinical Oncology, 26(5):e144-e149.

Quesada, P; Malanga, M; Di Meglio, S; De Lorenzo, S; Fabbrocini, A; Garbi, C; Bianco, A R; Pepe, S (2003). Recombinant IFN-alpha2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. European Journal of Cancer, 39(14):2103-2109.

Zagrodnik, B; Kempf, W; Seifert, Burkhardt; Müller, B; Burg, G; Urosevic, M; Dummer, R (2003). Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer, 98(12):2708-2714.

Unruh, A; Ressel, A; Mohamed, H G; Johnson, R S; Nadrowitz, R; Richter, E; Katschinski, D M; Wenger, R H (2003). The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 22(21):3213-3220.

2002

Dahm, K; Hübscher, U (2002). Colocalization of human Rad17 and PCNA in late S phase of the cell cycle upon replication block. Oncogene, 21(50):7710-7719.

Jäger, Elke; Karbach, Julia; Gnjatic, Sacha; Jäger, Dirk; Maeurer, Markus; Atmaca, Akin; Arand, Michael; Skipper, Jonathan; Stockert, Elisabeth; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander (2002). Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer Immunity, 2:12.

Jäger, Dirk; Stockert, Elisabeth; Karbach, Julia; Herrlinger, Kristina; Atmaca, Akin; Arand, Michael; Chen, Yao-Tseng; Gnjatic, Sacha; Old, Lloyd J; Knuth, Alexander; Jäger, Elke (2002). Urine antibody against human cancer antigen NY-ESO-1. Cancer Immunity, 2:10.

Höpfl, G; Wenger, R H; Ziegler, U; Stallmach, T; Gardelle, O; Achermann, R; Wergin, M; Kaser-Hotz, B; Saunders, H M; Williams, K J; Stratford, I J; Gassmann, M; Desbaillets, I (2002). Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Research, 62(10):2962-2970.

Beer, Gertrude M; Varga, Zsuzsanna; Budi, Srecko; Seifert, Burkhardt; Meyer, Viktor E (2002). Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer, 94(6):1619-1625.

Hofbauer, G F L; Böni, R; Simmen, D; Mihic, D; Nestle, F O; Burg, G; Dummer, R (2002). Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma research, 12(1):77-82.

Eppler, E; Hörig, H; Kaufman, H L; Groscurth, P; Filgueira, L (2002). Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA. European Journal of Cancer, 38(1):184-193.

Marty, C; Odermatt, B; Schott, H; Neri, D; Ballmer-Hofer, K; Klemenz, R; Schwendener, R (2002). Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes. British Journal of Cancer, 87(1):106-112.

Nyström-Lahti, M; Perrera, C; Räschle, M; Panyushkina-Seiler, E; Marra, Giancarlo; Curci, A; Quaresima, B; Costanzo, F; D'Urso, M; Venuta, S; Jiricny, J (2002). Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes, Chromosomes & Cancer, 33(2):160-167.

Roos, Dirk; Meischl, Christof; de Boer, Martin; Simsek, Suat; Weening, Ron S; Sanal, Özden; Tezcan, Ilhan; Güngör, Tayfun; Law, S K Alex (2002). Genetic analysis of patients with leukocyte adhesion deficiency. Experimental Hematology, 30(3):252-261.

Wong, W W L; Dimitroulakos, J; Minden, M D; Penn, L Z (2002). HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia, 16(4):508-519.

Szadkowski, M; Jiricny, J (2002). Identification and functional characterization of the promoter region of the human MSH6 gene. Genes, Chromosomes & Cancer, 33(1):36-46.

Wischhusen, J; Jung, G; Radovanovic, I; Beier, C; Steinbach, J P; Rimner, A; Huang, H; Schulz, J B; Ohgaki, H; Aguzzi, A; Rammensee, H G; Weller, M (2002). Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Research, 62(9):2592-2599.

Glatzel, M; Brandner, S; Klein, M A; Horstmann, S; Aguzzi, A (2002). Prions--role of the peripheral nervous system. Virus Research, 82(1-2):53.

Kaiser, U; Uebelacker, I; Abel, U; Birkmann, J; Trümper, L; Schmalenberg, H; Karakas, T; Metzner, B; Hossfeld, D K; Bischoff, H G; Franke, A; Reiser, M; Müller, P; Mantovani, L; Grundeis, M; Rothmann, F; von Seydewitz, C U; Mesters, R M; Steinhauer, E U; Krahl, D; Schumacher, K; Kneba, M; Baudis, Michael; Schmitz, N; Pfab, R; Köppler, H; Parwaresch, R; Pfreundschuh, M; Havemann, K (2002). Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma. Journal of Clinical Oncology, 20(22):4413-4419.

Buterin, T; Hess, M T; Gunz, D; Geacintov, N E; Mullenders, L H; Naegeli, H (2002). Trapping of DNA nucleotide excision repair factors by nonrepairable carcinogen adducts. Cancer Research, 62(15):4229-4235.

2001

Ringhoffer, M; Schmitt, M; Karbach, J; Jäger, E; Oesch, F; Arand, Michael (2001). Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction. International Journal of Oncology, 19(5):983-989.

Steinbach, J P; Kozmik, Z; Pfeffer, P; Aguzzi, A (2001). Overexpression of Pax5 is not sufficient for neoplastic transformation of mouse neuroectoderm. International Journal of Cancer, 93(4):459-467.

Rattat, D; Schubiger, P A; Berke, H G; Schmalle, H W; Alberto, R (2001). Dicarbonyl-nitrosyl-complexes of rhenium (Re) and technetium (Tc), a potentially new class of compounds for the direct radiolabeling of biomolecules. Cancer Biotherapy and Radiopharmaceuticals, 16(4):339-343.

Amann, A; Decristoforo, C; Ott, I; Wenger, M; Bader, D; Alberto, R; Putz, G (2001). Surfactant protein B labelled with [(99m)Tc(CO)3(H20)3](+) retains biological activity in vitro.. Nuclear Medicine and Biology, 28(3):243-250.

Gautschi, O; Tschopp, S; Olie, R A; Leech, S H; Simões-Wüst, Ana Paula; Ziegler, A; Baumann, B; Odermatt, B; Hall, J; Stahel, R A; Zangemeister-Wittke, U (2001). Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins. Journal of the National Cancer Institute, 93(6):463-471.

Kamarashev, Jivko; Ferrone, Soldano; Seifert, Burkhardt; Böni, Roland; Nestle, Frank O; Burg, Günter; Dummer, Reinhard (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. International Journal of Cancer, 95(1):23-28.

Xia, Z; Tan, M M; Wong, W Wei-Lynn; Dimitroulakos, J; Minden, M D; Penn, L Z (2001). Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia, 15(9):1398-1407.

Wong, W Wei-Lynn; Tan, M M; Xia, Z; Dimitroualakos, J; Minden, M; Penn, L Z (2001). Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clinical Cancer Research, 7(7):2067-2075.

Bentz, M; Barth, T F; Brüderlein, S; Bock, D; Schwerer, M J; Baudis, Michael; Joos, S; Viardot, A; Feller, A C; Müller-Hermelink, H K; Lichter, P; Döhner, H; Möller, P (2001). Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes, Chromosomes & Cancer, 30(4):393-401.

Schweizer, P; Moisio, A L; Kuismanen, S A; Truninger, K; Vierumäki, R; Salovaara, R; Arola, J; Butzow, R; Jiricny, J; Peltomäki, P; Nyström-Lahti, M (2001). Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer. Cancer Research, 61(7):2813-2815.

Percesepe, A; Borghi, F; Menigatti, M; Losi, L; Foroni, M; Di Gregorio, C; Rossi, G; Pedroni, M; Sala, E; Vaccina, F; Roncucci, L; Benatti, P; Viel, A; Genuardi, M; Marra, Giancarlo; Kristo, P; Peltomäki, P; Ponz de Leon, M (2001). Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. Journal of Clinical Oncology, 19(19):3944-3950.

Heinimann, K; Thompson, A; Locher, A; Furlanetto, T; Bader, E; Wolf, A; Meier, R; Walter, K; Bauerfeind, P; Marra, Giancarlo; Müller, H; Foernzler, D; Dobbie, Z (2001). Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis. Cancer Research, 61(20):7616-7622.

Marra, Giancarlo; D'Atri, S; Yan, H; Perrera, C; Cannavo, Elda; Vogelstein, B; Jiricny, Josef (2001). Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes. Cancer Research, 61(21):7719-7721.

Pepponi, R; Graziani, G; Falcinelli, S; Vernole, P; Levati, L; Lacal, P M; Pagani, E; Bonmassar, E; Jiricny, J; D'Atri, S (2001). hMSH3 overexpression and cellular response to cytotoxic anticancer agents. Carcinogenesis, 22(8):1131-1137.

2000

Klein, M A; Rüedi, D; Nozaki, M; Dell, E W; Diserens, A C; Seelentag, W; Janzer, R C; Aguzzi, A; Hegi, M E (2000). Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant. Oncogene, 19(47):5329-5337.

Santoro, M M; Penengo, Lorenza; Orecchia, S; Cilli, M; Gaudino, G (2000). The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site. Oncogene, 19(45):5208-5211.

Hegi, M E; Klein, M A; Rüedi, D; Chène, P; Hamou, M F; Aguzzi, A (2000). p53 transdominance but no gain of function in mouse brain tumor model. Cancer Research, 60(11):3019-3024.

Kessler, R; Hamou, M F; Albertoni, M; de Tribolet, N; Arand, Michael; Van Meir, E G (2000). Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. Cancer Research, 60(5):1403-1409.

D'Angelo, Maria G; Afanasieva, Tatiana; Aguzzi, Adriano (2000). Angiogenesis in transgenic models of multistep carcinogenesis. Journal of Neuro-Oncology, 50(1-2):89-98.

Cattaneo-Pangrazzi, R M; Schott, H; Wunderli-Allenspach, H; Rothen-Rutishauser, B; Guenthert, M; Schwendener, R (2000). Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. Journal of Cancer Research and Clinical Oncology, 126(5):247-256.

Horber, D H; Cattaneo-Pangrazzi, R M; von Ballmoos, P; Schott, H; Ludwig, P S; Eriksson, S; Fichtner, I; Schwendener, R (2000). Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5'-->5')-N4-octadecyl-1-beta-D-arabinofuranosylcytosi ne. Journal of Cancer Research and Clinical Oncology, 126(6):311-319.

Charrasse, S; Carena, I; Brondani, V; Klempnauer, K H; Ferrari, S (2000). Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Oncogene, 19(26):2986-2995.

Bearzatto, A; Szadkowski, M; Macpherson, P; Jiricny, J; Karran, P (2000). Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Research, 60(12):3262-3270.

Zhang, H; Marra, Giancarlo; Jiricny, J; Maher, V M; McCormick, J J (2000). Mismatch repair is required for O(6)-methylguanine-induced homologous recombination in human fibroblasts. Carcinogenesis, 21(9):1639-1646.

Wong, W W L; Macdonald, S; Langler, R F; Penn, L Z (2000). Novel synthetic organosulfur compounds induce apoptosis of human leukemic cells. Anticancer Research, 20(3a):1367-1374.

Buterin, T; Hess, M T; Luneva, N; Geacintov, N E; Amin, S; Kroth, H; Seidel, A; Naegeli, H (2000). Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. Cancer Research, 60(7):1849-1856.

Bentz, Martin; Plesch, Anja; Bullinger, Lars; Stilgenbauer, Stephan; Ott, German; Konrad Müller-Hermelink, Hans; Baudis, Michael; Barth, Thomas F E; Möller, Peter; Lichter, Peter; Döhner, Hartmut (2000). t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes, Chromosomes and Cancer, 27(3):285-294.

1999

Goswami, N; Higginbotham, C; Volkert, W A; Alberto, R; Nef, W; Jurisson, S (1999). Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation. Nuclear Medicine and Biology, 26(8):951-957.

Jäger, E; Stockert, E; Zidianakis, Z; Chen, Y T; Karbach, J; Jäger, D; Arand, Michael; Ritter, G; Old, L J; Knuth, A (1999). Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. International Journal of Cancer, 84(5):506-510.

Schibli, R; Katti, K V; Higginbotham, C; Volkert, W A; Alberto, R (1999). In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core. Nuclear Medicine and Biology, 26(6):711-716.

Hengstler, J G; Lange, J; Kett, A; Dornhöfer, N; Meinert, R; Arand, Michael; Knapstein, P G; Becker, R; Oesch, F; Tanner, B (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Research, 59(13):3206-3214.

Pohl, U; Wick, W; Weissenberger, J; Steinbach, J P; Dichgans, J; Aguzzi, A; Weller, M (1999). Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines. International Journal of Oncology, 15(4):829-834.

Koller-Lucae, S K; Schott, H; Schwendener, R (1999). Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells. British Journal of Cancer, 80(10):1542-9.

1998

Shivji, M K; Ferrari, E; Ball, K; Hübscher, U; Wood, R D (1998). Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1. Oncogene, 17(22):2827-2835.

Stucki, M; Pascucci, B; Parlanti, E; Fortini, P; Wilson, S H; Hübscher, U; Dogliotti, E (1998). Mammalian base excision repair by DNA polymerases delta and epsilon. Oncogene, 17(7):835-843.

Hengstler, J G; Kett, A; Arand, Michael; Oesch-Bartlomowicz, B; Oesch, F; Pilch, H; Tanner, B (1998). Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Letters, 130(1-2):43-48.

Santoro, M M; Penengo, Lorenza; Minetto, M; Orecchia, S; Cilli, M; Gaudino, G (1998). Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Oncogene, 17(6):741-749.

Vortmeyer, Alexander O; Pak, Evgenia; Pack, Svetlana; Böni, Roland; Zhuang, Zhengping (1998). Multiple Endocrine Neoplasia 1 Gene Alterations in MEN1-Associated and Sporadic Lipomas. Journal of the National Cancer Institute, 90(5):398-399.

Wenger, R H; Camenisch, G; Desbaillets, I; Chilov, D; Gassmann, M (1998). Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. Cancer Research, 58(24):5678-5680.

1997

Wimmer, I; Meyer, J C; Seifert, Burkhardt; Dummer, R; Flace, A; Burg, G (1997). Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Cancer Research, 57(22):5073-5076.

Ziegler, A; Luedke, G H; Stahel, R A; Zangemeister-Wittke, U; Fabbro, D; Altmann, K-H (1997). Induction of Apoptosis in Small-Cell Lung Cancer Cells by an Antisense Oligodeoxynucleotide Targeting the Bcl-2 Coding Sequence. Journal of the National Cancer Institute, 89(14):1027-1036.

Weissenberger, J; Steinbach, J P; Malin, G; Spada, S; Rülicke, T; Aguzzi, A (1997). Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene, 14(17):2005-2013.

Fasciati, R (1997). EGF- and CPA-induced mitogenic stimuli are differentially down- regulated by TGF-beta1 in cultured rat hepatocytes. Carcinogenesis, 18(5):911-917.

Jäger, E; Ringhoffer, M; Altmannsberger, M; Arand, Michael; Karbach, J; Jäger, D; Oesch, F; Knuth, A (1997). Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. International Journal of Cancer, 71(2):142-147.

Sherman, L; Jacoby, L B; Lampe, J; Pelton, P; Aguzzi, A; Herrlich, P; Ponta, H (1997). CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Cancer Research, 57(21):4889-4897.

Rentsch, K M; Horber, D H; Schwendener, R; Wunderli-Allenspach, H; Hänseler, E (1997). Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. British Journal of Cancer, 75(7):986-992.

Berg-Drewniok, Barbara; Weichenthal, Michael; Ehlert, Ulrike; Rümmelein, Bettina; Breitbart, Eckhard W; Rüdiger, Hugo W (1997). Increased spontaneous formation of micronuclei in cultured fibroblasts of first-degree relatives of familial melanoma patients. Cancer Genetics and Cytogenetics, 97(2):106-110.

Gutzwiller, Felix (1997). Vorwort. In: Gutzwiller, Felix; Stähli, Roland; Somogyi, Pia. Gesundheit für alle : Ziele zur Gesundheitspolitik für die Schweiz. Basel: Birkhäuser, 1-2.

1996

Jäger, E; Ringhoffer, M; Arand, Michael; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma research, 6(6):419-425.

Helfenstein, Ulrich; Schüler, Georges; Bopp, Matthias; Morf, S; Schüler, D (1996). Exploration of interactions between prognostic factors of stage I malignant melanoma. Melanoma research, 6(4):319-324.

Jäger, E; Ringhoffer, M; Dienes, H P; Arand, Michael; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. International Journal of Cancer, 67(1):54-62.

Jäger, E; Ringhoffer, M; Karbach, J; Arand, Michael; Oesch, F; Knuth, A (1996). Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. International Journal of Cancer, 66(4):470-476.

Jäeger, E; Bernhard, H; Romero, P; Ringhoffer, M; Arand, Michael; Karbach, J; Ilsemann, C; Hagedorn, M; Knuth, A (1996). Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. International Journal of Cancer, 66(2):162-169.

Hoeppner, D J; Hengartner, M O; Fisher, D E (1996). Programmed cell death: from development to disease. Biochimica et Biophysica Acta, 1242(3):217-220.

Vock, E H; Hoymann, H-G; Heinrich, U; Lutz, W K (1996). 32P-Postlabeling of a DNA adduct derived from 4,4′-methylenedianiline, in the olfactory epithelium of rats exposed by inhalation to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis, 17(5):1069-1073.

Marra, Giancarlo; Chang, C L; Laghi, L A; Chauhan, D P; Young, D; Boland, C R (1996). Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene, 13(10):2189-2196.

Schwendener, R A; Schott, H (1996). Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. Journal of Cancer Research and Clinical Oncology, 122(12):723-726.

Schwendener, R A; Horber, D H; Odermatt, B; Schott, H (1996). Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine. Journal of Cancer Research and Clinical Oncology, 122(2):102-108.

1995

Marra, Giancarlo; Boland, C R (1995). Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. Journal of the National Cancer Institute, 87(15):1114-1125.

Stuart, E T; Kioussi, C; Aguzzi, A; Gruss, P (1995). PAX5 expression correlates with increasing malignancy in human astrocytomas. Clinical Cancer Research, 1(2):207-214.

Horber, D H; von Ballmoos, P; Schott, H; Schwendener, Reto A (1995). Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine. British Journal of Cancer, 72(5):1067-1073.

Horber, D H; Schott, H; Schwendener, Reto A (1995). Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937. Cancer Chemotherapy and Pharmacology, 36(6):483-492.

Horber, D H; Schott, H; Schwendener, Reto A (1995). Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. British Journal of Cancer, 71(5):957-962.

Pestalozzi, B C; Vass, A; Adam, H; Horber, D H; Schwendener, Reto A; Sauter, C (1995). Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer. European Journal of Cancer, 31A(6):1024.

Stover, J F; Hopf, N J; Perneczky, A; Kempski, O S (1995). Unspecific metabolic blood parameters as used in clinical routine may differentiate malignant from benign cerebral tumors. Cancer Letters, 95(1-2):147-152.

1994

Stahel, R A; Gilks, W R; Schenker, T (1994). Antigens of Lung Cancer: Results of the Third International Workshop on Lung Tumor and Differentiation Antigens. Journal of the National Cancer Institute, 86(9):669-672.

Sengstag, Christian; Eugster, Hans-Pietro; Würgler, Friedrich (1994). High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase. Carcinogenesis, 15(5):837-843.

Fischer, Wolfgang H; Lutz, Werner K (1994). Mouse skin papilloma formation by chronic dermal application of 7, 12-dimethylbenz[a] anthracene is not reduced by diet restriction. Carcinogenesis, 15(1):129-131.

1993

Brüstle, O; Petersen, I; Radner, H; et al (1993). Complementary tumor induction in neural grafts exposed to N-ethyl-N-nitrosourea and an activated myc gene. Carcinogenesis, 14(8):1715-1718.

Cantoreggi, Sergio; Lutz, Werner K (1993). Covalent binding of styrene to DNA in rat and mouse. Carcinogenesis, 14(3):355-360.

Fischer, Wolfgang H; Beland, Peter E; Lutz, Werner K (1993). DNA adducts, cell proliferation and papilloma latency time in mouse skin after repeated dermal application of DMBA and TPA. Carcinogenesis, 14(7):1285-1288.

Utesch, Dietmar; Traiser, Margarete; Gath, Ingolf; Dorresteijn, Adriaan W C; Maier, Peter; Oesch, Franz (1993). Effects of sodium butyrate on DNA content, glutathione S-transferase activities, cell morphology and growth characteristics of rat liver nonparenchymal epithelial cells in vitro. Carcinogenesis, 14(3):457-462.

Petersen, Iver; Ohgaki, Hiroko; Ludeke, Barbara I; Kleihues, Paul (1993). p53 mutations in phenacetin-associated human urothelial carcinomas. Carcinogenesis, 14(10):2119-2122.

1992

Grammatico, P; Modesti, A; Steindl, Katharina; Scarpa, S; Heouaine, A; Picardo, M; Del Porto, G (1992). Lentigo maligna. Cytogenetic, ultrastructural, and phenotypic characterization of a primary cell culture. Cancer Genetics and Cytogenetics, 60(2):141-146.

Lutz, Werner K; Schlatter, Josef (1992). Chemical carcinogens and overnutrition in diet-related cancer. Carcinogenesis, 13(12):2211-2216.

Yamada, Y; Weller, R O; Kleihues, P; Ludeke, B I (1992). Effects of ethanol and various alcoholic beverages on the formation of O6-methyldeoxyguanosine from concurrently administered N-nitrosomethylbenzylamine in rats: a dose-response study. Carcinogenesis, 13(7):1171-1175.

Cantoreggi, S; Lutz, W K (1992). Investigation of the covalent binding of styrene-7,8-oxide to DNA in rat and mouse. Carcinogenesis, 13(2):193-197.

Ludeke, Barbara I; Dominé, Frédéric; Ohgaki, Hiroko; Kleihues, Paul (1992). Modulation of N-nitrosomethylbenzylamine bioactivation by diallyl sulfide in vivo. Carcinogenesis, 13(12):2467-2470.

Rümmelein, Bettina; Eloo, Ulrike; Bielfeld, Volker; Ehlert, Ulrike; Weichenthal, Michael; Breitbart, Eckhard W; Rüdiger, Hugo W (1992). Fibroblast cultures of patients with basal cell epithelioma exhibit a normal sensitivity to the genotoxic effect of ultraviolet irradiation. Cancer Genetics and Cytogenetics, 61(1):74-76.

Rümmelein, Bettina; Drieschner, Oliver; Ehlert, Ulrike; Weichenthal, Michael; Breitbart, Eckhard W; Rüdiger, Hugo W (1992). Increased mutagen sensitivity in human cultured fibroblasts with constitutively high micronucleus levels. Cancer Genetics and Cytogenetics, 58(2):186-190.

Schwendener, R A; Schott, H (1992). Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine. International Journal of Cancer, 51(3):466-469.

1991

von Hofe, Eric; Schmerold, Ivo; Nims, Raymond W; Keefer, Larry K; Reist, Elmer J; Kleihues, Paul (1991). β-Deuteration of N-nitrosoethylmethylamine causes a shift in DNA methylation from rat liver to esophagus. Carcinogenesis, 12(4):545-549.

Schwendener, Reto A; Fiebig, H H; Berger, M R; Berger, D P (1991). Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy. Cancer Chemotherapy and Pharmacology, 27(6):429-439.

Knees-Matzen, Susanne; Roser, Marianne; Reimers, Uta; Ehlert, Ulrike; Weichenthal, Michael; Breitbart, Eckhard W; Rüdiger, Hugo W (1991). Increased UV-induced sister-chromatid exchange in cultured fibroblasts of first-degree relatives of melanoma patients. Cancer Genetics and Cytogenetics, 53(2):265-270.

1990

Dirsch, O R; Koenigsmann, M; Ludeke, B I; Scherer, E; Kleihues, P (1990). Bioactivation of N-nitrosomethylbenzylamine and N-nitrosomethyl-amylamine in oesophageal papillomas. Carcinogenesis, 11(9):1583-1586.

Lutz, Werner K (1990). Dose-response relationship and low dose extrapolatioin in chemical carcinogenesis. Carcinogenesis, 11(8):1243-1247.

Buss, P; Caviezel, M; Lutz, W K (1990). Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1. Carcinogenesis, 11(12):2133-2135.

Mathis, Georg; Althaus, Felix R (1990). Uncoupling of DNA excision repair and nucleosomal unfolding in poly (ADP-ribose)-depleted mammalian cells. Carcinogenesis, 11(7):1237-1239.

1989

Alldrick, A J; Lutz, W K (1989). Covalent binding of [2-14C]2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) to mouse DNA in vivo. Carcinogenesis, 10(8):1419-1423.

Hegi, Monika E; Sagelsdorff, Peter; Lutz, Werner K (1989). Detection by 32P-postlabeling of thymidine glycol in γ-irradiated DNA. Carcinogenesis, 10(1):43-47.

Oesch, F; Arand, Michael (1989). Molecular aspects of carcinogenesis. Part B. Journal of Cancer Research and Clinical Oncology, 115(6):606-607.

1988

Kobori, Oichiro; Schmerold, Ivo; Ludeke, Barbara; Ohgaki, Hiroko; Kleihues, Paul (1988). DNA methylation in rat stomach and duodenum following chronic exposure to N-methyl-N′-nitro-N-nitrosoguanidine and the effect of dietary taurocholate. Carcinogenesis, 9(12):2271-2274.

Ludeke, Barbara I; Kleihues, Paul (1988). Formation and persistence of O6-(2-hydroxyethyl)-2′-deoxyguanosine in DNA of various rat tissues following a single dose of N-nitroso-N-(2-hydroxyethyl)urea. An immuno-slot-blot study. Carcinogenesis, 9(1):147-151.

Maier, P; Schawalder, H P (1988). Hepatocarcinogens induce gene mutations in rats in fibroblast-like cells from a subcutaneous granulation tissue. Carcinogenesis, 9(8):1363-1368.

1987

von Hofe, Eric; Schmerold, Ivo; Lijinsky, William; Jeltsch, Willy; Kleihues, Paul (1987). DNA methylation in rat tissues by a series of homologous aliphatic nitrosamines ranging from N-nitrosodimethylamine to N-nitrosomethyldodecylamine. Carcinogenesis, 8(9):1337-1341.

Büsser, Marie-Therese; Lutz, Werner K (1987). Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters. Carcinogenesis, 8(10):1433-1437.

1986

von Hofe, Eric; Kleihues, Paul; Keefer, Larry K (1986). Extent of DNA 2-hydroxyethylation by N-nitrosomethylethylamine and N-nitrosodiethylamine in vivo. Carcinogenesis, 7(8):1335-1337.

1984

Huber, Kurt W; Lutz, Werner K (1984). Methylation of DNA by incubation with methylamine and nitrite. Carcinogenesis, 5(3):403-406.

Huber, K W; Lutz, W K (1984). Methylation of DNA in stomach and small intestine of rats after oral administration of methylamine and nitrite. Carcinogenesis, 5(12):1729-1732.

1983

Sagelsdorff, Peter; Lutz, Werner K; Schlatter, Christian (1983). The relevance of covalent binding to mouse liver DNA to the carcinogenic action of hexachlorocyclohexane isomers. Carcinogenesis, 4(10):1267-1273.

1977

Keller, R (1977). Abrogation of antitumor effects of corynebacterium parvum and BCG by antimacrophage agents: brief communication. Journal of the National Cancer Institute, 59(6):1751-1753.

1976

Keller, R (1976). Promotion of tumor growth in vivo by antimacrophage agents. Journal of the National Cancer Institute, 57(6):1355-1361.

Keller, R (1976). Susceptibility of Normal and Transformed Cell Lines to Cytostatic and Cytocidal Effects Exerted by Macrophages. Journal of the National Cancer Institute, 56(2):369-374.

1974

Pierpaoli, W; Haran-Ghera, N; Bianchi, E; Müller, J; Meshorer, A; Bree, M (1974). Endocrine Disorders as a Contributory Factor to Neoplasia in SJL/J Mice2. Journal of the National Cancer Institute, 53(3):731-744.

1966

Haemmerli, Gisela; Fjelde, Audrey; Zweidler, Alfred; Sträuli, Peter (1966). Heterologous Transplantation, Chromosome Analyses, and DNA Measurements of the Human Carcinoma Tissue Culture Line, H.Ep. #22. Journal of the National Cancer Institute, 36(4):673-683.

This list was generated on Sat Jul 19 00:10:06 2025 CEST.